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Preface
About AICPA Audit and Accounting Guides
This AICPA Audit and Accounting Guide has been developed by the AICPA
Health Care Committee and the AICPA Health Care Audit and Accounting
Guide Overhaul Task Force to assist management in the preparation of their
financial statements in conformity with U.S. generally accepted accounting
principles (GAAP) and to assist auditors in auditing and reporting on such
financial statements.
The financial and reporting guidance contained in this guide was approved by
the affirmative vote of at least two-thirds of the members of the Accounting
Standards Executive Committee, now the Financial Reporting Executive Committee (FinREC). FinREC is the senior technical body of the AICPA authorized
to speak for the AICPA in the areas of financial accounting and reporting. This
guide does the following:

r
r

r
r

Identifies certain requirements set forth in Financial Accounting
Standards Board (FASB) Accounting Standards Codification™
(ASC).
Describes FinREC's understanding of prevalent or sole industry
practice concerning certain issues. In addition, this guide may
indicate that FinREC expresses a preference for the prevalent or
sole industry practice, or it may indicate that FinREC expresses
a preference for another practice that is not the prevalent or sole
industry practice; alternatively, FinREC may express no view on
the matter.
Identifies certain other, but not necessarily all, industry practices concerning certain accounting issues without expressing
FinREC's views on them.
Provides guidance that has been supported by FinREC on the
accounting, reporting, or disclosure treatment of transactions or
events that are not set forth in FASB ASC.

Accounting guidance for nongovernmental entities included in an AICPA Audit
and Accounting Guide is a source of nonauthoritative accounting guidance. As
discussed later in this preface, FASB ASC is the authoritative source of U.S.
accounting and reporting standards for nongovernmental entities, in addition
to guidance issued by the Securities and Exchange Commission (SEC) for public
entities.
Accounting guidance for governmental entities included in an AICPA Audit and
Accounting Guide is a source of authoritative accounting guidance, as described
in category (b) of the hierarchy of GAAP for state and local governmental entities. This guide has been cleared by the Governmental Accounting Standards
Board (GASB). AICPA members should be prepared to justify departures from
GAAP, as discussed in Rule 203, Accounting Principles (AICPA, Professional
Standards, ET sec. 203 par. .01).
Auditing guidance included in an AICPA Audit and Accounting Guide is recognized as an interpretive publication, pursuant to AU section 150, Generally Accepted Auditing Standards (AICPA, Professional Standards). Interpretive publications are recommendations on the application of Statements on Auditing
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Standards (SASs) in specific circumstances, including engagements for entities in specialized industries. An interpretive publication is issued under the
authority of the Auditing Standards Board (ASB) after all ASB members have
been provided an opportunity to consider and comment on whether the proposed interpretive publication is consistent with the SASs. The members of the
ASB have found this guide to be consistent with existing SASs.
The auditor should be aware of and consider interpretive publications applicable to his or her audit. If an auditor does not apply the auditing guidance
included in an applicable interpretive publication, the auditor should be prepared to explain how he or she complied with the SAS provisions addressed by
such auditing guidance.
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Guidance Considered in This Edition
Authoritative guidance issued through July 1, 2011, has been considered in
the development of this edition of the guide. Authoritative guidance discussed
in the text of the guide (as differentiated from the temporary footnotes, which
are denoted by a symbol rather than a number) is effective for entities with
fiscal years ending on or before July 1, 2011. Authoritative guidance discussed
only in temporary footnotes is not yet effective as of July 1, 2011, for entities
with fiscal years ending after that same date. However, chapter 15, "Unique
Considerations of State and Local Government Health Care Entities," of this
guide has been updated to reflect the issuance of GASB Statement No. 62,
Codification of Accounting and Financial Reporting Guidance Contained in
Pre-November 30, 1989 FASB and AICPA Pronouncements, as discussed later
in this preface.
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This includes relevant guidance issued up to and including the following:

r
r
r
r
r
r
r
r
r
r

FASB Accounting Standards Update (ASU) No. 2011-07, Health
Care Entities (Topic 954): Presentation and Disclosure of Patient
Service Revenue, Provisions for Bad Debts, and the Allowance for
Doubtful Accounts for Certain Health Care Entities (a consensus
of the FASB Emerging Issues Task Force)
GASB Statements, Interpretations, and Technical Bulletins issued through July 1, 2011
GASB Comprehensive Implementation Guide 2010 as of June 30,
2010
SAS No. 120, Required Supplementary Information (AICPA, Professional Standards, AU sec. 558)
Interpretation No. 19, "Financial Statements Prepared in Conformity With International Financial Reporting Standards as Issued
by the International Accounting Standards Board," of AU section
508, Reports on Audited Financial Statements (AICPA, Professional Standards, AU sec. 9508 par. .93–.97)
Revised interpretations issued through July 1, 2011, including Interpretation Nos. 1–4 of AU section 325, Communicating Internal
Control Related Matters Identified in an Audit (AICPA, Professional Standards, AU sec. 9325 par. .01–.13)
Statement of Position (SOP) 09-1, Performing Agreed-Upon Procedures Engagements That Address the Completeness, Accuracy,
or Consistency of XBRL-Tagged Data (AICPA, Technical Practice
Aids, AUD sec. 14,440)
Statement on Standards for Attestation Engagements No. 16, Reporting on Controls at a Service Organization (AICPA, Professional Standards, AT sec. 801)
Interpretation No. 7, "Reporting on the Design of Internal Control," of AT section 101, Attest Engagements (AICPA, Professional
Standards, AT sec. 9101 par. .59–.69)
Public Company Accounting Oversight Board (PCAOB) Auditing
Standard No. 15, Audit Evidence (AICPA, PCAOB Standards and
Related Rules, Auditing Standards)

Users of this guide should consider guidance issued subsequent to those items
in the preceding list to determine its effect on entities covered by this guide.
In determining the applicability of recently-issued guidance, its effective date
should also be considered.
Users may be able to obtain information about such subsequent pronouncements on FASB's website at www.fasb.org, GASB's website at www.gasb.org,
and the AICPA's website at www.aicpa.org. In addition, the AICPA's annual
Audit Risk Alert Health Care Industry Developments summarizes the provisions of selected pronouncements.

Applicability of U.S. Generally Accepted Auditing
Standards and PCAOB Standards
Audits of the financial statements of nonissuers (those entities not subject
to the Sarbanes-Oxley Act of 2002 or the rules of the SEC—that is, private
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entities, generally speaking) are conducted in accordance with U.S. generally
accepted auditing standards (GAAS), as issued by the ASB, the senior technical
committee of the AICPA with the authority to promulgate auditing standards
for nonissuers. The ASB develops and issues standards in the form of SASs
through a due process that includes deliberation in meetings open to the public,
public exposure of proposed SASs, and a formal vote. The SASs and their related
interpretations are codified in the AICPA's Professional Standards. Paragraph
.03 of AU section 150 establishes that an AICPA member's failure to follow
ASB standards for audits of nonissuers is a violation of Rule 202, Compliance
With Standards (AICPA, Professional Standards, ET sec. 202 par. .01).
Audits of the financial statements of issuers, as defined by the SEC (those
entities subject to the Sarbanes-Oxley Act of 2002 or the rules of the SEC—
that is, public entities, generally speaking), are conducted in accordance with
standards established by the PCAOB, a private sector, nonprofit corporation
created by the Sarbanes-Oxley Act of 2002 to oversee the audits of issuers. The
SEC has oversight authority over the PCAOB, including the approval of its
rules, standards, and budget.
For audits of a nonissuer, in accordance with both GAAS and PCAOB standards, Interpretation No. 18, "Reference to PCAOB Standards in an Audit
Report on a Nonissuer," of AU section 508 (AICPA, Professional Standards,
AU sec. 9508 par. .89–.92), provides reporting guidance applicable to such engagements.

References to Professional Standards
In citing GAAS and their related interpretations, references use section numbers within the codification of currently effective SASs, not the original statement number, as appropriate. For example, SAS No. 54, Illegal Acts by Clients
(AICPA, Professional Standards), is referred to as AU section 317, Illegal Acts
by Clients (AICPA, Professional Standards). In those sections of the guides
that refer to specific auditing standards of the PCAOB, references are made to
the AICPA's PCAOB Standards and Related Rules publication. This edition includes SOP 99-1, Guidance to Practitioners in Conducting and Reporting on an
Agreed-Upon Procedures Engagement to Assist Management in Evaluating the
Effectiveness of Its Corporate Compliance Program (AICPA, Technical Practice
Aids, AUD sec. 14,350), as appendix A, "Statement of Position 99-1, Guidance
to Practitioners in Conducting and Reporting on an Agreed-Upon Procedures
Engagement to Assist Management in Evaluating the Effectiveness of Its Corporate Compliance Program," and SOP 00-1, Auditing Health Care Third-Party
Revenues and Related Receivables (AICPA, Technical Practice Aids, AUD sec.
14,360), as appendix B, "Statement of Position 00-1, Auditing Health Care
Third-Party Revenues and Related Receivables." In using this guide, readers
should refer to the material in these SOPs.

FASB ASC
Overview
Released on July 1, 2009, FASB ASC is a major restructuring of accounting and reporting standards designed to simplify user access to all authoritative U.S. GAAP by topically organizing the authoritative literature. FASB
ASC disassembled and reassembled thousands of nongovernmental accounting
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pronouncements, including those of the FASB Emerging Issues Task Force and
the AICPA, to organize them under approximately 90 topics.
FASB ASC also includes relevant portions of authoritative content issued by
the SEC, as well as selected SEC staff interpretations, and administrative
guidance issued by the SEC; however, FASB ASC is not the official source
of SEC guidance and does not contain the entire population of SEC rules,
regulations, interpretive releases, and staff guidance. Moreover, FASB ASC
does not include governmental accounting standards.
FASB published a notice to constituents (NTC) that explains the scope,
structure, and usage of consistent terminology of FASB ASC. Constituents
are encouraged to read this NTC because it answers many common questions about FASB ASC. FASB ASC and its related NTC can be accessed at
http://asc.fasb.org/home and are also offered by certain third-party licensees,
including the AICPA. FASB ASC is offered by FASB at no charge in a Basic
View and for an annual fee in a Professional View.

Issuance of Amendments to FASB ASC
FASB ASC is amended through ASUs, which serve only to update FASB ASC.
FASB does not consider the ASUs authoritative in their own right; such amendments become authoritative when they are incorporated into FASB ASC.
The ASUs issued are in the form of "ASU No. 20YY-XX," in which "YY" is the
last two digits of the year and "XX" is the sequential number for each update.
For example, ASU No. 2011-01 is the first update in calendar year 2011. The
ASUs will include the amendments to FASB ASC and an appendix of FASB
ASC update instructions. ASUs also provide background information about the
amendments and explain the basis for FASB's decisions.

Pending Content in FASB ASC
Amendments to FASB ASC issued in the form of ASUs that are not fully
effective for all entities or transactions within their scope or that became effective within the last six months are reflected as "Pending Content" in FASB
ASC. This pending content is shown in text boxes below the paragraphs being
amended in FASB ASC and includes links to the transition information. The
pending content boxes are meant to provide users with information about how
a paragraph will change when new guidance becomes authoritative. After an
amended paragraph has been fully effective for six months, the outdated guidance will be removed, and the amended paragraph will remain without the
pending content box. FASB will keep any outdated guidance in the applicable
archive section of FASB ASC for historical purposes.
Because not all entities have the same fiscal year-ends, and certain guidance
may be effective on different dates for public and nonpublic entities, the pending
content will apply to different entities at different times. As such, pending
content will remain in place within FASB ASC until the roll-off date. Generally,
the roll-off date is six months following the latest fiscal year-end for which the
original guidance being amended or superseded by the pending content could
be applied, as specified by the transition guidance. For example, assume an
ASU has an effective date for fiscal years beginning after November 15, 2010.
The latest possible fiscal year-end of an entity still eligible to apply the original
guidance being amended or superseded by the pending content would begin
November 15, 2010, and end November 14, 2011. Accordingly, the roll-off date
would be May 14, 2012.
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Entities cannot disregard the pending content boxes in FASB ASC. Instead, all
entities must review the transition guidance to determine when the pending
content is applicable to them. This guide identifies pending content, when
applicable. As explained in the "Guidance Considered in This Edition" section,
pending content discussed in the text of the guide (as differentiated from the
temporary footnotes, which are denoted by a symbol rather than a number) is
effective for entities with fiscal years ending on or before July 1, 2011. Pending
content discussed only in temporary footnotes is not yet effective as of July 1,
2011, for entities with fiscal years ending after that same date.

Limitations and Relationships to Other
Authoritative Literature
This guide does not discuss the application of all GAAP and GAAS that are
relevant to the preparation and audit of financial statements of health care
entities. The guide is directed primarily to those aspects of the preparation and
audit of health care entities' financial statements that may be unique to those
entities or that are considered particularly significant to them.
This guide incorporates certain provisions of FASB ASC 954, Health Care
Entities; FASB ASC 958, Not-for-Profit Entities; GASB Statement No. 33, Accounting and Financial Reporting for Nonexchange Transactions, as amended;
and GASB Statement No. 34, Basic Financial Statements—and Management's
Discussion and Analysis—for State and Local Governments, as well as other
authoritative accounting and auditing literature. Not all guidance included
in that literature, however, is incorporated, repeated, or summarized in this
guide. Accordingly, FASB ASC, GASB statements and interpretations, AICPA
Professional Standards, and all authoritative guidance should be read in conjunction with this guide.
This guide is not the only industry-specific AICPA Audit and Accounting Guide
that auditors should consider when performing an audit of a governmental
health care entity. The Audit and Accounting Guide State and Local Governments includes governmental health care entities in its scope and was cleared
by GASB. Therefore, certain accounting and financial reporting guidance in
that guide constitutes category (b) of the hierarchy of GAAP for governmental health care entities. The auditing guidance in that guide should also be
considered during an audit of a governmental health care entity that is included in the scope of this guide. In practice, auditors of governmental health
care entities that issue separate financial statements as special-purpose governments engaged only in business-type activities1 may use this guide as the
primary source of guidance because this guide addresses transactions that are
unique to, or prevalent in, the health care industry. However, the Audit and
Accounting Guide State and Local Governments contains information about
1
Governmental Accounting Standards Board (GASB) Statement No. 34, Basic Financial
Statements—and Management's Discussion and Analysis—for State and Local Governments, does not
provide guidance on separate reporting by individual enterprise funds of a government. Although this
discussion of the guidance in GASB Statement No. 34 is written in terms of special-purpose businesstype activities that are governmental health care entities, the accounting, financial reporting, and
auditing considerations are usually equally applicable when the health care activity is conducted as a
function or program of a general-purpose government and reported in an enterprise fund (see footnote
7 in chapter 12, "Special Purpose and State Governments," of the Audit and Accounting Guide State
and Local Governments). Reporting guidance on separate reporting by individual enterprise funds of
a government is provided in the Audit and Accounting Guide State and Local Governments.
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governmental accounting and financial reporting standards and other matters
that are unique to, or prevalent in, government and not included in this guide.2
Special-purpose governments are legally separate entities, as that term is described in paragraph 15 of GASB Statement No. 14, The Financial Reporting
Entity. They may be component units of another governmental entity, or they
may be other stand-alone governments (component units and other stand-alone
governments are also defined in GASB Statement No. 14.). Because GASB
Statement No. 34 is written from the perspective of general-purpose governments, paragraph 138 of GASB Statement No. 34 discusses how those requirements apply to special-purpose governments engaged only in business-type
activities, such as certain governmental health care entities. Governmental
health care entities that are special-purpose governments engaged only in
business-type activities should present only the financial statements required
for enterprise funds. These financial statements are discussed further in chapter 15 of this guide.
Office of Management and Budget (OMB) Circular A-133, Audits of States, Local Governments and Non-Profit Organizations, sets forth audit requirements
for health care entities expending federal awards. Institutions covered by OMB
Circular A-133 include not-for-profit hospitals, public hospitals, institutions of
higher education and their affiliated hospitals, voluntary health and welfare
entities, and other community-based organizations.3 Auditors of health care entities who perform audits under Government Auditing Standards, the Single
Audit Act Amendments of 1996, and OMB Circular A-133 should also refer to
the Audit Guide Government Auditing Standards and Circular A-133 Audits.

New AICPA.org Website
The AICPA encourages you to visit its new website at www.aicpa.org. The website was launched in 2010 and provides significantly enhanced functionality
and content critical to the success of AICPA members and other constituents.
Certain content on the AICPA's website referenced in this guide may be restricted to AICPA members only.

Select Recent Developments Significant to This Guide
GASB Statement No. 62
In December 2010, GASB issued GASB Statement No. 62, which directly incorporates into GASB's authoritative literature certain pronouncements issued
by FASB and its predecessors on or before November 30, 1989. FASB statements and interpretations, Accounting Principles Board Opinions, Accounting
Research Bulletins of the AICPA Committee on Accounting Procedure, and
AICPA accounting interpretations issued on or before November 30, 1989, have
2
See paragraphs 1.21 and 12.11–.13 of the Audit and Accounting Guide State and Local Governments.
3
Office of Management and Budget (OMB) Circular A-133, Audits of States, Local Governments
and Non-Profit Organizations, also includes audit requirements for commercial organizations, including for-profit hospitals, that receive federal awards under Department of Health & Human Services
programs. Generally, the organization has two options regarding audits: a financial-related audit of
a particular award, in accordance with Government Auditing Standards, or an audit that meets the
requirements of OMB Circular A-133. See Title 45, Public Welfare, U.S. Code of Federal Regulations
Part 74.26(d) for further information.
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been included in GASB Statement No. 62 to the extent that they do not conflict
with or contradict GASB pronouncements. In that manner, GASB Statement
No. 62 eliminates the need for financial statement preparers and auditors to
determine which FASB and AICPA pronouncement provisions apply to state
and local governments. When the guidance from the pre-November 30, 1989,
pronouncements was included as part of GASB Statement No. 62, it was modified as necessary to appropriately recognize the governmental environment
and needs of governmental financial statement users.
In addition, GASB Statement No. 62 supersedes GASB Statement No. 20,
Accounting and Financial Reporting for Proprietary Funds and Other Governmental Entities That Use Proprietary Fund Accounting, thereby eliminating
the election provided in paragraph 7 of that statement. That election permitted enterprise funds and business-type activities to apply post-November 30,
1989, FASB Statements and Interpretations that do not conflict with or contradict GASB pronouncements on an-all-or none basis. However, those entities
can continue to apply post-November 30, 1989, FASB pronouncements as other
accounting literature, provided that those prouncements do not conflict with or
contradict GASB pronouncements, including GASB Statement No. 62.
The requirements of GASB Statement No. 62 are effective for financial statements for periods beginning after December 15, 2011. Although GASB Statement No. 62 is not effective immediately, GASB encourages early implementation, given that GASB does not anticipate that this standard will lead to
substantial changes in practice. When governmental health care entities implement the provisions of GASB Statement No. 62, they will need to remove
general or specific references, or both, to FASB and AICPA pronouncements
issued on or before November 30, 1989, from the financial statements and notes
thereto.
This guide reflects the issuance of GASB Statement No. 62 by including references to paragraphs in that statement, rather than the FASB and AICPA
pronouncements that it codifies. To assist preparers and auditors in the transition, appendix A, "Cross-Reference Table for Predecessor Guidance," of chapter 15 provides cross-references to the predecessor pronouncements for all
paragraphs from GASB Statement No. 62 that are included in chapter 15.
Appendix B, "Interim Guidance for Entities That Elect Paragraph 7 of Governmental Accounting Standards Board Statement No. 20," of chapter 15 provides interim guidance for entities that elect paragraph 7 of GASB Statement
No. 20 and have not yet implemented GASB Statement No. 62. In addition
to helping identify which FASB statements and interpretations may be applied as other accounting literature, appendix B will compensate for the fact
that upon the effective date of GASB Statement No. 62, GASB intends to
remove from its website its chart that provides nonauthoritative guidance regarding the applicability of post-November 30, 1989, FASB pronouncements
(www.gasb.org/jsp/GASB/Page/GASBSectionPage&cid=1175804837176).
As described in paragraphs 521–523 of the nonauthoritative basis for conclusions of GASB Statement No. 62, GASB excluded certain FASB and AICPA
pronouncements from codification because those pronouncements conflict with
or contradict GASB pronouncements in their entirety. As described in paragraphs 524–525, other FASB and AICPA pronouncements were omitted from
codification because they rarely apply to state and local governments. Readers
of this guide can find more information regarding GASB Statement No. 62 at
www.gasb.org.
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Summary of Significant Differences Between the PCAOB
and AICPA Risk Assessment Standards
On August 5, 2010, the PCAOB issued Release No. 2010-004, Auditing Standards Related to the Auditor's Assessment of and Response to Risk and Related
Amendments to PCAOB Standards (AICPA, PCAOB Standards and Related
Rules, Select PCAOB Releases). This release includes eight auditing standards
(collectively referred to as the PCAOB risk assessment standards), as adopted
by the PCAOB. The eight standards, which were approved by the SEC on
December 23, 2010, are as follows:
1. Auditing Standard No. 8, Audit Risk
2. Auditing Standard No. 9, Audit Planning
3. Auditing Standard No. 10, Supervision of the Audit Engagement
4. Auditing Standard No. 11, Consideration of Materiality in Planning
and Performing an Audit
5. Auditing Standard No. 12, Identifying and Assessing Risks of Material Misstatement
6. Auditing Standard No. 13, The Auditor's Responses to the Risks of
Material Misstatement
7. Auditing Standard No. 14, Evaluating Audit Results
8. Auditing Standard No. 15
The release also includes conforming amendments to other interim standards
related to the PCAOB risk assessment standards. The effective date of the
PCAOB risk assessment standards is for audits of financial statements of issuers with fiscal periods beginning on or after December 15, 2010.
In general, the PCAOB risk assessment standards are consistent with the
AICPA SASs related to risk assessment (the AICPA risk assessment standards). When differences exist, they are due to the PCAOB
a. addressing audits of financial statements in conjunction with audits of effectiveness of internal control (often referred to as integrated audits). The AICPA risk assessment standards only address
audits of financial statements.
b. presenting content in standards different than the AICPA risk assessment standards. For example, the PCAOB
i. incorporated fraud risk assessment procedures into the
PCAOB risk assessment standards.
ii. created Auditing Standard No. 10 to separately address
supervision of the audit engagement.
iii. created Auditing Standard No. 14 to separately address
the evaluation of audit results.
iv. moved content related to other audit areas, such as analytical review procedures and audits of group financial
statements.
The PCAOB risk assessment standards are not as voluminous as the AICPA
risk assessment standards because the PCAOB risk assessment standards
do not contain as much application guidance as the AICPA risk assessment
standards. Appendix 11 of the release contains a more detailed comparison
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of the differences between the PCAOB risk assessment standards and AICPA
risk assessment standards.

ASB Clarity Project
To address concerns over the clarity, length, and complexity of its standards,
the ASB has made a significant effort to clarify the SAS. In order to address
practice issues timely, SAS Nos. 117–120 have already been issued in the
clarity format and are already effective. The majority of the clarified standards
will be issued as one SAS, SAS No. 122. SAS No. 122 will contain 39 clarified
SASs and will recodify and supersede all outstanding SASs through No. 121
except

r
r
r
r
r

SAS No. 51, Reporting on Financial Statements Prepared for Use
in Other Countries
SAS No. 59, The Auditor's Consideration of an Entity's Ability to
Continue as a Going Concern, as amended
SAS No. 65, The Auditor's Consideration of the Internal Audit
Function in an Audit of Financial Statements
SAS No. 87, Restricting the Use of an Auditor's Report
SAS Nos. 117–120

SAS No. 122 will also withdraw SAS No. 26, Association With Financial Statements, as amended.
This statement will initially be codified in Professional Standards as "AU-C"
section numbers instead of "AU" section numbers and includes AU-C section
numbers in its original release.
"AU-C" is a temporary identifier to avoid confusion with references to existing
"AU" sections, which remain effective through 2013, in AICPA Professional
Standards. The "AU-C" identifier will revert to "AU" in 2014, by which time
this statement becomes fully effective for all engagements.
SAS No. 122 will be effective for audits of financial statements for periods
ending on or after December 15, 2012. Refer to individual AU-C sections for
specific effective date language.
The ASB established clarity drafting conventions and undertook to redraft all
of its SASs in accordance with those conventions, which include the following:

r
r
r
r
r
r

Establishing objectives for each clarified SAS
Including a definitions section, where relevant, in each clarified
SAS
Separating requirements from application and other explanatory
material
Numbering application and other explanatory material paragraphs using an A- prefix and presenting them in a separate
section that follows the requirements section
Using formatting techniques, such as bulleted lists, to enhance
readability
Including, when appropriate, special considerations relevant to
audits of smaller, less complex entities within the text of the clarified SAS
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r

Including, when appropriate, special considerations relevant to
audits of governmental entities within the text of the clarified
SAS

The project also has an international convergence component. AU-C section
numbers for clarified SASs based on equivalent International Standards on
Auditing (ISAs) are the same as the equivalent ISA numbers. AU-C section
numbers for clarified SASs with no equivalent ISAs have been assigned new
numbers. The ASB believes that this recodification structure will aid firms and
practitioners that use both ISAs and GAAS.
Consistent with the ASB's strategy to converge its SASs with ISAs promulgated
by the International Auditing and Assurance Standard Board while avoiding
unnecessary conflict with standards of the PCAOB, clarified SASs have been
developed using equivalent ISAs as a base, when applicable. Substantive differences in objectives, definitions, or requirements between a clarified SAS and
the equivalent ISA are identified in an exhibit to each applicable clarified SAS.

International Financial Reporting Standards
International Financial Reporting Standards (IFRSs) consist of accounting
standards and interpretations developed and issued by the International Accounting Standards Board (IASB), a London-based, independent accounting
standard-setting body. The IASB began operations in 2001 when it succeeded
the International Accounting Standards Committee (IASC). The IASC was
formed in 1973, soon after the formation of FASB. In 2001, when the IASB replaced the IASC, a new, independent oversight body—the IASC Foundation—
was created to appoint the members of the IASB and oversee its due process.
The IASC Foundation's oversight role is very similar to that of the Financial
Accounting Foundation (FAF) in its capacity as the oversight body of FASB.
The term IFRSs has both a narrow and broad meaning. Narrowly, IFRSs refer to the new numbered series of pronouncements issued by the IASB, as
differentiated from International Accounting Standards (IASs) issued by its
predecessor, the IASC. More broadly, however, IFRSs refer to the entire body
of authoritative IASB pronouncements, including those issued by the IASC
and their respective interpretive bodies. Therefore, the authoritative IFRSs
literature, in its broadest sense, includes the following:

r
r

r

Standards, whether labeled IFRSs or IASs
Interpretations of the International Financial Reporting Interpretations Committee (IFRIC); interpretations issued by the IFRS Interpretations Committee, the interpretive body of the IASC Foundation; or interpretations of the Standing Interpretations Committee, the predecessor to IFRIC and former interpretive body of
the IASC
IFRS framework

As of March 31, 2010, IFRIC formally changed its name to the IFRS Interpretations Committee, and on July 1, 2010, the IASC Foundation formally changed
its name to the IFRS Foundation.
The preface to the IFRS 2010 bound volume states that IFRSs are designed to
apply to the general-purpose financial statements and other financial reporting
of all profit-oriented entities, including commercial, industrial, and financial
entities, regardless of legal form or organization. Included within the scope
of profit-oriented entities are mutual insurance companies and other mutual
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cooperative entities providing dividends or other economic benefits to their
owners, members, or participants.
IFRSs are not designed to apply to not-for-profit entities or those in the public
sector, but these entities may find IFRSs appropriate in accounting for their
activities. In contrast, U.S. GAAP is designed to apply to all nongovernmental
entities, including not-for-profit entities, and includes specific guidance for notfor-profit entities, development stage entities, limited liability entities, and
personal financial statements.
The AICPA governing council voted in May 2008 to recognize the IASB as an
accounting body for purposes of establishing international financial accounting
and reporting principles. This amendment to appendix A of Rules 202 and 203
gives AICPA members the option to use IFRSs as an alternative to U.S. GAAP.
As a result, private entities in the United States can prepare their financial
statements in accordance with U.S. GAAP, as promulgated by FASB; an other
comprehensive basis of accounting, such as cash or tax-basis; or IFRSs, among
others. However, domestic issuers are currently required to follow U.S. GAAP
and rules and regulations of the SEC. In contrast, foreign private issuers may
present their financial statements in accordance with IFRSs, as issued by the
IASB, without a reconciliation to U.S. GAAP or in accordance with non-IFRS
home-country GAAP reconciled to U.S. GAAP, as permitted by Form 20-F.
The growing acceptance of IFRSs as a basis for U.S. financial reporting could
represent a fundamental change for the U.S. accounting profession. Acceptance
of a single set of high quality accounting standards for worldwide use by public
companies has been gaining momentum around the globe for the past few
years.

Blue Ribbon Panel on Private Company Financial Reporting
The Blue Ribbon Panel on Private Company Financial Reporting was established in December 2009 and is sponsored by the AICPA, FAF, and the National
Association of State Boards of Accountancy. This panel was formed to consider
how U.S. accounting standards can best meet the needs of users of private
company financial statements. Members of the panel represent a cross-section
of financial reporting constituencies, including lenders, investors, owners, preparers, and auditors.
In late 2010, the Blue Ribbon Panel voted to recommend that FAF accept a new
standard-setting model for private companies and the creation of a separate
board to set those standards. Work is continuing related to changes being
considered for private company financial reporting. For more information, visit
www.accountingfoundation.org/home.
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Chapter 1

Overview and Unique Considerations
of Health Care Entities
Purpose
1.01 This guide has been prepared to assist health care entities1 in preparing financial statements in conformity with generally accepted accounting principles in the United States of America and to assist independent auditors in
auditing and reporting on those financial statements. This guide focuses on
accounting and auditing issues that are pervasive in, or unique to, health care
entities.

Applicability
1.02 This guide applies to the following types of health care entities:

r
r
r

Investor-owned businesses.
Not-for-profit entities that have no ownership interest and are essentially self-sustaining from fees charged for goods and services
(the term not-for-profit entity is used as defined in the Financial
Accounting Standards Board [FASB] Accounting Standards Codification [ASC] glossary).
Governmental entities. See paragraph 1.08 and chapter 15,
"Unique Considerations of State and Local Government Health
Care Entities," of this guide for further discussion regarding governmental health care entities.

This guide applies to entities whose principal operations consist of providing
or agreeing to provide health care services and that derive all or almost all
of their revenues from the sale of goods or services; it also applies to entities
whose primary activities are the planning, organization, and oversight of such
entities, such as parent or holding companies of health care entities.
1.03 This guide does not apply to voluntary health and welfare entities, as
defined in the FASB ASC glossary. It also does not apply to not-for-profit entities that are fund-raising foundations, even if those foundations are included in
the consolidated financial statements of a health care entity. Voluntary health
and welfare entities and fund-raising foundations follow the AICPA Audit and
Accounting Guide Not-for-Profit Entities, rather than this guide.
1.04 Thus, this guide applies to the following entities, among others:

r
r

1

Clinics, medical group practices, individual practice associations,
individual practitioners, emergency care providers, laboratories,
surgery centers, imaging centers, and other ambulatory care organizations
Continuing care retirement communities

Refer to the glossary for definitions of certain terms used throughout this guide.
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r
r
r
r
r
r
r
r

Health Care Entities

Drug and alcohol rehabilitation centers and other rehabilitation
facilities
HMOs and similar prepaid health care plans
Home health agencies
Hospice care providers
Hospitals
Institutional facilities that provide skilled nursing, intermediate,
or less-intensive levels of health care
Integrated health care delivery systems that include one or more
of these entities
Providers of durable medical equipment and related medical services

1.05 Some entities may have health care as a component of a larger, more
diversified operation. For example, some senior independent living facilities
are primarily real estate operations with a health care component. The Financial Reporting Executive Committee believes that to the extent such entities
have unique transactions of the type covered by this guide, the recognition
and measurement guidance of this guide would be applicable. Professional
judgment should be exercised in determining the applicability of this guide to
transactions entered into by such entities.
1.06 A health care entity may be part of another entity, such as a medical
school or university, or a subsidiary of a corporation. The recommendations in
this guide apply to the separate financial statements of the health care entity.

Classification of Health Care Entities
1.07 The nature of the entity and its operating structure have a significant effect on the needs of financial statement users. According to paragraph
8 of FASB Concepts Statement No. 4, Objectives of Financial Reporting by
Nonbusiness Organizations
[s]ome organizations have no ownership interests but are essentially
self-sustaining from fees they charge for goods and services. Examples
are those private nonprofit hospitals . . . that may receive relatively
small amounts of contributions and grants but finance their capital
needs largely from the proceeds of debt issues and their operating
needs largely from service charges rather than from private philanthropy or governmental grants. As a result, assessment of amounts,
timing, and uncertainty of cash flows becomes the dominant interest of
their creditors and other resource providers and profitability becomes
an important indicator of performance. Consequently, the objectives
of Concepts Statement No. 1 may be more appropriate for those organizations.
1.08 Health care entities usually can be classified into the following categories on the basis of their operating characteristics:
a. Investor-owned health care entities. According to FASB ASC 95410-05-2, these entities are owned by investors or others with a
private equity interest and provide goods or services with the objective of making a profit.
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b. Not-for-profit business-oriented entities. According to FASB ASC
954-10-05-2, these entities are characterized by no ownership interests and are essentially self-sustaining from fees charged for
goods and services. The fees charged by such entities generally
are intended to help the entity maintain its self-sustaining status,
rather than maximize profits for the owner's benefit. Such entities
often are exempt from federal income taxes and may receive contributions of relatively small amounts from resource providers that
do not expect commensurate or proportionate pecuniary return.
c. Governmental health care entities. These are public corporations
and bodies corporate and politic. Other entities are governmental
entities if they have one or more of the following characteristics:
i. Popular election of officers or appointment or approval
of a controlling majority of the members of the entity's
governing body by officials of one or more state or local
governments
ii. The potential for unilateral dissolution by a government,
with the net assets reverting to a government
iii. The power to enact and enforce a tax levy.
Furthermore, entities are presumed to be governmental if they
have the ability to directly issue (rather than through a state or
municipal authority) debt that pays interest that is exempt from
federal taxation. However, entities possessing only that ability (to
issue tax-exempt debt) and none of the other governmental characteristics may rebut the presumption that they are governmental if
their determination is supported by compelling, relevant evidence.
d. Not-for-profit nonbusiness-oriented entities. According to FASB
ASC 954-10-15-3, these are voluntary health and welfare entities,
as defined in the FASB ASC glossary. Such entities are within the
scope of FASB ASC 958, Not-for-Profit Entities. Additional accounting guidance may be obtained in the AICPA Audit and Accounting
Guide Not-for-Profit Entities, rather than this guide, as discussed
in paragraph 1.03.

Regulatory Environment
1.09 Health care entities operate in a highly regulated environment.
These regulations affect the provider's operations, as well as certain estimates
in the financial statements, such as patient service revenue, third-party payor
settlements, and general and professional liabilities. The Department of Health
& Human Services (HHS) is the government's principal agency for protecting
the health of all Americans and providing essential human services. The following agencies operate under the HHS:

r
r
r
r
r
r

Administration on Aging
Centers for Medicare & Medicaid Services
Food and Drug Administration
Health Resources and Services Administration
National Institutes of Health
Office of Inspector General

AAG-HCO 1.09

4

Health Care Entities

1.10 Other important agencies include the Civil and Criminal Divisions
of the Department of Justice, each state's Office of the Attorney General, Medicaid, and insurance agencies or departments.
1.11 Some significant regulations affecting health care are the following:

r
r
r
r
r
r
r
r

False Claims Act
The antikickback statute of the Medicare and Medicaid Patient
and Program Protection Act of 1987
Stark I, II, and III
Emergency Medical Treatment and Active Labor Act
The Privacy Rule of the Health Insurance Portability and Accountability Act of 1996
Health Information Technology for Economic and Clinical Health
Act enacted as part of the American Recovery and Reinvestment
Act of 2009
Patient Protection and Affordable Care Act
Health Care and Education Reconciliation Act of 2010

Health Care Reform
1.12 In March 2010, Congress passed two pieces of legislation designed
to reform the U.S. health care system. The Patient Protection and Affordable
Care Act was enacted on March 23 and was quickly followed by the Health Care
and Education Reconciliation Act of 2010, which amended several portions of
the first act and added new provisions of its own. One of the goals of the
legislation is to reform the health care delivery system to improve its quality
while lowering its overall cost.
1.13 Much uncertainty exists about how health reform measures will
affect the way health care entities will deliver services to their patients in
the future and how they will be compensated for those services. The general
consensus seems to be that health reform is far-reaching and not yet finalized;
as a result, the ultimate outcome is uncertain. The AICPA has dedicated a
section on its website to health care reform legislation and its implementation;
see www.aicpa.org/Research/HCR/Pages/HealthCareReform.aspx.
1.14 The IRS has issued proposed guidance (IRS Notice 2010-39) for taxexempt hospitals to implement Internal Revenue Code (IRC) Section 501(r),
which was added by health care legislation. IRC Section 501(r) imposes four
new requirements on hospitals that want to qualify for tax exemption under
IRC Section 501(c)(3). Those four requirements are as follows:

r
r
r
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Conduct a community health-needs assessment every 2 years, and
adopt an implementation strategy to meet the community needs
identified through the assessment. Noncompliance carries with it
a $50,000 penalty.
Establish policies for financial assistance and emergency care that
are consistent with IRC Section 501(r)(4).
Limit amounts charged for emergency or other medically necessary care provided to individuals eligible for financial assistance
to the amounts generally charged to individuals with insurance
covering such care.

Overview and Unique Considerations of Health Care Entities

r

5

Forego aggressive collection efforts until the hospital has made
reasonable efforts to determine whether the individual receiving
the services is eligible for financial assistance.

Tax-exempt hospitals must comply with most of the new rules in tax years
beginning after March 23, 2010. Hospitals have two additional years to comply
with the community health-needs assessment requirement, which takes effect
for tax years beginning after March 23, 2012. Tax-exempt hospitals will also
be required to submit their audited financial statements along with Form 990.
1.15 This guide will be updated as further regulations are issued.
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Chapter 2

General Auditing Considerations
2.01 In accordance with AU section 150, Generally Accepted Auditing
Standards (AICPA, Professional Standards), an independent auditor plans,
conducts, and reports the results of an audit in accordance with generally
accepted auditing standards (GAAS). Auditing standards provide a measure
of audit quality and the objectives to be achieved in an audit. This section of
the guide provides guidance to health care entities primarily on the unique
application of the standards of fieldwork.

Audit Planning
2.02 The objective of an audit of a health care entity's financial statements
is to express an opinion about whether its financial statements present fairly,
in all material respects and in conformity with generally accepted accounting
principles (GAAP) or an other comprehensive basis of accounting (OCBOA),
the financial position, results of operations, changes in net assets, and cash
flows for the specified period just ended. To accomplish that objective, the
independent auditor's responsibility is to plan and perform the audit to obtain
reasonable assurance (a high but not absolute level of assurance) that material
misstatements, whether caused by error or fraud, are detected.
2.03 Auditors of health care entities should refer to auditing standards, including AU section 311, Planning and Supervision (AICPA, Professional Standards), for general planning considerations. This section addresses planning
considerations and other auditing considerations that are relevant to audits of
health care entities.
2.04 Planning procedures usually include reviewing the independent auditor's files relating to the entity and holding discussions with audit personnel
and the personnel of the entity. Industry-specific examples of these procedures
include the following:

r
r
r
r
r

Review the relationship of affiliated entities to the health care
entity, and determine the extent to which their financial information will be included in the financial statements of the entity. See
the related discussion in chapter 12, "The Reporting Entity and
Related Entities," of this guide.
Review the status of unsettled cost (reimbursement) reports for
prior periods filed with third-party payors.
Identify situations for which accounting estimates, such as thirdparty contractual allowances and medical malpractice liabilities,
are required, and identify relevant factors that may affect those
estimates.
Review periodic reports from and to third-party payors or other
regulatory bodies.
Establish materiality and tolerable misstatement levels, which
are set based on industry-specific factors, including the organizational structure of the entity.
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2.05 The independent auditor may find it helpful to maintain a permanent
file that includes copies of the following documents specifically relating to the
health care entity:

r
r
r
r

Specific documents concerning restrictions on donor gifts and bequests
Contracts and agreements, including leases, agreements with
physicians, agreements with third-party payors, and agreements
with affiliated entities
Loan agreements, bond indentures, and other debt instruments
IRS determination letter (for tax-exempt entities)

Scope of the Engagement
2.06 AU section 311 states that the auditor should establish an understanding with the client regarding the services to be performed for each engagement. This understanding should be documented through a written communication with the client in the form of an engagement letter. The understanding
includes the objectives of the engagement, management's responsibilities, the
auditor's responsibilities, and the limitations of the engagement.
Considerations for Audits Performed in Accordance With Public Company Accounting Oversight Board Standards
Paragraph .06 of AU section 310, Appointment of the Independent
Auditor (AICPA, PCAOB Standards and Related Rules, Interim Standards), includes requirements related to an auditor's understanding
when performing an integrated audit of financial statements and internal control over financial reporting and requirements related to an
audit of the financial statements in accordance with Public Company
Accounting Oversight Board (PCAOB) standards.
2.07 The auditor may consider certain health-care-specific matters in establishing the terms of the engagement. For example, with respect to thirdparty payment matters, language such as the following might be included:
An audit conducted in accordance with auditing standards generally
accepted in the United States of America does not include audit procedures specifically designed to detect illegal acts that have only an
indirect effect on the financial statements (for example, violations of
fraud and abuse statutes that result in fines or penalties being imposed on the company). The auditors' procedures do not include testing compliance with laws and regulations in any jurisdiction related
to Medicare and Medicaid antifraud and abuse. Management of the
company is responsible for the identification of, and the company's
compliance with, laws and regulations applicable to its activities, including, but not limited to, those related to Medicare and Medicaid
antifraud and abuse statutes.
With respect to cost reports that may be filed with a third party (such
as federal and state regulatory agencies), the auditors have not been
engaged to test in any way, or render any form of assurance on, the propriety or allowability of the specific costs to be claimed on, or charges
to be reported in, a cost report. Management is responsible for the accuracy and propriety of all cost reports filed with Medicare, Medicaid,
or other third parties.
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The auditors have not been engaged to provide any services with respect to confirming the tax-exempt status of any outstanding bond issue, including testing in any way or rendering any form of assurance
that the bonds are in compliance with the requirements as specified in
the Internal Revenue Code (IRC) and regulations thereunder. Management is responsible for monitoring the postissuance compliance
with these requirements.
2.08 In addition to reporting on the entity's basic financial statements,
the independent auditor may be engaged to report on the following special
reports: (a) cost reports for third-party payors;1 (b) cost reports related to research grants; (c) reports for contributors; (d) reports for local, state, or federal
authorities; (e) reports related to bond indentures and other debt instruments;
and (f) other special-purpose reports. The nature, timing, and extent of procedures to be performed and the type of reports to be issued are based on the
scope of services required by the entity and applicable professional standards.
AU section 600, Other Types of Reports (AICPA, Professional Standards), and
Statements on Standards for Attestation Engagements are useful for these
engagements.
2.09 The auditor and client may consider including a provision in the
engagement letter requiring the client to obtain consent from the auditor before
including the auditor's report in an official statement. If the auditor and client
agree not to include such a provision, the auditor considers including in the
engagement letter a requirement that if the client issues any official statement,
and the auditor is not associated with that statement, the client will include
therein a comment that the auditor is not associated with the contents of such
official statement. For example, the official statement might include a comment
such as the following: "[Name of firm], our independent auditor, has not been
engaged to perform and has not performed, since the date of its report included
herein, any procedures on the financial statements addressed in that report.
[Name of firm] also has not performed any procedures relating to this official
statement."

Business Associates Agreements
2.10 The Privacy Standards of the Health Insurance Portability and Accountability Act of 1996 (HIPAA), as amended by the Health Information Technology for Economic and Clinical Health (HITECH) Act, require a covered
entity to have written agreements with business associates in place. Many
health care entities, including health care providers and payors and certain
not-for-profit and governmental entities, are considered covered entities under
HIPAA. A business associate is a person or an entity who performs or assists
in the performance of a function or an activity on behalf of a covered entity
that involves access to, or use or disclosure of, protected health information
(PHI). Independent auditors and advisory and tax professionals may be considered business associates. The HITECH Act also requires business associates
to comply with the HIPAA Security Rule's administrative, technical, and physical safeguard requirements and to implement security policies and procedures
in the same manner as a covered entity. This will require a business associate

1
See Technical Questions and Answers section 9110.15, "Reporting on Medicaid/Medicare Cost
Reports" (AICPA, Technical Practice Aids), for additional guidance regarding auditor association with
cost reports in certain jurisdictions.
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to implement written policies and procedures that address each Security Rule
standard; implement a security awareness and training program for workforce
members; designate a security official; and conduct an accurate and thorough
security risk analysis, along with a security management process. Business
associates are subject to potentially significant civil and criminal penalties for
violation of data privacy and security rules governing the protection of PHI.
Business associates' agreements generally are an addendum to, or incorporated
into, the audit engagement letter. Auditors may need to work with management to tailor the form of the business associates' agreement, so that it is
consistent with the requirements of the privacy regulations of HIPAA and the
HITECH Act while recognizing the various rules and regulations applicable to
CPAs.

Audit Risk
2.11 AU section 312, Audit Risk and Materiality in Conducting an Audit (AICPA, Professional Standards), states that audit risk is a function of the
risk that the financial statements prepared by management are materially misstated and the risk that the auditor will not detect such material misstatement.
The auditor should consider audit risk in relation to the relevant assertions
related to individual account balances, classes of transactions, and disclosures
at the overall financial statement level.
2.12 At the account balance, class of transactions, relevant assertion,
or disclosure level, audit risk consists of (a) the risks of material misstatement (consisting of inherent risk and control risk) and (b) detection risk
(see the following for additional discussion of these components). Paragraph
.23 of AU section 312 states that auditors should assess the risk of material misstatement at the relevant assertion level as a basis to design and
perform further audit procedures (tests of controls or substantive procedures). Defaulting to a maximum inherent or control risk assessment is not
permitted.
2.13 In considering audit risk at the overall financial statement level, the
auditor should consider risks of material misstatement that relate pervasively
to the financial statements as a whole and potentially affect many relevant
assertions. Risks of this nature often relate to the entity's control environment
and are not necessarily identifiable with specific, relevant assertions at the
class of transactions, account balance, or disclosure level. Such risks may be
especially relevant to the auditor's consideration of the risks of material misstatement arising from fraud (for example, through management override of
internal control).
2.14 In many health care entities, certain accounts typically (a) will have a
low volume of transactions, (b) will consist of transactions that are not complex,
and (c) do not require the use of significant accounting estimates. Accounts such
as inventories, marketable securities, assets whose use is limited, property
and equipment, long-term debt, and net assets (equity) frequently have these
characteristics and may allow the auditor to assess inherent risk as being at a
relatively low level. However, in certain circumstances, such as investments in
complex investments and derivative financial instruments, inherent risk may
be higher.
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Planning Materiality
2.15 Materiality is defined as the magnitude of an omission or a misstatement of accounting information that, in light of the surrounding circumstances, makes it probable that the judgment of a reasonable person relying
on the information would have been changed or influenced by the omission or
misstatement.
2.16 The auditor's consideration of materiality is a matter of professional judgment and is influenced by the auditor's perception of the needs
of users of the financial statements. Materiality judgments necessarily take
into account qualitative considerations, as well as quantitative considerations.
See the following for additional discussion about the qualitative aspects of
materiality.
2.17 In accordance with paragraph .27 of AU section 312, the auditor
should determine a materiality level for the financial statements as a whole
when establishing the overall audit strategy. The auditor often may apply a
percentage to a chosen benchmark as a step in determining materiality for the
financial statements as a whole. In determining an appropriate benchmark,
the auditor may consider what might be important to the anticipated users of
the financial statements (for example, operating results, earnings per share,
compliance with restrictive debt covenants, and so on). For a for-profit entity,
net income and earnings per share are the major concern of financial statement
users, and operating results may be the most relevant measurement basis
for materiality. On the other hand, for most not-for-profit entities, financial
statement users are typically concerned primarily with the company's liquidity
and ability to repay its debt, and unrestricted net assets may be the most
relevant starting point for establishing planning materiality. However, other
factors also may be relevant, such as the entity's overall size (for example,
total revenues, total assets, and so on); compliance with its debt covenants
(for example, a debt service coverage ratio); and the stability of its operating
results (for example, as measured by operating income or the performance
indicator).
Considerations for Audits Performed in Accordance With PCAOB Standards
When performing an integrated audit of financial statements and internal control over financial reporting, refer to paragraph 20 of Auditing Standard No. 5, An Audit of Internal Control Over Financial
Reporting That Is Integrated with An Audit of Financial Statements
(AICPA, PCAOB Standards and Related Rules, Auditing Standards),
regarding materiality considerations.

Qualitative Aspects of Materiality
2.18 As previously indicated, judgments about materiality include both
quantitative and qualitative information. Qualitative considerations include
the following:

r
r

The nature of the client's business and industry sector (for example, hospital, managed care, assisted living, and so on)
Operating results (for example, stable earnings, consistently near
break-even, low-margin industry, or volatile results)
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Financial position (for example, concerns regarding liquidity, debt
covenants, and capital adequacy)

As a result of the interaction of quantitative and qualitative considerations in
materiality judgments, misstatements of relatively small amounts that come
to the auditor's attention could have a material effect on the financial statements. For example, an error of an otherwise immaterial amount could be
material if a reasonable possibility exists that it could lead to a violation
of the entity's debt covenants that would cause the debt to be classified as
current.
2.19 Qualitative considerations also influence the auditor in reaching a
conclusion about whether misstatements are material. Paragraph .60 of AU
section 312 provides qualitative factors that the auditor may consider relevant
in determining whether misstatements are material.

Use of Assertions in Obtaining Audit Evidence
2.20 Paragraphs .14–.19 of AU section 326, Audit Evidence (AICPA, Professional Standards), discuss the use of assertions in obtaining audit evidence.
In representing that the financial statements are fairly presented in accordance
with GAAP, management implicitly or explicitly makes assertions regarding
the recognition, measurement, and disclosure of information in the financial
statements and related disclosures. Assertions used by the auditor fall into the
following categories:
Categories of Assertions
Description of Assertions
Classes of
Transactions and
Events During the
Period

Account Balances
at the End of the
Period

Presentation
and Disclosure

Occurrence or Transactions and
existence
events that have
been recorded
have occurred and
pertain to the
entity.

Assets, liabilities,
and equity
interests exist.

Disclosed events
and transactions
have occurred.

Rights and
obligations

The entity holds
or controls the
rights to assets,
and liabilities are
the obligations of
the entity.

Disclosed events
and transactions
pertain to the
entity.

All assets,
liabilities, and
equity interests
that should have
been recorded
have been
recorded.

All disclosures
that should have
been included in
the financial
statements have
been included.

—

Completeness All transactions
and events that
should have been
recorded have
been recorded.
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Description of Assertions
Classes of
Transactions and
Events During the
Period
Accuracy or
valuation
and
allocation

Amounts and
other data
relating to
recorded
transactions and
events have been
recorded
appropriately.

Cut-off

Transactions and
events have been
recorded in the
correct accounting
period.

Transactions and
Classification events have been
and underrecorded in the
standability proper accounts.

Account Balances at
the End of the Period

Presentation
and Disclosure

Assets, liabilities,
and equity interests
are included in the
financial statements
at appropriate
amounts, and any
resulting valuation
or allocation
adjustments are
recorded
appropriately.

Financial and
other
information is
disclosed fairly
and at
appropriate
amounts.

—

—

—

Financial
information is
appropriately
presented and
described, and
information in
disclosures is
expressed
clearly.

2.21 Examples of industry-specific assertions for classes of transactions,
account balances, and presentation and disclosures are reflected in the individual chapters of this guide.

Understanding the Entity, Its Environment,
and Its Internal Control
2.22 AU section 314, Understanding the Entity and Its Environment and
Assessing the Risks of Material Misstatement (AICPA, Professional Standards),
requires auditors to obtain an understanding of the entity and its environment,
including its internal control. In accordance with paragraph .04 of AU section
314, the auditor should use professional judgment to determine the extent of the
understanding required of the entity and its environment, including its internal
control. The auditor's primary consideration is whether the understanding that
has been obtained is sufficient to (a) assess risks of material misstatement of
the financial statements and (b) design and perform further audit procedures
(tests of controls and substantive tests).
2.23 The auditor's understanding of the entity and its environment consists of an understanding of the following aspects:
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Industry, regulatory, and other external factors
Nature of the entity
Objectives and strategies and the related business risks that may
result in a material misstatement of the financial statements
Measurement and review of the entity's financial performance
Internal control, which includes the selection and application of
accounting policies

2.24 This section addresses unique aspects of health care entities that
may be helpful in developing the required understanding of the entity, its
environment, and its internal control.

Risk Assessment Procedures
2.25 As described in AU section 326, audit procedures performed to obtain
an understanding of the entity and its environment, including its internal
control, to assess the risks of material misstatement at the financial statement
and relevant assertion levels are referred to as risk assessment procedures.
Paragraph .21 of AU section 326 states that the auditor must perform risk
assessment procedures to provide a satisfactory basis for the assessment of
risks at the financial statement and relevant assertion levels. Risk assessment
procedures by themselves do not provide sufficient appropriate audit evidence
on which to base the audit opinion and must be supplemented by further audit
procedures in the form of tests of controls, when relevant or necessary, and
substantive procedures.
2.26 In accordance with paragraph .06 of AU section 314, the auditor
should perform the following risk assessment procedures to obtain an understanding of the entity and its environment, including its internal control:

r
r
r

Inquiries of management and others within the entity
Analytical procedures
Observation and inspection

See paragraphs .06–.13 of AU section 314 for additional guidance on risk assessment procedures.

Analytical Procedures
2.27 AU section 329, Analytical Procedures (AICPA, Professional Standards), provides guidance on the use of analytical procedures and requires
their use in the planning and overall review stages of all audits. Paragraphs
.04 and .06 of AU section 329 specify that the auditor should apply analytical
procedures in planning the audit to assist in understanding the entity and its
environment and to identify areas that may represent specific risks relevant to
the audit. For example, analytical procedures may be helpful in identifying the
existence of unusual transactions or events and amounts, ratios, and trends
that might indicate matters that have financial statement and audit implications. Per paragraph .09 of AU section 314, in performing analytical procedures
as risk assessment procedures, the auditor should develop expectations about
plausible relationships that are reasonably expected to exist. When comparison
of those expectations with recorded amounts or ratios developed from recorded
amounts yields unusual or unexpected relationships, the auditor should consider those results in identifying risks of material misstatement. However, if
such analytical procedures use data aggregated at a high level, generally, the
results of those analytical procedures provide only a broad initial indication
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about whether a material misstatement may exist. Accordingly, the results of
analytical procedures performed during planning may be considered along with
other information gathered by the auditor in identifying the risks of material
misstatement due to fraud.
2.28 Examples of sources of information for developing expectations include prior-period financial information, budgets, and health care financial and
statistical ratios. Additional information is available from various health care
industry associations.
2.29 The following are examples of analytical procedures that the independent auditor may find useful:

r
r
r
r
r

Comparison of account balances with budget and prior-period
amounts
Analysis of changes in revenues during the current period based
on statistical data (for example, admissions, patient days, visits,
and professional service procedure counts for laboratory, radiology, and surgery) and information concerning price changes
Comparison between periods of the number of days of revenue in
receivables
Relationship between periods of the allowance for uncollectible accounts to the balance of patient accounts receivable in the aggregate, based on known changes in the accounts receivable's aging
and composition by payor
Relationship between periods of the liability for claims incurred
but not reported (IBNR) to the related expense

Discussion Among the Audit Team
2.30 In obtaining an understanding of the entity and its environment, including its internal control, AU section 314 states that there should be discussion among the audit team. In accordance with paragraph .14 of AU section 314,
the members of the audit team, including the auditor with final responsibility
for the audit, should discuss the susceptibility of the entity's financial statements to material misstatements. This discussion could be held concurrently
with the discussion among the audit team that is specified by AU section 316,
Consideration of Fraud in a Financial Statement Audit (AICPA, Professional
Standards), to discuss the susceptibility of the entity's financial statements to
fraud.

Understanding of the Entity and Its Environment 2
2.31 Appendix A, "Understanding the Entity and Its Environment," of
AU section 314 includes examples of matters that the auditor may consider in
obtaining an understanding of the entity and its environment. The following
table includes some unique characteristics of health care entities that the auditor may consider, in addition to the factors listed in appendix A of AU section
314, when obtaining an understanding of the entity and its environment in
order to assess the risks of material misstatement. Some of these factors are
discussed in more detail following the table.
2
The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 will likely create regulations that will affect health care entities in many significant
ways. This section and table will be updated as those regulations are issued.
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Aspects of the
Auditor's
Understanding of
the Entity and Its
Environment
Industry,
regulatory, and
other external
factors

Considerations for Health Care Entities

•
•

•
•
•
Nature of the
entity

•
•
•

•
•

Objectives and
strategies and
related business
risks

•
•
•
•
•
•
•

Measurement and
review of the
entity's financial
performance
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Regulatory requirements unique to entities receiving
Medicare; Medicaid; or other federal payments,
including federal financial assistance.
Service delivery regulations (for example, antidumping,
Emergency Medical Treatment and Active Labor Act,
use of devices approved by the Food and Drug
Administration, Hill-Burton charity care, and so on).
Billing and coding regulations, including being subject
to peer reviews and governmental intermediary audits.
Factors arising from an entity's tax-exempt status (for
example, prohibited activities, unrelated business
income, bond arbitrage rules, and so on).
Insurance-related industry regulations (for example,
minimum capital requirements, statutory reporting
requirements, and so on).
The existence of related-party transactions.
The entity's experience with payment denials and other
matters subject to review by medical review entities.
The nature of reports expected to be rendered. Examples
include reports on consolidated or consolidating
financial statements, reports on financial statements
filed with the Securities and Exchange Commission,
reports filed with third-party payors or other regulatory
bodies, reports on compliance with debt covenants, and
other special reports.
Recognition of liabilities for costs incurred by providers
of prepaid health care services (see paragraph 2.32).
Contingencies for medical malpractice losses (see
paragraph 2.33).
Obligations under continuing care contracts.
Revenue recognition practices (see paragraphs 2.34–.43).
Minimum loss issues.
Limitations on the initiation of new services or
construction (for example, certificate of need).
Required federal certification prior to billing (for
example, Medicare certification).
Recognition of retrospective billing adjustments from
third-party payors.
Limitations on physician arrangements, such as ones
related to patient referrals.
Risk-based capital requirements (see the "Statutory
Reporting Considerations for Health Plans" section).
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Cost of Prepaid Health Care Services
2.32 Risks are associated with recognizing the liability for costs incurred
by providers of prepaid health care services (for example, HMOs) because such
costs may have been incurred but not yet reported to the providers. Therefore,
it is necessary to estimate the liability for those costs. These estimates often
necessitate a high degree of management judgment. Management considers
historical experience, as well as the effects of any changes in conditions, such
as seasonality trends and changes in subscriber population and the services and
benefits provided. Costs of prepaid health care services are discussed further in
chapter 13, "Financial Accounting and Reporting for Managed Care Services,"
of this guide.

Medical Malpractice Losses and Obligations
2.33 Risks also are associated with contingencies for medical malpractice
losses and obligations under continuing care contracts. A high degree of management judgment and complex analyses usually are involved in evaluating
the related financial statement assertions. The measurement of estimates is
inherently uncertain and depends on the outcome of future events. Because no
one accounting estimate that involves a degree of management judgment can
be considered accurate with certainty, material changes in such estimates do
not indicate that the audit was not performed in accordance with professional
standards. Medical malpractice losses and obligations are discussed further in
chapter 8, "Contingencies and Other Liabilities," of this guide.

Revenue Recognition
2.34 Because of the large monetary amounts and complexity of determining health care service revenue and receivables, risks are associated with
health care service revenue recognition and the valuation of the related receivables. A significant portion of services is usually paid by third parties, such
as Medicare, Medicaid, and various health insurance carriers, under statutory
provisions or other arrangements in amounts that can be significantly different from, and frequently less than, the entity's established rates. Statement
of Position (SOP) 00-1, Auditing Health Care Third-Party Revenues and Related Receivables (AICPA, Technical Practice Aids, AUD sec. 14,360), provides
guidance to auditors regarding uncertainties inherent in health care thirdparty revenue recognition. SOP 00-1 is included as appendix B, "Statement of
Position 00-1, Auditing Health Care Third-Party Revenues and Related Receivables," of this guide.
2.35 Typically, a number of clinicians (for example, the attending physician, consulting physicians, radiologists, pathologists, therapists, and nurses)
add documentation to a patient's medical record. Provider personnel generally review the medical record and assign a code (ICD-9-CM or CPT-4)* to the
record. The provider prepares and submits a bill that includes, among other
things, the assigned ICD-9-CM or CPT-4 code. The Medicare fiscal intermediary or other third-party payor typically reviews the bill and assigns a specific
payment code, such as a diagnosis related group (DRG) number. Payment is
based on the assigned DRG number or other payment code. The provider may
*
On January 16, 2009, the Department of Health & Human Services (HHS) published a final rule
adopting ICD-10-CM to replace ICD-9-CM in Health Insurance Portability and Accountability Act of
1996 transactions, with an effective implementation date of October 1, 2013. Early implementation
of the codes in ICD-10-CM is not valid for any use or purpose.
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check the assigned payment code and follow up on any identified discrepancies.
However, the final assignment of the payment code is generally determined by
the third-party payor.
2.36 Misstatements can occur throughout this process. Physicians or other
clinicians may not document the appropriate procedure. Coding personnel may
not notice or correctly interpret certain items in the medical record. Accordingly, an incorrect code may be assigned, and an erroneous amount may be
paid.
2.37 The auditor's expertise is in accounting and auditing matters, rather
than operational, clinical, or legal matters. Accordingly, the auditor's procedures focus on areas that normally are subject to internal controls relevant
to financial reporting. However, the further that a potential misstatement is
removed from the events and transactions ordinarily reflected in the financial
statements, the less likely the auditor is to become aware of the misstatement
and evaluate the effect on the financial statements. For example, determining whether a service was medically necessary; obtained through a legally
appropriate referral; properly performed (including using only approved devices, rendered in a quality manner from a clinical perspective, and so on);
adequately supervised; accurately documented and classified; or rendered and
billed by nonsanctioned individuals typically is not within the auditor's professional expertise. As a result, an audit in accordance with GAAS is not designed
to detect such matters.
2.38 Further, an audit conducted in accordance with GAAS does not include rendering an opinion or any form of assurance on an entity's compliance
with laws and regulations.3 Nor does an audit under GAAS include providing
any assurance on an entity's billings or cost report. In fact, cost reports typically are not prepared and submitted until after the financial statement audit
has been completed.
2.39 Due to the higher inherent risk associated with revenue recognition,
including the clinical coding process, the independent auditor may consider
obtaining an understanding of internal controls over documentation of the
services rendered; clinical coding, including the use of groupers and supervisory
reviews; and billing procedures (for example, admission, payor verification, and
discharge). The auditor also may consider the results of the internal compliance
program; the internal audit; and external reviews (consulting or regulator or
payor), including denials.
2.40 For reasons previously discussed, an auditor would not find it necessary to consider the process of assigning codes in planning and performing
an audit of the provider's financial statements. However, the auditor should
investigate matters coming to his or her attention that suggest potential material misstatements of the financial statements resulting indirectly from such
matters due to potential illegal acts. For example, after being informed about
a special regulatory review that was performed, the auditor inquires about
the results and considers whether performance of additional substantive audit
procedures is necessary to evaluate the contingency, including the need for
3
Even when auditors undertake a special engagement designed to attest to compliance with
certain provisions of laws, regulations, contracts, and grants (for example, an audit in accordance
with Office of Management and Budget [OMB] Circular A-133, Audits of States, Local Governments
and Non-Profit Organizations), the auditor's procedures do not extend to testing compliance with
laws and regulations related to Medicare and Medicaid fraud and abuse.
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possible recognition or disclosure pursuant to Financial Accounting Standards
Board (FASB) Accounting Standards Codification (ASC) 450, Contingencies.
2.41 The independent auditor should obtain an understanding of the specific cost-finding or other rate-setting methods used by third-party payors to
determine final amounts reimbursable to the health care entity. These payment methods may require that a health care entity accumulate and report
various statistical data, such as admissions, discharges, patient days, visits,
beds, square footage, and pounds of laundry.
2.42 Among other duties, the Medicare fiscal intermediary is responsible
for evaluating the propriety of submitted claims before processing them for
payment. Absent the client committing an illegal act, the payment of a claim
provides evidence that billed amounts were correct. As a result, the auditor
should obtain an understanding of the entity's billing and collection history,
paying particular attention to the entity's historical denial rate or the significance of coding changes.
2.43 The auditor should consider the adequacy of the financial statement
disclosures regarding the inherent risk relating to revenue recognition. Generally, the notes to the financial statements disclose that amounts recognized
as revenues are subject to retrospective review and laws and regulations that
are extremely complex and subject to interpretation; as a result, a reasonable
possibility exists that recorded estimates will change by a material amount in
the near term.

Additional Audit Considerations
Accounting Estimates
2.44 Certain areas of a health care entity's operations include accounting
estimates that may be material in the preparation and presentation of financial statements. FASB ASC 275, Risks and Uncertainties, requires entities to
include in their financial statements information about the use of estimates
in the preparation of financial statements. In addition, if specified disclosure
criteria in FASB ASC 275-10-50-8 are met, entities are required to include the
disclosures about certain significant estimates described in paragraphs 6–15 of
FASB ASC 275-10-50 in their financial statements. AU section 342, Auditing
Accounting Estimates (AICPA, Professional Standards), provides guidance on
obtaining and evaluating sufficient appropriate audit evidence to support significant accounting estimates in an audit of financial statements conducted in
accordance with GAAS.
Considerations for Audits Performed in Accordance With PCAOB Standards
Paragraph .10 of AU section 342, Auditing Accounting Estimates
(AICPA, PCAOB Standards and Related Rules, Interim Standards),
provides that for an integrated audit, auditors are required to obtain
an understanding of the process that management used to develop
estimates and to test controls over all relevant assertions related to
the estimate.
2.45 SOP 00-1 provides guidance for auditors regarding the sufficiency of
audit evidence supporting accounting estimates recorded for the proper valuation of health care third-party revenues and related receivables.
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2.46 Although significant accounting estimates may affect many elements
of a health care entity's financial statements, they most often affect the following:

r

r
r
r
r
r
r
r

The provision for third-party payor contractual adjustments
and allowances and the provision for estimated receivables and
payables for final settlements with those payors and any other valuation allowances for revenue recognition matters, as discussed
further in chapter 10, "Health Care Service Revenue and Related
Receivables," of this guide
The valuation of investments
The accruals for taxes
The provision for uncollectible accounts
Accruals for medical malpractice liabilities and other similar liabilities
Accruals for obligations under continuing care contracts
Accruals by providers of prepaid health care services for IBNR
costs
Accruals for loss contracts

Transactions Processed by Service Organizations
2.47 Health care entities may engage outside service organizations to
perform services that are part of the health care provider's information system.
2.48 Examples of service organizations used by health care entities include the following:

r
r
r
r

Investment managers that invest and service assets for health
care entities
Service organizations that process payroll, IT, and other administrative functions
Billing entities that prepare reimbursement claims to insurers
and other third parties
Administrators of employee benefit plans who process and pay
benefit claims and maintain participant records

2.49 AU section 314 states that the auditor should obtain an understanding of each of the five components of an entity's internal control sufficient to
assess the risks of material misstatement and design the nature, timing, and
extent of further audit procedures. This understanding may encompass controls placed in operation by the health care entity and service organizations
whose services are part of the health care entity's information system.
2.50 AU section 324, Service Organizations (AICPA, Professional
Standards),† explains the considerations that an auditor makes in obtaining
†
The guidance contained in AU section 324, Service Organizations (AICPA, Professional Standards), is in the process of being split into an attest standard and an auditing standard to better
reflect the nature of the work being performed. As part of this process, the Auditing Standards Board
issued Statement on Standards for Attestation Engagements (SSAE) No. 16, Reporting on Controls
at a Service Organization (AICPA, Professional Standards, AT sec. 801), in April 2010. SSAE No.
16 addresses examination engagements undertaken by a service auditor to report on controls at

(continued)
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an understanding of internal control and assessing control risk for entities that
use a service organization to process transactions.
Considerations for Audits Performed in Accordance With PCAOB Standards
Auditing Standard No. 5 provides guidance regarding the use of service organizations for an integrated audit.

Illegal Acts
2.51 The Social Security Act provides for criminal penalties for individuals or entities that offer, pay, solicit, or receive remuneration to induce business that is reimbursed under Medicare or state health care programs. The
types of remuneration covered by the antikickback statute of the Medicare and
Medicaid Patient and Program Protection Act of 1987 include, with certain
exceptions, kickbacks, bribes, and rebates made directly or indirectly, overtly
or covertly, and in cash or in kind. In addition, prohibited conduct includes
not only remuneration intended to induce referrals or patients but also remuneration intended to induce the purchasing, leasing, ordering, or arranging for
any good, facility, service, or item paid for by Medicare or state health care
programs. In addition, fraudulent activities may exist that are unrelated to
Medicare or state programs, such as fraudulent billing and admitting practices.
2.52 The auditor's procedures will vary based on his or her assessment of
the risk of material misstatement resulting from such illegal acts. AU section
317, Illegal Acts by Clients (AICPA, Professional Standards), states that the
auditor should plan and perform the audit to provide reasonable assurance of
detecting illegal acts having a direct and material effect on the determination
of financial statement amounts. AU section 317 also notes that an audit conducted in accordance with GAAS does not include audit procedures specifically
designed to detect illegal acts that have only an indirect effect on the financial
statements (for example, illegal acts that have a material effect as the result
of fines or penalties that may be imposed on the entity). Finally, AU section
317 provides guidance on the auditor's responsibilities when specific information concerning the possible existence of this type of illegal act comes to the
auditor's attention.
2.53 Examples of laws and regulations that are generally recognized by
auditors to have a direct and material effect on the determination of amounts
in financial statements of health care entities include tax laws affecting tax
accruals and tax expense, as well as Medicare and Medicaid laws directly
affecting the amount of revenue recognized during the accounting period, such
as those concerning the submission of bills for fictitious patients.

(footnote continued)
organizations that provide services to user entities when those controls are likely to be relevant
to user entities' internal control over financial reporting. It is effective for service auditors' reports
for periods ending on or after June 15, 2011. Early implementation is permitted. This standard
supersedes the guidance for service auditors in AU section 324.
AU-C section 402, Audit Considerations Relating to an Entity Using a Service Organization
(AICPA, Professional Standards), will supersede AU section 324 and addresses the user auditor's responsibility for obtaining sufficient appropriate audit evidence in an audit of the financial statements
of a user entity that uses one or more service organizations. It will be effective for audits of financial
statements for periods ending on or after December 15, 2012, and early adoption is prohibited.
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2.54 Health care entities also may be affected by many other laws and
regulations, such as those related to Medicare and Medicaid fraud and abuse,
discrimination related to patients or residents, violation of patient or resident
rights, securities trading, occupational safety and health, food and drug administration, environmental protection, equal employment opportunities, and
price-fixing or other antitrust violations. Generally, these laws and regulations
relate more to an entity's operating aspects than its financial and accounting
aspects, and their financial statement effect is only indirect. An auditor ordinarily does not have a sufficient basis for recognizing possible violations of such
laws and regulations. Their indirect effect is normally the result of the need
to disclose a contingent liability because of the allegation or determination
of illegality. For example, patients may be obtained based on illegal arrangements with physicians or other providers. Although the direct effects of the
services rendered may be appropriately recorded, their indirect effects, such
as the possible contingent liability for violating Medicare and Medicaid fraud
and abuse statutes, may not be appropriately disclosed. Even when violations
of such laws and regulations can have material consequences to the financial
statements, auditors may not become aware of the existence of the illegal act,
unless they are informed by the client or evidence exists of a governmental
agency investigation or enforcement proceeding in the records, documents, or
other information normally inspected in an audit of financial statements.
2.55 Whether an act is, in fact, illegal is a determination that is normally beyond the auditor's professional competence. The auditor's training,
experience, and understanding of the client and industry may provide a basis
for recognizing that some acts coming to the auditor's attention may be illegal.
However, determining whether a particular client act is illegal generally would
be based on the advice of an informed expert qualified to practice law or may
have to await final determination by a court of law. For example, determining
whether admitting a patient or providing a service is medically necessary or
whether a particular procedure or device was properly approved is not within
the auditor's professional competence.

Management Representations
2.56 AU section 333, Management Representations (AICPA, Professional
Standards), establishes a requirement that an auditor performing an audit
in accordance with GAAS obtain written representations from management
for all financial statements and periods covered by the auditor's report. The
specific written representations to be obtained depend on the circumstances
of the engagement and the nature and basis of presentation of the financial
statements.
2.57 The auditor may consider the following examples of specific representations for receivables, cost reports filed with third parties, and contingencies
related to health care third-party revenue recognition:

r

For receivables, consider the following:
—
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— Recorded valuation allowances are necessary, appropriate, and properly supported.

r

— All peer review organizations, fiscal intermediary, and
third-party payor reports and information have been
made available.
For cost reports filed with third parties, consider the following:
— All required Medicare, Medicaid, and similar reports
have been properly filed.
— Management is responsible for the accuracy and propriety of all filed cost reports.
— All costs reflected on such reports are appropriate and allowable under applicable reimbursement rules and regulations and are patient-related and properly allocated to
applicable payors.
— The employed reimbursement methodologies and principles are in accordance with applicable rules and regulations.
— Adequate consideration has been given to, and appropriate provision made for, audit adjustments by intermediaries, third-party payors, or other regulatory
agencies.
— All items required to be disclosed, including disputed
costs that are being claimed to establish a basis for a
subsequent appeal, have been fully disclosed in the cost
report.

r

— Recorded third-party settlements include differences between filed (and to-be-filed) cost reports and calculated settlements, which are necessary based on historical experience or new or ambiguous regulations
that may be subject to differing interpretations. Although management believes that the entity is entitled
to all amounts claimed on the cost reports, management also believes the amounts of these differences are
appropriate.
For contingencies, consider the following:
— No violations or possible violations of laws or regulations
exist, such as those related to Medicare and Medicaid
antifraud and abuse statutes, in any jurisdiction, whose
effects are considered for disclosure in the financial statements or as a basis for recording a loss contingency other
than those disclosed or accrued in the financial statements. This is including, but not limited to, the antikickback statute of the Medicare and Medicaid Patient and
Program Protection Act of 1987, limitations on certain
physician referrals (the Stark law), and the False Claims
Act.
— Billings to third-party payors comply in all material respects with applicable coding guidelines (for example,
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ICD-9-CM‡ and CPT-4) and laws and regulations, including those dealing with Medicare and Medicaid antifraud
and abuse, and billings reflect only charges for goods
and services that were medically necessary; properly approved by regulatory bodies (for example, the FDA), if
required; and properly rendered.
—

There have been no internal or external investigations
relating to compliance with applicable laws and regulations, including investigations in progress, that would
have an effect on the amounts reported in the financial
statements or on the disclosure in the notes to the financial statements.

—

There have been no oral or written communications from
regulatory agencies, governmental representatives, employees, or others concerning investigations or allegations of noncompliance with laws and regulations in
any jurisdiction, including those related to Medicare and
Medicaid antifraud and abuse statutes; deficiencies in financial reporting practices; or other matters that could
have a material adverse effect on the financial statements.

—

Adequate consideration has been given to, and appropriate provision made for, a continuing care retirement
community's obligation to provide future services and the
use of facilities to current residents.

—

Adequate consideration has been given to, and appropriate provision made for, a prepaid health care provider's
obligation to provide future health care services.

—

Guarantees, whether written or oral, under which the
health care entity is contingently liable, including guarantee contracts and indemnification agreements pursuant to FASB ASC 460, Guarantees, have been properly recorded or disclosed in the (consolidated) financial
statements.

2.58 The auditor of the health care entity also might obtain specific representations, if applicable, of the following items that are unique or pervasive
in the health care industry:

r
r
r
r

‡

The health care entity is in compliance with the provisions of IRC
Section 501(c)(3) and is exempt from federal income tax under
IRC Section 501(a), as evidenced by a determination letter, and
from state income tax.
Information returns (Form 990) have been filed on a timely basis.
Provision has been made, when material, for estimated retroactive
adjustments by third-party payors under reimbursement agreements.
The health care organization is in compliance with bond indentures or other debt instruments.

See footnote †.
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For each of its outstanding bond issues, the health care entity
is in compliance with postissuance requirements, as specified in
the IRC, including, but not limited to, the areas of arbitrage and
private business use.
Pending changes in the organizational structure, financing arrangements, or other matters that could have a material effect on
the financial statements of the entity are properly disclosed.
The health care entity is in compliance with contractual agreements, grants, and donor restrictions.
The health care entity has maintained an appropriate composition of net assets in amounts needed to comply with all donor
restrictions.
The internal controls over the receipt and recording of received
contributions are adequate.
The allocation of expenses reported in the notes to the financial
statements is reasonable based on the health care entity's current
operations.
The health care entity has properly classified equity securities
with readily determinable fair values and all debt securities as
either trading or other-than-trading securities and reported these
investments at fair value.
The health care entity has reported to its risk management department all known asserted and unasserted claims and incidents. Adequate and reasonable provision has been made for
losses related to asserted and unasserted malpractice, health insurance, worker's compensation, and any other claims.
The health care entity is (or is not) subject to the requirements of
Office of Management and Budget (OMB) Circular A-133, Audits
of States, Local Governments and Non-Profit Organizations, or Title 45 U.S. Code of Federal Regulations (CFR) Part 74.26 because
it expended (or did not expend) more than $500,000 in federal
awards during the year.
The health care entity has classified net assets as unrestricted,
temporarily restricted, or permanently restricted based on its assessment of the donor's intention, as specified in original donor
correspondence, when available. When not available, the entity
used other corroborating evidential matter, including minutes of
the board, accounting records, and financial statements. To the
extent that it was unable to review original donor correspondence
to determine the amount of the original gift and donor additions,
its determination of such amount was based on its best estimate
considering the relevant facts and circumstances. Amounts classified as temporarily restricted are subject to donor-imposed purpose or time restrictions that precluded the health care entity
from expending such amounts or recognizing such amounts as
unrestricted as of the balance sheet date. Amounts classified as
permanently restricted are subject to donor-imposed or statutory
restrictions that require these amounts to be held in perpetuity. In addition, the health care entity has classified appreciation
and income related to such donations in accordance with relevant donor or statutory restrictions. Losses on investments of a
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donor-restricted endowment fund have been classified in accordance with FASB ASC 958-205-45. Reclassifications between net
asset classes are proper.

Single Audit Act and Related Audit Considerations
2.59 An independent auditor may be engaged to audit the financial statements of a health care entity that expends federal awards from a governmental
agency in accordance with the Single Audit Act Amendments of 1996 and OMB
Circular A-133. Federal awards may take the form of grants, contracts, loans,
loan guarantees, property, cooperative agreements, interest subsidies, and insurance or direct appropriations.
2.60 OMB Circular A-133 prescribes policies, procedures, and guidelines
to implement the Single Audit Act Amendments of 1996 and requires state and
local governments and not-for-profit entities that expend total federal awards
equal to, or in excess of, $500,000 in a fiscal year to have an audit performed in
accordance with the Single Audit Act Amendments of 1996 and OMB Circular
A-133.
2.61 Institutions covered by OMB Circular A-133 include not-for-profit
hospitals, public hospitals, institutions of higher education and their affiliated
hospitals, voluntary health and welfare entities, and other community-based
entities.4 Medicare payments to a nonfederal entity for providing patient care
services to Medicare-eligible individuals are not considered expended federal
awards under OMB Circular A-133. Medicaid payments to a subrecipient for
providing patient care services to Medicaid-eligible individuals are not considered expended federal awards under OMB Circular A-133, unless a state
requires the funds to be treated as expended federal awards because reimbursement is on a cost-reimbursement basis.
2.62 OMB Circular A-110, Uniform Administrative Requirements for
Grants and Other Agreements with Institutions of Higher Education, Hospitals and Other Non-Profit Organizations, establishes standard requirements.
such as insurance, record retention, and banking, for obtaining consistency
and uniformity among federal agencies in the administration of grants to, and
agreements with, public and private hospitals and other entities. OMB Circular A-87, Cost Principles for State, Local and Indian Tribal Governments,
establishes principles and standards for determining allowable costs incurred
by state and local governments under grants, contracts, and other agreements.
OMB Circular A-21, Cost Principles for Educational Institutions, and A-122,
Cost Principles for Non-Profit Organizations, establish principles and standards for determining allowable costs incurred by educational institutions and
not-for-profit entities under grants, contracts, and other agreements. Federal
research and development awards under grants and contracts administered by
hospitals are exempt from OMB Circulars A-87, A-21, and A-122 but are subject to the requirements provided in appendix E, "Principles for Determining

4
The codification of OMB Circular A-133 by the HHS also includes audit requirements for
commercial entities, including for-profit hospitals, that receive federal awards under HHS programs.
Generally, the entity has two options regarding audits: a financial-related audit of a particular award,
in accordance with Government Auditing Standards (GAS), or an audit that meets the requirements
of OMB Circular A-133. See Title 45 U.S. Code of Federal Regulations Part 74.26(d) for further
information.

AAG-HCO 2.59

27

General Auditing Considerations

Costs Applicable to Research and Development Under Grants and Contracts
With Hospitals," of 45 CFR 74.
2.63 AU section 801, Compliance Audits (AICPA, Professional Standards),
provides general guidance for audits of governmental entities and entities that
receive federal awards. AU section 801 explains the requirements of the financial audit standards contained in Government Auditing Standards (GAS), as
amended and issued by the Comptroller General of the United States, and their
relationship to GAAS.5 It also provides general guidance on testing compliance
with requirements applicable to federal awards. AU section 801 clarifies that
the entity, rather than the independent auditor, is responsible for arranging
for audits that meet all applicable requirements and provides guidance on communications that the auditor makes upon becoming aware that the entity may
be subject to an audit requirement that may not be satisfied by the auditor's
engagement.
2.64 The Audit Guide Government Auditing Standards and Circular A133 Audits provides guidance on the auditor's responsibilities when conducting
a single audit or program-specific audit in accordance with the Single Audit Act
Amendments of 1996 and OMB Circular A-133. It discusses the auditor's responsibility for considering internal control and performing tests of compliance
with applicable laws, regulations, and program compliance requirements. Further, it provides reporting guidance, including examples of the reports required
by GAS and OMB Circular A-133.
2.65 In Guidance on Complying with Government Auditing Standards Reporting Requirements for the Report on Internal Control for Audits of Certain Entities Subject to the Requirements of the SarbanesOxley Act of 2002 and Government Auditing Standards, which is available
at www.gao.gov/govaud/ybpcaob.pdf, the Government Accountability Office
(GAO) provided guidance to entities that are subject to audits conducted in accordance with GAS and the standards issued by the PCAOB. The notice states
that GAS may be used in conjunction with professional standards issued by
other authoritative bodies, such as the PCAOB, even though those standards
are not incorporated into GAS. This GAO guidance states that it recognizes
that the use of the PCAOB's framework for assessing deficiencies in internal
control could result in inconsistencies in reporting on internal control under
GAS. Guidance is available to facilitate the reporting of deficiencies in internal
control identified during audits conducted under both PCAOB standards and
GAS to ensure the consistency of information included in the GAS report on
internal control and to assist auditors in complying with GAS. In November
2008, the GAO issued Interim Guidance on Reporting Deficiencies in Internal Control for GAGAS Financial Audits and Attestation Engagements, which
states that auditors may satisfy the internal control reporting requirements
in GAS by including in the GAS report all identified significant deficiencies
and material weaknesses, following the definitions and requirements from AU
section 325, Communicating Internal Control Related Matters Identified in an
Audit (AICPA, Professional Standards). Because the definitions of significant
deficiencies and material weaknesses are uniform between the PCAOB and
AU section 325, this interim guidance is relevant for those entities that are

5
In August 2010, the Government Accountability Office issued Government Auditing Standards 2010 Exposure Draft, a draft of proposed changes to GAS. The exposure draft is available at
www.gao.gov/new.items/d10853g.pdf.
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expected to apply both PCAOB standards and GAS. See the GAO website at
www.gao.gov for further information.

Statutory Reporting Considerations for Health Plans
2.66 Most health plans that provide insurance coverage and bear financial
risk are regulated. Generally speaking, regulated insurers are required by their
state of domicile to annually submit a set of audited financial statements that
are prepared using that state's prescribed or permitted statutory accounting
practices (statutory financial statements).
2.67 The National Association of Insurance Commissioners (NAIC) codified the statutory accounting practices for certain insurance entities, including
regulated health plans. Annually, in March of each year, the NAIC issues a
revised Accounting Practices and Procedures Manual (manual) reflecting revisions or additions to Statements of Statutory Accounting Principles (SSAPs)
and interpretations of SSAPs. States generally require health plans to comply
with the provisions of the NAIC manual, unless the provisions are preempted
by state statutes or regulations, or both. If the requirements of state laws,
regulations, and administrative rules differ from the guidance provided in the
NAIC manual, such state laws, regulations, and administrative rules take
precedence. Preparers and auditors of statutory financial statements might
find it useful to monitor the status of the NAIC manual, as well as all the
prescribed and permitted practices of an insurer's domiciliary state. Any permitted practices granted by the domiciliary state to the health plan must be
reconfirmed annually.
2.68 Statutory financial statements prepared in accordance with the
NAIC manual, as well as other prescribed and permitted statutory accounting
practices, are considered to be prepared in accordance with an OCBOA under
AU section 623, Special Reports (AICPA, Professional Standards). Interpretation No. 12, "Evaluation of the Appropriateness of Informative Disclosures in
Insurance Enterprises' Financial Statements Prepared on a Statutory Basis,"
of AU section 623 (AICPA, Professional Standards, AU sec. 9623 par. .60–.81),
provides guidance in evaluating the adequacy and appropriateness of informative disclosures in financial statements prepared on a statutory basis.
2.69 Various SSAPs included in the NAIC manual specifically address
issues related to health plans. These include SSAP No. 25, Accounting for
and Disclosures about Transactions with Affiliates and Other Related Parties;
No. 35, Guaranty Fund and Other Assessments; No. 47, Uninsured Plans; No.
50, Classifications and Definitions of Insurance or Managed Care Contracts in
Force; No. 54, Individual and Group Accident and Health Contracts; No. 55, Unpaid Claims, Losses and Loss Adjustment Expenses; No. 61, Life, Deposit-Type
and Accident and Health Reinsurance; No. 66, Retrospectively Rated Contracts;
No. 73, Health Care Delivery Assets—Supplies, Pharmaceutical and Surgical
Supplies, Durable Medical Equipment, Furniture, Medical Equipment and Fixtures, and Leasehold Improvements in Health Care Facilities; No. 84, Certain
Health Care Receivables and Receivables Under Government Insured Plans;
No. 85, Claim Adjustment Expenses, Amendments to SSAP No. 55—Unpaid
Claims, Losses and Loss Adjustment Expenses; No. 87, Capitalization Policy,
An Amendment to SSAP Nos. 4, 19, 29, 73, 79 and 82; and No. 96, Settlement
requirements for Intercompany Transactions, An Amendment to SSAP No. 25—
Accounting for and Disclosures about Transactions with Affiliates and Other
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Related Parties. Preparers and auditors should consider the applicability of all
the SSAPs and apply the SSAPs to the insurer, as appropriate.

RBC Requirements
2.70 The risk-based capital (RBC) formula is one of the tools used by regulators to evaluate the financial health of regulated entities. The RBC formula
generally consists of the following principal risk elements: (a) affiliated investment risk, (b) asset risk, (c) underwriting risk, (d) credit risk, and (e) general
business risk. Based on the outcome of the RBC formula, an insurer may be
classified into one of four regulatory action levels. In order of increasingly stringent level of regulatory response, the action levels are company action level,
regulatory action level, authorized control level, and mandatory control level.
At a minimum, the company action level classification requires the filing of
an RBC plan with the respective state insurance commissioner that details
conditions leading to the classification event and the insurer's proposals of corrective action. State laws vary regarding compliance with the RBC formula and
required actions to be taken by the health plan. Additional information can be
found on the NAIC website at www.naic.org.
2.71 When assessing the risks of material misstatement, an auditor might
consider the RBC formula and the impact that the RBC formula might have
on the health plan's accounting and reporting.

Communications With Regulators and the Annual Financial
Reporting Model Regulation
2.72 AU section 325 requires the auditor to communicate control deficiencies that are significant deficiencies or material weaknesses in internal control.
The definitions in AU section 325 are consistent with PCAOB Auditing Standards in AU section 325, Communications About Control Deficiencies in an
Audit of Financial Statements (AICPA, PCAOB Standards and Related Rules,
Interim Standards).
2.73 The NAIC Annual Financial Reporting Model Regulation, commonly
referred to as the Model Audit Rule (MAR), has incorporated the provisions
of AU section 325 (AICPA, Professional Standards). MAR establishes new requirements related to management reporting on the effectiveness of internal
controls over statutory financial reporting, audit committees, auditor independence, and other statutory filing matters.|| A health plan will be required
to file a written communication to its domiciliary state on the effectiveness
of its internal control, similar to the requirements under Section 404 of the
Sarbanes-Oxley Act of 2002. The NAIC developed a companion publication,
Implementation Guide for the Annual Financial Reporting Model Regulation.
The MAR implementation guide is intended to supplement MAR, not create
additional requirements, by providing interpretative guidance and clarifying
the meaning of terms used in MAR. The MAR implementation guide will be
updated in the future, as necessary, and is included in the NAIC manual.

||
The revised National Association of Insurance Commissioners Annual Financial Reporting
Model Regulation, commonly referred to as the Model Audit Rule, is effective in most states on
January 1, 2010. The requirement for a Management's Report of Internal Control over Financial
Reporting is for health plans that have more than $500 million in written and assumed premiums in
their most recent fiscal year.
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Chapter 3

Unique Financial Statement Considerations
for Not-for-Profit Health Care Entities
3.01 Not-for-profit health care entities must apply the not-for-profit financial reporting model described in Financial Accounting Standards Board
(FASB) Accounting Standards Codification (ASC) 958, Not-for-Profit Entities,
subject to, and in accordance with, additional financial reporting guidance
provided in FASB ASC 954, Health Care Entities. The incremental financial
reporting guidance in FASB ASC 954 tailors the not-for-profit financial reporting model to better serve the needs of users of financial statements of health
care entities.1

Complete Set of Financial Statements
3.02 In accordance with FASB ASC 958-205-45-5, a set of financial statements of a not-for-profit health care entity should include (either in the body of
the statements or accompanying notes) information required by generally accepted accounting principles (GAAP) that does not specifically exempt not-forprofit entities and information required by applicable, specialized accounting
and reporting principles and practices.
3.03 The financial reporting for not-for-profit business-oriented health
care entities and investor-owned health care entities generally is consistent,
except for transactions that clearly are not applicable. For example, not-forprofit business-oriented health care entities would have nothing to report for
shareholders' equity. On the other hand, investor-owned health care entities
typically would not have anything to report for contributions.
3.04 According to FASB ASC 954-205-45-1, the basic financial statements
of health care entities consist of a balance sheet, a statement of operations, a
statement of changes in net assets (or equity), a statement of cash flows, and
notes to the financial statements.2
3.05 Some not-for-profit health care entities may use fund accounting for
purposes of internal recordkeeping and managerial control. As noted in FASB
ASC 958-205-45-3, reporting by fund groups is not a necessary part of external
financial reporting; however, FASB ASC 958-205 does not preclude providing
disaggregated information by fund groups. In accordance with FASB ASC 958210-45-2, because receivables and payables between fund groups are not entity
assets or liabilities, a statement of financial position should clearly label and
arrange those interfund items to eliminate their amounts when displaying total
assets or liabilities.

1
See paragraph 1.07 of this guide for a discussion of the financial reporting objectives of notfor-profit entities that are essentially self-sustaining from fees they charge for goods and services.
2
As noted in Financial Accounting Standards Board Accounting Standards Codification 958205-45-2, the terms balance sheet and statement of operations indicate the content and purpose of
the respective statements and serve as possible titles for those statements. Other appropriately
descriptive titles may also be used. For example, a statement reporting financial position could be
called a statement of financial position, as well as a balance sheet Current practice and purpose
suggest, however, that a statement of cash flows only be titled "Statement of Cash Flows."
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Balance Sheet
3.06 Not-for-profit health care entities are subject to the unique balance
sheet reporting requirements for not-for-profit entities set forth in FASB ASC
958-210. That guidance is subject to the more specific reporting requirements
for health care entities contained in FASB ASC 954-210. In addition, not-forprofit health care entities also should apply the requirements of FASB ASC
210, Balance Sheet, that are not in conflict with the more specific industry
requirements.
3.07 FASB ASC 958-210-45-1 requires that a statement of financial position focus on the not-for-profit entity as a whole and report all of the following
amounts: total assets; total liabilities; total net assets; and the amount of each of
the three classes of net assets (permanently restricted, temporarily restricted,
and unrestricted). FASB ASC 958-810-45-1 describes how to report noncontrolling interests in the equity (net assets) of consolidated subsidiaries within the
appropriate class(es) of net assets.
3.08 FASB ASC 954-210-45-1 requires not-for-profit health care entities
to classify assets and liabilities as current and noncurrent, as discussed in
FASB ASC 210-10-45. However, rather than presenting a classified balance
sheet, a continuing care retirement community may instead sequence assets
according to their nearness of conversion to cash and may sequence liabilities
according to the nearness of the maturity and resulting use of cash.

Statement of Operations
3.09 FASB ASC 958-225 describes the unique standards relating to the
income statement (statement of activities) of a not-for-profit entity. FASB ASC
954-225 modifies the requirements of FASB ASC 958-225 as they pertain to
not-for-profit health care entities.
3.10 Health care entities present the information included within the
statement of activities in two separate statements: a statement of operations,
which reports all changes in unrestricted net assets for the period, and a statement of changes in net assets. Alternatively, in accordance with FASB ASC
954-225-45-1, these may be combined into a single statement of operations and
changes in net assets.
3.11 Revenues, expenses, gains, and losses increase or decrease net assets
and are classified as provided in paragraphs 4–8 of FASB ASC 958-225-45
and are briefly discussed subsequently. Reclassifications, equity transfers, and
equity transactions should be reported as separate items. A reclassification is
the simultaneous increase of one class of net assets and decrease of another,
usually as a result of the release or lapsing of restrictions. Paragraphs 12.70–
.73 of this guide describe equity transfers, and paragraphs 12.74–.77 of this
guide describe equity transactions.

Performance Indicator
3.12 FASB ASC 954-225-45-4 requires that the statement of operations
for a not-for-profit business-oriented health care entity include a performance
indicator. The FASB ASC glossary states that a performance indicator reports
results of operations. A performance indicator and the income from continuing
operations reported by for-profit health care entities generally are consistent,
except for transactions that clearly are not applicable to one kind of entity
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(for example, for-profit health care entities typically would not receive contributions, and not-for-profit health care entities would not award stock compensation). The performance indicator is analogous to income from continuing
operations of a for-profit entity.
3.13 FASB ASC 954-225-45-4 also states that because of the importance
of the performance indicator, it should be clearly labeled with a descriptive
term, such as revenues over expenses, revenues and gains over expenses
and losses, earned income, or performance earnings. Not-for-profit businessoriented health care entities should report the performance indicator in a statement that also presents the total changes in unrestricted net assets.
3.14 The performance indicator reports results of operations and represents an earnings measure for the entity.3 The section of the statement of
operations below the performance indicator (referred to as "Other Changes
in Unrestricted Net Assets") generally should be regarded as the functional
equivalent of other comprehensive income in an investor-owned entity.
3.15 FASB ASC 954-225-50-1 requires that the notes to the financial statements include a description of the nature and composition of the performance
indicator.
3.16 In accordance with FASB ASC 954-225-45-7, the following items are
excluded from the performance indicator:
a. Transactions with owners acting in that capacity.
b. Equity transfers involving other entities that control the reporting
entity, are controlled by the reporting entity, or are under common
control with the reporting entity.
c. Receipt of restricted contributions, including temporary restrictions, such as time or purpose, or permanent restrictions.
d. Contributions of, and assets released from donor restrictions related to, long-lived assets.
e. Items that are required to be reported in, or reclassified from, other
comprehensive income, such as gains or losses, prior service costs
or credits, and transition assets or obligations recognized in accordance with FASB ASC 715, Compensation—Retirement Benefits;
foreign currency translation adjustments; and the effective portion
of the gain or loss on derivative instruments designated and qualifying as cash flow hedging instruments.
f. Items that are required to be reported separately under specialized
not-for-profit standards. These include extraordinary items and the
effect of discontinued operations. See paragraph 3.21.
g. Unrealized gains and losses on investments other than trading
securities, in accordance with FASB ASC 954-320-45-1(b).
h. Investment returns restricted by donors or law. See also FASB ASC
954-320-45-2.
3
Investor-owned entities are required by generally accepted accounting principles to include
discontinued operations within their net income measure. Not-for-profit entities are required to report
discontinued operations just before the change in net assets, preceded by a subtotal. See paragraph
3.19. Accordingly, the performance indicator is considered to be analogous to income from continuing
operations, rather than net income, of an investor-owned health care entity. Further, the term net
income is not an appropriate caption for describing the earnings measure of a not-for-profit entity.

AAG-HCO 3.16

34

Health Care Entities

i. Investment losses that decrease unrestricted net assets if those
losses reduce the assets of a donor-restricted endowment fund below the required level, as described in FASB ASC 958-205-45-22.
j. Investment gains that increase unrestricted net assets if those
gains restore the fair value of the assets of a donor-restricted endowment fund to the required level, as described in FASB ASC
958-205-45-22.
k. An inherent contribution (see FASB ASC 958-805-25-31) received in a not-for-profit acquisition transaction that increases
temporarily-restricted or permanently-restricted net assets, as described in FASB ASC 954-805-45-2.
3.17 The preceding items that reflect increases or decreases in unrestricted net assets are reported below the performance indicator in the statement of operations. Items that reflect increases or decreases in temporarilyrestricted or permanently-restricted net assets are reported in the statement
of changes in net assets, rather than the statement of operations.

Other Intermediate Subtotals
3.18 As noted in paragraphs 5–6 of FASB ASC 954-225-45, classifying
revenues, expenses, gains, and losses within classes of net assets does not preclude incorporating additional classifications within the performance indicator.
For example, within a class or classes of changes in net assets, a not-for-profit
health care entity may classify items as operating and nonoperating, expendable and nonexpendable, earned and unearned, recurring and nonrecurring,
or in other ways. The guidance neither requires nor precludes reporting such
intermediate measures or subtotals. As discussed in paragraphs 9–12 of FASB
ASC 958-225-45, not-for-profit entities have the flexibility to choose whether to
report an operating measure.
3.19 FASB ASC 958-225-45-11 states that if an intermediate measure of
operations is reported, other subtopics within FASB ASC impose limitations
on an entity's use of that measure. If a subtotal is presented, such as income
from operations, it should include the amounts of the following items:
a. An impairment loss recognized for a long-lived asset (asset group)
that is to be held and used, pursuant to FASB ASC 360-10-45-4
b. Costs associated with an exit or a disposal activity that does not
involve a discontinued operation, pursuant to FASB ASC 420-1045-3
c. A gain or loss recognized on the sale of a long-lived asset (disposal
group) that is not a component of an entity, pursuant to FASB ASC
360-10-45-5
d. Amortization expense and impairment losses for intangible assets,
pursuant to FASB ASC 350-30-45-2
3.20 As required by FASB ASC 958-225-50-1, if a not-for-profit health care
entity's use of the term operations is not apparent from the details provided on
the face of the statement, a note to the financial statements should describe
the nature of the reported measure of operations or the items excluded from
operations.
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Extraordinary Items, Discontinued Operations,
and Accounting Changes
3.21 As illustrated in FASB ASC 958-225-55-6, GAAP requires a not-forprofit entity to appropriately report labeled subtotals for changes in classes of
net assets before the effects of discontinued operating segments or extraordinary items, if any.
3.22 Normally, a FASB Accounting Standards Update will provide specific
transition requirements. If a newly-issued standard requires that the effect of
an accounting change be reported as a cumulative-effect adjustment to the
change in net assets of the period of the change, rather than by retrospective
application, that amount would also be displayed with extraordinary items
and discontinued operations, unless the transition requirements provided otherwise.

Revenues
3.23 FASB ASC 958-225-45-5 requires that revenues be reported as increases in unrestricted net assets, unless the use of the received assets is
limited by donor-imposed restrictions.
3.24 The financial statement display requirements for patient service revenue and capitation revenue are discussed in chapter 10, "Health Care Service
Revenue and Related Receivables," of this guide, and display of managed care
revenue is discussed in chapter 13, "Financial Accounting and Reporting for
Managed Care Services," of this guide.
3.25 As discussed in FASB ASC 954-605-05-4, other revenue, gains, or
losses are derived from services other than providing health care services to
patients, residents, or enrollees. These typically include the following:

r
r
r
r
r
r
r
r
r

Interest and dividends from all funds held by a trustee, malpractice funds, or other miscellaneous investment activities
Certain realized changes in fair values of marketable securities
Fees from educational programs, which include tuition for schools,
such as nursing, or laboratory and X-ray technology
Rental of health care facility space
Sales of medical and pharmaceutical supplies to employees, physicians, and others
Fees charged for transcripts for lawyers, insurance companies,
and others
Proceeds from the sale of cafeteria meals and guest trays to employees, medical staff, and visitors
Proceeds from the sale of scrap, used X-ray film, and so on
Proceeds from sales at gift shops, snack bars, newsstands, parking
lots, vending machines, or other service facilities operated by the
health care entity

Expenses
3.26 FASB ASC 958-225-45-7 requires a not-for-profit entity to report
all expenses as decreases in unrestricted net assets. FASB ASC 958-720-45
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provides standards for the presentation of expenses in the financial statements
of a not-for-profit entity.
3.27 Expenses may be reported on the face of the statement of operations
using either a natural classification (for example, salaries and wages, supplies,
and so on) or functional presentation (a method of grouping expenses according
to the purpose for which costs are incurred). Pursuant to FASB ASC 958205-55-11, not-for-profit entities that report using a natural classification of
expenses on the face of the statement of operations are required to disclose
expenses by functional classification in the notes to the financial statements.
3.28 According to FASB ASC 954-225-45-3, the primary functional classifications are program services and supporting activities. The extent of classification and subclassification of expenses depends on many factors, such as
the nature and complexity of the health care entity. For example, in complying with the functional reporting requirements of FASB ASC 958-205-45-6,
958-720-05-4, and 958-720-45-2, some health care entities may present only
two categories: health services, including inpatient services, outpatient procedures, home health services, and so forth, and general and administrative. Others may present additional distinctions, such as physician services, research,
and teaching. Functional allocations should be based on full cost allocations.

Statement of Changes in Net Assets (or Equity)
3.29 The statement of changes in net assets (or equity) reports all changes
that have occurred during the reporting period in each classification of net assets (unrestricted, temporarily restricted, and permanently restricted). As discussed in paragraph 3.10, this statement may be combined with the statement
of operations or presented separately.
3.30 The statement of changes in net assets displays the four measures
required by FASB ASC 958-225-45-1: the change in permanently-restricted
net assets, the change in temporarily-restricted net assets, the change in unrestricted net assets, and the change in net assets for the entity as a whole. As
illustrated in FASB ASC 958-205-55-16, typically, the information presented
for the unrestricted net asset category in the statement of changes in net assets
is highly aggregated.
3.31 Restricted contributions and restricted investment return, which are
excluded from the performance indicator, are reported as increases or decreases
in temporarily-restricted or permanently-restricted net assets in the statement
of changes in net assets. Restricted contributions are discussed in chapter 11,
"Contributions Received and Made," of this guide, and restricted investment
return is discussed in paragraphs 4.32–.34 of this guide.
3.32 Because all expenses must be reported as decreases in unrestricted
net assets, as discussed in paragraph 3.26, no expenses should be reported
in the temporarily-restricted or permanently-restricted net asset categories.
However, certain losses may be reported within those categories, as discussed
in FASB ASC 958-225-45-8.

Statement of Cash Flows
3.33 The general standards for reporting cash flows are provided in FASB
ASC 230, Statement of Cash Flows. FASB ASC 958-230 provides incremental
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guidance related to reporting not-for-profit-specific transactions within this
statement. According to FASB ASC 230-10-45, the statement of cash flows
may be prepared using the direct or indirect method of reporting cash flows.
3.34 FASB ASC 230-10-45-28 requires a not-for-profit entity to reconcile
the change in net assets to net cash flows from operating activities. FASB ASC
958-205-55-20 provides an example of this reconciliation.
3.35 The reconciliation will need to accommodate certain items that are
not included in cash flow statements prepared for investor-owned health care
entities, such as equity transfers, contributions of long-lived assets, other contributions restricted for long-term purposes, unrealized gains and losses on
certain investments, investment returns restricted for long-term purposes by
donor or law, and the effective portion of fair value changes of cash flow hedging
derivatives.
3.36 FASB ASC 958-230 expands the description of financing activities
in FASB ASC 230 to encompass receipts of resources that are donor-restricted
for long-term purposes. As discussed in FASB ASC 958-210-45-6, cash or other
assets received with a donor-imposed restriction that limits their use to long
term should not be classified on a statement of financial position with cash
or other assets that are unrestricted and available for current use. Therefore,
as discussed in FASB ASC 958-230-55-3, when a not-for-profit entity reports
cash received with a donor-imposed restriction that limits its use to long-term
purposes, in conformity with FASB ASC 958-210-45-6, an adjustment is necessary for the statement of cash flows to reconcile beginning and ending cash
and cash equivalents. To report in conformity with FASB ASC 230, the receipt
of a cash contribution that is restricted for the purchase of equipment should
be reported as a cash flow from financing activities (using a caption such as
"Contributions Restricted for Purchasing Equipment"), and it should be simultaneously reported as a cash outflow from investing activities (using a caption
such as "Purchase of Assets Restricted to Investment in Property and Equipment" or, if the equipment was purchased in the same period, "Purchase of
Equipment"). An adjustment to reconcile the change in net assets to net cash
used or provided by operating activities would also be needed if the contributed
asset is not classified as cash or cash equivalents on the statement of financial
position. When the equipment is purchased in a subsequent period, both the
proceeds from the sale of assets restricted to investment in the equipment and
the purchase of the equipment should be reported as cash flows from investing
activities.

Notes to the Financial Statements
3.37 The individual chapters of this guide discuss the notes to the financial
statements that are unique to, or prevalent for, health care entities.

Subsequent Events
3.38 FASB ASC 855, Subsequent Events, establishes standards for accounting for, and disclosure of, events that occur after the balance sheet date
but before financial statements are issued or available to be issued. In accordance with FASB ASC 855-10-25, an entity should recognize in the financial
statements the effects of all subsequent events that provide additional evidence
about conditions that existed at the date of the balance sheet, including the
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estimates inherent in the process of preparing financial statements. An entity
should not recognize subsequent events that provide evidence about conditions
that did not exist at the date of the balance sheet but arose after the balance
sheet date but before financial statements are issued or available to be issued.
Instead, nonrecognized subsequent events are disclosed if they are of such a
nature that they must be disclosed to keep the financial statements from being
misleading.
3.39 As discussed in paragraphs 7.06–.08 of this guide, because of their use
of conduit debt that trades in public markets, many not-for-profit health care
entities fall into the class of entities that are required to evaluate subsequent
events through the issuance date of their financial statements. However, if a
not-for-profit health care entity issued tax-exempt debt in a private placement,
and the debt has not subsequently begun trading in a public market, the entity
is not a conduit bond obligor for the purpose of FASB ASC 855 because its debt
does not trade in a public market.
3.40 If a not-for-profit health care entity does not have conduit debt that
trades in a public market, it is required to evaluate subsequent events up
through the date that the financial statements are available to be issued. The
FASB ASC glossary definition of financial statements are available to be issued states that "[f]inancial statements are considered available to be issued
when they are complete in a form and format that complies with GAAP and
all approvals necessary for issuance have been obtained, for example, from
management, the board of directors, and/or significant shareholders."

Example Financial Statements
3.41 Some health care entities choose to present very detailed financial
statements; others present highly condensed statements, providing only summary totals of major classifications of revenue and expense. Each entity should
use the presentation that it considers to be most informative given its own
facts and circumstances, provided that the statements comply with the reporting parameters of GAAP.
3.42 Examples of financial statements of health care entities are not included in this guide. Examples may be found in the following places:

r

r
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The website for Electronic Municipal Market Access (EMMA),
(http://emma.msrb.org) for financial statements of not-for-profit
health care entities. EMMA is the official source for municipal
disclosures and market data maintained by the Municipal Securities Rulemaking Board. EMMA contains official statements and
continuing disclosures for not-for-profit entities with tax-exempt
bonds.
The website for the Electronic Data Gathering, Analysis, and Retrieval (EDGAR) system (www.sec.gov/edgar/aboutedgar.htm) for
financial statements of investor-owned health care entities that
are required to file forms with the Securities and Exchange Commission (SEC). EDGAR is the system for the automated collection,
validation, indexing, acceptance, and forwarding of submissions
by companies and others that are required by law to file forms
with the SEC.

r
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The websites of health care entities that are considered peers of
the reporting entity.
The websites of regulatory agencies, such as the secretary of state
or departments of health or insurance.
The AICPA publications Accounting Trends and Techniques—
Not-for-Profit Entities and Accounting Trends and Techniques
(www.cpa2biz.com), which are useful for the disclosure examples,
even though they do not contain example financial statements of
health care entities.
The AICPA publications Health Care Entities: Checklist and Illustrative Financial Statements (www.cpa2biz.com).
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Chapter 4

Cash, Cash Equivalents, and Investments
Cash and Cash Equivalents
4.01 Health care entities, both investor-owned and not for profit, hold
cash balances to meet payments arising in the ordinary course of operations
and unanticipated contingencies. These balances may be held as cash or cash
equivalents. This chapter discusses the following industry-pervasive matters
about accounting for cash and cash equivalents:

r
r
r

Centralized cash management arrangements (see paragraphs
4.03–.06)
Cash from restricted donations (see paragraph 4.07)
Other restricted or designated cash amounts (see paragraphs
4.08–.11)

4.02 The Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) glossary defines a cash equivalent as
short-term, highly liquid investments that have both of the following
characteristics:
a. Readily convertible to known amounts of cash
b. So near their maturity that they present insignificant risk of
changes in value because of changes in interest rates.
Generally, only investments with original maturities of three months
or less qualify under that definition. Original maturity means original
maturity to the entity holding the investment. For example, both a
three-month U.S. Treasury bill and a three-year U.S. Treasury note
purchased three months from maturity qualify as cash equivalents.
However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months.
Examples of items commonly considered to be cash equivalents are
Treasury bills, commercial paper, money market funds, and federal
funds sold (for an entity with banking operations).

Centralized Cash Management Arrangements
4.03 Many health care entities have centralized cash management arrangements whereby excess cash is swept into a cash pool. Subsidiary cash
requirements are met through withdrawals or borrowings from the cash pool.
The cash pool is invested in assets, such as deposits at banks, that are in the
parent company's name. Under this type of arrangement, the parent company
and its subsidiaries have sweep arrangements with their respective banks
whereby cash is transferred daily between the bank accounts of the entities
(the parent and its subsidiaries). These arrangements serve to reduce lending costs and provide a higher rate of return on invested cash. Careful review
of centralized cash management arrangements is necessary to determine the
appropriate accounting and reporting of a subsidiary's deposit in the cash pool.
4.04 The FASB ASC glossary states that cash "includes not only currency
on hand but demand deposits with banks or other financial institutions. Cash
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also includes other kinds of accounts that have the general characteristics of
demand deposits in that the customer may deposit additional funds at any time
and also effectively may withdraw funds at any time without prior notice or
penalty."
4.05 Funds deposited by a subsidiary in a parent company's cash account
under a centralized cash management arrangement generally would not be
classified as cash and cash equivalents in the subsidiary's financial statements
if the subsidiary does not have legal title to the cash on deposit. Generally,
legal title in a cash account is evidenced by the cash or cash equivalent being
deposited in a demand deposit account at a bank or other financial institution
in the subsidiary's name. A subsidiary's deposit in a cash pool generally is not
a short-term highly-liquid investment, as contemplated in the definition of a
cash equivalent in paragraph 4.02; rather, the deposit is considered a loan, and
the subsidiary would classify the deposit in the cash pool as a receivable from
an affiliated entity.
4.06 If the indirect method is used to prepare the statement of cash flows,
changes in the subsidiary's receivable relating to a centralized cash management program are presented as investing activities—as such, balances are generally considered loans. Payments to, and receipts from, the cash pool would
be presented on a gross or net basis, in accordance with the guidance in paragraphs 7–9 of FASB ASC 230-10-45.

Cash From Restricted Donations
4.07 FASB ASC 954-305-45-3 states that for fiduciary purposes, not-forprofit business-oriented health care entities may maintain separate checking or
savings accounts for restricted donations. However, unless required by FASB
ASC 954-305-45-1, as discussed in paragraph 4.08, such accounts are not reported on a line separate from other cash and cash equivalents because donor
restrictions generally relate to limitations on the use of net assets, rather than
the use of specific assets.1

Other Restricted or Designated Cash Amounts
4.08 FASB ASC 954-305-45-1 states that cash and claims to cash that
meet any of the following conditions should be reported separately and excluded
from current assets:
a. They are restricted regarding withdrawal or use for other-thancurrent operations.
b. They are designated for expenditure in the acquisition or construction of noncurrent assets.
c. They are required to be segregated for the liquidation of long-term
debt.
d. They are required by a donor-imposed restriction that limits their
use to long-term purposes (see paragraph 11.05 of this guide.).
Further, according to FASB ASC 954-210-45-4, internally designated funds
should be reported separately from externally designated funds either on the
face of the balance sheet or in the notes to the financial statements.
1
Per Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC)
954-305-45-3, a columnar presentation that highlights the three classes of net assets (permanently
restricted, temporarily restricted, and unrestricted) is not precluded if the totals for the reporting
entity as a whole are displayed.
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4.09 For example, such amounts could be reported on a separate line and
described as assets whose use has been limited or whose use is restricted, such
as designated for construction, limited by donor-imposed restrictions, held by
the trustee for liquidation of long-term debt, and so on.
4.10 FASB ASC 958-210-45-6 states that the asset whose use is limited
should be described in the notes to the financial statements if its nature is not
clear from the description on the face of the balance sheet.
4.11 Restricted cash is similar to investments in that the holder's ability to
withdraw restricted cash amounts is contractually limited. As a result, deposits
and withdrawals of principal balances in restricted cash accounts would be
reported as investing activities in the statement of cash flows.

Investments
4.12 Health care entities can maintain and manage significant investment portfolios. The nature of such investments held by health care entities
is dependent upon various factors, such as an entity's investment policies and
strategies, donor and other external restrictions, and regulations. The legal
structure, term, and features specific to an instrument, such as restrictions
on disposing of the investment or other internal and external restrictions, can
affect both the accounting and reporting of an investment and the valuation of
the investment.
4.13 This chapter discusses the following industry-pervasive matters
about accounting for investments:

r
r
r
r
r
r
r
r
r
r

The fair value option to measure financial assets (see paragraphs
4.17–.22)
Investments in equity securities that have readily determinable
fair values and all investments in debt securities for which an entity has not elected to apply the fair value option (see paragraphs
4.23–.35)
Investments for which a readily determinable fair value does not
exist and for which an entity has not elected to apply the fair
value option, including alternative investments, such as collective
trusts, funds of funds, or hedge funds (see paragraphs 4.36–.38)
Investment pools (see paragraphs 4.39–.47)
Fair value measurement (see paragraph 4.48)
Impairment of investments (see paragraphs 4.49–.59)
Securities lending arrangements (see paragraph 4.60)
Transfers of assets to a not-for-profit entity or charitable trust for
investment (see paragraphs 4.61–.63)
Regulation (see paragraph 4.64)
Other financial statement presentation matters (see paragraphs
4.65–.73)

4.14 The following investments are discussed elsewhere in this guide:

r

Chapter 5, "Derivatives," discusses investments in derivative instruments that are accounted for in accordance with FASB ASC
815, Derivatives and Hedging.
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Chapter 12, "The Reporting Entity and Related Entities," discusses investments accounted for under the equity method if the
investees are an integral part of the entity's operations, such as a
physician hospital organization or joint venture.2
Chapter 12 also discusses investments in consolidated or combined entities.

4.15 According to FASB ASC 954-325-35-1, other types of investments
that are not financial instruments, such as real estate or certain oil and gas
interests, are reported at amortized cost and subject to impairment considerations consistent with the "Impairment or Disposal of Long-lived Assets"
sections of FASB ASC 360-10.
4.16 Health care entities can use this chapter, not-for-profit health care
entities can use exhibit 12-1, and investor-owned health care entities can use
paragraph 12.55 to assist with the determination of which investments are required to be consolidated and which are accounted for using the equity method
if the entity has not elected to apply the fair value option, as discussed in
paragraph 4.17.

Fair Value Option
4.17 Most investments owned by health care entities are financial assets,
as defined in FASB ASC 825-10-20. The "Fair Value Option" sections of FASB
ASC 825-10 permit all entities to choose to measure eligible items at fair value
(the fair value option) at specified election dates. Paragraphs 4–5 of FASB ASC
825-10-15 describe which financial assets are eligible items.
4.18 The decision about whether to elect the fair value option should be (a)
applied instrument by instrument, except as discussed in FASB ASC 825-1025-7; (b) irrevocable, unless a new election date occurs, as discussed in FASB
ASC 825-10-25-4; and (c) applied only to an entire instrument, not specific
risks, specific cash flows, or portions of that instrument.
4.19 Health care entities should follow the guidance in FASB ASC 820,
Fair Value Measurements and Disclosures,* to determine and report an investment's fair value. FASB ASC 825-1-25-3 requires that upfront costs and
fees related to items for which the fair value option is elected be recognized in
earnings as incurred and not deferred. Health care entities that elect to apply
2
This chapter discusses the accounting and reporting for equity investments accounted for under
the equity method if such investment's purpose is investment income or return, such as collective
trusts, funds of funds, hedge funds, or other alternative investments, versus an equity investment
that represents an integral part of the reporting entity's operations, such as a physician hospital
organization or joint venture.
*
In May 2011, FASB issued Accounting Standards Update (ASU) No. 2011-04, Fair Value
Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure
Requirements in U.S. GAAP and IFRSs. According to FASB, the objective of this update is to improve the comparability of fair value measurements presented and disclosed in financial statements
prepared in accordance with U.S. generally accepted accounting principles (GAAP) and International
Financial Reporting Standards by changing the wording used to describe many of the requirements
in U.S. GAAP for measuring fair value and disclosing information about fair value measurements.
The amendments include those that clarify FASB's intent about the application of existing fair value
measurement and disclosure requirements and those that change a particular principle or requirement for measuring fair value or disclosing information about fair value measurements. This ASU,
which is to be applied prospectively, is effective for public entities during interim and annual periods
beginning after December 15, 2011 (early application is not permitted). For nonpublic entities, the
amendments are effective for annual periods beginning after December 15, 2011. Nonpublic entities
may early implement during interim periods beginning after December 15, 2011.
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the fair value option to an instrument should refer to the guidance in FASB
ASC 825-10-50 and 820-10-50 for the required financial statement disclosures.
FASB ASC 825-10-45-3 requires that entities classify cash receipts and payments related to items measured at fair value according to their nature and
purpose, as required by FASB ASC 230, Statement of Cash Flows.
4.20 In accordance with FASB ASC 825-10-35-4, investor-owned health
care entities should report unrealized gains and losses on items for which the
fair value option has been elected in earnings.
4.21 In accordance with FASB ASC 825-10-15-7, not-for-profit health care
entities should report unrealized gains and losses on items for which the fair
value option has been elected within the performance indicator or as part of discontinued operations, as appropriate. Consistent with the provisions of FASB
ASC 958-10 and 954-225-45-5, a not-for-profit health care entity may present
such gains and losses either within or outside an intermediate measure of operations, unless such gains or losses are part of discontinued operations; however, that intermediate measure must be within the performance indicator. For
not-for-profit entities, the disclosure requirements of FASB ASC 825-10-50-30
apply not only with respect to the effect on performance indicators or other intermediate measures of operations, if presented, but also on the change in each
of the net asset classes (unrestricted, temporarily restricted, and permanently
restricted), if applicable.
4.22 Per FASB ASC 825-10-50-28(f), for investments that would have
been accounted for under the equity method if the health care entity had not
chosen to apply the fair value option, the health care entity should disclose the
information required by FASB ASC 323-10-50-3, excluding the disclosures in
FASB ASC 323-10-50-3(a)(3), (b), and (d).

Investments in Debt Securities and Certain Equity Securities With
a Readily Determinable Fair Value That Are Not Recorded Under
the Fair Value Option
4.23 This section discusses the accounting and reporting for investments
in equity securities that have readily determinable fair values and all investments in debt securities held by investor-owned and not-for-profit entities for
which the health care entity has not elected to apply the fair value option to
the instrument, as discussed in paragraph 4.17.

Investor-Owned Entities
4.24 Investor-owned health care entities are subject to the accounting and
reporting requirements of FASB ASC 320, Investments—Debt and Equity Securities. FASB ASC 320 does not apply to (a) instruments for which the health
care entity elected to apply the fair value option, as discussed in paragraphs
4.17–.22; (b) equity securities that, absent the election of the fair value option
under FASB ASC 825-10-25-1, would be required to be accounted for under
the equity method; (c) investments in consolidated entities; (d) investments in
derivative instruments that are accounted for in accordance with FASB ASC
815, and (e) except with respect to impairment guidance in FASB ASC 320-1035, equity securities within the scope of FASB ASC 325-20 (that is, cost-method
investments). FASB ASC 320-10-15 provides a more complete description of the
scope of FASB ASC 320.

AAG-HCO 4.24

46

Health Care Entities

4.25 FASB ASC 320-10-25-1 states that at acquisition, an entity shall
classify its debt and equity securities into one of three categories:
a. Trading securities. If a security is acquired with the intent of selling
it within hours or days, the security should be classified as trading.
However, at acquisition, an entity is not precluded from classifying
as trading a security it plans to hold for a longer period. Classification of a security as trading should not be precluded simply because
the entity does not intend to sell it in the near term.
b. Available-for-sale securities. Investments in debt securities and equity securities that have readily determinable fair values and are
not classified as trading securities or held-to-maturity securities
should be classified as available-for-sale securities.
c. Held-to-maturity securities. Investments in debt securities should
be classified as held to maturity only if the reporting entity has the
positive intent and ability to hold those securities to maturity.
4.26 Per FASB ASC 320-10-35-1, investments in debt securities that are
classified as held to maturity should be measured subsequently at amortized
cost in the balance sheet. Investments that are classified as trading should
be measured subsequently at fair value in the balance sheet, and unrealized
holding gains and losses for trading securities should be included in earnings.
Investments that are classified as available for sale should be measured subsequently at fair value in the balance sheet, and unrealized holding gains and
losses for available-for-sale securities, including those classified as current assets, should be excluded from earnings and reported in other comprehensive
income until realized, except as indicated in the following sentence. All or a
portion of the unrealized holding gain and loss of an available-for-sale security
that is designated as being hedged in a fair value hedge should be recognized in
earnings during the period of the hedge, pursuant to paragraphs 1–4 of FASB
ASC 815-25-35.
4.27 For investments within the scope of FASB ASC 320, investor-owned
health care entities should follow the disclosure requirements of FASB ASC
320-10-50.

Not-for-Profit Entities
4.28 Not-for-profit health care entities are subject to the accounting and
reporting requirements of FASB ASC 958-320 and 954-320. FASB ASC 958320 does not apply to (a) instruments for which the health care entity elected
to apply the fair value option, as discussed in paragraphs 4.17–.22; (b) equity investments accounted for under the equity method; (c) investments in
consolidated subsidiaries; (d) investments in derivative instruments that are
accounted for in accordance with FASB ASC 815; (e) investments held by a financially interrelated entity, as discussed in paragraph 12.75 of this guide; and
(f) short sales of securities. FASB ASC 958-320-15 provides a more complete
description of the scope of FASB ASC 958-320.
4.29 Not-for-profit health care entities can designate investment portfolios or portions of investment portfolios as trading. Investment returns from
investments, inclusive of those securities designated as trading, accounted for
under FASB ASC 958-320 should be included as changes in net assets, consistent with paragraphs 4.30–.34.
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4.30 FASB ASC 958-320-35 requires investments in equity securities with
readily determinable fair values and all debt securities to be measured at fair
value in the balance sheet. According to FASB ASC 954-320-45-1, investment
returns, including realized and unrealized gains and losses, not restricted by
donors or law should be classified as changes in unrestricted net assets as
follows:
a. The following are included in the performance indicator (see paragraphs 3.12–.17 of this guide):
i. Dividend, interest, and other similar investment income
ii. Realized gains and losses
iii. Unrealized gains and losses on trading securities
iv. Other-than-temporary impairment losses
b. The following is excluded from the performance indicator:
i. Unrealized gains and losses on other-than-trading securities
4.31 Because the performance indicator is analogous to income from continuing operations of an investor-owned health care entity, as discussed in
paragraph 3.12 of this guide, the performance indicator would also include unrealized gains and losses on investments recorded under the fair value option
and equity earnings from investments in entities, such as investment companies and other alternative investments, accounted for under the equity method.
The performance indicator would exclude the portion of other-than-temporary
impairment losses on debt securities that is related to factors other than credit
losses, as discussed in paragraph 4.55.
4.32 Pursuant to paragraphs 1–2 of FASB ASC 958-320-45, except as
described in paragraphs 4.33–.34, dividend, interest, and other investment income and gains and losses should be reported as increases or decreases in unrestricted net assets, unless their use is temporarily or permanently restricted by
explicit donor stipulations or law. Donor-restricted investment income should
be reported as an increase in temporarily or permanently restricted net assets,
depending on the type of restriction.
4.33 FASB ASC 958-320-45-3 states that gains and investment income
that are limited to specific uses by donor-imposed restrictions may be reported
as increases in unrestricted net assets if the restrictions are met in the same
reporting period as the gains and income are recognized, provided that the
not-for-profit entity has a similar policy for reporting received contributions,
as discussed in paragraphs 3–5 of FASB ASC 958-605-45; reports consistently
from period to period; and discloses its accounting policy. The classification of
these gains and investment income within unrestricted net assets should be
consistent with paragraph 4.30.
4.34 Paragraphs 16–35 of FASB ASC 958-205-45 describe the accounting
for gains and losses on investments of donor-restricted endowment funds. FASB
ASC 958-205-45-22 states that in the absence of donor stipulations or law
to the contrary, losses on the investments of a donor-restricted endowment
fund should temporarily reduce restricted net assets to the extent that donorimposed temporary restrictions on net appreciation of the fund have not been
met before the loss occurs. Any remaining loss should reduce unrestricted
net assets. FASB ASC 954-225-45-7 requires that the portion of the loss that
reduces the assets of a donor-restricted endowment fund below the required
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level3 be excluded from the determination of the performance indicator. FASB
ASC 958-205-45-24 states that if losses reduce the assets of a donor-restricted
endowment fund below the level required by the donor stipulations or law, gains
that restore the fair value of the assets of the endowment fund to the required
level should be classified as increases in unrestricted net assets. FASB ASC
954-225-45-7 requires that those gains be excluded from the determination of
the performance indicator.
4.35 Not-for-profit health care entities should follow the disclosure requirements included in FASB ASC 954-320 and 958-320-50.

Investments in Certain Other Financial Instruments Without
a Readily Determinable Fair Value That Are Not Recorded
Under the Fair Value Option
4.36 In an effort to improve investment returns, health care entities may
invest in investment companies structured as limited liability companies, limited partnerships, institutional trusts, common and collective trusts, or financial instruments that do not have a readily determinable fair value. These types
of investments are commonly referred to as alternative investments. Assuming that the health care entity has not elected to apply the fair value option to
account for these investments, the accounting for these types of investments
can vary depending upon the legal structure of the investment, as well as
the investment's terms and features. An alternative investment may have a
formal notification period that requires the investor to provide the investee
60, 90, or 360 day's notification prior to redeeming the investment for cash.
Additionally, the legal structure of certain alternative investments provides
the investor ownership rights and responsibilities similar to a limited partnership whereas others do not provide such ownership rights to the investor. The
terms and features of each alternative investment must be carefully considered before concluding on the appropriate method of accounting. Exhibit 12-1
and paragraph 12.51 of this guide provide helpful guidance for determining
the appropriate method of accounting for not-for-profit health care entities and
investor-owned health care entities, respectively. Paragraphs 4.39–.47 provide
additional discussion for investment pools.
4.37 Determining the fair value of alternative investments may be necessary for recognition or disclosure purposes. Many of these investees provide
their investors with a net asset value (NAV) per share or its equivalent that
has been calculated in a manner consistent with FASB ASC 946, Financial
Services—Investment Companies. If those investments do not have readily determinable fair values, FASB ASC 820-10-35-59 permits a reporting entity, as
a practical expedient, to estimate the fair value of an investment within the
scope of paragraphs 4–5 of FASB ASC 820-10-15 using the NAV per share
of the investment or its equivalent, such as member units or an ownership
interest in partners' capital to which a proportionate share of net assets is attributed, if the NAV per share of the investment or its equivalent is calculated
3
Donors that create endowment funds can require that their gifts be invested in perpetuity or
for a specified term. Some donors may require that a portion of income, gains, or both be added to the
gift and invested, subject to similar restrictions. Not-for-profit health care entities in states that have
adopted the Uniform Prudent Management of Institutional Funds Act should refer to paragraphs
28–32 of FASB ASC 958-205-45 for additional information about the classification of net assets of
donor-restricted endowment funds. Not-for-profit health care entities in other states should refer to
paragraphs 33–35 of FASB ASC 958-205-45.
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in a manner consistent with the measurement principles of FASB ASC 946 as
of the reporting entity's measurement date. FASB ASC 820-10-50-6A requires
certain disclosures for alternative investments, regardless of whether NAV is
used as a practical expedient for fair value.
4.38 Sections .18–.26 of Technical Questions and Answers (TIS) section
2220, Long-Term Investments (AICPA, Technical Practice Aids), are intended
to assist reporting entities in applying the provisions of FASB ASC 820, which
are discussed in the preceding paragraph. TIS section 2220.27, "Determining
Fair Value of Investments When the Practical Expedient Is Not Used or Is Not
Available" (AICPA, Technical Practice Aids), assists reporting entities in determining the fair value of investments in circumstances in which the practical
expedient NAV is not used or available.

Investment Pools
4.39 In order to effectively manage investments and improve total investment returns, many not-for-profit health care entities pool part or all of their
investments with other not-for-profit health care entities. The not-for-profit
entities may or may not be financially-interrelated entities, as discussed in
FASB ASC 958-20-15-2 and paragraph 12.75 of this guide. The pooled investments are generally managed by a sponsoring entity's treasury department
(for example, a parent treasury division) in a manner similar to a mutual fund
arrangement. When a pool is established, ownership interests are initially assigned (typically through unitization) to the various pool investors (sometimes
referred to as participants) based on the fair value of the cash and securities
placed in the pool by each investor (participant). Current fair value is generally used to determine the number of units allocated to additional assets placed
in the pool and to value withdrawals from the pool (for example, the sponsor
calculates a NAV per unit, and the investor's [participant's] purchases and
sales are based on the NAV unit value). Investment income, realized gains and
losses, and any recognized unrealized gains and losses are allocated equitably
based on the number of units assigned to each investor (participant). Generally
the investor's (participant's) ownership interest in the pool is due on demand;
however, in certain arrangements, investors (participants) may be required to
provide notification to the pool sponsor prior to divesting, or further limitations
on withdrawal may be imposed on the investors (participants). The investors
(participants) generally do not have rights or interests in specific assets or investments held in the pool but, instead, own a beneficial-type interest in the
pool. These pools typically do not have a formal legal structure, and no security,
as defined by either FASB ASC 825, Financial Instruments, or FASB ASC 958320, is created. Paragraphs 4.40–.47 provide the Financial Reporting Executive
Committee's (FinREC's) recommendation on how to implement the standards
in FASB ASC 958-20 and the "Transfers of Assets to a Not-for-Profit Entity
or Charitable Trust that Raises or Holds Contributions for Others" sections of
FASB ASC 958-605 when they are applied to investment pools.
4.40 The underlying investments are owned by the sponsor and included in the sponsor's assets. The investor's (participant's) recognition of its
beneficial-type interest in the pool depends upon the relationship of the sponsor
and investor (participant), as follows:

r

If the investor (participant) and sponsor are neither affiliates
nor financially interrelated entities (see paragraph 12.75 of this
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guide), the investor (participant) should recognize its beneficialtype interest as described in paragraphs 4.41–.42.
If the investor (participant) and sponsor are affiliates or otherwise
financially interrelated entities, the investor (participant) should
recognize its beneficial-type interest as described in paragraphs
4.43–.45.

4.41 If the investor (participant) (beneficiary) and sponsor (recipient entity) are neither affiliates nor financially interrelated entities, the investor
(participant) would recognize its rights to the assets held by the sponsor as a
beneficial interest in an identifiable pool of assets, as described in FASB ASC
958-605-25-33(d). FASB ASC 958-605-30-14 and 958-605-35-3 state that if a
beneficiary has an unconditional right to receive all or a portion of the specified
cash flows from a charitable trust or other identifiable pool of assets, the beneficiary should measure and subsequently remeasure that beneficial interest at
fair value.
4.42 Changes in fair value of the beneficial interest in the investment
pool are reported above (included in) the performance indicator in the statement of operations if the investment return was unrestricted. In the investor's
(participant's) balance sheet, the interest in the pool might be reported using a
caption such as "Beneficial Interest in Investment Pool" or "Interest in Investment Pool." If the investor's (participant's) balances are due on demand, the
change in value of the beneficial interest that related to purchases and sales
of pool units would be reported net in the "Investing" section of the cash flow
statement. However, if the balances are not due on demand, the purchases
and sales of pool units would be recorded gross in the investor's (participant's)
"Investing" section of the cash flow statement, unless the cash flows qualified
for net reporting, as discussed in paragraphs 7–9 of FASB ASC 230-10-45. The
change in value of the beneficial interest related to unrealized gains and losses
would be reported in the cash flow statement in the same manner as unrealized
gains and losses on investments are reported.
4.43 If the investor (participant) and sponsor are financially-interrelated
entities, as discussed in FASB ASC 958-20-15-2 and paragraph 12.75 of this
guide, the investor (participant) (beneficiary) would account for its investment
in the pool as part of its interest in the sponsor (recipient entity). FASB ASC
958-20-25-2 requires that if a beneficiary and recipient entity are financiallyinterrelated entities, the beneficiary should recognize its interest in the net
assets of the recipient entity. Recognizing an interest in the net assets of the
recipient entity and adjusting that interest for a share of the change in net
assets of the recipient entity is similar to the equity method, which is described
in FASB ASC 323-10. Alternatively, the investor (participant) may elect the
fair value option described in the "Fair Value Option" sections of FASB ASC
825-10.
4.44 Sections .36–.43 of TIS section 6400, Health Care Entities (AICPA,
Technical Practice Aids), which are reproduced in appendix A, "TIS Section
6400, Health Care Entities," of chapter 11, "Contributions Received and Made,"
of this guide, discuss how a beneficiary should report and classify its interest
in the net assets of a recipient entity and changes in that interest. In the investor's (participant's) balance sheet, the interest in the pool might be reported
using a caption such as "Beneficial Interest in Investment Pool" or "Interest in
Investment Pool." If the investor's (participant's) balances are due on demand,
the change in value of the beneficial interest that related to purchases and
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sales of pool units would be reported net in the "Investing" section of the cash
flow statement. However, if the balances are not due on demand, the purchases
and sales of pool units would be recorded gross in the investor's (participant's)
"Investing" section of the cash flow statement, unless the cash flows qualified
for net reporting, as discussed in paragraphs 7–9 of FASB ASC 230-10-45.
The change in value of the beneficial interest related to unrealized gains and
losses would be reported in the cash flow statement in the same manner as all
unrealized gains and losses on investments are reported.
4.45 TIS section 6400.42, "Application of FASB ASC 958—Classification
of a Beneficiary's Interest in the Net Assets of a Financially Interrelated FundRaising Foundation (Recipient Entity)—Accounting for Unrealized Gains and
Losses on Investments Held by the Foundation" (AICPA, Technical Practice
Aids), discusses how a beneficiary should display unrealized gains and losses
related to investments held for its benefit by a financially interrelated entity. It
states that in circumstances in which the beneficiary (investor or participant)
can influence the financial decisions of the recipient entity (pool sponsor) to
such an extent that the beneficiary can determine the timing and amount of
distributions from the recipient entity to the beneficiary, changes in a beneficiary's interest in the net assets of the recipient entity should be included in,
or excluded from, the beneficiary's performance indicator in the same manner
that they would have been had the beneficiary held the investments directly.
Thus, the beneficiary should include in the performance indicator the portion
of the change attributable to unrealized gains and losses on trading securities
that are not restricted by donors or law and should exclude from the performance indicator the portion of the change attributable to all other unrealized
gains and losses. This manner of reporting is similar to the reporting by an
investor that combines its proportionate share of an investee's other comprehensive income amounts with its own other comprehensive income items, as
described in FASB ASC 323-10-45-3.† TIS section 6400.42 also discusses how
to report unrealized gains and losses in circumstances in which the beneficiary
cannot influence the financial decisions of the recipient organization to such
an extent that it can determine the timing and amount of distributions that it
receives from the recipient entity.
4.46 As noted in FASB ASC 958-20-45-3, if the beneficiary and recipient entity are included in consolidated financial statements, the beneficiary's
interest in the net assets of the recipient entity should be eliminated, in accordance with FASB ASC 810-10-45-1. Therefore, if the investor (participant) and
sponsor were both included in consolidated financial statements, the interest
in the investment pool and changes in that interest would be eliminated.
4.47 To determine the sponsor's accounting, the pooling arrangement
would be carefully reviewed to determine if the sponsor has legal ownership

†
In June 2011, FASB issued ASU No. 2011-05, Comprehensive Income (Topic 220): Presentation
of Comprehensive Income. This ASU is intended to increase the prominence of other comprehensive
income in financial statements. This ASU requires that an entity that reports items of other comprehensive income present comprehensive income in either a single statement with net income or
in an income statement that is followed consecutively by a statement of comprehensive income. The
current option to present other comprehensive income in the statement of changes in equity has been
eliminated. The amendments in the ASU should be applied retrospectively. For public entities, the
amendments are effective for fiscal years, and interim periods within those years, beginning after
December 15, 2011. For nonpublic entities, the amendments are effective for fiscal years ending after
December 15, 2012, and interim and annual periods thereafter. Early adoption is permitted.
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and rights to the underlying investments (for example, would the pool sponsor's creditors have claim against the investments in the pool in bankruptcy)
or if the sponsor is merely acting as an agent for the investors (participants).
If the investments in the pool are legally owned by the sponsor, then the sponsor would report the pool of investments and related activities in its financial
statements on a gross basis. At each reporting period, the sponsor would record
100 percent of the pooled investments in its balance sheet, along with a corresponding liability to the respective pool investor (participant). The sponsor
would report the pool's investment returns gross in its statement of operations.
If the sponsor is a not-for-profit entity that is acting as an agent, FASB ASC
958-320 and 958-325 require investments held as agent and investment return to be reported as assets and liabilities, rather than changes in net assets.
However, if the sponsor is an investor-owned entity merely acting as an agent,
it may be appropriate for the sponsor to record the investments and related
liability to the investors (participants) on a net basis in the sponsor's financial
statements.

Fair Value Measurements
4.48 FASB ASC 820 defines fair value, establishes a framework for measuring fair value, and requires extensive disclosures about fair value measurements. Health care entities that are required to apply fair value measures and
that provide fair value disclosures are advised to read FASB ASC 820 in its
entirety.

Impairment of Investments
4.49 The following guidance should be considered when determining and
evaluating whether an investment's impairment is other than temporary:

r
r
r

Paragraphs 17–35 of FASB ASC 320-10-35
Paragraphs 1A–2 of FASB ASC 325-20-35
Paragraphs 8–13 of FASB ASC 958-325-35

Paragraphs 4.50–.58 summarize some of the more significant matters included
in those paragraphs. The list is not meant to be all-inclusive. Health care entities should refer to the aforementioned guidance for comprehensive guidance
of matters to consider.
4.50 According to FASB ASC 320-10-35-20, impairment is assessed at
the individual security level (referred to as an investment). Individual security
level means the level and method of aggregation used by the reporting entity
to measure realized and unrealized gains and losses on its debt and equity
securities. FASB ASC 320-10-35-21 states that an investment is impaired if
the fair value of the investment is less than its cost.
4.51 Per FASB ASC 320-10-35-25, because the fair value of cost-method
investments is not readily determinable, the evaluation of whether an investment is impaired should be determined as follows:
a. If an entity has estimated the fair value of a cost-method investment (for example, for disclosure under FASB ASC 825-10-50), that
estimate should be used to determine if the investment is impaired
for the reporting periods in which the entity estimates fair value.
b. For reporting periods in which an entity has not estimated the
fair value of a cost-method investment, the entity should evaluate
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whether an event or a change in circumstances has occurred in that
period that may have a significant adverse effect on the fair value
of the investment (an impairment indicator, examples of which are
provided in paragraphs 27–28 of FASB ASC 320-10-35).
4.52 Per FASB ASC 320-10-35-30, if the fair value of an investment is
less than its amortized cost basis at the balance sheet date of the reporting
period for which impairment is assessed, the impairment is either temporary
or other than temporary. Other than temporary does not mean permanent.
The standards for measuring other-than-temporary impairment are dependent
upon the type of investment: equity securities or debt securities. Per FASB ASC
320-10-35-17, entities should not look through the form of their investment to
the nature of the securities held by an investee. For example, an investment
in shares of a mutual fund that invests primarily in debt securities would be
assessed for impairment as an equity security under FASB ASC 320-10-35.
4.53 For equity securities, FASB ASC 320-10-35-32A states that an entity
should apply guidance that is pertinent to the determination of whether an impairment is other than temporary, such as FASB ASC 325-40-35. Additionally,
FASB ASC 320-10-35-33 states that when an entity has decided to sell an impaired available-for-sale security, and the entity does not expect the fair value
of the security to fully recover before the expected time of sale, the security
should be deemed other-than-temporarily impaired in the period in which the
decision to sell is made, not the period in which the sale occurs. However, an
entity should recognize an impairment loss when the impairment is deemed
other than temporary, even if a decision to sell has not been made. Further,
FASB ASC 325-20-35-2 states that a series of operating losses of an investee
or other factors may indicate that a decrease in value of the investment has
occurred that is other than temporary and that should be recognized. FASB
ASC 320-10-S99-1 provides guidance in the form of Topic No. 5(M), "Other
Than Temporary Impairment of Certain Investments in Equity Securities,"
of the Securities and Exchange Commission's Codification of Staff Accounting
Bulletins.
4.54 For a debt security, an other-than-temporary impairment should be
considered to have occurred if an entity (a) has decided to sell the debt security,
as discussed in FASB ASC 320-10-35-33A, or (b) has not decided to sell the debt
security, but the entity more likely than not will be required to sell the security
before recovery of its amortized cost basis, as discussed in FASB ASC 32010-35-33B. Paragraphs 33C–33I of FASB ASC 320-10-35 provide additional
guidance for making an assessment of whether an impairment of a debt security
is other than temporary, including guidance for determining whether the entire
amortized cost basis of the debt security will be recovered.
4.55 In accordance with FASB ASC 320-10-35-34C, if the health care
entity does not intend to sell the debt security, and it is not more likely than not
that the health care entity will be required to sell the security before recovery
of its amortized cost basis less any current-period credit loss, the other-thantemporary impairment should be separated into both of the following:
a. Amounts representing the credit loss
b. Amounts related to all other factors
4.56 In accordance with FASB ASC 320-10-45-8A, in periods in which
an investor-owned health care entity determines that a security's decline in
fair value below its amortized cost basis is other than temporary, the entity
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should present the total other-than-temporary impairment in the statement
of earnings, with an offset for the amount of the total other-than-temporary
impairment, if any, that is recognized in other comprehensive income, in accordance with FASB ASC 320-10-35-34D (for example, the portion of the loss on
a debt security that is due to factors other than the credit loss). The amount of
the total other-than-temporary impairment on a debt security that is related
to the other factors should be recognized in other comprehensive income net
of applicable taxes. A not-for-profit health care entity would report the total
other-than-temporary impairment within the performance indicator, with an
offset for the portion of the loss on a debt security that is due to factors other
than the credit loss, in accordance with FASB ASC 320-10-35-34D, as modified
by FASB ASC 320-10-35-17. The amount of the total other-than-temporary
impairment on a debt security that is related to the other factors should be
recognized outside of the performance indicator.
4.57 FASB ASC 320-10-35-34 states that the measurement of the impairment of an equity security should not include partial recoveries subsequent to
the balance sheet date. The fair value of the investment would then become
the new amortized cost basis of the investment and should not be adjusted for
subsequent recoveries in fair value.
4.58 FASB ASC 320-10-35-34E states that for debt securities, the previous
amortized cost basis less the other-than-temporary impairment recognized in
earnings becomes the new amortized cost basis of the debt security. That new
amortized cost basis should not be adjusted for subsequent recoveries in fair
value. However, the amortized cost basis should be adjusted for accretion and
amortization, as prescribed in FASB ASC 320-10-35-35.
4.59 FinREC believes that if a health care entity engages an external
investment manager and grants the manager broad discretion to purchase
and sell investments to achieve a stated portfolio objective, the health care
entity may not be able to assert that it has both the intent and ability to hold
equity investments that have unrealized losses until those unrealized losses
can be recovered. Further, if a debt security was sold shortly after year-end,
the health care entity may not be able to assert that there was not the intent to
sell the debt security at the balance sheet date. If the health care entity cannot
make the necessary assertions, then the entity should recognize an otherthan-temporary impairment loss. If a health care entity develops procedures
to determine whether the manager has made a decision at the balance sheet
date to sell any debt securities, it will be able to document when the decision
was made, by whom, the factors that drove the decision to sell, and when the
health care entity became aware of those factors.

Securities Lending Activities
4.60 A health care entity that has a significant investment portfolio may
enter into securities lending arrangements. These arrangements allow the
health care entity to increase the overall yield from the investment activity.
Depending on the terms of the security lending agreements, collateral received
may be required to be shown separately on the transferor's balance sheet, with
a corresponding liability to show the obligation to return the collateral. Each
agreement should be carefully reviewed, and the guidance in FASB ASC 860-30
would be considered to determine the appropriate accounting and reporting.
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Transfers of Assets to a Not-for-Profit Entity or Charitable
Trust for Investment
4.61 Sometimes, a health care entity transfers assets, including investments, to a not-for-profit entity or charitable trust (the recipient entity) that
accepts those assets and agrees to use them on behalf of the health care entity
or transfer them or their investment return, or both, back to the health care
entity or its affiliate. Examples of this type of reciprocal transfer include (a) a
health care entity that transfers assets to a community foundation to establish
an endowment for the benefit of the health care entity or its affiliate and (b) a
health care entity that transfers assets to a foundation that it creates to hold
those assets.
4.62 FASB ASC 958-605-25-33 states that a transfer of assets to a recipient entity is not a contribution if the resource provider (the health care entity)
specifies itself or its affiliate as the beneficiary of the transfer. Paragraphs 4–7
of FASB ASC 958-20-25 describe the following two types of reciprocal transfers:

r

r

An equity transaction, which is a transfer of assets to a recipient
entity that meets all of the following conditions: (a) the resource
provider (health care entity) specifies itself or its affiliate as the
beneficiary; (b) the resource provider (health care entity) and the
recipient entity are financially interrelated entities; and (c) neither the resource provider (health care entity) nor its affiliate
expects payment of the transferred assets, although payment of
investment return on the transferred assets may be expected.
Paragraph 12.75 of this guide discusses financially interrelated
entities.
The resource provider (health care entity) specifies itself or its affiliate as the beneficiary, and the transfer is not an equity transaction (one or both of criteria (b) and (c) in the previous bullet are
not met).

4.63 According to FASB ASC 958-605-25-33, if the transfer in which the
resource provider specifies itself or its affiliate as the beneficiary is not an equity transaction, the resource provider (health care entity) should report an
asset, and the recipient entity should report a liability. Accounting for equity
transactions is discussed in paragraphs 12.70–.73 of this guide. If the resource
provider (the health care entity) transfers assets to a recipient entity and specifies itself or its affiliate as the beneficiary, it should disclose the following
information for each period for which a statement of financial position is presented, in accordance with FASB ASC 958-605-50-6:

r
r
r
r

The identity of the recipient entity to which the transfer was
made.
Whether variance power was granted to the recipient entity and,
if so, a description of the terms of the variance power. Because
of their reciprocal nature, such transfers are presumed not to
be contributions received or made, even if the health care entity
granted variance power at the time of transfer.
The terms under which amounts will be distributed to the health
care entity or its affiliate.
The aggregate amount recognized in the statement of financial
position for those transfers and whether that amount is recorded
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as an interest in the net assets of the recipient entity or as another
asset (for example, as a beneficial interest in assets held by others
or a refundable advance).

Regulation
4.64 Because health plans have a public responsibility to be able to meet
their obligations to policy holders, state statutes and regulations prescribe
standards and limitations on investment activities. Regulatory requirements
and restrictions vary by state. Most states require health plans to invest a
certain percentage of policy reserves in specified classes of investments. Once
the state regulatory agency's minimum standards are met, the health plan may
invest in other types of investments. However, many states specify a maximum
percentage of assets that may be invested in particular classes of investments.
State regulations may also prescribe methods for reporting investments, set requirements regarding matters such as the location and safeguarding of assets,
and set limitations on investing in derivatives. For example, a regulatory authority may require some investments to be deposited with the state insurance
department as a condition of writing business in that state. Insurance statutes
and regulations vary by state, but the regulations of the state of domicile have
precedence; however, compliance provisions in states in which the plan does
business also must be followed. An understanding of the statutory requirements to be followed by a health plan concerning investments is advisable, so
that their impact on investment strategy, as well as accounting and reporting,
are appropriately considered.

Other Financial Statement Presentation Matters
Classification
4.65 Securities should be reported as either current or noncurrent, as appropriate, under the provisions of FASB ASC 210-10-45. According to the FASB
ASC glossary, the term current assets is used to designate cash and other assets or resources commonly identified as those that are reasonably expected to
be realized in cash or sold or consumed during the normal operating cycle of
the business. According to FASB ASC 210-10-45-1, current assets include marketable securities representing the investment of cash available for current
operations, including investments in debt and equity securities classified as
trading securities under FASB ASC 320-10. FASB ASC 210-10-45-3 indicates
that a one-year time period should be used as a basis for the segregation of current assets in cases when several operating cycles occur within a year. FASB
ASC 210-10-45-4 states that the concept of the nature of current assets contemplates the exclusion from that classification cash and claims to cash that are
restricted regarding withdrawal or use for other-than-current operations, designated for expenditure in the acquisition or construction of noncurrent assets,
or segregated for the liquidation of long-term debts. Even though not actually
set aside in special accounts, funds that are clearly to be used in the near future
for the liquidation of long-term debts, payments to sinking funds, or similar
purposes should also, under this concept, be excluded from current assets.
However, if such funds are considered to offset maturing debt that has been
set up properly as a current liability, they may be included within the current
asset classification. FASB ASC 958-205-55-7 explains that when a statement
of financial position that sequences assets and liabilities based on their relative liquidity is presented, cash and cash equivalents of permanent endowment
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funds held temporarily until suitable long-term investment opportunities are
identified are included in the long-term investments classification.
4.66 According to FASB ASC 230-10-45-19, cash receipts and payments
resulting from purchases, sales, and maturities of trading securities, as discussed in FASB ASC 320, should be classified as investing or operating cash
flows based on the nature and purpose for which the securities were acquired.
According to FASB ASC 230-10-45-11, cash flows from purchases, sales, and
maturities of available-for-sale securities should be classified as cash flows
from investing activities and reported gross in the statement of cash flows.
FASB ASC 320-10-45-13 states that if entities report certain investments in
debt securities as cash equivalents, in accordance with the provisions of FASB
ASC 230, the notes to the financial statements should reconcile the reporting
classifications used in the statement of financial position.
4.67 Paragraphs 4.28–.34 discuss the classification of investment income,
realized and unrealized gains and losses on investments, and equity earnings
from investments in investment companies accounted for under the equity
method by a not-for-profit health care entity.

Disclosure
4.68 All health care entities with investments that meet the definition
of financial instruments set forth in the FASB ASC glossary are subject to
the disclosure requirements of FASB ASC 825-10-50.4 Investor-owned health
care entities with investments in equity and debt securities should refer to
the disclosure requirements of FASB ASC 320-10-50 and 325-50. Not-for-profit
health care entities should refer to the disclosure requirements of FASB ASC
958-320-50 and 958-325-50.
4.69 If the health care entity has concentrations of credit risk related
to financial instruments, the disclosure requirements of paragraphs 20–22 of
FASB ASC 825-10-50 should be followed. Examples of potential exposure to
credit risk include funds deposited with a single financial institution in excess
of Federal Deposit Insurance Corporation limits and investments in obligations
that are not insured or guaranteed by the government.
4.70 Health care entities that are accounting for investments under the
equity method, including alternative investments held for investment-return
purposes, should consider the disclosure requirements of FASB ASC 323-10-50.
4.71 FASB ASC 860-30-50 requires entities that enter into securities
lending transactions or repurchase agreements to disclose their policies for
requiring collateral or other security. FASB ASC 860-30-50 also requires the
disclosure of (a) the fair value of collateral at the reporting date and (b) the
portion of the collateral that has been sold or repledged if an entity accepts
collateral that is permitted by contract or custom to be sold or repledged.
Health care entities that are public entities should also consider the disclosure
requirements of FASB ASC 860-10-50.
4.72 Health care entities should consider the fair value disclosure requirements in FASB ASC 820-10-50.

4
Disclosures about the fair value of financial instruments prescribed in FASB ASC 825-10-50
are optional for an entity that meets the criteria in FASB ASC 825-10-50-3.
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4.73 Not-for-profit health care entities that have investments held in
donor-restricted endowment funds should consider the disclosure requirements
of FASB ASC 958-205-50.

Auditing
4.74 Auditing objectives and procedures for investments of health care
entities generally are similar to those of other entities. AU section 332, Auditing Derivative Instruments, Hedging Activities, and Investments in Securities
(AICPA, Professional Standards), among other matters, provides guidance to
auditors in planning and performing auditing procedures for assertions about
investments in securities that are made in an entity's financial statements.
The guidance in AU section 332 applies to all debt and equity securities.
AU section 332 uses the definitions of debt security and equity security that
are in included in the FASB ASC glossary. However, those definitions apply
to debt and equity securities without regard to whether they are subject to
the requirements of FASB ASC 320-10, such as assertions about securities
accounted for under the equity method following the requirements of FASB
ASC 323, Investments—Equity Method and Joint Ventures. A companion Audit
Guide, Auditing Derivative Instruments, Hedging Activities, and Investments
in Securities, provides practical guidance for implementing AU section 332.
Considerations for Audits Performed in Accordance With Public Company Accounting Oversight Board (PCAOB) Standards
Paragraph .11 of AU section 332, Auditing Derivative Instruments,
Hedging Activities, and Investments in Securities (AICPA, PCAOB
Standards and Related Rules, Interim Standards), states that when
performing an integrated audit of financial statements and internal
control over financial reporting, paragraph 39 of PCAOB Auditing
Standard No. 5, An Audit of Internal Control Over Financial Reporting That Is Integrated with An Audit of Financial Statements (AICPA,
PCAOB Standards and Related Rules, Auditing Standards), states
that "[t]he auditor should test those controls that are important to the
auditor's conclusion about whether the company's controls sufficiently
address the assessed risk of material misstatement to each relevant
assertion." Therefore, in an integrated audit of financial statements
and internal control over financial reporting, if relevant assertions exist that are related to the company's investments in derivatives and
securities, the auditor's understanding of controls should include controls over derivatives and securities transactions from their initiation
to their inclusion in the financial statements and should encompass
controls placed in operation by the entity and service organizations
whose services are part of the entity's information system.
PCAOB Staff Audit Practice Alert No. 2, Matters Related to Auditing Fair Value Measurements of Financial Instruments and the Use
of Specialists (AICPA, PCAOB Standards and Related Rules, PCAOB
Staff Guidance, sec. 400.02), provides guidance on auditors' responsibilities for auditing fair value measurements of financial instruments
and when using the work of specialists under the existing standards
of the PCAOB. PCAOB Staff Audit Practice Alerts are not rules of the
PCAOB nor have they been approved by the PCAOB.
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4.75 Interpretation No. 1, "Auditing Investments in Securities Where a
Readily Determinable Fair Value Does Not Exist" of AU section 332 (AICPA,
Professional Standards, AU sec. 9332 par. .01–.04), provides guidance for auditors of nonissuers regarding the adequacy of audit evidence, with respect
to the existence and valuation assertions in AU section 332 (AICPA, Professional Standards), in confirmations received from third parties when auditing
investments in securities when a readily determinable fair value does not exist, and the auditor determines that auditing procedures include verifying the
existence and testing the measurement of the investments. Further guidance
for auditors of nonissuers is provided in the AICPA Practice Aid Alternative
Investments—Audit Considerations. The guidance focuses on the existence and
valuation assertions associated with auditing investments for which a readily
determinable fair value does not exist (collectively referred to in the practice
aid as alternative investments).5 The auditing portion of that practice aid is
an other auditing publication, as defined in AU section 150, Generally Accepted Auditing Standards (AICPA, Professional Standards). Other auditing
publications have no authoritative status; however, they may help the auditor
understand and apply Statements on Auditing Standards.
4.76 In addition, the independent auditor may need to consider the examples of specific auditing objectives, selected control activities, and auditing
procedures that are presented in exhibit 4-1.

5
The AICPA Practice Aid Alternative Investments—Audit Considerations can be found at
www.aicpa.org/InterestAreas/FRC/AuditAttest/Fieldwork/DownloadableDocuments/Alternative
Investments Practice Aid.pdf.
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Exhibit 4-1
The following table illustrates the use of assertions in developing audit objectives and designing substantive tests. The examples are not
intended to be all-inclusive nor is it expected that all the procedures
would necessarily be applied in an audit. The auditor should design
and perform substantive procedures for all relevant assertions related
to each material class of transactions, account balance, and disclosure
to obtain sufficient appropriate audit evidence. The use of assertions
in assessing risks and designing appropriate audit procedures to obtain audit evidence is described in paragraphs .14–.26 of AU section
326, Audit Evidence (AICPA, Professional Standards). Various audit
procedures and the purposes for which they may be performed are
described in paragraphs .27–.41 of AU section 326.

Auditing Considerations
Financial
Statement
Assertions

Specific Auditing
Objectives

Selected Control
Activities

Auditing
Procedures

Marketable
securities are
fairly stated and
properly
classified,
described, and
disclosed.

An independent
trustee manages
the investments.
The trustee's
reports are
reviewed by a
responsible
employee.

Verify existence
through confirmation.
Test the valuation of
equity and debt
securities not intended
to be held to maturity
by comparing the
recorded values with
the fair values reported
by the trustee or
another independent
source. For fair value
estimates obtained from
third-party sources, the
auditor should consider
the applicability of the
guidance in AU section
336, Using the Work of a
Specialist (AICPA,
Professional
Standards); AU section
324, Service
Organizations (AICPA,
Professional
Standards); or AU
section 324, Service
Organizations (AICPA,
PCAOB Standards and
Related Rules, Interim
Standards).1

Account Balances
Existence,
completeness,
rights and
obligations, and
valuation and
allocation
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Financial
Statement
Assertions
Valuation and
allocation, rights
and obligations

Transactions
Accuracy and
completeness

Specific Auditing
Objectives

Selected Control
Activities

Endowment
funds are
properly stated
at their required
value, and
related gains
and losses are
properly
classified.

Value of
endowment
funds are
reviewed
periodically to
ensure that the
balance is at its
required level.

Verified that values of
endowments are at
required levels through
confirmation. Review
treatment of gains and
losses on endowment
funds to ensure that
they are properly
classified.

Investment
income and
gains or losses,
or both, are
recorded in
accordance with
donor
restrictions.

Review
investment
transactions to
ensure that they
are recorded in
compliance with
donor
restrictions.

Test the recording of
selected transactions to
ensure that amounts
are properly classified
in accordance with
donor restrictions.

Classification is
monitored
periodically and
is based on
management's
intent or ability
to dispose of
excess funds
that are
available for
operations
within an
operating cycle.

Test the classification of
investments as trading,
available for sale, or
held to maturity to
determine whether
gains and losses are
properly classified
within or outside the
performance indicator
(for not-for-profit health
care entities ) or within
the income statement or
statement of other
comprehensive income
(for investor-owned
health care entities).

Presentation and Disclosure
Classification
Securities are
and understand- properly
ability
classified.

Auditing
Procedures

1
Paragraphs .35–.46 of AU section 332, Auditing Derivative Instruments,
Hedging Activities, and Investments in Securities (AICPA, Professional
Standards), establish requirements and provide guidance to auditors on audit
evidence that may be used to support assertions about the fair value of securities.
Paragraphs 6.15–.37 in the companion Audit Guide Auditing Derivative
Instruments, Hedging Activities, and Investments in Securities also provide
guidance on that topic. That guidance should be considered in context of specific
accounting requirements. AU section 328, Auditing Fair Value Measurements and
Disclosures (AICPA, Professional Standards), establishes requirements and
provides guidance on auditing fair value measurements and disclosures contained
in financial statements. AU section 328 does not address specific types of assets,
liabilities, components of equity, transactions, or industry-specific practices.
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Chapter 5

Derivatives
Introduction
5.01 Health care entities use a wide range of derivative products,1 with
the objective of more effectively managing their financial risks related to debt,
investments, and other assets and liabilities and transactions. Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC)
815-10-15-83 describes a derivative instrument as
a financial instrument or other contract with all of the following characteristics:
a. Underlying, notional amount, payment provision. The contract has both of the following terms, which determine the
amount of the settlement or settlements, and, in some
cases, whether or not a settlement is required:
1. One or more underlyings
2. One or more notional amounts or payment provisions or both.
b. Initial net investment. The contract requires no initial net
investment or an initial net investment that is smaller
than would be required for other types of contracts that
would be expected to have a similar response to changes
in market factors.
c. Net settlement. The contract can be settled net by any of
the following means:
1. Its terms implicitly or explicitly require or permit
net settlement.
2. It can readily be settled net by a means outside
the contract.
3. It provides for delivery of an asset that puts the
recipient in a position not substantially different
from net settlement.
5.02 FASB ASC 815-10-15-88 states that an underlying is a variable
that, along with either a notional amount or payment provision, determines
the settlement of a derivative instrument. FASB ASC 815-10-15-88 provides
examples of underlyings, which include a security price or security price index,
a commodity price or commodity price index, and an interest rate or interest
rate index. As explained in FASB ASC 815-10-15-92, a notional amount is a
number of currency units, shares, bushels, pounds, or other units specified in
the contract. FASB ASC 815-10-93 states that a payment provision specifies
a fixed or determinable settlement to be made if the underlying behaves in a
1
Chapter 18, "Derivative Instruments: Futures, Forwards, Options, Swaps, and Other Derivative Instruments," of the AICPA Audit and Accounting Guide Depository and Lending Institutions:
Banks and Savings Institutions, Credit Unions, Finance Companies, and Mortgage Companies provides useful background information on various types of derivative instruments and hedging activities
and the risks associated with various forms of contracts and transactions.
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specified manner. Paragraphs 83–139 of FASB ASC 815-10-15 provide a more
complete definition of a derivative instrument.
5.03 One of the most common uses of derivatives by health care entities
is in conjunction with borrowings. The objective is that the combined cash
flows of the derivative and the debt will effectively create long-term fixedrate or variable-rate debt at an aggregate cost lower than traditional fixed- or
variable-rate debt. Common examples include the following:

r
r
r
r
r

An interest rate swap that is intended to effectively convert
variable-rate debt to fixed-rate debt.
An interest rate swap that is intended to effectively convert fixedrate debt to variable-rate debt.
A basis swap in which counterparties exchange payments based
on the changes of two variable rates.
An option on an interest rate swap—a swaption—that gives the
purchaser the right but not the obligation to enter into an interest
rate swap. The purchaser pays a premium to the issuer or writer.
An interest rate cap specifically purchased to give the purchaser
protection against rates rising above a given level.

5.04 Derivative instruments also might be used to

r

r

lock in the interest rate for an anticipated future borrowing. At
times, a health care entity may need to borrow money in the
near term and wish to fix the interest rate on the borrowing at
the current rate, even though the money will not be needed until
sometime in the future. Derivative instruments, such as interestrate options or forward contracts, can accomplish this objective.
lock in the current price of a commodity, such as electricity, for anticipated purchases. This hedging strategy often involves the use
of forward contracts or option combinations that can be settled
net. A derivative instrument that is used to fix the price of anticipated future purchases could be a cash flow hedge if the derivative
instrument does not meet the conditions for the normal purchase
exception.

5.05 FASB ASC 815-10-55-2 contains a diagram that depicts the process
for determining whether a freestanding contract is within the scope of FASB
ASC 815, Derivatives and Hedging. The diagram is a visual supplement to the
written standards. It should not be interpreted to alter any requirements of
FASB ASC 815 nor should it be considered a substitute for the requirements.
In addition, FASB ASC 815-15 excludes certain contracts from being accounted
for using the guidance in FASB ASC 815, even though, technically, the contract
may meet the definition of a derivative instrument.

General Guidance
5.06 FASB ASC 815 establishes accounting and reporting standards for
derivative instruments and hedging activities. FASB ASC 815-10-05-4 explains
that FASB ASC 815 requires that an entity recognize derivative instruments,
including certain derivative instruments embedded in other contracts, as either
assets or liabilities in the statement of financial position and measure them
at fair value. If certain conditions are met, an entity may elect to designate
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a derivative instrument in any one of the following ways: (a) a hedge of the
exposure to changes in the fair value of a recognized asset or liability or of
an unrecognized firm commitment that is attributable to a particular risk
(referred to as a fair value hedge), (b) a hedge of the exposure to variability in
the cash flows of a recognized asset or liability or of a forecasted transaction
that is attributable to a particular risk (referred to as a cash flow hedge), or (c)
a hedge of foreign currency exposure.2
5.07 FASB ASC 954-815-25-2 states that except as provided in FASB ASC
954-815-50-1 and as discussed in paragraph 5.44, not-for-profit health care entities should apply the provisions of FASB ASC 815, including the provisions
pertaining to cash flow hedge accounting, in the same manner as for-profit
entities. The gain or loss items that affect a for-profit entity's income from continuing operations similarly should affect the not-for-profit health care entity's
performance indicator, and the gain or loss items that are excluded from a
for-profit entity's income from continuing operations, such as items reported
in other comprehensive income, similarly should be excluded from the performance indicator by the not-for-profit health care entity. As explained in FASB
ASC 954-815-45-1, the absence of a requirement to report a separate component of equity in the balance sheet of a not-for-profit business-oriented health
care entity should not preclude those entities from using comprehensive income reporting for qualifying gains and losses on cash flow hedges. Although
accumulated other comprehensive income will inherently be carried forward in
a not-for-profit health care entity's net assets, no compelling need exists for it
to be reported separately in the balance sheet.
5.08 FASB ASC 815-10-35-2 states that the accounting for changes in
the fair value (that is, gains and losses) of a derivative instrument depends on
whether it has been designated and qualifies as part of a hedging relationship
and, if so, the reason for holding it.

Fair Value Hedges
5.09 FASB ASC 815-20-35-1(b) states that the gain or loss on a derivative
instrument designated and qualifying as a fair value hedging instrument, as
well as the offsetting loss or gain on the hedged item attributable to the hedged
risk, should be recognized currently in earnings in the same accounting period,
as provided in paragraphs 1–6 of FASB ASC 815-25-35-1.
5.10 Thus, investor-owned health care entities recognize the gain or loss
on the derivative in earnings in the period of change, together with the offsetting loss or gain on the hedged item attributable to the risk being hedged.
Similarly, not-for-profit health care entities report the derivative gains and
losses, together with the offsetting loss or gain on the hedged item, in the
performance indicator in the period of change.

Cash Flow Hedges
5.11 FASB ASC 815-20-35-1(c) states that the effective portion of the gain
or loss on a derivative instrument designated and qualifying as a cash flow
hedging instrument should be reported as a component of other comprehensive
income (outside earnings) and reclassified into earnings in the same period(s)

2
Health care entities do not frequently enter into foreign currency hedges; therefore, this chapter
focuses on matters pertaining to fair value and cash flow hedges.
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during which the hedged forecasted transaction affects earnings, as provided
in FASB ASC 815-30-35-3 and paragraphs 38–41 of FASB ASC 815-30-35.
The remaining gain or loss on the derivative instrument, if any, should be
recognized currently in earnings, as provided in FASB ASC 815-30-35-3. If an
entity's defined risk management strategy for a particular hedging relationship
excludes a specific component of the gain or loss (or related cash flows) on the
hedging derivative from the assessment of hedge effectiveness, as explained
in paragraphs 81–83 of FASB ASC 815-20-25, that excluded component of the
gain or loss should be recognized currently in earnings.
5.12 FASB ASC 815-30-35-39 states that if the hedged transaction results
in the acquisition of an asset or the incurrence of a liability, the gains and
losses in accumulated other comprehensive income should be reclassified into
earnings in the same period(s) during which the acquired asset or incurred
liability affects earnings, such as in the periods that depreciation expense,
interest expense, or cost of sales is recognized.
5.13 Thus, for an investor-owned health care entity, the effective portion
of the derivative's gain or loss is initially reported as a component of other
comprehensive income (outside earnings) and subsequently reclassified into
earnings when the forecasted transaction affects earnings. For a not-for-profit
health care entity, the effective portion of the derivative's gain or loss is initially
excluded from the performance indicator and subsequently reclassified into the
performance indicator when the forecasted transaction affects earnings. For
example, the accumulated gain or loss of a derivative instrument that hedges
the variability of the cash flows of long-term debt is amortized into earnings
or the performance indicator over the remaining term of the debt instrument
(that is, as long as the debt remains outstanding), even if the cash flow hedge
itself is terminated. Any ineffective portion of the gain or loss is immediately
reported in earnings or the performance indicator.

Derivatives Not Designated as a Hedging Instrument
5.14 The gain or loss on a derivative instrument not designated as a
hedging instrument should be recognized in current earnings or, in the case of
a not-for-profit health care entity, the performance indicator.

Hedge Accounting 3
5.15 A primary purpose of hedge accounting is to link items or transactions
whose changes in fair values or cash flows are expected to offset each other.
5.16 To qualify for hedge accounting, at inception of the hedge, there must
be formal documentation of all the information identified in FASB ASC 81520-25-3. Specific documentation requirements include identifying the hedging
relationship, the hedging instrument, the hedged item or transaction, the nature of the risk being hedged, the method that will be used to retrospectively
3
On May 26, 2010, the Financial Accounting Standards Board (FASB) issued a proposed Accounting Standards Update (ASU) Accounting for Financial Instruments and Revisions to the Accounting for Derivative Instruments and Hedging Activities—Financial Instruments (Topic 825) and
Derivatives and Hedging (Topic 815). This proposed ASU would create a consistent, comprehensive
framework for the recognition and measurement of financial instruments. It also includes changes to
standards for hedge accounting and recognizing impairments. Its far-reaching scope would include
most receivables, investments, payables, long-term debt, and derivative instruments. Readers should
be alert to the issuance of a final standard.
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and prospectively assess hedge effectiveness, and the method that will be used
to measure hedge ineffectiveness, among others.
5.17 To qualify for hedge accounting, the hedging relationship, both at
inception of the hedge and on an ongoing basis, should be expected to be highly
effective. An entity should consider hedge effectiveness in two different ways: in
prospective considerations and retrospective evaluations. Paragraphs 74–117
of FASB ASC 815-20-25 provide the criteria for assessing hedge effectiveness
that are applicable to both fair value hedges and cash flow hedges.
5.18 FASB ASC 815-20-35-2 states that at least quarterly, the hedging
entity should determine whether the hedging relationship has been highly effective in having achieved offsetting changes in fair value or cash flows through
the date of the periodic assessment. If the hedge fails the effectiveness test at
any time (that is, if the entity does not expect the hedge to be highly effective at achieving offsetting changes in fair values or cash flows), the hedge
ceases to qualify for hedge accounting.4 The shortcut method for hedges of interest rate risk, which is described in paragraphs 5.21–.29, assumes no hedge
ineffectiveness.
5.19 FASB ASC 815-25-40-1 and 815-30-40-1 state that an entity must
discontinue prospectively specialized hedge accounting for an existing hedge
if any one of the following occurs: (a) any criteria in FASB ASC 815-20-25 is
no longer met; (b) the derivative instrument expires or is sold, terminated, or
exercised; or (c) the entity removes the designation of the hedge.
5.20 Documentation that the criteria described in FASB ASC 815-20-25
are met for the entire period to which hedge accounting is being applied is
critical. Derivative instruments are designated as hedges only if appropriate,
contemporaneous documentation of both the election and periodic assessment
of effectiveness has been executed in conformity with FASB ASC 815.

Shortcut Method
5.21 As noted in paragraph 5.03, one of the most common uses of derivatives by health care entities is entering into interest rate swaps in connection
with borrowings. If an entity enters into transactions to hedge interest rate
risk related to a recognized liability, a shortcut method for determining effectiveness is available if certain conditions are met.
5.22 Paragraphs 102–117 of FASB ASC 815-20-25 describe a set of conditions that determine which hedging relationships qualify for a shortcut version
of hedge accounting, which does not immediately recognize hedge ineffectiveness. If all of the applicable conditions in the list in FASB ASC 815-20-25-104
are met, an entity may assume no ineffectiveness in a relationship hedging
interest rate risk that involves a recognized interest-bearing asset or liability and an interest rate swap. In addition, FASB ASC 815-20-25-105 provides
incremental conditions that apply to fair value hedges only, and FASB ASC
815-20-25-106 provides incremental conditions that apply to cash flow hedges
only. Special rules apply to a firm commitment arising on the trade (pricing)
date to purchase or issue an interest-bearing asset or liability. The set of conditions and resulting assumption of ineffectiveness are known as the shortcut
4
The requirement to assess hedge effectiveness at least every three months applies to health
care entities that issue financial statements only on an annual basis, as well as entities that issue
quarterly financial statements.
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method. FASB ASC 815-20-25-103 notes that implicit in the conditions for the
shortcut method is the requirement that a basis exist for concluding on an
ongoing basis that the hedging relationship is expected to be highly effective
in achieving offsetting changes in fair values or cash flows. If a hedging relationship qualifies for use of the shortcut method, the effectiveness of the hedge
does not have to be proven in order to qualify for hedge accounting.
5.23 FASB ASC 815-20-25-102 states that given the potential for not
recognizing hedge ineffectiveness in earnings under the shortcut method, its
application should be limited to hedging relationships that meet each and every
applicable condition. All the conditions applicable to fair value hedges must be
met to apply the shortcut method to a fair value hedge, and all the conditions
applicable to cash flow hedges must be met to apply the shortcut method to
a cash flow hedge. A hedging relationship cannot qualify for application of
the shortcut method based on an assumption of no ineffectiveness justified by
applying other criteria.
5.24 If an interest rate swap does not qualify for use of the shortcut
method, the entity must prove (initially and on an ongoing basis, as discussed
in FASB ASC 815-20-25) that the hedging relationship between the hedging
instrument and hedged item (the liability being hedged) is highly effective
in achieving the offset of changes in those fair values or cash flows that are
attributable to the hedged risk.
5.25 As a condition for using the shortcut method, FASB ASC 815-20-25104(f) requires that the index on which the variable leg of the interest rate
swap is based match the benchmark interest rate designated as the interest
rate risk being hedged for that hedging relationship. FASB ASC 815-20-25-6A
states that in the United States, currently, only the interest rates on direct
Treasury obligations of the U.S. government and, for practical reasons, the
London Interbank Offered Rate (LIBOR) swap rate are considered to be benchmark interest rates. In each financial market, only the one or two most widely
used and quoted rates that meet these criteria may be considered benchmark
interest rates. The federal funds rate, the prime rate, the Federal National
Mortgage Association (Fannie Mae) par mortgage rate, and the Securities Industry and Financial Markets Association (SIFMA) Municipal Swap Index (formerly called the Bond Market Association/PSA Municipal Swap Index) should
not be used as the benchmark interest rate in the United States.
5.26 Many health care entities use swaps whose underlying is the SIFMA
Municipal Swap Index as hedges of interest rate risk associated with variablerate tax-exempt debt. Because the SIFMA Municipal Swap Index does not
constitute a benchmark interest rate for purposes of applying the shortcut
method, if the variable leg of a swap is indexed to the SIFMA Municipal Swap
Index (or any rate other than Treasury obligations or LIBOR), the hedging
relationship does not qualify for the shortcut method. Similarly, if a bond's
variable coupon references the SIFMA Municipal Swap Index or any rate other
than Treasury obligations or LIBOR, the hedging relationship does not qualify
for use of the shortcut method, even if the variable leg of the interest rate swap
is indexed to Treasury obligations or LIBOR.
5.27 Paragraphs 71–79 and FASB ASC 815-20-55, paragraphs 40–52 of
FASB ASC 815-25-55, and paragraphs 24–33 of FASB 815-30-55 contain implementation guidance and examples for use of the shortcut method.
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5.28 In cash flow hedges of variable-rate debt, interest rate risk cannot
be hedged, unless the cash flows of the hedged transaction are explicitly based
on the same benchmark interest rate. Many not-for-profit health care entities
have issued a form of variable-rate debt referred to as auction-rate debt. The
interest rate is reset through a Dutch auction process.5
5.29 FASB ASC 815-20-55-42 states that a variable-rate financial asset or
liability that is reset through an auction process is not based on a benchmark
interest rate. Although the interest rate may be described as a designated
benchmark interest rate plus or minus an adjustment specified by the bidder,
the clearing rate is effectively established by a bidding process that does not
provide for transparent separation of interest rate risk and credit risk. Thus,
the designated risk being hedged in an auction rate note cannot be interest rate
risk. However, health care entities wishing to hedge auction rate debt may be
able to do so as a cash flow hedge of a risk of overall changes in the hedged
cash flows, as described in FASB ASC 815-20-55-43.

Hybrid Instruments, Host Contracts,
and Embedded Derivatives
5.30 FASB ASC 815-15-05-1 explains that contracts that do not meet the
definition of a derivative instrument in their entirety, such as bonds, insurance
policies, and leases, may contain embedded derivatives. Embedded derivatives,
as defined in the FASB ASC glossary, are "[i]mplicit or explicit terms that affect some or all of the cash flows or the value of other exchanges required
by a contract in a manner similar to a derivative instrument." The effect of
embedding a derivative instrument in another type of contract (the host contract) is that some or all of the cash flows or other exchanges that otherwise
would be required by the host contract, whether unconditional or contingent
on the occurrence of a specified event, will be modified based on one or more
underlyings. FASB ASC 815-15 applies to embedded derivatives. A contract
that embodies both an embedded derivative and a host contract is referred to
as a hybrid instrument.
5.31 If an embedded derivative is within the scope of FASB ASC 81515, as defined in FASB ASC 815-15-15, and all of the criteria in FASB ASC
815-15-25-1 are met, the embedded derivative instrument must be separated
from the host contract and accounted for separately as a derivative instrument
pursuant to FASB ASC 815-10. However, if a hybrid instrument is a financial instrument, paragraphs 4–6 of FASB ASC 815-15-25 allow an entity to
irrevocably elect to initially and subsequently measure the hybrid financial instrument in its entirety at fair value, with changes in fair value recognized in
earnings, instead of requiring bifurcation. Alternatively, the entity may elect
to measure the hybrid financial instrument at fair value, as described in the
"Fair Value Option" sections of FASB ASC 825-10.
5.32 Although the requirement to separate an embedded derivative from
a host contract applies to both parties to a contract, application of the requirements of FASB ASC 815-15 may result in different conclusions regarding the
need for bifurcation based on whether the reporting entity is the holder or
issuer of the hybrid instrument.
5
In a Dutch auction, investors bid for the bonds, which are sold at the lowest yield necessary to
sell the entire issue.
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5.33 The most common host for an embedded derivative is a debt instrument that pays a fixed-rate, floating-rate, or zero-coupon rate of interest. When
applying the clearly- and closely-related criteria in FASB ASC 815-15-25-1 to
debt hosts, the focus is on determining whether the economic characteristics
and risks of the embedded derivative have features unrelated to interest rates,
such as equitylike or commoditylike features, or, if the characteristics of the
derivative are related to interest rates, whether the features involve leverage
or do not change in the same direction as interest rates (an inverse floater).
Host contracts with debt characteristics are discussed in paragraphs 23–51 of
FASB ASC 815-15-25.

Calls and Puts in Debt
5.34 Bonds and other forms of long-term debt often are structured with
call and put options. An entity applies paragraphs 26–27 and 40–43 of FASB
ASC 815-15-25 to determine whether embedded calls and puts are derivatives
that must be accounted for separately from the debt host contract. Additional
guidance is provided by the table in FASB ASC 815-15-55-13.
5.35 Issuance of convertible debt securities when the conversion feature
is a written call option may involve a host of potential embedded derivatives. In
such case, the need for bifurcation of embedded derivatives may differ for the
holder of the debt instrument than for the issuer, particularly if the conversion
is contingent on the occurrence of a specified event.

Derivatives Embedded in Split-Interest Agreements
5.36 The FASB ASC glossary defines a split-interest agreement as "[a]n
agreement in which a donor enters into a trust or other arrangement under
which a not-for-profit entity ... receives benefits that are shared with other
beneficiaries."6 The amount of benefit to each beneficiary often is a function of
the fair value of the donated assets over the term of the agreement. Not-forprofit entities that are trustees or fiscal agents for a split-interest agreement
report a liability for the obligation to make future payments to the other beneficiaries of the agreement. Although that liability is initially measured at its fair
value, it will not reflect fair value in future periods because the discount rate
used in remeasuring the liability each period is not revised to reflect current
interest rates, unless a fair value election is made. Because the liability is not
measured at fair value, the potential for an embedded derivative exists.
5.37 Paragraphs 7–14 of FASB ASC 958-30-25 and FASB ASC 958-30-55
provide guidance for determining whether a split-interest agreement includes
an embedded derivative and, if so, whether the embedded derivative must
be separated from its debt host contract and accounted for separately. As explained in FASB ASC 958-30-25-8, if the obligation is solely life contingent (that
is, contingent upon the survival of an identified individual, in which case the
payments are made only if the individual is alive when the payments are due),
that obligation would qualify for the exception from bifurcation in paragraphs
52–57 of FASB ASC 815-10-15. If the payments are variable, and the agreement
is period certain rather than life contingent, FASB ASC 958-30-25-12 states
that, generally, the liability representing an obligation under a split-interest
6
See FASB Accounting Standards Codification 958-30 and chapter 6, "Split-Interest Agreements," of the AICPA Audit and Accounting Guide Not-for-Profit Entities for a detailed discussion of
split-interest agreements.
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agreement contains an embedded derivative. The embedded derivative should
be bifurcated and accounted for as a derivative instrument pursuant to the
requirements of FASB ASC 815-15-25-1, unless a fair value election is made
pursuant to FASB ASC 815-15-25 or the "Fair Value Option" sections of FASB
ASC 825-10.
5.38 Irrevocable split-interest agreements held by an independent thirdparty trustee generally do not give rise to embedded derivatives. Neither do
(a) revocable split-interest agreements or (b) situations in which a not-forprofit entity holds a split-interest agreement in the capacity of an independent
trustee without having any beneficial interest in the arrangements (that is,
acting similar to a financial institution or fiscal agent).

Financial Statement Presentation and Disclosure
5.39 FASB ASC 815 provides guidance for evaluating financial statement
presentation and disclosure requirements related to derivative instruments
and hedging activities. Certain aspects of presentation and disclosure relative
to classification of derivative gains and losses are highlighted subsequently.

Qualifying Hedges
5.40 Paragraphs 5.09–.13 describe how to report the gains and losses on
cash flow hedges and fair value hedges. FASC ASC 815-10-50-4G states that
for purposes of the disclosure requirements beginning in FASB ASC 815-1050-4A, not-for-profit health care entities should present a similarly formatted
table. They should refer to amounts within their performance indicator, instead of in income, and amounts outside their performance indicator, instead
of in other comprehensive income. All not-for-profit entities also would indicate which class or classes of net assets (unrestricted, temporarily restricted,
or permanently restricted) are affected.
5.41 Paragraphs 8–9 of FASB ASC 815-25-35 provide standards for the
changes in fair value of the hedged item. The adjustment of the carrying amount
of a hedged asset or liability required by FASB ASC 815-25-35-1(b) (for a fair
value hedge) should be accounted for in the same manner as other components
of the carrying amount of that asset or liability. An adjustment of the carrying
amount of a hedged interest-bearing financial instrument should be amortized
to earnings. Amortization should begin no later than when the hedged item
ceases to be adjusted for changes in its fair value that are attributable to the
risk being hedged.
5.42 FASB ASC 815-30-35-44 states that if a reclassification to earnings
of the amount in accumulated comprehensive income resulting from a cash flow
hedge of debt is required when debt is extinguished, the amount reclassified
from accumulated comprehensive income to earnings should be excluded from
extinguishment gain or loss.

Nonhedging Derivatives
5.43 Some derivatives may represent hedges for risk management purposes (entered into to hedge a specific exposure) that do not receive special
hedge accounting either because the hedge relationship does not qualify for
hedge accounting under the criteria in FASB ASC 815 or because an entity
does not elect hedge accounting. Alternatively, nonhedging derivatives may be
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entered into for speculative purposes. Gains and losses related to nonhedging derivatives are reported in earnings (that is, included in the performance
indicator) in the period of change.

Additional Requirements for Not-for-Profit Health Care Entities
5.44 FASB ASC 954-815-50-1 requires not-for-profit health care entities
to separately disclose the beginning and ending accumulated derivative gain
or loss that has been excluded from the performance indicator, as discussed in
paragraph 5.07; the related net change associated with current-period hedging
transactions; and the net amount of any reclassifications into the performance
indicator in a manner similar to that described in FASB ASC 815-30-50-2.
Similarly, FASB ASC 954-815 requires not-for-profit health care entities to
provide disclosures that are analogous to those required by paragraphs 1–3
of FASB ASC 815-30-50 and FASB ASC 815-35-50-2 for for-profit enterprises,
including the disclosure of anticipated reclassifications into the performance
indicator of gains and losses that have been excluded from that measure and
reported in accumulated derivative gain or loss as of the reporting date.
5.45 In accordance with FASB ASC 958-225-45-8, the changes in fair
value of derivative instruments or hedged items are classified as increases or
decreases in unrestricted net assets, unless their use is temporarily or permanently restricted by explicit donor stipulations or law.

Auditing
5.46 AU section 332, Auditing Derivative Instruments, Hedging Activities,
and Investments in Securities (AICPA, Professional Standards), provides guidance on auditing procedures for assertions that are made in an entity's financial
statements about derivative instruments and hedging activities. A companion
Audit Guide, Auditing Derivative Instruments, Hedging Activities, and Investments in Securities, provides practical guidance to clarify and illustrate the
application of the requirements of AU section 332.
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Chapter 6

Property and Equipment and Other Assets
Overview
6.01 Health care entities use various kinds of property and equipment.
Those assets are generally significant to the financial position of institutional
health care entities, such as hospitals and nursing homes. Typical accounts
used to record property and equipment transactions are land, land improvements, buildings and improvements, leasehold improvements, fixed and movable equipment, leased property and equipment, accumulated depreciation and
amortization, and construction in progress.
6.02 Health care entities also have intangible assets, which may be acquired in connection with business combinations or purchases or developed
from other resources of the entity. Intangibles with finite lives are amortized
according to their useful life. Examples of intangibles include the following:

r

Health plans, which include the following:
— Customer relationships, such as employer groups or
members
— Provider networks
— Trademarks
— Trade names
— Software
— Licenses
— Favorable leases
— Noncompete agreements

r

— Goodwill
Hospitals and other health care facilities, which include the following:
— Licenses
— Certificates of need
— Managed care contracts

r

— Goodwill
Physician practices, which include the following:
— Medical charts
— Noncompete agreements
— Managed care contracts
— Goodwill

6.03 Supplies inventories are generally not very significant to the financial position of health care entities. However, because of the volume and cost
of supplies used, they may be much more significant to operating expenses
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and the statement of operations. Supplies typically include medical and surgical supplies; pharmaceuticals; linens, uniforms, and garments; food and other
commodities; and housekeeping, maintenance, and office supplies.
6.04 Health care entities, whether investor owned or not for profit, may
receive donations in the form of property, equipment, or supplies. Donations
of property, equipment, and supplies are measured at fair value at the date of
donation, which then becomes the cost basis for the assets, and are recorded as
an increase to fixed assets, inventory, or supply expense, as appropriate.
6.05 Accounting policies and disclosure requirements for property and
equipment, supplies, and certain other assets of health care entities are similar
to those used by other business entities. Health care entities should apply
the guidance in Financial Accounting Standards Board (FASB) Accounting
Standards Codification (ASC) 360, Property, Plant, and Equipment, and FASB
ASC 340, Other Assets and Deferred Costs, except when the guidance conflicts
with the specialized guidance in FASB ASC 954, Health Care Entities.

Capitalized Interest
6.06 Many not-for-profit health care entities finance acquisitions, additions, and renovations of facilities by issuing tax-exempt debt, as discussed
in chapter 7, "Municipal Bond Funding," of this guide. If the proceeds of taxexempt borrowings are externally restricted to finance the acquisition of specified qualifying assets or to service the related debt, the amount of interest
cost to be capitalized is determined in accordance with paragraphs 8–12 of
FASB ASC 835-20-25. If the health care entity uses taxable debt or otherwise
does not qualify for interest capitalization under those paragraphs, then the
amount of interest cost to be capitalized is determined pursuant to paragraphs
2–7 of FASB ASC 835-20-35. Frequently, not-for-profit health care entities are
required to capitalize interest under paragraphs 2–7 of FASB ASC 835-20-35
for some projects and paragraphs 8–12 of FASB ASC 835-20-35 for others.
6.07 Among the differences between the two sets of guidance are the
interest cost to be capitalized and the capitalization period. For interest costs
on qualifying assets acquired with proceeds of tax-exempt borrowings that
are externally restricted, FASB ASC 835-20-30-11 requires that the amount
of capitalized interest be all interest cost of the borrowing less any interest
earned on related interest-bearing investments acquired with proceeds of the
related tax-exempt borrowings from the date of the borrowing until the assets
are ready for their intended use. For other borrowings, paragraphs 2–7 of FASB
ASC 835-20-30 use a weighted average construction expenditures concept that
is applied during the period for which the three criteria in FASB ASC 835-2025-3 are present. Those criteria are (a) expenditures for the asset have been
made, (b) activities that are necessary to get the asset ready for its intended
use are in progress, and (c) interest cost is being incurred.
6.08 In accordance with FASB ASC 835-20-30-12, the interest cost of a
tax-exempt borrowing should be eligible for capitalization on other qualifying
assets of the entity when the specified qualifying assets are no longer eligible for
interest capitalization. The entire interest cost on that portion of the proceeds
that is available for other uses, such as refunding an existing debt issue other
than a construction loan related to those assets, also is eligible for capitalization
on other qualifying assets. Example 1 in FASB ASC 835-20-55-4 illustrates this
guidance.

AAG-HCO 6.04

75

Property and Equipment and Other Assets

6.09 In certain circumstances in which an entity has an investment (equity, loans, and advances) accounted for by the equity method, and the investee has not begun its planned principal operations, FASB ASC 835-20-35-2
requires capitalization of interest cost. As explained in FASB ASC 835-20-155(c), the investor's investment in the investee, not the individual assets or
projects of the investee, is the qualifying asset for purposes of interest capitalization. Interest is capitalized while the investee has activities in progress
necessary to commence its planned principal operations, provided that the
investee's activities include the use of funds to acquire qualifying assets for
operations.
6.10 FASB ASC 835-20-15 specifies the types of assets for which interest is not capitalized. Among the listed items are assets acquired with gifts
and grants that are restricted by the donor or grantor to acquisition of those
assets, to the extent that funds are available from such gifts and grants; interest earned from the temporary investment of those funds that is similarly
restricted should be considered an addition to the gift or grant for this purpose.
Other items include assets not included in the consolidated balance sheet of the
parent company and consolidated subsidiaries and assets that are not being
used in the earning activities of the entity and not undergoing the activities
necessary to get them ready for use.
6.11 Some health care entities finance construction projects with municipal securities that have both taxable and tax-exempt components. The aggregate proceeds are to finance a specific construction project and are restricted
by a common indenture or trust agreement to use only for construction of the
project, repayment of the debt, or both. In such situations, the interest to be
capitalized on the taxable portion of the issue is accounted for separate from
the interest on the tax-exempt portion, based on paragraphs 2–7 of FASB ASC
835-20-30.

Supplies, Rebates, and Discounts
6.12 Many health care entities receive rebates and discounts from purchase agreements or other arrangements with vendors. Time may pass between
the purchase of supplies and receipt of the rebate. Rebates and discounts are
credited to the related expense or asset account. Paragraphs 10–12 of FASB
ASC 605-50-25 and paragraphs 12–15 of FASB ASC 605-50-45 provide guidance when a health care entity is given cash considerations, rebates, refunds,
or other up-front considerations by vendors.
6.13 Supply purchase contracts or other arrangements that include the
use of vendor equipment may be considered to include a lease, as discussed in
FASB ASC 440-10-25.

Lessee Involvement in Fixed Asset Construction 1
6.14 Frequently, health care entities, such as hospitals and the hospital's
employed physicians, enter into agreements with real estate developers for the

1
On August 17, 2010, the Financial Accounting Standards Board (FASB) issued a proposed
Accounting Standards Update (ASU), Leases (Topic 840), which would make significant changes to
the accounting requirements for both lessees and lessors. Readers should be alert to the issuance of
a final standard.
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construction of satellite buildings (for example, ambulatory surgery centers
and medical office buildings). If the health care entity agrees to lease space in
the building, the transaction is referred to as a build-to-suit transaction.
6.15 In these situations, FASB ASC 840-40-15-5 states that the health
care entity (lessee) should be considered the owner of an asset during the
construction period and, thus, be subject to FASB ASC 840-40 if it bears substantially all of the construction period risks; effectively, a sale and leaseback
of the asset occurs when construction of the asset is complete, and the lease
term begins. Paragraphs 2–16 of FASB ASC 840-40-55 provide specific criteria
to apply in order to determine whether the health care entity (lessee) should be
considered the owner of the asset during the construction period. If deemed to
be the owner, the health care entity (lessee) should account for the arrangement
as a sale-leaseback, in accordance with FASB ASC 840-40.
6.16 Thus, if the health care entity (lessee) bears substantially all of
the construction-period risks, it should recognize construction in progress and
a related financing obligation during the construction period. When the construction of the asset is complete, the health care entity (lessee) determines if
it has met the requirements of sale-leaseback accounting, and if so, the deemed
sale is recognized.
6.17 Additional guidance for build-to-suit transactions is found in the
following standards:

r
r

Paragraphs 42–47 of FASB ASC 840-40-55 provide guidance for
costs incurred by a lessee before entering into a lease agreement
with the developer-lessor.
Paragraphs 7–16 of FASB ASC 958-810-55 provide guidance if a
not-for-profit health care entity is engaged in leasing transactions
with a special-purpose-entity lessor.

Asset Retirement and Environmental
Remediation Obligations
6.18 Many health care entities operate facilities that were originally constructed prior to the existence of modern building codes. FASB ASC 410, Asset
Retirement and Environmental Obligations, provides guidance for a facility
that, upon disposal or abandonment, would be required by current regulations
to remove, treat, or dispose of items such as asbestos; hazardous chemicals; test
equipment; and building improvements, such as lead shielding or underground
storage tanks, and to remediate environmental liabilities.
6.19 FASB ASC 410-20 addresses financial accounting and reporting for
obligations associated with the retirement, sale, abandonment, recycling, disposal, or other-than-temporary idling of tangible long-lived assets and the associated asset retirement costs. It applies to legal obligations associated with
the retirement of long-lived assets that result from the acquisition, construction, development, or normal operation of a long-lived asset, except for certain
obligations. Paragraphs 8.59–.61 of this guide provide additional information
about asset retirement obligations.
6.20 FASB ASC 410-30 requires that an entity recognize a liability for
obligations associated with environmental remediation liabilities that relate to
pollution arising from some past act, generally as a result of the provisions of
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Superfund, the corrective-action provisions of the Resource Conservation and
Recovery Act, or analogous state and non-U.S. laws and regulations. Generally,
an environmental remediation liability results from the improper operation of
a long-lived asset; an environmental remediation liability that results from the
normal operation of a long-lived asset and is associated with the retirement of
that asset is an asset retirement liability, as discussed in paragraph 6.19. FASB
ASC 410-30 provides a brief overview of environmental laws and regulations,
which may be helpful in understanding potential remediation liabilities.

Impairment or Disposal
6.21 The "Impairment or Disposal of Long-Lived Assets" sections of FASB
ASC 360-10 provide guidance whenever events or changes in circumstances
indicate that the carrying amount of a long-lived asset (asset group2 ) may not
be recoverable. FASB ASC 360-10-35-17 states that an impairment loss should
be recognized only if the carrying amount of the long-lived asset or asset group
is not recoverable and exceeds its fair value.
6.22 Some of the following changes in circumstances of health care
providers may indicate that the carrying amount of a long-lived asset group is
not recoverable:

r
r
r
r
r

There has been an adverse change in the use of the assets, such
as the loss of certain core services to a specialty hospital.
Patient volumes have significantly declined.
Market conditions, such as the payment rates being received, increased competition, declining market demographics, or other conditions, have changed in such a manner that operating cash flow
losses have been incurred or are projected to occur.
The provider has lost its eligibility to be paid for services by a
major payor, such as Medicare.
The provider has lost its federal or state tax exemption.

6.23 FASB ASC 360-10-35-23 requires that for purposes of recognition and
measurement of an impairment loss, a long-lived asset or assets be grouped
with other assets and liabilities at the lowest level for which identifiable cash
flows are largely independent of the cash flows of other assets and liabilities.
Further, because FASB ASC 205-20 requires discontinued operations to be
reported separately from continuing operations at the level of a component of
an entity, a health care entity needs to determine whether a disposal group is a
component of an entity. The FASB ASC glossary states that a component of an
entity "comprises operations and cash flows that can be clearly distinguished,
operationally and for financial reporting purposes, from the rest of the entity."
6.24 It may be difficult for health care systems to apply those guidelines
due to arrangements that affect numerous entities under common control,
such as multientity managed care contracts, centralized billing offices, and
2
The FASB Accounting Standards Codification (ASC) glossary defines an asset group as "the
unit of accounting for a long-lived asset or assets to be held and used, which represents the lowest
level for which identifiable cash flows are largely independent of the cash flows of other groups of
assets and liabilities." The FASB ASC glossary states that "[a] disposal group for a long-lived asset
or assets to be disposed of by sale or otherwise represents assets to be disposed of together as a group
in a single transaction and liabilities directly associated with those assets that will be transferred in
the transaction."
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shared purchasing operations and arrangements with physicians involved in
providing services at multiple locations. Additionally, it is not uncommon for
health care entities that operate multiple entities to support a service or facility
that generates ongoing negative cash flows because the related services may be
either (a) central to the furtherance of the overall entity's mission or (b) offered
in order to reach a market segment that management believes will ultimately
utilize other services within the entity to generate positive cash flows.
6.25 If a health care entity commits to a plan to abandon a long-lived asset
before the end of its previously estimated useful life, FASB ASC 350-10-35-47
requires depreciation estimates to be revised, in accordance with paragraphs
17–20 of FASB ASC 250-10-45 and FASB ASC 250-10-50-4, to reflect the use
of the asset over the shortened useful life.
6.26 Paragraphs 9–11 of FASB ASC 360-10-45 provide the criteria for
classifying a long-lived asset group as held for sale. Consideration of those criteria by not-for-profit health care entities may be complicated by multiple levels
of corporate governance and the interests of other authorities, such as the state
attorney general, in the use of the assets. Large health care systems may be
organized in such a way that the sale of certain assets must be approved by the
governing board of the entity that owns the assets; any parent corporations;
and, potentially, appointed representatives of groups that sponsor the system,
such as religious congregations. Additionally, many transactions require approval by the state attorney general. These factors will affect the assessment of
whether management has the authority to approve a sale and may also affect
the timing of the completion of the transaction and, thus, the probability that
the sale will be completed within one year.
6.27 In accordance with FASB ASC 360-10-35-44, if the health care entity
decides not to sell a long-lived asset (disposal group) previously classified as
held for sale, the asset (disposal group) should be reclassified as held and used.
A long-lived asset that is reclassified should be measured individually at the
lower of (a) its carrying amount before the asset (disposal group) was classified
as held for sale, adjusted for any depreciation (amortization) expense that
would have been recognized had the asset (disposal group) been continuously
classified as held and used, or (b) its fair value at the date of the subsequent
decision not to sell.
6.28 Per FASB ASC 205-20-45-1, the results of operations of a component
of a health care entity that either has been disposed of or is classified as
held for sale under the requirements of FASB ASC 360-10-45-9 should be
reported in discontinued operations, in accordance with FASB ASC 205-20-453, if both of the following conditions are met: (a) the operations and cash flows
of the component have been or will be eliminated from the ongoing operations
of the health care entity as a result of the disposal transaction, and (b) the
health care entity will not have any significant continuing involvement in the
operations of the component after the disposal transaction. FASB ASC 205-2055 provides implementation guidance to help an entity determine whether the
two conditions are met.
6.29 In evaluating those criteria, consideration may be given to the geographic proximity of similar facilities operated by the health care entity, the existence of plans to relocate services to facilities under common control, whether
the medical staff utilizing the disposed facility will be utilizing a facility
within the same health care entity, and whether the health care entity will be
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continuing to utilize any of the long-lived assets previously included in the
disposed component.
6.30 Per FASB ASC 205-20-45-3, the results of discontinued operations
less applicable income taxes (benefit) should be reported as a separate component of income before extraordinary items. For not-for-profit health care
entities, FASB ASC 954-225-45-7 requires that discontinued operations be reported separately from the performance indicator.

Nonreciprocal Transfers
6.31 A health care entity may transfer ownership of its long-lived assets,
either individual pieces of equipment or an entire facility, to another health
care entity in a nonreciprocal transaction.
6.32 FASB ASC 720-25 applies if such transactions are contributions,
as defined in the FASB ASC glossary. Accounting for contributions made is
discussed in paragraph 11.39 of this guide.
6.33 Similar to the recording of an impairment of long-lived assets, a
gain or loss recognized to adjust to fair value would be included in income
from continuing operations before income taxes in the income statement of
an investor-owned health care entity or in the performance indicator in the
statement of operations of a not-for-profit entity. If a subtotal, such as "Income
From Operations," is presented, it would include the amounts of those gains or
losses.

Other Long-Lived Assets
6.34 Health care entities that incur costs for upgrading or improving
computer systems should follow the guidance in FASB ASC 350-40 for costs
of computer software developed or obtained for internal use and FASB ASC
720-45 for business and technology reengineering. Business and technology
reengineering may include software development, software acquisition, software implementation, training, and ongoing support.
6.35 Many health care entities have other long-lived or intangible assets,
such as goodwill, trademarks, prepaid benefits, patents, and costs associated
with certificates of need. These assets may be acquired by purchase, through
internal development, or through research and development efforts, among
other activities.
6.36 The cost of an intangible asset acquired other than in an acquisition
by a not-for-profit entity or business combination is capitalized in accordance
with FASB ASC 350, Intangibles—Goodwill and Other. Costs of start-up activities, including organization costs, should be expensed as incurred, as discussed
in FASB ASC 720-15.
6.37 In accordance with FASB ASC 350-20, goodwill that is not written
off on the acquisition date, as discussed in paragraph 12.99 of this guide,
should not be amortized. Instead, it should be tested for impairment at a level
of reporting referred to as a reporting unit. Paragraphs 33–46 of FASB ASC
350-20-35 provide guidance on determining reporting units. Impairment is
the condition that exists when the carrying amount of goodwill exceeds its
implied fair value. The fair value of goodwill can be measured only as a residual
and cannot be measured directly. Therefore, FASB ASC 350-20 includes a
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methodology to determine an amount that achieves a reasonable estimate of the
value of goodwill for purposes of measuring an impairment loss. That estimate
is referred to as the implied fair value of goodwill. The two-step impairment
test discussed in paragraphs 4–19 of FASB ASC 350-20-35 should be used to
identify potential goodwill impairment and measure the amount of a goodwill
impairment loss to be recognized, if any.*
6.38 Under the requirements of FASB ASC 350-30, accounting for a recognized intangible asset is based on its useful life to the reporting entity. An
intangible asset with a finite useful life should be amortized; an intangible
asset with an indefinite useful life should not be amortized. If an intangible
asset has a finite useful life, but the precise length of that life is not known,
that intangible asset should be amortized over the best estimate of its useful life. The method of amortization should reflect the pattern in which the
economic benefits of the intangible asset are consumed or otherwise used up.
If that pattern cannot be reliably determined, a straight-line amortization
method should be used. An intangible asset that is subject to amortization
should be reviewed for impairment in accordance with the "Impairment or
Disposal of Long-Lived Assets" sections of FASB ASC 360-10 by applying the
recognition and measurement provisions in paragraphs 17–35 of FASB ASC
360-10-35.
6.39 If an intangible asset is determined to have an indefinite useful
life, it should not be amortized until its useful life is determined to be no
longer indefinite. Instead, an intangible asset that is not subject to amortization should be tested for impairment annually or more frequently if events
or changes in circumstances indicate that the asset might be impaired, as
described in paragraphs 15–20 of FASB ASC 350-30-35. FASB ASC 360-10-3521 includes examples of impairment indicators. The impairment test should
consist of a comparison of the fair value of an intangible asset with its carrying amount. If the carrying amount of an intangible asset exceeds its fair
value, an impairment loss should be recognized in an amount equal to that
excess.

Financial Statement Presentation
6.40 Financial statement presentation of property and equipment, supplies, and other assets of health care entities is similar to that of other business
entities.
6.41 FASB ASC 954-205-45-9 states that the expiration of donor-imposed
restrictions on long-lived assets should be recognized when the asset is placed
in service, rather than as depreciated, as permitted by FASB ASC 958-205-4512. Thus, if contributions of long-lived assets with explicit donor restrictions
are reported as temporarily-restricted support, a health care entity reports
expirations of those donor restrictions when the stipulation is fulfilled, and the
assets are placed in service. Similarly, donations of cash or other assets that
*
In December 2010, FASB issued ASU No. 2010-28, Intangibles—Goodwill and Other (Topic
350): When to Perform Step 2 of the Goodwill Impairment Test for Reporting Units with Zero or Negative Carrying Amounts (a consensus of the FASB Emerging Issues Task Force). This ASU simplifies
how an entity is required to test goodwill for impairment. For public entities, this ASU is effective
for fiscal years, and interim periods within those years, beginning after December 15, 2010. For nonpublic entities, it is effective for fiscal years, and interim periods within those years, beginning after
December 15, 2011. Early adoption is not permitted for public entities, but nonpublic entities may
adopt the amendments using the effective date for public entities.
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must be used to acquire long-lived assets are reported as temporarily-restricted
support in the period received, and expirations of those donor restrictions are
reported when the acquired long-lived assets are placed in service, and donorimposed restrictions are satisfied.
6.42 According to FASB ASC 954-360-45-1, property held for investment
purposes is presented as part of investments.
6.43 FASB ASC 958-360-50-4 requires that donor or legal restrictions on
the use of, or proceeds from, the disposition of donated property and equipment
or property and equipment purchased with cash restricted for the acquisition
of long-lived assets be disclosed.

Auditing
6.44 Auditing objectives for property and equipment, supplies, and other
assets of health care entities are similar to those in audits of other business
entities. The auditor may be able to assess the risks of material misstatement
for these accounts as being relatively low because the transactions therein are
generally small in number, relatively simple in nature, and do not involve the
use of complex estimates. The auditor must obtain a sufficient understanding
of the entity and its environment, including its internal control, to assess the
risk of material misstatement for these accounts.
6.45 A health care entity may have access to the use of property and
equipment under a variety of arrangements. It may (a) own property and
equipment; (b) rent property and equipment from an independent or related
entity; (c) use property and equipment provided by a related entity, such as a
religious order, or an unrelated entity under an affiliation program; or (d)
use property and equipment provided by a government agency or unit or
government-related hospital district. The independent auditor may inquire
into, and the financial statements might disclose, the nature of any relationship between the health care entity and lessors, bailors, or other owners of
property.
6.46 In evaluating the entity's capitalization policies, the independent
auditor should consider whether interest has been capitalized in accordance
with the provisions of FASB ASC 835-20.
6.47 In evaluating the entity's depreciation policies, the auditor may wish
to refer to the American Hospital Association's Estimated Useful Lives of Depreciable Hospital Assets, which is revised periodically and sets forth plant
asset classifications and the estimated useful lives of depreciable assets. Additionally, social, economic, and scientific advances in the health care industry
make obsolescence an important factor to be considered when evaluating depreciation policies and methods.
6.48 In considering a health care entity's application of the "Impairment
or Disposal of Long-Lived Assets" sections of FASB ASC 360-10, auditors may
obtain an understanding of the policies and procedures used by management
to determine whether all impaired assets have been properly identified. In
addition to evaluating the entity's procedures for identifying indicators of impairment, the auditor may consider information obtained during the audit in
determining whether the health care entity has identified appropriate indicators of impairment. For example, a change in the use of a facility from an
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acute-care hospital to an ambulatory surgery center may require that the asset
be reviewed for impairment.
6.49 In obtaining sufficient appropriate audit evidence with respect to
property and equipment, supplies, and other assets, the auditor may consider
the examples of specific auditing objectives, selected control activities, and
auditing procedures that are presented in exhibit 6-1.
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Exhibit 6-1
The following table illustrates the use of assertions in developing audit objectives and designing substantive tests. The examples are not
intended to be all-inclusive nor is it expected that all the procedures
would necessarily be applied in an audit. The auditor should design
and perform substantive procedures for all relevant assertions related
to each material class of transactions, account balance, and disclosure
to obtain sufficient appropriate audit evidence. The use of assertions
in assessing risks and designing appropriate audit procedures to obtain audit evidence is described in paragraphs .14–.26 of AU section
326, Audit Evidence (AICPA, Professional Standards). Various audit
procedures and the purposes for which they may be performed are
described in paragraphs .27–.41 of AU section 326.
Auditing Considerations
Financial Statement
Assertions

Specific Auditing
Objectives

Selected Control
Activities

Auditing
Procedures

Procedures ensure
that the donation
of property and
equipment is
known and
recorded and that
documentation
supports the
determination of
the fair value.

Review the
documentation
supporting the
determination of
the fair value.2

Donated Property Equipment
Account Balances
Valuation and
allocation

Donated property
and equipment is
reported at fair
value at the date
of donation.1

Presentation and Disclosure
Classification and
understandability

The receipt of
donated property
and equipment is
properly reported.

Review material
donated property
and equipment
transactions to
ensure the
propriety of the
reporting.

Property and Equipment Not Held for Use in Operations
Presentation and Disclosure
Classification and
understandability

Property and
equipment not
used for
operations is
reported
separately.

Property records
segregate property
and equipment not
used for operating
purposes.

Determine that
property held for
nonoperating
purposes is
reported
separately.
(continued)
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Auditing Considerations—continued
Financial Statement
Assertions

Specific Auditing
Objectives

Selected Control
Activities

Auditing
Procedures

Management
regularly monitors
compliance with
health care
planning agency
regulations
related to
additions of
property and
equipment.

For material new
construction,
determine
compliance with
health care
planning agency or
other regulatory
agency
requirements.

Property and Equipment Additions
Rights and
obligations

The appropriate
health care
planning agency
or other
regulatory
agency approvals,
if required, have
been obtained for
property and
equipment
additions.

Additions are
authorized in the
capital budget.
Existence and
valuation and
allocation

1

Recorded
property and
equipment are
owned by the
entity and
carried at the
appropriate
amounts.

Inventory of
property and
equipment is
taken periodically.
Detailed property
records are
periodically
reconciled to the
recorded amounts.

Review a summary
of property and
equipment (cost
and accumulated
depreciation),
including
additions,
deletions, and
transfers.

For additional discussion on fair value measurements, refer to chapter 4, "Cash,
Cash Equivalents, and Investments," of this guide.
2
AU section 328, Auditing Fair Value Measurements and Disclosures (AICPA,
Professional Standards), provides guidance on auditing fair value measurements
and disclosures contained in financial statements. AU section 328 does not address
specific types of assets, liabilities, components of equity, transactions, or industryspecific practices. Considerations for Audits Performed in Accordance With Public
Company Accounting Oversight Board (PCAOB) Standards PCAOB Staff Audit
Practice Alert No. 2, Matters Related to Auditing Fair Value Measurements of Financial Instruments and the Use of Specialists (AICPA, PCAOB Standards and
Related Rules, PCAOB Staff Guidance, sec. 400.02), provides guidance on auditors'
responsibilities for auditing fair value measurements of financial instruments and
when using the work of specialists under the existing standards of the PCAOB.
This practice alert is focused on specific matters that are likely to increase audit
risk related to the fair value of financial instruments in a rapidly changing economic environment. This practice alert also highlights certain requirements in the
auditing standards related to fair value measurements and disclosures in the financial statements and certain aspects of generally accepted accounting principles
that are particularly relevant to the current economic environment. PCAOB Staff
Audit Practice Alerts are not rules of the PCAOB nor have they been approved by
the PCAOB.
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Chapter 7

Municipal Bond Financing
Introduction
7.01 Although health care entities utilize many forms of debt financing,
this chapter focuses on municipal bonds issued on behalf of not-for-profit health
care entities. Because of its capital-intensive nature, health care is among
the largest industry sectors that raise funds through the municipal securities
market.
7.02 Typically, a qualified governmental agency, such as a health care financing authority (the issuer), issues the securities and then lends the proceeds
to the health care entity (the obligor). In these conduit financings, although the
securities bear the name of the issuing government, the issuer has no obligation for repayment of the debt; the bondholders' principal and interest will be
paid solely from resources of the obligor.
7.03 Most municipal bonds issued on behalf of health care entities are
revenue bonds. For revenue bond issues, the health care entity pledges a specific revenue stream, typically revenue derived from the project or enterprise
being funded. There may also be a mortgage on the financed property and
other restrictive covenants. To obtain project financing, a financing authority
may require a health care entity to enter into a lease arrangement, a sublease
arrangement, or both. It is also common practice for a health care system to
create an obligated group of affiliated entities, the assets and revenues of which
serve as collateral for the debt.
7.04 Municipal bonds are issued with either a variable or fixed interest
rate. A fixed-rate bond bears interest at a specified, constant rate. Variable-rate
(floating-rate) bonds bear interest at a rate that is reset from time to time. Some
documents provide the ability to change the interest mode (for example, from
auction rate1 to variable rate). In addition, financing strategies have emerged
that convert a variable-rate obligation into a fixed-rate obligation, or vice versa,
using derivative instruments. For example, a common financing structure involves creating fixed-rate debt by initially issuing lower cost variable-rate debt
coupled with a floating-to-fixed interest rate swap. Additional considerations
related to interest rate swaps are discussed in chapter 5, "Derivatives," of this
guide.
7.05 The type of project(s) that is funded with municipal bond proceeds
affects the taxability of income received by the bond holders and, thus, whether
the bonds are characterized as tax exempt or taxable. Generally, tax-exempt
bonds are issued to finance services or facilities that are for the public good.
Interest paid to holders of tax-exempt bonds is often exempt from all federal
income taxes and sometimes state or local taxes, as well. Taxable bonds may be
issued for uses not qualifying for tax-exempt financing (for example, medical
office buildings). Tax considerations are discussed in paragraphs 7.39–.43.

1
In a Dutch auction, investors bid for the bonds, which are sold at the lowest yield necessary to
sell the entire issue.
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Conduit Bonds That Trade in Public Markets
7.06 Certain accounting standards require entities that have securities
that trade in public markets to provide more extensive disclosures than is
required for entities that do not have securities trading in public markets.
Generally, the rationale behind these requirements is that the entity's financial
statements are being utilized in public markets for making decisions about
whether to buy, sell, or hold that entity's securities.
7.07 The Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) glossary has multiple definitions for the term public
entity. Generally, these are entities that have debt or equity securities that
trade in public markets. When applying accounting standards that refer to
public entities, careful attention should be paid to the requirements to determine which definition applies and whether the definition includes conduit bond
obligors within its scope. If within its scope, it is also necessary to determine
whether the obligor's securities trade in public markets (for example, over-thecounter markets). As discussed in paragraph 7.12, if conduit bonds have been
issued on behalf of a health care entity in a competitive or negotiated offering,
they are deemed to trade in public markets. Bonds issued in a private placement would not be deemed to trade in public markets for as long as the bonds
are privately held.
7.08 The fact that a not-for-profit health care entity with conduit bonds
that trade in public markets is considered a public entity does not change
that entity's status for purposes of applying accounting standards with requirements that are specific to not-for-profit entities or that explicitly exclude
not-for-profit entities. If the scope of an accounting standard that contains
expanded disclosure requirements or additional accounting requirements for
public entities explicitly excludes not-for-profit entities, not-for-profit health
care entities would not apply that standard. Additionally, classification as a
public entity under generally accepted accounting principles (GAAP) does not
impose Securities and Exchange Commission (SEC) or other regulatory filing
requirements (such as Regulations S-X or S-K) on not-for-profit health care conduit debt obligors. It also does not result in a not-for-profit health care entity
being required to comply with the portions of the Sarbanes-Oxley Act of 2002
that apply only to issuers, as defined by the Securities Exchange Act of 1934.

Credit Enhancement 2
7.09 Health care entities may utilize credit enhancements to make their
bonds more attractive to investors or to allow them to access the market at more
favorable rates. Credit enhancement involves the use of the credit standing of
an entity, other than the issuer or obligor, to provide additional security in a
bond or note financing. Credit enhancement typically refers to bond insurance,
bank letters of credit, and similar facilities but also may refer more broadly
to the use of any form of guaranty; secondary source of payment; or similar,
additional credit-improving instruments.
7.10 When credit enhancement is provided through a bank letter of credit,
the bonds bear the rating of the issuing bank that commits to pay the principal
and interest on the securities in the event that the obligor is unable to do so.
2
Paragraph 7.67 discusses the fair value of bonds with third-party credit enhancements,
whether measured for purposes of disclosure or reporting under the "Fair Value Option" sections
of Financial Accounting Standards Board (FASB) Accounting Standards Codification 825-10.
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Letters of credit cover a specified time period. Bond insurance is an unconditional and irrevocable commitment from a municipal bond insurance company
to make scheduled bond debt service payments in the event of nonpayment
by the obligor. Bonds secured by a municipal bond insurance policy carry the
rating of the municipal bond insurer. Once acquired, a bond insurance policy
generally is in place for the life of the bonds. Government programs, such as
the Federal Housing Administration Section 242 mortgage insurance program,
enable some obligors to enhance their credit using the creditworthiness of the
federal government.
7.11 Because credit-enhanced bonds are rated based on the credit standing of another entity, downgrades of the other entity's ratings can have implications for the obligor's own credit ratings, as well as potentially triggering
defaults under debt agreements and derivative contracts. See related discussion in paragraph 7.82.

Issuance of Municipal Bonds
7.12 Municipal bonds are issued through negotiated sales, competitive
bids, or private placements. In a negotiated sale, the issuer or obligor negotiates
a price with one or more underwriters. In a competitive bid sale, the securities
are sold to one or more underwriters who submitted the best acceptable bid(s).
The underwriters then resell the securities to the general investing public.
Municipal bonds issued in negotiated sales or competitive bids are deemed to be
traded in public markets; thus, conduit borrowers under those arrangements
are considered public entities for purposes of providing certain disclosures
under accounting standards, as discussed in paragraph 7.06. In addition, when
underwriters sell municipal securities to the general investing public, the SEC
imposes certain requirements on the underwriters, who in turn require the
obligors to file certain disclosure documents. An overview of SEC considerations
related to municipal bonds is provided in appendix A, "Municipal Securities
Regulation," of this chapter. In a private placement, the securities generally
are sold directly to qualified investors (for example, an institutional investor),
rather than through an offering to the general investing public. Municipal
bonds issued in private placements are not deemed to trade in public markets
because the investors typically are subject to restrictions on resale.
7.13 A health care entity that is issuing municipal bonds through a financing authority prepares an official statement that offers the securities for sale
and provides appropriate financial and other information about the offering,
the health care entity, and any guarantors or credit-enhancement providers.
Financial advisers; bond counsel; and, frequently, engineers and appraisers assist the health care entity in preparing information for the official statement.
Professional requirements related to auditor association with municipal securities offerings are discussed in paragraph 7.86. The following are important
stages in a municipal securities offering (the time periods between these stages
may vary):

r
r
r

The preliminary official statement is issued to all prospective buyers of the securities.
The financing authority, health care entity, and underwriters execute the bond purchase agreement.
The official statement is issued at the time of sale (sometimes
referred to as the effective date) and identifies the actual debt
service requirements of the securities.
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The closing date is the date that the transaction is finalized, and
the proceeds are transferred from the buyers to the health care
entity.

Extinguishment and Modification Transactions
7.14 Not-for-profit health care entities generally follow the same accounting and financial reporting standards for extinguishment and modification of
debt as investor-owned entities. Those standards are found in FASB ASC 40520 and 470-50.
7.15 FASB ASC 405-20-40 states that a liability is extinguished either
when the debtor pays the creditor and is relieved of its obligation for the liability
or when the debtor is legally released from being the primary obligor under the
liability, either judicially or by the creditor. FASB ASC 405-20-40-1(a)(4) states
that paying the creditor includes reacquisition by the debtor of its outstanding
debt securities, regardless of whether the securities are cancelled or held as
Treasury bonds.
7.16 Thus, a debt obligation is derecognized if a health care entity reacquires its bonds through open market purchases, regardless of whether the
reacquired securities are then held by the debtor as Treasury bonds or retired.
Treasury bonds that are held should never be reported as an asset of the health
care entity, even if the entity intends to remarket the bonds at a future date or
hold and manage them as part of its investment portfolio.
7.17 Another way that a health care entity may extinguish its debt is
by issuing new bonds whose proceeds are used to repay the previously-issued
bonds (a refunding transaction). If the new bonds are held by the same creditor
as the old bonds, the refunding may be a modification of debt terms, rather than
an extinguishment, as discussed in paragraphs 6–12 of FASB ASC 470-50-40.
See also paragraphs 7.27–.31. Three types of refunding transactions exist:
current refunding, advance refunding, and crossover refunding. In a current
refunding, the new debt proceeds may be used to repay the old bonds within 90
days of the first call date or maturity of the bonds to be refunded. In an advance
refunding, the new debt proceeds are placed with an escrow agent and invested
until they are used to pay principal and interest of the old debt at a future time;
outstanding securities are refinanced more than 90 days prior to their call or
maturity date.3 In a crossover refunding, bonds referred to as crossover bonds
are issued for the purpose of paying off an existing bond issue (referred to as the
refunded bonds). The crossover bonds are initially collateralized by an escrow
of investments purchased with the crossover bond proceeds, and the refunded
bonds continue to be secured by their original collateral or revenue stream.
On a specified date, the investments held in escrow are sold, and the refunded
bonds are redeemed. Then, the crossover bonds become collateralized by the
original collateral or payable from the original revenue stream. In refunding
transactions, the entity must either call the bonds (if allowed) to redeem them
early or irrevocably set aside the funds to pay them off in a defeasance. These
situations are discussed subsequently.

3
Per the Tax Reform Act of 1986, new money bonds issued prior to January 1, 1986, can be
advance refunded twice, but bonds issued on or after that date can only be advance refunded once.
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Calls and Mode Conversions
7.18 Some bond contracts allow a health care entity to repay the bonds
prior to their scheduled maturity date, which is referred to as a call option.
Typically, new bonds are issued to pay off the outstanding bonds (a refunding).
7.19 Some bonds are structured as multimodal, which permits the health
care entity to exercise an interest mode conversion. A multimodal feature provides the health care entity with a contractual right to change the interest
feature of the bond from one form to another (for example, an auction-based interest rate to a fixed-rate or index-based variable interest rate). In most cases,
a mode conversion involves a call (referred to as a mandatory tender) of the old
bonds and marketing of new bonds to new investors, as well as existing bondholders. Thus, the mode conversion is similar to a traditional refunding, and
the same accounting considerations apply to mode conversions as refunding.

Defeasance
7.20 If the health care entity would like to retire the debt early but does
not have a call option, defeasance is a financing tool that allows it to obtain
some or all of the benefits of repaying bondholders prior to actually retiring the
debt. In a defeasance, the health care entity purchases government securities
for deposit into an escrow account and irrevocably pledges the securities to the
payment of the outstanding bonds. The securities and their related earnings
are sufficient to pay the principal and interest on the bonds when they come
due. In essence, the health care entity is substituting collateral on the debt.
Often, some or all of the funds deposited into the escrow account arise from an
advance refunding. Generally, the revenues originally pledged as security on
the outstanding securities switch over to become security for payment of the
refunding bonds (the new issue) on the date that the advance refunding bonds
are issued.
7.21 Defeasances are categorized as legal or economic. The terms of some
bond contracts allow for legal defeasance, which is the termination of the rights
and interests of the bondholders and their lien on the pledged revenues or
other security. When the conditions specified in the bond contract for legal
defeasance are met, the health care entity's obligation for repayment of the
bonds is satisfied in full, and the debt is extinguished.
7.22 In other situations, sometimes referred to as an in-substance or
economic defeasance, establishing a defeasance escrow account makes the revenues pledged as collateral available for other purposes without actually effecting a legal defeasance. This might be used if, for example, the bond contract
does not provide a procedure for termination of the bondholders' rights and
interests other than through redemption of the bonds. In an economic defeasance, if for some reason the escrowed funds prove insufficient to make future
payments on the old debt, the health care entity is still legally obligated to
make payment on such debt from the pledged revenues.
7.23 FASB ASC 405-20-55 provides implementation guidance on the extinguishment of liabilities, including in-substance and legal defeasances.
7.24 When a defeasance occurs, the debtor has not paid the creditor.
Therefore, liabilities are considered extinguished for accounting purposes only
if the debtor is legally released from being the primary obligor under the liability, either judicially or by the creditor. In a legal defeasance, generally, the
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creditor legally releases the debtor from being the primary obligor under the
liability; however, the question of whether the debtor has in fact been legally
released is a matter of law, not an accounting determination. A legal opinion may be required. An in-substance defeasance transaction normally does
not meet the derecognition criteria for either the liability or escrowed assets,
unless a legal release is obtained.
7.25 Paragraphs 4–6 of FASB ASC 860-10-40 provide standards for determining whether financial assets should be derecognized.
7.26 Derecognition of the assets in the defeasance trust may need to be
separately evaluated, even if the defeased debt has met the criteria for derecognition. Because the obligor must surrender control over the assets transferred
to the trust, and the transferred assets must be legally isolated from the obligor
(for example, presumptively put beyond the reach of the obligor and its creditors, even in bankruptcy or other receivership), if the obligor has any type of continuing involvement with the transferred assets (for example, if the obligor has
the ability to direct the investment of trust assets or is entitled to residual assets upon termination of the trust), a separate legal isolation opinion may be required in order to conclude that the conditions for derecognition have been met.

Modifications
7.27 When one debt instrument is replaced with another, such as occurs
in refundings or interest mode conversions, and the new debt instrument is
held by the same creditor(s) as the old, questions may arise about whether the
transaction is considered a debt modification or debt extinguishment.
7.28 Paragraphs 6–12 of FASB ASC 470-50-40 provide guidance for determining whether a replacement of one debt instrument with another is a
modification of the original debt terms or the extinguishment of one obligation
and issuance of another. FASB ASC 470-50-40-6 states that an exchange of
debt instruments with substantially different terms is a debt extinguishment
and should be accounted for in accordance with FASB ASC 405-20-40-1 by derecognizing the liability. FASB ASC 470-50-40-10 states that from the debtor's
perspective, an exchange of debt instruments between a debtor and creditor in
a nontroubled debt situation is deemed to have been accomplished with debt
instruments that are substantially different if the present value of the cash
flows under the terms of the new debt instrument is at least 10 percent different from the present value of the remaining cash flows under the terms of the
original instrument. However, if the debt modification is considered a troubled
debt restructuring, the guidance in FASB ASC 760-60 would apply.
7.29 When evaluating whether a modification or an exchange has occurred
with a public debt issuance, the debt instrument is the individual security held
by an investor, and the creditor is the security holder. Thus, the unit of account
is not for the bond issue in total but on a bondholder-by-bondholder basis. As a
practical matter, if the bonds are widely held, it may be reasonable to conclude
that the issuance of new bonds to pay off old bonds is not a refinancing of
debt with the same creditors; thus, it is an extinguishment, rather than a
modification. If the bonds are not widely held, and the transaction is in essence
a refinancing of debt with the same creditor(s), it is necessary to determine
whether the difference between the present value of the remaining cash flows
associated with the original obligation and the present value of the cash flows
associated with the new obligation is less than 10 percent. If the difference is
less than 10 percent, the transaction is a modification.
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7.30 For a conduit bond offering involving a governmental financing
agency, a health care entity should determine whether the financing agency is
acting as a principal or an agent of the obligor in order to determine whether
the transaction is an extinguishment or a modification.
7.31 Paragraphs 19–20 of FASB ASC 470-50-40 and paragraphs 4–7 of
FASB ASC 470-50-55 provide guidance and indicators to consider in making
such a determination.

Gain or Loss on Debt Extinguishment
7.32 FASB ASC 470-50 addresses how a gain or loss on a debt extinguishment should be measured. It applies to all extinguishments of debt, regardless of whether the extinguishment is early, except debt that is extinguished
through a troubled debt restructuring or convertible debt. Per FASB ASC 47050-40-2, the difference between the reacquisition price and net carrying amount
of the extinguished debt should be recognized currently in income of the period
of extinguishment as losses or gains and identified as a separate item. Gains
and losses should not be amortized to future periods. Classification of the gain
or loss is discussed in FASB ASC 470-50-45. See paragraph 7.64 for additional
discussion.
7.33 The reacquisition price of debt is the amount paid on extinguishment, including a call premium and miscellaneous costs of reacquisition. If
extinguishment is achieved by a direct exchange of new securities, the reacquisition price is the fair value of the new securities. The net carrying amount of
the extinguished debt is the amount due at maturity, adjusted for unamortized
premium, discount, and cost of issuance.

Debt Issuance Costs
7.34 Paragraphs 17–18 of FASB ASC 470-50-40 provide guidance for reporting costs incurred by the debtor in connection with an exchange or a modification of debt instruments. The accounting treatment depends on whether
the fees are paid to the creditor or other third parties. The following paragraph
summarizes that guidance but is not a substitute for reading the referenced
paragraphs.
7.35 If the exchange or modification is to be accounted for in the same
manner as a debt extinguishment, and the new debt instrument is initially
recorded at fair value, then (a) the fees between the debtor and creditor are
included in determining the debt extinguishment gain or loss to be recognized,
and (b) the third-party costs are amortized over the term of the new debt
instrument using the interest method in a manner similar to debt issue costs. If
the exchange or modification is not accounted for in the same manner as a debt
extinguishment, then (a) the fees between the debtor and creditor, along with
any existing unamortized premium or discount, are amortized as an adjustment
of interest expense over the remaining term of the replacement or modified
debt instrument using the interest method, and (b) the third-party costs are
expensed as incurred.
7.36 As discussed in FASB ASC 470-50-40, in the event of a mode conversion, modification, or extinguishment of debt, there may be effects on the
related prepaid bond issuance costs or deferred issuance costs, such as writing
off all or a portion of these costs or revised amortization periods.
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Puts or Tender Options
7.37 Some bond contracts allow the bonds to be repaid prior to their stated
maturity at the option of the bondholder. The bondholder's right to request earlier payment is referred to as a tender option (or sometimes a put option). Some
health care entities utilize bank agreements, such as letters of credit or standby
bond purchase agreements (a liquidity facility), to provide liquidity for the put
or tender feature. If a bondholder exercises its put option, the health care entity generally will seek to sell the put bonds to another investor through its
remarketing agent. If another investor is found who accepts the same terms as
the original bondholder, the transaction occurs between the bondholders and
does not affect the accounting by the health care entity. The proceeds of the
resale are used to pay the original bondholder. If another investor cannot be
found (for example, a failed remarketing), the health care entity is required to
pay the bondholder. If the health care entity has a liquidity facility, then the
liquidity provider generally advances the funds needed to pay the bondholder.
At that point, ownership of the bonds transfers to the liquidity provider, and
they become bank bonds. The interest rate payable on bank bonds converts
to the rate stipulated in the liquidity facility agreement. Efforts continue to
remarket the bank bonds for the period of time stipulated in the liquidity facility agreement. If another bondholder is found within that period, the proceeds
generally are used to pay off the liquidity facility; the interest rate returns to
the terms in the original bond agreement; and the bonds revert to their normal
status, with the one exception discussed in paragraph 7.15.
7.38 If another buyer cannot be found after a certain period, the liquidity
facility generally ceases to be interest only and converts to a term loan. The
health care entity repays the debt over a relatively short period of time, rather
than over the original stated maturity of the bonds. In effect, the bank (the
liquidity facility) exchanges the term loan for the bond, and the bond is derecognized because its terms are substantially different from those of the term
loan.
7.39 In some cases, health care entities may forego using an external
liquidity facility. If a failed remarketing occurs, the health care entity pays
the holder of the put bonds using its own cash and liquid investments (selfliquidity). In these situations, the bonds are considered extinguished when the
failed remarketing occurs, regardless of whether the put bonds are retained by
the health care entity as Treasury bonds or retired.

IRS Considerations
7.40 As discussed in paragraph 7.05, interest paid to holders of tax-exempt
bonds is often exempt from all federal income taxes and sometimes state or
local taxes, as well. In order to maintain the bonds' tax-exempt status, health
care entities must comply with all applicable federal tax laws and Treasury
regulations, including, but not limited to, the use of bond-financed property
and arbitrage requirements. The IRS encourages Internal Revenue Code (IRC)
Section 501(c)(3) organizations to implement procedures that will enable them
to adequately safeguard against postissuance violations that could result in
the loss of the tax-exempt status of the bonds. IRS Publication 4078, TaxExempt Private Activity Bonds (available for download at www.irs.gov/pub/irspdf/p4078.pdf) is a helpful source of information regarding the requirements.
Requirements related to arbitrage and the qualified use of proceeds are briefly
summarized subsequently.
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7.41 Tax-exempt bonds bear interest at lower rates than taxable bonds
due to the inherent federal tax subsidy. Safeguards exist, so that entities do
not attempt to inappropriately benefit from this subsidy by issuing tax-exempt
bonds and then investing the proceeds to earn arbitrage, which is the difference
between the interest earned on the invested funds and the interest rate that
the health care entity must pay to the bondholders. Specific IRS requirements
control arbitrage and dictate which bond issues are subject to rebate (for example, remitting excess earnings to the federal government) and when the yield
on investments must be restricted. Certain exceptions apply to these provisions
based on the nature and timing of the expenditures paid by the bond proceeds.
7.42 FASB ASC 954-470-25-2 states that IRS regulations concerning taxexempt debt prohibit the yield realized from the investment of the proceeds
of tax-exempt debt from exceeding the interest rate to be paid on such debt.
Whenever a health care entity invests tax-exempt bond proceeds, and the ultimate yield is higher than the interest rate on the bonds, the entity may be
subject to an arbitrage rebate liability. The arbitrage determination is made
as of the date of the issue; however, intentional acts undertaken after the date
of the issue can retroactively disqualify the issue. The earnings in excess of
interest expense represent a liability that must be paid to the Department of
the Treasury in order for the bonds to maintain their tax-exempt status. The
arbitrage rebate liability may be a substantial amount if the bond proceeds
are not spent as quickly as planned. For example, this may occur if a provider
encounters a delay in a major construction project.
7.43 The type of project(s) that is funded by a bond affects the taxability of
income received by the bondholders. Conduit bonds issued for projects that only
benefit private parties (private activity bonds) normally are taxable. Conduit
bonds issued to finance facilities owned and utilized by IRC Section 501(c)(3)
nonprofit organizations are exempt from federal income tax if they are qualified
501(c)(3) bonds. To qualify for tax exemption, at least 95 percent of the net bond
proceeds must be used for exempt activities. Thus, no more than 5 percent of
the net proceeds may be used in any private business use or by the not-forprofit entity in an unrelated trade or business activity. Bond issuance costs
are considered part of the 5 percent private use and reduce the available net
proceeds for other types of private use. IRC Section 501(c)(3) borrowers must
ensure that the IRS rules on private use are met both at the time that the
bonds are issued and throughout the life of the bonds.
7.44 Treasury regulations provide for certain remedial actions to cure uses
of proceeds that would otherwise cause the qualified 501(c)(3) bonds to lose their
exempt status. Those remedial actions can include redemption or defeasance
of bonds, alternative qualified use of disposition proceeds, or alternative use
of the bond-financed facilities. Entities may also be eligible to enter into a
closing agreement under IRS Notice 2008-31, Voluntary Closing Agreement
Program For Tax-Exempt Bonds and Tax Credit Bonds, which is available at
www.irs.gov/pub/irs-drop/n-08-31.pdf.

Financial Statement Presentation and Disclosure
Balance Sheet
7.45 According to FASB ASC 954-470-25-1, when a financing authority
issues tax-exempt bonds or similar debt instruments and uses the proceeds
for the benefit of a health care entity, the obligation should be reported as a
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liability in the entity's balance sheet if the health care entity is responsible
for repayment. In some cases, this obligation may take the form of a liability
arising from a capital lease.* If a health care entity has no obligation to make
payments of principal and interest on the debt or capital or operating lease
payments on related buildings or equipment, the entity should not reflect the
liability on its balance sheet. In such circumstances, proceeds from the bond
issue shall be reported as contributions from the sponsoring entity.
7.46 Although bonds typically have a stated maturity of many years,
careful consideration should be given to classification of the liability as current
or noncurrent based on the features of the debt. Debt that appears to be long
term based on its legal maturity might not be considered long term for financial
reporting purposes because of subjective acceleration clauses or due-on-demand
(put) provisions. Careful consideration of the bond agreements and related
documents (for example, bond indenture, loan and trust agreement, liquidity
facility, and so on) may be required in order to make a determination of whether
debt is properly classified.
7.47 The principal guidance for evaluating the appropriate balance sheet
classification of debt obligations is found in FASB ASC 210-10-45, 470-10-45,
and 470-10-55.

Classification of Debt With Due-on-Demand or Put Provisions
7.48 FASB ASC 470-10-45-10 states that the current liability classification should include obligations that, by their terms, are due on demand or
will be due on demand within one year (or operating cycle, if longer) from the
balance sheet date, even though liquidation may not be expected within that
period.
7.49 For example, some variable-rate bonds have a demand feature (a put
or tender option) whereby the bondholder may require the health care entity or
its remarketing agent to repurchase the bonds, often on short notice. Demand
obligations normally are classified as current liabilities, despite the fact that the
bond's stated maturities cover many years. However, such obligations often are
supported by a liquidity facility, such as a standby bond purchase agreement or
letter of credit from a financial institution, that provides the health care entity
with the ability to refinance, on a long-term basis, any obligation that may
arise if tendered bonds cannot immediately be remarketed to another investor,
as discussed in paragraph 7.37.
7.50 FASB ASC 470-10-55-8 states that debt agreements that allow a
debt holder to redeem (or put) a debt instrument on demand (or within one
year) should be classified as short-term liabilities despite the existence of a
best-efforts remarketing agreement. Unless the issuer (health care entity) of
the redeemable debt instrument has the ability and intent to refinance the
debt on a long-term basis, as provided for in FASB ASC 470-10-45-14, the debt
should be classified as a current liability.
7.51 FASB ASC 470-10-45-14 requires that the intent to refinance the
short-term obligation on a long-term basis be supported by an ability to consummate the refinancing that is demonstrated in either of the following ways:
*
On August 17, 2010, FASB issued proposed Accounting Standards Update Leases (Topic 840),
which would make significant changes to the accounting requirements for both lessees and lessors.
Readers should be alert to the issuance of a final standard.
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(a) postbalance sheet date issuance of a long-term obligation or equity securities or (b) a financing agreement. If a financing agreement is used to justify
noncurrent classification of the bonds, FASB ASC 470-10-45-14(b) requires
that before the balance sheet is issued or available to be issued, the entity
must have entered into a financing agreement that clearly permits the entity
to refinance the short-term obligation on a long-term basis on terms that are
readily determinable, and all three conditions in FASB ASC 470-10-45-14(b)
must be met.
7.52 In summary, those three conditions are as follows:
a. The agreement does not expire within one year from the date of
the entity's balance sheet, and during that period, the agreement
is not cancelable by the lender, except for violation of a provision
with which compliance is objectively determinable or measurable.
Further, any obligations incurred under the agreement are not
callable during that period.
b. No violation of any provision in the financing agreement exists at
the balance sheet date, and no available information indicates that
a violation has occurred thereafter, or if a violation has occurred
thereafter, a waiver has been obtained.
c. The lender is expected to be financially capable of honoring the
agreement.
However, the conditions are very complex, and the preceding summary is not
intended as a substitute for reading paragraphs 14–20 of FASB ASC 470-10-45.
7.53 If the liquidity facility, which is the financing agreement, contains
a subjective acceleration clause, the liquidity facility does not meet the first
condition in the previous paragraph because compliance with that clause is
not objectively determinable or measureable. The health care entity is not
deemed to have the ability and intent to finance on a long-term basis and, thus,
cannot classify the debt as noncurrent, even if the repayment terms of the
liquidity facility would otherwise support such classification. See paragraph
7.55 for the definition of a subjective acceleration clause. The probability of the
subjective acceleration clause being exercised is irrelevant when attempting
to demonstrate the ability to refinance a short-term obligation on a long-term
basis. See related discussion in paragraph 7.56.
7.54 Rather than utilizing a liquidity facility issued by an external third
party, some health care entities choose to utilize their own funds for satisfying
puts or tenders. Health care entities that do so have no basis for excluding
those put and tender obligations from current liabilities because no third party
provides liquidity that would effectively allow the entity to refinance the debt
on a long-term basis.

Classification of Debt With a Subjective Acceleration Clause
7.55 The FASB ASC glossary defines a subjective acceleration clause as
"a provision in a debt agreement that states that the creditor may accelerate
the scheduled maturities of the obligation under conditions that are not objectively determinable (for example, if the debtor fails to maintain satisfactory
operations or if a material adverse change occurs)." For long-term obligations,
the effect of a subjective acceleration clause on balance sheet classification is
determined by FASB ASC 470-10-45-2. That paragraph states that in some situations, the circumstances (for example, recurring losses or liquidity problems)
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would indicate that long-term debt subject to a subjective acceleration clause
should be classified as a current liability. Other situations would indicate only
disclosure of the existence of such clauses. Neither reclassification nor disclosure would be required if the likelihood of the acceleration of the due date was
remote, such as if the lender historically has not accelerated due dates of loans
containing similar clauses and the financial condition of the borrower is strong
and its prospects are bright.
7.56 In other words, a long-term obligation could continue to be classified
as noncurrent, unless it was probable it would be called. For an obligation that
by its terms is short term, FASB ASC 470-10-55-1 states that a higher standard
is required for a financing agreement that permits an entity to refinance a shortterm obligation on a long-term basis than is required for an existing long-term
loan for which early repayment might be requested. As discussed in paragraph
7.53, if a financing agreement that permits an entity to refinance a short-term
obligation on a long-term basis contains a subjective acceleration clause, its
mere presence is enough to preclude long-term classification.

Classification of Long-Term Debt With a Covenant Violation
7.57 Violations of covenants could cause termination of the financing
agreement or demand for immediate repayment. Thus, debt covenant violations can affect the balance sheet classification.
7.58 Paragraphs 11–12 of FASB ASC 470-10-45 discuss the classification
of long-term obligations that are callable by the creditor because the debtor's
violation of a provision of the debt agreement at the balance sheet date either
makes the obligation callable or may become callable because the violation,
if not cured within a specified grace period, will make the obligation callable.
Those paragraphs require that such callable obligations be classified as current
liabilities, unless either of the two conditions in FASB ASC 470-10-45-11 is met.
7.59 In summary, those two conditions are as follows:
a. The creditor has waived or subsequently lost the right to demand
repayment more than one year from the balance sheet date.
b. The long-term obligation contains a grace period within which the
debtor may cure the violation, and it is probable that the violation
will be cured within that period.
However, the conditions are complex, and the preceding summary is not intended as a substitute for reading paragraphs 11–12 of FASB ASC 470-10-45.
7.60 If neither of those two conditions is met, the debt is classified as short
term, regardless of the fact that the creditor has not demanded repayment,
and no indication exists that the creditor intends to do so within the next year.
Further, no distinction between significant and insignificant violations should
be drawn. That is the right of the creditor, and if the violation is considered
insignificant by the creditor, the debtor should be able to obtain a waiver.
7.61 Paragraphs 2–6 of FASB ASC 470-10-55 provide examples of classification of long-term debt when a debt covenant violation at the balance sheet
date is waived by a lender for a period greater than one year, but the entity
must meet the covenant on a quarterly or semiannual basis.

Subsequent Events
7.62 Events occurring subsequent to the balance sheet date but before
the financial statements are issued or available to be issued may need to be
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reflected in the financial statements, either by changing the balance sheet
classification of the debt or by disclosure. For example, bond restructuring
transactions occurring after the balance sheet date may have an effect on the
debtor's current or noncurrent balance sheet classifications as of that balance
sheet date, and extinguishing or modifying the terms of a bond issue may require disclosure. Chapter 3, "Unique Financial Statement Considerations for
Not-for-Profit Health Care Entities," of this guide includes additional information about subsequent events, including a discussion of whether a health care
entity evaluates subsequent events through the issuance date of the financial
statements or the date that the financial statements are available to be issued.

Assets Limited as to Use
7.63 Debt-financing instruments may require either cash or investments,
or both, to be set aside in special accounts that can only be used for debt-related
purposes, such as unexpended proceeds of debt issues and funds deposited with
a trustee and limited to use in accordance with the requirements of a bond
indenture or similar document (for example, sinking funds, debt reserve funds,
or defeasance-related escrows). Such assets are usually reported in the balance
sheet caption "Assets Limited as to Use." The portion of assets whose use is
limited (that is, required for liquidation of current liabilities) is reported as
current assets, with the remainder reported as noncurrent assets.

Statement of Operations
7.64 If the proceeds of tax-exempt borrowings are externally restricted to
the acquisition of specified qualifying assets or to service the related debt, the
amount of interest cost capitalized should be determined in accordance with
paragraphs 10–12 of FASB ASC 835-20-30. Those considerations are discussed
in chapter 6, "Property and Equipment and Other Assets," of this guide.
7.65 Pursuant to FASB ASC 470-50-40-2, gains or losses on the extinguishment of debt should be recognized currently in income of the period of
extinguishment and identified as a separate item. Paragraphs 2–7 of FASB
ASC 225-20-45 provide the criteria that must be met for gains and losses from
the extinguishment of debt to be classified as extraordinary items.

Disclosures
7.66 General disclosure requirements for debt, such as description of the
debt, collateral, interest rate, covenants, and guarantees, are set forth in FASB
ASC 470-10-50. If debt was considered to be extinguished by in-substance
defeasance under the provisions of FASB Statement No. 76, Extinguishment
of Debt—an amendment of APB Opinion No. 26, before the effective date of
FASB Statement No. 125, Accounting for Transfers and Servicing of Financial
Assets and Extinguishments of Liabilities (that is, before December 31, 1996),
FASB ASC 470-40-50-1 requires disclosure of the amount of the debt and a
description of the transaction as long as the debt remains outstanding. FASB
ASC 860-30-50-2 provides disclosure requirements for assets that are set aside
solely for the purpose of satisfying scheduled payments of a specific obligation.
7.67 If short-term obligations are classified in the balance sheet as a
long-term liability because the health care entity has the ability and intent
to refinance the debt on a long-term basis, as discussed in paragraph 7.51,
those obligations need to be included in the disclosure of the combined aggregate amount of maturities and sinking fund requirements for all long-term
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borrowings that is required by FASB ASC 470-10-50-1. In those situations, the
health care entity must ensure that disclosure is made of both the debt repayment schedule of the liquidity facility and the stated maturity of the bonds.
This can be done by either (a) including one repayment schedule in the table
and providing a narrative disclosure related to the other or (b) providing two
tabular schedules (one for the liquidity facility payment schedule and the other
based on the stated maturity of the bonds).
7.68 As discussed in paragraphs 7.06–.08, additional disclosures are required for entities defined as public entities. Generally, public entities are those
that have debt or equity securities that trade in public markets. Because FASB
ASC has multiple definitions for the term public entity, careful attention should
be paid to such disclosure requirements to determine if their scope includes
conduit bond obligors whose bonds trade in public markets.
7.69 Paragraphs 10–19 of FASB ASC 825-10-50 require that public entities disclose the fair value of all financial instruments, whether recognized or
not recognized in the statement of financial position, for which it is practicable
to estimate that value. The disclosure is also required of nonpublic entities if
their assets are $100 million or more on the date of the financial statements or
if they have derivative instruments.
7.70 As discussed in paragraphs 7.09–.11, some health care entities may
utilize a credit enhancement to make their bonds more attractive to investors
or to allow them to access the market at more favorable rates. FASB ASC 82010-35-18A states that an entity should not include the effect of an inseparable
third-party credit enhancement in the fair value measurement of the liability.
For the issuer (obligor), the unit of accounting for a liability measured or disclosed at fair value does not include the third-party credit enhancement. Thus,
when disclosing the fair value of debt obligations that have a third-party credit
enhancement that is inseparable from the liability, such as bond insurance, the
fair value measurement should consider only the credit standing of the health
care entity, rather than the credit standing of the guarantor. If fair value is
determined based on the prices at which the bonds are trading in markets, an
adjustment needs to be made for the difference between the credit standing of
the guarantor (on which the market trades are based) and the credit standing
of the health care entity.
7.71 FASB ASC 855-10-55-2 cites the sale of a bond after the balance
sheet date but before financial statements are issued or available to be issued
as an example of an event that requires disclosure in the notes to the financial
statements.
7.72 Other events occurring after the balance sheet date, such as failed
auctions, potential or actual cancellation of a liquidity facility, defaults, or
a mandatory tender of bonds may also need to be disclosed in the financial
statements as subsequent events.

Obligated Group Reporting
7.73 Many debt agreements involving obligated groups require audited
financial statements for the obligated group to use in the bond offering document and thereafter to the underwriters or bond repositories, or both, on an
annual, on-going basis. Often, this special financial statement presentation will
exclude entities otherwise required to be consolidated in a health care entity's
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general-purpose financial statements. Financial statements that exclude these
entities are no longer a GAAP presentation, and AU section 623, Special Reports (AICPA, Professional Standards), requires that a special-purpose report
must be issued that is restricted to use by specified parties.
7.74 Many obligated groups are required to annually submit audited financial statements to the Municipal Securities Rulemaking Board's (MSRB's)
Electronic Municipal Market Access (EMMA) system, which is a system for disseminating the information to investors in municipal securities and other interested parties. See appendix A of this chapter for additional information. Because this system would make the obligated group financial statements broadly
available, it is not appropriate to submit statements containing a restricted-use
report. Paragraph .25 of AU section 623 states that a separate paragraph in
a special-purpose report is not appropriate if the report and related financial
presentation are to be filed with a regulatory agency, such as the SEC, and
are to be included in a document, such as a prospectus, that is distributed to
the general public. Instead, consolidating schedules presenting the obligated
group as supplemental information to the consolidated financial statements
may meet the requirements within the bond contract.

Interim Financial Reporting
7.75 Often, continuing disclosure agreements entered into by a health care
entity in connection with municipal bond financings will require the entity to
provide financial information to investors on both a quarterly and an annual
basis. In such situations, the entity should consider the requirements of FASB
ASC 270, Interim Reporting, which provides guidance on accounting and disclosure issues peculiar to interim reporting and sets forth minimum disclosure
requirements for interim financial reports of publicly-traded companies. FASB
ASC 270-10-50-3 states that it is presumed that users of summarized interim
financial data will have read the latest published annual report, including the
financial disclosures required by GAAP and management's commentary concerning the annual financial results, and that the summarized interim data
will be viewed in that context.
7.76 FASB ASC 270-10-50-1 provides the minimum requirements for summarized financial information at interim dates, including reports on fourth
quarters, presented by publicly-traded companies. In addition, FASB ASC
270-10-50-4 encourages publicly-traded companies to publish balance sheet
and cash flow data at interim dates because this data often assists users of the
interim financial information in their understanding and interpretation of the
reported income data. If condensed interim balance sheet information or cash
flow data is not presented at interim reporting dates, significant changes since
the last reporting period with respect to liquid assets, net working capital,
long-term liabilities, and stockholders' equity (net assets) should be disclosed.

Auditing
General
7.77 Auditing objectives and procedures for long-term debt issued by
health care entities generally are similar to those of other entities. In obtaining sufficient appropriate audit evidence with respect to long-term debt, the
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auditor may consider the examples of specific auditing objectives, selected control activities, and auditing procedures that are presented in exhibit 7-1.
7.78 The amount, type, and classification of bonds in the financial statements is of interest to investors, bond rating agencies, and others who influence
the supply of financial resources, such as financial guarantors. As discussed
in the accounting sections of this chapter, many bond-related transactions
and accounts involve special accounting measurement, presentation, and disclosure principles that require particular audit attention. The auditor should
read financing instruments carefully to be sure that the financing is properly
classified and described in the financial statements. Determining whether debt
is considered long term or short term for accounting purposes has pervasive
implications for financial reporting and compliance with debt covenants. Audit
implications of certain other matters are highlighted subsequently, including
compliance with debt covenants, credit-related triggers in debt agreements,
and implications of transactions related to the issuance, remarketing, and refinancing of debt.

Covenants
7.79 The auditor should consider reviewing restrictive covenants of the
various bond-related agreements to evaluate the health care entity's compliance with covenants and the appropriateness of the presentation and disclosure of covenants in the financial statements. A borrower's failure to comply
with financial covenants may be a signal that the borrower is facing financial
troubles and that the debt may become callable, changing the historical classification and disclosure requirements associated with its debt. If a default on a
bond covenant has occurred, the auditor should evaluate the appropriateness
of classification of debt as long term. If several types of financing are outstanding, the auditor should compare transactions in each type with the restrictions
and provisions of the others. For example, some debt obligations contain a
cross-default provision, which could result in acceleration of the lender's right
of repayment because of default under, or violation of, other agreements. The
existence of certain types of covenants can have implications for classification
of the bonds, even in the absence of a covenant violation.
7.80 The auditor should obtain written waivers of conditions of noncompliance of debt covenants directly from the responsible lending officers or trustees.
It is not appropriate for the auditor to rely solely on management's written or
oral representations or representations from the client's legal counsel that
lenders or trustees have waived the violations. In reviewing a waiver of debt
covenant violations to determine whether the liability should be classified as
current or long term, the auditor should obtain assurance that the waiver is unconditional for a period greater than one year from the balance sheet date and
that it specifically and appropriately addresses each event of noncompliance.
7.81 Some covenants take the form of a subjective acceleration clause in
which the creditor may accelerate the scheduled maturities of the obligation
under conditions that are not objectively determinable (for example, if the
debtor fails to maintain satisfactory operations or a material adverse change
occurs). The mere presence of a subjective acceleration clause in a lending
document has implications for balance sheet classification, even if it is not in
danger of being triggered. In evaluating those implications, the auditor will
need to carefully consider whether the underlying debt is considered long term
or short term (see paragraphs 7.53 and 7.55–.56).
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Credit Ratings
7.82 Credit rating downgrades of material counterparties to debt-related
transactions of the health care entity can have implications for the entity's own
credit standing. For example, if bonds are credit enhanced, the credit rating on
the health care entity's bonds is based on the credit rating of the guarantor or
letter of credit provider, rather than the financial stability of the health care
entity itself. A downgrade in the credit rating of the credit enhancer will automatically trigger a downgrade of the rating on the health care entity's bonds,
even if the health care entity's financial health has not deteriorated. Credit
rating downgrades of others may trigger clauses in derivative agreements that
result in the automatic termination of a swap, a demand presented to a health
care entity for immediate payment of a swap liability, or a requirement for
a health care entity to post collateral based on the downgrade of either the
derivative counterparty (or its guarantor) or the health care entity.

Debt Restructuring
7.83 Changes in market conditions may cause health care entities to restructure their bonds in various ways. Some may seek to issue new bonds,
to change the interest mode on existing bonds, or buy back their own bonds.
In such situations, the auditor may be required to evaluate management's
analysis of whether the transaction represented a modification of debt or an
extinguishment. In addition, such actions may affect the balance sheet classification of the liabilities. A refinancing from long-term debt to short-term debt
(for example, from fixed-rate or auction-rate bonds to variable-rate demand
obligations) can potentially cause changes in the balance sheet classification
and potentially trigger liquidity covenants. Debt restructuring may result in
the discontinuation of hedge accounting for related interest rate swaps, which
can also have bond covenant compliance implications.
7.84 An advance refunding transaction that results in defeasance may
trigger the need for audit evidence supporting assertions of legal release from
liabilities or legal isolation of escrowed assets. Although no direct auditing
guidance regarding the form and content of a typical legal letter governing a
legal defeasance exists, the principles outlined in Interpretation No. 1, "The
Use of Legal Interpretations as Audit Evidence to Support Management's Assertion That a Transfer of Financial Assets Has Met the Isolation Criterion in
Paragraphs 7–14 of Financial Accounting Standards Board Accounting Standards Codification 860-10-40," of AU section 336, Using the Work of a Specialist
(AICPA, Professional Standards, AU sec. 9336 par. .01–.21), may be helpful in
determining whether documentation obtained by the health care entity is adequate audit evidence that the debtor has been legally released as the primary
obligor of the bonds. Based on the facts and circumstances of a particular defeasance transaction, in the auditor's judgment, a legal opinion obtained by
the health care entity may be needed as audit evidence to support the assertion that the assets transferred to the defeasance escrow trust have met the
isolation criterion discussed in paragraph 7.26.
7.85 Some bonds (for example, variable-rate demand obligations) may involve the use of remarketing agreements and backup liquidity facilities. Failed
remarketings and resulting draws upon liquidity facilities may create or exacerbate liquidity problems for a health care entity. As discussed in paragraph
7.37, if a significant amount of bonds are tendered and ultimately become
bank bonds, the health care entity must repay those obligations based on the
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much shorter debt repayment schedule of the liquidity facility, rather than the
expected maturity of the bonds. In some cases, the financial viability of the
liquidity provider may be in question. The implications of such matters should
be considered when assessing debt covenant compliance, liquidity, and going
concern.

Auditor Association With Disclosure Documents
7.86 Because no SEC requirement exists for auditor association with official statements in municipal securities offerings, an auditor generally is not required to participate in, or undertake any procedures with respect to, a client's
official statement.4 However, when an auditor becomes associated with the official statement, as discussed subsequently, AU section 550A, Other Information
in Documents Containing Audited Financial Statements (AICPA, Professional
Standards), provides requirements and guidance on the auditor's responsibilities for information in those official statements other than the financial
statements covered by the auditor's opinion† (see the overview of the provisions of AU section 550A in paragraph 7.89). The following are the situations
in which the auditor becomes associated with the official statement:

r
r
r
r
r

Assisting in preparing the financial information5 included in the
official statement
Reviewing a draft of the official statement at the client's request
Manually or electronically signing the independent auditor's report for inclusion in a specific official statement6
Providing written agreement (for example, through a consent letter or signed authorization form) for the use of the independent
auditor's report in a specific official statement (see paragraphs
7.92–.96)
Providing a revised independent auditor's report7 for inclusion in
a specific official statement

4
Some auditors require that they become associated with a health care entity's official statements, even though the conditions described in this paragraph establishing association would not
otherwise exist. See the discussion in paragraph 7.87.
†
In February 2010, the Auditing Standards Board issued Statement on Auditing Standards
(SAS) No. 118, Other Information in Documents Containing Audited Financial Statements (AICPA,
Professional Standards, AU sec. 550). This SAS will supersede AU section 550A, Other Information
in Documents Containing Audited Financial Statements (AICPA, Professional Standards). SAS No.
118 is effective for audits of financial statements for periods beginning on or after December 15, 2010.
Early application is permitted. Appendix E, "Other Information, Supplementary Information, and
Required Supplementary Information," of this guide provides additional information on SAS No. 118.
5
For the purpose of this requirement, financial information does not include the financial
statements covered by the auditor's opinion or, for governmental health care entities, the required
supplementary information (RSI) or supplementary information, other than RSI accompanying those
financial statements that the auditor has already considered during the audit of the financial statements.
6
This situation involves an original manual or electronic signature on the auditor's report, not
a reproduction of an auditor's report that was manually or electronically signed. For example, the
underwriter or bond counsel may require a copy of the auditor's report with an original manual or
electronic signature to file with the official closing documents for the offering.
7
A revised report would, for example, eliminate the references made by the auditor in the
original report to audits and reports required by Government Auditing Standards (GAS), which is
issued by the Comptroller General of the United States. See the discussion in paragraph 7.96.
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Issuing a comfort letter, as described in paragraph .09 of AU section 634, Letters for Underwriters and Certain Other Requesting
Parties (AICPA, Professional Standards), or an attestation engagement report in lieu of a comfort or similar letter on information included in the official statement (see paragraphs 7.98–.101)
Issuing a report on an attestation engagement relating to the debt
offering (see paragraph 7.103)

7.87 Although an auditor is not required to become associated with a
client's official statements, except in the situations described in paragraph 7.86,
some auditors include a provision in the terms of the engagement requiring
the client to obtain permission from the auditor before using the independent
auditor's report in the official statement. Such a provision may be used by the
auditor to establish a requirement that the auditor become associated with the
client's official statements when the client requests the required permission
from the auditor.
7.88 When the auditor and client agree not to include a provision in the
terms of the engagement that would require auditor association, as discussed
in paragraph 7.86, the auditor may include in the terms of the engagement a
requirement that any official statements issued by the client with which the
auditor is not associated clearly indicate that the auditor is not associated with
the contents of such official statements. Such a disclosure could read as follows:
"[Name of firm], our independent auditor, has not been engaged to perform and
has not performed, since the date of its report included herein, any procedures
on the financial statements addressed in that report. [Name of firm] also has
not performed any procedures relating to this official statement."
7.89 If the auditor is associated with an official statement, the guidance in
paragraphs .04–.06 of AU section 550A provides that the auditor has no obligation to perform any procedures to corroborate other information8 contained in
those documents. However, the auditor should read the other information and
consider whether that information or the manner of its presentation is materially inconsistent with information or the manner of its presentation appearing
in the financial statements. AU section 550A provides guidance if the auditor
concludes that a material inconsistency or material misstatement of fact exists
that is not a material inconsistency.‡
7.90 AU section 380, The Auditor's Communication With Those Charged
With Governance (AICPA, Professional Standards), states that the auditor
should determine that certain significant and relevant financial statement
audit-related matters are communicated orally or in writing to those charged
with governance of the entity. AU section 380 states that the auditor should
discuss his or her responsibility for other information in documents containing
audited financial statements, any procedures performed, and the results. That
requirement pertains to the financial statements currently being issued and,
thus, would not apply retroactively to official statements. However, that communication could supply that information for official statements issued during
the current audit period and through the auditor's report date, regardless of
whether the auditor was associated with those official statements.
8
Other information is a term used in AU section 550, Other Information in Documents Containing Audited Financial Statements (AICPA, Professional Standards), and is defined therein as
information in addition to audited financial statements and the independent auditor's report thereon.
‡
See footnote †.
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7.91 The auditor is not required to participate in, or undertake any procedures with respect to, a client's continuing disclosure documents, even though
they may include audited financial statements. A client's continuing disclosures
are not required to be submitted to, or disseminated from, the distributing organizations as a single document. Thus, an auditor's association with other
information encompassed by such disclosures cannot be clearly established.
Therefore, the provisions of AU section 550A do not apply to documents that
contain those disclosures.|| Any attention that the auditor devotes to other information included with audited financial statements in continuing disclosure
documents at the client's request should be considered a consulting engagement under the provisions of Statement on Standards for Consulting Services
No. 1, Consulting Services: Definitions and Standards (AICPA, Professional
Standards, CS sec. 100).
7.92 The AICPA has issued interpretations to AU section 711, Filings Under Federal Securities Statutes (AICPA, Professional Standards), that address
the auditor's agreement9 to (a) being named and (b) the use of an auditor's
report in an offering document other than one registered under the Securities
Act of 1933 (the 1933 Act).10
7.93 Interpretation No. 2, "Consenting to Be Named as an Expert in an
Offering Document in Connection With Securities Offerings Other Than Those
Registered Under the Securities Act of 1933," of AU section 711 (AICPA, Professional Standards, AU sec. 9711 par. .12–.15), states that when a client wishes
to make reference to the auditor's role in an offering document in connection
with a securities offering that is not registered under the 1933 Act, the caption
"Independent Auditors" should be used to title that section of the document;
the caption "Experts" should not be used nor should the auditor be referred to
as an expert anywhere in the document. The following paragraph should be
used to describe the auditor's role:11
Independent Auditors
The financial statements as of December 31, 20XX, and for the year
then ended, included in this [name of document], have been audited by
ABC, independent auditor, as stated in its report(s) appearing herein.
If the client refuses to delete from the offering document the reference to the auditor as an expert, then the auditor should not permit inclusion of the auditor's
report in the offering document.
7.94 Interpretation No. 3, "Consenting to the Use of an Audit Report in
an Offering Document Other Than One Registered Under the Securities Act
of 1933," of AU section 711 (AICPA, Professional Standards, AU sec. 9711
par. .16–.17), states that the auditor is not required to but may provide an
agreement to the inclusion of the auditor's report in an offering document

See footnote †.
The term consent is a Securities and Exchange Commission (SEC) term that relates to registered securities, and municipal securities are not registered securities. Therefore, this guide uses the
term agreement, even though the AICPA interpretations refer to consent.
10
As discussed in the glossary, an official statement is not considered to be an offering document
registered under the Securities Act of 1933.
11
As discussed in paragraph 7.88, if the auditor is not associated with the offering document,
and the terms of the engagement require disclosure of this fact, additional disclosure similar to that
illustrated in paragraph 7.88 should be included here.
||
9
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other than one registered under the 1933 Act. The interpretation provides the
following example language that the auditor may use:
We agree to the inclusion in this [name of document] of our report,
dated February 5, 20XX, on our audit of the financial statements of
[name of entity].
7.95 When the auditor is asked to issue a letter agreeing to the inclusion
of the auditor's report in the offering document, the effective date of the letter
can be the preliminary official statement date or the official statement date, as
defined in paragraph 7.13.

Independent Accountants’ Reports Included in an Official Statement
7.96 If the auditor is associated with a client's official statement, he or
she should consider which auditors' reports the client presents in the official
statement. The official statement should not include the reports required by
Government Auditing Standards (GAS), which is issued by the Comptroller
General of the United States, because those reports are restricted-use reports
under the provisions of AU section 532, Restricting the Use of an Auditor's
Report (AICPA, Professional Standards). Further, it generally is advisable for
the official statements to use an auditor's report on the financial statements
that does not refer to the GAS audit or those reports because those references,
without the presentation of the reports in the official statements, could confuse
the users of the official statement.

Independent Accountants’ Reports Included on a Continuing
Disclosure Website
7.97 Many obligated groups are required to annually submit audited financial statements to the MSRB's EMMA system. When obligated group financial statements exclude entities that are required under GAAP to be consolidated, the accountants' reports should restrict the use of the financial statements to specified parties. Because inclusion in the EMMA system of financial
statements for such an obligated group would make those financial statements
broadly available, it is not appropriate to submit financial statements containing a restricted-use report (see paragraph 7.74). Instead, consolidating
schedules presenting the obligated group as supplemental information to the
consolidated financial statements may meet the requirements within the bond
contract.

Letters for Underwriters #
7.98 Underwriting agreements between a health care entity and its underwriters may require the auditor to prepare a comfort letter addressed to the
underwriters. AU section 634 defines the term underwriters and gives guidance
to auditors12 in providing letters to underwriters and certain other requesting
parties in connection with the offering or placement of securities. An auditor
may provide a comfort letter to a broker-dealer or other financial intermediary acting as principal or agent in offerings of securities that are exempt from
#
In July 2010, the AICPA issued an exposure draft of a proposed SAS, Letters for Underwriters
and Certain Other Requesting Parties (Redrafted), which would supersede the guidance in AU section
634, Letters for Underwriters and Certain Other Requesting Parties (AICPA, Professional Standards).
This guide will be revised as necessary upon issuance of a final standard.
12
Because of its use in SEC literature, certain auditing literature uses the term accountant to
refer to the auditor; however, this chapter replaces the term accountant with the term auditor.
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registration under the 1933 Act only if the broker-dealer or other financial intermediary provides the required representation letter described in paragraph
.06 of AU section 634.
7.99 When a party requesting a comfort letter has provided the auditor
with the required representation letter, the auditor should refer to the requesting party's representations in the comfort letter. See example P in paragraph
.64 of AU section 634, which is a typical comfort letter in a non-1933 Act
offering, including the required underwriter representations. If the required
representation letter is not provided by the broker-dealer or other financial
intermediary, paragraph .09 of AU section 634 provides requirements and
guidance for auditors.
7.100 As discussed in paragraph .10 of AU section 634, when a comfort letter is requested by a party other than the underwriter, broker-dealer, or other
financial intermediary, the auditor should not provide that party with a comfort letter or the letter described in paragraph .09 of AU section 634. Instead,
the auditor may provide the party with a report on agreed-upon procedures and
should refer to AT section 201, Agreed-Upon Procedures Engagements (AICPA,
Professional Standards), for additional specific guidance. See paragraphs .06–
.10 of AU section 634 for further discussion.
7.101 Auditors may be asked to comment upon information other than
audited financial statements. Guidance for the procedures to be performed and
the form of the comments is provided by the following paragraphs of AU section
634:
a. Unaudited condensed interim financial information (paragraphs
.36–.38)
b. Capsule financial information (paragraphs .36 and .39–.41)
c. Pro forma financial information (paragraphs .42–.43)
d. Financial forecasts (paragraphs .36 and .44)
e. Changes in capital stock, increases in long-term debt, and decreases in other specified financial statement items (paragraphs
.36 and .45–.53)
f. Tables and statistics (paragraphs .54–.60)
7.102 When the auditor is asked to prepare a letter for the underwriter,
the letter can be as of the preliminary official statement date or the official
statement date, as defined in paragraph 7.13, with updating letters issued as of
the official statement date, if applicable, and the closing date. Paragraph .23 of
AU section 634 states that the underwriting agreement ordinarily specifies the
date, often referred to as the cutoff date, to which certain procedures described
in the letter are to relate (for example, a date five days before the date of
the letter). The letter should state that the inquiries and other procedures
described in the letter did not cover the period from the cutoff date to the date
of the letter. The five-day cutoff period in AU section 634 is illustrative only
and does not set a standard, but practice generally does not exceed a five-day
cutoff period.

Attestation Engagements Related to Securities Issuance
7.103 During the process of issuing municipal securities, health care entities or other involved parties often engage practitioners to provide certain
needed information. For example, a health care entity or its bond counsel may
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engage an auditor to review the health care entity's compliance with the revenue coverage requirements on outstanding bonds or to verify the calculation of
escrow account requirements for an advance refunding of bonds. Those engagements should be conducted in accordance with AT section 201.13 If the auditor
of the financial statements included in the official statement also provides an
attestation engagement report relating to a debt offering, that establishes an
association with the official statement, as indicated in paragraph 7.86. An attestation engagement report relating to a debt offering need not be referred
to or included in the official statement to associate the auditor of the financial
statements with the official statement. Sometimes, the attestation engagement
report may only be included in the official closing documents for the offering.
Also, if the practitioner providing the attestation engagement report is not
the auditor of the financial statements included in the official statements, the
issuance of the attestation engagement report does not, by itself, associate either the auditor of the financial statements or the practitioner who issued the
attestation report with the official statement.

13
Generally, these attestation engagements are performed only in accordance with the AICPA's
Statements on Standards for Attestation Engagements. However, if the auditor is performing the
engagement in accordance with GAS, the auditor should apply the guidance of GAS, including chapter 6, "General, Field Work, and Reporting Standards for Attestation Engagements." The auditor
also should consider the guidance in Interpretation No. 6, "Reporting on Attestation Engagements
Performed in Accordance With Government Auditing Standards," of AT section 101, Attest Engagements (AICPA, Professional Standards, AT sec. 9101 par. .56–.58), which explains how an attestation
report should be modified when the engagement is performed in accordance with GAS and provides
an illustrative attestation report.
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Exhibit 7-1
The following table illustrates the use of assertions in developing audit objectives and designing substantive tests. The examples are not
intended to be all-inclusive nor is it expected that all the procedures
would necessarily be applied in an audit. The auditor should design
and perform substantive procedures for all relevant assertions related
to each material class of transactions, account balance, and disclosure
to obtain sufficient appropriate audit evidence. The use of assertions
in assessing risks and designing appropriate audit procedures to obtain audit evidence is described in paragraphs .14–.26 of AU section
326, Audit Evidence (AICPA, Professional Standards). Various audit
procedures and the purposes for which they may be performed are
described in paragraphs .27–.41 of AU section 326.
Auditing Considerations
Financial Statement
Assertions

Specific Auditing
Objectives

Selected Control
Activities

Auditing
Procedures

Procedures ensure
that the health
care entity
appropriately
classifies debt
based on its terms
and monitors its
compliance with
restrictive debt
covenants.

Review the terms
of the bond
indenture for the
presence of any
put options.

Bonds Payable
Presentation and
disclosure

Bond liabilities
are properly
classified in the
financial
statements, and
related
disclosures are
adequate.

Review the terms
of lines of credit
or other liquidity
facilities
underlying
puttable bonds.
Review the debt
instruments for
the presence of
any restrictive
debt covenants,
including
subjective
acceleration
clauses and
cross-default
provisions.
Test compliance
with restrictive
debt covenants.
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Appendix A—Municipal Securities Regulation
A-1 Currently, municipal securities are exempt from all the provisions of
the Securities Act of 1933 (the 1933 Act) and the Securities Exchange Act of
1934 (the 1934 Act), except the antifraud provisions of Section 17(a) of the
1933 Act and Section 10(b) of the 1934 Act and the associated Securities and
Exchange Commission (SEC) Rule 10b-5. Those antifraud provisions prohibit
any person from misrepresenting or omitting material facts in the offering or
sale of securities. Instances of the application of the antifraud provisions in SEC
enforcement actions offer guidance within the context of actual transactions.
A-2 The SEC published its views with respect to the disclosure obligations of
participants in the municipal securities markets under the antifraud provisions
of the federal securities laws in its 1994 Release No. 33-7049, Statement of the
Commission Regarding Disclosure Obligations of Municipal Securities Issuers
and Others. In it, the SEC reviews numerous municipal disclosure practices
needing improvement in light of the antifraud provisions.
A-3 SEC Rule 15c2-12 and associated SEC releases impose certain requirements on the underwriters of municipal securities.1 Because of Rule 15c2-12,
obligors of most municipal securities offerings over set dollar amounts must
provide certain disclosure documents when issuing securities (primary market
disclosures), as well as at certain times thereafter (referred to as continuing
disclosures or secondary market disclosures). Primary market disclosures are
made by issuing an official statement. Secondary market disclosures consist of
(a) annual continuing disclosures as contractually established and (b) material
events notices. Both primary and secondary market disclosure documents are
available through the nationally-recognized municipal securities information
repository known as the Electronic Municipal Market Access (EMMA) system
and state information depositories, if one exists in the obligor's state.

SEC’s Office of Municipal Securities
A-4 The Office of Municipal Securities (OMS), which is located in the Division
of Trading and Markets, coordinates the SEC's municipal securities activities,
advises the SEC on policy matters relating to the municipal bond market,
and provides technical assistance in the development and implementation of
major SEC initiatives in the municipal securities area. In addition, the OMS
assists the Division of Enforcement and other SEC offices and divisions on a
wide array of municipal securities matters. The OMS works closely with the
municipal securities industry to educate state and local officials and conduit
borrowers about risk-management issues and foster a thorough understanding
of the SEC's policies. The OMS also maintains a website of helpful information specifically directed to municipal securities issues and conduit obligors
(www.sec.gov/info/ municipal.shtml).

Secondary Market Disclosure Requirements
A-5 In 1994, as a condition of the issuance of debt securities, the SEC issued
rules requiring that the obligor agree to implement a system of continuing
disclosure that remains in effect as long as the bonds are outstanding. The core
1
For the adopting release, see www.sec.gov/rules/final/adpt6.txt. For the text of Rule 15c2-12,
see www.law.uc.edu/CCL/34ActRls/rule15c2-12.html.
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of this system is the continuing disclosure agreement (sometimes referred to
as a 15c2-12 contract or 15c2-12 agreement). This is a covenant entered into by
the obligor in which the obligor agrees to provide certain specified information
to bondholders and beneficial owners throughout the life of the bond issue. The
terms of the obligor's continuing disclosure agreement are spelled out in the
indenture or bond resolution and also are summarized in the official statement.
A-6 The system is much less prescriptive than the system of periodic reporting
required of publicly-traded companies. The primary elements are (a) annual
reporting of financial and operating information and (b) material events reporting. Quarterly reporting is encouraged but not required, unless agreed to
in the continuing disclosure covenant for a particular issue.
A-7 Similar to Form 10-K, no prescribed reporting format exists for submission
of the annual financial and operating information. The specific list of items to be
included in the annual report will be agreed upon by the parties to the financing transaction and enumerated in the continuing disclosure agreement and an
appendix to the official statement. Usually, it consists largely of audited financial statements and updates of specified categories of financial information and
operating data or specific sections and charts in the final official statements.
A-8 Unlike Form 10-K filings, no statutory due date exists for filing annual
financial information. Instead, the filing deadline is contractually agreed to
in the continuing disclosure agreement. If an obligor fails to file information
by the agreed-upon deadline and subsequently issues an official statement for
new bonds, it must disclose its failure to file in that official statement. Failure to disclose this information constitutes a material omission in the official
statement.
A-9 The annual report does not have to be submitted all at once in a single
document; it may be submitted as a single document or separate documents
comprising a package.
A-10 Similar to Form 8-K filings, the continuing disclosure agreement also
requires the obligor to file disclosures related to significant events within 10
days of their occurrence.* The following events are required disclosures:

r
r
r
r
r
r
r
r
r

*

Principal and interest payment delinquencies
Unscheduled draws on debt service reserves reflecting financial
difficulties
Unscheduled draws on credit enhancements reflecting financial
difficulties
Substitution of credit or liquidity providers or their failure to perform
Adverse tax opinions or events affecting the tax status of the
security
Defeasances
Rating changes
Tender offers
Bankruptcy, insolvency, receivership, or similar event of the obligated person

Readers can view Rule 15c2-12 in its entirety at www.sec.gov/rules/final/2010/34-62184afr.pdf.
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Notices of failure to provide annual financial information on or
before the date specified on the continuing disclosure agreement

The following events must be disclosed, if material:

r
r
r
r
r
r

Appointment of successor or additional trustees or the change of
name of a trustee
Nonpayment-related defaults
Modifications to rights of security holders
Bond calls
Matters affecting collateral (for example, release, substitution, or
sale of property securing repayment of the securities)
Consummation of a merger, consolidation or acquisition involving
an obligated person, or the sale of substantially all the assets of
an obligated person, other than in the ordinary course of business;
the entry into definitive agreements to undertake such an action;
or the termination of an agreement as it relates to any such sale,
other than pursuant to its terms

EMMA System
A-11 Effective July 1, 2009, EMMA became the nationally recognized municipal securities information repository for filing annual reports, material event
notices, and voluntarily-submitted information. EMMA is an Internet-based
centralized database that provides free public access to disclosure and transaction information about municipal bonds to the municipal market. EMMA also
provides access to official statements, advance refunding documents, real-time
trade and historical trade information, daily market information, and other
educational materials about municipal bonds. Essentially, EMMA makes municipal disclosure information available to the market in a manner similar
to the SEC's Electronic Data Gathering, Analysis, and Retrieval system for
the disclosures of publicly-traded companies. Rule 15c2-12 requires all continuing disclosure information to be filed using EMMA. EMMA's website is
www.emma.msrb.org. The SEC release concerning this amendment to Rule
15c2-12 is available at www.sec.gov/rules/sro/msrb/2008/34-59061.pdf.
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Chapter 8

Contingencies and Other Liabilities
8.01 Health care entities are similar to other industries, recording liabilities associated with accounts payable; salaries and payroll taxes; deferred revenue; commitments and contingencies; and other accruals for pension or profit
sharing contributions, compensated absences, and income and other taxes.
This chapter considers those liabilities that are not discussed elsewhere in
this guide. This chapter also discusses certain tax considerations relevant to
not-for-profit entities.

Contingencies and Commitments
8.02 Self-insured obligations, other contingencies, and commitments may
include the following:
a. Losses arising from medical malpractice, worker's compensation,
and other self-insured claims
b. Contingencies related to risk contracting
c. Construction contract commitments
d. Commitments and guarantees that include contractual agreements
with physicians, specialists, and others who perform services by
agreement with health care entities
e. Losses arising from litigation and other regulatory matters, such
as Medicare and Medicaid fraud and abuse settlements

The Essentials of Recognition, Measurement, and Disclosure
for Contingencies
8.03 The following locations provide the primary standards for contingencies and commitments:

r
r
r
r

Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 440, Commitments, which provides general guidance regarding commitments such as those for plant acquisition; unused letters of credit; and obligations to reduce debts,
maintain working capital, or restrict dividends
FASB ASC 450, Contingencies, which provides general guidance
regarding loss contingencies
FASB ASC 460, Guarantees, which provides general guidance regarding guarantees, including minimum revenue guarantees and
guarantees of the indebtedness of others
FASB ASC 275, Risks and Uncertainties, which provides general
guidance regarding disclosure of certain significant risks and uncertainties

8.04 FASB ASC 450-20-25 states that when it is probable that a loss has
been incurred, and the available information indicates that the loss is within a
range of amounts, it follows that some amount of loss has occurred and can be
reasonably estimated, and the loss should be recognized. According to FASB
ASC 450-20-30-1, if some amount within a range of loss appears at the time
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to be a better estimate than any other amount within the range, that amount
should be accrued. However, when no amount within the range is a better
estimate than any other amount, the minimum amount in the range should be
accrued. FASB ASC 450-20-50-3 requires that disclosure of the contingency be
made if at least a reasonable possibility exists that a loss or an additional loss
may have been incurred, and either an exposure to loss exists in excess of the
accrued amount or an accrual is not made for a loss contingency because any
of the conditions in FASB ASC 450-20-25-2 are not met.
8.05 According to FASB ASC 954-450-35-1, estimated losses are reviewed
and changed, if necessary, at each reporting date. The amounts of the changes
are recognized currently as additional expense or a reduction of expense.
8.06 Consistent with the guidance in FASB ASC 210-10-45-6, accrued
unpaid claims and expenses that are expected to be paid during the normal
operating cycle (generally within one year of the date of the financial statements) are classified as current liabilities. All other accrued unpaid claims and
expenses are classified as noncurrent liabilities.

Recognition of Insurance Recoveries
8.07 The amount of a contingency should be determined independently
from any potential claim for recovery, and an asset relating to the recovery
may be recognized only when realization of the claim for recovery is deemed
probable.
8.08 In accordance with FASB ASC 954-450-25-2, the liability for malpractice or similar claims should not be presented net of anticipated insurance
recoveries. Per FASB ASC 954-450-25-2, to the extent that an entity is indemnified for those liabilities, the entity should recognize an insurance receivable
at the same time that it recognizes the liability, measured on the same basis as
the liability and subject to the need for a valuation allowance for uncollectible
amounts. Per FASB ASC 720-20-25-5, if a purchased insurance contract includes coverage for legal and other costs, the accounting for those costs should
be consistent between the asset and liability. If the entity's accounting policy
is to accrue legal and other costs, then the insurance receivable should reflect those costs if they are covered under the terms of the insurance policy.
If an entity's accounting policy is not to accrue for those costs, then the insurance receivable should not reflect those costs on an accrual basis. FASB ASC
954-720-25-1 states that insurance recoveries from a retrospectively-rated insurance policy whose ultimate premium is based primarily on the health care
entity's loss experience should not be recognized until the estimated losses
exceed the stipulated maximum premium.

Managing Risk of Loss
8.09 Health care entities typically use commercial insurance to manage
some portion of the risk of loss from medical malpractice, workers' compensation, and employee health claims. However, as the cost of commercial insurance has continued to rise, many health care entities are managing their risk
through higher deductibles, self-insured retentions, retrospective premiums,
and reduced or no coverage under their insurance policies. In some cases, a
health care entity will form its own insurance company, known as a captive
insurance company, to manage its risk. It is important for the health care entity to identify its risk and the portion of that risk that is insured. Generally,
a health care entity uses actuaries to assist in identifying and quantifying the
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retained risk. An assessment of the risk that is insured is necessary for the
determination of anticipated insurance recoveries.
8.10 Insurance policies may be issued on either an occurrence basis or
a claims-made basis. Occurrence basis policies provide coverage for insured
events occurring during the contract period, regardless of the length of time
that passes before the insurance company is notified of the claim. A claimsmade policy only covers claims reported to the insurer during the contract
period; however, in practice, claims-made policies generally cover claims reported to either the insurer or insured during the contract period. As a result,
claims might be reported to the insurer after the contract expires. Even if
claims have been reported to the insurer during the contract period, it may
take several months for the insurer to investigate and establish a case reserve
for reported claims. In practice, most claims-made insurance policies contain
extended reporting clauses or endorsements that, in specified circumstances,
provide for coverage of claims occurring during the contract period but reported
after the expiration of the policy.
8.11 Although paragraphs 8.12–.44 provide specific guidance relating to
accounting for medical malpractice, the guidance may be helpful in accounting
for other self-insured liabilities, including workers' compensation and employee
health insurance.

Medical Malpractice
8.12 According to FASB ASC 954-450-25-2, a health care entity should
evaluate its exposure to losses arising from claims and record a liability, if
appropriate. The provisions in FASB ASC 720-20-25 and 944-40 discuss the
accounting for insurance claims costs, including estimates of costs relating to
incurred-but-not-reported (IBNR) claims. The liability should not be presented
net of anticipated insurance recoveries. See paragraph 8.08 for additional information about insurance recoveries.
8.13 In determining the best estimates of the ultimate costs of malpractice
claims, health care entities should consider the guidance for contingencies in
FASB ASC 450-20 and 954-450. Health care entities should take into consideration how malpractice claims develop over time (for example, the fact that
some claims require a number of years before they are settled). FASB ASC
944-40 discusses accounting for claims costs, including estimates of costs relating to IBNR claims. Although health care entities are not required to apply the
guidance in FASB ASC 944-40, that guidance may be helpful in estimating loss
liabilities. Governmental health care entities should also consider the accounting and disclosure requirements of Governmental Accounting Standards Board
Statement No. 10, Accounting and Financial Reporting for Risk Financing and
Related Insurance Issues, as amended.
8.14 According to FASB ASC 954-450-25-2, the ultimate costs of malpractice claims, which include costs associated with litigating or settling claims,
should be accrued when the incidents that give rise to the claims occur. FASB
ASC 954-450-30-1 states that estimated losses from asserted and unasserted
medical malpractice claims should be accrued either individually or on a group
basis, based on the best estimates of the ultimate costs of the claims and the relationship of past reported incidents to eventual claims payments. The accrual
includes an estimate of the losses that will result from unreported incidents,
which are probable of having occurred before the end of the reporting period. All relevant information, including industry experience, the entity's own
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historical experience, the entity's existing asserted claims, and reported incidents should be used in estimating the expected amount of claims.
8.15 FASB ASC 954-450-30-2 states that in estimating losses from malpractice claims, a health care entity may need to modify data drawn from
industry experience, so it is relevant to developing an estimate that is specific
to the entity. Various factors, such as the nature of operations, size, and the
entity's past experience, are considered in assessing comparability. Further,
industry data that is not current may not be relevant.
8.16 According to FASB ASC 954-720-25-3, an accrual for malpractice
losses should be based on estimated ultimate losses and costs associated with
litigating and settling claims.
8.17 FASB ASC 954-450-25-2A indicates that accruals should not be based
on recommended funding amounts, which in addition to a provision for the
actuarially-determined liability may also include a provision for (a) credit for
investment income and (b) an excess margin for risk of adverse deviation.
FASB ASC 954-450-25-2B provides the following examples of factors to consider and adjustments that may be required to convert actuarially-determined
malpractice funding amounts to an appropriate loss accrual to be reported in
the financial statements:

r
r

r
r

The risk of adverse deviation is an additional cost factor applied
to bring a funding requirement to a selected confidence level. This
factor does not meet the criteria for recognition as a liability in
accordance with FASB ASC 450.
An evaluation should be made of the extent and validity of industry data when the credibility factor actuarial technique is used.
The lower the credibility factor, the greater the blending of industry data. This may create an unacceptable level of industry data
at lower confidence levels. Further, a low credibility factor may
indicate that provider-specific data is not sufficient to support the
claims liability estimation process.
A review of the discounting approach that is used is necessary
to develop the required disclosure. The impact on the discounting calculation of any other adjustment made to the actuariallydetermined amounts, such as risk of adverse deviation or the
credibility of the risk-management system, has to be evaluated.
A review of the expenses included in the loss estimation process
should be made. Such expenses include the expense of settlement
and litigation (that is, allocated loss-adjustment expenses).

8.18 Limitations on the availability of provider-specific data, lack of a sufficient patient population for claims projection purposes, a very low credibility
factor, and a variety of other factors may cause the actuary's estimate of loss
to be of limited value in developing an estimate of the liability under generally
accepted accounting principles (GAAP).
8.19 According to FASB ASC 954-450-30-2, in estimating the probability
that unreported incidents have occurred, some health care entities may develop
a range of possible estimates of the number of unreported incidents, including
zero. However, the greater the volume of a health care entity's operations, the
greater the likelihood that the entity's minimum estimate of the number of
probable unreported incidents will be greater than zero.
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8.20 If a health care entity cannot estimate losses from asserted or
unasserted malpractice claims, and therefore, an accrual is not made, FASB
ASC 450-20-50-3 requires disclosure of the contingency if at least a reasonable
possibility exists that a loss or an additional loss may have been incurred.
8.21 Further guidance about specific risk-management approaches is provided as follows:

r
r
r
r

Policies written by captive insurance companies are discussed in
paragraphs 8.27–.30.
Claims-made insurance policies are discussed in paragraphs 8.31–
.33.
Retrospectively-rated insurance policies are discussed in paragraphs 8.34–.40.
Self-funded trust funds are discussed in paragraphs 8.41–.44

Discounting of Medical Malpractice Liabilities
8.22 The Financial Reporting Executive Committee (FinREC) believes
that the accrued liabilities for medical malpractice claims may be discounted to
reflect the time value of money if all of the following are true: (a) the amount of
the liability, individually or in the aggregate, is fixed or reliably determinable;
(b) the amount and timing of cash payments for the liability, individually or in
the aggregate, based on the health care entity's specific experience, are fixed
or reliably determinable; and (c) expected insurance recoveries, if any, are also
discounted. FASB Concepts Statement No. 7, Using Cash Flow Information
and Present Value in Accounting Measurements, provides a useful discussion
of general principles governing the use of present value and the objective of
present value in accounting measurements. FASB Concepts Statements are not
sources of established accounting principles; thus, they do not amend, modify,
or justify a change from GAAP currently in effect.
8.23 The objective of discounting loss reserves is to account for the time
value of money in a way that accurately reflects the anticipated future cash
flows based on the characteristics of the obligation. Reasonable diversity exists
regarding what rates should be used for discounting liabilities for unpaid claims
and claim adjustment expenses and how they are applied. If an entity decides
to discount, it might analogize to the following guidance in determining an
appropriate discount rate:

r
r

FASB ASC 340-30-35-6 states that for the insurer or assuming
entity, the discount rate used to determine the deposit liability
should be the current rate on U.S. government obligations with
similar cash flow characteristics.
FASB ASC 450-20-S99-1 states that the rate used to discount the
cash payments should be the rate that will produce an amount at
which the environmental or product liability could be settled in
an arm's-length transaction with a third party. Statement of Position (SOP) 96-1, Environmental Remediation Liabilities, further
states that the discount rate used to discount the cash payments
should not exceed the interest rate on monetary assets that are essentially risk free, as described in FASB Concepts Statement No.
7, and have maturities comparable to that of the environmental
or product liability.
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FASB ASC 944-20-S99-1 notes that pending authoritative guidance resulting from those efforts, the Securities and Exchange
Commission staff will raise no objection if a registrant follows a
policy for GAAP reporting purposes of discounting liabilities for
unpaid claims and claim adjustment expenses at the same rate
that it uses for reporting to state regulatory authorities with respect to the same claim liabilities.

8.24 Careful consideration of the facts and circumstances surrounding a
change in the discount rate for the liabilities for unpaid claims is needed to determine the proper accounting for the change (change in accounting principle or
change in accounting estimate). A change from not discounting loss reserves to
discounting loss reserves would generally be a change in accounting principle.
8.25 FASB ASC 954-450-50-2 requires that health care entities that discount accrued malpractice claims disclose in the notes to the financial statements the carrying amount of accrued malpractice claims that are discounted in
the financial statements and the interest rate(s) used to discount those claims.
8.26 FinREC recommends that a health care entity that discounts accrued malpractice claims also disclose the following information: (a) its policy
concerning the timing of recognition of insurance recoveries; (b) its policy for
discounting accrued malpractice claims and, if it has any, recognized insurance
recoveries; (c) the interest rate(s) used to discount its insurance recoveries receivable; and (d) the undiscounted amount of accrued malpractice claims that
are discounted in the financial statements.

Captive Insurance Companies
8.27 Health care entities may be insured by wholly-owned or multiprovider captive insurance companies. See chapter 12, "The Reporting Entity
and Related Entities," of this guide for a discussion of considerations related to
consolidation and the use of the equity method for equity interests, including
equity interests in captive insurance companies.
8.28 The economic substance of the terms of an insurance policy with a
captive insurance company may more closely resemble a claims-funding mechanism than an instrument that provides rights for recovery of loss from an
external third party. The health care entity should consider whether the economic substance of a captive insurance company is sufficient that the health
care entity can recognize anticipated insurance recoveries. For example, any
anticipated insurance recoveries under a policy with a wholly-owned captive
insurance company would be eliminated in the consolidation of the entities.
Because the captive insurance company is part of the reporting entity, the liability for asserted and unasserted claims is assessed for both the parent and
wholly-owned subsidiary at the reporting entity level.
8.29 FASB ASC 954-720-50-3 requires that a health care entity that is
insured by a multiprovider captive insurance company disclose in its financial
statements (a) that it is insured by such an entity; (b) its ownership percentage
in the captive company; and (c) the method of accounting for its investment in,
and the operations of, the captive entity.
8.30 Retrospectively-rated policies written by captive insurance companies are discussed in paragraphs 8.38–.40.
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Claims-Made Insurance
8.31 A claims-made insurance policy provides rights for recovery of losses
within the policy limits for asserted claims and incidents reported to the insurance carrier during the policy period. However, the policy does not provide
rights for recovery of losses for claims and incidents not reported to the insurance carrier during the policy period. Unless the policy is continually renewed
or tail coverage is purchased, the health care entity is uninsured for claims
reported after the termination of the policy, even if the event occurred during
the period in which the policy was in force.
8.32 As discussed in FASB ASC 720-20-25-14, a health care entity that is
insured under a claims-made insurance policy recognizes the estimated cost of
those IBNR claims and incidents to the insurance carrier if the loss is both probable and reasonably estimable. The "Claims-Made Contracts" sections of FASB
ASC 720-20 apply if a health care entity purchases a claims-made insurance
policy, subject to the measurement guidance in the following paragraph.
8.33 FASB ASC 720-20-30-2 states that the estimated cost of purchasing
tail coverage is not relevant in determining the loss to be accrued because FASB
ASC 210-20-45-1 prohibits netting the insurance receivable against the claim
liability. However, if the insured health care entity had the unilateral option to
purchase tail coverage at a premium not to exceed a specified fixed maximum,
then the entity could record a receivable for expected insurance recoveries,
after considering deductibles and policy limits, for the portion of the IBNR
liability that is insurable under the tail coverage. In that case, the health care
entity would need to record as a cost the expected premium for the coverage.
The purchase of tail coverage does not eliminate the need to determine if an
additional liability should be accrued because of policy limits or other factors.

Retrospectively-Rated Premium Policies
8.34 An insurance policy with a premium that is adjustable based on
actual experience during the policy term is known as a retrospectively-rated
premium policy. Under this type of policy, a deposit premium is generally paid
to the insurer at the beginning of the coverage period. This usually consists of a
minimum premium representing the insurance company's expenses and profits
and an additional amount for estimated claims. The portion for estimated
claims is adjusted during the term of the policy, subject to any minimums or
maximum limitations specified in the policy. The economic substance of the
terms of a retrospectively-rated insurance policy may more closely resemble a
claims-funding mechanism.
8.35 The "Retroactive Contracts" and "Multiple-Year Retrospectively
Rated Contracts" sections of FASB ASC 720-20 provide guidance for those
insurance contracts, subject to the guidance in paragraphs 8.36–.37. For a
multiple-year retrospectively-rated contract accounted for as insurance, FASB
ASC 720-20-25-15 states that the health care entity should recognize either of
the following:

r
r

A liability to the extent that the insured has an obligation to pay
cash or other considerations to the insurer that would not have
been required, absent experience under the contract
An asset to the extent that any cash or other consideration would
be payable by the insurer to the insured based on experience to
date under the contract
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Per FASB ASC 720-20-30-3, the amount to be recognized in the current period should be computed using a with and without method as the difference
between the health care entity's total contract costs before and after the experience under the contract as of the reporting date, including costs such as
premium adjustments, settlement adjustments, and impairments of coverage.
The amount of premium expense related to impairments of coverage should be
measured in relation to the original contract terms. Future experience under
the contract (that is, future losses and future premiums that would be paid regardless of past experience) should not be considered in measuring the amount
to be recognized. The liability would be measured in accordance with FASB
ASC 720-20-30-4 if the health care entity could terminate the contract before
the end of its term and if termination would change the paid amounts.
8.36 FASB ASC 954-720-25-1 states that a health care entity with a
retrospectively-rated insurance policy whose ultimate premium is based primarily on the health care entity's loss experience accounts for the minimum
premium as an expense over the period of coverage under the policy.
8.37 FASB ASC 954-720-35-1 requires that a health care entity insured
under a retrospectively-rated policy whose ultimate premium is based primarily on the experience of a group of health care entities amortize the initial
premium to expense on a pro rata basis over the policy term. FASB ASC 954720-25-2 states that the health care entity also should accrue additional premiums or refunds on the basis of the group's experience to date, which includes
a provision for the ultimate cost of asserted and unasserted claims before the
financial statement date, whether reported or unreported. FASB ASC 954-72050-1 requires that the health care entity disclose that (a) it is insured under a
retrospectively-rated policy, and (b) premiums are accrued based on the ultimate cost of the experience to date of a group of entities.

Retrospectively-Rated Policy Written by a Captive
Insurance Company
8.38 A health care entity insured by an unconsolidated multiprovider captive insurance company for medical malpractice claims under a retrospectivelyrated insurance policy whose ultimate premium is based primarily on the
health care entity's experience up to a maximum premium, if any, accounts
for such insurance as indicated in paragraph 8.36.
8.39 FASB ASC 954-720-35-2 states that a health care entity insured by
an unconsolidated multiprovider captive insurance company for medical malpractice claims under a retrospectively-rated policy whose ultimate premium is
based primarily on the experience of a group of health care entities accounts for
such insurance as indicated in FASB ASC 954-720-25-2 and further discussed
in paragraph 8.37.
8.40 According to FASB ASC 954-720-50-2, the health care entity should
disclose that (a) it is insured under a retrospectively-rated policy of a multiprovider captive insurance company, and (b) the premiums are accrued based
on the captive insurance company's experience to date.

Trust Funds
8.41 Some health care entities establish a medical malpractice self-funded
trust fund for the purpose of paying medical malpractice claims.
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8.42 FASB ASC 954-810-45-4 states that in general, a trust fund, whether
legally revocable or irrevocable, should be included in the financial statements
of the health care entity. A portion of the fund equal to the amount of assets expected to be liquidated to pay malpractice claims classified as current
liabilities is classified as a current asset; the balance of the fund, if any, is
classified as a noncurrent asset. Revenues and administrative expenses of the
trust fund are included in the statement of operations. In some circumstances,
the foregoing may not be possible (for example, if a common trust fund exists
for a group of health care entities; if the health care entity is part of a common
municipality risk-financing internal-service fund; or if the legal, regulatory, or
indenture restrictions prevent the inclusion of a trust fund in a health care
entity's financial statements). In those circumstances, the provisions of FASB
ASC 954-450-25-3, 954-720-25-5, and 954-810-50-1 apply; those provisions are
included in the following two paragraphs.
8.43 FASB ASC 954-450-25-3 states that estimated losses from asserted
and unasserted claims should be accrued and reported, as indicated in paragraphs 1–2 of FASB ASC 954-450-30 (see paragraphs 8.14–.15). The estimated
losses are not based on payments to the trust fund. FASB ASC 954-720-25-5
states that an entity that participates in a common trust fund and forfeits its
rights to any excess funding should expense its contributions and account for
its participation in the trust fund based on the type of obtained coverage (for
example, occurrence basis, claims made, or retrospectively rated).
8.44 FASB ASC 954-810-50-1 requires that the existence of the trust fund
and whether it is irrevocable be disclosed in the financial statements.

Disclosures for Medical Malpractice 1
8.45 Disclosures about medical malpractice should be consistent with the
requirements of FASB ASC 450-20-50. Disclosure of a contingency should be
made if at least a reasonable possibility exists that a loss or an additional loss
may have been incurred, and an accrual is not made for a loss contingency
because any of the conditions in FASB ASC 450-20-25-2 are not met. The guidance further states that disclosure is preferable to accrual when a reasonable
estimate of loss cannot be made.
8.46 In addition to the disclosures required by FASB ASC 450-20-50 and
those discussed in paragraphs 8.13, 8.25–.26, 8.29, 8.37, 8.40, and 8.44, FASB
ASC 954-450-50-1 requires that a health care entity disclose its program of
medical malpractice insurance coverages.
8.47 FinREC recommends that those disclosures include the nature of the
insurance coverage (for example, claims made or occurrence); related terms
(for example, self-insured retention and excess levels); and expected insurance
recoveries and the basis for any related loss accruals.
8.48 If the entity cannot estimate losses relating to a particular category
of malpractice claims (for example, asserted claims, reported incidents, or unreported incidents), the potential losses related to that category of claims are
1
On August 24, 2010, the Financial Accounting Standards Board issued proposed Accounting
Standards Update Health Care Entities (Topic 954): Accounting for Legal Costs Associated with
Medical Malpractice and Similar Claims, which would eliminate the requirement that health care
entities accrue legal costs. Instead, health care entities would make a policy election to either expense
legal costs as incurred or accrue estimated legal costs when the associated claim is incurred. Readers
should be alert to the issuance of a final standard.
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not accrued. However, the contingency is disclosed in the notes to the financial
statements.
8.49 FinREC recommends that health care entities disclose the reasons
for significant changes in the costs of incurred claims recognized in the income statement or statement of operations, including the costs associated with
litigating or settling those claims. In addition to medical malpractice, this disclosure is recommended for all significant claims obligations, such as workers'
compensation and employee health insurance.
8.50 FASB ASC 275-10-50 requires disclosures regarding an estimate
when, based on known information available before the financial statements
are issued or available to be issued, as discussed in FASB ASC 855-10-25, it
is reasonably possible that the estimate will change in the near term, and the
effect of the change will be material. For more information, see paragraphs
8.90–.96 of this guide.

Physician Guarantees and Other Agreements With Physicians
8.51 The physicians practicing at health care entities may be employees
of the entity or affiliated entity or independent of the entity. These physicians
join the entity's medical staff and agree to abide by those bylaws and govern
themselves accordingly. Health care entities enter into a variety of agreements
with physicians. Although this section provides accounting guidance relating
to certain of these agreements, health care entities and their independent
auditors also should consider the associated regulatory issues. See chapter 1,
"Overview and Unique Considerations of Health Care Entities," of this guide
for a discussion of those regulatory issues.
8.52 Health care entities sometimes guarantee nonemployee physicians
that the revenue of the physicians' business or a specific portion of the business
for a specified period of time will be at least a specified amount. Some of these
guarantees are structured as minimum revenue guarantees (see paragraph
8.53); others are structured as financing transactions (see paragraph 8.54).
8.53 FASB ASC 460 applies to minimum revenue guarantees, which the
FASB ASC glossary defines as "[a] guarantee granted to a business or its
owners that the revenue of the business (or a specific portion of the business)
for a specified period of time will be at least a specified minimum amount."
FASB ASC 460-10-55-11 provides an example of a minimum revenue guarantee
granted to a nonemployee physician by a not-for-profit health care facility. In
the example, the health care facility has recruited the physician to move to the
facility's geographical area to establish a practice. The health care facility, as
the guarantor, has agreed to make payments to the newly arrived physician
(the guaranteed party) at the end of specific periods of time if gross revenues
(gross receipts) generated by the physician's new practice during that period
of time do not equal or exceed a specific dollar amount. FASB ASC 460 applies
to minimum revenue guarantees granted to physicians, regardless of whether
the physician's practice qualifies as a business, as defined in the FASB ASC
glossary. FASB ASC 460-10 requires that at the inception of a guarantee, the
health care entity, as a guarantor, should recognize in its statement of financial
position a liability for that guarantee. The liability should be initially measured
at fair value.
8.54 Certain income guarantees are structured as advances whereby the
physician is required to repay the outstanding balance of all advances after

AAG-HCO 8.49

Contingencies and Other Liabilities

123

the end of the guarantee period, although a forgiveness clause may be included
in exchange for the physician's commitment to stay in the community for a
specified period of time. If the health care entity is tax exempt, the agreement
is often structured as an advance to avoid potential problems associated with
private inurement. See paragraphs 8.82–.83 for a discussion of private inurement. In determining the appropriate accounting for a physician income
guarantee, it is important to evaluate the substance of the agreement. Such
agreements may be promissory notes. In those situations, the income guarantee may be a financing arrangement. As noted in Technical Questions and
Answers (TIS) section 6400.45, "Applicability of FASB Interpretation No. 45—
Accounting and Disclosure Requirements for Guarantees, Including Indirect
Guarantees of Indebtedness of Others" (AICPA, Technical Practice Aids), financing arrangements are excluded from the scope of FASB ASC 460 and,
generally, would be accounted for as loans.
8.55 Another common recruitment incentive is a guarantee of a physician's personal home mortgage for his or her residence in the health care
entity's service area. If the physician is not an employee, TIS section 6400.46,
"Applicability of FASB ASC 460—Guarantor's Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of
Others—Mortgage Guarantees" (AICPA, Technical Practice Aids), notes that
the agreement is considered a guarantee under FASB ASC 460. The presence
of the health care entity's guarantee, obtained through a local bank, reduces
the interest rate on the physician's mortgage loan. At inception, the health
care entity would record an obligation to stand ready to perform in an amount
equal to the fair value of the guarantee. In the preceding situation, the health
care entity typically would be released from risk as the physician's outstanding
mortgage obligation is reduced.
8.56 In current practice, most health care entities offset the entry recognizing the liabilities for the guarantees described in paragraphs 8.53 and 8.55
by recognizing an intangible asset. That intangible asset is then amortized over
the life of the contract.
8.57 Health care entities need to ensure that they maintain adequate
physician coverage to support their operations. This means that the entity
needs to have certain specialties available based on the needs of the patients.
For example, a patient who arrives at the emergency room may require surgery,
and as a result, the entity needs to have physician coverage to provide this
service. Historically and in many cases, the physicians have provided this
service to the entity free of charge as part of their responsibilities of being on
the medical staff; however, this practice has changed. Health care entities are
routinely reimbursing physicians to provide emergency room coverage. This
might be done through paying stipends, actual claims for services provided to
uninsured or Medicaid patients, or through other agreements negotiated with
the physicians. These agreements may include settlement provisions based on
volumes or the mix of patients. In all cases, these costs should be accrued as
incurred by the health care entity.
8.58 In addition, health care entities contract with certain physicians as
medical directors to provide clinical oversight. These medical director agreements may be at a specific stipend, hourly rate, or even involve more complex
formulas based on the services and needs of the entity. In all cases, these costs
should be accrued as incurred by the entity.
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Other Liabilities
Asset Retirement Obligations
8.59 An asset retirement obligation is an obligation associated with the
other-than-temporary removal of a tangible long-lived asset from service. That
term encompasses sale, abandonment, recycling, or disposal in some other
manner. Chapter 6, "Property and Equipment and Other Assets," provides
examples of asset retirements that may cause obligations. The FASB ASC
glossary defines conditional asset retirement obligation as "[a] legal obligation
to perform an asset retirement activity in which the timing and (or) method
of settlement are conditional on a future event that may or may not be within
the control of the entity." FASB ASC 410-20-25-7 states that an entity should
recognize a liability for the fair value of a conditional asset retirement obligation if the fair value of the liability can be reasonably estimated. Paragraphs
4–5 of FASB ASC 410-20-25 require an entity to recognize the fair value of a
liability for an asset retirement obligation in the period in which it is incurred,
if a reasonable estimate of fair value can be made, and increase the carrying
amount of the related long-lived asset by the same amount as the liability. An
expected present value technique incorporates uncertainty about the timing
and method of settlement into the fair value measurement. Uncertainty is factored into the measurement of the fair value of the liability through assignment
of probabilities to cash flows.
8.60 FASB ASC 410-20-25-13 states that if current law, regulation, or
contract, including the doctrine of promissory estoppel, requires an entity to
perform an asset retirement activity when an asset is sold, abandoned, recycled,
dismantled, demolished, or disposed of in some other manner, an unambiguous requirement exists to perform the retirement activity, even if that activity
can be indefinitely deferred. At some time, deferral will no longer be possible
because no tangible asset will last forever, except land. Therefore, the obligation to perform the asset retirement activity is unconditional, even though
uncertainty exists about the timing or method, or both, of settlement.
8.61 The evaluation of the existence of an asset retirement obligation
is generally performed on an asset-by-asset basis. The health care industry
is capital intensive, and many health care entities have older physical plant
facilities. Health care entities may have asset retirement obligations associated
with these assets because federal, state, and local regulations typically require
one or more specified activities to be performed upon abandonment, disposal,
or significant renovation of long-lived assets. These activities typically relate to
asbestos removal but may also relate to the disposal of medical waste, certain
medical equipment, or underground storage tanks. A provision may even be
included to restore a leased asset to its original condition upon termination of
a lease.

Compensation and Related Benefits
8.62 Health care entities are usually labor intensive and compete for a
limited number of qualified employees. The workforce at some health care entities is unionized, subjecting the entity to collective bargaining agreements that
outline the compensation and benefits provided to employees. In many cases,
more than one union will be present at the entity, resulting in multiple collective bargaining agreements. In addition, not-for-profit entities have additional
regulatory restrictions regarding the amount and structure of compensation
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arrangements and benefit plans for their employees. These environmental factors have resulted in health care entities developing and maintaining multiple
compensation and benefit plans.
8.63 Careful consideration of the compensation arrangements is required
in order to apply the appropriate standards. FASB ASC 710-10-15 may be
helpful in locating the appropriate standards. The following four FASB ASC
topics provide guidance for compensation:

r
r

FASB ASC 710, Compensation—General

r
r

FASB ASC 715, Compensation—Retirement Benefits

FASB ASC 712, Compensation—Nonretirement Postemployment
Benefits
FASB ASC 718, Compensation—Stock Compensation

Complex Pay Practices
8.64 For many health care entities, the majority of employees are nonexempt (subject to overtime compensation for hours worked over certain statutory
limits) and compensated under complex pay practices. To attract and retain
staff in many critical positions, employees may be paid multiple pay differentials, in addition to their base rate. The determination of benefit eligibility or
calculation of benefit amounts may relate to only some of the pay practices of
the entity. As a result, these practices require entities to develop systems to
capture time worked in a manner consistent with the practice or benefit plans,
or both.

Incentive and Deferred Compensation Plans
8.65 Health care entities typically maintain an incentive compensation
plan for all or certain groups of employees. When compensation is based on
attaining a particular goal or set of goals over a period of time, such as achieving
a certain operating margin or quality score, it is accrued over the period in
relation to the results achieved to date.
8.66 Due to the regulations relating to deferred compensation for not-forprofit entities, health care entities utilize a variety of structures to provide
deferred compensation benefits to their employees that are competitive with
other entities, including for-profit entities. These deferred compensation plans
are designed for highly compensated employees and are considered nonqualified plans. Some plans are considered eligible plans by the IRS (for example,
457(b) plans); in other cases, they are considered nonqualified plans. In the
simplest form, deferred compensation plans provide that an employee may defer a portion of his or her salary until a later date. That date may be after the
employee has left the entity or retired. More complex deferred compensation
plans provide for payments of periodic amounts or noncompete arrangements
for a specified period of time, or both.
8.67 Although many scope limitations exist, and care should be taken
when determining the appropriate standards, in general, guidance for deferred
compensation is found in the following locations:

r

FASB ASC 715-10 and 715-30 provide guidance for individual deferred compensation contracts if those contracts, taken together,
are equivalent to a defined benefit pension plan.
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FASB ASC 715-10 and 715-60 provide guidance for individual deferred compensation contracts if those contracts, taken together,
are equivalent to a defined benefit other postretirement benefit
plan.
FASB ASC 710-10 provides guidance for rabbi trusts.
FASB ASC 710-10 provides guidance for individual deferred compensation arrangements that do not fall within the scope of other
topics in FASB ASC.

8.68 Typically, any funding for these deferred compensation arrangements provided by the health care entity is available to its general creditors.
An entity may establish a trust to fund compensation for a certain group of
management or highly paid executives. In some cases, the executives or management may invest these funds in a select group of securities.
8.69 FASB ASC 710-10-25-18 requires that assets held by a rabbi trust
be accounted for in accordance with GAAP for the particular asset and that the
deferred compensation obligation be classified as a liability. Paragraphs 16–17
of FASB ASC 710-10-25 apply if the rabbi trust is invested in the employer's
stock.
8.70 In addition, a health care entity may utilize split-dollar life insurance
policies to fund its obligation under the deferred compensation agreements.
The "Split-Dollar Life Insurance Arrangements" sections of FASB ASC 715-60
provide guidance for accounting for these benefits.

Sabbaticals and Other Compensated Absences
8.71 Health care entities typically provide employees with compensated
absences, such as for holidays, vacations, and illness. These liabilities should
be accounted for in accordance with FASB ASC 710-10. In addition to these
typical compensated absences, FASB ASC 710-10 also provides guidance for
health care entities that have a sabbatical program for certain employees.

Postretirement and Postemployment Benefit Plans
8.72 Similar to other industries, health care entities historically have provided pension benefits to their employees. Over the last several years, many
health care entities have converted their traditional defined benefit plans to
cash balance or defined contribution plans. In addition, some health care entities have agreed to provide postretirement health benefits.
8.73 Although many scope limitations exist, and care should be taken
when determining the appropriate standards, in general, guidance for postretirement and postemployment benefits is found in the following locations:

r
r
r
r
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FASB ASC 715-20 and 715-30 provide guidance for pension benefits provided through defined benefit pension plans.
FASB ASC 715-20 and 715-60 provide guidance for other postretirement benefits provided through defined benefit plans.
FASB ASC 715-70 provides guidance for defined contribution
plans.
FASB ASC 715-80 provides guidance for multiemployer pension
and other postretirement benefit plans, including those provided
pursuant to one or more collective bargaining agreements.

r
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FASB ASC 712-10 provides guidance for special or contractual
termination benefits that are payable before retirement and not
payable from a pension or other postretirement plan, including
guidance for health care entities that have a formal severance
plan as part of their health and welfare plans.
FASB ASC 712-10 also provides guidance for all types of other
postemployment benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment
but before retirement.

Agency Funds
8.74 As described in FASB ASC 954-305-45-4, health care entities may receive and hold assets owned by others under agency relationships. For example,
they may perform billing and collection services for physicians. In accepting
responsibility for those assets, the health care entity incurs a liability to the
principal under the agency relationship to return the assets in the future or, if
authorized, disburse them to another party on behalf of the principal. If held
by not-for-profit business-oriented health care entities, such agency funds shall
be reported as unrestricted assets.
8.75 As a result, physician fees collected by the health care entity as a
conduit are reported as a liability to the physicians and not recognized in the
statement of income or operations and changes in net assets.

Tax Considerations for Not-for-Profit Health Care Entities
8.76 Not-for-profit health care entities generally are exempt from taxation. Tax exemption is a privilege and not a right. At the federal level, the IRS
has the authority to revoke an entity's exempt status for any one of several
reasons. Furthermore, individual states have regulatory bodies that oversee
not-for-profit entities and can revoke their state tax-exempt status without regard to their federal tax-exempt status and even prevent them from operating.
Many potential threats exist to an entity's federal tax-exempt status, of which
the following are particularly important:

r
r
r
r
r
r
r
r
r

Material changes in the entity's character, purpose, or method of
operation
Private inurement
Private benefit
Commerciality
Lobbying
Political campaign activities
Unrelated business income
Failure of the entity to meet the commensurate test
Violation of public policy by the entity

8.77 Not-for-profit entities should be aware of relevant federal and state
tax laws and regulations and their potential impact on the entity and its financial statements. An entity's failure to maintain its tax-exempt status could have
serious financial consequences. As discussed in chapter 2, "General Auditing
Considerations," of this guide, failure to comply with tax laws and regulations
could be an illegal act that may have either a direct and material effect on the
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determination of financial statement amounts (for example, the result of an
incorrect accrual for taxes on unrelated business income) or a material indirect
effect on the financial statements that would require appropriate disclosures
(for example, the result of a potential loss of tax-exempt status).
8.78 Not-for-profit health care entities usually seek exemption from federal income tax under Internal Revenue Code (IRC) Section 501(a). Under
IRC Section 501(a), entities organized and operated exclusively for religious,
charitable, or educational purposes, as described in IRC Section 501(c)(3), are
exempt from federal income taxes. The following are additional requirements
for such entities:

r
r
r

No part of the organization's net earnings, either directly or indirectly, inures to any private shareholder or individual.
No substantial part of the organization's activities consists of carrying on propaganda or otherwise attempting to influence legislation. IRC Section 501(h) provides a limited exception to the
general rule that public charities may not incur expenditures to
influence legislation.
The organization does not participate or intervene in any political
campaign on behalf of, or in opposition to, any candidate for public
office.

8.79 The term charitable is used in IRC Section 501(c)(3) in its generally
accepted legal sense. Providing health care to the community is considered a
charitable activity when provided by a health care organization not organized
or operated for the benefit of private interests, such as designated individuals,
the founder or founder's family, shareholders of the organization, or people
directly or indirectly controlled by such private interests.
8.80 FASB ASC 954-740-50-1 requires that a not-for-profit health care
entity disclose its tax-exempt status.
8.81 Health care entities must file annual information returns (Form
990) with the IRS. Most states also have their own registration and filing
requirements, some of which include using Form 990 as part of an annual
report. In 2008, the IRS issued a completely revised Form 990 with expanded
reporting requirements in the areas of governance and compensation of officers,
directors, and other key employees. Other changes include an increased focus
on the determination of public charity status and public support, supplemental
financial statement reporting, and fundraising. Separately, the IRS Exempt
Organizations (TE/GE) Hospital Compliance Project Final Report, issued in
February 2009, places increased emphasis on community benefit reporting and
executive compensation. Additional changes are expected because of health
care reform, which is discussed further in chapter 1 of this guide.

Private Inurement and Intermediate Sanctions
8.82 Under IRC Section 501(c)(3), no part of the net earnings of the charitable organization shall inure to the benefit of any private shareholder, individual, or insider. A private shareholder, individual, or insider refers to a
person(s) having a private or personal interest in the activities of the organization. Insiders are individuals with a personal or private interest in the
organization, such as governing board members, officers, certain employees,
and substantial contributors. The IRS has stated that physicians have a personal or private interest in the activities of a health care organization and could
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be subject to the private inurement proscription. Transactions between insiders and not-for-profit entities are permitted, but the not-for-profit entity has
the burden of proving that the transactions do not result in private inurement.
The not-for-profit entity must be able to satisfy the IRS that the transaction
was reasonable, was adequately documented, had independent approval, and
did not violate any law or regulation. Employee compensation can create an
inurement problem if it is judged to be unreasonably high.
8.83 The IRS instituted intermediate sanctions regulations that allow the
IRS to penalize the individuals who received and approved the excess benefit
transactions. The intermediate sanctions regulations are designed to curtail
excess benefits (private inurement) provided to individuals with substantial
influence over the affairs of the not-for-profit entity (organizational insiders).
The intermediate sanctions regulations provide the IRS with the ability to punish those who participate in private inurement (excess benefit) transactions. An
insider (generally, certain members of management, officers, physicians, and
board members) is subject to a 25 percent tax or up to 200 percent if the amount
of an excess benefit is not repaid within a certain period of time. However, even
if an insider does not benefit from the transaction, he or she may be subject to
the 10 percent tax if he or she knowingly and willfully approved a transaction
subsequently determined by the IRS to be an excess benefit transaction.

Unrelated Business Income
8.84 Although not-for-profit entities may be exempt from federal income
tax, they may be subject to tax on unrelated business income. The objective
of the tax on unrelated business is to place such activities on the same basis
as that of taxable entities. Unrelated business income is the income from any
regularly carried on trade or business, the conduct of which is not substantially
related to the exercise or performance of the organization's tax-exempt purpose
or function. The fact that proceeds from an activity are used exclusively for the
organization's tax-exempt purpose does not make the activity substantially
related to its tax-exempt purpose or function. As is the case with most taxrelated definitions, qualifications and exceptions exist.

State and Local Taxes
8.85 Tax-exempt entities may also be subject to property taxes or other
state and local business and occupancy taxes. Exemptions from state and local
sales, real estate, and other taxes vary from jurisdiction to jurisdiction and may
be different than for federal taxes. Entities are generally subject to the laws of
the state of incorporation, as well as the laws of states in which they conduct
significant activities. Each state's laws govern exemption from its taxes and
should be consulted for the applicable definitions and requirements.

Tax Positions
8.86 The tax considerations discussed in this chapter often result in an
entity or its for-profit or not-for-profit subsidiaries making a determination
about whether a transaction or event must be reported in a tax return. The
term tax position refers to a position in a previously-filed tax return or a position
expected to be taken in a future tax return that is reflected in measuring current
or deferred income tax assets and liabilities for interim or annual periods. The
term tax position encompasses, but is not limited to, the following:
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An entity's status, including its status as a tax-exempt not-forprofit entity
A decision to classify a transaction, entity, or other position in a
tax return as tax exempt or subject to a lower rate of tax
A decision not to file a tax return, such as a decision that Form
990-T need not be filed
The characterization of income, such as a characterization of income as passive, or a decision to exclude reporting taxable income
in a tax return
An allocation or a shift of income between jurisdictions (federal,
state, local, or foreign)

8.87 The validity of a tax position is a matter of tax law. It is not controversial to recognize the benefit of a tax position in financial statements when
the degree of confidence is high that that tax position will be sustained upon
examination by a taxing authority. However, in some cases, the law is subject to
varied interpretation, and whether a tax position will ultimately be sustained
may be uncertain. FASB ASC 740-10-25-6 limits the recognition of uncertain
tax positions to only those positions that are more likely that, based on the
technical merits, the position will be sustained on examination.

Medicaid Voluntary Contribution or Taxation Programs
8.88 The Medicaid program is set up on a state-by-state basis to provide
medical assistance to the indigent. Although state administered, the program
is actually a joint federal and state program for which the federal government
funds a portion of the cost. Under this arrangement, the federal government
matches a percentage of the total amount paid by the state to health care
entities. This matching is referred to as federal financial participation. States
have attempted to increase the amount of federal matching funds for which
they are eligible by increasing the amount of medical assistance they provide.
In order to pay for the increased medical assistance, some states have imposed
a tax on health care entities or sought donations or other voluntary payments
from them, or both. As a result, the states have been able to generate additional
federal matching funds without expending additional state funds.
8.89 TIS section 6400.30, "Accounting for Transactions Involving Medicaid Voluntary Contribution or Taxation Programs" (AICPA, Technical Practice
Aids), notes that the accounting for these types of programs is dependent on
the individual facts and circumstances. For example, if a guarantee exists that
specific monies given to the state by the health care entity will be returned to
the entity from the state, those amounts should be recorded as receivables. In
addition, if the health care entity has met all the requirements to be legally
entitled to additional funds from the state, the revenue or gain should be recognized. However, if the monies go into a pool with other contributions that are
then disbursed based on factors over which the health care entity has little or
no control, the payments should be recognized as an expense. Any subsequent
reimbursements would be recognized as revenue or gain when the entity is entitled to them and payment is assured. Care should be taken to avoid delayed
recognition of expenses or improperly recognizing contingent gains. Because
of the complexities that are involved, it may be necessary for the health care
entity to consult with legal counsel.
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Risks and Uncertainties
8.90 FASB ASC 275-10-50 requires entities to include in their financial
statements information about risks and uncertainties in the following areas as
of the date of those statements:

r
r
r
r

The nature of their operations
Use of estimates in the preparation of financial estimates
Certain significant estimates
Current vulnerability due to certain concentrations

8.91 FASB ASC 275-10-50-6 requires discussion of estimates when, based
on known information available before the financial statements are issued or
available to be issued, as discussed in FASB ASC 855-10-25, it is reasonably
possible that the estimate will change in the near term, and the effect of the
change will be material. The estimate of the effect of a change in a condition, situation, or set of circumstances that existed at the date of the financial
statements should be disclosed, and the evaluation should be based on known
information available before the financial statements are issued or available to
be issued.
8.92 Examples of estimates that may be included in financial statements
of health care entities that are particularly sensitive to changes in the near
term include, but are not limited to, the following:

r
r
r
r
r
r
r
r
r
r
r

Third-party revenue and related receivables
Provision for bad debts
Obligation by continuing care retirement communities to provide
future services and the use of facilities to current residents
IBNR relating to medical malpractice and prepaid health care
services liabilities
Accruals for loss contracts under managed care agreements
Assets subject to impairment (for example, goodwill)
Environmental remediation-related obligations
Litigation-related contingencies (for example, fraud and abuse
actions by regulators)
Estimated risk pool settlements arising from managed care contracting
Amounts reported for long-term obligations, such as amounts reported for pensions and postemployment benefits
Estimated net proceeds recoverable or the provisions for expected
loss to be incurred, or both, on the disposition of a business or
assets

8.93 In the health care environment, it almost always is reasonably possible that estimates regarding third-party payments could change in the near
term as a result of one or more future confirming events (for example, regulatory action reflecting local or national audit or enforcement initiatives). Paragraph .07 of SOP 00-1, Auditing Health Care Third-Party Revenues and Related
Receivables (AICPA, Technical Practice Aids, AUD sec. 14,360), provides examples of risks unique to the government-contracting environment that make
it difficult to estimate net realizable third-party revenues and receivables. For
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most entities with significant third-party revenues, the effect of the change
could be material to the financial statements. When material exposure exists,
the uncertainty regarding revenue realization is disclosed in the notes to the
financial statements. A sample disclosure is presented in paragraph .37 of SOP
00-1. Among other things, the sample disclosure indicates that laws and regulations governing the Medicare and Medicaid programs are extremely complex
and subject to interpretation. As a result, at least a reasonable possibility exists
that recorded estimates will change by a material amount in the near term.2
8.94 FASB ASC 275-10-50-16 requires that financial statements disclose
certain concentrations (those described in the following paragraph) if, based on
information known to management before the financial statements are issued
or available to be issued, as discussed in FASB ASC 855-10-25, all of the
following criteria are met:

r
r
r

The concentration exists at the date of the financial statements.
The concentration makes the entity vulnerable to the risk of a
near-term severe impact.
It is at least reasonably possible that the events that could cause
the severe impact will occur in the near term.

8.95 Examples of concentrations that may meet those criteria and that
require disclosure in the financial statements of health care entities include
the following:

r
r
r
r

Concentrations in the volume of business transacted with a particular payor, supplier, lender, grantor, or contributor
Concentrations in revenue from particular products, services, or
fund-raising events
Concentrations in the available sources of supply of material, labor, or services or licenses or other rights used in the entity's
operations
Concentrations in the market or geographic area in which an
entity conducts its operations

8.96 FASB ASC 275-10-50-20 requires health care entities to disclose the
percentage of the labor force covered by a collective bargaining agreement and
the percentage of labor force covered by a collective bargaining agreement that
will expire within one year.

Auditing Contingencies and Other Liabilities
8.97 Auditing objectives and procedures for contingencies and other liabilities generally are similar to those of other entities. The independent auditor
may need to consider the specific auditing objectives, selected control activities,
and auditing procedures presented in exhibit 8-1.

2
Statement of Position (SOP) 00-1, Auditing Health Care Third-Party Revenues and Related
Receivables (AICPA, Technical Practice Aids, AUD sec. 14,360), provides guidance to independent
auditors regarding uncertainties inherent in health care revenue recognition. SOP 00-1 is included
as appendix B, "Statement of Position 00-1, Auditing Health Care Third-Party Revenues and Related
Receivables," of this guide.
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Auditing Medical Malpractice Loss Contingencies
8.98 Although this chapter focuses on medical malpractice loss contingencies, the auditing objectives and procedures that are discussed also are
relevant to other self-insured obligations. The existence of an insurance policy,
by itself, is no assurance that malpractice contingencies are assumed by others.
The independent auditor should review the insurance contracts and determine
the extent of the risk retained by the entity. Specific auditing procedures to
consider include the following:

r
r

Determine the type, such as occurrence basis or claims made, and
level (per occurrence or in the aggregate) of insurance protection
that the entity has obtained.
Determine if the coverage actually provides for the recovery of
losses from malpractice risks. Is the insurance with a related party
(for example, a captive insurance company)? Does it provide for
retrospective premiums or similar adjustments?

Once the extent of the retained risk is understood, the independent auditor
will be able to determine the nature, extent, and timing of other auditing
procedures.
8.99 Paragraph 8.33 discusses the conditions for which an insured health
care entity can recognize a receivable for expected insurance recoveries, even
though tail coverage has not been purchased at the balance sheet date. In evaluating the amount of the receivable, the independent auditor should consider
the extent to which the claim liability is insurable under the coverage. The receivable cannot be recognized if the insured entity did not have the unilateral
option to purchase the tail coverage at the balance sheet date and record as
an expense the premium for the tail coverage. See paragraphs 8.31–.33 for a
discussion of accounting for claims-made insurance policies and tail coverage.
8.100 Management's intent to renew a claims-made policy is not sufficient to recognize a receivable for expected insurance recoveries as of the
balance sheet date, unless management contractually obligates itself for renewal before the issuance date of the financial statements, and the cost is expensed in the period covered by the financial statements. The requirement to
renew a claims-made policy or purchase and expense tail coverage applies even
if state regulations require that renewal of claims-made coverage be offered
continually.
8.101 If the health care entity discounts accrued malpractice claims, the
auditor should consider whether that discounting is appropriate (for example,
that the conditions in paragraph 8.22 are met). The auditor should consider
tests of the estimates of the amount and timing of cash payments based on
the health care entity's specific experience. The auditor should also consider
whether the discount rate is reasonable. Paragraph 41 of FASB Concepts Statement No. 7 and paragraphs 12–13 of FASB ASC 835-30-25 provide general
principles for present value measurements and determining an appropriate
discount rate. Also, see paragraph 8.23 for additional discussion on determining an appropriate discount rate.

Auditing Accounting Estimates
8.102 Management is responsible for making the accounting estimates
that are included in the financial statements. Management is also responsible
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for providing proper disclosure of (a) the use of estimates in the preparation
of financial statements and (b) certain significant estimates.3 The independent
auditor is responsible for evaluating the reasonableness of management's estimates and the adequacy of the related disclosures. AU section 342, Auditing
Accounting Estimates (AICPA, Professional Standards), provides guidance to
auditors on obtaining and evaluating sufficient appropriate audit evidence to
support significant accounting estimates in an audit of financial statements in
accordance with GAAP. The independent auditor does this using one or more
of the following approaches:

r
r
r

Review and test the process used by management to develop the
estimate.
Develop an independent expectation of the estimate to corroborate
the reasonableness of management's estimate.
Review subsequent events or transactions occurring prior to the
date of the auditor's report.

8.103 In evaluating management's estimates of asserted and unasserted
claims, the independent auditor should consider factors such as management's
description and evaluation of asserted and unasserted claims arising from
reported incidents; the lawyer's and, if appropriate, the outside risk manager's
assessment of asserted claims and reported incidents not covered by insurers;
and the actuary's evaluations of the aggregate liability covering asserted and
unasserted claims arising from reported and unreported incidents.
8.104 Paragraph .06 of AU section 333, Management Representations
(AICPA, Professional Standards), requires that the management representation letter include a specific representation that unasserted claims or assessments that the entity's lawyer has advised are probable of assertion have been
disclosed, in accordance with FASB ASC 450.
8.105 According to AU section 337, Inquiry of a Client's Lawyer Concerning Litigation, Claims, and Assessments (AICPA, Professional Standards), a
letter of audit inquiry to the lawyer handling the claims is the auditor's primary means of obtaining corroboration of the information furnished by management concerning claims made and known incidents for which claims have
not been made that are either uninsured or in excess of the insurance coverage.
Audit inquiry letters generally would not be required with respect to reported
contingencies that were not considered to have a material potential loss. In
evaluating the information provided by legal counsel, it may be necessary to
supplement the written representations with inquiries if the representations
are not clear regarding the probability of the litigation outcome or potential
range of loss. The inability or unwillingness of counsel to evaluate asserted
claims or reported incidents, or both, would give rise to a modification of the
auditor's opinion.
8.106 The independent auditor should consider the frequency of losses
due to unreported incidents and the magnitude of prior losses and underlying
causes for the IBNR claims. If a basis for an accrual exists, the independent
auditor should then determine whether the entity's prior history supports the
estimation of the number of claims and probable settlement value.

3

See paragraphs 8.59–.73.
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Use of Actuaries and Actuarial Methods
8.107 Developing the estimate of the medical malpractice loss amount
often requires special skill or knowledge. In the auditor's judgment, the work
of a specialist may be required to obtain appropriate audit evidence. An actuary may be engaged by management to help prepare or review management's
estimate of the medical malpractice loss amount (or range of amounts) or to
assist in developing certain factors and assumptions used in estimating the
malpractice liability. The decision to use an actuary should be based on a consideration of whether (a) the estimated claim liability is potentially material
to the fair presentation of financial statements in conformity with GAAP and
(b) special skill or knowledge is required to estimate the claim liability.
8.108 If an actuary is involved in a substantial way in determining the
amount of an entity's malpractice self-insurance liability, the independent auditor should follow the requirements of AU section 336, Using the Work of a
Specialist (AICPA, Professional Standards). The independent auditor should
consider the actuary's professional qualifications, reputation, prior experience
in estimating malpractice claim losses, and relationship to the client. There
should be an understanding among the independent auditor, client, and actuary of the objectives and scope of the analysis and the methods and assumptions
used.
8.109 Paragraph .12 of AU section 336 states that the appropriateness
and reasonableness of methods and assumptions used and their application
are the responsibility of the specialist. The auditor should (a) obtain an understanding of the methods and assumptions used by the specialist; (b) make
appropriate tests of data provided to the specialist, taking into account the
auditor's assessment of control risk; and (c) evaluate whether the specialist's
findings support the related assertions in the financial statements. Ordinarily,
the auditor would use the work of the specialist, unless the auditor's procedures
lead him or her to believe that the findings are unreasonable in the circumstances. If the auditor believes that the findings are unreasonable, he or she
should apply additional procedures, which may include obtaining the opinion
of another specialist.
8.110 The independent auditor should perform an appropriate test of the
accounting data provided to the actuary by the client. Such accounting data
may include historical claim experience; policy terms, such as coverage, expiration, deductibles, presence of retrospectively-determined premiums, and
indemnity limitations; exposure data, such as the number of beds, high-risk
medical specialties, outpatient visits, and emergency room visits; and information about risk-management systems, personnel, and procedures. Other factors
that might be considered include inflation rates, judicial decisions assessing liability and noneconomic damages, changes in legislation affecting payment
levels and settlement practices, changes in the entity's experience or trends
in loss reporting and settlements, divergence in an entity's experience relative
to industry experience, reinsurance programs and changes therein, and recent
catastrophic occurrences.

Evaluating Lawyers’ Responses
8.111 Determining the outcome of pending or threatened litigation,
claims, and assessments, including unasserted claims and assessments,
normally is beyond the independent auditor's professional competence.
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Accordingly, the independent auditor's evaluation of the need for disclosures or
report modifications is based primarily on the opinion of the lawyer handling
the matter. The American Bar Association (ABA) has adopted a Statement
of Policy Regarding Lawyers' Responses to Auditors' Requests for Information
under which lawyers accept certain responsibility for responses to independent auditors' inquiries. However, the ABA statement is not enforceable by the
ABA in the same way that the AICPA is able to enforce its standards under
the accounting profession's Code of Professional Conduct. As a result, lawyers'
responses may vary widely.
8.112 Interpretation No. 7, "Assessment of a Lawyer's Evaluation of the
Outcome of Litigation," of AU section 337 (AICPA, Professional Standards,
AU sec. 9337 par. .18–.23), includes the following examples of evaluations
of litigation, which may be considered to communicate in a sufficiently clear
manner a remote likelihood of an unfavorable outcome:

r
r
r
r
r

"We are of the opinion that this action will not result in any liability to the company."
"It is our opinion that the possible liability to the company in this
proceeding is nominal in amount."
"We believe the company will be able to defend this action successfully."
"We believe that the plaintiff's case against the company is without merit."
"Based on the facts known to us, after a full investigation, it is our
opinion that no liability will be established against the company
in these suits."

8.113 On the other hand, the lawyer may use terms, such as meritorious
defenses, that have different meanings to different lawyers. Paragraph .22 of
AU section 9337 includes the following examples of lawyers' evaluations that
are unclear regarding the likelihood of an unfavorable outcome:

r
r
r
r

"This action involves unique characteristics wherein authoritative
legal precedents do not seem to exist. We believe that the plaintiff
will have serious problems establishing the company's liability
under the act; nevertheless, if the plaintiff is successful, the award
may be substantial."
"It is our opinion that the company will be able to assert meritorious defenses to this action." (The term "meritorious defenses"
indicates that the company's defenses will not be summarily dismissed by the court; it does not necessarily indicate counsel's opinion that the company will prevail.)
"We believe the action can be settled for less than the damages
claimed."
"We are unable to express an opinion as to the merits of the litigation at this time. The company believes there is absolutely no
merit to the litigation." (If client's counsel, with the benefit of all
relevant information, is unable to conclude that the likelihood of
an unfavorable outcome is "remote," it is unlikely that management would be able to form a judgment to that effect.)
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"In our opinion, the company has a substantial chance of prevailing in this action." (A "substantial chance," a "reasonable opportunity," and similar terms indicate more uncertainty than an
opinion that the company will prevail.)

8.114 When the lawyer's response is unclear, the independent auditor
may request a conference to clarify the lawyer's opinion. If the response is
still unclear, or the materiality of the uncertainty cannot be determined, the
independent auditor should consider the guidance in paragraphs .29–.32 of AU
section 508, Reports on Audited Financial Statements (AICPA, Professional
Standards).

Income Taxes
8.115 The auditor should perform procedures to determine whether the
health care entity has obtained a qualifying income tax exemption from the
appropriate governmental authority and whether disclosures relating to the
entity's tax-exempt status are appropriate.

Auditing Considerations
8.116 The auditor may need to consider the examples of specific auditing
objectives, selected control activities, and auditing procedures for contingencies
and other liabilities that are presented in exhibit 8-1.
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Exhibit 8-1
The following table illustrates the use of assertions in developing audit objectives and designing substantive tests. The examples are not
intended to be all-inclusive nor is it expected that all the procedures
would necessarily be applied in an audit. The auditor should design
and perform substantive procedures for all relevant assertions related
to each material class of transactions, account balance, and disclosure
to obtain sufficient appropriate audit evidence. The use of assertions
in assessing risks and designing appropriate audit procedures to obtain audit evidence is described in paragraphs .14–.26 of AU section
326, Audit Evidence (AICPA, Professional Standards). Various audit
procedures and the purposes for which they may be performed are
described in paragraphs .27–.41 of AU section 326.

Auditing Considerations
Financial Statement
Assertions

Specific Auditing
Objectives

Selected Control
Activities

Auditing
Procedures

Malpractice Loss Contingencies
Existence and
occurrence,
completeness,
rights and
obligations, and
valuation

The liability for
malpractice
claims is properly
reported in the
balance sheet.

Review the amount
of insurance
coverage, the type
of coverage (claims
made or
occurrence), the
deductible
provisions, and so
The
risk-management on to determine the
system identifies level of risk that is
retained by the
and monitors
entity. Consider the
malpractice
financial viability
incidents and
of the insurance
evaluates
associated losses. carrier.
Insurance
coverage is
reviewed
regularly,
including the
financial viability
of the insurer.

Outside legal
counsel and
insurance
carriers review
and monitor all
claims.
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Send letters of
inquiry to
malpractice
insurance carriers
and legal counsel,
in accordance with
AU section 337,
Inquiry of a Client's
Lawyer Concerning
Litigation, Claims,
and Assessments
(AICPA,
Professional
Standards).
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Contingencies and Other Liabilities
Financial Statement
Assertions

Presentation and
disclosure

Specific Auditing
Objectives

Selected Control
Activities

Auditing
Procedures

The adequacy of
malpractice
accruals is
regularly reviewed
by management,
including
information
obtained from
qualified
specialists.
Information
supplied to
specialists is
reviewed for
accuracy and
completeness.
Actuarial
assumptions are
reviewed for
compliance with
generally accepted
accounting
principles.

Review and test
the method of
estimating
accruals (for
example, review
actuarial reports
and prior historical
loss experience). If
the accrual is
discounted, review
and test the
present value
calculation,
including the
reasonableness of
the inputs.

Changes in the
risk-management
system are
communicated on
a timely basis.

Review prior
estimates and
historical loss
experience.

Determine that
additional
premiums charged
by insurers for
retrospectivelyrelated policies are
reported as a
liability.

Determine
whether
uncertainties
related to medical
malpractice claims
need to be
disclosed in the
independent
auditor's report.

The program of
medical
malpractice
insurance
coverage and the
basis for any loss
accruals are
adequately
disclosed in the
financial
statements.
(continued)
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Auditing Considerations—continued
Financial Statement
Assertions

Specific Auditing
Objectives

Selected Control
Activities

Auditing
Procedures

Income Taxes
Rights and
obligations

The not-for-profit
entity has
obtained a
qualifying income
tax exemption
from the
appropriate
governmental
authority.

Management
monitors
compliance with
applicable tax
regulations.
Transactions are
reviewed for their
effect on the tax
status and tax
liabilities,
including Internal
Revenue Code
(IRC) Section
4958.

Determine that the
not-for-profit
entity has obtained
a determination of
its tax-exempt
status. Consider
the effect of new,
expanded, or
unusual activities
on the
not-for-profit
entity's tax status.
Inquire if tax
returns have been
filed on a timely
basis.
Determine the
status of the tax
returns under
examination.
Read the prior
year's tax returns.
Read the minutes
and accounting for
evidence of
significant
unrelated business
activities.
Review for
reasonableness the
unrelated business
income tax
liability.
Review
transactions with
disqualified
persons, as defined
in IRC Section
4958.

Presentation and
disclosure

AAG-HCO 8.116

The entity's
tax-exempt
status and its tax
contingencies are
disclosed in the
notes to the
financial
statements.

Determine that the
entity's tax-exempt
status is disclosed
in the notes to the
financial
statements.
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Chapter 9

Net Assets (Equity)
Investor-Owned Health Care Entities
9.01 The equity accounts of investor-owned health care entities are similar
to those of other investor-owned entities.

Not-for-Profit Entities
9.02 The Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) glossary defines net assets as "[t]he excess or deficiency of assets over liabilities of a not-for-profit entity (NFP), which is classified into three mutually exclusive classes according to the existence or absence
of donor-imposed restrictions."1
9.03 As a residual interest, net assets cannot be measured independently
of a not-for-profit entity's assets and liabilities. Changes in net assets result
from transactions and other events and circumstances in which total assets and
total liabilities change by different amounts. In many not-for-profit entities,
such changes include nonreciprocal transfers of assets received from donors
who do not expect to receive either repayment or proportionate economic benefit
in return. See chapter 11, "Contributions Received and Made," of this guide for
further discussion. Display of, and disclosures about, net assets and changes
in them are intended to assist donors and other users in assessing an entity's
efforts to provide goods and services to its constituencies, its efficiency and
effectiveness in providing such services, and its continuing ability to do so.
9.04 Changes in net assets result from revenue, expenses, gains, losses,
and equity transfers; those changes are discussed in other chapters of this
guide. This chapter describes the principles for reporting total net assets in
statements of financial position and changes in total net assets in statements
of operations, as well as related disclosures.

Net Asset Classes
9.05 Paragraphs 9–11 of FASB ASC 958-210-45 provide guidance for the
classification of net assets. According to FASB ASC 958-210-45-1, the statement
of financial position (balance sheet) of a not-for-profit health care entity should
focus on the entity as a whole and report separate amounts for each of three
classes of net assets: (a) permanently-restricted net assets, (b) temporarilyrestricted net assets, and (c) unrestricted net assets.2 Net assets are included
in one of the three classes depending on the presence and type of donor-imposed
restrictions.
1
Although some health care entities may use other terms, such as equity, this guide uses the
term net assets to describe the residual interest.
2
As explained in Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 958-210-55-3, FASB ASC 958, Not-for-Profit Entities, encourages the use of the terms
unrestricted, temporarily restricted, and permanently restricted net assets; however, other labels exist.
For example, equity may be used for net assets, and other or not donor restricted may be used with
care to distinguish unrestricted net assets from the temporarily and permanently restricted classes
of net assets.
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9.06 The FASB ASC glossary defines a donor-imposed restriction as
[a] donor stipulation that specifies a use for a contributed asset that
is more specific than the broad limits resulting from the following:
a. The nature of the not-for-profit entity (NFP)
b. The environment in which it operates
c. The purposes specified in its articles of incorporation or
bylaws or comparable documents for an unincorporated
association.
A donor-imposed restriction on an NFP's use of the asset contributed
may be temporary or permanent. Some donor-imposed restrictions
impose limits that are permanent, for example, stipulating that resources be invested in perpetuity (not used up). Others are temporary,
for example, stipulating that resources may be used only after a specified date, for particular programs or services, or to acquire buildings
and equipment.
9.07 In addition to the three classes of net assets—permanently restricted,
temporarily restricted, and unrestricted—further disaggregation of total net
assets may also be reported. For example, unrestricted net assets may be subdivided into board-designated net assets and undesignated net assets. Donorimposed restrictions limit a not-for-profit health care entity's ability to use
or dispose of specific contributed assets or the economic benefits embodied in
those assets. Donor stipulations should not be considered restrictions, unless
they include limitations on the use of contributed assets that are more specific
than the broad limits imposed by the not-for-profit health care entity's purpose
and nature.
9.08 As explained in FASB ASC 958-210-45-3, generally, restrictions apply to net assets, not specific assets. However, assets may be restricted by
donors. For example, land could be restricted to use as a public park.

Permanently-Restricted Net Assets
9.09 The FASB ASC glossary defines permanently restricted net assets as
[t]he part of net assets of a not-for-profit entity (NFP) resulting from
the following:
a. Contributions and other inflows of assets whose use by the
NFP is limited by donor-imposed stipulations that neither
expire by passage of time nor can be fulfilled or otherwise
removed by the actions of the NFP
b. Other asset enhancements and diminishments subject to
the same kinds of stipulations
c. Reclassifications from or to other classes of net assets as a
consequence of donor-imposed stipulations.
9.10 Permanently-restricted net assets must be maintained by the notfor-profit health care entity in perpetuity. For example, contributions of cash
or securities restricted by the donor with the stipulation that they be invested
in perpetuity (donor-restricted endowment funds) are recognized as increases
in permanently-restricted net assets.
9.11 Permanently-restricted net assets also may change as a result of
increases and decreases in assets that are subject to permanent restrictions.
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FASB ASC 958-205-45-18 provides the following examples. If a donor stipulates that net gains be added to the principal of its gift until that endowed
gift plus accumulated gains increases to a specified dollar level, the gains are
permanently restricted. Similarly, if a donor states that a specific investment
security must be held in perpetuity, the gains and losses on that security are
subject to that same permanent restriction, unless the donor specifies otherwise. However, if a donor allows the not-for-profit entity to choose suitable
investments, the gains are not permanently restricted, unless the donor or law
requires that an amount be permanently retained.

Temporarily-Restricted Net Assets
9.12 The FASB ASC glossary defines temporarily restricted net assets as
[t]he part of the net assets of a not-for-profit entity (NFP) resulting
from the following:
a. Contributions and other inflows of assets whose use by the
NFP is limited by donor-imposed stipulations that either
expire by passage of time or can be fulfilled and removed
by actions of the NFP pursuant to those stipulations
b. Other asset enhancements and diminishments subject to
the same kinds of stipulations
c. Reclassification from or to other classes of net assets as a
consequence of donor-imposed stipulations, their expiration by passage of time, or their fulfillment and removal
by actions of the NFP pursuant to those stipulations.
9.13 Temporarily-restricted net assets are those net assets whose use by
the not-for-profit health care entity have been limited by donors to (a) later
periods or after specified dates or (b) specified purposes.3 For example, contributions restricted by the donor to be used by the entity over the next five years
or support a specific future program are recognized as increases in temporarilyrestricted net assets. Contributions of assets, such as equipment or buildings,
that by their nature are used up over time and that the donor stipulates must
be used by the entity also are recognized as increases in temporarily-restricted
net assets. Paragraphs 9.25–.31 discuss the temporarily-restricted net assets
of endowment funds.
9.14 Temporarily-restricted net assets also may change as a result of
increases and decreases in assets or the economic benefits embodied in those
assets that are subject to donor-imposed temporary restrictions. For example,
as explained in paragraphs 9.28–.29, if a donor has stipulated that assets be
held in perpetuity as a donor-restricted endowment fund, the net appreciation
of those assets and their income are temporarily restricted until appropriated
for expenditure by the not-for-profit health care entity.

Unrestricted Net Assets
9.15 The FASB ASC glossary defines unrestricted net assets as
[t]he part of net assets of a not-for-profit entity (NFP) that is neither
permanently restricted nor temporarily restricted by donor-imposed
3
As described in paragraph 11.12 of this guide, contributions received with restrictions that are
met in the same reporting period may be reported as unrestricted if the health care entity discloses
its policy and consistently reports from period to period.
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stipulations. The only limits on the use of unrestricted net assets are
the broad limits resulting from the following:
a. The nature of the NFP
b. The environment in which the NFP operates
c. The purposes specified in the NFP's articles of incorporation or bylaws
d. Limits resulting from contractual agreements with suppliers, creditors, and others entered into by the NFP in
the course of its business.
Unrestricted net assets generally result from revenues from providing services, producing and delivering goods, receiving unrestricted
contributions, and receiving dividends or interest from investing in
income-producing assets, less expenses incurred in providing services,
producing and delivering goods, raising contributions, and performing
administrative functions.
9.16 In accordance with FASB ASC 958-210-50-2, information about significant limits resulting from contractual agreements with suppliers, creditors,
and others, including the existence of loan covenants, generally is provided in
the notes to the financial statements. FASB ASC 958-210-45-11 states that information about self-imposed limits also may be useful, including information
about voluntary resolutions by the governing board of an entity to designate a
portion of its unrestricted net assets to function as an endowment (sometimes
called a board-designated endowment). That information may be presented in
notes to, or on the face of, the financial statements.
9.17 For example, a health care entity might include information about
voluntary resolutions to designate a portion of its unrestricted net assets for
funded depreciation.
9.18 FASB ASC 958-810-45-1 states that noncontrolling interests4 in the
equity (net assets) of consolidated subsidiaries should be reported as a separate
component of the appropriate class of net assets in the consolidated statement
of financial position of a not-for-profit entity. That amount should be clearly
identified and described (for example, as noncontrolling ownership interest in
subsidiaries) to distinguish it from the components of net assets of the parent,
which includes the parent's controlling financial interest in its subsidiaries.
The effects of donor-imposed restrictions, if any, on a partially-owned subsidiary's net assets should be reported in accordance with FASB ASC 958-205
and 958-320. Paragraphs 17–25 of FASB ASC 958-810-55 illustrate one way
in which the consolidated financial statements of a hospital might satisfy the
presentation and disclosure requirements for noncontrolling interests in a consolidated subsidiary and subsequent changes in ownership interests of that
subsidiary.

Reclassifications
9.19 FASB ASC 958-225-45-13 states that reclassifications of net assets
(that is, simultaneous increases in one net asset class and decreases in another) should be made if any of the following events occur: (a) the not-for-profit

4
A noncontrolling interest is the portion of equity in a subsidiary that is not directly or indirectly
attributable to a parent.
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entity fulfills the purposes for which the net assets were restricted, (b) donorimposed restrictions expire with the passage of time or death of a split-interest
agreement beneficiary5 (if the net assets are not otherwise restricted), (c) a
donor withdraws or court action removes previously-imposed restrictions, or
(d) donors impose restrictions on otherwise unrestricted net assets.
9.20 For example, the amount of a donor's contribution that must be used
by the health care entity for a specified program would be reclassified from
temporarily-restricted to unrestricted net assets in the period in which the
health care entity conducts the program. A purpose restriction is often fulfilled
when the entity incurs an expense or recognizes a liability to a vendor to acquire
goods or services that satisfies the restriction.
9.21 FASB ASC 958-205-45-9 states that if two or more temporary restrictions are imposed on a contribution, the effect of the expiration of those
restrictions should be recognized in the period in which the last remaining restriction has expired. Expirations of donor-imposed restrictions are reported as
reclassifications, decreasing temporarily-restricted net assets and increasing
unrestricted net assets. In accordance with FASB ASC 958-225-45-3, reclassifications of amounts between net asset classes are reported separately from
other transactions in the statement of operations.
9.22 As explained in FASB ASC 958-205-45-11, if an expense is incurred
for a purpose for which both unrestricted and temporarily-restricted net assets
are available, a donor-imposed restriction is fulfilled to the extent of the incurred expense, unless the expense is for a purpose that is directly attributable
to another specific external source of revenue. Temporarily-restricted net assets with time restrictions are not available to support expenses until the time
restrictions have expired.
9.23 For example, an employee's salary may meet donor-imposed restrictions to support the activity on which the employee is working. In that situation,
the restriction is met to the extent of the incurred salary expense, unless incurring the salary will lead to inflows of revenue from a specific external source,
such as revenue from a cost reimbursement contract or a conditional promise to
give that becomes unconditional when the health care entity incurs the salary
expense.
9.24 As explained in FASB ASC 954-210-50-1 and 954-205-45-9, health
care entities are prohibited from implying a time restriction that expires over
the useful life of a donated long-lived asset. Thus, if contributions of long-lived
assets with explicit donor restrictions are reported as temporarily-restricted
support, a health care entity reports expirations of those donor restrictions
when the stipulation is fulfilled, and the assets are placed in service. Similarly, donations of cash or other assets that must be used to acquire long-lived
assets are reported as temporarily-restricted support in the period that they
are received, and expirations of those donor restrictions are reported when the

5
FASB ASC 958-30 provides guidance for reporting arrangements under which a not-for-profit
entity shares the benefits of assets with other beneficiaries (a split-interest agreement). Those other
beneficiaries generally are not not-for-profit entities. For example, a donor may give a not-for-profit
entity the right to receive all or a portion of the specified cash flows from a charitable trust or
other identifiable pool of assets that is held either by the not-for-profit entity or an unrelated third
party, such as a bank, trust company, foundation, or private individual. Chapter 6, "Split Interest
Agreements," of the Audit and Accounting Guide Not-for-Profit Entities provides additional guidance
on split-interest gifts.
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acquired long-lived assets are placed in service, and donor-imposed restrictions
are satisfied.

Classification of Donor-Restricted Endowment Funds
9.25 The FASB ASC glossary defines a donor-restricted endowment fund
as "[a]n endowment fund that is created by a donor stipulation requiring investment of the gift in perpetuity or for a specified term. Some donors may
require that a portion of income, gains, or both be added to the gift and invested subject to similar restrictions." FASB ASC 958-205-45-14 states that
when classifying an endowment fund, each source—original gift, gains and
losses, and interest and dividends—must be evaluated separately. Each source
is unrestricted, unless its use is temporarily or permanently restricted by explicit donor stipulations or law. Thus, an endowment fund that is created by a
governing board from unrestricted net assets is classified as unrestricted because all three sources are free of donor restrictions. If an endowment fund is
created by a donor, the donor may have placed different restrictions on each
of the three sources. Classification of the original gifts and the income earned
by endowments generally is straightforward because, usually, donors explicitly
state any time or purpose restrictions on those two sources. Determining how
to classify gains on endowments may not be as easy because agreements with
donors often are silent on how gains should be used and whether losses must
be restored immediately from future gains or not at all.
9.26 FASB ASC 958-205-05-9 notes that because donor stipulations and
laws vary, not-for-profit entities must assess the relevant facts and circumstances for their endowment gifts and relevant laws to determine if net appreciation on endowments is available for spending or permanently restricted.
Paragraphs 13–35 of FASB ASC 958-205-45 provide guidance for reporting
the net assets of endowment funds and the changes in those net assets. The
guidance for states that have enacted a version of the Uniform Prudent Management of Institutional Funds Act (UPMIFA) is summarized in the following
four paragraphs, but it is not intended as a substitute for reading the standards
themselves.
9.27 A not-for-profit entity that is subject to an enacted version of UPMIFA should classify a portion of a donor-restricted endowment fund of perpetual duration as permanently-restricted net assets. The amount classified as
permanently restricted should be either (a) the amount of the fund that must
be permanently retained in accordance with explicit donor stipulations, as explained in paragraphs 3–4 of FASB ASC 958-605-45, or (b) the amount of the
fund that, in the absence of explicit donor stipulations, the not-for-profit entity's governing board determines must be permanently retained (preserved),
consistent with the relevant law, as explained in FASB ASC 958-205-45-21.
9.28 The relevant law of a state that has enacted a version of UPMIFA
may include the limitation "[u]nless stated otherwise in the gift instrument,
the assets in an endowment fund are donor-restricted assets until appropriated
for expenditure by the institution," which is from subsection 4(a) of UPMIFA.
For each donor-restricted endowment fund for which the restriction described
in subsection 4(a) of UPMIFA applies, a not-for-profit entity should classify the
portion of the fund that is not classified as permanently-restricted net assets
as temporarily-restricted net assets (time restricted) until appropriated for
expenditure by the not-for-profit entity.
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9.29 Upon appropriation for expenditure, the time restriction expires to
the extent of the amount appropriated and, in the absence of any purpose
restrictions, results in a reclassification of that amount to unrestricted net
assets. If the fund is also subject to a purpose restriction, the reclassification
of the appropriated amount to unrestricted net assets would not occur until
that purpose restriction also has been met, in accordance with the guidance
beginning in FASB ASC 958-205-45-9. Pursuant to FASB ASC 958-205-45-11,
temporarily-restricted net assets with time restrictions are not available to
support expenses until the time restrictions have expired.
9.30 In the absence of donor stipulations or law to the contrary, losses
on the investments of a donor-restricted endowment fund should reduce
temporarily-restricted net assets to the extent that donor-imposed temporary
restrictions on net appreciation of the fund have not been met before a loss occurs. Any remaining loss should reduce unrestricted net assets. The amount of
permanently-restricted net assets is not reduced by losses on the investments
of the fund or a not-for-profit entity's appropriations from the fund. If losses
or, as UPMIFA states, appropriations reduce the assets of a donor-restricted
endowment fund below the level required by the donor stipulations or law,
gains that restore the fair value of the assets of the endowment fund to the
required level should be classified as increases in unrestricted net assets. After the fair value of the assets of the endowment fund equals the required
level, gains that are restricted by the donor should be classified as increases in
temporarily-restricted or permanently-restricted net assets, depending on the
donor's restrictions on the endowment fund.
9.31 Paragraphs 3.16, 4.21, and 4.30 of this guide provide information
about whether the income, gains, and losses of donor-restricted endowment
funds are included or excluded from the performance indicator.

Disclosure
9.32 FASB ASC 958-210-45-9 requires that information about the nature
and amounts of different types of permanent or temporary restrictions be provided either by reporting their amounts on the face of the financial statements
or including relative details in the notes to financial statements.
9.33 For example, information about the following would be shown on the
face of the financial statements or in the notes:

r
r

Different kinds of permanent restrictions, such as specific assets
to be held in perpetuity and assets that have been contributed by
donors with stipulations that they be invested in perpetuity
Different kinds of temporary restrictions, such as those concerning the support of specific operating activities, use in specific future periods, or acquisition of long-term assets

9.34 Separate disclosures of significant limitations other than those imposed by donors, such as those imposed by governing boards or regulatory
bodies, are permitted to be made on the face of the financial statements or in
the notes to the financial statements.
9.35 Paragraphs 1A–2A of FASB ASC 958-205-50 require disclosures
for both donor-restricted and board-designated endowment funds. A health
care entity should disclose information about net asset classification, net asset
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composition, changes in net asset composition, spending policies, and related
investment policies.
9.36 FASB ASC 958-810-50-1 requires that if consolidated financial statements are presented, the reporting entity (parent) should disclose any restrictions made by entities outside of the reporting entity on distributions from
the controlled not-for-profit entity (subsidiary) to the parent and any resulting
unavailability of the net assets of the subsidiary for use by the parent.

Auditing
9.37 The independent auditor may need to consider the examples of specific auditing objectives, selected control activities, and auditing procedures
relating to net assets (equity) that are presented in exhibit 9-1.
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Exhibit 9-1
The following table illustrates the use of assertions in developing audit objectives and designing substantive tests. The examples are not
intended to be all-inclusive nor is it expected that all the procedures
would necessarily be applied in an audit. The auditor should design
and perform substantive procedures for all relevant assertions related
to each material class of transactions, account balance, and disclosure
to obtain sufficient appropriate audit evidence. The use of assertions
in assessing risks and designing appropriate audit procedures to obtain audit evidence is described in paragraphs .14–.26 of AU section
326, Audit Evidence (AICPA, Professional Standards). Various audit
procedures and the purposes for which they may be performed are
described in paragraphs .27–.41 of AU section 326.
Auditing Considerations
Financial
Statement
Assertions

Specific Auditing
Objectives

Selected Control
Activities

Auditing
Procedures

Net Assets (Equity)
Account Balances
Rights and
obligations

Resources are
used and
accounted for in
accordance with
donor and grantor
restrictions.

Presentation and Disclosure
Net assets are
Classification presented and
and underdisclosed properly
standability
in the financial
statements.
Temporarilyrestricted net
assets are
reclassified as
unrestricted net
assets when
donor-imposed
restrictions have
been fulfilled.

Management
monitors
compliance with
these restrictions.

Review the minutes of
board and board
committee meetings for
evidence of donor
restrictions.

Procedures ensure
proper
authorization,
recording, and
presentation.

Test significant net
asset transactions to
determine that they are
properly authorized
and recorded.

Controls ensure
that reclassification
of temporarilyrestricted net
assets occurs when
donor-imposed
restrictions have
been fulfilled.

Determine compliance
with donor and grantor
restrictions. Test
expenditures to
determine that
restricted net assets
are used for their
restricted purposes.
Determine that
appropriate
reclassifications are
reported in the
statement of activities
when donor-imposed
restrictions have been
fulfilled.
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Chapter 10

Health Care Service Revenue
and Related Receivables *
Overview of the Health Care Environment
10.01 A unique aspect of the health care industry is the involvement of
multiple parties in the provision of, and payment for, health care services. As
many as four parties may be involved in a health care service transaction,
including the following:

r
r
r
r

The patient who receives the care
The physician who orders the services on behalf of the patient
The health care entity that provides the setting or administers
the treatment (for example, hospital, home health company, and
so on)
The third-party payor(s) that provides payment to the health care
entity on behalf of the patient

10.02 The third-party payor may be a government program, such as Medicare or Medicaid; a commercial insurer, such as a managed care plan; a commercial insurance company; a preferred provider organization (PPO); or a selffunded employer plan. In managed care entities, the physician, health care
entity, and third-party payor may all be part of the same reporting entity.
10.03 The extent to which third-party payors are involved in paying for
services varies by type of health care facility. For hospitals, rehabilitation facilities, and home health companies, third-party payors typically pay for the
majority of provided services. In the nursing home sector, a certain portion of
the patients are considered private pay (that is, the patient or his or her family
pays for the care); for the remainder, Medicaid is the dominant third-party
payor for care provided to low-income individuals. Minimal commercial insurance coverage presently exists for nursing home care, and Medicare provides
limited nursing home benefits for short stays. In continuing care retirement
communities (CCRCs), the residents themselves typically pay entrance and
monthly service fees, and third-party payor involvement is limited to the payment of some services that may be provided in the nursing care portion of the
facility.
10.04 Revenue recognition and the valuation of related receivables of
health care entities are subject to inherent uncertainties and complexities,
including the following:

*
On June 24, 2010, the Financial Accounting Standards Board (FASB) issued proposed Accounting Standards Update (ASU) Revenue Recognition (Topic 605): Revenue from Contracts with
Customers, to improve and align with International Financial Reporting Standards the financial reporting of revenue from contracts with customers and related costs. The core principle of the draft
standard is that an entity should recognize revenue from contracts with customers when it transfers
goods or services to the customer in the amount of consideration that the entity receives or expects to
receive from the customer. The proposed standard would replace most of the guidance in FASB Accounting Standards Codification 605, Revenue Recognition. Readers should be alert for the issuance
of a final standard.
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Rate setting with third-party payors, including settlements that
are not known with certainty until after a considerable period of
time has elapsed after the related services were rendered
The regulations and laws on which governmental third-party payments are based
The determination of what constitutes charity care

Rate Setting With Third-Party Payors
10.05 Third-party payors typically do not pay the health care entity's full
established rates. The paid amount may be based on government regulations
for Medicare, Medicaid, and other government programs or contractual arrangements for PPOs, health maintenance organizations, or HMOs, workers'
compensation insurers, and commercial insurers. When multiple third-party
payors are involved, payment rates and coverages often vary by payor.
10.06 As noted in Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 954-605-05-5, payment rates established by
regulations or contractual agreements may be determined either prospectively
or retrospectively. Some rate-setting methods described as prospective, such as
the Medicare Prospective Payment System (PPS), may include provisions for
retrospective adjustments (for example, billing denials, coding changes, and
settlements with third-party payors). Some third parties pay prospective rates
for certain services and retrospective rates for other services.
10.07 Prospective rate setting is a method used to set payment rates in
advance of the delivery of health care services. Such payment rates determine
what third parties will pay for health care services during the rate period
(generally one year). Prospective rate setting may result from a contractual
agreement with a third party, or it may be mandated through legislation. The
intent of prospective rate setting is to establish payment rates before the period
to which they will apply and that are not subject to change.
10.08 Under retrospective rate setting, third parties usually determine
an interim payment rate and, during the rate period (generally one year), pay
the health care entity for rendered services using that rate. After the rate
period has ended, a final settlement is made in accordance with federal or state
regulations or contractual agreements.
10.09 When rates are subject to retrospective adjustments, the amounts
of the final settlements may not be known with certainty until a considerable
period of time has elapsed from when the related services were rendered. Reasonable estimates of such settlements are central to the revenue recognition
process in health care in order to avoid recognizing revenue that the health
care entity will not ultimately realize or failing to recognize revenues that
will ultimately be realized. The basis for such estimates may range from relatively straightforward calculations using information that is readily available
to highly complex judgments based on assumptions about future decisions.
The estimation process is further complicated by the complexities of billing
and reimbursement regulations. Estimating revenues from third-party payors
is discussed in paragraphs 10.20–.24.
10.10 FASB ASC 954-605-25-9 requires that rate-setting methods that
are described as prospective but provide for retrospective adjustments should
be accounted for as retrospective rate-setting systems for the services to which
they apply.
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The Government-Contracting Environment
10.11 The largest third-party payor in the United States is the federal
government, which purchases health care services through its Medicare, Medicaid, TRICARE, and Federal Employees Health Benefits programs. Most institutional health care providers and many managed care plans serve Medicare
or Medicaid beneficiaries, or both, to some extent. Consequently, most health
care entities are considered to be government contractors. The contractual
relationship is defined by regulations written by government agencies and enforced by an elaborate oversight network of government auditors and contract
administrators. For example, Medicare administers its own contracts and subcontracts audits and claims processing functions to private-sector Medicare
Administrative Contractors (MAC). The regulations and laws on which they
are based are inherently political and subject to frequent change and differing
interpretations.
10.12 Health care entities doing business with governmental payors (for
example, Medicare and Medicaid) are subject to the following risks that are
unique to the government-contracting environment, that are hard to anticipate
and quantify, and that may vary from entity to entity:

r

r
r
r
r
r
r
r
r
r

A health care entity's revenues and allowable costs may be subject
to adjustment as a result of examination by government agencies
or contractors. The audit process and resolution of significant related matters, including disputes based on differing interpretations of the regulations, often are not finalized until several years
after the services were rendered.
Different MACs (entities that contract with the federal government to assist in the administration of the Medicare program)
may interpret governmental regulations differently.
Differing opinions on a patient's principal medical diagnosis, including the appropriate sequencing of codes used to submit claims
for payment, can have a significant effect on the payment amount.
Otherwise valid claims may be determined to be nonallowable
after the fact due to differing opinions on medical necessity.
Claims for rendered services may be nonallowable if they are later
determined to have been based on inappropriate referrals.
Government agencies may make changes in program interpretations, requirements, or conditions of participation, some of which
may have implications for previously-estimated amounts.
Certain states determine rates of payment for Medicare or Medicaid payments, or both, in accordance with the statewide ratesetting method, which is different from the method used by the
federal government.
Government agencies have the right to withhold or reduce contract payments for an extended period of time.
Health care entities may receive add-on payments for serving a
disproportionately high percentage of low-income patients.
Extensive and complex reimbursement methodologies exist for
teaching institutions.
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10.13 As a result of such risks, retrospective adjustments can be particularly difficult to estimate with respect to governmental payors. The delay between rendering services and reaching final settlement, as well as the complexities and ambiguities of billing and reimbursement regulations, makes it difficult to estimate net patient service revenue associated with government programs. However, despite the difficulty, health care entities paid through programs that are subject to retrospective adjustments need to estimate amounts
that ultimately will be realizable in order for revenues associated with those
payment systems to be fairly stated in accordance with generally accepted accounting principles (GAAP). Estimating revenues from government programs
is discussed in paragraphs 10.20–.24.
10.14 In addition, risks may result from the applicability of certain laws
that provide for potentially significant penalties to be assessed if the contractor
violates them. For example, a contractor that submits a false claim to the
government may be subject to penalties ranging from a monetary penalty for
each submitted false claim to suspension or exclusion from the program. Thus,
noncompliance could result in a material contingent liability, a material loss
of future revenue, or cause the health care entity to be unable to continue as a
going concern.

Charity Care
10.15 The FASB ASC glossary states that "[c]harity care represents
health care services that are provided but are never expected to result in cash
flows. Charity care is provided to a patient with demonstrated inability to
pay. Each entity establishes its own criteria for charity care consistent with
its mission statement and financial ability." Distinguishing charity care from
bad-debt expense requires the exercise of judgment. Charity care is discussed
further in paragraphs 10.25–.28.

Types of Health Care Revenue
10.16 In accordance with FASB ASC 954-605-45-1, health care revenue
should be classified based on the type of services rendered or contracted to be
rendered. Examples include the following: ,

r
r
r
r

Patient service revenue, which is derived from fees earned in exchange for providing services to patients
Resident service revenue, which is derived from fees charged to
residents of a long-term care facility, such as a skilled nursing
facility or CCRC1
Capitation revenue, which is derived from capitation-type arrangements with third-party payors by which fees are earned by
agreeing to provide services to qualified beneficiaries, not necessarily as a result of actually providing the care2
Premium revenue, which is the primary source of revenue of prepaid health care plans3

1
Refer to chapter 14, "Financial Accounting and Reporting by Continuing Care Retirement
Communities," of this guide for additional information.
2
Refer to chapter 13, "Financial Accounting and Reporting for Managed Care Services," of this
guide for additional information.
3
See footnote 2.
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Refundable and nonrefundable advance fees received by certain
types of CCRCs4

Types of Payment Methodologies
10.17 Common payment methodologies utilized by third-party payors include the following:

r

r

r

r

r

4

Fee-for-service. Under fee-for-service arrangements, payment is
based on the specific services that are provided to the patient;
therefore, the health care entity earns revenue as a result of providing those services. Payment may be at the health care entity's
full established rates, with a predetermined discounted rate (for
example, percent of charges), or based on a fee schedule agreed to
by the health care entity and third-party payor.
Per diem. Under a per diem arrangement, the health care entity
is paid a flat rate per day of inpatient care, regardless of the level
of intensity of the provided care. Therefore, revenue is earned as
a result of the patient occupying an inpatient bed for a particular
day. The Medicare PPS for skilled nursing facility services is an
example of a per diem methodology. The contract specifies the
manner in which partial days of care, such as the day of admission
or discharge, will be paid, and revenue for those days is recognized
accordingly. A prorated payment may be made for a partial day
of care. Alternatively, the terms of the payor's policy may provide
for a full payment for the day of admission and pay nothing for
the day of discharge.
Per case. When payment is made on a per-case basis, the health
care entity is paid a predetermined amount based on the patient's
discharge category. The Medicare PPS for hospital inpatient services is an example of a per-case payment methodology. Under
per-case payment, revenue is earned as a result of the patient receiving treatment from the health care entity. If the contract calls
for payment on a per-case basis, and the patient is hospitalized
at the end of the accounting period, a portion of the total revenue
for the case will be earned in one period, with the balance earned
in the next period. In such situations, the total revenue for the
case is allocated between the two accounting periods using an
allocation method that fairly apportions the revenue between periods.
Episodic. Under an episodic payment methodology, the health
care entity is paid a predetermined amount for services provided
to patients during an episode of care (for example, a stipulated
period of time). Revenue normally is earned based on the passage
of time. Medicare's PPS for home health services is an example of
an episodic payment methodology.
Capitation. Generally, capitation payments are received at the
beginning of each month and obligate the health care entity to
stand ready to render covered services during the month. Capitation revenue is earned as a result of agreeing to provide services

See footnote 1.
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to qualified beneficiaries, not as a result of actually providing the
care. If the health care entity's accounting system records patient charges and establishes patient receivables as services are
rendered, appropriate valuation allowances or adjustments are
recorded, so only the amount of contract revenue is reported.

Patient (or Resident) Service Revenue
Revenue Recognition
10.18 Paragraph 83 of FASB Concepts Statement No. 5, Recognition and
Measurement in Financial Statements of Business Enterprises, provides a general rule that revenue is earned when an entity has substantially accomplished
what it must do to be entitled to those revenues.
10.19 With respect to third-party payor arrangements, governmental regulations or contractual terms will specify the performance requirements or
conditions that the health care entity must meet in order to be entitled to revenue under the contract or provider agreement. Regulations or contracts also
will address payment terms and the degree of risk that is to be assumed by
the health care entity. Consequently, a thorough understanding of the terms
of the health care entity's arrangements with significant third-party payors is
important for appropriate revenue recognition.

Estimating Revenue Related to Government Programs
and Other Third-Party Payors
10.20 The amount of revenue earned under arrangements with government programs is determined under complex rules and regulations that subject
the health care entity to the potential for retrospective adjustments in future
years. Several years may elapse before all potential adjustments related to a
particular fiscal year are known and before the amount of revenue to which the
health care entity is entitled is known with certainty. As noted in paragraph
.10 of Statement of Position (SOP) 00-1, Auditing Health Care Third-Party
Revenues and Related Receivables (AICPA, Technical Practice Aids, AUD sec.
14,360), management makes a reasonable estimate of amounts that ultimately
will be realized, considering, among other things, adjustments associated with
regulatory reviews, future program audits, billing reviews, investigations, or
other proceedings. In making these estimates, management also considers the
potential for regulatory investigations that may result in the denial of otherwise valid claims for payment. These matters are discussed in SOP 00-1,
which, among other matters, provides guidance to auditors regarding uncertainties inherent in third-party revenue recognition.5
10.21 As noted in paragraph .06 of SOP 00-1, health care entities need to
estimate amounts that ultimately will be realizable in order for revenues to be
fairly stated in accordance with GAAP. Thus, in the period in which services are
rendered, health care entities estimate the amount to which they ultimately
will be entitled for providing those services and report that amount as revenue.
The difference between that estimated amount and the amount of payments
received prior to the balance sheet date is reflected as a receivable or payable in
5
Statement of Position 00-1, Auditing Health Care Third-Party Revenues and Related Receivables (AICPA, Technical Practice Aids, AUD sec. 14,360), is included as appendix B, "Statement of
Position 00-1, Auditing Health Care Third-Party Revenues and Related Receivables," of this guide.
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the balance sheet. The difference between gross patient service revenues and
the estimated amount is a contractual adjustment that, along with courtesy and
policy discounts and other adjustments and deductions, adjusts gross service
revenues, which excludes charity care, to arrive at net service revenues in
the statement of operations. The relationship between various amounts can be
depicted as follows:
Gross charges

XXX,XXX

Less charges associated with charity patients
Gross patient service revenue

(XX,XXX)
XXX,XXX

Less deductions from revenue:
Contractual allowances
Courtesy/policy/other discounts
Net patient service revenue

(XXX,XXX)
(XX,XXX)
XXX,XXX

10.22 Management's estimates relating to third-party contractual adjustments are based on subjective, as well as objective, factors. This requires judgment that normally is based on management's knowledge of, and experience
with, past and current events and its assumptions about conditions that it
expects to exist and courses of action that it expects to take.
10.23 Approaches for making estimates of third-party contractual adjustments vary from entity to entity, depending on individual facts and circumstances. Some entities with significant prior experience may attempt to
quantify the effects of individual potential intermediary or other governmental
(for example, Office of Inspector General or Department of Justice) or private
payor adjustments based on detailed calculations and assumptions regarding
potential future adjustments. Some entities may prepare cost report analyses6
to estimate the effect of potential adjustments. Other entities may base their
estimates on an analysis of potential adjustments in the aggregate, in light of
the payors involved; the nature of the payment mechanism; the risks associated
with future audits; and other relevant factors.
10.24 In some situations (for example, Medicare or Medicaid provider
agreements), payments received under contracts with third-party payors are
subject to adjustment after the contract term is completed, based on findings
of audits, reviews, or investigations. In such cases, net service revenue also
includes a provision for estimated future retroactive adjustments. Such provisions are accrued on an estimated basis in the period that the related services
are rendered and adjusted in future periods as additional information is obtained or adjustments become known, or both. That accrual is subsequently
adjusted as events occur that change the estimate of earned revenue. Such
adjustments have the potential to materially affect the health care entity's
financial position and results of operations. Accounting for the subsequent adjustments is discussed beginning at paragraph 10.43.

6
Medicare cost reimbursement is based on the application of highly complex technical rules,
some of which are ambiguous and subject to different interpretations, even among Medicare's Administrative Contractors. To estimate the effects of potential adjustments, some health care entities will
prepare a cost report based on alternative assumptions.
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Charity Care
10.25 Each health care entity establishes its own criteria for charity care
consistent with its mission statement, its financial ability, the current economy,
and other circumstances. In some instances, prior to any care being provided, a
health care entity is able to obtain information regarding a patient's financial
status and determine whether that patient meets the criteria for uncompensated care. If so, the patient would be classified as charity prior to receiving
treatment. In other cases, such as trauma care, patient financial information
may not be available at the time that treatment is provided to the patient. A
health care entity may provide care because it either is required to do so by
law (for example, emergency care) or chooses to do so, with the understanding
that a charity care application will be completed in the future.
10.26 FASB ASC 954-605-25-10 states that charity care does not qualify
for recognition as revenue in the financial statements. Distinguishing charity
care from bad-debt expense requires the exercise of judgment. Only the portion
of a patient's account that meets the health care entity's charity care criteria
is recognized as charity. As noted in FASB ASC 954-605-25-11, although it
is not necessary for the entity to make this determination upon admission or
registration of an individual, the entity determines at some point whether the
individual meets the established criteria for charity care.
10.27 This determination is made as quickly as practicably possible, generally before any substantial collection effort is initiated. Charity care does not
include contractual adjustments that result from third-party arrangements,
such as Medicare, Medicaid, government funding programs, or other thirdparty arrangements, because the health care entity has accepted the payment
terms for the services provided by agreement. In addition, charity care does not
include discounts given to uninsured or underinsured patients if those patients
do not qualify under the health care entity's charity care policy.
10.28 Pursuant to FASB ASC 954-605-50-3, management's policy for providing charity care, as well as the level of charity care provided, should be disclosed in the financial statements. Such disclosure should be measured based
on the health care entity's direct and indirect costs of providing charity care
services. If costs cannot be specifically attributed to services provided to charity
care patients (for example, based on a cost accounting system), management
may estimate the costs of those services using reasonable techniques. For example, one such estimation technique might involve calculating a ratio of cost
to gross charges and then multiplying that ratio by the gross uncompensated
charges associated with providing care to charity patients. Other reasonable
techniques also are permitted. The method used to identify or estimate such
costs should be disclosed. Funds received to offset or subsidize provided charity
services (for example, from gifts or grants restricted for charity care or from an
uncompensated care fund) also should be separately disclosed.

Estimating Revenue Related to Care Not Covered
by Third-Party Payors
10.29 A portion of a health care entity's charges typically will not be paid
by third-party payors, and the patient will be responsible. This self-pay portion of revenue comprises revenue for services provided to uninsured patients;
insurance copays and deductibles; as well as noncovered services (for example, cosmetic surgery). Estimating revenue for the self-pay portion also may be
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challenging, but as noted in paragraph .06 of SOP 00-1, health care entities
need to estimate amounts that ultimately will be realizable in order for revenues to be fairly stated in accordance with GAAP. The predominant industry
practice for reporting revenue from self-pay patients is to recognize gross service revenue for those patients at the health care entity's gross charges (that
is, full established billing rates) when the services are provided and adjust for
bad debts (an operating expense) based on collection assessments. No revenues
are recognized for patients identified as receiving charity care services. If the
health care entity offers a discount to uninsured patients, those discounts are
recorded as a reduction to gross service revenues, so that the resulting net
service revenue is recorded in the statement of operations. Bad debt expense
is then recognized as an operating expense based on collection assessments.†

Accounting and Financial Reporting Requirements
10.30 Per FASB ASC 954-605-25-3, in general, gross service revenue is
recorded in the accounting records on an accrual basis at the health care entity's
established rates, regardless of whether the health care entity expects to collect
that amount.
10.31 That amount that is used for internal record-keeping purposes is
referred to as gross service revenues. The revenues are recorded as services
are rendered. Any difference between the established rates for provided services and amounts agreed to under agreements with third parties is accounted
for as a contractual adjustment. An estimate of the contractual adjustment
is recorded in the same period that the services were provided. In addition,
some health care entities offer discounts (for example, courtesy, prompt pay, or
employee discounts). The discount also is recorded in the same period that the
services were provided. Thus, internal records will generally reflect the gross
patient service revenues offset by the contractual adjustments and discounts.
10.32 Per FASB ASC 954-605-25-4, the provision for contractual adjustments (that is, the difference between established rates and third-party payors'
payments) and discounts (that is, the difference between established rates and
the collectible amount) are recognized on an accrual basis and deducted from
gross services revenue to determine net service revenue. For financial reporting
purposes, FASB ASC 954-605-45 requires that revenue be classified based on
the type of rendered service and that service revenue, including patient service
revenue, be reported net of contractual and other adjustments in the statement
of operations.
10.33 In accordance with FASB ASC 954-605-25-6, estimates of contractual adjustments, other adjustments, and the allowance for uncollectibles
should be reported in the period during which the services are provided, even
†
In July 2011, FASB issued ASU No. 2011-07, Health Care Entities (Topic 954): Presentation
and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful
Accounts for Certain Health Care Entities (a consensus of the FASB Emerging Issues Task Force),
which would require certain health care entities to change the presentation of their statement of
operations by reclassifying the provision for bad debts associated with patient service revenue from
an operating expense to a deduction from patient service revenue (net of contractual allowances and
discounts). Additionally, those health care entities are required to provide enhanced disclosures about
their policies for recognizing revenue and assessing bad debts. The amendments also require disclosures of patient service revenue (net of contractual services), as well as qualitative and quantitative
information about changes in the allowance for doubtful accounts. The amendments in this ASU will
be effective for fiscal years beginning after December 15, 2011, for public entities, and for the first
annual period ending after December 15, 2012, for nonpublic entities.
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though the actual amounts may become known at a later date. This later date
may be any one of the following: (a) when the patient is discharged, (b) subsequent to discharge or completion of service, (c) when the third party is billed,
or (d) when payment or partial payment is received. Also, as discussed in paragraph 10.26, charity care does not qualify for recognition as revenue in the
financial statements.

Premium and Capitation Revenues
10.34 As noted in FASB ASC 954-605-05-6, in many cases, revenues are
generated as a result of an agreement to provide health care, rather than from
the actual provision of services. For example, an integrated delivery system
may agree to provide all health-related services for a specified group residing
within its primary service area for an agreed-upon amount per member per
month. These revenues are premium revenues, not patient service revenues,
because they are earned by agreeing to provide care, regardless of whether
services are rendered.
10.35 FASB ASC 954-405-25-1 states that if a capitation contract obligates the health care entity to assume the risk of physician referrals and
other outside services, a liability for unpaid claims, including incurred but
not reported claims, should be established. A lag analysis may be helpful in
estimating the liability.
10.36 In addition to the capitation payments, the amount of contract
revenue may be affected by factors such as reinsurance recoveries, deductibles,
coinsurance, and risk pool adjustments. Risk pool adjustments may be based
on factors such as utilization or cost targets.
10.37 In accordance with FASB ASC 954-605-45-3, significant revenue
earned under capitation arrangements should be reported separately.

Patient Receivables
10.38 Patient receivables may include amounts due (a) from patients,
third-party payors, and employers for provided health care services and (b)
for premiums and stop-loss insurance recoveries. Premiums and stop-loss insurance recoveries are discussed in chapter 13, "Financial Accounting and
Reporting for Managed Care Services," of this guide.
10.39 In accordance with FASB ASC 954-310-30-1, contractual adjustments, discounts, and an allowance for uncollectibles should be recorded to initially measure the receivables for health care services at net realizable value.
FASB ASC 954-605-25-6 explains that estimates of contractual adjustments,
other adjustments, and the allowance for uncollectibles should be reported in
the period during which the services are provided, even though the actual
amounts may become known at a later date. FASB ASC 954-310-45-1 states
that although the aggregate amount of receivables may include balances due
from patients and third-party payors, including final settlements and appeals,
the amounts due from third-party payors for retroactive adjustments of items
such as final settlements or appeals should be reported separately in the financial statements.
10.40 Accounts receivable of health care entities generally are subject to
the same financial disclosure requirements as those of other business entities.
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Health care entities with loans and trade receivables follow the presentation
and disclosure guidance in FASB ASC 310-10 to the extent that guidance is
applicable.
10.41 Paragraphs 20–22 of FASB ASC 825-10-50 set forth disclosure requirements concerning significant concentrations of credit risk arising from
all financial instruments, including trade accounts receivable. Concentration
of credit risk frequently is an issue because most health care entities tend to
treat patients from their local or surrounding communities. Accordingly, disclosure is made of the primary service area of patients. It should be noted that
concentration of credit risk may be a significant issue in stand-alone financial
statements issued for a member hospital of a large, national multihospital system but may not be an issue for financial statements prepared for the hospital
system. When the individual facilities' financial statements are consolidated
into statements prepared for the entire system, the credit risk is dispersed over
a much larger base of health plans, patients, and geographies and, therefore,
is not as concentrated.
10.42 Off-balance-sheet risk exists when the potential accounting loss
from a financial instrument is not reflected on the balance sheet. Health care
entities (most notably hospitals) may enter into arrangements in which they
will factor or securitize their patient accounts receivable as a cash flow management strategy or to manage their concentrations of customer credit risk.
These arrangements may not qualify for sale transactions under the criteria of
FASB ASC 860, Transfers and Servicing. Consequently, the patient accounts
receivable and the corresponding financing obligation would be reflected on the
balance sheet of the health care entity. Health care entities should follow the
presentation and disclosure guidance in paragraphs 9–10 of FASB ASC 31010-50 regarding credit losses on off-balance-sheet instruments to the extent
that guidance is applicable.

Estimated Final Settlements
10.43 Under a retrospective rate-setting system, a health care entity may
be entitled to receive additional payments or required to refund amounts received in excess of amounts earned under the system. Although final settlements are not made until a subsequent period, as discussed in paragraphs
10.20–.24, they are usually subject to reasonable estimation and reported in
the financial statements in the period in which services are rendered.
10.44 For example, as noted in FASB ASC 954-310-05-3, some thirdparty payors retrospectively determine final amounts that are reimbursable
for services rendered to their beneficiaries based on allowable costs. These
payors reimburse the health care entity on the basis of interim payment rates
until the retrospective determination of allowable costs can be made. In most
instances, the accumulation and allocation of allowable costs and other factors
result in final settlements that are different from the interim payment rates.
Final settlements are determined after the close of the fiscal periods to which
they apply.
10.45 The balance sheet accounts "Settlements Due to Third-Party Payors" and "Settlements Due From Third-Party Payors" reflect management's
best estimate of amounts expected to be payable or receivable. As a result
of the complex nature of government reimbursement rules and the fact that
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settlements may occur years after the services are provided, it is not unusual
for actual settlement amounts to differ significantly from estimated amounts.
10.46 FASB ASC 954-605-35-1 requires that differences between original
estimates and subsequent revisions, including final settlements, be included
in the period in which the revisions are made. FASB ASC 954-605-50-2 states
that those differences should be disclosed. Those differences are not treated
as restatements of prior periods, unless they meet the definition of an error in
previously issued financial statements, as defined in FASB ASC 250, Accounting
Changes and Error Corrections.
10.47 As explained in paragraphs .15 and .17 of SOP 00-1, the fairness or
reasonableness of the financial statement presentation of estimates is not dependent on the outcome of the uncertainty (for example, management's ability
to predict the future with accuracy) but, rather, on the quality and nature of
the evidence supporting management's assertions at the time that the estimate
is made. The fact that future events may differ materially from management's
assumptions or estimates does not necessarily mean that management's estimates were not reasonable or valid at the time that they were made.
10.48 The likelihood for subsequent revisions of estimates, coupled with
their potential material effect on the financial statements, generally requires
disclosure in accordance with FASB ASC 275-10-50. Such disclosures might
include the significance of government program revenues to the entity's overall revenues and a description of the complex nature of applicable laws and
regulations indicating that the possibility of future government review and
interpretation exists. Paragraph .37 of SOP 00-1 provides a sample disclosure
for the possibility of material differences between an original estimate and
subsequent revisions.
10.49 FASB ASC 275-10-50-6 states that a discussion of estimates is required when, based on known information available before the financial statements are issued or available to be issued, it is reasonably possible that the
estimate will change in the near term, and the effect of the change will be
material. The estimate of the effect of a change in a condition, situation, or set
of circumstances that existed at the date of the financial statements should be
disclosed, and the evaluation should be based on known information available
before the financial statements are issued or available to be issued. In addition,
FASB ASC 954-405-50-1 requires that, with regard to contractual adjustments
and third-party settlements, identification and explanation of the estimated
amounts that are payable by the entity should be disclosed.
10.50 The Financial Reporting Executive Committee recommends that
the following additional disclosures also be included in the financial statements:

r
r
r

Disclose settlement amounts due to and from each significant
third-party payor.
For each significant third-party payor, provide a summary of activity for each operating period. The summary would distinguish
settlements relating to prior years from those relating to the current year's activity and would identify current-year changes to
settlement amounts estimated in prior periods.
Disclose the status of third-party settlement claims.

10.51 In accordance with FASB ASC 210-10-45, settlements due to or from
third-party payors should be classified as current or noncurrent, depending on
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the expected timing of the settlements. Settlements can be netted only if a right
of setoff exists, as described in FASB ASC 210-20-45.

Auditing
Note: This guide presents auditing guidance to help you implement
auditing standards included in both AICPA Professional Standards
and Public Company Accounting Oversight Board (PCAOB) professional standards. In citing the professional standards, references are
made to the AICPA's Professional Standards publication and the
AICPA's PCAOB Standards and Related Rules publication, depending
upon the applicable professional standards. Additionally, when referencing professional standards, this guide cites section numbers, not
the original statement number, as appropriate. For example, Statement on Auditing Standards No. 54, Illegal Acts by Clients (AICPA,
Professional Standards), is referred to as AU section 317.
10.52 In general, receivables, particularly those arising from health care
services, are material to the financial position of health care entities. Examples
of specific auditing objectives, selected control activities, and auditing procedures that may be considered by the independent auditor as they relate to the
major components of receivables of health care entities are presented in exhibit
10-1.
10.53 SOP 00-1 provides guidance to auditors in evaluating the reasonableness of management's estimates regarding the proper valuation of health
care third-party revenues and receivables embodied in the financial statements. SOP 00-1 is included as appendix B, "Statement of Position 00-1, Auditing Health Care Third-Party Revenues and Related Receivables," of this guide.
10.54 Paragraphs .17–.18 of SOP 00-1 state that the auditor's judgment
regarding the sufficiency and appropriateness of the evidence is based on the
evidence that is available or can reasonably be expected to be available in the
circumstances. If after considering the existing conditions and available evidence, the auditor concludes that the evidence is sufficient and appropriate
and supports management's assertions about the valuation of revenues and
receivables and their presentation and disclosure in the financial statements,
ordinarily, an unqualified opinion is appropriate. The inability to obtain relevant evidence that the auditor needs may require the auditor to express a
qualified opinion or disclaim an opinion because of a scope limitation.

Accounts Receivable Confirmations
10.55 Generally, the amount receivable for a patient's care is not determinable until the medical coding process is complete; thus, alternative procedures, rather than confirmation, are performed for receivables from patients
for whom care is continuing. Further, many patients whose accounts are expected to be paid by a third-party payor may not have received bills, and many
third-party payors may be unable to respond to confirmation requests on specific account balances. In addition, obtaining confirmation of receivables from
patients who are not discharged or final billed may be impracticable because
those patients may not yet know the amount of their indebtedness. However,
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there may be instances when direct confirmation may be an appropriate audit
procedure to be considered to obtain evidence about the existence and accuracy
of amounts that are due.
10.56 If confirmation of amounts that are due from patients and thirdparty payors is impracticable or determined not to be effective, the independent
auditor should document this decision in accordance with AU section 330,
The Confirmation Process (AICPA, Professional Standards), and should use
alternative procedures such as the following:

r
r
r
r
r

Performing an analytical procedure or testing the details of subsequent cash receipts
Reviewing third-party contracts or payment agreements
Comparing billings with documentation in medical records and
census data
Reviewing the results of third-party payor audits and, if available,
independent review or internal audit reports
Examining or confirming interim payments with third-party
payors
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Exhibit 10-1
The following table illustrates the use of assertions in developing audit objectives and designing substantive tests. The examples are not
intended to be all-inclusive nor is it expected that all the procedures
would necessarily be applied in an audit. The auditor should design
and perform substantive procedures for all relevant assertions related
to each material class of transactions, account balance, and disclosure
to obtain sufficient appropriate audit evidence. The use of assertions
in assessing risks and designing appropriate audit procedures to obtain audit evidence is described in paragraphs .14–.26 of AU section
326, Audit Evidence (AICPA, Professional Standards). Various audit
procedures and the purposes for which they may be performed are
described in paragraphs .27–.41 of AU section 326.

Auditing Considerations1
Financial Statement
Assertions

Specific Auditing
Objectives

Selected Control
Activities

Auditing
Procedures

Receivables for Health Care Services
Account Balances
Existence

Amounts reported
in the financial
statements
represent valid
receivables, which
do not include
charity care
balances.

Charges are
generated
automatically
when services are
performed.

Review and test
subsequent cash
receipts.

A medical record is Compare billing
prepared.
information to the
documentation
contained in the
medical records
or census records.
(continued)

1
Statement of Position (SOP) 00-1, Auditing Health Care Third-Party Revenues and Related
Receivables (AICPA, Technical Practice Aids, AUD sec. 14,360), discusses matters for auditors to
consider in testing third-party revenues and related receivables and provides guidance to auditors
regarding the sufficiency of evidential matter and reporting on financial statements of health care
entities exposed to material uncertainties. SOP 00-1 is included as appendix B, "Statement of Position
00-1, Auditing Health Care Third-Party Revenues and Related Receivables," of this guide.
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Auditing Considerations—continued
Financial Statement
Assertions

Completeness

AAG-HCO 10.56

Specific Auditing
Objectives

Amounts reported
in the financial
statements are
complete and
properly
calculated and
accumulated.

Selected Control
Activities

Auditing
Procedures

Procedures ensure
that amounts due
from third-party
payors for
individual
accounts are
properly
supported.

Review the
independent
review or internal
audit, if any, and
insurance
company reviews
for evidence that
might indicate
receivables may
not be realized.

Procedures ensure
the proper
recording of cash
receipts.

Trace the receipts
applicable to
patient accounts
to the accounts
receivable records.

Procedures ensure
that charity care
balances are
identified and
excluded from
gross receivables.

Review the
management
policy for
determining
charity care.
Review the
reasonableness of
charity care
measurement.

Procedures ensure
that (a) detailed
accounts
receivable records
are routinely
compared with
control accounts
and third-party
payor logs; (b)
differences are
investigated and
reconciled; and (c)
adjustments, if
necessary, are
promptly made.

Compare detailed
accounts
receivable records
with control
accounts and
third-party payor
logs, and
investigate
reconciling items.
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Financial Statement
Assertions

Specific Auditing
Objectives

Selected Control
Activities

Auditing
Procedures

Valuation and
allocation

Receivables are
reported in the
financial
statements at net
realizable value.

Allowances for
uncollectibles and
contractual
adjustments are
periodically
reviewed by
management to
ensure that
receivables are
reported at
estimated net
realizable value.

Review
third-party
contracts, and
recompute patient
receivables.
Examine contracts
or confirm interim
third-party
payments with
third-party
payors.

Write-offs and
allowances for
uncollectibles are
identified and
approved in
accordance with
the entity's
established policy.

Review and test
the method used
to determine the
allowances for
uncollectible
accounts.

Determine that
patient accounts
are appropriately
classified by payor
(for example,
Medicare or
self-pay) to
evaluate
collectibility.
Test Medicare logs
for accuracy and
completeness.
Test and analyze
aged accounts
receivable trial
balances,
collection trends,
delinquent
accounts,
subsequent period
write-offs, and
economic or other
factors used to
determine the
allowance for
uncollectible
accounts.
(continued)
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Auditing Considerations—continued
Financial Statement
Assertions

Specific Auditing
Objectives

Selected Control
Activities

Auditing
Procedures

Presentation and Disclosure
Classification and
understandability

Determine that
significant
contractual
arrangements
with third parties
are disclosed.

Significant
contractual
arrangements
with third parties
are disclosed.

Estimated Third-Party Settlements
Account Balances
Existence

Amounts reported
in the financial
statements
represent valid
receivables or
payables, or both.

Procedures ensure
that estimated
third-party
settlements are
determined in
accordance with
the
reimbursement
and rate-setting
methodologies
applicable to the
entity.

Review
correspondence
from significant
third-party payors
related to (a)
interim payment
rates applicable to
periods for which
final settlements
have not been
made and (b) the
amount of interim
or final
settlements made
during the period.

Amounts
included in the
financial
statements are
accurate and
complete.

Procedures ensure
that estimated
third-party
settlements are
reasonably
calculated and
reported.

Test the
reasonableness of
settlement
amounts,
including specific
and unallocated
reserves, in light
of the involved
payors, the nature
of the payment
mechanism, the
risks associated
with future audits,
and other relevant
factors.

Transactions
Completeness and
accuracy and
valuation and
allocation
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Financial Statement
Assertions

Specific Auditing
Objectives

Selected Control
Activities

Auditing
Procedures
Review
third-party payor
audit reports and
adjustments for
prior years' cost
reports or
settlements to
consider whether
(a) the effect of
such adjustments
has been properly
reported in the
financial
statements and (b)
adjustments of a
similar nature
apply to the
current period.
Obtain a
representation
from management
that provisions for
estimated
retroactive
adjustments by
third-party payors
under
reimbursement
agreements for
open years are
adequate.

Presentation and Disclosure
Classification and
understandability

Amounts reported
in the financial
statements are
properly
presented, and all
required
disclosures are
made.

Determine that
the tentative
nature of
third-party
settlement
amounts is
properly
disclosed.
(continued)
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Auditing Considerations—continued
Financial Statement
Assertions

Specific Auditing
Objectives

Selected Control
Activities

Auditing
Procedures
Determine that
differences
between original
estimates and
subsequent
revisions,
including final
settlements, are
included in the
statement of
operations in the
period in which
the revisions are
made and
disclosed, if
material.

Revenue and Gains for Health Care Services
Transactions, Account Balances, Presentation, and Disclosure
Existence and
occurrence,
completeness, and
classification and
understandability

AAG-HCO 10.56

Revenue and
gains are
reported in the
proper period
using the accrual
basis of
accounting and
are properly
classified by the
type of service
rendered.

Procedures help
ensure that
revenue is accrued
as services are
performed or
contractual
obligations are
satisfied.

Perform a
walk-through of
the revenue
system.
Compare the
current period's
revenue with prior
periods' revenue
or budgets, or
both, and obtain
explanations for
large or unusual
variances.

Management
establishes and
monitors controls
over the
recognition of
revenue.

Consider the
adequacy of the
controls over the
revenue
recognition
process.

Health Care Service Revenue and Related Receivables
Financial Statement
Assertions

Specific Auditing
Objectives

Selected Control
Activities

In the statement
of operations,
revenue from
health care
services is
reported net of
contractual
adjustments and
other
adjustments in
the proper period
and is properly
classified.

Controls ensure
that deductions
from revenue are
recorded in the
proper period and
properly classified.
Contractual and
other adjustments
are authorized,
controlled, and
properly recorded.
Charity care,
bad-debt
write-offs, and
courtesy and
policy discounts
are authorized,
controlled, and
properly recorded.
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Auditing
Procedures
Review the
financial
statements to
determine that
revenue is
reported net of
contractual
adjustments and
other
adjustments.
Test contractual
adjustments, other
adjustments, and
bad debts to
determine that
they are accounted
for both in
accordance with
the respective
contracts and the
entity's policy.
Review
third-party payor
contracts and
methods of
payment, and test
the entity's
computation of
estimated
adjustments to
revenue as
required under
such contracts.
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Chapter 11

Contributions Received and Made
11.01 Health care entities that receive contributions are subject to the
requirements of the "Contributions Received" sections of Financial Accounting
Standards Board (FASB) Accounting Standards Codification (ASC) 958-605.
Health care entities that make contributions are subject to the requirements
of FASB ASC 720-25.

Contributions Received
11.02 FASB ASC 958-605-25-2 states that except as provided for contributed services and art collections, contributions received should be recognized as revenues or gains in the period received and as assets, decreases of
liabilities, or expenses depending on the form of the benefits received. FASB
ASC 958-605-55-26 observes that contributions are received in several different forms. Most often, the contributed item is an asset, but it also can be
forgiveness of a liability. The types of assets commonly contributed include
cash, marketable securities, land, buildings, the use of facilities or utilities,
materials and supplies, intangible assets, other goods or services, and unconditional promises to give those items in the future. FASB ASC 958-605-30-2
requires that contributions received be measured at their fair values. FASB
ASC 820, Fair Value Measurements and Disclosures, establishes a framework
for measuring fair value.*
11.03 Accounting for contributions depends on whether the transfer of
assets is received by the not-for-profit entity with donor-imposed conditions,
donor-imposed restrictions, or both. Donor-imposed conditions create a barrier
that must be overcome before a contribution can be recognized; by definition,
a contribution is unconditional. Donor-imposed restrictions do not affect recognition; instead, they affect the classification of the contribution revenue.
11.04 Donations received without restrictions attached are reported as
unrestricted support in the statement of operations within the performance
indicator. Donations with explicit donor restrictions attached are reported as
restricted support. Some restrictions permanently limit the not-for-profit entity's use of contributed assets (for example, permanent endowments). Other
restrictions are temporary in nature, limiting the not-for-profit entity's use of
contributed assets to (a) later periods or after specific dates (time restrictions),
*
In May 2011, the Financial Accounting Standards Board (FASB) issued Accounting Standards
Update (ASU) No. 2011-04, Fair Value Measurement (Topic 820): Amendments to Achieve Common
Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs. According to FASB,
the objective of this update is to improve the comparability of fair value measurements presented
and disclosed in financial statements prepared in accordance with U.S. generally accepted accounting
principles (GAAP) and International Financial Reporting Standards (IFRSs) by changing the wording
used to describe many of the requirements in U.S. GAAP for measuring fair value and disclosing
information about fair value measurements. The amendments include those that clarify FASB's
intent about the application of existing fair value measurement and disclosure requirements and those
that change a particular principle or requirement for measuring fair value or disclosing information
about fair value measurements. This ASU, which is to be applied prospectively, is effective for public
entities during interim and annual periods beginning after December 15, 2011 (early application is
not permitted). For nonpublic entities, the amendments are effective for annual periods beginning
after December 15, 2011. Nonpublic entities may early implement during interim periods beginning
after December 15, 2011.
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(b) specific purposes (purpose restrictions), or (c) both. As noted in paragraph
3.17 of this guide, items that reflect increases or decreases in temporarilyrestricted or permanently-restricted net assets are reported in the statement
of changes in net assets, rather than the statement of operations.

Contributions of Long-Lived Assets, the Use of Long-Lived Assets,
or Resources to Acquire Them
11.05 Contributions of long-lived assets, including the use of long-lived
assets such as land, buildings, and equipment, are reported as support or gains
in the period received. The donation is measured at its fair value. In accordance
with FASB ASC 958-605-45-6, in the absence of donor-imposed restrictions on
the use of the asset, gifts of long-lived assets should be reported as unrestricted
support. Contributions of long-lived assets with explicit donor restrictions are
reported as temporarily- or permanently-restricted support.
11.06 Donations of cash or other assets that must be used to acquire
long-lived assets are reported as temporarily-restricted support in the period
received. In accordance with FASB ASC 958-210-45-6, cash or other assets received with a donor-imposed restriction that limits their use to long-term purposes should not be classified with cash or other assets that are unrestricted
and available for current use. Consistent with FASB ASC 958-205-55-7, those
items are reported as assets restricted to investment in land, buildings, and
equipment and are sequenced closer to land, buildings, and equipment. See
paragraph 4.08 of this guide for additional discussion of restricted assets. Pursuant to FASB ASC 958-210-50-3, when the title "Assets Whose Use Is Limited"
is used on the face of the statement of financial position, the kind of asset (that
is, cash, receivables, investments, and so forth) is required to be described in
the notes to the financial statements because its nature is not clear from the
description on the face of the statement of financial position.
11.07 FASB ASC 954-205-45-9 states that the expiration of donor-imposed
restrictions on long-lived assets should be recognized when the asset is placed
in service, rather than as depreciated, as permitted by FASB ASC 958-20545-12. Thus, if contributions of long-lived assets with explicit donor restrictions are reported as temporarily-restricted support, a not-for-profit health
care provider reports expirations of those donor restrictions when the stipulation is fulfilled, and the assets are placed in service. Similarly, donations of cash
or other assets that must be used to acquire long-lived assets are reported as
temporarily-restricted support in the period received, and expirations of those
donor restrictions are reported when the acquired long-lived assets are placed
in service, and donor-imposed restrictions are satisfied.

Contributed Services
11.08 The nature and extent of donated services received by health care
entities varies and can range from the limited participation of many people in
fund-raising activities to active participation in the entity's service programs.
11.09 FASB ASC 958-605-25-16 requires that contributions of services be
recognized if the services received meet any of the following criteria:
a. They create or enhance a nonfinancial asset. The FASB ASC glossary defines a nonfinancial asset as "[a]n asset that is not a financial
asset. Nonfinancial assets include land, buildings, use of facilities
or utilities, materials and supplies, intangible assets, or services."
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b. They require specialized skills, are provided by individuals possessing those skills, and would typically need to be purchased if
they are not provided by donation. Services requiring specialized
skills are provided by accountants, architects, carpenters, doctors,
electricians, lawyers, nurses, plumbers, teachers, and other professionals and craftspeople.
11.10 FASB ASC 958-605-25-16 states that contributed services and
promises to give services that do not meet these criteria should not be recognized. Additional guidance with regard to the accounting for, and reporting
of, contributed services is provided in paragraphs 52–68 of FASB ASC 958-60555.

Expiration of Donor-Imposed Restrictions
11.11 Paragraphs 9–12 of FASB ASC 958-205-45 and FASB ASC 958225-45-13 provide guidance for reporting reclassifications for the expiration of
donor-imposed restrictions. A restriction expires when the stipulated time has
elapsed, when the stipulated purpose for which the resource was restricted has
been fulfilled, or both. If two or more temporary restrictions are imposed on a
contribution, the effect of the expiration of those restrictions should be recognized in the period in which the last remaining restriction has expired. When
the restriction expires, the temporarily-restricted net assets are reclassified to
unrestricted net assets and reported in the statement of operations as "Net Assets Released From Restriction." In accordance with FASB ASC 958-225-45-3,
reclassifications are presented as separate items.
11.12 FASB ASC 958-605-45-4 states that donor-restricted contributions
whose restrictions are met in the same reporting period may be reported as
unrestricted support, provided that a not-for-profit health care entity has a
similar policy for reporting investment gains and income, as explained in FASB
ASC 958-320-45-3; reports consistently from period to period; and discloses its
accounting policy.
11.13 Paragraph 11.26 provides guidance for the expiration of restrictions
on unconditional promises to give. Paragraphs 9.19–.24 of this guide provide
guidance for the expiration of other donor-imposed restrictions.

Distinguishing Contributions From Exchange Transactions
11.14 FASB ASC 958-605-55-4 states that foundations, business entities,
and other types of entities may provide resources to health care entities under
programs referred to as grants, awards, or sponsorships. Those asset transfers
are contributions if the resource providers receive no value in exchange for the
transferred assets or if the value received by the resource provider is incidental
to the potential public benefit from using the transferred assets.
11.15 Because some exchange transactions may appear to be much like
contributions, a careful assessment of the characteristics of the transaction
from the perspectives of both the resource provider and recipient is required to
determine whether the recipient of a transfer of assets has given up an asset or
incurred a liability of commensurate value. Additional guidance can be found
in FASB ASC 958-605-55-8.
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11.16 For example, a research grant made by a foundation to a hospital
would likely be a contribution if the research program is to be planned and
carried out by the hospital, and the hospital has the right to publish the results.
However, if the grant is made by a pharmaceutical manufacturer that provides
potential new medications to be tested in the hospital's research facilities and
retains the right to any patents or other results, the grant would likely be an
exchange transaction.
11.17 As noted in FASB ASC 958-605-55-6, a single transaction may be in
part an exchange and in part a contribution. For example, if a donor transfers
a building to an entity at a price significantly lower than its market value,
and no unstated rights or privileges are involved, the transaction is in part an
exchange of assets and in part a contribution to be accounted for as required
by the "Contributions Received" sections of FASB ASC 958-605.

Reporting the Cost of Special Events and Other
Fund-Raising Activities
11.18 Some health care entities conduct fund-raising or joint activities,
including special social and educational events, such as symposia, dinners,
dances, and theater parties, in which the attendee receives a direct benefit (for
example, a meal or theater ticket).
11.19 FASB ASC 958-225-45-17 states that a not-for-profit health care
entity may report net amounts for its special events if they result from peripheral or incidental transactions. However, so-called special events often are
ongoing and major activities; if so, a not-for-profit health care entity should
report the gross amounts of revenues and expenses of those activities. Costs
netted against receipts from peripheral or incidental special events should be
limited to direct costs.
11.20 Paragraphs 11–15 of FASB ASC 958-225-55 illustrate three possible
methods to display a special event that is an ongoing and major activity. Health
care entities may report the gross revenues of special events and other fundraising activities, with the cost of direct benefits to donors (for example, meals
and facilities rental) displayed either (a) as a line item deducted from the
special event revenues or (b) in the same section of the statement of operations
as other programs or supporting services, allocated, if necessary, among those
various functions. Alternatively, the health care entity could consider revenue
from special events and other fund-raising activities as part exchange (for the
fair value the participant received) and part contribution (for the excess of the
payment over that fair value) and report the two parts separately.

Promises to Give in Future Periods (Pledges)
11.21 Health care entities involved in fund-raising campaigns frequently
are the recipients of promises to give, with payments due in future periods.
Pledge drives are a common example. Health care entities may also be the
beneficiaries of fund-raising campaigns conducted by others.
11.22 FASB ASC 958-310 and 958-605 establish the accounting and financial reporting guidance for promises to give (contributions receivable). A general summary of those standards is presented subsequently but is not intended
as a substitute for reading the standards themselves. Additional guidance is
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provided in chapter 5, "Contributions Received and Agency Transactions," of
the Audit and Accounting Guide Not-for-Profit Entities.
11.23 The recognition guidance in paragraphs 7–15 of FASB ASC 958605-25 depends on whether the promise to give is unconditional or conditional.
That guidance is summarized in the next two paragraphs but is not intended
as a substitute for reading the standards themselves.
11.24 Conditional promises to give, which depend on the occurrence of a
specified future and uncertain event to bind the promisor, should be recognized
when the conditions on which they depend are substantially met (that is, when
the conditional promise becomes unconditional). Imposing a condition creates a
barrier that must be overcome before the recipient of the transferred assets has
an unconditional right to retain those promised assets. For example, a transfer
of cash with a promise to contribute that cash if a like amount of new gifts is
raised from others within 30 days and a provision that the cash be returned if
the gifts are not raised imposes a condition on which a promised gift depends.
A transfer of assets with a conditional promise to contribute them should be
accounted for as a refundable advance (that is, a liability) until the conditions
have been substantially met or explicitly waived by the donor.1
11.25 An unconditional promise to give should be recognized when it is
received. However, to be recognized, there must be sufficient evidence in the
form of verifiable documentation that a promise was made and received. According to FASB 958-605-45-5, contributions of unconditional promises to give,
with payments due in future periods, should be reported as restricted support,
unless explicit donor stipulations or circumstances surrounding the receipt of
a promise make clear that the donor intended it to be used to support activities of the current period. It is reasonable to assume that by specifying future
payment dates, donors indicate that their gift is to support activities in each
period in which a payment is scheduled. For example, receipts of unconditional
promises to give cash in future years generally increase temporarily-restricted
net assets.
11.26 The expiration of those restrictions or the expiration of a portion of
the restriction is recognized as the donor makes the future payment(s). If the
promise is to be paid in one future payment, the related temporarily-restricted
net assets will be transferred to unrestricted net assets in the period in which
that payment is due. If the donor sets forth a schedule of future payments,
a reclassification from temporarily-restricted net assets to unrestricted net
assets is made in each period that a payment is due. If other explicit donor
restrictions are attached to the promise, such as that the gift be used for a
specific purpose, the expiration of the restriction is recognized in the time period
in which the purpose restriction has been fulfilled because, as noted in FASB
ASC 958-205-45-11, temporarily-restricted net assets with time restrictions
are not available to support expenses until the time restrictions have expired.
In the period(s) in which the restrictions expire, temporarily-restricted net
assets or the portion of the temporarily-restricted net assets that relate to the
1
According to FASB Accounting Standards Codification (ASC) 958-605-25-12, a conditional
promise to give is considered unconditional if the possibility that the condition will not be met is
remote. FASB ASC 958-605-25-14 states that in cases of ambiguous donor stipulations, a promise
containing stipulations that are not clearly unconditional should be presumed to be a conditional
promise. Additional guidance on distinguishing conditional promises from unconditional promises
is provided in paragraphs 14–15 of FASB ASC 958-605-25 and paragraphs 15–17 of FASB ASC
958-605-55.
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particular payment installment are reclassified to unrestricted net assets and
reported in the statement of operations as net assets released from restriction.
11.27 Paragraphs 4–7 of FASB ASC 958-605-30 provide guidance for initially measuring unconditional promises to give. If present value techniques
are used to measure the fair value of unconditional promises to give, a not-forprofit entity should determine the amount and timing of the future cash flows of
unconditional promises to give cash or, for promises to give noncash assets, the
quantity and nature of assets expected to be received. In determining the estimated future cash flows of unconditional promises to give cash, not-for-profit
entities should consider all the elements in FASB ASC 820-10-55-5, including
the following: (a) when the receivable is expected to be collected; (b) the creditworthiness of the other parties; (c) the entity's past collection experience and
its policies concerning the enforcement of promises to give; (d) expectations
about possible variations in the amount or timing of the cash flows (that is, the
uncertainty inherent in the cash flows); and (e) other factors concerning the
receivable's collectability. Unconditional promises to give that are expected to
be collected in less than one year may be measured at their net realizable value
because that amount results in a reasonable estimate of fair value.
11.28 Paragraphs 4–13 of FASB 958-310-35 discuss the subsequent measurement of contributions receivable. According to FASB ASC 958-310-35-7,
if the fair value of a contribution receivable decreases because of changes in
the quantity or nature of assets expected to be received, the decrease should
be recognized in the period(s) in which the expectation changes. That decrease
should be reported as an expense or a loss (bad debt), in accordance with FASB
ASC 958-310-45-3.2 According to FASB ASC 958-310-35-6, if an unconditional
promise to give cash is initially measured using a present value technique, subsequent accruals of the interest element should be accounted for as contribution
revenue by donees, pursuant to FASB ASC 835-30-35.
11.29 If a health care entity routinely conducts fund drives, an estimate of
the future cash flows of a portfolio of short-term unconditional promises to give
resulting from a mass fund-raising appeal may be made based on experience
gained from similar appeals in prior years.

Investments Gain or Loss Related to Donor-Restricted
Contributions
11.30 Chapter 4, "Cash, Cash Equivalents, and Investments," of this guide
discusses the classification of dividend, interest and other investment income,
and gains and losses. Chapter 9, "Net Assets (Equity)," of this guide discusses
the classification of the net assets of donor-restricted endowment funds.

Transfers of Assets to a Not-for-Profit Organization or Charitable
Trust That Raises or Holds Contributions for Others
11.31 The "Transfers of Assets to a Not-for-Profit Entity or Charitable
Trust That Raises or Holds Contributions for Others" sections of FASB ASC
958-605 establish standards for transactions in which an entity (donor) makes
a contribution by transferring assets to a not-for-profit entity or charitable
2
According to FASB ASC 958-310-45-3, because all expenses are reported as decreases in the
unrestricted net asset class, those decreases should be reported as losses if they are decreases in
temporarily-restricted or permanently-restricted net assets.
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trust (recipient entity) that accepts the assets from the donor and agrees to use
the assets on behalf of another entity or transfer those assets, the return on
investment of those assets, or both to another entity (the beneficiary) that is
specified by the donor.3
11.32 Federated fund-raising organizations, community foundations, and
institutionally-related entities are examples of not-for-profit entities that commonly serve as recipient entities, such as agents, trustees, or intermediaries,
but any not-for-profit entity or charitable trust can function in that capacity.
Not-for-profit health care entities often are the ultimate recipients (for example, specified beneficiaries of the contribution or grant).
11.33 Paragraphs 28–30 of FASB ASC 958-605-25 provide guidance for
recognition by the specified beneficiary of the transfer of assets from the donor.
A specified beneficiary should recognize its rights to the financial or nonfinancial assets held by a recipient entity as an asset, unless the recipient entity
is explicitly granted variance power, as discussed in paragraph 11.34. Those
rights are any one of the following:
a. An interest in the net assets of the recipient entity, as discussed in
paragraph 11.35
b. A beneficial interest, as discussed in paragraph 11.36
c. A receivable, as discussed in paragraph 11.37
11.34 The FASB ASC glossary defines variance power as
[t]he unilateral power to redirect the use of the transferred assets to
another beneficiary. A donor explicitly grants variance power if the
recipient entity's unilateral power to redirect the use of the assets is
explicitly referred to in the instrument transferring the assets. Unilateral power means that the recipient entity can override the donor's
instructions without approval from the donor, the specified beneficiary, or any other interested party.
As discussed in FASB ASC 958-605-25-31, if the donor explicitly grants a
recipient entity variance power, and the specified beneficiary is not an affiliate
of the recipient entity or the donor, the specified beneficiary (not-for-profit
health care entity) should not recognize its potential for future distributions
from the assets held by the recipient entity. Those future distributions, if they
occur, should be recognized as contributions by the specified beneficiary (health
care organization) when received or unconditionally promised.
11.35 If a recipient entity and specified beneficiary are financially interrelated entities (see paragraph 12.75 of this guide), and the recipient entity is
not a trustee, FASB ASC 958-605-25-27 states that the recipient entity should
recognize a contribution received when it receives assets (financial or nonfinancial) from the donor that are specified for the beneficiary. FASB ASC 958-20-25
provides the following example. A foundation that exists to raise, hold, and
invest assets for the specified beneficiary or a group of affiliates of which the
3
The "Transfers of Assets to a Not-for-Profit Entity or Charitable Trust that Raises or Holds
Contributions for Others" sections of FASB ASC 958-605 also establish standards for transactions
that take place in a similar manner but are not contributions because the transfers are revocable,
repayable, or reciprocal. For example, if a resource provider transfers assets to a recipient organization
and names itself or its affiliate as beneficiary, that transaction is reciprocal, even if the resource
provider grants variance power. Those reciprocal transactions are discussed in chapters 4, "Cash,
Cash Equivalents, and Investments," and 12, "The Reporting Entity and Related Entities," of this
guide.
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specified beneficiary is a member generally is financially interrelated with the
not-for-profit entity(ies) it supports. The foundation should recognize contribution revenue when it receives assets from the donor. Pursuant to FASB ASC
958-20-25-2, the beneficiary should recognize its interest in the net assets of
the recipient entity and adjust that interest for its share of the change in net
assets of the recipient entity using a method similar to the equity method of
accounting for investments in common stock.4 Examples 1–3 in paragraphs
3–17 of FASB ASC 958-20-55 provide examples of this guidance. Appendix A,
"TIS Section 6400, Health Care Entities," of this chapter provides guidance for
the classification of a beneficiary's interest in the net assets of a financiallyinterrelated fund-raising foundation.
11.36 If the beneficiary has an unconditional right to receive all or a portion of the specified cash flows from a charitable trust or other identifiable pool
of assets, the beneficiary should recognize that beneficial interest. Pursuant
to FASB ASC 958-605-30-14 and 958-605-45-35-3, the beneficiary recognizes
that beneficial interest as an asset and a contribution received, measuring and
subsequently remeasuring it at fair value.
11.37 FASB ASC 958-605-25-30 states that if the beneficiary's rights are
neither an interest in the net assets of the recipient entity nor a beneficial
interest, the beneficiary should recognize its rights to the assets held by a
recipient entity as a receivable and contribution revenue, in accordance with
paragraphs 8–10 of FASB ASC 958-605-25 and FASB ASC 958-605-45-5 for
unconditional promises to give. Paragraphs 11.21–.29 discuss the recognition
of promises to give.
11.38 Additional information about transfers of assets to a not-for-profit
entity or charitable trust that raises or holds contributions for others is found
in chapters 4, "Cash and Cash Equivalents" (for investments held by others)
and 5 (for accounting and reporting by the recipient entity) of the Audit and
Accounting Guide Not-for-Profit Entities.

Contributions Made
11.39 FASB ASC 720-25 states that contributions made should be recognized as expenses in the period made and decreases of assets or increases of
liabilities, depending on the form of the benefits given. For example, gifts of
items from inventory held for sale are recognized as decreases of inventory and
contribution expenses, and unconditional promises to give cash are recognized
as payables and contribution expenses. For guidance on conditional promises
to give and determining whether a promise is conditional or unconditional, see
paragraphs 11–15 of FASB ASC 958-605-25 and FASB ASC 958-605-25-33. See
paragraphs 45–48 of FASB ASC 958-605-55 for an example that illustrates a
donor's accounting for an unconditional promise to give. Contributions made
are measured at fair value. If the fair value of a transferred asset differs from
its carrying amount, a gain or loss should be recognized on the disposition of
the asset, as discussed in paragraphs 1–2 of FASB 845-10-30.

Other Considerations
11.40 A split-interest agreement is a form of contribution in which a
not-for-profit entity receives benefits that are shared with other beneficiaries
4
FASB ASC 958-20-55-11 states that an interest in the net assets of an affiliate would be
eliminated if that affiliate was included in consolidated financial statements of the interest holder.

AAG-HCO 11.36

Contributions Received and Made

181

designated by the donor. Common kinds of such agreements include charitable lead and remainder trusts, charitable gift annuities, and pooled (life)
income funds. The special accounting for split-interest agreements is discussed
in FASB ASC 958-30 and chapter 6, "Split-Interest Agreements," of the Audit
and Accounting Guide Not-for-Profit Entities.
11.41 The majority of the disclosures for contributions receivable and
transfers of assets to a not-for-profit entity that raises or holds contributions
for others are located in FASB ASC 958-310-50 and 958-605-50. The following
paragraphs discuss the more common of those disclosures but are not intended
as a substitute for the "Disclosures" sections of FASB ASC 958, Not-for-Profit
Entities.
11.42 Contributions receivable should be reported net of an allowance for
uncollectible amounts. That allowance may be based on the receivable's age,
the creditworthiness of the parties, the entity's past collection experience and
its policies concerning the enforcement of promises to give, and other factors
concerning the receivable's collectability. After the date of initial measurement,
bad debt expense should be reported for the amount of promises to give that
are expected to be uncollectible.
11.43 In accordance with FASB ASC 958-310-45-1, contributions receivable should be reported net of the discount that arises if measuring a promise
to give at present value. The discount should be separately disclosed by reporting it as a deduction from contributions receivable either on the face of the
statement of financial position or in the notes to financial statements.
11.44 FASB ASC 958-310-50-1 requires that a health care entity that
is the recipient of unconditional pledges (promises to give in future periods)
disclose the following:
a. The amounts of promises receivable in less than one year, in one to
five years, and in more than five years
b. The amount of the allowance for uncollectible promises receivable
c. The discount that arises if measuring a promise to give at present
value, if that discount is not separately disclosed by reporting it
as a deduction from contributions receivable on the face of the
statement of financial position, pursuant to FASB ASC 958-31045-1
11.45 FASB ASC 958-310-50-4 requires that a health care entity that is
the recipient of conditional pledges (promises to give in future periods) disclose
both of the following:
a. The total of the amounts promised
b. A description and amount for each group of promises having similar characteristics, such as amounts of promises conditioned on
establishing new programs, completing a new building, or raising
matching gifts by a specified date
11.46 Pursuant to FASB ASC 958-205-50-3, if a not-for-profit health care
entity discloses in its financial statements a ratio of fund-raising expenses to
amounts raised, it also should disclose how it computes that ratio.
11.47 When reporting unrestricted contributions, not-for-profit health
care entities should apply the standards in paragraphs 4–7 of FASB ASC
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954-225-45 to determine whether contributions are reported within or outside
the performance indicator.

Auditing
11.48 Because investor-owned entities do not usually receive contributions or enter into agency transactions, the specific audit objectives; selected
controls; and auditing procedures related to contributions, contributions receivable, and agency transactions are unique to not-for-profit entities and presented
in the following paragraphs.
11.49 A not-for-profit health care entity that receives a significant amount
of contributions may have an increased risk of material misstatement if it does
not have proper internal controls in place. Paragraph .54 of AU section 314,
Understanding the Entity and Its Environment and Assessing the Risks of Material Misstatement (AICPA, Professional Standards), states that obtaining an
understanding of internal control involves evaluating the design of a control
and determining whether it has been implemented. Evaluating the design of
a control involves considering whether the control, individually or in combination with other controls, is capable of effectively preventing or detecting and
correcting material misstatements. Implementation of a control means that the
control exists, and the entity is using it. An improperly designed control may
represent a significant deficiency or material weakness in the entity's internal
control, and the auditor should consider whether to communicate this to those
charged with governance and management.
11.50 In order to have an effective system of internal control, a not-forprofit health care entity that receives significant amounts of contributions
should have an internal control system that provides effective controls to ensure that all contributions received are recorded, and suitable collection efforts
are pursued for unconditional promises to give. The internal control system
also should provide effective controls to ensure that revenues arising from
conditional promises to give are recognized when the conditions have been
substantially met, and restrictions on contributions are recognized in the appropriate net asset class.
11.51 Contributions received are measured at fair value. AU section 328,
Auditing Fair Value Measurements and Disclosures (AICPA, Professional Standards), addresses audit considerations relating to the measurement and disclosure of assets, liabilities, and specific components of equity presented or
disclosed at fair value in financial statements. Interpretation No. 1, "Auditing
Interests in Trusts Held by a Third-Party Trustee and Reported at Fair Value,"
of AU section 328 (AICPA, Professional Standards, AU sec. 9328 par. .01–.04),
provides guidance for auditing interests in trusts held by a third-party trustee.
11.52 Paragraph .34 of AU section 330, The Confirmation Process (AICPA,
Professional Standards), states that confirmation of accounts receivable is a
generally accepted auditing procedure and that a presumption exists that the
auditor will request the confirmation of accounts receivable, except under certain specified circumstances. That paragraph defines accounts receivable as (a)
the entity's claims against customers that have arisen from the sale of goods or
services in the normal course of business and (b) a financial institution's loans.
Although under that definition contributions receivable are not accounts receivable to which that presumption would apply, the auditor may nevertheless
decide to request confirmation of contributions receivable.
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11.53 Receivables are usually principally confirmed to provide evidence
about the existence assertion. FASB ASC 958-605-25-8 specifies that for a
promise to give to be recognized in financial statements, there must be sufficient
evidence in the form of verifiable documentation that a promise was made and
received. If the documentation is not present, an asset should not be recognized.
The verifiable documentation for recognition of promises to give may not be
sufficient evidence concerning the existence assertion. Confirming recorded
promises to give (contributions receivable) may provide additional evidence
about the existence of promises to give, the existence or absence of restrictions
or conditions, and the periods over which the promises to give become due. If
the auditor confirms promises to give, AU section 330 provides requirements
and guidance concerning the confirmation process.
11.54 The following table illustrates the use of assertions in developing
audit objectives and designing substantive tests. The examples are not intended
to be all-inclusive nor is it expected that all the procedures would necessarily
be applied in an audit. The auditor should design and perform substantive
procedures for all relevant assertions related to each material class of transactions, account balance, and disclosure to obtain sufficient appropriate audit
evidence. The use of assertions in assessing risks and designing appropriate
audit procedures to obtain audit evidence is described in paragraphs .14–.26 of
AU section 326, Audit Evidence (AICPA, Professional Standards). Various audit procedures and the purposes for which they may be performed are described
in paragraphs .27–.41 of AU section 326.

AAG-HCO 11.54

184

Health Care Entities

Exhibit 11-1

The following table illustrates the use of assertions in developing audit objectives and designing substantive tests. The examples are not
intended to be all-inclusive nor is it expected that all the procedures
would necessarily be applied in an audit. The auditor should design
and perform substantive procedures for all relevant assertions related
to each material class of transactions, account balance, and disclosure
to obtain sufficient appropriate audit evidence. The use of assertions
in assessing risks and designing appropriate audit procedures to obtain audit evidence is described in paragraphs .14–.26 of AU section
326, Audit Evidence (AICPA, Professional Standards). Various audit
procedures and the purposes for which they may be performed are
described in paragraphs .27–.41 of AU section 326.
Auditing Considerations
Financial
Statement
Assertions

Specific Audit
Objectives

Selected Controls
Activities

Auditing
Procedures

Transactions
Contributions Received
Occurrence

Amounts
recognized as
contribution
revenues represent
valid
unconditional
contributions.

Controls ensure
that only
unconditional
contributions are
recognized in the
financial
statements.

Examine
documentation
supporting the
recognition of
contribution
revenues, noting
information such
as the absence of
conditions.

Completeness

All unconditional
contributions are
recognized.

Controls ensure
that all
unconditional
contributions are
recognized in the
financial
statements.
Controls ensure
that revenue is
recognized when
the conditions on
conditional
promises to give
have been
substantially met.

Select from data
accumulated and
maintained by the
fund-raising
function, and
determine whether
a contribution
should have been
recognized and, if
so, vouch it to a
recognized
contribution,
investigating
reconciling items.
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Financial
Statement
Assertions

Specific Audit
Objectives

Selected Controls
Activities

Auditing
Procedures

Valuation
and
allocation

Contribution
revenues are
appropriately
valued.

Controls ensure the
appropriate
valuation of
contribution
revenue at the time
of initial
recognition.

Review and test
the methods and
assumptions used
to measure
contribution
revenue at the
time of initial
recognition.

Cut-off

Contributions are
reported in the
period in which
they were given.

Controls ensure that
contributions
occurring near fiscal
period-end are
recorded in the
proper period.

Examine
contributions
reported before
and after fiscal
period-end to
determine if they
are reported in the
appropriate period.

Contributed Services, Utilities, Facilities, and Use of Long-Lived Assets
Occurrence,
completeness,
valuation and
allocation

Assets, expenses,
and revenues from
contributed
services, utilities,
facilities, and use
of long-lived
assets meet the
appropriate
recognition
criteria; all such
contributions that
meet the
recognition
criteria are
recognized and
appropriately
measured.

Controls ensure that
only contributed
services, utilities,
facilities, and use of
long-lived assets
that meet the
appropriate
recognition criteria
are recognized;
controls ensure that
all such
contributions that
meet the recognition
criteria are
recognized and
appropriately
measured.

Review the
documentation
underlying the
recognition of
contributed
services, utilities,
facilities, and use
of long-lived assets
for completeness
and propriety of
recognized
amounts.

Controls ensure that
only unconditional
contributions made
and promises to give
are recognized in
the financial
statements.

Examine
documentation
supporting the
recognition of
contributions
made, including
notification of the
donee and whether
the contribution is
conditional or
unconditional.

Contributions Made
Occurrence

Amounts
recognized as
contributions
made are properly
authorized and
reported in the
period in which
they become
unconditional.

(continued)
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Auditing Considerations—continued
Financial
Statement
Assertions

Specific Audit
Objectives

Selected Controls
Activities

Auditing
Procedures

Completeness

All unconditional
contributions
made are
recognized.

Controls ensure
that all
unconditional
contributions
made are
recognized in the
financial
statements.

Review minutes of
governing board
and governing
board committee
meetings for
information about
contributions.

Valuation and
allocation

Contributions
made are
measured at fair
value at initial
recognition.

Controls ensure
the appropriate
valuation of
contributions
made, including
promises to give,
at the time of
initial recognition.

Review and test
the method used
for valuing
contributions
made, including
promises to give.

Account Balances
Contributions Receivable
Occurrence

Amounts
recognized as
contributions
receivable
represent valid
unconditional
promises to give.

Controls ensure
that only
unconditional
promises to give
are recognized in
the financial
statements.

Examine
documentation
supporting the
recognition of
promises to give,
noting information
such as the
absence of
conditions and the
periods over which
the promises to
give become due.

Completeness

All unconditional
promises to give
are recognized.

Controls ensure
that all
unconditional
promises to give
are recognized in
the financial
statements.
Controls ensure
that conditional
promises to give
are recognized
when the
conditions have
been substantially
met.

Compare the detail
of contributions
receivable with
data accumulated
and maintained by
the fund-raising
function, and
investigate
reconciling items.
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Financial
Statement
Assertions
Valuation and
Allocation

Specific Audit
Objectives
Contributions
receivable are
appropriately
valued.

Selected Controls
Activities

Auditing
Procedures

Controls ensure
the appropriate
valuation of
promises to give at
the time of initial
recognition.

Review and test
the methods and
assumptions used
to measure
promises to give at
the time of initial
recognition.

The valuation of
promises to give is
periodically
reviewed by
management.

Review promises
to give for
collectability and,
if appropriate,
changes in fair
value of the
underlying asset.

Write-offs of
uncollectible
promises to give
are identified and
approved in
accordance with
the entity's
established policy.
Promises to Give
Occurrence

Amounts
recognized as
contributions
payable represent
valid
unconditional
promises to give.

Controls ensure
that only
unconditional
promises to give
are recognized in
the financial
statements.

Examine
documentation
supporting
recognition of
contributions
payable, including
information such
as the absence of
conditions and the
periods over which
the promises to
give become due.

Completeness

All unconditional
promises to give
are recognized.

Controls ensure
that all
unconditional
promises to give
are recognized in
the financial
statements.

Review minutes of
governing board
and governing
board committee
meetings for
information about
promises to give.
(continued)
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Auditing Considerations—continued
Financial
Statement
Assertions

Specific Audit
Objectives

Selected Controls
Activities

Auditing Procedures

Cut-off

All unconditional
promises to give
are recognized in
the proper period.

Controls ensure
that contributions
made near fiscal
period-end are
recorded in the
appropriate
period.

Review cash
disbursements
subsequent to
year-end to ascertain
that contributions
made were recorded
in the proper period.

Valuation
and
allocation

Contributions
made and related
liabilities expected
to be paid beyond
one year are
measured using
the method
elected by the
not-for-profit
entity.

Controls ensure
the appropriate
valuation of
promises to give at
the end of the
fiscal period.

Review and test the
method used for
valuing promises to
give that are payable
more than one year
from the date of the
financial statements.

Controls ensure
that (a) only
resources received
and paid in agency
transactions are
recognized as
agency
transactions, and
(b) all such
transactions are
recognized.

Review the
documentation
underlying the
receipt of assets from
resource providers
for propriety of
classification and
recognition as
resources that are to
be transferred to
others.

Agency Transactions
Occurrence
Assets and
and
liabilities from
completeness agency
transactions meet
the criteria for
classification and
recognition as
agency
transactions.

All agency
transactions are
recognized.

Review the
documentation
underlying the
distribution of assets
to others for
propriety of
classification and
recognition.
Review the historical
patterns of the
distribution of gifts
in kind and other
assets to determine
the extent of the
entity's discretion
over those
distributions.
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Financial
Statement
Assertions

Specific Audit
Objectives

Selected Controls
Activities

Auditing Procedures

Presentation and Disclosures
Contribution Revenues and Contributions Receivable
Classification Restricted
and undercontributions are
standability
reported in the
proper net asset
class.

Contributions are
reviewed for
restrictions and
other limitations.

Review the
documentation
underlying
contributions and
promises to give,
including donor
correspondence and
governing board
minutes, for propriety
of classification,
including
classification within
or outside the
performance
indicator.

Disclosures
related to
contributions are
clear and
understandable.

Controls ensure
that contributions
are appropriately
presented and
disclosed.

Determine the
appropriateness of
disclosures for
conditional and
unconditional
promises to give.

Controls ensure
that those
transactions are
identified and not
included in
contribution
totals.

Determine whether
agency transactions
are excluded from the
statement of
operations and the
statement of changes
in net assets. If they
are not, determine
that the transactions
are reported as
described in the
"Transfers of Assets
to a Not-for-Profit
Entity or Charitable
Trust that Raises or
Holds Contributions
for Others" sections of
Financial Accounting
Standards Board
Accounting
Standards
Codification 958-605.

Agency Transactions
Rights and
obligations

Intermediary or
agent
transactions or
transactions for
which the health
care entity acts as
a recipient are not
included in
reported amounts
of contributions.
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Appendix A—TIS Section 6400, Health Care Entities
.35 Note to Sections 6400.36–.42—Implementation of FASB ASC
958—Classification of a Beneficiary’s Interest in the Net Assets of a
Financially Interrelated Fund-Raising Foundation (in the
Beneficiary’s Financial Statements)
Some not-for-profit entities have separate fund-raising foundations (commonly referred to as "institutionally related foundations") that solicit contributions on their behalf. FASB ASC 958 provides guidance on (among other things)
the accounting that should be followed by such in-stitutionally related foundations and their related beneficiary entity(ies) with respect to contributions
received by the foundation.
Some institutionally related foundations and their beneficiary entities meet
the characteristics of financially interrelated entities provided in FASB ASC
958-20-15-2. If entities are financially interrelated, FASB ASC 958 provides
that the balance sheet of the beneficiary entity(ies) should reflect that entity's
interest in the net assets of the foundation, and that interest should be periodically adjusted to reflect the beneficiary's share of the changes in the net
assets of the foundation. This accounting is similar to the equity method of
accounting, which is described in FASB ASC 323.
FASB ASC 323-10-35-5 requires that the periodic adjustment of the investment be included in the determination of the investor's net income. The purpose
of sections 6140.14–.18 (applicable to not-for-profit entities [NPEs] other than
health care [HC] entities) and sections 6400.36–.42 (applicable to not-for-profit
health care entities) is to clarify that in circumstances in which the recipient
and the beneficiary are financially interrelated:

r
r

r

Beneficiary entities should segregate the adjustment into changes in
restricted and unrestricted net assets. (NPE TPA [sections 6140.14–
.16]; HC TPA [sections 6400.36–.37 and .39])
In circumstances in which the beneficiary can influence the financial
decisions of the recipient entity to such an extent that the beneficiary
can determine the timing and amount of distributions from the recipient to the beneficiary, the existence of the recipient entity should be
transparent in determining the net asset classifications in the beneficiary's financial statements. In other words, the recipient cannot impose time or purpose restrictions beyond those imposed by the donor.
(NPE TPA [section 6140.14 and .16]; HC TPA [sections 6400.36 and
.39])
In circumstances in which the beneficiary cannot influence the financial decisions of the recipient entity to such an extent that the beneficiary can determine the timing and amount of distributions from
the recipient to the beneficiary, the existence of the recipient entity
creates an implied time restriction on the beneficiary's net assets attributable to the beneficiary's interest in the net assets of the recipient
(in addition to any other restrictions that may exist). Accordingly, in
recognizing its interest in the net assets of the recipient entity and the
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changes in that interest, the beneficiary should classify the resulting
net assets and changes in those net assets as temporarily restricted
(unless donors placed permanent restrictions on their contributions).
(NPE TPA [section 6140.15]; HC TPA [section 6400.37])
In circumstances in which the beneficiary can influence the financial
decisions of the recipient entity to such an extent that the beneficiary
can determine the timing and amount of distributions from the recipient to the beneficiary and some net assets held by the recipient for the
benefit of the beneficiary are subject to purpose restrictions [for example, net assets of the recipient restricted to the beneficiary's purchase
of property, plant, and equipment (PPE)], expenditures by the beneficiary that meet those purpose restrictions result in the beneficiary
(and recipient) reporting reclassifications from temporarily restricted
to unrestricted net assets (assuming that the beneficiary has no other
net assets subject to similar purpose restrictions), unless those net
assets are subject to time restrictions that have not expired, including time restrictions that are implied on contributed long-lived assets
as a result of the beneficiary's accounting policy pursuant to FASB
ASC 958-605-45-6. (If those net assets are subject to time restrictions
that have not expired and the beneficiary has other net assets with
similar purpose restrictions, the restrictions on those other net assets
would expire in accordance with FASB ASC 958. These TPAs do not,
however, establish a hierarchy pertaining to which restrictions are released first—restrictions on net assets held by the recipient or purpose
restrictions on net assets held by the beneficiary.) (NPE TPA [section
6140.17]; HC TPA [section 6400.40])
In circumstances in which the beneficiary cannot influence the financial decisions of the recipient entity to such an extent that the beneficiary can determine the timing and amount of distributions from the
recipient to the beneficiary and some net assets held by the recipient
for the benefit of the beneficiary are subject to purpose restrictions,
though not subject to time restrictions other than the implied time
restrictions that exist because the beneficiary cannot determine the
timing and amount of distributions from the recipient to the beneficiary, expenditures by the beneficiary that are consistent with those
purpose restrictions should not result in the beneficiary reporting a
reclassification from temporarily restricted to unrestricted net assets,
subject to the exceptions in the following sentence. Expenditures by
the beneficiary that are consistent with those purpose restrictions
should result in the beneficiary reporting a reclassification from temporarily restricted to unrestricted net assets if (a) the recipient has no
discretion in deciding whether the purpose restriction is met1 or (b)
the recipient distributes or obligates itself to distribute to the beneficiary amounts attributable to net assets restricted for the particular

1
In some circumstances, the purpose restrictions may be so broad that the recipient entity
has discretion in deciding whether expenditures by the beneficiary that are consistent with those
purpose restrictions actually meet those purpose restrictions. For example, the recipient's net assets
may have arisen from a contribution that was restricted for the beneficiary's purchase of research
equipment, with no particular research equipment specified. Purchasing an XYZ microscope, which
is consistent with that purpose restriction, may or may not meet that purpose restriction, depending
on the decision of the recipient. In contrast, the net assets may have arisen from a contribution that
was restricted for an XYZ microscope. Purchasing an XYZ microscope, which also is consistent with
that purpose restriction, would result in the recipient having no discretion in determining whether
that purpose restriction is met.
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purpose, or otherwise indicates that the recipient intends for those
net assets to be used to support the particular purpose as an activity
of the current period. In all other circumstances, (a) purpose restrictions and (b) implied time restrictions on the net assets attributable
to the interest in the recipient entity exist and have not yet expired.
(However, if the beneficiary has other net assets with similar purpose
restrictions, those restrictions would expire in accordance with FASB
ASC 958. These TPAs do not establish a hierarchy pertaining to which
restrictions are released first—restrictions on net assets held by the
recipient or restrictions on net assets held by the beneficiary.) (NPE
TPA [section 6140.18]; HC TPA [section 6400.41])
For HC NPEs Only. In circumstances in which the beneficiary can
influence the financial decisions of the recipient to such an extent
that the beneficiary can determine the timing and amount of distributions from the recipient to the beneficiary, changes in the beneficiary's
interest in the net assets of a recipient entity attributable to unrealized gains and losses on investments should be included or excluded
from the performance indicator in accordance with FASB ASC 954-10,
FASB ASC 954-205-45, FASB ASC 954-320-45, FASB ASC 954-32055, and FASB ASC 954-605, in the same manner that they would
have been had the beneficiary had the transactions itself. Similarly,
in applying this guidance, the determination of whether amounts are
included or excluded from the performance measure should comprehend that if the beneficiary cannot influence the financial decisions
of the recipient entity to such an extent that the beneficiary can determine the timing and amount of distributions from the recipient to
the beneficiary, an implied time restriction exists on the beneficiary's
net assets attributable to the beneficiary's interest in the net assets
of the recipient (in addition to any other restrictions that may exist).
Accordingly, in circumstances in which the beneficiary cannot influence the financial decisions of the recipient entity to such an extent
that the beneficiary can determine the timing and amount of distributions from the recipient to the beneficiary, the beneficiary should
classify the resulting net assets and changes in those net assets as
temporarily restricted (unless donors placed permanent restrictions
on their contributions) and therefore exclude those changes from the
performance indicator. (HC TPA [section 6400.42])
For HC NPEs Only. In circumstances in which the recipient entity and
the beneficiary are both controlled by the same entity, entities should
consider the specific facts and circumstances to determine whether
the beneficiary can influence the financial decisions of the recipient
entity to such an extent that the beneficiary can determine the timing
and amount of distributions from the recipient to the beneficiary. (HC
TPA [section 6400.38])
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Technical Practice Aids for Not-for-Profit Entities
Implementation of FASB ASC 958—Classification of a Beneficiary's
Interest in the
Net Assets of a Financially Interrelated Fund-Raising Foundation (in
the Beneficiary's Financial Statements)
HC NPEs
NPEs that are not HC NPEs
Can the
beneficiary
determine
the timing
and amount
of distributions from
the
recipient to
the
beneficiary?
[Not-forprofit health
care entities
(HC NPEs)
under
common
control
consider HC
Technical
Practice Aid
(TPA)
section
6400.38]

How does
the
existence of
the
recipient
affect the
beneficiary's
reporting of
its interest?

Are any net assets
held by the
recipient for the
benefit of the
beneficiary
subject to
donor-imposed
purpose
restrictions and
has the
beneficiary made
expenditures that
meet those
purpose
restrictions (in
circumstances in
which the
beneficiary can
determine the
timing and
amount of
distributions
from the recipient
to the beneficiary)
or that are
consistent with
those purpose
restrictions (in
circumstances in
which the
beneficiary
cannot determine
the timing and
amount of
distributions
from the recipient
to the
beneficiary)?

Are any changes
in the
beneficiary's
interest in the net
assets of the
recipient
attributable to
unrealized gains
and losses on
investments?

(continued)
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HC NPEs
NPEs that are not HC NPEs
Yes

Existence of
recipient is
transparent
in
determining
net asset classifications.
(NPE TPA
[sections
6140.14 and
.16]; HC TPA
[sections
6400.36 and
.39])

Reclass the applicable
net assets from
temporarily restricted
(TR) to unrestricted
(UR) unless those net
assets are subject to
time restrictions that
have not expired.
(NPE TPA [section
6140.17]; HC TPA
[section 6400.40])

Changes in the
beneficiary's interest
in the net assets of a
recipient entity
attributable to
unrealized gains and
losses on investments
should be included or
excluded from the
per-formance indicator
in accordance with
FASB ASC 954-10,
FASB ASC
954-205-45, FASB
ASC 954-320-45,
FASB ASC
954-320-55, and FASB
ASC 954-605, in the
same manner that
they would have been
had the benefici-ary
had the transactions
itself. (HC TPA
[section 6400.42])

No

Existence of
the recipient
creates an
implied time
restriction on
the
beneficiary's
net assets
attributable
to the
beneficiary's
interest in the
net assets of
the recipient.
(NPE TPA [
section
6140.15]; HC
TPA [section
6400.37])

Reclass the applicable
net assets from TR to
UR only if the purpose
restriction and the
implied time
restriction are met.
Whether the purpose
restriction is met
depends in part on (1)
whether the recipient
has discretion in
determining whether
the purpose restriction
is met and (2) the
recipient's decision in
exercising that
discretion, if any.
(NPE TPA [section
6140.18]; HC TPA
[section 6400.41])

An implied time
restriction exists on
the beneficiary's net
assets attributable to
the beneficiary's
interest in the net
assets of the recipient.
The beneficiary should
classify the resulting
net assets and changes
in those net assets as
temporarily restricted
(unless donors placed
permanent
restrictions on their
contributions) and
therefore exclude
those changes from
the performance
indicator. (HC TPA
[section 6400.42])

[Revised, June 2009, to reflect conforming changes necessary
due to the issuance of FASB ASC.]
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.36 Application of FASB ASC 958—Classification of a Beneficiary’s
Interest in the Net Assets of a Financially Interrelated Fund-Raising
Foundation (The beneficiary can influence the operating and
financial decisions of the foundation to such an extent that the
beneficiary can determine the timing and amount of distributions
from the foundation.)
Inquiry—ABC Hospital, a not-for-profit health care entity subject to FASB
ASC 9542 and ABC Foundation are financially interrelated entities as described
in FASB ASC 958-20-15-2. ABC Foundation's bylaws state that it is organized
for the purpose of stimulating voluntary financial support from donors for the
sole benefit of ABC Hospital. Assume that ABC Hospital can influence the
operating and financial decisions of ABC Foundation to such an extent that
ABC Hospital can determine the timing and amount of distributions from ABC
Foundation to ABC Hospital.
During its most recent fiscal year, ABC Foundation's activities resulted in
an increase in net assets (before distributions) of $3,200, comprised of $2,000
in unrestricted contributions, $1,000 in temporarily restricted contributions
(purpose restrictions), $500 in unrestricted dividend and interest income, and
$300 in expenses. In addition, ABC Foundation distributed $2,500 in cash
representing unrestricted net assets to ABC Hospital. How should this activity
be reported in ABC Hospital's financial statements?
Reply—Because ABC Foundation (the recipient entity) and ABC Hospital
(the beneficiary) are financially interrelated, FASB ASC 958-20-25-2 requires
ABC Hospital to recognize its interest in the net assets of ABC Foundation
and periodically adjust that interest for its share of the change in net assets of
ABC Foundation. This is similar to the equity method of accounting described
in FASB ASC 323.
In recognizing its interest in the net assets of ABC Foundation and the
changes in that interest, ABC Hospital should classify the resulting net assets as if contributions were received by ABC Hospital directly from the donor,
because ABC Hospital can influence the operating and financial decisions of
ABC Foundation to such an extent that ABC Hospital can determine the timing and amount of distributions from ABC Foundation to ABC Hospital. In
other words, the existence of ABC Foundation should be transparent in determining the net asset classifications in ABC Hospital's financial statements
because ABC Foundation cannot impose time or purpose restrictions beyond
those imposed by the donor. (Any instructions given by ABC Foundation are
designations, rather than restrictions.)
In the circumstances described previously, ABC Hospital would initially
increase its asset, "Interest in Net Assets of ABC Foundation" for the change in
ABC Foundation's net assets ($3,200). ABC Hospital's Statement of Operations
would include "Change in Unrestricted Interest in ABC Foundation" of $2,200

2
This section addresses not-for-profit health care entities subject to Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 954, Health Care Entities. Section
6140.14, "Application of FASB ASC 958—Classification of a Beneficiary's Interest in the Net Assets
of a Financially Interrelated Fund-Raising Foundation (The beneficiary can influence the operating
and financial decisions of the foundation to such an extent that the beneficiary can determine the
timing and amount of distributions from the foundation.)," addresses a similar issue for not-for-profit
entities subject to FASB ASC 958, Not-for-Profit Entities.
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(which would be included in the performance indicator in accordance with
FASB ASC 954-10, FASB ASC 954-205, FASB ASC 954-310, 954-405, and
FASB ASC 954-605) and "Change in Temporarily Restricted Interest in ABC
Foundation" of $1,000 which would be reported in the Statement of Changes
in Net Assets.
The $2,500 distribution from ABC Foundation to ABC Hospital would not
be reported as an increase in net assets on ABC Hospital's Statement of Operations or its Statement of Changes in Net Assets. By analogy to equity method
accounting, the $2,500 would be reported in a manner similar to a distribution
from a subsidiary to its parent (for example, a dividend). ABC Hospital should
report the distribution by increasing cash and decreasing its interest in the net
assets of ABC Foundation.
If the distribution represented restricted net assets, ABC Hospital would
not reclassify the net assets from temporarily restricted to unrestricted at the
time of the distribution. Instead, ABC Hospital would reclassify the net assets
from temporarily restricted to unrestricted when those restrictions were met.
[Revised, June 2009, to reflect conforming changes necessary
due to the issuance of FASB ASC.]

.37 Application of FASB ASC 958—Classification of a Beneficiary’s
Interest in the Net Assets of a Financially Interrelated Fund-Raising
Foundation (The beneficiary cannot influence the operating and
financial decisions of the foundation to such an extent that the
beneficiary can determine the timing and amount of distributions
from the foundation.)
Inquiry—ABC Hospital, a not-for-profit health care entity subject to FASB
ASC 9543 and ABC Foundation are financially interrelated entities described in
FASB ASC 958-20-15-2. ABC Foundation's bylaws state that it is organized for
the purpose of stimulating voluntary financial support from donors for the sole
benefit of ABC Hospital. Assume that ABC Hospital cannot, however, influence
the operating and financial decisions of ABC Foundation to such an extent that
ABC Hospital can determine the timing and amount of distributions from ABC
Foundation to ABC Hospital.
During its most recent fiscal year, ABC Foundation's activities resulted in
an increase in net assets (before distributions) of $3,200, comprised of $2,000
in unrestricted contributions, $1,000 in temporarily restricted contributions
(purpose restrictions), $500 in unrestricted dividend and interest income, and
$300 in expenses. In addition, ABC Foundation elected to distribute $2,500 in
cash representing unrestricted net assets to ABC Hospital. How should this
activity be reported in ABC Hospital's financial statements?
Reply—Because ABC Foundation (the recipient entity) and ABC Hospital
(the beneficiary) are financially interrelated, FASB ASC 958-20-25-2 requires

3
This section addresses not-for-profit health care entities subject to FASB ASC 954. Section
6140.15, "Application of FASB ASC 958—Classification of a Beneficiary's Interest in the Net Assets of
a Financially Interrelated Fund-Raising Foundation (The beneficiary cannot influence the operating
and financial decisions of the foundation to such an extent that the beneficiary can determine the
timing and amount of distributions from the foundation.)," addresses a similar issue for not-for-profit
entities subject to FASB ASC 958.
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ABC Hospital to recognize its interest in the net assets of ABC Foundation
and periodically adjust that interest for its share of the change in net assets of
ABC Foundation. This is similar to the equity method of accounting described
in FASB ASC 323.
ABC Hospital cannot influence the operating and financial decisions of ABC
Foundation to such an extent that ABC Hospital can determine the timing and
amount of distributions from ABC Foundation. Therefore, an implied time restriction exists on ABC Hospital's interest in the net assets of ABC Foundation
(in addition to any other restrictions that may exist). Accordingly, in recognizing its interest in the net assets of ABC Foundation and the changes in that
interest, ABC Hospital should classify the resulting net assets as changes in
temporarily restricted net assets (unless donors placed permanent restrictions
on their contributions).
In the circumstances previously described, ABC Hospital would initially
increase its asset, "Interest in Net Assets of ABC Foundation" for the change
in ABC Foundation's net assets ($3,200). ABC Hospital's Statement of Changes
in Net Assets would include "Change in Temporarily Restricted Interest in ABC
Foundation" of $3,200 as an increase in temporarily restricted net assets.
The $2,500 distribution from ABC Foundation to ABC Hospital would not
be reported as an increase in net assets on ABC Hospital's Statement of Operations or its Statement of Changes in Net Assets. By analogy to equity method
accounting, the $2,500 would be treated similar to a distribution from a subsidiary to its parent (for example, a dividend). ABC Hospital should report the
distribution by increasing cash and decreasing its interest in the net assets of
ABC Foundation.
ABC Hospital would reclassify the net assets from temporarily restricted to
unrestricted at the time of the distribution, because the time restriction would
expire at the time of the distribution. The reclassification would be reported
as "net assets released from restrictions" and included in the performance indicator in the statement of operations. (If those net assets were subject to
purpose or time restrictions that remained even after the net assets had been
distributed to ABC Hospital, ABC Hospital would not reclassify the net assets
from temporarily restricted to unrestricted at the time of the distribution. Instead, ABC Hospital would reclassify the net assets from temporarily restricted
to unrestricted when those restrictions were met and the reclassification would
be included in or excluded from the performance indicator in accordance with
FASB ASC 954-10, FASB ASC 954-205, FASB ASC 954-310, FASB ASC 954405, and FASB ASC 954-605.)
[Revised, June 2009, to reflect conforming changes necessary
due to the issuance of FASB ASC.]

.38 Application of FASB ASC 958—Classification of a Beneficiary’s
Interest in the Net Assets of a Financially Interrelated Fund-Raising
Foundation—Does Common Control Lead to the Conclusion That
the Beneficiary Can Determine the Timing and Amount of
Distributions from the Recipient?
Inquiry—ABC Holding Company (a not-for-profit entity) has two not-forprofit subsidiaries (ABC Hospital and ABC Foundation) that it controls and
consolidates in accordance with the guidance in FASB ASC 954-10, FASB ASC
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954-205, FASB ASC 954-605, and FASB ASC 954-810. ABC Hospital and ABC
Foundation are brother-sister entities that are financially interrelated entities
as described in FASB ASC 958-20-15-2. ABC Hospital issues separate financial
statements in connection with a loan agreement. ABC Foundation's bylaws
state that it is organized for the purpose of stimulating voluntary financial
support from donors for the sole benefit of ABC Hospital.
Because ABC Hospital and ABC Foundation are under common control,
does that lead to the conclusion that ABC Hospital can influence the financial
decisions of ABC Foundation (either directly or indirectly) to such an extent
that ABC Hospital can determine the timing and amount of distributions from
ABC Foundation to ABC Hospital?
Reply—In some circumstances ABC Hospital, though a subsidiary of ABC
Holding Company, may be able to influence the financial decisions of ABC
Foundation (either directly or indirectly) to such an extent that ABC Hospital
can determine the timing and amount of distributions from ABC Foundation to
ABC Hospital. For example, if ABC Hospital formed ABC Holding Company as
a nominally-capitalized shell with no real operating powers, a rebuttable presumption exists that ABC Hospital can influence the financial decisions of ABC
Foundation (either directly or indirectly) to such an extent that ABC Hospital
can determine the timing and amount of distributions from ABC Foundation
to ABC Hospital. On the other hand if, for example, ABC Hospital formed ABC
Holding Company to be an operating entity with substance, other factors would
need to be considered in determining whether ABC Hospital can influence the
financial decisions of ABC Foundation (either directly or indirectly) to such
an extent that ABC Hospital can determine the timing and amount of distributions from ABC Foundation to ABC Hospital. Therefore, it is necessary to
consider the facts and circumstances surrounding the relationships between
ABC Holding Company and ABC Hospital, and ABC Hospital and ABC Foundation, to determine whether ABC Hospital exerts enough influence over ABC
Foundation to determine the timing and amount of distributions from ABC
Foundation to ABC Hospital. Indicators to consider may include, but are not
limited to, the following:

r

r

What is the extent of overlap among the boards of ABC Hospital, ABC
Holding Company, and ABC Foundation (for example, do a majority
of the individuals who govern ABC Hospital also govern ABC Foundation; do a majority of the individuals who govern ABC Hospital also
govern ABC Holding Company; are the boards of ABC Hospital, ABC
Foundation and ABC Holding Company substantially independent of
one another)? The greater the overlap among the boards of ABC Hospital and either ABC Holding Company or ABC Foundation, the more
likely that ABC Hospital can influence the financial decisions of ABC
Foundation (either directly or indirectly) to such an extent that ABC
Hospital can determine the timing and amount of distributions from
ABC Foundation to ABC Hospital.
What is the extent of overlap among management teams of ABC Hospital, ABC Holding Company, and ABC Foundation (for example, do
the individuals who manage ABC Hospital also manage ABC Foundation; do the individuals who manage ABC Hospital also manage
ABC Holding Company; does ABC Holding Company have a separate management team that exercises significant authority over both
ABC Hospital and ABC Foundation)? The greater the overlap between
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r

r

ABC Hospital's management and management of either ABC Holding
Company or ABC Foundation, the more likely that ABC Hospital can
influence the financial decisions of ABC Foundation (either directly
or indirectly) to such an extent that ABC Hospital can determine the
timing and amount of distributions from ABC Foundation to ABC
Hospital.
What are the origins of the parent/holding company structure? For
example, were ABC Holding Company and ABC Foundation created by
ABC Hospital through a corporate restructuring, which may indicate
that ABC Hospital, as the original entity, can influence the financial
decisions of ABC Foundation (either directly or indirectly) to such an
extent that ABC Hospital can determine the timing and amount of
distributions from ABC Foundation to ABC Hospital. Alternatively,
were ABC Hospital and ABC Foundation independent entities that
merged and created ABC Holding Company to govern the combined
entity, which may indicate that ABC Hospital cannot influence the
financial decisions of ABC Foundation (either directly or indirectly)
to such an extent that ABC Hospital can determine the timing and
amount of distributions from ABC Foundation to ABC Hospital.
What is the number of entities under common control? The greater
the number of entities under ABC Holding Company's control, the
less likely it is that any one subsidiary, such as ABC Hospital, can
influence the financial decisions of another brother-sister subsidiary,
such as ABC Foundation, (either directly or indirectly) to such an
extent that ABC Hospital can determine the timing and amount of
distributions from ABC Foundation to ABC Hospital

Other relevant facts and circumstances should also be considered.
[Revised, June 2009, to reflect conforming changes necessary
due to the issuance of FASB ASC.]

.39 Application of FASB ASC 958—Classification of a Beneficiary’s
Interest in the Net Assets of a Financially Interrelated Fund-Raising
Foundation (More Than One Beneficiary—Some Contributions Are
Designated)
Inquiry—DEF Health Entity is the parent company of three brother-sister
not-for-profit entities: Health A, a not-for-profit health care entity subject to
FASB ASC 9544 Health B, and Foundation. Foundation is organized for the
purpose of raising contributions for the benefit of both Health A and Health B.
The four entities are legally separate not-for-profit entities that are financially
interrelated pursuant to the guidance in FASB ASC 958-20-15-2. Assume that
Health A can influence the financial decisions of Foundation to such an extent
that Health A can determine the timing and amount of distributions from
Foundation to Health A.
A donor contributes $5,000 cash to Foundation and stipulates that the
contribution is for the benefit of Health A. Foundation would record the
4
This section addresses not-for-profit health care entities subject to FASB ASC 954. Section
6140.16, "Application of FASB ASC 958—Classification of a Beneficiary's Interest in the Net Assets
of a Financially Interrelated Fund-Raising Foundation (More Than One Beneficiary—Some Contributions Are Designated)," addresses a similar issue for not-for-profit entities subject to FASB ASC
958.
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contribution as temporarily restricted revenue because Foundation must use
the contribution for the benefit of Health A. In its separately issued financial
statements, Health A would recognize its interest in the net assets attributable
to that contribution by debiting "Interest in Net Assets of Foundation" for
$5,000. Would the offsetting credit be reported as temporarily restricted revenue (because the net assets attributable to the contribution are restricted
on Foundation's Balance Sheet) or unrestricted revenue (because there are no
donor-imposed time restrictions or purpose restrictions on how Health A must
use the contribution)?
Reply—Health A should report the offsetting credit as unrestricted revenue.
Because Health A can influence the financial decisions of Foundation to such
an extent that Health A can determine the timing and amount of distributions
from Foundation to Health A, no implied time restriction exists on Health
A's net assets attributable to its interest in the net assets of Foundation. Accordingly, in recognizing its interest in the net assets of Foundation and the
changes in that interest, Health A should classify the resulting net assets as
if contributions were received by Health A directly from the donor. In other
words, the existence of Foundation should be transparent in determining the
net asset classifications in Health A's separately issued financial statements
because Foundation cannot impose time or purpose restrictions beyond those
imposed by the donor. (Any instructions given by Foundation are designations,
rather than restrictions.)
Because no donor-imposed restrictions exist on how Health A must use the
contribution, Health A should report the change in its interest in the net assets
attributable to the contribution as an increase in unrestricted net assets that
is included in its performance indicator (in accordance with FASB ASC 954-10,
FASB ASC 954-205, FASB ASC 954-310, FASB ASC 954-405, and FASB ASC
954-605) in its separately issued Statement of Operations. When Foundation
actually distributes the funds, Health A should increase cash and decrease its
interest in net assets of Foundation; the distributions would have no effect on
Health A's Statement of Operations or its Statement of Changes in Net Assets.
[Revised, June 2009, to reflect conforming changes necessary
due to the issuance of FASB ASC.]

.40 Application of FASB ASC 958—Classification of a Beneficiary’s
Interest in the Net Assets of a Financially Interrelated Fund-Raising
Foundation (The beneficiary makes an expenditure that meets a
purpose restriction on net assets held for its benefit by the recipient
entity—The beneficiary can influence the operating and financial
decisions of the recipient to such an extent that the beneficiary can
determine the timing and amount of distributions from the
recipient.)
Inquiry—ABC Hospital, a not-for-profit health care entity subject to FASB
ASC 9545 and ABC Foundation are financially interrelated entities as described

5
This section addresses not-for-profit health care entities subject to FASB ASC 954. Section
6140.17, "Application of FASB ASC 958—Classification of a Beneficiary's Interest in the Net Assets
of a Financially Interrelated Fund-Raising Foundation (The beneficiary makes an expenditure that

(continued)
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in FASB ASC 958-20-15-2. ABC Foundation's bylaws state that it is organized
for the purpose of stimulating voluntary financial support from donors for the
sole benefit of ABC Hospital. Assume that ABC Hospital can influence the
operating and financial decisions of ABC Foundation to such an extent that
ABC Hospital can determine the timing and amount of distributions from ABC
Foundation to ABC Hospital.
ABC Foundation's net assets consist of $3,000,000 resulting from cash contributions restricted for the purchase of property, plant, and equipment (PPE)
by ABC Hospital. ABC Hospital has recorded its interest in those net assets by
debiting "Interest in net assets of ABC Foundation" and crediting "Change in
interest in ABC Foundation," which is reported as an increase in temporarily
restricted net assets. ABC Hospital's accounting policy is to not imply a time
restriction that expires over the useful life of the donated long-lived assets
pursuant to FASB ASC 958-605-45-6 and it has no other net assets restricted
for the purchase of PPE.6 ABC Hospital subsequently purchased and placed
into service $3,000,000 of PPE that meets those donor restrictions prior to receiving a distribution from ABC Foundation. Should ABC Hospital reclassify
$3,000,000 from temporarily-restricted net assets as a result of building and
placing into service the $3,000,000 of PPE?
Reply—Because ABC Foundation (the recipient entity) and ABC Hospital
(the beneficiary) are financially interrelated, FASB ASC 958-20-25-2 requires
ABC Hospital to recognize its interest in the net assets of ABC Foundation
and periodically adjust that interest for its share of the change in net assets of
ABC Foundation. This is similar to the equity method of accounting described
in FASB ASC 323.
In recognizing its interest in the net assets of ABC Foundation and the
changes in that interest, ABC Hospital should classify the resulting net assets
as if contributions were received by ABC Hospital directly from the donor, because ABC Hospital can influence the operating and financial decisions of ABC
Foundation to such an extent that ABC Hospital can determine the timing
and amount of distributions from ABC Foundation to ABC Hospital. Accordingly, the net assets representing contributions restricted for the purchase
of PPE should be reported as temporarily restricted net assets (purpose restricted) in ABC Hospital's financial statements. Upon purchasing and placing
into service the PPE, ABC Hospital (and ABC Foundation) should reclassify
$3,000,000 from temporarily restricted to unrestricted net assets,7 reported
separately from the performance indicator in the statement of operations in
(footnote continued)
meets a purpose restriction on net assets held for its benefit by the recipient entity—The beneficiary
can influence the operating and financial decisions of the recipient to such an extent that the
beneficiary can determine the timing and amount of distributions from the recipient.)," addresses a
similar issue for not-for-profit entities subject to FASB ASC 958.
6
The assumption that ABC Hospital has no other net assets restricted for the purchase of PPE
is intended to avoid establishing a hierarchy pertaining to which restrictions are released first—
restrictions on net assets held by the recipient or restrictions on net assets held by the beneficiary.
That issue is not addressed in this TPA.
7
In this fact pattern, ABC Research Institute's interest in the net assets of ABC Foundation is
subject to only purpose restrictions because the net assets arose from cash contributions with no time
restrictions. If instead the net assets arose from promises to give rather than from cash contributions,
the net assets might be subject to time restrictions in addition to the purpose restrictions. In determining whether net assets that arose from promises to give are subject to time restrictions, NPEs
should consider the guidance in section 6140.04, Lapsing of Restrictions on Receivables if Purpose
(continued)
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accordance with the guidance in FASB ASC 954-10, FASB ASC 954-205, FASB
ASC 954-310, FASB AC 954-405, and FASB ASC 954-605. In other words,
the existence of ABC Foundation should be transparent in determining the
net asset classifications in ABC Hospital's financial statements because ABC
Foundation cannot impose time or purpose restrictions beyond those imposed
by the donor. (Any instructions given by ABC Foundation are designations,
rather than restrictions.)
[Revised, June 2009, to reflect conforming changes necessary
due to the issuance of FASB ASC.]

.41 Application of FASB ASC 958—Classification of a Beneficiary’s
Interest in the Net Assets of a Financially Interrelated Fund-Raising
Foundation (The beneficiary makes an expenditure that is
consistent with a purpose restriction on net assets held for its
benefit by the recipient entity—The beneficiary cannot influence the
operating and financial decisions of the recipient to such an extent
that the beneficiary can determine the timing and amount of
distributions from the recipient.)
Inquiry—ABC Hospital, a not-for-profit health care entity subject to FASB
ASC 9548 and ABC Foundation are financially interrelated entities as described
in FASB ASC 958-20-15-2. ABC Foundation's bylaws state that it is organized
for the purpose of stimulating voluntary financial support from donors for the
sole benefit of ABC Hospital. Assume that ABC Hospital cannot, however,
influence the operating and financial decisions of ABC Foundation to such an
extent that ABC Hospital can determine the timing and amount of distributions
from ABC Foundation to ABC Hospital.
ABC Foundation's net assets consist of $3,000,000 resulting from cash contributions restricted for the purchase of property, plant, and equipment (PPE)
by ABC Hospital. ABC Hospital has recorded its interest in those net assets by
debiting "Interest in net assets of ABC Foundation" and crediting "Change in
interest in ABC Foundation," which is reported as an increase in temporarily
restricted net assets. ABC Hospital has no other net assets restricted for the
purchase of PPE.9

(footnote continued)
Restrictions Pertaining to Long-Lived Assets are Met Before the Receivables are Due, which discusses
whether restrictions on net assets arising from promises to give that are restricted by donors for
investments in long-lived assets are met when the assets are placed in service or when the receivables
are due.
8
This section addresses not-for-profit health care entities subject to FASB ASC 954. Section
6140.18, "Application of FASB ASC 958—Classification of a Beneficiary's Interest in the Net Assets
of a Financially Interrelated Fund-Raising Foundation (The beneficiary makes an expenditure that
is consistent with a purpose restriction on net assets held for its benefit by the recipient entity—The
beneficiary cannot influence the operating and financial decisions of the recipient to such an extent
that the beneficiary can determine the timing and amount of distributions from the recipient.),"
addresses a similar issue for not-for-profit entities subject to FASB ASC 958.
9
The assumption that ABC Hospital has no other net assets restricted for the purchase of PPE
is intended to avoid establishing a hierarchy pertaining to which restrictions are released first—
restrictions on net assets held by the recipient or restrictions on net assets held by the beneficiary.
That issue is not addressed in this TPA.
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ABC Hospital subsequently built and placed into service the New Modern
Hospital Wing (at a cost of $3,000,000) prior to receiving a distribution from
ABC Foundation or any indication from ABC Foundation that it intends to
support building and placing into service the New Modern Hospital Wing.
Should ABC Hospital reclassify $3,000,000 from temporarily-restricted net
assets to unrestricted net assets as a result of building and placing into service
the New Modern Hospital Wing?
Reply—From ABC Hospital's perspective, its interest in the net assets of
ABC Foundation has two restrictions—a purpose restriction (the purchase of
the PPE) and an implied time restriction. (ABC Hospital cannot influence the
operating and financial decisions of ABC Foundation to such an extent that
ABC Hospital can determine the timing and amount of distributions from
ABC Foundation to ABC Hospital, including distributions pertaining to expenditures by ABC Hospital that meet the donor-imposed purpose restrictions.
Therefore, an implied time restriction exists on ABC Hospital's interest in the
net assets of ABC Foundation.) FASB ASC 958-205-45-9 provides, in part, as
follows:
If two or more temporary restrictions are imposed on a contribution,
the effect of the expiration of those restrictions is recognized in the
period in which the last remaining restriction has expired.
FASB ASC 958-205-45-11 further provides, in part:
Temporarily restricted net assets with time restrictions are not
available to support expenses until the time restrictions have expired.
In considering whether the purpose restriction on ABC Hospital's interest
in the net assets of ABC Foundation is met, ABC Hospital should determine
whether ABC Foundation has discretion in deciding whether an expenditure
by ABC Hospital that is consistent with the purpose restriction satisfies that
purpose restriction. For example, if the restricted net assets arose from a contribution that was restricted for "building projects of ABC Hospital," with no
particular building project specified, purchasing and placing into service the
New Modern Hospital Wing is consistent with the purpose restriction but may
or may not meet it, because ABC Foundation has some discretion in deciding
which building project releases the purpose restriction. In other words, ABC
Foundation may, at its discretion, either release restricted net assets in support of building the New Modern Hospital Wing or not, because the purpose
restriction imposed by the donor was broad enough to give ABC Foundation
discretion in deciding which building projects meet the purpose restriction.
If ABC Foundation has such discretion, a purpose restriction and an implied
time restriction on ABC Hospital's interest in the net assets of ABC Foundation exist. Therefore, ABC Hospital should not reclassify $3,000,000 from
temporarily-restricted net assets to unrestricted net assets as a result of building and placing into service the New Modern Hospital Wing unless ABC Foundation distributes or obligates itself to distribute to ABC Hospital amounts
attributable to net assets restricted for the purchase of PPE by ABC Hospital, or ABC Foundation otherwise indicates that it intends for those net
assets to be used to support the building and placing into service the New
Modern Hospital Wing as an activity of the current period (assuming that
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ABC Hospital had no other net assets that were restricted for the purchase of
PPE).10,11
In contrast to the example in the previous paragraph, if the restricted net
assets arose from a contribution that was restricted for "building and placing
into service the New Modern Hospital Wing," ABC Foundation has no discretion in deciding whether that purpose restriction is met by building and placing
into service the New Modern Hospital Wing. Therefore, if ABC Hospital builds
and places into service the New Modern Hospital Wing, the purpose restriction
is met (assuming that ABC Hospital had no other net assets that were restricted for building and placing into service the New Modern Hospital Wing).
In addition, the implied time restriction is met because ABC Foundation is
required to distribute the funds to ABC Hospital in order to meet the donor's
stipulation. Therefore, ABC Hospital (and ABC Foundation) should reclassify
$3,000,000 from temporarily-restricted net assets as a result of building and
placing into service the New Modern Hospital Wing.
In summary, ABC Hospital should not reclassify $3,000,000 from
temporarily-restricted net assets to unrestricted net assets as a result of building and placing into service the New Modern Hospital Wing until both the
purpose restriction and the implied time restriction are met. If both the purpose restriction and the implied time restriction are met, ABC Hospital should
decrease its interest in the net assets of ABC Foundation and increase cash

10
In this fact pattern, the expenditure is made prior to meeting the purpose restriction and the
implied time restriction that exists because ABC Hospital cannot determine the timing and amount
of distributions from ABC Foundation to ABC Hospital. FASB ASC 958-205-45-11 provides that in
circumstances in which both purpose and time restrictions exist, expenditures meeting the purpose
restriction must be made simultaneous with or after the time restriction has expired in order to satisfy
both the purpose and time restriction and result in a reclassification of net assets from temporarily
restricted to unrestricted. In other words, time restrictions, if any, must be met before expenditures
can result in purpose restrictions being met. In this fact pattern, however, the time restriction is an
implied time restriction that exists because the beneficiary cannot determine the timing and amount
of distributions from the recipient to the beneficiary, rather than an implied time restriction that
exists because a promise to give is due in a future period or because of an explicit donor stipulation.
Accordingly, in this fact pattern, temporarily restricted net assets with implied time restrictions
are available to support expenditures made before the expiration of the time restrictions and the
net assets should be reclassified from temporarily restricted to unrestricted in the period in which
the last remaining restriction has expired. In other words, in this fact pattern, if the expenditure
that meets the purpose restriction is made before meeting the implied time restriction that exists
because the beneficiary cannot determine the timing and amount of distributions from the recipient
to the beneficiary, all the restrictions should be considered met once the implied time restriction
is met.
11
In this fact pattern, ABC Hospital's interest in the net assets of ABC Foundation is subject
to an implied time restriction that exists because ABC Hospital cannot determine the timing and
amount of distributions from ABC Foundation to ABC Hospital and a purpose restriction. Because
the net assets arose from cash contributions with no other donor-imposed time restrictions, no time
restrictions other than those imposed by ABC Foundation exist. If instead the net assets arose from
promises to give rather than from cash contributions, the net assets might be subject to donorimposed time restrictions in addition to the time restriction imposed by ABC Foundation and the
purpose restriction. In determining whether net assets that arose from promises to give are subject
to donor-imposed time restrictions in addition to the time restrictions imposed by ABC Foundation,
NPEs should consider the guidance in section 6140.04, Lapsing of Restrictions on Receivables if
Purpose Restrictions Pertaining to Long-Lived Assets are Met Before the Receivables are Due, which
discusses whether restrictions on net assets arising from promises to give that are restricted by
donors for investments in long-lived assets are met when the assets are placed in service or when
the receivables are due. In circumstances in which the net assets are subject to (a) donor-imposed
time restrictions in addition to the (b) implied time restrictions that exist because ABC Hospital
cannot determine the timing and amount of distributions from ABC Foundation to ABC Hospital
and (c) purpose restrictions, the last remaining time restriction should be considered in applying the
guidance in FASB ASC 958-205-45-11 that provides that temporarily restricted net assets with time
restrictions are not available to support expenses until the time restrictions have expired.
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(or a receivable, if the Foundation has merely obligated itself to make the distribution) by the amount of the distribution, and simultaneously reclassify the
same amount from temporarily restricted net assets to unrestricted net assets.
The reclassification should be reported separately from the performance indicator in the statement of operations in accordance with the guidance in FASB
ASC 954-10, FASB ASC 954-205, FASB ASC 954-310, FASB ASC 954-405, and
FASB ASC 954-605.
[Revised, June 2009, to reflect conforming changes necessary
due to the issuance of FASB ASC.]

.42 Application of FASB ASC 958—Classification of a Beneficiary’s
Interest in the Net Assets of a Financially Interrelated Fund-Raising
Foundation (Recipient Entity)—Accounting for Unrealized Gains
and Losses on Investments Held by the Foundation
Inquiry—FASB ASC 958 provides that if entities are financially interrelated, the balance sheet of the beneficiary entity should reflect that entity's
beneficial interest in the net assets of the recipient entity, and that that interest should be adjusted periodically to reflect the changes in the net assets of
the recipient entity. This accounting is similar to the equity method of accounting. FASB ASC 954-10, FASB ASC 954-205-45, FASB ASC 954-320-45, FASB
ASC 954-320-55, and FASB ASC 954-605 provide guidance pertaining to the
classification of investment returns in the financial statements of health care
entities.
ABC Hospital and ABC Foundation are financially interrelated entities.
How should changes in ABC Hospital's interest in the net assets of ABC Foundation attributable to unrealized gains and losses on Foundation's investments
be classified in ABC Hospital's financial statements?
Reply—In circumstances in which ABC Hospital can influence the financial decisions of ABC Foundation to such an extent that ABC Hospital can
determine the timing and amount of distributions from Foundation to ABC
Hospital, changes in ABC Hospital's interest in the net assets of ABC Foundation attributable to unrealized gains and losses on investments should be
classified in the same manner that they would have been had ABC Hospital
held the investments and had the transactions itself. In accordance with the
guidance in FASB ASC 954-10, FASB ASC 954-205-45, FASB ASC 954-320-45,
FASB ASC 954-320-55, and FASB ASC 954-605, ABC Hospital should include
in the performance indicator the portion of the change attributable to unrealized gains and losses on trading securities that are not restricted by donors or
by law, and should exclude from the performance indicator the portion of the
change attributable to all other unrealized gains and losses.
In circumstances in which ABC Hospital cannot influence the financial
decisions of Foundation to such an extent that ABC Hospital can determine the
timing and amount of distributions ABC Hospital receives from Foundation,
an implied time restriction exists on ABC Hospital's net assets attributable to
its interest in the net assets of Foundation (in addition to any other restrictions
that many exist). Accordingly, ABC Hospital should classify all changes in that
interest, including the portion of the change attributable to unrealized gains
and losses on investments, as changes in temporarily restricted net assets
(unless donors placed permanent restrictions on investment gains and losses
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pertaining to their contributions) and therefore should exclude those changes
from the performance indicator.
[Revised, June 2009, to reflect conforming changes necessary
due to the issuance of FASB ASC.]

.43 Application of FASB ASC 958—Classification of Distributions
From a Financially Interrelated Fund-Raising Foundation (Recipient
Entity) to a Health Care Beneficiary
Inquiry—How should a fund-raising foundation (recipient), a not-for-profit
entity subject to FASB ASC 958 report (in its separately issued financial statements) distributions to a financially interrelated beneficiary that is a health
care entity? In other words, should such distributions be reported following
(a) the guidance on reporting transfers among affiliated health care entities in
FASB ASC 954-10, FASB ASC 954-205, FASB ASC 954-605, and FASB ASC
954-810 or (b) the guidance in FASB ASC 958.
Reply—FASB ASC 958 applies to all not-for-profit entities, except those
that are providers of health care services (FASB ASC 958-10-15-3). Therefore,
the guidance in FASB ASC 954 generally does not apply to financial statements
of recipient entities that are financially interrelated fund-raising foundations.
The foundation should follow the accounting and reporting requirements of
FASB ASC 958 rather than FASB ASC 954 in the foundation's separately
issued financial statements. The foundation should report distributions to beneficiary entities as expenses or distributions to related entities. The guidance
in the previous sentence applies regardless of whether the recipient entity and
the beneficiary are under common control or whether one controls the other in
a parent-subsidiary relationship.
[Revised, June 2009, to reflect conforming changes necessary
due to the issuance of FASB ASC.]

AAG-HCO 11.55

207

The Reporting Entity and Related Entities

Chapter 12

The Reporting Entity and Related Entities
Overview
12.01 Health systems are complex operations made up of various business
lines and subsidiaries. Not-for-profit systems are likely to operate through a
combination of for-profit and not-for-profit entities. Various for-profit entities,
such as health maintenance organizations (HMOs) or insurance entities, may
be organized as stock corporations, partnerships, or limited liability entities.
Fund-raising typically is accomplished through a separate foundation. There
may be financial transfers of cash or assets among related entities either to
fund capital needs or start-up costs or to provide operating subsidies. Certain
entities within the system may be obligated for repayment of the system's
municipal bonds, but others are not. The system may also be involved in joint
ventures or joint operating agreements. This chapter addresses accounting
and financial reporting considerations associated with these issues, including
consolidation and combinations of entities (that is, mergers and acquisitions).
12.02 This chapter discusses the accounting and reporting for equity investments accounted for under the equity method if the investee is an integral
part of the reporting entity's operations, such as a physician hospital organization or joint venture. Chapter 4, "Cash, Cash Equivalents, and Investments,"
of this guide discusses accounting and reporting if the investment's purpose
is investment income or return (for example, collective trusts, funds of funds,
hedge funds, or other alternative investments).

Reporting by Not-for-Profit Health Care Entities
12.03 The guidance that follows in this section of the guide discusses a
not-for-profit health care entity's relationships with for-profit and not-for-profit
entities that result in either consolidation of parent-subsidiary relationships,
whether through stock ownership or other means of control, or equity method
accounting. Other circumstances may exist in the health care industry in which
combined financial statements involving commonly controlled entities are more
meaningful than their separate financial statements. More specific guidance
related to combined financial statements can be found in paragraphs 12.67–.68.
12.04 Per Financial Accounting Standard Board (FASB) Accounting Standards Codification (ASC) 954-810-45-1, whether the financial statements of a
reporting health care entity and those of one or more other for-profit or not-forprofit entities should be consolidated; whether those other entities should be
reported using the equity method; and the extent of disclosure that should be
required, if any, if consolidated financial statements are not presented should
be based on the nature of the relationship between the entities.
12.05 Health care organizations may be related to one or more other entities in numerous ways, including ownership, control, or economic interests.
Exhibit 12-1, "Relationships of a Not-for-Profit Reporting Entity," describes
some common relationships with other entities and identifies where those relationships are discussed in this chapter and FASB ASC. Exhibit 12-1 and this
chapter summarize certain guidance in FASB ASC but are not intended as a
substitute for reading the guidance itself.
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Exhibit 12-1
Relationships of a Not-for-Profit Reporting Entity

Relationship

Financial Accounting
Standards Board
Accounting Standards
Codification Reference

Discussion in
This Chapter

Relationships With Not-for-Profit Entities
The reporting entity is the
sole corporate member of a
not-for-profit entity.

Use the guidance in
Financial Accounting
Standards Board (FASB)
Accounting Standards
Codification (ASC)
958-810-25-2 and
954-810-45-3A.

Paragraphs
12.09–.10

The reporting entity has a
controlling financial
interest through a direct or
indirect ownership of a
majority voting interest in
the other not-for-profit
entity.

Use the guidance in FASB
ASC 958-810-25-2.

Paragraph 12.09

The reporting entity
controls another
not-for-profit entity
through a majority voting
interest in its board and
has an economic interest in
that other entity.

Use the guidance in FASB
ASC 958-810-25-3.

Paragraph 12.11

The reporting entity
Use the guidance in FASB
controls a not-for-profit
ASC 958-810-25-4.
entity through a form other
than majority ownership,
sole corporate membership,
or majority voting interest
in its board and has an
economic interest in that
other entity.

Paragraphs
12.12–.14

The reporting entity has
control over another
not-for-profit entity or an
economic interest in the
other but not both.

Paragraph 12.15
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Relationship
The reporting entity
receives distributions from
a related fund-raising
foundation, but it does not
control that foundation.

Financial Accounting
Standards Board
Accounting Standards
Codification Reference
Use the guidance in the
"Transfers of Assets to a
Not-for-Profit Entity or
Charitable Trust that
Raises or Holds
Contributions for Others"
sections of FASB ASC
958-605.

Discussion in
This Chapter
Paragraphs
12.16–.24

Relationships With For-Profit Entities
The reporting entity owns
a majority of a for-profit
entity's common voting
stock.

Use the guidance in the
"General" sections of FASB
ASC 810-10 to determine
whether that interest
constitutes a controlling
financial interest.

Paragraphs
12.28–.30

The reporting entity owns
50 percent or less of the
common voting stock of an
investee and can exercise
significant influence over
operating and financial
policies.

Except when the reporting
entity elects to report such
interests at fair value, in
accordance with the "Fair
Value Option" sections of
FASB ASC 825-10, use the
equity method of
accounting, in accordance
with FASB ASC 323-10.

Paragraphs
12.33–.35

The reporting entity has an Except when the reporting
interest in a general
entity elects to report such
partnership.
interests at fair value, in
accordance with the "Fair
Value Option" sections of
FASB ASC 825-10, entities
typically use by analogy
the guidance in FASB ASC
970-810.

Paragraph 12.36

The reporting entity is the
general partner of a
for-profit limited
partnership or similar
entity, such as a limited
liability company that has
governing provisions that
are the functional
equivalent of a limited
partnership.

Paragraphs
12.37–.38

Use the guidance in FASB
ASC 810-20 to determine
whether the general
partner within the group
controls and, therefore,
should consolidate the
limited partnership or
similar entity.

(continued)
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Relationships of a Not-for-Profit Reporting Entity—continued

Relationship

Financial Accounting
Standards Board
Accounting Standards
Codification Reference

Discussion in
This Chapter

The reporting entity has an
investment in a limited
liability company that has
governing provisions that
are the functional
equivalent of a regular
corporation.

Use the guidance in FASB Paragraph 12.29
ASC 810-10 to determine
whether the reporting
entity has a majority voting
interest that provides it
with a controlling financial
interest.

The reporting entity has a
noncontrolling interest
that constitutes more than
a minor interest in a
for-profit partnership,
limited liability entity, or
similar entity engaged in
real estate activities.

Except when the reporting
entity elects to report such
interests at fair value, in
accordance with the "Fair
Value Option" sections of
FASB ASC 825-10, use the
equity method, in
accordance with the
guidance in FASB ASC
970-323.

Paragraphs
12.40–.42

The reporting entity has a
noncontrolling interest
that constitutes more than
a minor interest in a
for-profit partnership,
limited liability entity, or
similar entity other than
one engaged in real estate
activities.

Except when the reporting
entity elects to report such
interests at fair value, in
accordance with the "Fair
Value Option" sections of
FASB ASC 825-10, entities
typically use by analogy
the equity method, in
accordance with the
guidance in FASB ASC
970-323.

Paragraph 12.39

The reporting entity has a
contractual management
relationship with another
entity in which it does not
have an investment (for
example, a physician
practice).

Use the guidance in the
"Consolidation of Entities
Controlled by Contract"
sections of FASB ASC
810-10 to determine
whether the arrangement
constitutes a controlling
financial interest.

Paragraphs
12.30–.32
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Relationship

Financial Accounting
Standards Board
Accounting Standards
Codification Reference

Discussion in
This Chapter

Relationships With Special Entities
The reporting entity has a
relationship with a variable
interest entity (VIE), as
described in the "Variable
Interest Entities" sections
of FASB ASC 810-10.

Pursuant to FASB ASC
810-10-15-17, not-for-profit
health care entities are not
subject to the "Variable
Interest Entities" sections
of FASB ASC 810-10,
unless the not-for-profit
entity is used by a business
entity in a manner similar
to a VIE in an effort to
circumvent the provisions
of those standards.

The reporting entity is
engaged in a leasing
transaction with a
special-purpose entity
lessor.

Use the guidance in
paragraphs 8–10 of FASB
ASC 958-810-25 and
paragraphs 7–16 of FASB
ASC 958-810-55 to
determine whether to
consolidate the lessor.

Paragraphs
12.46–.50

The reporting entity has
entered into a joint
operating agreement with
another entity. They agree
to jointly conduct an
activity while sharing the
operating results and a
residual interest upon
dissolution.

If housed in a separate
legal entity, use the equity
method of accounting in
FASB ASC 323-10, except
when the reporting entity
elects to report such
interests at fair value, in
accordance with the "Fair
Value Option" sections of
FASB ASC 825-10;
otherwise, use the
guidance in FASB ASC
808, Collaborative
Arrangements.

Paragraphs
12.51–.53

The reporting entity is a
sponsor in a research and
development arrangement.

Use the guidance in FASB
ASC 810-30.

Uncommon; not
discussed in this
chapter.

The reporting entity has
another type of
relationship with a
special-purpose entity.

In practice, entities
analogize to the guidance
in paragraphs 8–10 of
FASB ASC 958-810-25 and
paragraphs 7–16 of FASB
ASC 958-810-55.

Paragraph 12.54
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Relationships With Another Not-for-Profit Entity
12.06 FASB ASC 958-810-05-3 states that ownership of not-for-profit entities may be evidenced in various ways because not-for-profit entities may exist
in various legal forms, such as corporations issuing stock, corporations issuing
ownership certificates, membership corporations issuing membership certificates, joint ventures, partnerships, and other forms. As discussed in FASB
ASC 954-810-05-3, the rights and powers of the controlling entity may vary
depending on the legal structure of the controlled entity and the nature of
control.
12.07 As a result, whether the financial statements of a controlled not-forprofit entity should be consolidated with those of the reporting entity depends
on the nature of control and whether an economic interest exists, as follows:

r
r
r
r

Certain kinds of control, such as controlling financial interests,
require consolidation (see paragraphs 12.09–.10).
Other kinds of control (for example, a majority voting interest in
the board of the other not-for-profit entity) result in consolidation
only if coupled with an economic interest (see paragraph 12.11).
Still other kinds of control, if coupled with an economic interest, result in consolidation being permitted but not required (see
paragraphs 12.12–.14).
The existence of either control or an economic interest, but not
both, precludes consolidation but may trigger disclosure requirements (see paragraph 12.15).

12.08 The FASB ASC glossary defines control as "[t]he direct or indirect
ability to determine the direction of management and policies through ownership, contract, or otherwise." The FASB ASC glossary states that an economic
interest is
[a] not-for-profit entity's (NFP's) interest in another entity that exists
if any of the following criteria are met:
a. The other entity holds or utilizes significant resources that
must be used for the unrestricted or restricted purposes of
the NFP, either directly or indirectly by producing income
or providing services.
b. The NFP is responsible for the liabilities of the other entity.
FASB ASC 958-810-55-6 provides the following examples of economic interests:
a. Other entities solicit funds in the name of and with the expressed or
implied approval of the not-for-profit entity, and substantially all
the solicited funds are intended by the contributor or are otherwise
required to be transferred to the not-for-profit entity or used at its
discretion or direction.
b. The not-for-profit entity transfers significant resources to another
entity whose resources are held for the benefit of the not-for-profit
entity.
c. The not-for-profit entity assigns certain significant functions to another entity.
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d. The not-for-profit entity provides or is committed to provide funds
for another entity, or the not-for-profit entity guarantees significant
debt of another entity.
e. The not-for-profit entity has a right to, or the responsibility for, the
operating results of another entity, or upon dissolution, the not-forprofit entity is entitled to the net assets or is responsible for any
deficit of another entity.

Consolidation Required if a Controlling Financial Interest Exists
12.09 FASB ASC 958-810-25-2 states that a not-for-profit entity with
a controlling financial interest in another not-for-profit entity through direct
or indirect ownership of a majority voting interest or through sole corporate
membership in that other not-for-profit entity should consolidate that other
not-for-profit entity, unless control does not rest with the majority owner or
sole corporate member (for instance, if the other not-for-profit entity is in legal
reorganization or bankruptcy), in which case consolidation is prohibited, as
discussed in FASB ASC 810-10-15-8. In addition, FASB ASC 958-810-25-2A
states that if certain actions require approval by a supermajority vote of the
board, such voting requirements might overcome the presumption of control by
the owner or holder of a majority voting interest. Paragraphs 12.28–.32 provide
additional information about controlling financial interests.
12.10 FASB ASC 954-810-45-3A states that a parent corporation typically owns stock in a for-profit entity whereas a sole corporate member holds
membership rights in a not-for-profit entity. Sole corporate membership in a
not-for-profit entity, such as ownership of a majority voting interest in a forprofit entity, should be considered a controlling financial interest, unless control does not rest with the sole corporate member, as discussed in the previous
paragraph.

Majority Voting Interest in the Board Coupled With an Economic Interest
12.11 According to FASB ASC 958-810-25-3, in the case of control of a
related but separate not-for-profit entity through (a) a majority voting interest
in the board of the other not-for-profit entity by means other than ownership
or sole corporate membership1 and (b) an economic interest in the other such
entity, consolidation is required, unless control does not rest with the holder
of the majority voting interest, in which case consolidation is prohibited. A
not-for-profit health care entity has a majority voting interest in the board of
another health care entity if it has the direct or indirect ability to appoint individuals that together constitute a majority of the votes of the fully constituted
board (that is, including any vacant board positions). See paragraph 12.29 for
discussion about when control does not rest with a majority owner.

1
A majority voting interest in the board of another entity by means other than ownership or sole
corporate membership is illustrated by the following example from Financial Accounting Standards
Board (FASB) Accounting Standards Codification (ASC) 958-810-55-5. Entity B has a five-member
board, and a simple voting majority is required to approve board actions. Entity A will have a majority
voting interest in the board of Entity B if Entity A has the ability to appoint three or more of Entity
B's board members. If three of Entity A's board members, employees, or officers serve on the board
of Entity B, but Entity A does not have the ability to require that those members serve on Entity B's
board, Entity A does not have a majority voting interest in the board of Entity B.
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Control Through Other Means Coupled With an Economic Interest
12.12 FASB ASC 958-810-25-4 states that control of a related but separate
not-for-profit entity in which the reporting entity has an economic interest may
take forms other than majority ownership interest, sole corporate membership,
or majority voting interest in the board of the other entity (for example, control
may be through contract or affiliation agreement). In circumstances such as
these, consolidation is permitted but not required.2 Consolidation is encouraged
for these entities if it would be meaningful.
12.13 Evidence of control, as discussed in the preceding paragraph, may
include authority to amend articles of incorporation and bylaws or authority
to approve operating, capital, and construction budgets; capital acquisitions;
strategic plans, goals, and objectives; authority to select, terminate, and set
the compensation of management responsible for implementing the policies
and procedures; and mergers or dissolutions.
12.14 According to FASB ASC 958-810-50-2, if a not-for-profit entity (the
reporting entity) controls a related but separate not-for-profit entity through
a form other than majority ownership, sole corporate membership, or majority
voting interest in the board of the other entity and has an economic interest in
that other not-for-profit entity, the reporting entity should disclose all of the
following information if it does not present consolidated financial statements:
a. Identification of the other not-for-profit entity and the nature of its
relationship with the reporting entity that results in control
b. Summarized financial data of the other not-for-profit entity, which
should include the following information: total assets, liabilities,
net assets, revenue, and expenses and resources that are held for
the benefit of the reporting entity or under its control
c. The related-party disclosures set forth in paragraphs 1–6 of FASB
ASC 850-10-50.

Consolidation Precluded if Either Control or an Economic Interest
(but Not Both) Are Present
12.15 FASB ASC 958-810-25-5 states that the existence of control or an
economic interest, but not both, precludes consolidation. Pursuant to FASB
ASC 958-810-50-3, the reporting entity should disclose the information required by paragraphs 1–6 of FASB ASC 850-10-50 for these relationships.3

Related Fund-Raising Organizations
12.16 A common situation in which a health care entity may have an
economic interest in another entity but may not control it is the fund-raising
entity described in paragraph 12.08(a). In such situations, the related not-forprofit entity acts as a recipient entity (an agent, a trustee, or an intermediary)
for contributions made to the health care entity.
12.17 The "Transfers of Assets to a Not-for-Profit Entity or Charitable Trust that Raises or Holds Contributions for Others" sections of FASB
2
Additional information about the consolidation of entities controlled by contract can be found
in paragraphs 12.30–.32.
3
FASB ASC 958-810-50-3 states that the existence of an economic interest does not necessarily
cause the entities to be related parties, as defined in the FASB ASC glossary. However, the disclosures
required by paragraphs 1–6 of FASB ASC 850-10-50 are required if an economic interest exists.
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ASC 958-605 apply if contributions intended to benefit a specific not-for-profit
entity (the beneficiary) are made through another not-for-profit entity acting as
an agent, a trustee, or an intermediary. In such transactions, a donor makes a
contribution by transferring assets to a not-for-profit entity or charitable trust
(the recipient entity) that accepts the assets from the donor and agrees to use
those assets on behalf of an unaffiliated entity (beneficiary) or transfer those
assets, the return on investment of those assets, or both to an unaffiliated entity (the beneficiary) that is specified by the donor.4 FASB ASC 958-605-55-78
states that a donor may specify the beneficiary by (a) name; (b) stating that all
entities that meet a set of donor-defined criteria are beneficiaries; or (c) actions
surrounding the transfer that make clear the identity of the beneficiary, such
as by responding to a request from a recipient entity to raise assets for the
beneficiary. Paragraphs 80–115 of FASB ASC 958-605-55 provide examples of
donor stipulations and discuss whether those stipulations specify a beneficiary.
12.18 According to FASB ASC 958-20-25-1, if a recipient entity and specified health care entity (beneficiary) are financially-interrelated entities, as defined in FASB ASC 958-20-15-2 and described in paragraph 12.75, and the
recipient entity is not a trustee, the recipient entity should recognize a received contribution when it receives financial or nonfinancial assets from the
donor that are specified for the beneficiary. For example, a foundation that
exists to raise, hold, and invest assets for the specified health care entity (beneficiary) or a group of affiliates of which the specified health care entity is a
member generally is financially interrelated with the not-for-profit entity(ies)
it supports and recognizes contribution revenue when it receives assets from
the donor.5 According to FASB ASC 958-20-25-2 and 958-20-35-1, the specified
health care entity (beneficiary) should recognize its interest in the net assets
of the foundation (the recipient entity) and adjust that interest for its share
of the change in net assets of the recipient entity. Recognizing an interest in
the net assets of the recipient entity and adjusting that interest for a share of
the change in net assets of the recipient entity is similar to the equity method,
which is described in FASB ASC 323-10.6
12.19 According to FASB ASC 958-20-55-11, when measuring its interest
in the foundation (recipient entity), the health care entity (specified beneficiary)
would include only the net assets of the recipient entity that are restricted to
that health care entity's use. According to FASB ASC 958-20-55-12, if the recipient entity supports more than one beneficiary, and an agreement with the
recipient entity specifies how unrestricted gifts to the recipient entity should be
divided between the supported entities, the specified health care entity would
also include its share of the recipient entity's unrestricted assets, computed in

4
The "Transfers of Assets to a Not-for-Profit Entity or Charitable Trust that Raises or Holds
Contributions for Others" sections of FASB ASC 958-605 also establish standards for transactions
that take place in a similar manner but are not contributions because the transfers are revocable,
repayable, or reciprocal. For example, FASB ASC 958-605-55-110 states that if a resource provider
transfers assets to a recipient entity and specifies itself or its affiliate as the beneficiary, a presumption
that the transfer is reciprocal and, therefore, not a contribution is necessary, even if the resource
provider explicitly grants the recipient entity variance power. Those standards and transactions are
discussed in paragraphs 4.61–.63 and 12.74–.77 of this guide. FASB ASC 958-605 and this guide do
not use the word donor in discussing those transactions because they are not contributions.
5
Foundations that are not providers of health care services are not covered by this guide and
should follow the Audit and Accounting Guide Not-for-Profit Entities.
6
FASB ASC 958-20-45-3 states if the beneficiary and recipient entity are included in consolidated financial statements, the beneficiary's interest in the net assets of the recipient entity should
be eliminated, in accordance with FASB ASC 810-10-45-1.
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accordance with that agreement, when it measures its interest in the recipient
entity. Similarly, if a parent entity controls both the recipient entity and specified health care entity, and the parent directed that unrestricted gifts would
be distributed to affiliates in accordance with a specified formula, each affiliate
would include its share of unrestricted net assets, computed in accordance with
that formula, when it measures its interest in the recipient entity.
12.20 According to FASB ASC 954-605-25-12, distributions from a
financially-interrelated recipient entity to a nongovernmental health care entity that it supports should generally be reported by the health care entity as
a reduction of its interest in the recipient entity. However, if the distribution
is made from net assets that are not includable in that interest because the
health care entity does not have rights to them (that is, the recipient entity
can determine to whom the assets will be distributed), the health care entity
should report a contribution from the related recipient entity.
12.21 For example, assume a foundation's mission is to raise contributions
for 2 financially interrelated health care entities: Hospital A and Hospital
B. The foundation receives $10,000 in contributions from donors who do not
specify which of the 2 hospitals should benefit from their gifts. No agreement
exists between the foundation and Hospitals A and B that specifies how gifts
to the foundation should be divided between the hospitals if the donor does
not specify a beneficiary. Hospital A would report contribution revenue for any
portion of the $10,000 that it receives from the foundation. Likewise, Hospital
B would report contribution revenue for any portion of the $10,000 that it
receives, but neither Hospital A nor Hospital B would record an interest in
those assets before the foundation either distributes them or unconditionally
promises them.
12.22 As discussed in FASB ASC 958-605-25-24, if the recipient entity and
specified health care entity are not financially-interrelated entities, as defined
in FASB ASC 958-20-15-2 (see paragraph 12.75), a recipient entity that accepts
assets from a donor and agrees to use those assets on behalf of the specified
health care entity (beneficiary) or transfer those assets, the return on investment of those assets, or both to the specified health care entity (beneficiary)
should recognize its liability to the specified health care entity (beneficiary)
concurrent with its recognition of cash or other financial assets received from
the donor, unless the recipient entity is explicitly granted variance power (see
the discussion of variance power in paragraph 11.34 of this guide). Except in
cases when the donor grants variance power, or the entities are financially
interrelated, as described in paragraphs 25–26 of FASB ASC 958-605-25 and
FASB ASC 958-605-25-27, respectively, a recipient entity that receives nonfinancial assets is permitted, but not required, to recognize its liability and those
assets, provided that the recipient entity consistently reports from period to
period and discloses its accounting policy. The FASB ASC glossary defines nonfinancial asset as "[a]n asset that is not a financial asset. Nonfinancial assets
include land, buildings, use of facilities or utilities, materials and supplies, intangible assets, or services." According to FASB ASC 968-605-25-28, a specified
health care entity (beneficiary) should recognize its rights to the financial or
nonfinancial assets held by a recipient entity as an asset, unless the recipient
entity is explicitly granted variance power (see further discussion in paragraph
11.34 of this guide).
12.23 In contrast, if the donor does not specify a beneficiary (see further
discussion in paragraph 12.17, and the foundation and a hospital are under
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common control, but they are not financially interrelated, the recipient entity
should recognize contribution revenue when it receives the gift. At a later
date, when the foundation transfers assets to the hospital, the gift should be
accounted for as contributions received by the hospital, consistent with the
"Contributions Received" sections of FASB ASC 958-605, provided that the
foundation is acting other than as an owner.
12.24 Additional guidance regarding accounting for contributions received
by agents, trustees, and intermediaries can be found in sections .35–.43 of
Technical Questions and Answers section 6400, Health Care Entities (AICPA,
Technical Practice Aids) (appendix A, "TIS Section 6400, Health Care Entities,"
of chapter 11, "Contributions Received and Made," of this guide) and chapter 5,
"Contributions Received and Agency Transactions," of the Audit and Accounting Guide Not-for-Profit Entities.

Relationships With a For-Profit Entity
12.25 A not-for-profit health care system may own stock, partnership interests, or other ownership interests in for-profit entities, such as HMOs or
insurance entities, that may or may not provide patient care. Whether the
financial statements of a for-profit entity should be consolidated with the reporting entity depends on the nature of control. Certain types of control require
consolidation; other relationships require the equity method of accounting to be
used. Chapter 4 of this guide discusses the reporting of an interest in a for-profit
entity if it is neither consolidated nor reported using the equity method.
12.26 When applying the guidance in FASB ASC 810-10, not-for-profit
health care entities do not apply tests to determine whether the other entity
is a variable interest entity (VIE). According to FASB ASC 810-10-15-17, notfor-profit entities are not subject to the "Variable Interest Entities" sections
of FASB ASC 810-10, except that they may be related parties for purposes of
applying paragraphs 42–44 of FASB ASC 810-10-25.
12.27 Guidance in this section is organized as follows:

r
r
r
r

Consolidation required by a controlling financial interest
Equity method of accounting for noncontrolling interests in corporations
Interests in general partnerships
Interests in limited partnerships and similar entities

Consolidation Required by a Controlling Financial Interest
12.28 Pursuant to FASB ASC 810-10-15-10(a), all majority-owned subsidiaries (that is, all entities in which a parent has a controlling financial interest) should be consolidated. However, exceptions exist to this general rule.
12.29 FASB ASC 810-10-15-10(a)(1) provides an exception if control
does not rest with the majority owner. For instance, a majority-owned subsidiary should not be consolidated if any of the following are present: (a)
the subsidiary is in legal reorganization; (b) the subsidiary is in bankruptcy;
(c) the subsidiary operates under foreign exchange restrictions, controls, or
other governmentally-imposed uncertainties that are so severe that they
cast significant doubt on the parent's ability to control the subsidiary; and
(d) the rights of noncontrolling shareholder(s) are so restrictive that it is
questioned whether control rests with the majority owner. The guidance in
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paragraphs 2–14 of FASB ASC 810-10-25 should be applied in assessing the
impact of consolidation on noncontrolling shareholder approval or veto rights.
That guidance is also applied to determine the impact of consolidation on investments in which the investor has a majority voting interest in a limited
liability company that has governing provisions that are the functional equivalent of a regular corporation.
12.30 FASB ASC 810-10-15-8 states that the usual condition for a controlling financial interest is ownership of a majority voting interest; therefore,
as a general rule, direct or indirect ownership by one reporting entity of more
than 50 percent of the outstanding voting shares of another entity is a condition pointing toward consolidation. The power to control may also exist with
a lesser percentage of ownership (for example, by contract, lease, agreement
with other stockholders, or court decree).
12.31 Legal or business reasons often preclude a physician practice management entity from acquiring the outstanding equity instruments of the physician practice. Per FASB ASC 810-10-15-21, a physician practice management
entity can establish a controlling financial interest in a physician practice
through contractual management arrangements. Specifically, a controlling financial interest exists if, for a requisite period of time, the physician practice
management entity has control over the physician practice and a financial interest in the physician practice that meets all six of the requirements listed
in FASB ASC 810-10-15-22. That paragraph contains guidance that describes
how those six requirements are to be applied. FASB ASC 810-10-55-206 contains a decision tree illustrating the basic analysis called for by both the six
requirements and presumptive, but not other, interpretive guidance.
12.32 The "Consolidation of Entities Controlled by Contract" sections of
FASB ASC 810-10 provide additional guidance about consolidation by physician practice management entities and other situations in which one entity
manages another under similar circumstances and arrangements.

Equity Method of Accounting for Noncontrolling Interests
in Corporations
12.33 Investments in common stock of for-profit entities in which the
reporting entity has 50 percent or less of the voting stock in the investee
should be reported under the guidance in FASB ASC 323, Investments—Equity
Method and Joint Ventures, unless the reporting entity elects to report that
investment at fair value, in accordance with the "Fair Value Option" sections
of FASB ASC 825-10. FASB ASC 323-10-15-3 requires that the equity method
of accounting should be used if investments in common stock or in-substance
common stock give the investor the ability to exercise significant influence over
operating and financial policies of an investee, even though the investor holds
50 percent or less of the common stock or in-substance common stock or both
common stock and in-substance common stock.
12.34 Significant influence is defined in paragraphs 6–11 of FASB ASC
323-10-15. Determining the ability of an investor to exercise significant influence is not always clear, and applying judgment is necessary to assess the
status of each investment. A direct or indirect investment of 20 percent or
more of the voting stock of an investee should lead to a presumption that in the
absence of predominant evidence to the contrary, an investor has the ability to
exercise significant influence over an investee. However, this presumption can
be overcome in certain instances. Paragraphs 10–11 of FASB ASC 323-10-15
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provide examples of indications that an investor may be unable to exercise
significant influence. Conversely, an investment of less than 20 percent of the
voting stock of an investee should lead to a presumption that an investor does
not have the ability to exercise significant influence, unless such ability can
be demonstrated. According to FASB ASC 323-10-25-2, the limitations under
which a majority-owned subsidiary should not be consolidated, as discussed in
FASB ASC 810-10-15-8 and 810-10-15-10, should also be applied as limitations
to the use of the equity method. Health care entities that report investments on
the equity method should make the financial statement disclosures required
by FASB ASC 323-10-50.
12.35 Paragraphs 37–39 of FASB ASC 323-10-35 provide guidance on
how an investor should account for its proportionate share of an investee's
equity adjustments for other comprehensive income (below the performance
indicator) in all of the following circumstances: (a) a loss of significant influence,
(b) a loss of control that results in the retention of a cost method investment,
and (c) discontinuation of the equity method for an investment in a limited
partnership because the conditions in FASB ASC 970-323-25-6 are met for
applying the cost method. Those paragraphs do not provide guidance for entities
that have not historically recorded their proportionate share of an investee's
equity adjustments for other comprehensive income. In accordance with FASB
ASC 954-225-45-7(e), a not-for-profit health care entity should report items
that are required to be reported in, or reclassified from, other comprehensive
income separately from (below) the performance indicator.

Interests in General Partnerships
12.36 FASB ASC 970-810 provides consolidation guidance for the real
estate industry and partners in general partnerships. Although health care
entities are not required to apply that guidance, in current practice, they often
apply it for their interests in general partnerships. FASB ASC 970-810-25-1
states that a general partnership that is directly or indirectly controlled by an
investor is, in substance, a subsidiary of the investor. FASB ASC 970-810-25-2
states that a noncontrolling investor in a general partnership should account
for its investment by the equity method and be guided by the provisions of
FASB ASC 323. Alternatively, the reporting entity may elect to report that
investment at fair value, in accordance with the "Fair Value Option" sections
of FASB ASC 825-10.

Interests in Limited Partnerships and Similar Entities
12.37 FASB ASC 810-20 discusses the potential consolidation of partnerships and similar entities. It provides a framework for the determination of
which, if any, general partner within the group controls and, therefore, should
consolidate a limited partnership or limited liability company that has governing provisions that are the functional equivalent of a limited partnership. See
paragraph 12.29 for a limited liability company that is the functional equivalent of a regular corporation.
12.38 FASB ASC 810-20-25-3 states that the general partners in a limited partnership are presumed to control a limited partnership, regardless of
the extent of the general partners' ownership interest in the limited partnership. Paragraphs 4–20 of FASB ASC 810-20-25 provide guidance for purposes
of assessing whether the limited partners' rights might preclude a general
partner from controlling a limited partnership. Paragraphs 10–11 of FASB
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ASC 810-20-25 state that if the presumption of control by the general partners
is overcome, each of the general partners would account for its investment in
the limited partnership using the equity method of accounting.
12.39 FASB ASC 970-323 provides guidance for the real estate industry
and limited partners in limited partnerships, noncontrolling interests in corporate joint ventures, and undivided interests in real property. Although health
care entities are not required to apply that guidance, except as indicated in
the following paragraph, in current practice, not-for-profit health care entities
often apply it for their noncontrolling interests in all limited partnerships, limited liability companies, corporate joint ventures, and similar entities. Alternatively, the reporting entity may elect to report that investment at fair value,
in accordance with the "Fair Value Option" sections of FASB ASC 825-10.
12.40 FASB ASC 954-810-15-3(i) states that noncontrolling interests in
for-profit real estate partnerships, limited liability entities, and similar entities
over which the reporting entity has more than a minor interest should be
reported under the equity method, in accordance with the guidance in the
"General" sections of FASB ASC 970-323, unless the reporting entity elects to
report that investment at fair value, in accordance with the "Fair Value Option"
sections of FASB ASC 825-10. Those sections state that the equity method of
accounting is generally appropriate for accounting by limited partners for their
investments in limited partnerships. Alternatively, a not-for-profit health care
entity can irrevocably elect fair value as the initial and subsequent measure for
noncontrolling interests in partnerships under the "Fair Value Option" sections
of FASB ASC 825-10. Paragraph 12.44 provides additional information about
distinguishing a minor interest from a more than a minor interest.
12.41 FASB ASC 954-810-15-3(i) also states that a not-for-profit health
care entity should apply the guidance in FASB ASC 970-323-25-2 to determine
whether its interest in a for-profit real estate partnership, limited liability entity, or similar entity is a controlling or noncontrolling interest. FASB ASC
970-323-25-2 refers to FASB ASC 970-810-25-2, which states that a majority
interest holder may not control the entity if one or more of the other partners
have substantive participating rights that permit those other partners to effectively participate in significant decisions that would be expected to be made
in the ordinary course of business. The determination of whether the rights
of the other partners are substantive participating rights should be evaluated
in accordance with the guidance for substantive participating rights in FASB
ASC 810-20. If the other partners have substantive participating rights, the
presumption of control by the majority interest holder is overcome.
12.42 A not-for-profit health care entity should apply the guidance in
FASB ASC 323-30-35-3 to determine whether a limited liability company
should be viewed as similar to a partnership, as opposed to a corporation,
for purposes of determining whether a noncontrolling interest in a limited liability entity or similar entity should be accounted for in accordance with FASB
ASC 970-323 or 323-10. FASB ASC 323-30-35-3 states that an investment in a
limited liability company should be viewed as similar to an investment in a limited partnership if the limited liability company maintains a specific ownership
account for each investor—similar to a partnership capital account structure.
12.43 A limited partner's interest may be so minor that the limited partner may have virtually no influence over partnership operating and financial
policies. FASB ASC 970-323-25-6 states that such a limited partner is, in sub-
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stance, in the same position (with respect to the investment) as an investor that
owns a minor common stock interest in a corporation; accordingly, accounting
for the investment using the cost method may be appropriate.
12.44 Although not registrants, many not-for-profit health care entities analogize to the guidance in FASB ASC 323-30-S99-1 to determine what
is more than a minor interest. FASB ASC 323-30-S99-1 states that the Securities and Exchange Commission (SEC) staff understands that practice generally
has viewed investments of more than 3 percent to 5 percent to be more than
minor.

Special Entities
12.45 This section discusses relationships with three types of special entities, as follows:

r
r
r

Special-purpose leasing entities
Joint operating agreements
Other special-purpose entities

Consolidation of a Special-Purpose Leasing Entity
12.46 FASB ASC 954-810-15-3(g) states that if a not-for-profit businessoriented health care entity is engaged in leasing transactions with a specialpurpose-entity (SPE) lessor, it should consider whether it should consolidate
the lessor, in accordance with the guidance in paragraphs 8–10 of FASB ASC
958-810-25.
12.47 FASB ASC 958-810-25-8 states that a not-for-profit entity should
consolidate such a lessor if all of the following conditions exist:
a. Substantially all of the activities of the SPE involve assets that are
to be leased to a single lessee.
b. The expected substantive residual risks, substantially all the residual rewards of the leased asset(s), and the obligation imposed by
the underlying debt of the SPE directly or indirectly reside with
the lessee through means such as any of the following:
i. The lease agreement
ii. A residual value guarantee through, for example, the assumption of first-dollar-of-loss provisions
iii. A guarantee of the SPE's debt
iv. An option granting the lessee a right to do either of the
following:
(1) Purchase the leased asset at a fixed price or a
defined price other than fair value determined at
the date of the exercise
(2) Receive any of the lessor's sales proceeds in excess
of a stipulated amount
c. The owner(s) of record of the SPE has not made an initial, substantive, residual equity capital investment that is at risk during
the entire term of the lease. This criteria should be considered met
if the majority owner(s) of the lessor is not an independent third
party, regardless of the level of capital investment.
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12.48 According to FASB ASC 958-810-25-9, to satisfy the at-risk requirement in FASB ASC 958-810-25-8(c) (see paragraph 12.47), an initial, substantive, residual equity capital investment should meet all of the following
conditions:
a. It represents an equity interest in legal form.
b. It is subordinate to all debt interests.
c. It represents the residual equity interest during the entire lease
term.
12.49 FASB ASC 958-810-25-10 states that if all the conditions in FASB
ASC 958-810-25-8 (see paragraph 12.47) exist, the assets, liabilities, results of
operations, and cash flows of the SPE should be consolidated in the lessee's
financial statements. This conclusion should be applied to SPEs that are established for both the construction and subsequent lease of an asset for which
the lease would meet all the conditions in FASB ASC 958-810-25-8 (see paragraph 12.47). In those cases, the consolidation by the lessee should begin at the
lease inception, rather than the beginning of the lease term. Implementation
guidance may be found in FASB ASC 958-810-55-4A and 958-840-55-1.
12.50 The Financial Reporting Executive Committee believes that 3 percent is the minimum acceptable investment to qualify as an initial, substantive,
residual equity capital investment. A greater investment may be necessary depending on the facts and circumstances, including the credit risk associated
with the lessee and market risk factors associated with the leased property.
For example, the cost of borrowed funds for the transaction might be indicative
of the risk associated with the transaction and whether an equity investment
greater than 3 percent is needed.

Agreements to Jointly Operate a Facility or Other Activity
12.51 Health care systems may enter into an agreement in which two
or more entities agree to jointly operate and control a certain endeavor, such
as a hospital or treatment center, while sharing in the operating results and
residual interest upon dissolution, based upon an agreed-upon ratio. Those
agreements are similar to joint ventures and, typically, are characterized by
factors such as the following:

r
r
r
r

Common purpose. For example, to share risks and rewards; develop a new market, health service, or program; or pool resources.
Joint funding. All parties contribute resources toward the accomplishment.
Defined relationship. Typically governed by an agreement.
Joint control. No one entity controls the joint operating activity.

12.52 If the endeavor is housed in a separate legal entity, such as a
corporation or partnership, it would be accounted for similar to a corporate
joint venture using the equity method of accounting described in FASB ASC
323-10. Alternatively, the reporting entity may elect to report such interests at
fair value, in accordance with the "Fair Value Option" sections of FASB ASC
825-10.
12.53 If the endeavor is not conducted within a separate legal entity, it
would be accounted for based on the guidance in FASB ASC 808, Collaborative
Arrangements. FASB ASC 808-10-45-1 states that participants in a collaborative arrangement should report costs incurred and revenue generated from
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transactions with third parties (that is, parties that do not participate in the
arrangement) in each entity's respective income statement, pursuant to the
guidance in FASB ASC 605-45 for principal agents. An entity should not apply
the equity method of accounting to the activities of a collaborative arrangement.

Other Special-Purpose Entities
12.54 A not-for-profit business-oriented health care entity may be engaged in transactions with an SPE that are other than leasing transactions
or transactions of a collaborative arrangement. In practice, entities analogize
to the guidance in paragraphs 8–10 of FASB ASC 958-810-25 and paragraphs
7–16 of FASB ASC 958-810-55 to determine whether to consolidate the SPE.

Reporting by Investor-Owned Health Care Entities
12.55 FASB ASC 954-810-15-2 provides a summary of the locations of
standards that an investor-owned health care entity uses for reporting relationships with other entities, as follows:
a. Pursuant to FASB ASC 810-10-15-3(a), an investor-owned health
care entity should first apply the guidance in the "Variable Interest
Entities" sections of FASB ASC 810-10 if it is within the scope of
those sections.
b. Pursuant to FASB ASC 810-10-15-3(b), if the investor-owned
health care entity has an investment in another entity that is not
determined to be a VIE, it should use the guidance in the "General"
sections of FASB ASC 810-10 to determine whether that interest
constitutes a controlling financial interest. That guidance also is
used to determine if a not-for-profit health care entity has a controlling financial interest in a for-profit entity, and it is discussed
in paragraphs 12.28–.32.
c. Pursuant to FASB ASC 810-10-15-3(c), if the investor-owned health
care entity has a contractual management relationship with another entity (for example, a physician practice), and that other
entity is not determined to be a VIE, it shall use the guidance in
the "Consolidation of Entities Controlled by Contract" sections of
FASB ASC 810-10 to determine whether the arrangement constitutes a controlling financial interest. That guidance also is used
to determine if a not-for-profit health care entity has a controlling financial interest in a for-profit entity, and it is discussed in
paragraphs 12.30–.32.
d. Pursuant to FASB ASC 810-20-15, if the investor-owned health
care entity is the general partner of a limited partnership or similar entity, such as a limited liability entity that has governing provisions that are the functional equivalent of a limited partnership,
it should apply the guidance in FASB ASC 810-20. That guidance
also is used by a not-for-profit health care entity that has an interest in a for-profit partnership, and it is discussed in paragraph
12.38.
e. Pursuant to FASB ASC 810-30-15, if the investor-owned health
care entity is a sponsor in a research and development arrangement, it shall apply the guidance in FASB ASC 810-30.
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12.56 In addition, the SEC staff's position is that health care entities
that are registrants should follow applicable SEC guidance and the guidance
in paragraphs 6–7 of FASB ASC 970-323-25 for their noncontrolling interests
in non-real estate limited partnerships. Although investor-owned health care
entities that are not registrants are not required to apply that guidance, in
current practice, they often apply it for their noncontrolling interests in general
partnerships, limited partnerships, limited liability companies, corporate joint
ventures, and similar entities.
12.57 The "Variable Interest Entities" sections of FASB ASC 810-10 address consolidation by business entities of VIEs. An investor-owned health care
entity should follow the guidance in the "Variable Interest Entities" sections if,
by design, any of the conditions in FASB ASC 810-10-15-14 exist. The phrase by
design refers to entities that meet the conditions in that paragraph because of
the way they are structured. For example, a legal entity under the control of its
equity investors that originally was not a VIE does not become one because of
operating losses. The design of the legal entity is important in the application of
these provisions. Although according to FASB ASC 810-10-15-17, not-for-profit
entities are not subject to the "Variable Interest Entities" sections of FASB
ASC 810-10, if a not-for-profit entity is used by a business reporting entity
in a manner similar to a VIE in an effort to circumvent the provisions of the
"Variable Interest Entities" sections, that not-for-profit entity is subject to the
guidance in the "Variable Interest Entities" sections.

Presentation of Consolidated and Combined
Financial Statements
12.58 Some accounting standards, including some for reporting relationships with other entities, specify the display of certain financial statement elements or items without considering the reporting model used by not-for-profit
health care entities. Therefore, FASB ASC 958-10-45-1 states that preparers of
financial statements of not-for-profit entities should follow the guidance in an
analogous manner that is appropriate for their method of reporting financial
performance and financial position and should consider the reporting objectives
of the guidance when exercising judgment about how best to display elements,
such as in which net asset class.
12.59 FASB ASC 810-10-10-1 states that the purpose of consolidated financial statements is to present, primarily for the benefit of the shareholders
and creditors of the parent entity, the results of operations and financial position of a parent entity and its subsidiaries essentially as if the group was a
single entity with one or more branches or divisions. A presumption exists that
consolidated financial statements are more meaningful than separate financial
statements and that they are usually necessary for a fair presentation when
one of the entities in the group has a direct or indirect controlling financial
interest in the other entities.
12.60 FASB ASC 810-10-25-15 states that application of guidance of an
industry-specific topic to a subsidiary within the scope of that industry-specific
topic should be retained in consolidation of that subsidiary.
12.61 For example, if a not-for-profit health care entity has a controlling
financial interest in an investor-owned entity, and that entity in turn has a
controlling financial interest in a VIE, the consolidation of the VIE is retained
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in the consolidated financial statements. Similarly, if a not-for-profit health
care entity has a controlling financial interest in an investor-owned entity, the
debt and equity securities owned by the investor-owned entity are measured
and reported using the standards in FASB ASC 320, Investments—Debt and
Equity Securities, rather than being remeasured using the standards in FASB
ASC 958-320.
12.62 FASB ASC 958-810-45-1 states that noncontrolling interests in the
equity (net assets) of consolidated subsidiaries should be reported as a separate
component of the appropriate class of net assets in the consolidated statement
of financial position of a not-for-profit health care entity. That amount shall
be clearly identified and described (for example, as noncontrolling ownership
interest in subsidiaries) to distinguish it from the components of net assets
of the parent, which includes the parent's controlling financial interest in its
subsidiaries. The effects of donor-imposed restrictions, if any, on a partiallyowned subsidiary's net assets should be reported in accordance with FASB
ASC 958-205 and 958-320. Paragraphs 4–6 of FASB ASC 958-810-50 require
certain disclosures about noncontrolling interests. Paragraph 9.18 of this guide
provides additional information about noncontrolling interests.
12.63 According to FASB ASC 954-810-45-3B, when consolidated financial
statements are required or permitted by FASB ASC 958-810-25, a noncontrolling interest in the other not-for-profit entity should be provided if such interest is represented by an economic interest whereby the noncontrolling interest
would share in the operating results or residual interest upon dissolution.
12.64 According to FASB ASC 958-810-50-1, if consolidated financial
statements are presented by a not-for-profit entity (parent), the parent should
disclose any restrictions made by entities outside the reporting entity on distributions from the controlled not-for-profit entity (subsidiary) to the parent and
any resulting unavailability of the net assets of the subsidiary for use by the
parent.
12.65 FASB ASC 810-10-45-11 states that in some cases, parent-entity
financial statements may be needed, in addition to consolidated financial statements, to adequately indicate the position of bondholders and other creditors
or preferred shareholders of the parent. Consolidating financial statements,
in which one column is used for the parent and other columns for particular
subsidiaries or groups of subsidiaries, often are an effective means of presenting the pertinent information. However, consolidated financial statements are
the general-purpose financial statements of a parent having one or more subsidiaries; thus, parent-entity financial statements are not a valid substitute for
consolidated financial statements.
12.66 However, neither generally accepted accounting principles (GAAP)
nor this guide discuss the use of the parent entity's financial statements as
other than the general-purpose financial statements for the primary reporting entity.7 GAAP does not preclude the issuance of financial statements for
the subsidiary only. However, care should be taken to include all disclosures
required by FASB ASC 850, Related Party Disclosures, and other relevant pronouncements.
7
Contractual agreements or regulatory provisions may require parent company-only financial
statements. AU section 623, Special Reports (AICPA, Professional Standards), provides guidance for
reporting on financial presentations to comply with contractual agreements or regulatory provisions.
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12.67 FASB ASC 810-10-55-1B states that in some circumstances, combined financial statements, as distinguished from consolidated financial statements, of commonly controlled entities are likely to be more meaningful than
their separate statements. Combined statements would be useful if one individual owns a controlling financial interest in several entities that are related
in their operations. Combined financial statements might also be useful to
present the financial position and results of operations of entities under common management. Pursuant to FASB ASC 810-10-45-10, both consolidation
and combination require elimination of intraentity transactions and profits
and losses.
12.68 In some situations, debt agreements may require the combined financial statements of affiliated entities, the assets or revenues of which serve
as collateral for the related debt (sometimes called an obligated group). However, if debt or other agreements prescribe a financial presentation that varies
from GAAP (for example, exclusion of entities otherwise required to be consolidated), AU section 623, Special Reports (AICPA, Professional Standards),
establishes requirements and provides guidance regarding auditor's reports.

Accounting for Transfers Between Related Entities
12.69 Transfers from a foundation that acts as an agent, a trustee, or
an intermediary (that is, a recipient entity) for contributions to a related nongovernmental health care entity are discussed in paragraphs 12.16–.24. This
section discusses equity transfers, equity transactions, and other transfers between related entities.

Equity Transfers
12.70 The FASB ASC glossary defines an equity transfer as follows:
An equity transfer is nonreciprocal. An equity transfer is a transaction directly between a transferor and a transferee. Equity transfers
are similar to ownership transactions between a for-profit parent and
its owned subsidiary (for example, additional paid-in capital or dividends). However, equity transfers can occur only between related notfor-profit entities (NFPs) if one controls the other or both are under
common control. An equity transfer embodies no expectation of repayment, nor does the transferor receive anything of immediate economic
value (such as a financial interest or ownership).
Per FASB ASC 954-225-45-2, equity transfers are reported separately as
changes in net assets, are excluded from the performance indicator, and do
not result in any step-up in the basis of the transferred underlying assets.
12.71 The "Transactions Between Entities Under Common Control" sections of FASB ASC 805-50 provide guidance when accounting for a transfer
of assets or exchange of shares between entities under common control. The
entity that receives the net assets or equity interests should recognize the
transferred assets and liabilities at the date of transfer, initially measuring
them at their carrying amounts in the accounts of the transferring entity. If
the carrying amounts of the transferred assets and liabilities differ from the
historical cost of the parent of the entities under common control (for example,
because push-down accounting had not been applied), then the financial statements of the receiving entity should reflect the transferred assets and liabilities
at the historical cost of the parent of the entities under common control. FASB
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ASC 805-50-45 provides guidance on the presentation of financial statements
for the period of transfer and comparative financial statements for prior years,
and disclosures are required by FASB ASC 805-50-50.
12.72 FASB ASC 805-50-30-6 notes that in some instances, the entity that
receives the net assets or equity interests (the receiving entity) and the entity
that transferred the net assets or equity interests (the transferring entity) may
account for similar assets and liabilities using different accounting methods.
In such circumstances, the carrying amounts of the transferred assets and
liabilities may be adjusted to the basis of accounting used by the receiving
entity if the change would be preferable. Any such change in accounting method
should be applied retrospectively, and financial statements presented for prior
periods should be adjusted, unless it is impracticable to do so. FASB ASC
250-10-45 provides guidance if retrospective application is impracticable.
12.73 In most situations, transfers are recorded at the time they are
formally obligated to occur (formal board resolutions, legal notes, passage of
title to real estate, and so on), as would be the case when each of the entities
have independent governance, and the timing of the transfer is controlled by the
governing board of the transferor. Yet, in situations of clear, common control
of the related entities, it would be appropriate to record transfers at the time
when both the transfer amount is known, and the receiving entity is given
control over the timing of the transfer.

Equity Transactions
12.74 According to FASB ASC 958-20-25-4, a transfer from a nongovernmental health care entity to a not-for-profit entity or charitable trust (referred
to as a recipient entity) is an equity transaction if all of the following conditions
are present:

r

r
r

A nongovernmental health care entity transfers assets to a notfor-profit entity or charitable trust (called a recipient entity) that
accepts those assets and agrees to use them on behalf of the nongovernmental health care entity or transfer them, their investment return, or both back to the nongovernmental health care
entity or its affiliate (that is, the nongovernmental health care
entity specifies itself or its affiliate as the beneficiary of the transfer).
The nongovernmental health care entity and recipient entity are
financially-interrelated entities.
Neither the nongovernmental health care entity nor its affiliate
expects payment of the transferred assets, although payment of
investment return on the transferred assets may be expected.

12.75 FASB ASC 958-20-15-2 provides that a recipient entity and specified beneficiary are financially-interrelated entities if the relationship between
them has both of the following characteristics: one entity has the ability to influence the operating and financial decisions of the other, and one entity has an
ongoing economic interest in the net assets of the other. The ability to exercise
that influence can be demonstrated in several ways, including the following:
a. The entities are affiliates, as defined in the FASB ASC glossary.
b. One entity has considerable representation on the governing board
of the other entity.
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c. The charter or bylaws of one entity limits its activities to those that
are beneficial to the other entity.
d. An agreement between the entities allows one entity to actively
participate in the policy-making processes of the other, such as
setting organizational priorities, budgets, and management compensation.
The FASB ASC glossary defines an ongoing economic interest in the net assets
of another as "[a] residual right to another not-for-profit entity's (NFP's) net
assets that results from an ongoing relationship. The value of those rights
increases or decreases as a result of the investment, fundraising, operating,
and other activities of the other entity."
12.76 Per FASB ASC 954-225-55-1, an equity transaction differs from an
equity transfer in that an equity transaction, as described in FASB ASC 95820-25-4, involves a financially-interrelated party either as a third party in a
transfer from an entity to one of its affiliates or a counterparty in a transfer from
an entity to itself. An equity transfer, as described in the guide, is a transaction
directly between a transferor and transferee. In addition, an equity transaction
is reciprocal; the health care entity or its affiliate named as the beneficiary
receives an ongoing economic interest in the assets held by the recipient entity.
As noted in the FASB ASC glossary definition of equity transfer, an equity
transfer is nonreciprocal; no expectation of repayment exists, and the transferor
does not receive a financial interest or ownership (see paragraphs 12.70–.73).
12.77 The reporting of an equity transaction depends upon whether the
resource provider or its affiliate is the specified beneficiary. As discussed in
FASB ASC 958-20-25-5, if the resource provider specifies itself as beneficiary,
it should report an equity transaction as an asset—an interest in the net assets of the recipient entity or an increase in a previously-recognized interest.8
According to FASB ASC 958-20-25-6, if a resource provider specifies an affiliate as beneficiary of an equity transaction, the resource provider should report
an equity transaction as a separate line in its statement of activities, and the
affiliate named as beneficiary should report an interest in the net assets of
the recipient entity.9 In accordance with FASB ASC 958-20-45-1, the recipient
entity should report an equity transaction as a separate line in its statement
of activities. The resource provider should disclose the information described
in FASB ASC 958-605-50-6 (see paragraph 4.63 of this guide) for each period
for which a statement of financial position is presented.

Other Transfers
12.78 Other transfers may occur among related entities. If the entities
are consolidated or combined, such transfers are eliminated in consolidation
or combination, or both. If the entities are not consolidated or combined (for
example, in separate subsidiaries or obligated group financial statements),10
the method of accounting for such transfers is dictated by the substance of
8
According to FASB ASC 958-20-45-3, if the beneficiary (resource provider) and recipient entity
are included in consolidated financial statements, the beneficiary's interest in the net assets of the
recipient entity should be eliminated, in accordance with FASB ASC 810-10-45-1.
9
According to FASB ASC 958-20-45-3, if the beneficiary (affiliate) and recipient entity are included in consolidated financial statements, the beneficiary's interest in the net assets of the recipient
entity should be eliminated, in accordance with FASB ASC 810-10-45-1.
10
See paragraphs 7.72–.74 of this guide for additional discussion regarding obligated group
financial statements.
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the transaction, as well as the legal form. For example, certain transfers by a
foundation to a related not-for-profit health care entity are reported as contributions, as discussed in paragraphs 12.16–.24. In other situations, payments may
be made for services provided between not-for-profit entities under common
control, which should be accounted for as revenues and expenses depending on
the types of provided services. Transfers that result in changes in ownership
interest are accounted for as investments, in accordance with FASB ASC 323
and 810.
12.79 Assets transferred from one commonly controlled entity to another
should be recorded by the transferee at the carrying value of the transferring entity. This treatment is consistent with the guidance prescribed in the
"Transactions Between Entities Under Common Control" sections of FASB
ASC 805-50. For additional information, see paragraphs 12.71–.73.
12.80 According to FASB ASC 954-310-25-3, a health care entity may loan
or advance resources to a related entity. If repayment is reasonably assured, a
receivable or payable should be recorded by the entities.
12.81 Subsequent to the time that a receivable is recorded, the ability of
the receiving entity to repay the receivable should be considered.
12.82 According to FASB ASC 954-310-40-1, if the receivable from a related entity is not to be repaid, or the related entity is perceived as unable to
repay, the write-off of the receivable is recognized as an equity transfer, as discussed in FASB ASC 954-225-45-2, with the transferor reducing net assets and
the transferee increasing net assets at the date such determination is made.
See paragraphs 12.70–.73 for additional discussion.

Disclosure
12.83 Significant relationships and transactions not in the ordinary course
of business with directors; management; medical staff; or other related parties,
including unconsolidated related entities, should be disclosed in accordance
with FASB ASC 850. AU section 334, Related Parties (AICPA, Professional
Standards), establishes requirements and provides guidance for the auditor
when determining the existence of transactions with related parties and identifying them.
12.84 Hospital boards may contract with management companies to operate their facilities. Frequently, the management company will employ the
administrator, as well as other key personnel. Further, services may be acquired from entities related to the management company. The auditor should
evaluate the impact of these arrangements on the hospital's internal controls
and disclose related-party transactions, as required by FASB ASC 850.

Mergers and Acquisitions
12.85 The reporting entity is changed by mergers and acquisitions (referred to jointly as combinations) entered into by the health care entity. Standards for financial accounting and reporting for combinations differ depending
upon whether the combining entities are investor-owned entities, not-for-profit
entities, or one of each. Paragraphs 12.86–.108 summarize some of the guidance in FASB ASC 958-805 and FASB ASC 805, Business Combinations, but
are not intended as a substitute for reading those standards.
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12.86 FASB ASC 805 provides guidance on accounting and reporting for
transactions or other events in which an acquirer obtains control of one or more
businesses in a combination to be accounted for under the acquisition method.
FASB ASC 958-805 provides guidance on a transaction or other event in which
a not-for-profit entity that is the reporting entity combines with one or more
other not-for-profit entities, businesses, or nonprofit activities.
12.87 If the reporting entity is an investor-owned health care entity, all
combinations are accounted for using the acquisition method, including transactions or events referred to as true mergers or mergers of equals.
12.88 If the reporting entity is a not-for-profit health care entity, FASB
ASC 958-805-25-1 requires that it determine whether the combination transaction or event is a merger of not-for-profit entities or an acquisition by a
not-for-profit entity by applying the definitions of those combinations. FASB
ASC 958-805-55-1 states that ceding control to a new not-for-profit entity is the
sole definitive criteria for identifying a merger, and one entity obtaining control over the other is the sole definitive criteria for an acquisition. Paragraphs
1–31 of FASB ASC 958-805-55 provide guidance on distinguishing between a
merger and an acquisition.
12.89 The guidance for combinations of entities in this section is organized
as follows:

r
r
r
r

Mergers of not-for-profit entities
Acquisitions by a not-for-profit entity
Acquisitions by an investor-owned entity, including a for-profit
subsidiary of a not-for-profit health care entity
Disclosures about combinations

Merger of Not-for-Profit Entities
12.90 The FASB ASC glossary defines merger of not-for-profit entities as
"[a] transaction or other event in which the governing bodies of two or more
not-for-profit entities cede control of those entities to create a new not-forprofit entity." FASB ASC 958-805-25-3 requires that the not-for-profit entity
resulting from a merger (the new entity) account for the merger by applying the
carryover method described in the "Merger of Not-for-Profit Entities" sections
of FASB ASC 958-805.
12.91 Applying the carryover method requires combining the assets and liabilities recognized in the separate financial statements of the merging entities
as of the merger date (or that would be recognized if the entities issued financial
statements as of that date), with certain adjustments. The new not-for-profit
entity does not recognize additional assets or liabilities, such as internallydeveloped intangible assets, that GAAP did not require or permit the merging
entities to recognize. However, if a merging entity's separate financial statements are not prepared in accordance with GAAP, those statements should be
adjusted to GAAP before the new entity recognizes the assets and liabilities.
The new not-for-profit health care entity should carry forward at the merger
date the merging entities' classifications and designations of their assets and
liabilities, unless one of the exceptions in FASB ASC 958-805-25-9 applies.
Those exceptions are for certain modifications in contracts as a result of the
merger and for conforming accounting policies to reflect a consistent method of
accounting.
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Acquisition by a Not-for-Profit Entity
12.92 The FASB ASC glossary defines acquisition by a not-for-profit entity as "[a] transaction or other event in which a not-for-profit acquirer obtains
control of one or more nonprofit activities or businesses and initially recognizes
their assets and liabilities in the acquirer's financial statements." A not-forprofit health care entity should account for each acquisition of a business or
nonprofit activity by applying the acquisition method described in the "Acquisition by a Not-for-Profit Entity" sections of FASB ASC 958-805. That acquisition
method is the same as the acquisition method described in FASB ASC 805; however, FASB ASC 958-805 includes guidance on aspects of the items that are
unique or especially significant to a not-for-profit entity.
12.93 Pursuant to FASB ASC 805-10-05-4, as modified by FASB ASC
958-805-25-13, the steps for applying the acquisition method are as follows:
a. Identifying the acquirer
b. Identifying the acquisition date
c. Recognizing the identifiable acquired assets, the assumed liabilities, and any noncontrolling interest in the acquiree
d. Recognizing acquired goodwill or a contribution received, including
transferred consideration
e. Determining what is part of the acquisition transaction
12.94 FASB ASC 805-10-25-4 requires that one of the combining entities
be identified as the acquirer. The guidance on control and consolidation of
not-for-profit entities should be used to identify the acquirer. For a not-forprofit entity acquirer other than a health care entity, the guidance to be used
is the guidance in FASB ASC 958-810, including the guidance referenced in
FASB ASC 958-810-15-4. Consolidation of not-for-profit entities is discussed
beginning at paragraph 12.03. If that guidance does not clearly indicate which
of the combining entities is the acquirer, the factors in paragraphs 42–46 of
FASB ASC 958-805-55 should be considered in making that determination.
12.95 Paragraphs 6–7 of FASB ASC 805-10-25 require that the acquirer
identify the acquisition date, which is the date on which it obtains control of
the acquiree. The date on which the acquirer obtains control of the acquiree
generally is the date on which the acquirer legally transfers the consideration,
if any; acquires the assets; and assumes the liabilities of the acquire (the closing
date). In addition, FASB ASC 958-805-25-17 states that the date on which a notfor-profit acquirer obtains control of a not-for-profit entity with sole corporate
membership generally is also the date on which the acquirer becomes the sole
corporate member of that entity.
12.96 FASB ASB ASC 805-20 requires that as of the acquisition date, the
acquirer recognize separately from goodwill the identifiable acquired assets,
the assumed liabilities, and any noncontrolling interest in the acquiree.
12.97 In conformity with FASB ASC 958-805-30-6(b), a not-for-profit acquirer determines the net of the acquisition date amounts of the identifiable
acquired assets and assumed liabilities, measured in accordance with FASB
ASC 805-20 and 958-805. Most assets and liabilities are measured at fair value.
However, FASB ASC 805-20-25-16 notes that limited exceptions exist to the
recognition and measurement principles applicable to business combinations,
including acquisitions by a not-for-profit entity. The limited exceptions are
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specified in paragraphs 16–28 of FASB ASC 805-20-25, paragraphs 12–23 of
FASB ASC 805-20-30, and paragraphs 21–26 of FASB ASC 958-805-25. Examples of items that are either not recognized or are measured at an amount
other than their acquisition date fair values include income taxes, employee
benefits, assets held for sale, collections, conditional promises to give, donor
relationships, and certain assets and liabilities arising from contingencies.
12.98 Next, in conformity with FASB ASC 958-805-30-6(a), a not-for-profit
acquirer determines the aggregate of the following:
a. The transferred consideration, measured at its acquisition date fair
value, as discussed in paragraphs 10–13 of FASB ASC 958-805-30
b. The fair value of any noncontrolling interest in the acquire
c. In an acquisition by a not-for-profit entity achieved in stages, the
acquisition date fair value of the acquirer's previously-held equity
interest in the acquire
12.99 If the amount in FASB ASC 958-805-30-6(a) is greater than the
amount in FASB 958-805-30-6(b), a not-for-profit acquirer should determine
whether the operations of the acquiree as part of the combined entity are expected to be predominantly supported by contributions and returns on investments. If the operations of the acquiree are not expected to be predominantly
supported by contributions and returns on investments, in conformity with
FASB ASC 958-805-25-28, a not-for-profit acquirer should recognize goodwill
as of the acquisition date, measured as of the acquisition date as the excess
of FASB ASC 958-805-30-6(a) over FASB ASC 958-805-30-6(b). Predominantly
supported by means that contributions and returns on investments are expected to be significantly more than the total of all other sources of revenues.
12.100 In rare cases, the operations of the acquiree as part of the combined
not-for-profit health care entity are expected to be predominantly supported
by contributions and returns on investments. If so, FASB ASC 958-805-25-29
requires a not-for-profit acquirer to recognize a separate charge in its statement
of activities as of the acquisition date, measured as the excess of FASB ASC
958-805-30-6(a) over FASB 958-805-30-6(b), rather than goodwill.
12.101 If the amount in FASB ASC 958-805-30-6(b) is greater than the
amount in FASB 958-805-30-6(a), FASB ASC 958-805-25-31 requires a notfor-profit acquirer to recognize an inherent contribution received, measured as
the excess of FASB ASC 958-805-30-6(b) over FASB ASC 958-805-30-6(a). The
inherent contribution is reported as a separate credit in the statement of activities as of the acquisition date and, in accordance with FASB ASC 958-805-45-6,
is classified on the basis of the type of restrictions imposed on the related net
assets. FASB ASC 958-805-45-6 states that those restrictions include restrictions imposed on the net assets of the acquiree by a donor before the acquisition
and those imposed by the donor of the acquired business or nonprofit activity,
if any. Donor-restricted contributions are reported as restricted support, even
if the restrictions are met in the same reporting period in which the acquisition
occurs. The acquirer should not apply the reporting exception in FASB ASC
958-605-45-4, as discussed in paragraph 11.12 of this guide, to restricted net
assets acquired in an acquisition.

Performance Indicator
12.102 FASB ASC 954-805 provides standards for reporting amounts related to an acquisition by a not-for-profit health care entity within or outside
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of the performance indicator. The following amounts are reported within the
performance indicator:

r
r
r

The changes in the fair value of a contingent consideration recognized in accordance with FASB ASC 958-805-35-3, unless the
arrangement is a hedging instrument for which FASB ASC 954815 requires the entity to recognize the changes outside the performance indicator
The separate charge that is recognized in accordance with FASB
ASC 958-805-25-29 (that is, the immediate write-off of the goodwill amount)
The gain or loss resulting from remeasuring a previously-held
equity interest in the acquiree in an acquisition achieved in stages,
as discussed in paragraphs 9–10 of FASB ASC 805-10-25 and
FASB ASC 954-805-45-3

12.103 Per FASB ASC 954-805-45-2, whether the inherent contribution
received, recognized in accordance with FASB ASC 958-805-25-31, is presented
within or outside the performance indicator depends on whether the contribution is unrestricted or restricted. An unrestricted contribution should be
presented within the performance indicator. A contribution that is either temporarily restricted or permanently restricted should be presented outside the
performance indicator.
12.104 FASB ASC 954-805-50 requires disclosures about the performance
indicator in periods in which mergers or acquisitions occur.

Acquisition by an Investor-Owned Entity, Including a For-Profit
Subsidiary of a Not-for-Profit Health Care Entity
12.105 FASB ASC 805-10-25-1 requires that an investor-owned health
care entity determine whether a transaction or other event is a business combination by applying the definition of a business combination, which requires that
the acquired assets and assumed liabilities constitute a business, as defined.
If the acquired assets are not a business, the reporting entity should account
for the transaction or other event as an asset acquisition. An entity should
account for each business combination by applying the acquisition method.
12.106 FASB ASC 805-10-05-4 states that the acquisition method requires
all of the following steps:
a. Identifying the acquirer, which is discussed in FASB ASC 805-10
b. Determining the acquisition date, which is discussed in FASB ASC
805-10
c. Recognizing and measuring the identifiable acquired assets, the
assumed liabilities, and any noncontrolling interest in the acquiree,
as discussed in FASB ASC 805-20
d. Recognizing and measuring goodwill or a gain from a bargain purchase, as discussed in FASB ASC 805-30
12.107 FASB ASC 958-805-25-14 identifies the differences in the application of the acquisition method by a not-for-profit acquirer from the application
of the acquisition method by a business entity. Those differences include all of
the following:
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a. An investor-owned health care entity identifies the acquirer in accordance with FASB ASC 805-10-25-5 instead of the guidance in
paragraphs 15–16 of FASB ASC 958-805-25.
b. An investor-owned health care entity recognizes and measures
goodwill in accordance with FASB ASC 805-30-25-1 and paragraphs 1–3 of FASB ASC 805-30-30-3 instead of the guidance in
paragraphs 27–30 of FASB ASC 958-805-25. Only a not-for-profit
acquirer may recognize the immediate charge to the statement of
activities.
c. An investor-owned health care entity recognizes and measures a
gain from a bargain purchase in accordance with paragraphs 2–4
of FASB ASC 805-30-25 and paragraphs 4–6 of FASB ASC 80530-30 instead of the guidance for an inherent contribution received
in FASB ASC 958-805-25-31 and paragraphs 8–9 of FASB ASC
958-805-30.

Disclosures About Combinations *
12.108 FASB ASC 958-805-50 requires a not-for-profit health care entity
to disclose information that enables users of its financial statements to evaluate
the nature and financial effect of a merger of not-for-profit entities or an acquisition by a not-for-profit entity. Similarly, FASB ASC 805-10-50, 805-20-50,
and 805-30-50 require an investor-owned health care entity to disclose information that enables users of its financial statements to evaluate the nature
and financial effect of a business combination. If acquisitions are individually
immaterial but collectively material, the entity should disclose the required
information in the aggregate. Disclosures are also required if an acquisition
date is after the reporting date but before the financial statements are issued
or available for issue. If the initial accounting for an acquisition by an entity
is incomplete, the entity should disclose information that enables users of its
financial statements to evaluate the financial effects of adjustments recognized
in the current reporting period that relate to acquisitions that occurred in the
current or previous reporting periods.

Auditing
12.109 The independent auditor may consider the examples of specific auditing objectives, selected control activities, and auditing procedures for related
parties, balances, and transactions that are presented in exhibit 12-2.

*
In December 2010, FASB issued Accounting Standards Update (ASU) No. 2010-29, Business
Combinations (Topic 805): Disclosure of Supplementary Pro Forma Information for Business Combinations (a consensus of the FASB Emerging Issues Task Force). This ASU is intended to clarify
requirements for reporting pro forma revenue and earnings disclosures in business combinations.
This ASU is effective for business combinations with acquisition dates on or after the beginning of
the first annual reporting period beginning on or after December 15, 2010.
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Exhibit 12-2
The following table illustrates the use of assertions in developing audit objectives and designing substantive tests. The examples are not
intended to be all-inclusive nor is it expected that all the procedures
would necessarily be applied in an audit. The auditor should design
and perform substantive procedures for all relevant assertions related
to each material class of transactions, account balance, and disclosure
to obtain sufficient appropriate audit evidence. The use of assertions
in assessing risks and designing appropriate audit procedures to obtain audit evidence is described in paragraphs .14–.26 of AU section
326, Audit Evidence (AICPA, Professional Standards). Various audit
procedures and the purposes for which they may be performed are
described in paragraphs .27–.41 of AU section 326.

Auditing Considerations
Financial Statement Specific Auditing Selected Control
Assertions
Objectives
Activities

Auditing
Procedures

Reporting Entity and Related Entities
Transactions/Account Balances/Presentation and Disclosure
Existence and
occurrence,
completeness, and
presentation and
disclosure

The reporting
entity is
appropriate.

Procedures
ensure that
investees,
affiliates, and
other related
entities are
accounted for
appropriately.

Review the
articles of
incorporation,
bylaws, and
minutes of
directors'
meetings;
shareholder lists;
and filings with
regulatory
authorities to
determine the
existence of
related parties.
Obtain
representations
from
management
about whether all
investees,
affiliates, and
related entities
have been
accounted for
properly or
disclosed.
(continued)
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Auditing Considerations—continued
Financial Statement Specific Auditing Selected Control
Assertions
Objectives
Activities

Auditing
Procedures
Review
transactions with
investees,
affiliates, and
other related
entities to
determine that
they are properly
reported and
clearly expressed.

Relationships
and transactions
with related
entities are
identified and
disclosed, if
appropriate,
because of
economic
dependence of
the entity.

Procedures
ensure that
conflict-ofinterest
policies,
procedures, and
disclosure
requirements
are met.

Test significant
related-party
transactions as
follows:

•
•

•
•

Determine
substance.
Examine
documents
(invoices,
contracts, and
agreements).
Determine the
basis of pricing.
Determine the
collectibility of
receivables and
advances.

Review
related-party
transactions for
completeness by

•

•

•
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previously
identified
transactions or
relationships.
reviewing the
minutes of
directors' and
other meetings.
discussing
related-party
transactions
with entity
personnel.
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Financial Statement Specific Auditing Selected Control
Assertions
Objectives
Activities

Auditing
Procedures

•
•

reviewing
unusual
transactions.
reviewing the
responses to
related-party
(conflict-ofinterest)
questionnaires.

Presentation and Disclosure
Classification and
understandability

Related-party
transactions and
entities are
properly
reported.

Review the
presentation and
disclosure of
related-party
information for
completeness and
understandability.
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Chapter 13

Financial Accounting and Reporting
for Managed Care Services
Overview
13.01 Managed care entities, health maintenance organizations (HMOs),
physicians, hospitals, and other health care providers and managers have organized into integrated delivery systems and networks that combine inpatient,
outpatient, pharmacy, and physician services into single contracting entities.
These systems and networks may be formed by merger, joint venture, affiliation, or contractual risk sharing. Services may be provided under predetermined, fixed-fee capitation arrangements, such as per member per month, or
other risk-based arrangements, rather than charging fees for provided services
(fee for service). As health care providers and managed care entities adopt new
structures and commence new operations in response to the demands of the
market, many activities that were traditionally performed by insurance entities, such as assuming medical insurance risk, are being performed by health
care entities. Conversely, many activities that were performed by health care
entities, such as arranging for the provision of medical services, are being
performed by managed care entities.
13.02 This chapter provides guidance for transactions in which an entity
assumes or transfers the medical insurance risk or administers the costs of
health care services for a predetermined amount. Examples of entities that enter into such transactions include HMOs, hospitals, nursing homes, specialty
care managers, managed care entities, physician entities, preferred provider
organizations (PPOs), public entity risk pools, and third-party administrators.
This chapter covers various kinds of managed care arrangements, including
group health managed care, capitation arrangements, and administrative services only (ASO) arrangements. Paragraphs 2.66–.73 of this guide provide additional guidance on statutory reporting and other regulatory considerations.

Recognition and Classification of Revenue
13.03 Revenue from managed care arrangements is classified based on
the assumed risk and type of service provided, as follows:

r
r

Revenue received in exchange for assuming full medical risk is
recognized as premium revenue.
Revenue received in exchange for performing administrative services is recognized as administrative fees. See paragraphs 13.25–
.29.

Under arrangements in which administrative services are typically an integral
part of providing or arranging medical care, revenue from those administrative
services is included in premium revenue.
13.04 Premium revenue is recognized in income in the period that members are entitled to receive services, as specified by the provisions of the
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arrangement. Premiums billed or received in advance are reported as deferred
revenue (unearned premiums).
13.05 Administrative fees are recognized in income in the period that
the related services are performed. Administrative fees billed or received in
advance are reported as deferred revenue.
13.06 Under arrangements that include performing administrative services, such as third-party administrator, cost-plus, and minimum premium
contracts, entities (a) act as administrators or network managers between employers or other obligated entities and providers of health care services and
(b) handle cash inflows and outflows in connection with amounts due from obligated entities to providers of health care services. The inflows and outflows
associated with the health care payments from obligated entities to providers
of health care services are not revenue and expenses of the entity providing the
administrative services.

Capitation Arrangements
13.07 Costs of capitation arrangements are reported as health care expenses. The Financial Reporting Executive Committee (FinREC) recommends
that amounts received under capitation arrangements be reported as premium
revenue. The recognition of premium revenue from capitation arrangements is
discussed in paragraphs 10.34–.37 of this guide.

Accounting for Health Care Costs
13.08 According to Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 954-405-25-2, health care costs should
be accrued as services are rendered, including estimates of the costs of services
rendered but not yet reported. Furthermore, if a provider of prepaid health care
services is obligated to render services to specific members beyond the premium
period due to provisions in the contract or regulatory requirements, the costs
of such services to be incurred also should be currently accrued. Costs that will
be incurred after a contract is terminated, such as guaranteed salaries, rent,
and depreciation, net of any anticipated revenue, should be accrued when it is
determined that a contract with a sponsoring employer or other group will be
terminated.
13.09 FASB ASC 954-405-25-2 also requires that amounts payable to hospitals, physicians, or other health care providers under risk-retention, bonus,
or similar programs be accrued during the contract period based on relevant
factors, such as experience to date.
13.10 According to FASB ASC 954-405-50-2, providers of prepaid health
care services should disclose the basis for accruing health care costs and the
nature of significant business and contractual arrangements (for example, capitation arrangements) with hospitals, physicians, or other associated entities
in the notes to the financial statements.
13.11 The following health care costs are accrued:

r

Estimated costs of services rendered but not reported. Typically,
health care entities utilize actuaries to assist in determining estimated costs of services rendered but not reported. Auditors often
also use actuaries to assist in auditing the recorded liability. See
paragraphs 8.107–.110 of this guide for additional discussion on
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the use of actuaries and actuarial methods. Paragraph 2.32 of
this guide discusses the risks associated with costs of services
rendered but not reported.
Estimated costs of future health care services to be rendered that
the entity is presently obligated to provide, with or without receiving future premiums, according to the terms of the arrangement,
regulatory requirements, or other requirements.

13.12 The effects of reinsurance and stop-loss insurance recoveries are
considered in calculating those estimated costs. See paragraphs 13.18–.19 for
additional information.

Accounting for Loss Contracts
13.13 FASB ASC 954-450-25-4 states that a prepaid health care provider
enters into contracts to provide members with specified health care services
for specified periods in return for fixed periodic premiums. The premium revenue is expected to cover health care costs and other costs over the terms of
the contracts. Only in unusual circumstances would a provider be able to increase premiums on contracts in force to cover expected losses. A provider may
be able to control or reduce future health care delivery costs to avoid anticipated losses, but the ability to avoid losses under existing contracts may be
difficult to measure or demonstrate. Associated entities, such as hospitals,
medical groups, and individual practice associations, may enter into similar
contracts with prepaid health care providers in which they agree to deliver
identified health care services to the providers' members for specified periods
in return for fixed fees.
13.14 In accordance with FASB ASC 954-450-30-4, losses under prepaid
health care services contracts should be recognized when it is probable that
expected future health care costs and maintenance costs under a group of existing contracts will exceed anticipated future premiums and stop-loss insurance
recoveries on those contracts. Contracts should be grouped in a manner consistent with the provider's method of establishing premium rates (for example,
by community rating practices, geographical area, or statutory requirements)
to determine whether a loss has been incurred. FASB ASC 954-450-30-3 states
that the estimated future health care costs and maintenance costs to be considered in determining whether a loss has been incurred should include fixed
and variable, direct, and allocable indirect costs.
13.15 For example, for purposes of determining whether a loss (premium
deficiency) will occur over the remaining terms of existing contracts for which
premiums will be received, managed care arrangements, including noncancellable, executed contracts that are not yet in force, would be grouped on a
basis consistent with the entity's manner of acquiring, servicing, and measuring the profitability of those arrangements. Groupings would be done on a
consistent basis from year to year. A loss would be recognized if the sum of expected future fixed and variable, direct, and allocable indirect costs, including
health care costs, claim adjustment expenses, maintenance costs, and other
costs that are related to a group of contracts, exceeds the sum of related anticipated future premiums, other direct contract revenue, unearned premiums,
reinsurance recoveries on those contracts, and investment income considered.
See paragraph 13.17 for additional discussion.
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13.16 The calculation of loss contracts would be made at the end of each
reporting period. Changes in loss contract accruals represent changes in estimate that are reported in the current period's operations.

Consideration of Anticipated Investment Income
13.17 For purposes of determining whether a premium deficiency will occur and measuring that deficiency, FinREC recommends that entities consider
investment income that is expected to be earned on premiums received in advance of health care costs incurred during the contract period for the group of
contracts. Entities would disclose their accounting policy concerning whether
they consider investment income in determining whether a premium deficiency
exists on managed care arrangements.

Accounting for Stop-Loss Insurance
13.18 By using stop-loss insurance, prepaid health care providers or associated entities contract to recover health care costs in excess of stated amounts
during the contract periods.
13.19 FASB ASC 954-720-45-1 requires that stop-loss insurance premiums be included in reported health care costs. Stop-loss insurance recoveries
should be reported as reductions of related health care costs. FASB ASC 954310-25-2 states that amounts recoverable from stop-loss insurers, reduced by
appropriate valuation allowances, should be included in receivables. In addition, FASB ASC 954-720-50-4 requires that the nature, amounts, and effects
of significant stop-loss insurance contracts be disclosed.

General and Administrative Expenses
13.20 General and administrative expenses are reported as gross amounts, rather than net of other items, such as fees for administering payments
under Medicare and Medicaid arrangements.

Acquisition Costs
13.21 As described in FASB ASC 954-720-05-2, many prepaid providers
of managed care services incur costs that vary with, and are primarily related
to, the marketing of subscriber contracts and member enrollment. These costs,
sometimes referred to as acquisition costs, consist mainly of commissions paid
to agents or brokers and incentive compensation based on new enrollments.
Commissions and incentive compensation may be paid when the contracts are
written, at later dates, or over the terms of the contracts as premiums are
received. Some providers incur additional costs related directly to the acquisition of specific contracts, such as the costs of specialized brochures, marketing,
and advertising. Providers also incur costs that are related to the acquisition
of new members but do not relate to specific contracts and are not considered
acquisition costs. These costs include salaries of the marketing director and
staff, general marketing brochures, and general advertising and promotion
expenses.
13.22 FASB ASC 954-720-25-6 explains that although theoretical support exists for deferring certain contract or member acquisition costs, acquisition costs of providers of prepaid health care services, other than costs of
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advertising, should be expensed as incurred. Advertising costs should be accounted for in accordance with the guidance in FASB ASC 720-35.

Financial Statement Display Considerations
Balance Sheet
13.23 Pursuant to FASB ASC 954-210-45-1, entities whose primary business is engaging in managed care arrangements should classify assets and
liabilities as current and noncurrent, as discussed in FASB ASC 210-10-45.
13.24 Receivables and payables related to ASO contracts usually are reported at gross values. An ASO arrangement involves three parties (the employer, the hospital or other provider of health care to employees, and the
ASO organization); therefore, these arrangements do not meet the conditions
of FASB ASC 210-20-45-1 for right of offset. Those conditions are not met in
situations involving more than two parties.

Income and Cash Flow Statement
13.25 When entities act as administrators or network managers between
employers or other obligated entities and providers of health care services,
cash inflows and outflows associated with amounts due from obligated entities
to providers of health care services are not accounted for as revenues and
expenses in the income statement. Cash flow related to both ASO revenue
and cash inflows and outflows through the company would be reflected in the
operating cash flows in the cash flow statement.
13.26 FASB ASC 605-45 provides guidance about whether an entity
should report revenue gross or net of certain amounts paid to others. The
reporting depends on whether the entity functions as principal or agent. FASB
ASC 605-45-45 states that it is a matter of judgment whether an entity should
report revenue based on either of the following: (a) the gross amount billed to
a customer because it has earned revenue as a principal from the sale of the
goods or services or (b) the retained net amount (that is, the amount billed
to the customer less the amount paid to a supplier) because it has earned a
commission or fee as an agent. The factors or indicators set forth in FASB ASC
605-45-45 should be considered in that evaluation. Those factors are listed in
paragraphs 13.28–.29 but are not intended as a substitute for reading the cited
paragraphs.
13.27 Although FASB ASC 605-45-15-4(b)(3) lists insurance and reinsurance premiums as transactions to which the guidance does not apply, that
exclusion pertains to transactions for which guidance is provided in other
subtopics of FASB ASC, rather than the managed care arrangements addressed
in this guide. Gross versus net revenue reporting is a matter of judgment that
depends on each entity's relevant facts and circumstances after evaluating
those facts and circumstances using the indicators.

Indicators of Gross Revenue Reporting
13.28 FASB ASC 605-45-45 describes the following eight indicators that
may support reporting gross revenue:

r

The entity is the primary obligor in the arrangement, as discussed
in FASB ASC 605-45-45-4.
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The entity has general inventory risk before a customer order is
placed or upon customer return, as discussed in paragraphs 5–7
of FASB ASC 605-45-45.
The entity has latitude in establishing price, as discussed in FASB
ASC 605-45-45-8.
The entity changes the product or performs part of the service, as
discussed in FASB ASC 605-45-45-9.
The entity has discretion in supplier selection, as discussed in
FASB ASC 605-45-45-10.
The entity is involved in the determination of product or service
specifications, as discussed in FASB ASC 605-45-45-11.
The entity has physical loss inventory risk after a customer order
or during shipping, as discussed in FASB ASC 605-45-45-12.
The entity has credit risk, as discussed in paragraphs 13–14 of
FASB ASC 605-45-45.

Indicators of Net Revenue Reporting
13.29 FASB ASC 605-45-45 describes the following three indicators that
may support reporting net revenue:

r
r
r

The entity's supplier is the primary obligor in the arrangement,
as discussed in FASB ASC 605-45-45-16.
The amount that the entity earns is fixed, as discussed in FASB
ASC 605-45-45-17.
The supplier has credit risk, as discussed in FASB ASC 605-4545-18.

Disclosures
13.30 Consistent with the requirements of FASB ASC 275, Risks and
Uncertainties, managed care entities may consider disclosing the following in
the notes to the financial statements:
a. Nature of operations, such as the following:
i. Types of rendered managed care services (for example,
health maintenance, third-party administrator, and risk
sharing)
ii. Types of entity structures from which the services are rendered (for example, HMO, PPO, point of service, and indemnity)
iii. Types of customers
b. Risk assumption and risk management profile.
c. The amount of ceded premiums and recognized reinsurance recoveries, if not reported in the income statement as separate line items
or parenthetically.
d. Entities that incur health care costs pertaining only to premium
revenue disclose total health care costs either in the income
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statement as separate line items or parenthetically or in the notes
to the financial statements.
e. Entities that incur health care costs pertaining to both other revenue and premiums disclose health care costs related to premiums,
if practicable.
Nature of, and amounts paid under, capitation arrangements included in
health care costs.
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Chapter 14

Financial Accounting and Reporting by
Continuing Care Retirement Communities
Overview
14.01 Continuing care retirement communities (CCRCs) provide residents
with a diversity of residential, social, and health care services, in accordance
with a resident service agreement (resident agreement or contract) or other
agreement specifying the obligations of the CCRC to the resident. This chapter provides guidance on applying generally accepted accounting principles
(GAAP) to transactions found in CCRCs for refundable and nonrefundable advance fees, obligations to provide future services and the use of facilities to
current residents, and the costs of acquiring initial care contracts.
14.02 The United States has over 1,800 CCRCs. Many CCRCs are operated by not-for-profit organizations, and many are affiliated with religious
organizations. Recently, there has been an increase in the number of investorowned entities operating CCRCs.
14.03 Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 954-605-05-7 explains that CCRC facilities may be
independent, or they may be affiliated with other health care facilities. They
usually provide less intensive care than hospitals.
14.04 CCRCs may provide a variety of health care services, including
nursing care, home health care, physician services, and other services either
directly or by agreement with other health care providers. These health care
services are provided in addition to the residential services and amenities,
including social, recreational, dining, and laundry services. In addition to providing services to CCRC residents, certain services, predominantly nursing
services, may be provided to nonresidents. CCRCs have increased the diversity
of residential, social, and health care services rendered in response to consumer
demands.
14.05 Many states regulate CCRCs; however, state oversight of CCRCs
and the CCRC's disclosures to residents may take various forms.

Types of Contracts
14.06 CCRCs use a variety of contracts, which are constantly undergoing change based on financial and consumer-driven considerations. These
continuing-care contracts contain a number of different approaches to providing delivery of services and the fees associated with those services. The fees
charged to residents generally consist of three basic components: advance fees,
periodic fees, and use fees (or a combination of these fees).
14.07 The contract provisions generally stipulate the amount of the advance fee; whether periodic fees and use fees, or both, are required; whether
those fees can be adjusted; and the underlying circumstances and computations
for such adjustments. In addition, contracts generally detail the future services
that will be provided to residents; explain how residents will be charged for services; and describe the CCRC's refund policies, if applicable, and formula for
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calculating the amount of the refunds, if any. Furthermore, the contract would
describe the obligation of the CCRC and resident if a contract is terminated,
and a residential unit is or is not reoccupied. Contracts that convey the right
to use facilities may contain a lease if the arrangement conveys to the resident
the right to control the use of the underlying facilities, as discussed in FASB
ASC 840-10-15.1

Advance Fees
14.08 Advance fees (one-time fee typically at the time of occupancy) are
those paid by the resident as a condition of admission to the CCRC for future
services and use of the facilities, as specified in the resident agreement. The
advance fee generally entitles the resident to the use of the residential facilities; access to amenities and social services; and the provision of, or access to,
certain health care services. In addition to advance fees for admission to the
CCRC, residents may also pay advance fees relating to upgraded furnishings
and amenities, renovation or additions to the residential facility, or other upgrades. These additional advance fees may be nonrefundable or refundable to
the resident or resident's estate, depending on the terms of the contract with
the resident. The extent to which amenities, social services, and health care
services are included is based on the respective resident agreement. In certain
instances, the advance fee may be payment for an all-inclusive continuing-care
contract that includes residential facilities, meals, and amenities. It may also
provide nursing care for little or no increase in periodic fees, except to cover
normal operating costs and inflation.

Periodic Fees
14.09 Periodic fees, sometimes referred to as service or maintenance fees,
are those paid periodically (generally monthly) for services typically provided
by CCRCs that are not covered by the advance fees. These periodic fees may
be fixed at the time of admission, fixed with periodic modification based on
increases in operating costs, or dependent on circumstances defined in the
resident agreement or other agreement between the CCRC and resident.

Use Fees
14.10 Use fees are those that may be charged to the resident based on
personal preferences or usage by the resident. These fees are paid periodically
(generally monthly) for services not covered by the advance or periodic fees.
Items typically provided for a separate use fee could include provision of a
special parking arrangement, beauty and salon services, health care services
above those included in the advance or periodic fees, excess meal or other
amenity services beyond those provided through the payment of advance or
periodic fees, and other items or services specified in the resident agreement
or other agreement with the resident.

Types of Living Accommodations
14.11 CCRCs offer different types of living accommodations to residents,
such as single or shared apartment units or individual homes. They also provide
1
On August 17, 2010, the Financial Accounting Standards Board issued proposed Accounting Standards Update Leases (Topic 840), which would make significant changes to the accounting
requirements for both lessees and lessors. Readers should be alert to the issuance of a final standard.
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a variety of amenities, including social, recreational, dining, housekeeping, and
laundry services.
14.12 CCRCs may provide nursing-care services at the same location or,
by agreement, with another facility. Residents are transferred to or from a nursing center as medical care is required. As the health of a resident declines, he
or she may be permanently transferred to an assisted living facility; a nursing
center; or a specialized long-term care facility or unit, such as a memory-care
facility.

Fees and Payment Methods
14.13 As explained in FASB ASC 954-605-05-10, a CCRC may require
several different payment methods for services and the use of facilities. The
following are the three most prevalent methods:
a. Advance fee only. Under this method, a resident pays an advance
fee in return for future services and the use of facilities. Such services generally include CCRC housing-related services (for example, meals, laundry, housekeeping, and social services) and health
care. These services usually are provided to the resident for the
remainder of his or her life or until the contract is terminated.
Additional periodic fees are not paid, regardless of how long a resident lives or if the resident requires more services than anticipated.
Generally, the resident receives no ownership interest in the facility.
b. Advance fee with periodic fees. Under this method, a resident pays
an advance fee and periodic fees for services and the use of facilities. Such periodic fees may be fixed, or they may be subject to
adjustment for increases in operating costs or inflation or other
economic reasons.
c. Periodic fees only. Under this method, a resident pays a fee at
periodic intervals for services and the use of the facilities provided
by the CCRC. Such fees may be either fixed or adjustable.
14.14 According to FASB ASC 954-605-05-11, an advance fee may be
met by transferring a resident's personal assets, which may include rights to
future income or paying a lump sum of cash to the CCRC. Some contracts allow
the advance fee to be paid by installment payments. Advance fees received for
future services may be refunded at the occurrence of some future event, such as
death, withdrawal from the CCRC, termination of the contract, or reoccupancy
of a residential unit. The amount and timing of the refund generally is based
on contractual provisions or statutory requirements.
14.15 As explained in FASB ASC 954-605-05-9, many continuing-care
contracts are similar to annuity contracts. Under those contracts, the CCRC
assumes the risks associated with both of the following: (a) estimating the
amount of the advance fee and other fees to be paid by a resident and (b) determining whether such fees will be sufficient to cover the cost of providing a
resident's required services and the use of facilities. For some contracts, residents may share the future costs without limit. The CCRC has an obligation
to provide future services for the length of the contract or life of the resident. In certain circumstances, this obligation continues regardless of whether
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advance or periodic fees are sufficient to meet the costs of providing services to
a resident.

Accounting for Refundable Advance Fees
14.16 As explained in FASB ASC 954-605-05-12, payment of an advance
fee generally is required before a resident acquires a right to reside in an
apartment or a residential unit for life. A portion of advance fees may be
refundable by rescission within a legally or contractually set time period or if
a certain future event occurs, such as the death or withdrawal of a resident or
termination of the contract. Some refunds are paid only if a residential unit is
reoccupied.
14.17 FASB ASC 954-605-05-13 states that CCRC refund policies vary
either by region or according to statutory requirements, but generally, the
amount of the refund is based on provisions specified in a contract. For example,
some contracts require a refund of the advance fee less a reasonable processing
fee. Refunded amounts may be based on a fixed amount or percentage, an
amount that declines to a fixed amount over time (see paragraph 14.19), an
amount that declines to zero (see paragraph 14.19), or an amount based on the
resale amount. Refunds may be contingent on vacating the unit, resale of the
unit, or passage of a fixed period of time if the unit is not resold.
14.18 For some contracts, the refundable amount is determinable because the contract is fully refundable, the refund amount is fixed, or the refund amount is a percentage. Contracts that provide for fully-refundable advance fees are accounted for and reported as liabilities. If contracts provide for
amounts to be refunded based on a fixed amount or percentage, the portion of
the advance fee attributable to the fixed amount or percentage is accounted for
and reported as a liability, with the balance accounted for as deferred revenue
within the "Liability" section of the balance sheet and amortized as discussed
in paragraph 14.20. In situations in which the refundable amount declines over
time to a fixed amount or zero, the guidance in paragraph 14.19 is applied.
14.19 For other contracts, the refundable amount must be estimated.
FASB ASC 954-430-25-1 states that the estimated amount of advance fees
that is expected to be refunded to current residents under the terms of the
contracts should be accounted for and reported as a liability. The remaining
amount of refundable advance fees should be accounted for as deferred revenue
within the "Liability" section of the balance sheet. According to FASB ASC
954-430-30-1, the estimated amount of advance fees that are expected to be
refunded to current residents under the terms of contracts should be based
on the individual facility's own experience or, if records are not available,
the experience of comparable facilities. FASB ASC 954-430-35-3 states that
adjustments to the estimated liability should be accounted for as deferred
revenue and amortized together with nonrefundable advance fees, as discussed
in FASB ASC 954-430-35-1 (see paragraph 14.20).
14.20 In accordance with FASB ASC 954-430-35-1, deferred revenue from
advance fees from a resident should be amortized to income over future periods
based on the estimated life of the resident or the contract term, if shorter. The
period of amortization should be adjusted annually based on the actuarially
determined, estimated remaining life expectancy of each individual or the joint
and last survivor life expectancy of each pair of residents occupying the same
unit. The straight-line method is used to amortize deferred revenue, except in
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certain circumstances when costs are expected to increase at a significantly
higher rate than future revenues in the later years of residence. In those situations, deferred revenue may be amortized to income using a method that
reflects the disproportionate ratio between the costs of the expected services
and expected revenues. The amortized amount should not exceed the amount
available to the CCRC under state regulations, contract provisions, or management policy. According to FASB ASC 954-430-40-1, unamortized deferred
revenue from nonrefundable advance fees should be recorded as revenue upon
a resident's death or termination of the contract.

Accounting for Fees Refundable to Residents Only
From Reoccupancy Proceeds of a Contract Holder’s Unit
14.21 As explained in FASB ASC 954-605-05-14, some contracts between
a CCRC and resident stipulate that all or a portion of the advance fee may
be refundable if the contract holder's unit is reoccupied by another person.
The source of money for the payment is from the proceeds of the advance fees
collected by the CCRC from the next resident of the reoccupied unit. The terms
governing how the proceeds from the next resident are to be paid to the previous
resident vary from contract to contract. In effect, the CCRC acts as if it were
an agent for present and future residents.
14.22 According to FASB ASC 954-430-25-1, the portion of the fees that
will be paid to current residents or their designees, only to the extent of the
proceeds of reoccupancy of a contract holder's unit, should be accounted for as
deferred revenue, provided that legal and management policy and practice support the withholding of refunds under this condition. Similar amounts received
from new residents in excess of the amount to be paid to previous residents or
their designees also should be deferred. According to FASB ASC 954-430-35-4,
the resulting deferred revenue should be amortized to income over future periods based on the remaining useful life of the facility. The basis and method of
amortization should be consistent with the method for calculating depreciation
and should be disclosed in the notes to the financial statements, in accordance
with FASB ASC 954-430-50-4.

Accounting for Nonrefundable Advance Fees
14.23 FASB ASC 954-430-25-1 states that under provisions of continuingcare contracts entered into by a CCRC and residents, nonrefundable advance
fees represent payment for future services and are accounted for as deferred
revenue. According to FASB ASC 954-430-35-2, if a CCRC has sufficient historical experience and relevant statistical data about life expectancies, it should
consider that information when determining the remaining life of residents.
A CCRC with insufficient historical experience or reliable actuarial data may
use relevant data of similar communities within that area, relevant national
industry statistics, or other appropriate data. Nonrefundable advance fees are
amortized in the manner discussed in FASB ASC 954-430-35-1 (see paragraph
14.21).
14.24 The application of the conclusions in paragraphs 14.22–.23 is presented in exhibit 14-1.
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Classification of Refundable Advance Fees
14.25 Diversity in practice exists regarding classification of the refundable
portion of the advance fee between CCRCs that are Securities and Exchange
Commission (SEC) registrants and those that are not.
14.26 CCRCs that are SEC registrants are required to consider paragraphs 9–10 of FASB ASC 470-10-45 in determining the classification of the
refundable portion of advance fees. Frequently, resident agreements will provide that refundable advance fees are subject to repayment if the residents
elect to terminate the agreement and put the refund obligation to the CCRC.
CCRC residents do not frequently exercise the option to terminate the resident
agreement early; however, the resident does have the contractual right to do
so. Upon the resident's election to terminate, the CCRC is then obligated to
repay the refundable portion of the advance fee deposit to the resident within
a short period of time, generally less than one year. In many cases, this put or
on-demand provision will require that the refundable advance fees be shown
as a current liability.
14.27 In practice, CCRCs that are not SEC registrants classify refundable advance fees based upon the expected timing of refunds to be made. The
classification as current or noncurrent depends upon the CCRC's own history
of refunds and the terms of its resident agreements.
14.28 Other contract provisions or regulations also may affect the CCRC's
ability to control the timing of refund payments. For example, provisions that
make refunds to a former resident dependent upon resale to, and reoccupancy
by, a new resident might allow the CCRC to classify some or all of the refundable advance fees as a noncurrent liability. In addition, if contract provisions
or regulations state that a portion of a nonrefundable advance fee (for example,
the deferred revenue component) is repayable to the resident only if the CCRC
contract is terminated in its early years, and after that period, the advance
fee is nonrefundable, the specific terms of each agreement or regulation may
indicate that some or all of the advance fees would be reported as a liability
(see paragraph 14.19) and that some portion of that liability might be classified
as current.
14.29 The Financial Reporting Executive Committee (FinREC) recommends CCRCs provide disclosure of the classification of these refundable advance fees; the key terms of the underlying agreements; and, if classified as
noncurrent, the amount of the advance fees that are subject to repayment
based on the residents' ability to terminate the agreement and put the refund
obligation to the CCRC.

Accounting for the Obligation to Provide Future Services
and the Use of Facilities to Current Residents
14.30 FASB ASC 954-440 discusses the commitments of CCRCs to provide
services. This paragraph and paragraphs 14.32–.33 summarize that guidance.
A CCRC expects to provide services and the use of facilities to individuals over
their remaining lives under continuing-care contract agreements. The nature
and extent of such services depend on such variables as the individual's age,
health, sex, and economic status upon entering the CCRC. Thus, the CCRC
assumes a risk in estimating the cost of future services and use of facilities.
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Although many CCRCs are contractually allowed to increase periodic fees,
some contracts may restrict increases in periodic fees and require continuing
services without additional compensation. If the advance and periodic fees
that are charged are insufficient to meet the costs of providing future services
and the use of facilities, the CCRC should record a liability based on actuarial
assumptions, such as mortality and morbidity rates, on estimates of future costs
and revenues and on the specific CCRC's historical experience and statistical
data. The liability is equal to the amount that is expected to be incurred to
provide services and the use of facilities to individuals over their remaining
lives under continuing-care contracts, including resident-care, dietary, health
care, facility, interest, depreciation, and amortization costs, in excess of the
related anticipated revenues.
14.31 In accordance with paragraphs 1 and 3 of FASB ASC 954-440-35,
the obligation of a CCRC to provide future services and the use of facilities to
current residents should be calculated annually in order to determine whether
a liability should be reported in the financial statements. The liability related
to continuing-care contracts should be the present value of future net cash
flows, minus the balance of unamortized deferred revenue, plus depreciation
of facilities to be charged related to the contracts, plus unamortized costs of
acquiring the related initial continuing-care contracts, if applicable. The calculation should be made by grouping contracts by type, such as all contracts with
a limit on annual increases in fees, contracts with unlimited fee increases, and
so on.
14.32 In measuring the liability, FASB ASC 954-440-35-3 states that the
cash inflows should include revenue contractually committed to support the
residents and inflows resulting from monthly fees, including anticipated increases in accordance with contract terms. This measurement should include
third-party payments, contractually- or statutorily-committed investment income from services related to CCRC activities, contributions pledged by donors
to support CCRC activities, and the volume of deferred nonrefundable advance
fees. Cash outflows should comprise operating expenses, including interest expense and excluding selling expense, and general and administrative expenses.
Anticipated cost increases affecting these operating expenses should be considered in determining cash outflows. The expected inflation rate, as well as other
factors, is considered in determining the discount rate. In calculating the liability, the specific CCRC's historical experience or statistical data relating to
the residents' life spans should be used. The life spans that are used should
be the same as those used to amortize deferred revenue (see paragraph 14.21).
For a new CCRC, either relevant data of similar communities in the area or
relevant national industry statistics may be used if they are deemed to be
representative.
14.33 FASB Concepts Statement No. 7, Using Cash Flow Information
and Present Value in Accounting Measurements, provides a useful discussion
of general principles governing the use of present value and of the objective of
present value in accounting measurements. FASB Concepts Statements are not
sources of established accounting principles and, thus, do not amend, modify,
or justify a change from GAAP currently in effect.
14.34 The application of the conclusions in paragraph 14.32 is presented
in exhibit 14-2.
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Accounting for the Costs of Acquiring Initial
Continuing-Care Contracts
14.35 Advertising costs incurred in connection with acquiring initial
continuing-care contracts should be accounted for in conformity with the guidance in FASB ASC 720-35. Start-up costs are expensed as incurred, in accordance with FASB ASC 720-15. However, according to FASB ASC 954-340-25-1
and 954-720-25-7, costs of acquiring initial continuing-care contracts that are
within the scope of FASB ASC 970, Real Estate—General, should be expensed
or capitalized in accordance with that guidance. FASB ASC 954-340-35-1 states
that capitalized costs should be amortized to expenses on a straight-line basis
over the average expected remaining lives of the residents under the contract
or the contract term, if shorter. According to FASB ASC 954-720-25-7, the costs
of acquiring continuing-care contracts after a CCRC is substantially occupied
or one year following completion should be expensed when incurred.

Financial Statements
14.36 FASB ASC 954-210-45-1 indicates that rather than presenting a
classified balance sheet, a CCRC may instead sequence assets according to
their nearness of conversion to cash and may sequence liabilities according to
the nearness of the maturity and resulting use of cash.
14.37 The following information about advance fees is required to be
disclosed, per FASB ASC 954-430-50:

r
r
r

The method of accounting for advance fees, the method of calculating the obligation to provide future services and the use of
facilities, and the refund policy for refundable fees
The gross amount of contractual refund obligations under existing
contracts and the CCRC's refund policy
The method(s) of amortization for refundable advance fees and
deferred revenue for advance fees

14.38 Because the liability amount in the balance sheet is based upon the
CCRC's expected refunds, the amount disclosed in the preceding paragraph will
exceed the amount of the liability for entities that have sliding scale contracts.
14.39 FASB ASC 954-440-50 requires that a CCRC disclose the following
in the notes to the financial statements for each year presented:
a. A description of the CCRC and the nature of the related continuingcare contracts entered into by the CCRC
b. The carrying amount of the liability to provide future services and
the use of facilities related to continuing-care contracts that is presented at present value in the financial statements, if not separately disclosed in the balance sheet
c. The interest rate used to discount that liability to provide future
services
d. The statutory escrow or similar requirements
e. The refund policy of the CCRC and the general amount of refund
obligation under the existing contracts
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14.40 In addition to the required disclosures, FinREC recommends that
CCRCs disclose all of the following:

r
r
r
r
r

Amounts classified as current and noncurrent for deferred revenues and liabilities under provisions of resident contracts
Any applicable state regulatory requirements regarding refunds
under existing contracts
The carrying amount of the obligation to provide future services
and the use of facilities to current residents, which is presented
at present value in the financial statements, if not separately
disclosed in the balance sheet
The interest rate used to discount that liability
The disclosures recommended in paragraph 14.29 for the classification of refundable advance fees

14.41 FASB ASC 954-430-50-2 requires that advance fees refunded be
disclosed in the statement of cash flows as a financing transaction.
14.42 Paragraphs 3.41–.42 discuss locating example financial statements.

Auditing
14.43 When auditing a CCRC, the independent auditor may need to consider the examples of specific auditing objectives, selected control activities,
and auditing procedures that are presented in exhibit 14-3.
14.44 A CCRC ordinarily documents the terms of its arrangements with
its residents using standardized sales or residency contracts. As discussed in
paragraphs 14.13–.24, the terms of those contracts may significantly affect
the accounting treatment for the transactions. Reading the standardized contract(s) and analyzing the terms allows auditors to determine whether the revenue associated with the transactions is recognized in accordance with GAAP.
14.45 In determining which standardized agreements to read and analyze,
audit procedures may include the following:

r
r
r

Requesting copies of all standardized contract(s) currently in use
Evaluating the standardized contracts for terms that may affect
revenue recognition
Reviewing a sample of transactions for compliance with the standardized agreement

14.46 In determining which transactions to review, the auditor should
select a sufficient number and type of contracts to reduce audit risk to an
acceptable level. In determining which transactions to select, the auditor might
consider the following:

r
r

The materiality of the transaction. An auditor may be able to reduce audit risk to an acceptable level by analyzing all material
contracts entered into during the audit period, together with a selection of other contracts that, individually, were not considered
material.
The date the contract was entered into. To reduce the risk of
revenues being recorded in the wrong period, the auditor might
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r
r

consider focusing audit attention on transactions near the end of
the reporting period.
Whether the transaction utilizes a new form of standardized contract. To reduce the risk of misstatement of revenues due to transactions on new forms of standardized contracts, the auditor might
focus attention on whether revenues and obligations were recognized in the correct amount and period.
Contracts relating to transactions with a relatively higher inherent
risk. For example, auditors might consider focusing audit attention on transactions that include notes receivable or that restrict
or limit future revenues. If the resident has negotiated a note
receivable, a risk exists that payments will not be collected in
accordance with terms. Contract terms that require continuing
services or provide for other services without additional compensation or with limitations of fee increases may require recognition
of a liability, as discussed in paragraphs 14.31–.35.

14.47 When reviewing a transaction, the auditor might consider the following:

r
r
r
r
r

Whether the contract was fully executed by both parties during
the fiscal period
The fees provided for under the contract
The payment provisions
The obligations of both parties under the contract
Any other terms that affect the revenue recognition

14.48 In order to address the completeness assertion, the auditor also
should determine whether any revenue recognized is subject to forfeiture, refund, or other concessions. To make this determination, the auditor may consider such factors as the terms specified in the contract(s) and management's
intent to provide refunds or the historical pattern of providing refunds or other
concessions that are not required under the provisions of the contract.

AAG-HCO 14.47

257

Care Retirement Communities

Exhibit 14-1
The following example is reproduced from paragraphs 1–3 of Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC)
954-430-55.
Continuing Care Retirement Community
Accounting for Refundable and Nonrefundable Advance Fees
This Example illustrates the guidance in Sections 954-430-25, 954-430-35, and
954-430-40. This Example has the following assumptions for a continuing care
retirement community and a resident of that community:
a. The unit is occupied for 20 years.
b. The facility has an estimated 30-year life.
c. The resident is admitted on the first day of the year indicated and
dies on the last day of year indicated.
d. The estimated remaining life expectancy is taken from an appropriate actuarial table.
e. The cost of providing future services is expected to be incurred
equally over the remaining life.
Advance fees are accounted for as follows.
Advance Fees
Year
Entry
Admitted Dies Resident Age
1

(a)

Total

Nonrefundable Refundable
25%
75%

4

A

68

$100,000

$25,000

5

8

B

82

120,000

9

13

C

79

150,000

14

—

D

80

130,000

Refunded to
the Previous
Occupant(a)

$75,000

—

30,000

90,000

$75,000

37,500

112,500

90,000

32,500

97,500

97,500

Per contract, the amount is limited to 75% of proceeds of reoccupancy up to amount
originally paid by previous occupant.
Amortization of Advance Fees Refundable to Residents
$75,000 years = $2,500 per year for Years 1 through 4
15,000 years = $577 additional or $3,077 per year for Years 5 through 8
22,500 years = $1,023 additional or $4,100 per year for Years 9 through next
change in occupancy

The following tables illustrate the amortization of nonrefundable advance fees.
Estimated
Remaining
Life (in Years)

Income

Resident A

Unamortized
Deferred
Revenue

Year 1

$25,000

12.1 =

$2,066

Year 2

22,934

11.5 =

1,994

Year 3

20,940

11.1 =

1,886

Year 4

19,054

10.6 =

1,798

Unamortized deferred revenue recognized
upon the death of the resident

17,256

Total

$25,000
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Resident B

Unamortized
Deferred
Revenue

Estimated
Remaining
Life (in Years)

Year 5

$30,000

6.1 =

$4,918

Year 6

25,082

5.8 =

4,324

Year 7

20,758

5.5 =

3,774

Year 8

16,984

5.3 =

3,205

Unamortized deferred revenue recognized
upon the death of the resident

Resident C

Unamortized
Deferred
Revenue

Income

13,779

Total

$30,000

Estimated
Remaining
Life (in Years)

Income

Year 9

$37,500

7.0 =

$5,357

Year 10

32,143

6.7 =

4,797

Year 11

27,346

6.4 =

4,273

Year 12

23,073

6.1 =

3,783

Year 13

19,290

5.8 =

3,324

Unamortized deferred revenue recognized
upon the death of the resident

15,966

Total

$37,500

Estimated
Remaining
Life (in Years)

Income

Resident
D

Unamortized
Deferred
Revenue

Year 14

$32,500

6.7 =

$4,851

Year 15

27,649

6.4 =

4,321

Year 16

23,328

6.1 =

3,824

Year 17

19,504

5.8 =

3,363

Year 18

16,141

5.5 =

2,935

Year 19

13,206

5.3 =

2,492

Year 20

10,714

5.1 =

2,100

Amortization continues until the death of the resident.
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Exhibit 14-2
The following example is reproduced from paragraphs 1–4 of Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC)
954-440-55.
Continuing Care Retirement Community
Accounting for the Obligation to Provide [Future] Services and the
Use of Facilities to Current Residents
This Example illustrates the guidance in Sections 954-440-25 and 954-440-35.
This example has the following assumptions:
a. All residents pay a $50,000 fee, which is refundable less 2 percent
per month for the first 36 months. After that period, none of the fee
is refundable. The continuing care retirement community opened
on 1/1/X4. (See exhibit 14-1 for an illustration of how to compute
refundable and deferred revenue.)
b. An additional periodic fee of $1,000 is payable monthly with a 5
percent increase annually.
c. The unamortized (deferred) costs of acquiring related initial contracts on 12/31/X6 are assumed to be $17,000.
d. The unamortized deferred revenue on 12/31/X6 is assumed to be
$27,027.
The following tables illustrate the present value of net cash flow on 12/31/X6.

Resident

Estimated
Remaining Life
(in Months)
on 12/31/X6

[20]X7

[20]X8

[20]X9

A

36

$12,000

$12,600

$13,230

—

B

22

12,000

10,500

—

—

C

27

12,000

12,600

3,308

—

D

38

Estimated cash inflows

Estimated Cash Inflows
[20]X0

12,000

12,600

13,230

$2,315

$48,000

$48,300

$29,768

$2,315

Resident

Estimated
Remaining Life
(in Months)
on 12/31/X6

[20]X7

[20]X8

[20]X9

A

36

$10,000

$12,000

$15,000

—

B

22

15,000

11,000

—

—

C

27

14,000

17,000

5,000

—

D

38

8,000

12,000

14,000

$4,000

$47,000

$52,000

$34,000

$4,000

Estimated cash outflows

Estimated Cash Outflows
[20]X0
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Recapitulation

[20]X7

[20]X8

[20]X9

[20]X0

Cash inflows

$ 48,000

$ 48,300

$29,768

$ 2,315

Cash outflows

(47,000)

(52,000)

(34,000)

(4,000)

$1,000

$(3,700)

$(4,232)

$(1,685)

Present value of net cash flows discounted at 10 percent

$(7,137)

The following tables illustrate the depreciation of facilities to be charged to
current residents.
Original cost of facility

$17,000,000

Cost of facility allocable to revenue-producing
service areas

$(2,000,000)

Cost of facility to be allocated to residents
(including common areas)

$15,000,000

Useful life

40 years

Annual depreciation using straight-line method

$375,000

Number of residents expected to occupy the
facility

200

Annual depreciation per resident

$1,875

Monthly depreciation per resident

$156

Resident

Estimated
Remaining Life
(in Months) on
12/31/X6

A

36

$1,875

$1,875

$1,875

—

B

22

1,875

1,560

—

—

C

27

1,875

1,875

468

—

D

38

1,875

1,875

1,875

$ 312

$7,500

$7,185

$4,218

$ 312

Yearly estimated
depreciation of facilities to
be charged to current
residents

[20]X7

[20]X8

[20]X9

Total estimated depreciation of the use of facilities to be charged
to the current residents

[20]X0

$19,215

The following table illustrates the liability for providing future services and
the use of facilities to current residents.
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Present value of future net cash outflows

$7,137

Minus:
Unamortized deferred revenue on 12/31/X6

(27,027)

Plus:
Depreciation to be charged to current residents

19,215

Unamortized costs of acquiring initial
contracts—see paragraph 954-440-55-1(c)

17,000(a)

Liability for providing future services and the use of
facilities to current residents on 12/31/X6

(a)

$16,325

These numbers are for illustrative purposes only and no inference has
been made as to the recoverability of the $17,000.
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Exhibit 14-3
The following table illustrates the use of assertions in developing audit objectives and designing substantive tests. The examples are not
intended to be all-inclusive nor is it expected that all the procedures
would necessarily be applied in an audit. The auditor should design
and perform substantive procedures for all relevant assertions related
to each material class of transactions, account balance, and disclosure
to obtain sufficient appropriate audit evidence. The use of assertions
in assessing risks and designing appropriate audit procedures to obtain audit evidence is described in paragraphs .14–.26 of AU section
326, Audit Evidence (AICPA, Professional Standards). Various audit
procedures and the purposes for which they may be performed are
described in paragraphs .27–.41 of AU section 326.
Auditing Considerations
Financial
Statement
Assertions

Specific Auditing
Objectives

Selected Control
Activities

Auditing Procedures

Transactions, Account Balances, and Presentation and Disclosures
Existence,
completeness,
and presentation
and maturity

Liabilities
relating to
refundable fee
arrangements
are accounted for
and properly
reported.

Written
documentation is
prepared for
refundable fee
arrangements.

Review the
refundable fee
arrangements
regarding
stipulations for
repayments, and
determine that such
arrangements are
properly classified
and disclosed in the
financial statements.

Liabilities are
accounted for and
properly
reported.

All liabilities are
classified,
described, and
properly disclosed
in the financial
statements.

Compare the account
balances with the
prior periods'
balance and
amortization
schedules.

Management
monitors
compliance with
restrictive
covenants.

Confirm any
significant new
obligations.

Deferred Revenue
Transactions, Account Balances, and Presentation and Disclosures
Completeness,
rights and
obligations, and
presentation and
disclosure
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Financial
Statement
Assertions

Specific Auditing
Objectives

Selected Control
Activities

Auditing Procedures

facilities by,
future services and
current residents the use of facilities
of continuing care is reported.
retirement
communities are
recognized and
properly reported.

obligation to provide
future services and
the use of facilities is
properly reported.

Deferred revenues
are appropriately
classified on the
balance sheet.

Review and
document any
applicable state
requirements
relating to the
timing and other
factors relating to
making refunds to
residents.

Appropriate
consideration is
given to those
factors influencing
classification of
deferred revenues
relating to refunds
based on
reoccupancy
proceeds.

Long-Term Obligations
Transactions, Account Balances, and Presentation and Disclosures
Existence,
completeness,
and presentation
and maturity

Liabilities relating
to refundable fee
arrangements are
accounted for and
properly reported.

Written
documentation is
prepared for
refundable fee
arrangements.

Review the
refundable fee
arrangements
regarding
stipulations for
repayments, and
determine that such
arrangements are
properly classified
and disclosed in the
financial statements.

Obligations to Provide Future Services
Existence,
completeness,
and presentation
and maturity

Liabilities relating
to any obligations
to provide future
services
appropriately
consider
contractual rate
constraints.

Written
documentation is
maintained and
used in future cash
flow considerations
based on existing
resident
agreements.

Review the resident
agreements for
appropriate
consideration in the
determination of
future cash flows.

Revenues From Periodic Service Fees
Transactions, Account Balances, and Presentation and Disclosures
Existence and
completeness

Propriety of
revenue from
periodic service
fees

Written
documentation and
monitoring of
service fees
established and
charged to
residents.

Review resident
agreements and
charges, including
changes in charges
to residents, for
consistency.
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Chapter 15

Unique Considerations of State and Local 1
Government Health Care Entities
Introduction
15.01 This chapter discusses the accounting, financial reporting, and auditing requirements of this guide as they apply to governmental health care
entities. The topics covered in this chapter are organized in a manner similar
to the organization of topics by chapter in this guide. This chapter is intended
to be the primary source of guidance for governmental health care entities;
content in the other chapters of this guide is referenced, if applicable. This
chapter addresses transactions that are unique to, or prevalent in, the health
care industry. However, the Audit and Accounting Guide State and Local Governments contains information about governmental accounting and financial
reporting standards and other matters that are unique to, or prevalent in,
governmental entities that are not comprehensively addressed in this guide.
15.02 The Governmental Accounting Standards Board (GASB) is the primary accounting and financial reporting standard setter for governmental entities. This chapter references provisions of certain GASB statements, as well
as the Audit and Accounting Guide State and Local Governments. However, not
all guidance included in the GASB statements and that guide is incorporated,
repeated, or summarized in this chapter. Accordingly, the GASB statements,
that guide, and all other relevant authoritative guidance should be read in
conjunction with this chapter.

Applicability of this Chapter
15.03 The definition of a governmental health care entity (see paragraph
1.08(c) of this guide) must be applied to determine whether a health care
entity is subject to the governmental generally accepted accounting principles
(GAAP) hierarchy or private-sector GAAP (for example, Financial Accounting
Standards Board [FASB] Accounting Standards Codification™ [ASC]). Entities
are governmental or nongovernmental for accounting and financial reporting
purposes based solely on the application of that definition.
15.04 The provisions of this chapter apply to governmental health care entities that report as special-purpose governments engaged only in business-type
activities (that is, whose financial statements are prepared using enterprise
fund accounting and reporting).2 Accounting, financial reporting, and auditing
matters associated with other types of governmental health care entities (that
is, those that use governmental fund accounting and financial reporting) are

1
Paragraph 1.08 of this guide defines a governmental health care entity. This guide is not
applicable to federal government health care entities.
2
Paragraph 15 of Governmental Accounting Standards Board (GASB) Statement No. 34, Basic
Financial Statements—and Management's Discussion and Analysis—for State and Local Governments, as amended, describes business-type activities as those financed in whole or part by fees
charged to external parties for goods or services. Paragraphs 91–105 and 138 of GASB Statement No.
34 describe the financial statements of enterprise funds.
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not within the scope of this chapter or guide.3 A governmental health care entity that uses enterprise fund accounting and reporting may be part of a larger
entity, such as a general-purpose government, medical school, or university. In
those situations, the recommendations in this chapter apply to the health care
entity's separately-issued financial statements.

GAAP Hierarchy for Governmental Health Care Entities
15.05 GASB Statement No. 55, The Hierarchy of Generally Accepted Accounting Principles for State and Local Governments, identifies the framework
for the GAAP hierarchy for state and local governmental entities. For financial
statements of state and local governmental entities, the hierarchy is summarized as follows (in descending order of authority):

r

r
r

r

Category (a) consists of officially established accounting principles, which are GASB Statements and Interpretations. GASB
Statements and Interpretations are periodically incorporated in
the Codification of Governmental Accounting and Financial Reporting Standards. Category (a) standards are the subject of Rule
203, Accounting Principles (AICPA, Professional Standards, ET
sec. 203 par. .01).
Category (b) consists of GASB Technical Bulletins and, if specifically made applicable to state and local governmental entities by
the AICPA and cleared4 by GASB, AICPA Audit and Accounting
Guides and AICPA Statements of Position (SOPs).
Category (c) consists of AICPA Practice Bulletins, if specifically
made applicable to state and local governmental entities and
cleared5 by GASB, as well as consensus positions of a group of
accountants organized by GASB that attempts to reach consensus positions on accounting issues applicable to state and local
governmental entities.6
Category (d) consists of implementation guides published by the
GASB staff, as well as practices that are widely recognized and
prevalent in state and local government.

15.06 If the accounting treatment for a transaction or other event is not
specified by a pronouncement in category (a), a governmental health care entity
should consider whether the accounting treatment is specified by an accounting principle from a source in another category. In such cases, if categories
(b)–(d) contain accounting principles that specify accounting treatments for

3
Often, governments will use governmental funds, rather than enterprise funds, to report activities relating to long-term institutional care, which includes health care, of the elderly; children; and
mentally impaired when user fees (for example, fees for services) are not a principal revenue source
for the activity. Although activities that are reported in governmental funds are not within the scope
of this guide, chapter 12, "Special Purpose and State Governments," of the Audit and Accounting
Guide State and Local Governments indicates that auditors of such entities should consider referring
to this guide for specific auditing considerations unique to health care entities, such as audit procedures relating to amounts due from discharged patients and third-party payors, to the extent they
are relevant.
4
Auditors should assume that such pronouncements specifically made applicable to state and
local governments have been cleared by GASB, unless the pronouncement indicates otherwise.
5
See footnote 4.
6
As of the date of this guide, GASB had not organized such a group.
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a transaction or other event, the governmental entity should follow the accounting treatment specified by the accounting principle from the source in
the highest category—for example, follow category (b) treatment over category
(c) treatment. If the accounting treatment for a transaction or other event is
not specified by a pronouncement or established in practice, as described in
categories (a)–(d), a governmental entity should consider accounting principles
for similar transactions or other events within categories (a)–(d) and may consider other accounting literature. A governmental health care entity should
not follow the accounting treatment specified in accounting principles for similar transactions or other events in cases in which those accounting principles
either prohibit the application of the accounting treatment to the particular
transaction or other event or indicate that the accounting treatment should
not be applied by analogy.
15.07 Other accounting literature includes, for example, GASB Concepts
Statements; the pronouncements referred to in categories (a)–(d) of the GAAP
hierarchy for nongovernmental entities if not specifically made applicable to
state and local governmental entities by GASB; FASB ASC and Concepts Statements; Federal Accounting Standards Advisory Board Statements, Interpretations, Technical Bulletins, and Concepts Statements; AICPA issues papers;
International Public Sector Accounting Standards of the International Public
Sector Accounting Standards Board; International Financial Reporting Standards of the International Accounting Standards Board; pronouncements of
other professional associations or regulatory agencies; Technical Questions and
Answers included in AICPA Technical Practice Aids; and accounting textbooks,
handbooks, and articles. The appropriateness of other accounting literature depends on its relevance to particular circumstances, the specificity of the guidance, and the general recognition of the issuer or author as an authority. For
example, GASB Concepts Statements would normally be more influential than
other sources in this category. Inclusion in this guide of other accounting
literature does not elevate that guidance to category (b) guidance.
15.08 This chapter makes various references to implementation guidance
published in the GASB staff document Comprehensive Implementation Guide
(hereafter referred to as GASB Q&A). That implementation guidance is category (d) guidance in the governmental GAAP hierarchy. References to the
guidance in the GASB Q&A in this chapter do not elevate that guidance
to category (b) guidance. Further, GASB’s clearance of this guide does
not elevate the guidance it contains from the implementation guides
to category (b) guidance. Similarly, references in this chapter to discussions or examples in the nonauthoritative appendixes of GASB pronouncements do not elevate that guidance from other accounting literature.

Applicability of FASB and AICPA Pronouncements
15.09 GASB Statement No. 62, Codification of Accounting and Financial
Reporting Guidance Contained in Pre-November 30, 1989 FASB and AICPA
Pronouncements,* directly incorporates into GASB's authoritative literature
certain pronouncements issued by FASB and its predecessors on or before
*
The requirements of GASB Statement No. 62, Codification of Accounting and Financial Reporting Guidance Contained in Pre-November 30, 1989 FASB and AICPA Pronouncements, are effective for financial statements for periods beginning after December 15, 2011. Earlier application is

(continued)
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November 30, 1989. Governmental entities, including health care entities,
were required by paragraph 17 of GASB Statement No. 34, Basic Financial
Statements—and Management's Discussion and Analysis—for State and Local Governments, to apply those pronouncements to the extent that they do
not conflict with or contradict GASB pronouncements. FASB Statements and
Interpretations, Accounting Principles Board (APB) Opinions, Accounting Research Bulletins of the AICPA Committee on Accounting Procedure, and AICPA
accounting interpretations issued on or before November 30, 1989, have been
included in GASB Statement No. 62 to the extent that they do not conflict
with or contradict GASB pronouncements. In that manner, GASB Statement
No. 62 eliminates the need for financial statement preparers and auditors to
determine which FASB and AICPA pronouncement provisions apply to state
and local governments. When the guidance from the pre-November 30, 1989,
pronouncements was included as part of GASB Statement No. 62, it was modified as necessary to appropriately recognize the governmental environment
and needs of governmental financial statement users.
15.10 GASB Statement No. 62 also eliminates the election provided in
paragraph 7, as amended, of GASB Statement No. 20, Accounting and Financial Reporting for Proprietary Funds and Other Governmental Entities That
Use Proprietary Fund Accounting.† That election permitted governmental entities engaged in business-type activities to elect to apply all FASB statements
and interpretations issued after November 30, 1989, that are applicable to
private-sector business enterprises and do not conflict with or contradict GASB
pronouncements. However, those governmental entities can continue to apply
as other accounting literature post-November 30, 1989, FASB pronouncements
that do not conflict with or contradict GASB pronouncements, as discussed in
paragraph 15.07.
15.11 As governmental health care entities and their auditors consider
the applicability of private-sector standards discussed in the other chapters
of this guide, they must be mindful that governmental health care entities
were prohibited by GASB Statement No. 29‡ from applying FASB Statement
No. 116, Accounting for Contributions Received and Contributions Made; No.
117, Financial Statements of Not-for-Profit Organizations; No. 124, Accounting
for Certain Investments Held by Not-for-Profit Organizations; No. 136, Transfers of Assets to a Not-for-Profit Organization or Charitable Trust That Raises
or Holds Contributions for Others; and No. 164, Not-for-Profit Entities: Mergers and Acquisitions—Including an amendment of FASB Statement No. 142,
as level (a) GAAP. (Those FASB Statements are included in FASB ASC 958,
Not-for-Profit Entities.) For governmental health care entities that have implemented GASB Statement No. 62, those FASB statements cannot be applied as

(footnote continued)
encouraged. The provisions of GASB Statement No. 62 generally are required to be applied
retroactively for all periods that are presented. Appendix A, "Cross-Reference Table for Predecessor
Guidance," of this chapter cross-references the GASB Statement No. 62 paragraphs used in the
chapter to their predecessor guidance in Financial Accounting Standards Board (FASB) Statements
and Interpretations.
†
See footnote * and appendix B, "Interim Guidance for Entities That Elect Paragraph 7 of
Governmental Accounting Standards Board Statement No. 20," of this chapter. Appendix B provides
interim guidance for entities that have not yet implemented GASB Statement No. 62.
‡
GASB Statement No. 29, The Use of Not-for-Profit Accounting and Financial Reporting Principles by Governmental Entities, is superseded by GASB Statement No. 62, which is effective for periods
beginning after December 15, 2011.
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other accounting literature if they are in conflict with GASB pronouncements,
including the guidance in GASB Statement No. 31, Accounting and Financial Reporting for Certain Investments and for External Investment Pools; No.
33, Accounting and Financial Reporting for Nonexchange Transactions; No.
34; and No. 39, Determining Whether Certain Organizations Are Component
Units—an amendment of GASB Statement No. 14. FASB Statement No. 164
cannot be applied even as other accounting literature because it is not part of
current practice, as further discussed in paragraphs 15.139–.140.

Basic Financial Statements
15.12 Governmental health care entities covered by this chapter use a
financial reporting model established by GASB Statement No. 34, as amended,
for special-purpose governments engaged only in business-type activities.
GASB Statement No. 34 requires the following statements and information to be provided in separately-issued, general-purpose external financial
statements of special-purpose governments engaged only in business-type
activities:7,8
a. Statement of net assets or balance sheet||
b. Statement of revenues, expenses, and changes in net assets or equity
c. Statement of cash flows
d. Notes to financial statements
e. Management's discussion and analysis (MD&A) as required supplementary information (RSI)
f. If applicable, other RSI established by GAAP
The statements must be prepared using the accrual basis of accounting and
economic resources measurement focus.9

7

Paragraph 138 of GASB Statement No. 34.
Although this discussion of the guidance in GASB Statement No. 34 is written from the
perspective of legally-separate governmental health care entities, the accounting, financial reporting,
and auditing considerations are usually equally applicable when the health care activity is conducted
as a function or program of a general-purpose government and reported within an enterprise fund of
that government. In developing an opinion on financial statements for one or more individual funds,
the auditor considers generally accepted accounting principles (GAAP) to the extent those principles
apply to the fund financial statements. Although GASB standards do not address the accounting and
financial reporting for separately-issued, GAAP-based financial statements for one or more individual
funds, and accordingly, GASB did not clear the provisions set forth in this footnote, paragraph 14.65
of the Audit and Accounting Guide State and Local Governments states that in auditing financial
statements of such activities, auditors should consider long-established practice dictating that those
presentations should apply all relevant GAAP. Thus, in developing an opinion on the separatelyissued, GAAP-based financial statements for one or more individual funds, the auditor considers
whether the financial statements include all relevant GAAP financial statements, note disclosures,
management's discussion and analysis topics, and other required supplementary information (RSI).
||
In June 2011, GASB issued GASB Statement No. 63, Financial Reporting of Deferred Outflows
of Resources, Deferred Inflows of Resources, and Net Position. Among other changes, the statement
amends the net asset reporting requirement of GASB Statement No. 34 by incorporating deferred
outflows of resources and deferred inflows of resources into the definitions of the required components
of the residual measure and by renaming that measure as net position, rather than net assets. Readers
should be alert to the issuance of a final standard. The provisions of this statement are effective for
financial statements for periods beginning after December 15, 2011. Earlier application is encouraged.
9
See paragraph 92 of GASB Statement No. 34.
8
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Statement of Net Assets or Balance Sheet 10
15.13 Governmental health care entities may report their financial position using either a balance sheet format (assets equal liabilities plus net assets
or equity) or a net assets format (assets less liabilities equal net assets or equity). The difference between assets and liabilities is referred to as either net
assets or equity (use of either term is acceptable).
15.14 Assets and liabilities must be presented in a classified format that
distinguishes between current and long-term assets and liabilities, as discussed
in paragraphs 29–44 of GASB Statement No. 62.11 Paragraph 99 of GASB
Statement No. 34 states that restricted assets should be reported when restrictions, as defined in paragraph 34 of GASB Statement No. 34, on asset use
change the nature or normal understanding of the availability of the asset.
Restrictions12 or constraints may require assets that normally would be reported as current, such as cash and cash equivalents, short-term investments,
and certain receivables, to be classified as noncurrent for financial reporting purposes. Paragraph 31(a) of GASB Statement No. 62 states that current
assets should exclude cash and claims to cash that are restricted regarding
withdrawal or use for other than current operations, designated for disbursement in the acquisition or construction of noncurrent assets, or segregated for
the liquidation of long-term debt. When such constraints exists (for example,
when cash or short-term investments are held as collateral on debt obligations,
set aside within debt sinking funds and debt service reserve funds, donor restricted for the construction or purchase of property and equipment, or donor
restricted for permanent or term endowment), the assets should be reported as
noncurrent. Item 7.71.1 of the GASB Q&A discusses the reporting of restricted
assets in a classified balance sheet. GASB Statement No. 34 does not otherwise
require restricted assets to be displayed separately from unrestricted assets on
the face of the balance sheet.
15.15 Either the term net assets or equity may be used to refer to the
difference between assets and liabilities. Net assets or equity is required to be
reported in three broad components: invested in capital assets, net of related
debt; restricted; and unrestricted. When a portion of restricted net assets is
required to be retained in perpetuity, restricted net assets should be displayed
in two additional components: expendable and nonexpendable.13 The individual
components of net assets are discussed in more detail in paragraphs 15.107–
.108.
15.16 Some governmental health care entities may be organized and operated on a fund basis (for example, they use several separate enterprise funds
for the purpose of carrying on specific activities or attaining certain objectives

10

See paragraphs 97–99 GASB Statement No. 34.
The requirements of GASB Statement No. 62 related to the classification of items as current
or noncurrent are similar to those applied by nongovernmental entities. To the extent that other
chapters of this guide discuss the balance sheet classification of certain specific assets or liabilities
(for example, investments and long-term debt) as current or noncurrent, that information may be
helpful to governmental health care entities, provided that it does not conflict with or contradict
GASB pronouncements.
12
The term restricted is defined by paragraphs 34, as amended, and 99 of GASB Statement No.
34. As discussed in paragraph 15.102, a restriction is a constraint placed on the use of assets or net
assets that is either externally imposed, such as by creditors through debt covenants, or imposed by
law through constitutional provisions or enabling legislation.
13
See paragraph 35 of GASB Statement No. 34.
11
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in accordance with regulatory restrictions or limitations). Interfund receivable
and payable balances are eliminated in the "Total Primary Government" column. Paragraph 14 of GASB Statement No. 38, Certain Financial Statement
Note Disclosures, requires disclosure of certain information pertaining to interfund balances.

Statement of Revenues, Expenses, and Changes in Net Assets
15.17 A governmental health care entity's statement of revenues, expenses, and changes in net assets14 presents the same types of activities and
transactions that are reported in a not-for-profit health care entity's statement
of operations and statement of changes in net assets. The required format for
this statement is illustrated in paragraph 101 of GASB Statement No. 34, as
follows:
Operating revenues (detailed)
Total operating revenues
Operating expenses (detailed)
Total operating expenses
Operating income (loss)
Nonoperating revenues and expenses (detailed)
Income before other revenues, expenses, gains, losses, and transfers
Capital contributions (grant, developer, and other); additions to permanent and term endowments; special and extraordinary items
(detailed); and transfers
Increase (decrease) in net assets
Net assets—beginning of period
Net assets—end of period
Although this prescribed sequence, including the provision of required subtotals, must be adhered to, paragraph 434 of the nonauthoritative basis for
conclusions of GASB Statement No. 34 indicates that it does not preclude
governments from presenting additional subtotals before the comprehensive
performance measure, such as the increase (decrease) in net assets.
15.18 The format of the governmental statement of revenues, expenses,
and changes in net assets does not disaggregate transactions by components
of net assets (for example, it does not segregate transactions that increase
restricted net assets from those that increase unrestricted net assets). The
statement does not require disaggregated reporting of transactions based on
the types of restrictions that may exist, such as unrestricted, restricted expendable, or restricted nonexpendable. For example, restricted contributions are not
reported separately from unrestricted contributions, except for those that are
restricted for capital acquisition or endowments, as discussed subsequently.
Because of this all-inclusive focus, reclassifications of net assets representing
the expiration of restrictions are not reported. Therefore, reclassifications and
subtotals, such as net assets released from restrictions, changes in temporarilyrestricted net assets, and changes in permanently-restricted net assets, that

14
As discussed in paragraph 15.13, it is equally appropriate to refer to equity, rather than net
assets, in the title of this statement.
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are customarily seen in not-for-profit health care entities' statements of activities are not displayed in a governmental health care entity's statement of
revenues, expenses, and changes in net assets.
15.19 Governmental health care entities must distinguish between operating revenues and expenses and nonoperating revenues and expenses and
provide an intermediate subtotal for operating income or loss. This is a difference from the not-for-profit model in which entities are permitted, but not
required, to classify transactions as operating or nonoperating. GASB requires
entities to establish a policy for defining operating revenues and expenses
that is appropriate to the nature of the activities being reported; however,
the determination of which revenues and expenses should be classified as operating should consider how the underlying transactions would be classified
in the statement of cash flows.15 Using this approach, transactions that are
considered investing, capital and related financing, and noncapital financing
activities in the statement of cash flows (for example, investment revenues and
interest expense, as well as most nonexchange transactions, including taxes
and noncapital grants and contributions) would be classified as nonoperating,
rather than operating. Once established, this policy should be consistently applied and must be disclosed in the notes to the financial statements.
15.20 Contributions of capital assets or financial resources required to be
used to acquire capital assets, contributions of term and permanent endowments, special and extraordinary items, and transfers are reported separately
after nonoperating revenues and expenses. The determination of whether a
transaction is an extraordinary item is made based on the guidance in paragraphs 45–50 of GASB Statement No. 62. Special items should be reported separately after capital contributions and contributions to permanent and term
endowments but before extraordinary items, if any. Paragraph 56 of GASB
Statement No. 34 defines a special item as a significant transaction or other
event that is within the control of management and that meets one, but not
both, of the criteria for classification as an extraordinary item (that is, it is
either unusual in nature or infrequent in occurrence). Similar transactions
that are beyond the control of management are not special items but should be
disclosed in accordance with paragraph 56 of GASB Statement No. 34.
15.21 As discussed in paragraph 15.16, some governmental health care
entities may be organized and operated on a fund basis. Those entities should
display interfund transfers, if any, after special and extraordinary items. Interfund transfers include capital contributions received from other funds of
the same financial reporting entity, as discussed in item 7.74.4 of the GASB
Q&A. Paragraph 15 of GASB Statement No. 38 requires disclosure of certain
information pertaining to interfund transfers.
15.22 If a governmental health care entity has a change in accounting
principle during a reporting period, as described in paragraphs 63–89 of GASB
Statement No. 62, the effect of the change should be reported as a restatement of net assets at the beginning of the period, not a separately identified
cumulative effect in the current-period statement of revenues, expenses, and
changes in net assets.16 If a governmental health care entity must correct a
prior-period's error, item 7.22.16 of the GASB Q&A states that the entity should
report the correction by displaying either (a) the amount of the change as an
15
16

See paragraph 102 of GASB Statement No. 34.
See footnote 13 to paragraph 17 of GASB Statement No. 34.
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adjustment to beginning net assets on the face of the statement of revenues,
expenses, and changes in net assets, as previously reported, or (b) beginning
net assets restated on the face of the statement of revenues, expenses, and
changes in net assets, with the details of the restatement provided in the notes
to the financial statements.
15.23 APB Opinion No. 30, Reporting the Results of Operations—
Reporting the Effects of Disposal of a Segment of a Business, and Extraordinary,
Unusual and Infrequently Occurring Events and Transactions, addresses the
accounting for a segment of a business (discontinued operations). As explained
in paragraph 535 of the nonauthoritative basis for conclusions of GASB Statement No. 62, the provisions of APB Opinion No. 30 pertaining to accounting
for the disposal of a segment of a business were not incorporated into GASB
Statement No. 62 because GASB intends to address these matters in its project
on government combinations. However, the separate reporting of discontinued
operations described in APB Opinion No. 30 conflicts with the reporting format
required for the statement of revenues, expenses, and changes in net assets
under GASB Statement No. 34.
15.24 FASB ASC 220, Comprehensive Income, conflicts with the allinclusive format required by GASB Statement No. 34, as discussed in item
7.72.1 of the GASB Q&A, and should not be applied by governmental health
care entities. Gains and losses that private-sector standards classify as elements of other comprehensive income should be reported no differently than
other gains and losses. As previously described, they are classified by governmental health care entities as operating, nonoperating, special, or extraordinary.

Statement of Cash Flows
15.25 GASB Statement No. 9, Reporting Cash Flows of Proprietary and
Nonexpendable Trust Funds and Governmental Entities That Use Proprietary
Fund Accounting, as amended, establishes standards for cash flow reporting
for governmental entities. The requirements of GASB Statement No. 9 differ
from those of FASB ASC 230, Statement of Cash Flows, as described in item
2.2.1 of the GASB Q&A. Those differences are as follows:

r
r

r

GASB Statement No. 9, as amended, requires the use of the direct
method of presenting operating cash flows,17 with a reconciliation
provided of operating cash flows to operating income (loss).
GASB Statement No. 9 requires two categories of financing activities—noncapital financing and capital and related
financing—for a total of four categories in the statement of cash
flows. The capital and related financing category is used for acquiring and disposing of capital assets, borrowing money for acquiring capital assets, and repaying the borrowed amounts. All
other financing is classified as noncapital.18
Some transactions are classified differently by GASB and FASB.
For example, under GASB Statement No. 9, unrestricted contributions are classified as noncapital financing, interest expense is

17

See paragraph 105 of GASB Statement No. 34.
Paragraph 29 of GASB Statement No. 9, Reporting Cash Flows of Proprietary and Nonexpendable Trust Funds and Governmental Entities That Use Proprietary Fund Accounting, provides
criteria for distinguishing between capital and noncapital financing activities.
18
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classified as either capital and related financing or noncapital financing, and investment income is classified as investing. Under
FASB ASC 220, unrestricted contributions, interest expense, and
investment income are all operating cash flows. Similarly, capital
asset purchases are classified under GASB Statement No. 9 as
capital and related financing activities. Under FASB ASC 220,
they are investing activities.
Paragraph 8 of GASB Statement No. 9 provides that a statement
of cash flows should explain the change in all cash and cash equivalents, regardless of any restrictions on their use. This would include any cash and cash equivalents classified as noncurrent, as
discussed in paragraph 15.14. The total amount of cash and cash
equivalents in the statement of cash flows should be easily traceable to similarly-titled line items in the statement of net assets.
If it is not, a reconciliation should be provided on the face of the
statement or in the notes.

Chapter 2 of the GASB Q&A discusses implementation issues regarding GASB
Statement No. 9.

Segment Reporting
15.26 If applicable, governmental health care entities must comply with
the segment reporting requirements of GASB Statement No. 34.19 GASB's definition of segment differs from that in FASB ASC 280, Segment Reporting.
GASB's definition focuses solely on information about activities financed by
revenue-backed debt. GASB Statement No. 34 defines a segment as an identifiable activity or grouping of activities reported as or within an enterprise
fund or another stand-alone entity that (a) has one or more outstanding bonds
or other debt instruments, such as certificates of participation, with a revenue
stream pledged in support of that debt and (b) is required by an external party,
such as through a bond indenture, to separately account for that activity's assets, liabilities, revenues, and expenses. Segment disclosures are not required
if the activity is not financed with revenue-backed debt; the requirement to
separately report is not imposed by an external party; or separate reporting is
required for only a portion of the activity's transactions, such as for only the
revenues and expenses.
15.27 Paragraph 122 of GASB Statement No. 34, as amended, details
the disclosures required for segments. Additional information on segment reporting can be found in chapter 8, "Expenses or Expenditures and Liabilities,"
of the Audit and Accounting Guide State and Local Governments and items
7.86.1–7.86.6 of the GASB Q&A.

RSI, Including MD&A
15.28 Some GASB standards require the presentation of certain specified
information to accompany the basic financial statements. This RSI differs from
other types of information that accompanies the basic financial statements
because RSI is considered an essential part of financial reporting, and GASB
has established authoritative guidelines for measuring and presenting that
19
See paragraphs 122–123 of GASB Statement No. 34 and paragraph 17 of GASB Statement No.
37, Basic Financial Statements—and Management's Discussion and Analysis—for State and Local
Governments: Omnibus—an amendment of GASB Statements No. 21 and No. 34.
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information. At present, RSI applicable to governmental health care entities
consists of MD&A and certain information related to employer-sponsored benefit plans. RSI other than MD&A should be presented immediately following the
notes to the financial statements.20 MD&A should precede the basic financial
statements.
15.29 GASB standards require MD&A to introduce the basic financial
statements by presenting certain financial information, as well as management's analytical insights on that information. That analysis should provide
users with the information they need to help them assess whether the government's financial position has improved or deteriorated as a result of a given
year's operations. Paragraphs 8–11 of GASB Statement No. 34, as amended,
establish eight required elements of MD&A for general-purpose governments.
Because certain of those elements would not apply to special-purpose governments engaged only in business-type activities, governmental health care
entities should limit their MD&A to only those required elements that are applicable to their activities. The information to be presented in MD&A should
be confined to the topics discussed in paragraphs 8–11 of GASB Statement
No. 34.
15.30 When a governmental health care entity presents comparative financial statements, MD&A is also required to be comparative, which would
include comparative, condensed financial information and related analyses for
both years, as discussed in item 7.5.4 of the GASB Q&A. MD&A should provide
data so that each of the two years presented in the comparative financial statements can be compared with its prior year. Therefore, there should be three
years of comparative data and accompanying analyses: the current year, the
prior year, and the year preceding the prior year. If only comparative financial
data is presented for the prior year, as distinguished from a complete set of
comparative statements, notes, and RSI, MD&A requirements apply only to
the current year, with comparisons to the prior year, as discussed in item 7.5.6
of the GASB Q&A.
15.31 Paragraph 22 of GASB Statement No. 27, Accounting for Pensions
by State and Local Governmental Employers, as amended, and paragraphs
26–27 of GASB Statement No. 45, Accounting and Financial Reporting by Employers for Postemployment Benefits Other Than Pensions, require employers
that participate in single-employer and agent multiple-employer defined benefit pension and other postemployment benefit (OPEB) plans to report certain
multiyear actuarial data as RSI.
15.32 Inclusion of information relating to discretely-presented component
units in MD&A or other RSI is a matter of professional judgment. If component
unit information is provided, the RSI should focus on the primary government
and distinguish between information pertaining to the primary government
and information pertaining to the component unit(s).

Cash, Cash Equivalents, and Investments
Cash and Cash Equivalents
15.33 In accordance with paragraph 9 of GASB Statement No. 9, cash and
cash equivalents include all cash and highly liquid investments that are both (a)
20

See paragraph 6 and footnote 5 of GASB Statement No. 34.
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readily convertible to known amounts of cash and (b) so near to their maturity
that they present an insignificant risk of changes in value because of changes
in interest rates. Cash equivalents generally are limited to investments with
original maturities of three months or less from the date of purchase, although
paragraph 11 of GASB Statement No. 9 provides that not all investments that
meet GASB's definition of cash equivalents are required to be accounted for
as such. Paragraph 8 of GASB Statement No. 9 states that the total amounts
of cash and cash equivalents at the beginning and end of the period in the
statement of cash flows should be easily traceable to similarly-titled items or
subtotals shown in the statement of net assets as of those dates.
15.34 Cash and cash equivalents are considered to be restricted21 when
limitations on the use of those assets change the nature or normal understanding of the availability of the asset. For example, cash normally is classified as
current assets, and a normal understanding of those assets presumes that no
limitations exist on the government's ability to use those resources to satisfy
current liabilities. However, cash held by a trustee that can only be used to
pay bond principal and interest and that cannot be used to pay other current
liabilities would be considered restricted assets. See paragraph 15.102 for a
discussion of classification of net assets when the use of assets is restricted.
Such restrictions or constraints may require cash and cash equivalents to
be classified as noncurrent for financial reporting purposes, as discussed in
paragraph 15.14.
15.35 Governmental health care entities are required by GASB standards
to provide disclosures related to cash and deposit accounts. For example, paragraph 8 of GASB Statement No. 40, Deposit and Investment Risk Disclosures—
an amendment of GASB Statement No. 3, requires certain disclosures related
to deposit accounts that are exposed to custodial credit risk. Deposits are exposed to custodial credit risk if they are not covered by depository insurance,
and the deposits are (a) uncollateralized, (b) collateralized with securities held
by the pledging financial institution, or (c) collateralized with securities held
by the pledging financial institution's trust department or agent but not in the
depositor-government's name. Paragraph 11 of GASB Statement No. 9 requires
disclosure of the governmental health care entity's policy for determining which
investments are treated as cash equivalents. Paragraph 113 of GASB Statement No. 62 requires disclosure of any pledge of cash and cash equivalents as
security for loans. Additional GASB disclosures related to deposit accounts are
discussed in paragraph 15.51.
15.36 Additional guidance related to cash and cash equivalents can be
found in chapter 5, "Cash, Investments, and Derivative Instruments," of the
Audit and Accounting Guide State and Local Governments and chapters 1–2 of
the GASB Q&A.

Investments
15.37 When accounting for investments, governmental health care entities follow the accounting and financial reporting requirements of the following
GASB statements:

r

21

GASB Statement No. 3, Deposits with Financial Institutions, Investments (including Repurchase Agreements), and Reverse Repurchase Agreements

See footnote 12.
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GASB Statement No. 10, Accounting and Financial Reporting for
Risk Financing and Related Insurance Issues
GASB Statement No. 28, Accounting and Financial Reporting for
Securities Lending Transactions
GASB Statement No. 31
GASB Statement No. 40
GASB Statement No. 52, Land and Other Real Estate Held as
Investments by Endowments
GASB Statement No. 53, Accounting and Financial Reporting for
Derivative Instruments
GASB Statement No. 59, Financial Instruments Omnibus
GASB Interpretation No. 3, Financial Reporting for Reverse
Repurchase Agreements—an interpretation of GASB Statement
No. 3

Additional guidance can be found in chapter 5 of the Audit and Accounting
Guide State and Local Governments and chapter 6 of the GASB Q&A.
15.38 For private-sector entities, the starting point in analyzing the accounting for an equity investment is determining whether the investee must be
consolidated.22 In the governmental sector, investments in for-profit companies
made with the intent of generating investment return do not require evaluation
for consolidation (that is, for presentation as a blended or discretely-presented
component unit).23,# Instead, once the determination is made that the purpose
is investment, the starting point is to determine if the investment must be
accounted for using the equity method of accounting described in paragraphs
202–210 of GASB Statement No. 62.
15.39 Investments in equity securities must be evaluated to determine
if the equity method of accounting described in paragraphs 202–210 of GASB
Statement No. 62 must be applied.24 (Note that GASB and FASB have differing
definitions of a security, as discussed in paragraph 15.40.) If so, then the investment is within the scope of those paragraphs, rather than GASB Statement
No. 31.
15.40 The scope of GASB Statement No. 31 is somewhat similar to privatesector standards in that it includes equity securities with readily-determinable
fair values, debt securities, and open-ended mutual funds. The differences are
as follows:

r

GASB defines a security differently, focusing in part on an instrument's transferability. GASB Statement No. 31 defines a security

22

See chapter 12, "The Reporting Entity and Related Entities," of this guide.
See paragraph 55 of GASB Statement No. 14, The Financial Reporting Entity.
#
In November 2010, GASB issued GASB Statement No. 61, The Financial Reporting Entity:
Omnibus—an amendment of GASB Statements No. 14 and No. 34. The objective of the statement
is to improve the financial reporting of a governmental financial reporting entity by modifying the
criteria for inclusion of component units and amending the criteria for blending. The statement
also clarifies the reporting of equity interests in legally-separate entities. The provisions of GASB
Statement No. 61 are effective for financial statements for periods beginning after June 15, 2012.
For additional information, see footnote ## to "The Reporting Entity and Related Entities" section
heading.
24
See paragraph 5 of GASB Statement No. 31 and item 6.4.3 of the GASB Comprehensive
Implementation Guide (GASB Q&A).
23
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r

r

as "a transferable financial instrument that evidences ownership
or creditorship, whether in physical or book entry form." As a result, certain types of investments that would be considered equity
securities under FASB literature (for example, certain limited
partnership interests) are not considered equity securities under
GASB Statement No. 31.
Private-sector standards include certain interest-earning contracts, such as guaranteed investment contracts and certificates
of deposit, in their scope but only to the extent that those
investments meet FASB's definition of a security. GASB Statement No. 31 includes all such contracts, regardless of whether
they are considered a security.
The scope of GASB Statement No. 31 includes external investment pools, which are not included in private-sector investment
standards unless they are securities.

Appendix 6-1 of the GASB Q&A provides GASB's definitions of a number of
different types of investments.
15.41 Investments within the scope of GASB Statement No. 31 are reported in the balance sheet at fair value, with the exception of nonparticipating, interest-earning investment contracts and money market investments
with a remaining maturity of one year or less at time of purchase, which are
permitted to be reported at amortized cost. Fair value is the amount at which
an investment could be exchanged in a current transaction between willing
parties, other than in a forced or liquidation sale, as discussed in paragraph 3
of GASB Statement No. 31 and item 6.11.2 of the GASB Q&A. Paragraphs 7
and 10–11 of GASB Statement No. 31 describe how fair value is measured for
various types of investments.25
15.42 Evaluating whether an alternative investment, as described in
paragraph 4.36 of this guide, falls within the scope of GASB Statement No.
31 typically focuses on whether a particular investment vehicle meets the definition of an equity security, as discussed in paragraph 15.40; an external investment pool; or some other type of investment. Paragraph 22 of GASB Statement
No. 31 defines an external investment pool as an arrangement that commingles
(pools) the monies of more than one legally-separate entity and invests in an
investment portfolio on the participants' behalf; one or more of the participants
is not part of the sponsor's reporting entity.26 Some instruments that convey an
ownership interest are not equity securities, as defined by GASB, because they
do not meet the definition of a security. Item 1.11.1 of the GASB Q&A states
that investments without a transferable financial instrument that evidences
ownership or creditorship are not securities. Item 1.48.2 of the GASB Q&A
states that shares in closed-end mutual funds and unit investments trusts are
securities but that open-end mutual funds are not. Item 1.11.1 of the GASB
Q&A states that the term securities does not include investments made directly
with another party (for example, a limited partnership interest). In evaluating

25
FASB Statement No. 157, Fair Value Measurement, is not applicable to investments within the
scope of GASB Statement No. 31 because GASB Statement No. 31 provides guidance for measuring
the fair value of those investments. However, FASB Statement No. 157 may be applicable as other
accounting literature to certain other fair value measurements of governmental health care entities
(see paragraph 15.07).
26
See also item 6.34.1 of the GASB Q&A.
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the nature of an alternative investment, careful consideration should be given
to the specific characteristics of the investment.
15.43 Some alternative investments, such as hedge funds, are arrangements that commingle the money of multiple investors and invest them in an
investment portfolio. Based on the definitions in GASB Statement No. 31, such
investments, particularly those in a limited liability corporation or those as a
limited partner in a limited partnership or limited liability partnership, may
appear to meet the definition of both an external investment pool (an arrangement that commingles the money of more than one legally-separate entity and
invests in an investment portfolio on the participants' behalf) and an equity
security (any security that represents an ownership interest in an entity). Analyzing the characteristics of the investment to determine whether it meets the
definition of a security may be helpful in determining whether and how GASB
Statement No. 31 applies to the investment. Because the definition of a security focuses in part on transferability, an alternative investment that cannot
be transferred would not be considered a security. In addition, investments
that are transacted directly with another party, such as most commingled investment vehicles in limited partnership form, are not considered securities. A
commingled investment vehicle that does not meet the definition of a security
is evaluated to determine if it is an interest in an external investment pool,
which is reported at fair value, or a financial instrument that is reported at
amortized cost, as discussed in paragraph 15.45.
15.44 GASB Statement No. 52 requires that certain land and other real
estate held as investments by endowments be reported at fair value, with
changes in fair value reported as investment income. GASB Statement No. 52
applies to permanent and term endowments and permanent funds; it does not
apply to quasiendowments.
15.45 Except as provided in paragraph 15.37, GASB has not issued any
standards regarding the valuation or recognition of investments by health care
entities. Investments for which GASB has not issued standards and that are not
financial instruments, such as real estate held by a quasiendowment or certain
oil and gas interests, are required by this guide to be reported at amortized
cost and subsequently evaluated for impairment, as discussed in paragraphs
15.46–.47.27 All other investments are reported using cost-based measures,
provided that there has not been an impairment in that value, as discussed in
items 6.4.2 and 6.12.8 of the GASB Q&A. Evaluating cost-basis investments
for impairment is discussed in paragraphs 15.46–.47. Item 6.4.1 of the GASB
Q&A describes a number of different types of investments that generally would
not fall within the scope of GASB Statement No. 31.

Impairment of Investments
15.46 Other-than-temporary impairment is not an issue for investments
reported at fair value, in accordance with GASB Statement No. 31, because
GASB does not provide for the segregation of realized gains and losses from
unrealized gains and losses. For investments covered by GASB Statement No.
31 that are reported using cost-based measures, such as money market investments and certain investment contracts, paragraphs 8–9 of GASB Statement
27
This requirement is established by this guide and is category (b) of the governmental GAAP
hierarchy (see paragraph 15.05). This requirement is consistent with paragraph 5.24, which applies
to governmental funds, of the Audit and Accounting Guide State and Local Governments and items
6.4.2 and 6.12.8 of the GASB Q&A.
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No. 31 require the cost-based measure to be reevaluated if the fair value of
the investment is significantly affected by the impairment of the credit standing of the issuer or other factors.28 Determining the amount and timing of a
write-down of those investments is a matter of professional judgment.
15.47 For all other investments reported using cost-based measures, if the
fair value of investments declines, an unrealized loss may have to be recorded
if the decline is not due to a temporary condition.29 In making impairment
evaluations for these investments, health care entities might consider as other
accounting literature (see paragraph 15.07) the guidance in FASB ASC 32010-35 for other-than-temporary impairments of investments and FASB ASC
360-10-35 for impairments of long-lived assets.

Investment Return
15.48 Investment income arises from interest and dividend income, sales
of investments at a gain or loss, and changes in the fair value of investments
during the holding period. Under the GASB Statement No. 34 reporting model,
all investment income of governmental health care entities, regardless of any
restrictions placed upon its use, is reported as nonoperating revenue.30 This
differs significantly from the private-sector standards described in paragraphs
4.30–.34 of this guide. GASB Statement No. 31 permits the change in fair value
of investments, such as the difference between the fair value of investments
at the beginning of the year and end of the year, taking into consideration
investment purchases, sales, and redemptions, to be presented separately or
combined with other investment income as a single amount. If the change in the
fair value of investments is displayed as a separate element within investment
income, it should be captioned "Net Increase (Decrease) in the Fair Value of
Investments." GASB Statement No. 31 prohibits displaying realized gains and
losses separately from other fair value changes on the face of the statement.
However, note disclosure of realized gains and losses is permitted, provided that
certain information about the nature of those amounts and their relationship to
the amounts reported in the financial statements also is disclosed, as illustrated
in appendix C of GASB Statement No. 31.
15.49 Cash flows from purchases, sales, maturities, and income of investments should be classified as cash flows from investing activities in the
statement of cash flows.

Securities Lending and Reverse Repurchase Agreements
15.50 Governmental health care entities account for securities lending
transactions in accordance with GASB Statement No. 28 and reverse repurchase agreements in accordance with GASB Statement No. 3 and GASB Interpretation No. 3. That accounting differs from the private-sector standards of
FASB ASC 860, Transfers and Servicing.

28

See paragraphs 8–9 of GASB Statement No. 31.
See paragraph 5.24 of the Audit and Accounting and Guide State and Local Governments.
30
As discussed in items 7.73.5 and 7.74.3 of the GASB Q&A, interest earned on endowments
generally should be classified as nonoperating revenue. This includes investment income restricted
to increase permanent or term endowments. It is not appropriate to report such amounts as additions
to permanent or term endowments.
29
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Financial Reporting and Disclosure
15.51 Investments held by governmental health care entities should be reported as either current or noncurrent, as appropriate, under the provisions of
paragraphs 29–44 of GASB Statement No. 62. Entities are required to disclose
information about their investments in accordance with the GASB Statements
and Interpretation included in paragraph 15.37. Among the required disclosures are the following:

r
r
r
r
r
r

r

r

The types of deposits or investments authorized by legal or contractual provisions. See paragraph 65 of GASB Statement No. 3,
as amended.
Deposit and investment policies related to the risks that GASB
Statement No. 40 requires to be disclosed. If a government has no
investment policy that addresses a specific type of risk to which it
is exposed, the disclosure should indicate that fact. See paragraph
6 of GASB Statement No. 40.
Significant violations during the period of legal or contractual
provisions for deposits and investments and the actions taken to
address such violations. See paragraph 66 of GASB Statement
No. 3 and paragraph 9 of GASB Statement No. 38.
The policy for determining which investments, if any, are reported
at amortized cost. See paragraph 15 of GASB Statement No. 31.
The methods and significant assumptions used to estimate the
fair value of investments if that fair value is based on other
than quoted market prices. See paragraph 15 of GASB Statement
No. 31.
The credit quality ratings of investments in debt securities as described by nationally-recognized statistical-rating organizations
(rating agencies) as of the date of the financial statements. This
disclosure does not apply to investments issued or explicitly guaranteed by the U.S. government, but it does apply to investments
in external investment pools, money market funds, bond mutual
funds, and other pooled investments of fixed-income securities. If
a credit quality disclosure is required, and the investment is unrated, the disclosure should indicate that fact. See paragraph 7 of
GASB Statement No. 40, as amended.
For investment securities and deposits, including securities underlying repurchase agreements, at the end of the period that
are exposed to custodial credit risk, the investment's type, the
reported amount, and how the investments are held. This disclosure does not apply to investments in external investment
pools and open-end mutual funds or securities underlying reverse
repurchase agreements. See paragraph 9 of GASB Statement
No. 40.
Investments in any one issuer, by amount and issuer, that represent 5 percent or more of total investments. This disclosure does
not apply to investments issued or explicitly guaranteed by the
U.S. government or investments in mutual funds, external investment pools, or other pooled investments. See paragraph 11 of
GASB Statement No. 40, as amended.
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Information about interest rate risk using one of the five disclosure methods listed in GASB Statement No. 40. If a method
requires an assumption regarding timing of cash flows, interest
rate changes, or other factors that affect interest rate information, that assumption should be disclosed. This disclosure applies
to investments in debt (bond) mutual funds, external debt (bond)
investment pools, or other pooled debt investments that do not
meet the definition of a 2a7-like pool. See paragraphs 14–15 of
GASB Statement No. 40, as amended.
The terms of debt investments or an investment derivative instrument with fair values that are highly sensitive to changes in interest rates, such as coupon multipliers, benchmark indexes, reset
dates, and embedded options, to the extent investment terms are
not considered in the interest rate risk disclosure requirements of
paragraph 15 of GASB Statement No. 40. See paragraphs 14 and
16 of GASB Statement No. 40, as amended.
Certain information about investments in external investment
pools. See paragraph 15 of GASB Statement No. 31.
The U.S. dollar balances of deposits or investments exposed to
foreign currency risk, organized by currency denomination and,
if applicable, investment type. See paragraph 17 of GASB Statement No. 40.
For entities with donor-restricted endowments, disclosures about
the use of investment income generated by those endowments.
See paragraph 121 of GASB Statement No. 34.
For reverse repurchase agreements, whether the maturities of
investments made with the proceeds of reverse repurchase agreements generally are matched to the maturities of the agreements,
as well as the extent of such matching. See paragraph 6 of GASB
Interpretation No. 3.
For investments arising from securities lending activities, the
authority for securities lending activities and any violations, a
description of the securities lending activities, whether the maturities of investments made with invested collateral generally
are matched to the maturities of the securities loans, the extent
of such matching, the amount of assumed credit risk, and losses
arising from securities lending. See paragraphs 12–15 of GASB
Statement No. 28, as amended.

Derivatives
15.52 A derivative instrument is a financial instrument or other contract
with all three of the characteristics in the following list:

r
r

Settlement factors. It has one or more reference rates and one
or more notional amounts or payment provisions, or both. Those
terms determine the amount of the settlement(s) and, in some
cases, whether a settlement is required.
Leverage. It requires no initial net investment or an initial net
investment that is smaller than would be required for other types
of contracts that would be expected to have a similar response to
changes in market factors.
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Net settlement. Its terms require or permit net settlement, it can
readily be settled net by a means outside the contract, or it provides for delivery of an asset that puts the recipient in a position
not substantially different from net settlement.

15.53 GASB Statement No. 53 requires that all derivatives within its
scope, including certain derivative instruments embedded in a financial instrument or other contract, be reported in the statement of net assets at fair value.
An exception exists to fair value measurement for fully benefit-responsive, synthetic guaranteed investment contracts; they are measured at contract value.
The scope of GASB Statement No. 53 excludes derivative instruments that are
normal purchases and normal sales contracts; insurance contracts accounted
for under GASB Statement No. 10, as amended; certain financial guarantee
contracts; certain contracts that are not exchange traded; and loan commitments. The definition of derivative and the scope of the statement are similar
to that used by private-sector entities.
15.54 GASB Statement No. 53 divides derivative instruments into two
types, which determines how changes in the fair value of a derivative instrument are reported, as follows:

r

r

Hedging derivative instruments are derivative instruments associated with a hedgeable item and significantly reduce an identified
financial risk by substantially offsetting changes in cash flows or
fair values of that hedgeable item. Changes in fair values of hedging derivative instruments should be recognized through the application of hedge accounting, with deferred inflows and deferred
outflows reported in the statement of net assets.
Investment derivative instruments are derivative instruments
that are entered into primarily for the purpose of obtaining income or profit or a derivative instrument that does not meet,
or no longer meets, the definition of a hedging derivative instrument. Changes in fair values of investment derivative instruments
should be reported within investment revenue (nonoperating) in
the statement of revenues, expenses, and changes in net assets.
See paragraph 15.48 for further discussion.

15.55 Paragraphs 36–62 of GASB Statement No. 53 provide guidance
on methods to be used for evaluating the effectiveness of a potential hedging
derivative instrument. Users of this guide should refer to GASB Statement No.
53, chapter 5 of the Audit and Accounting Guide State and Local Governments,
and chapter 10 of the GASB Q&A for additional guidance related to these
methods.
15.56 A health care entity that holds derivative instruments should disclose the information required by paragraphs 69–79 of GASB Statement No.
53. Those disclosures include summary information about derivative instrument activity during the reporting period, information about the objectives for
entering into hedging derivative instruments, their significant terms, contingent features of the derivative instruments, and information about the entity's
exposure to various types of risk that is caused by holding derivative instruments at the end of the reporting period. Disclosures are also required for
the companion instrument of any embedded derivatives and about synthetic
guaranteed investment contracts.
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Property and Equipment and Other Assets
15.57 The accounting requirements for capital assets and intangible assets of governmental health care entities are summarized subsequently. Accounting for supplies inventories and other assets of governmental health care
entities is similar to that used by nongovernmental health care entities, as
described in chapter 6, "Property and Equipment and Other Assets," of this
guide.

Capital Assets—General
15.58 The primary differences related to capital assets involve impairment evaluation and financial statement display and disclosure. Capital assets
are defined in paragraph 19 of GASB Statement No. 34 as "land, improvements
to land, easements, buildings, building improvements, vehicles, machinery,
equipment, works of art and historical treasures, infrastructure, and all other
tangible or intangible assets that are used in operations and that have initial
useful lives extending beyond a single reporting period." Acquired or donated
capital assets are capitalized and depreciated over their estimated useful lives.
Works of art and historical treasures need not be capitalized if they are added
to collections that meet the requirements of paragraph 27 of GASB Statement
No. 34. Chapter 7, "Capital Assets," of the Audit and Accounting Guide State
and Local Governments contains additional information.
15.59 If the potential exists that a capital asset has been impaired, governmental health care entities should consider the guidance in GASB Statement
No. 42, Accounting and Financial Reporting for Impairment of Capital Assets
and for Insurance Recoveries. These standards differ significantly from the
model applied by private-sector entities for the impairment of tangible capital
assets. FASB ASC 360-10-35 should not be applied by governmental health
care entities. GASB Statement No. 42 establishes accounting and financial reporting standards for the impairment of capital assets, including standards
for the assessment of the impairment of capital assets and the measurement
of impairment. It requires the evaluation of prominent events or changes in
circumstances affecting a capital asset's use to determine whether impairment
has occurred. A capital asset generally should be considered impaired if both
the decline in service utility of the capital asset is large in magnitude, and
the event or change in circumstances is unexpected (for example, outside the
normal life cycle of the capital asset).
15.60 If the governmental health care entity will continue to use the
impaired asset, it should measure the amount of impairment by one of three
methods that most appropriately reflect the decline in service utility of the
asset. The three methods, which are described more fully in paragraph 12 of
GASB Statement No. 42, are as follows:

r
r
r

The restoration cost approach, which derives the amount of the
impairment from the estimated costs to restore the service utility
of the capital asset
The service units approach, which isolates the historical cost of
the service utility of the capital asset that cannot be used due to
the impairment event or change in circumstances
The deflated depreciated replacement cost approach, which replicates the historical cost of the produced service
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The restoration cost approach generally should be used to measure impairments resulting from physical damage. The service units approach generally
should be used to measure impairments resulting from the enactment or approval of laws or regulations or other changes in environmental factors or from
technological development or obsolescence. The deflated depreciated replacement cost or the service units approach generally should be used to measure
impairments identified from a change in manner or duration of use. An impairment loss recognized in accordance with GASB Statement No. 42 should not
be reversed in future years, even if the events or circumstances causing the
impairment have changed.
15.61 Impairment losses should be reported in the statement of revenues,
expenses, and changes in net assets as an operating expense, special item, or
extraordinary item, in accordance with the guidance in paragraphs 41–46, 55–
56, and 101–102 of GASB Statement No. 34 and paragraphs 45–50 of GASB
Statement No. 62. If not otherwise apparent from the face of the financial
statements, a general description, the amount, and the financial statement
classification of the impairment loss should be disclosed in the notes to the financial statements. Additional guidance related to reporting impairment losses
is provided in chapter Z.42 of the GASB Q&A.

Intangible Assets Other Than Goodwill
15.62 Many governmental health care entities have goodwill and other
intangible assets. GASB Statement No. 51, Accounting and Financial Reporting for Intangible Assets, provides guidance for accounting for intangibles other
than goodwill. Accounting for goodwill is discussed in paragraph 15.65.
15.63 An intangible asset should be recognized only if it is identifiable,
meaning that the asset either (a) is capable of being separated or divided from
the governmental health care entity and sold, transferred, licensed, rented,
or exchanged, either individually or together with a related contract, asset,
or liability, or (b) arises from contractual or other legal rights, regardless of
whether those rights are transferable or separable from the entity or other
rights and obligations. Intangible assets that are internally generated are capitalized only if they meet the conditions in paragraph 8 of GASB Statement No.
51. Paragraphs 9–15 of GASB Statement No. 51 provide additional guidance
for internally-generated software. GASB Statement No. 51 also provides guidance on determining the useful life of intangibles that are limited by legal or
contractual provisions. Intangible assets with a finite useful life are amortized
over that life. If no factors exist that indicate a limitation on the useful life
of an intangible asset, the asset has an indefinite useful life. Indefinite-lived
intangibles should not be amortized, unless their useful life is subsequently
determined to be finite due to a change in circumstances.
15.64 GASB Statement No. 51 also considers all intangible assets within
its scope to be capital assets and extends existing authoritative guidance related to the accounting and financial reporting for capital assets, such as recognition, measurement, depreciation or amortization, impairment, presentation,
and disclosure, to intangible assets within its scope. Among other matters, this
requires intangible assets other than goodwill to be included in the roll-forward
disclosure of capital assets by major classes. See paragraph 15.69 for further
discussion.
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Goodwill
15.65 GASB Statement No. 51 excludes from its scope goodwill created
through the combination of a government and another entity. GASB currently
has on its agenda a project that is considering the financial reporting requirements for government combinations and the resulting goodwill. Until that
project is complete, paragraph 534 of the nonauthoritative basis for conclusions of GASB Statement No. 62 states, "In the interim, the Board believes that
state and local governments should continue their current practice of accounting and reporting of government combinations until the Board can develop
specific accounting and financial reporting standards for government combinations." Thus, governmental health care entities that previously applied APB
Opinion No. 17, Intangible Assets, continue to do so. Those entities that previously applied FASB Statement No. 142, Goodwill and Other Intangible Assets,
in accordance with an ongoing election under paragraph 7 of GASB Statement
No. 20 to apply post-November 30, 1989, FASB Statements and Interpretations that do not conflict with or contradict GASB pronouncements, should
continue to apply that FASB Statement until the entity implements GASB
Statement No. 62 or until GASB completes its combinations project, and the
new standards are effective, whichever is earlier.

Leases
15.66 Paragraphs 211–271 of GASB Statement No. 62 provide essentially the same guidance as FASB Statement No. 13, Accounting for Leases, as
amended and interpreted as of November 30, 1989, and they provide additional
guidance on specific matters unique to governmental entities. GASB Statement
No. 13, Accounting for Operating Leases with Scheduled Rent Increases, provides additional guidance for operating leases of governmental health care
enterprises.31

Asset Retirement and Pollution Remediation Obligations
15.67 When evaluating asset retirement and pollution remediation obligations, such as asbestos removal, governmental health care entities consider
the guidance in GASB Statement No. 49, Accounting and Financial Reporting for Pollution Remediation Obligations. Those standards differ significantly
from the private-sector standards of FASB ASC 410, Asset Retirement and
Environmental Obligations. GASB Statement No. 49 provides guidance on reporting the costs of, and obligations for, pollution remediation (for example,
the cleanup of pollution or asbestos contamination). GASB Statement No. 49
does not require governmental entities to search for pollution remediation obligations but, instead, sets forth triggers that would signal that a governmental
entity should determine if it has to report a remediation liability.
15.68 The scope of GASB Statement No. 49 includes obligations that
address the current or potential detrimental effects of existing pollution by
31
The provisions of GASB Statement No. 13, Accounting for Operating Leases with Scheduled
Rent Increases, and paragraphs 211–271 of GASB Statement No. 62 should not be applied to a service
concession arrangement, which is an arrangement between a transferor (government) and an operator
(governmental or nongovernmental entity) in which (a) the transferor conveys to an operator the right
and related obligation to provide services through the use of infrastructure or another public asset
(a facility) in exchange for significant consideration, and (b) the operator collects and is compensated
by fees from third parties. Those arrangements are within the scope of GASB Statement No. 60,
Accounting and Financial Reporting for Service Concession Arrangements. The provisions of GASB
Statement No. 60 are effective for financial statements for periods beginning after December 15, 2011.
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participating in pollution remediation activities, such as obligations to clean
up spills of hazardous wastes or substances and obligations to remove contamination, such as asbestos. The scope of GASB Statement No. 49 excludes
pollution prevention or control obligations with respect to current operations.
It also excludes future pollution remediation activities that are required upon
retirement of an asset, such as landfill closure and postclosure care and nuclear power plant decommissioning. However, GASB Statement No. 49 applies
to activities at the retirement of an asset if the obligating events are met,
and pollution-related asset retirement obligations have not been previously
recognized.

Disclosures
15.69 Governmental standards require specific disclosures pertaining to
capital assets, as follows:

r
r
r

r

r
r
r
r

32

The policy for capitalizing assets and estimating the useful lives
of those assets in the entity's summary of significant accounting
policies. See paragraph 115(e) of GASB Statement No. 34.
A general description of the method(s) used to compute depreciation with respect to major classes of depreciable assets. See
paragraph 95 of GASB Statement No. 62.
Information about major classes of capital assets presented in
a roll-forward format, including beginning and ending balances,
capital acquisitions, sales or other dispositions, current period depreciation expense, and accumulated depreciation. Intangible assets, if any, must be included in this disclosure as a major class(es)
of capital assets. See paragraphs 116–117 and 120 of GASB Statement No. 34 and item Z.51.29 of the GASB Q&A.
If significant, capital assets that are not being depreciated, including construction in progress,32 should be reported on the face
of the statement of net assets separately from capital assets being
depreciated. These two categories of capital assets should also be
disclosed separately in the roll-forward disclosure. See paragraph
20 of GASB Statement No. 34.
Construction commitments. See paragraph 158 of National Council on Governmental Accounting (NCGA) Statement No. 1, Governmental Accounting and Financial Reporting Principles, as
amended, and paragraph 4 of NCGA Interpretation No. 6, Notes
to the Financial Statements Disclosure.
Pertinent data regarding leases. See paragraphs 223, 231, 239,
255–256, and 270 of GASB Statement No. 62.
If not otherwise apparent from the face of the financial statements, a general description, the amount, and the financial statement classification of capital asset impairment losses. See paragraph 17 of GASB Statement No. 42.
The carrying amount of impaired capital assets that are idle at
year-end, if any, regardless of whether the impairment is considered permanent or temporary. See paragraph 20 of GASB Statement No. 42.

See item 7.11.1 of the GASB Q&A.
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Municipal Bond Financing and Other Long-Term Debt
15.70 Like not-for-profit health care entities, governmental health care
entities typically finance their acquisitions, additions, and renovations with
tax-exempt debt. Thus, many of the general considerations discussed in chapter 7, "Municipal Bond Financing," of this guide will also apply to governmental
health care entities. The primary differences arise with respect to measurement and disclosure; when they exist, such differences are highlighted in the
discussion that follows.
15.71 In accordance with paragraph 42 of NCGA Statement No. 1, as
amended, when a financing authority issues tax-exempt bonds or similar debt
instruments and uses the proceeds for the benefit of a governmental health care
entity, the obligation is reported as a liability in the health care entity's balance
sheet if the health care entity is responsible for repayment. In some cases, this
obligation may take the form of a liability arising from a capital lease. If a health
care entity has no obligation to make payments of principal and interest on the
debt or capital or operating lease payments on related buildings or equipment
(for example, if general obligation debt is issued on behalf of the governmental
enterprise), the health care entity should not reflect the liability on its balance
sheet. In those circumstances, proceeds from the bond issue are reported as
contributions from the sponsoring government.33
15.72 Among the many provisions normally included in the bond indentures of tax-exempt issues are the requirements to annually set aside funds
from operations to ensure that bond principal and interest payments and other
requirements are met. Cash, cash equivalents, and investments that can only
be used to pay debt principal and interest would be reported as restricted assets, as discussed in paragraph 15.34. The classification of net assets relating
to assets set aside based on the requirements of debt-financing instruments is
discussed in items 7.24.1, 7.24.2, 7.24.7, and 7.24.25 of the GASB Q&A and
paragraphs 15.99–.106. The restricted component of net assets represents restricted assets reduced by liabilities related to those assets; thus, the net assets
associated with assets restricted to debt service are restricted net assets. This
differs from the financial reporting requirements applicable to not-for-profit
health care entities under which such resources are part of the entity's unrestricted net assets, unless restricted by a donor for debt service, and the related
assets generally are reported as assets whose use is limited.

Debt Defeasance and Extinguishment
15.73 GASB Statement No. 7, Advance Refundings Resulting in Defeasance of Debt, and No. 23, Accounting and Financial Reporting for Refundings
of Debt Reported by Proprietary Activities, as amended, provide accounting
and financial reporting guidance for refundings that result in the defeasance
of debt. In a refunding, a government issues new debt to finance the repayment of previously-issued (old) debt. The repayment of the old debt may either be immediate (a current refunding) or at some future time (an advance
refunding).
15.74 An advance refunding may defease the old debt, either legally or
in substance, as described in paragraphs 3–4 of GASB Statement No. 7, as
33
This requirement is established by this guide and is category (b) of the governmental GAAP
hierarchy. See paragraph 15.05 for additional discussion.
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amended. A legal defeasance occurs when debt is legally satisfied based on
certain provisions in the debt instrument, even though the debt is not actually
paid. In-substance defeasance occurs if the government irrevocably places cash
or other qualifying assets with an escrow agent in a trust to be used solely to
satisfy scheduled interest and principal payments of the debt, and the possibility that the government will be required to make future payments on the debt is
remote.34 When debt is defeased, neither that liability nor the escrowed assets
are reported in the financial statements; only the new debt is reported. That
accounting is different in the private sector. Private-sector standards require
the debt to be reported as a liability until it is legally defeased.
15.75 GASB Statement No. 23 requires that the difference between the
reacquisition price and net carrying amount of the old debt be deferred and
amortized as a component of interest expense in a systematic and rational
manner over the remaining life of the old debt or the life of the new debt,
whichever is shorter. This deferred amount should be reported as a deduction
from, or an addition to, the new debt liability in the statement of net assets.
The deferred amount may be reported net, with either parenthetical or note
disclosure of the deferred amount on refunding, or it may be reported gross,
with both the debt liability and related deferred amount presented in the statement of net assets. GASB Statement No. 23 provides additional standards for
debt that refunds previous refunding debt.
15.76 Paragraphs 124–127 of GASB Statement No. 62 require that a gain
or loss in the period of extinguishment be recognized if debt is extinguished
by means other than defeasance in a current or an advanced refunding or a
troubled debt restructuring.35 The gain or loss should be identified as a separate
item in the statement of revenues, expenses, and changes in net assets. That
accounting and reporting is similar to the private-sector standards of FASB
ASC 470-50-40.

Capitalization of Interest Cost
15.77 Interest expense and investment income associated with taxexempt debt are capitalized pursuant to the guidance in paragraphs 19–20
of GASB Statement No. 62. Those standards are similar to private-sector standards for capitalizing the interest on tax-exempt borrowings that are externally
restricted to finance the acquisition of specified qualifying assets or to service
the related debt, as discussed in chapter 6 of this guide.

Disclosures
15.78 GASB standards require certain disclosures about debt, including
the following:

r

34

Information about long-term debt, such as bonds payable, including beginning and ending balances, increases, decreases, and the
portions of each item that are due within one year. See paragraphs
116 and 119–120 of GASB Statement No. 34.

See paragraph 4 of GASB Statement No. 7, Advance Refundings Resulting in Defeasance of

Debt.
35
A debtor applies paragraphs 128–148 of GASB Statement No. 62 if debt is extinguished in a
troubled debt restructuring. That accounting and reporting is similar to the private-sector standards
of FASB Accounting Standards Codification (ASC) 470-60.
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Debt service requirements to maturity presented separately for
each of the five subsequent years and in five-year increments
thereafter. Principal and interest requirements are required to be
disclosed separately. Similar requirements apply to obligations
under capital leases and noncancelable operating leases. See paragraphs 10–11 of GASB Statement No. 38.
For governmental health care entities with conduit debt obligations, a general description of the conduit debt transactions, the
aggregate amount of all conduit debt obligations outstanding at
the financial statement date, and a clear indication that the entity
has no obligation for the debt beyond the resources provided by
related leases or loans. See paragraph 3 of GASB Interpretation
No. 2, Disclosure of Conduit Debt Obligations—an interpretation
of NCGA Statement 1.
Disclosures about short-term debt activity during the year, even
if no short-term debt is outstanding at year-end. For this purpose, short-term debt consists of anticipation notes, use of lines of
credit, and similar loans. Disclosures should include a schedule of
changes in short-term debt, as well as a discussion of the purposes
for which short-term debt was issued. See paragraph 12 of GASB
Statement No. 38.
Disclosure of actions taken to remedy significant violations of
finance-related legal or contractual provisions. See paragraph 9
of GASB Statement No. 38.
In all periods following an advance refunding during which debt
that was defeased in substance remains outstanding, governments should disclose the outstanding amount of that debt, if
any, at the financial statement date. See paragraph 14 of GASB
Statement No. 7.
The following disclosures are required for all defeasances in the
year of refunding: (a) a general description of the transaction,
(b) the difference between the cash flow required to service the
old debt and the cash flow required to service the new debt and
complete the refunding, and (c) the economic gain or loss resulting
from the transaction. These are similar to disclosures required
of private-sector entities. Paragraph 11 of GASB Statement No.
7 provides guidance on the various measures needed for those
disclosures.

Contingencies and Other Liabilities
Insurance-Related Contingencies
15.79 Governmental health care entities are generally exposed to the
same risks of loss that are described in chapter 8, "Contingencies and Other
Liabilities," of this guide. The most common losses arise from medical malpractice, worker's compensation, and medical benefits provided to employees.
GASB has issued standards that governmental health care entities must apply
in accounting for insurance-related contingencies (primarily GASB Statement
No. 10, as amended). Paragraphs 52–80 of GASB Statement No. 10 apply to
health care entities and include the following standards:
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General principles for recognition, measurement, and disclosure
of claims liabilities (paragraphs 52–58), which are discussed in
paragraph 15.80
Incurred but not reported losses (paragraph 56 and footnote 5),
which are recognized if the loss can be reasonably estimated, and
it is probable that a claim will be asserted
Discounting of claims liabilities (paragraphs 59–60), which is neither mandated nor prohibited
Annuity contracts purchased to satisfy a claim liability (paragraph 61)
Investments that are separately maintained for risk financing
(paragraph 62), which are accounted for in the same manner as
all other investments, as discussed in paragraphs 15.37–.56
Participation in a public-entity risk pool (paragraphs 69–71),
which is discussed in paragraph 15.83
Claims-made policies (paragraph 72), which are discussed in paragraph 15.81
Retrospectively-rated policies and contracts (paragraph 73–74),
which are discussed in paragraph 15.82
Disclosures (paragraphs 77–80)

General Principles for Recognition, Measurement,
and Disclosure of Contingencies
15.80 The recognition and measurement requirements in paragraphs 53–
56 and the disclosure requirements in paragraph 58 of GASB Statement No.
10 are primarily those of FASB Statement No. 5, Accounting for Contingencies,
and FASB Interpretation No. 14, Reasonable Estimation of the Amount of a
Loss—an interpretation of FASB Statement No. 5, which are included in FASB
ASC 450-20.36 Therefore, much of the insurance-related guidance in chapter 8
of this guide applies to governmental health care entities. However, recognition
and measurement of claims liabilities differ because GASB Statement No. 10
looks to whether risk has, in fact, been transferred when determining whether
to recognize a loss. An estimated loss from a claim is reported as an expense
and a liability if risk has not been transferred to an unrelated third party,
and claims expenses and liabilities should be reduced by amounts expected
to be recovered through insurance. Private-sector standards require that the
amount of a contingency be determined independently from any potential claim
for recovery and that possible insurance recoveries be reported separately as
assets.

Claims-Made Policies
15.81 Paragraph 72 of GASB Statement No. 10 states that a claimsmade policy represents a transfer of risk within the policy limits for incidents
reported to the insurer. Consequently, a health care entity should account
for the estimated cost of claims and incidents that are not reported to the
insurer, unless the entity has purchased tail coverage and included the cost
of the premium or required contribution as an expense for the period. This
36
See paragraph 107 of GASB Statement No. 10, Accounting and Financial Reporting for Risk
Financing and Related Insurance Issues.
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accounting is similar to the private-sector standards described in paragraphs
8.31–.33 of this guide, except that amounts recoverable through insurance
reduce the liability, rather than being reported as a receivable.

Retrospectively-Rated Policies and Contracts
15.82 Paragraph 73 of GASB Statement No. 10 states that an entity with
a retrospectively-rated policy or contract whose ultimate premium or required
contribution is based on the entity's loss experience should account for the
minimum premium as an expense over the period of coverage and accrue estimated losses from reported and unreported claims in excess of the minimum
premium. However, losses should not be accrued in excess of the stipulated
maximum premium or contribution requirement. If the entity cannot estimate
those losses, the entity should disclose the contingency, in accordance with
paragraph 58 of GASB Statement No. 10. Paragraph 74 of GASB Statement
No. 10 provides guidance when the premium or contribution amount is based
on the experience of a group of entities.

Participation in Public-Entity Risk Pools
15.83 GASB Statement No. 10 specifically addresses situations in which
governmental health care entities participate in risk-financing programs sponsored by other governments (for example, a public-entity risk pool). That guidance is summarized as follows. A governmental health care entity that participates in a public-entity risk pool in which risk is transferred or pooled with
other entities should present its premium or required contribution as insurance
expense, as discussed in paragraphs 69–70 of GASB Statement No. 10. Entities that participate in public-entity risk pools that do not involve transfer or
pooling of risk should report payments made to pools as deposits and recognize
and measure claims liabilities, in accordance with paragraphs 53–58 of GASB
Statement No. 10, as discussed in paragraph 15.79. Governmental health care
entities that are component units of a state or local governmental reporting entity and participate in that entity's risk-financing internal-service fund
should report the charges from the internal service fund as claims expenses if
those charges meet the requirements of paragraphs 65–68 of GASB Statement
No. 10.

Irrevocable Self-Insurance Trusts
15.84 The risk-financing techniques of some governmental health care
entities include risk retention (sometimes referred to as self-insurance). A governmental health care entity that has not transferred risk to a third party
should evaluate its exposure to losses arising from all claims and incidents
and recognize liabilities and expenses, in accordance with paragraphs 53–56
of GASB Statement No. 10. Assets that have been contributed to irrevocable
self-insurance trusts are reported as restricted assets, such as assets limited
regarding use or otherwise segregated, in its statement of net assets. This restricted classification is due to the limited use of the funds as defined in the
trust fund document and the fact that the funds are not available to finance
other activities of the government. A governmental health care entity would
also report restricted net assets to the extent that the assets exceed the associated self-insured liability and will be used to liquidate the liability. See
paragraph 15.103 for a discussion on calculating restricted net assets. Privatesector not-for-profit health care entities report the net assets related to the
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excess of self-insurance assets over related liabilities in unrestricted net assets
because the limitations on use are not imposed by a donor.

Physician Guarantees and Other Agreements
15.85 Risk of loss due to guarantees, including guarantees of the indebtedness of others, should be evaluated by applying the loss contingency standards
in paragraphs 96–113 of GASB Statement No. 62. The private-sector standards for guarantees, including indirect guarantees of indebtedness of others
and minimum revenue guarantees, in FASB ASC 460-10 conflict with the requirements of NCGA Statement No. 4, Accounting and Financial Reporting
Principles for Claims and Judgments and Compensated Absences, as amended,
and, therefore, should not be applied by governmental health care entities.**

Other Contingencies
15.86 Governmental health care entities are also exposed to loss contingencies that are outside the scope of GASB Statement No. 10. The criteria
in paragraphs 96–113 of GASB Statement No. 62 are used as guidelines for
recognizing certain liabilities that arise from loss contingencies, including collectability of receivables; agreements to repurchase receivables (or the related
property) that have been sold; and breach of contract or similar actions, such
as claims for delays or inadequate specifications on contracts or guarantees
of the indebtedness of others,†† property tax appeals, and unemployment compensation claims.37 Those criteria are similar to the private-sector standards
in FASB ASC 450-20.

Compensation and Related Benefits
15.87 GASB pronouncements require governmental health care entities
to present information related to compensation and related benefits beyond or
different from that presented by not-for-profit and investor-owned entities. The
primary standards related to compensation and employee benefits are highlighted subsequently. Chapter 8 of the Audit and Accounting Guide State and
Local Governments contains more expansive discussions of these standards.

Pensions ‡‡
15.88 Governmental health care entities follow GASB Statement No. 27,
as amended; GASB Statement No. 50, Pension Disclosures—an amendment
of GASB Statements No. 25 and No. 27; and GASB Technical Bulletin (TB)
2004-2, Recognition of Pension and Other Postemployment Benefit Expenditures/Expense and Liabilities by Cost-Sharing Employers, for accounting and
financial reporting of pension expenses and related assets and liabilities. Chapter 5 of the GASB Q&A provides implementation guidance for pensions.

**
GASB currently has a project on its agenda, the objective of which is to establish additional
guidance regarding the recognition and disclosure of financial guarantees made by state and local
governments.
††
See footnote **.
37
See paragraphs 9 and 14 of National Council on Governmental Accounting Statement No.
4, Accounting and Financial Reporting Principles for Claims and Judgments and Compensated Absences, as amended.
‡‡
In July 2011, GASB issued an exposure draft, Financial Reporting for Pension Plans—an
amendment of GASB Statement No. 25. GASB is considering improvements to the existing standards
of accounting and financial reporting for pension benefits by state and local governmental employers
and the trustees, administrators, or sponsors of pension plans.
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15.89 GASB Statement No. 27, as amended, has accounting and reporting
requirements for multiple-employer cost-sharing defined benefit and defined
contribution plans that are similar to those for private-sector health care entities. The principal measurement differences between the standards for governmental and nongovernmental entities relate to accounting for single employer
and agent multiple-employer defined benefit plans. GASB Statement No. 27,
as amended, requires the measurement of employer pension expense based on
funding requirements whereas private-sector standards require a standardized measure of employer net periodic pension cost. Under GASB Statement
No. 27, as amended, the over- or underfunded status of a plan is disclosed in
the notes to the financial statements and not recognized as a liability.

Postemployment Benefits Other Than Pensions
15.90 GASB Statement No. 45 establishes standards for the measurement, recognition, and display of other postemployment benefit expenses and
related liabilities (assets), which are referred to as OPEB. OPEB includes
postemployment health care benefits, such as medical, dental, vision, and hearing, even if those benefits are provided through a Public Employees Retirement
System (PERS) plan or pension plan. OPEB also includes, for example, life
insurance, disability income, tuition assistance, legal services, and other assistance programs, unless the benefits are provided through a PERS or pension
plan.
15.91 The approach used in GASB Statement No. 45 generally is consistent with the approach used for pensions in GASB Statement No. 27, as
amended, with appropriate modifications to reflect differences between OPEB
and pension benefits. GASB Statement No. 45 requires systematic, accrualbasis measurement and recognition of OPEB cost over a period that approximates employees' years of service. GASB Statement No. 45 also requires information related to the funded status of the plan to be presented in the notes
and RSI, not reflected on the face of the balance sheet as a liability or an asset.
Chapter 8 of the GASB Q&A provides additional guidance on GASB Statement
No. 45.
15.92 Employers that provide postretirement prescription drug coverage
benefits may receive federal subsidy payments related to Medicare Part D
prescription drug coverage. Governmental health care entities must account for
those payments as a voluntary nonexchange transaction received based on the
requirements of GASB TB No. 2006-1, Accounting and Financial Reporting by
Employers for Payments from the Federal Government Pursuant to the Retiree
Drug Subsidy Provisions of Medicare Part D. That accounting is different in
the private sector. Private-sector health care entities net the subsidy payments
against the related OPEB costs and liabilities.

Sabbaticals and Other Compensated Absences
15.93 Compensated absences, such as holidays, vacations, sick leave, and
sabbaticals, should be accounted for in accordance with GASB Statement No.
16, Accounting for Compensated Absences. The underlying concepts of GASB
Statement No. 16 are similar to those of FASB ASC 710-10 for compensated
absences, with some differences, such as the following:

r

GASB Statement No. 16 does not require accrual prior to the
occurrence of the illness, unless it is probable that the employer
will compensate the employee for unused sick leave or similar
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benefits with cash payment at termination or retirement. FASB
ASC 710-10-25 addresses sick leave in the context of the vesting
of sick leave benefits; it does not require the accrual of a liability
for nonvesting rights to receive sick pay.
GASB Statement No. 16 requires accrual of payments that an
employer expects to make that will be directly and incrementally
associated with payments made for compensated absences at termination or retirement, such as FICA or Medicare tax. FASB ASC
710-10 has no similar requirement.
GASB Statement No. 16 mandates the use of certain rates of pay
for calculating the liability, and it limits the liability to amounts
that employers will pay at termination or retirement. FASB ASC
710-10 has no similar requirement.

Termination Benefits and Restructuring Costs
15.94 GASB Statement No. 47, Accounting for Termination Benefits, establishes accounting standards for the measurement, recognition, and disclosures of voluntary and involuntary termination benefits. Section Z.47 of the
GASB Q&A provides additional helpful guidance. To date, this is the only
guidance that GASB has issued on accounting for costs associated with exit
or disposal activities. Thus, the accounting for exit and disposal activities by
governmental entities differs from the accounting in FASB ASC 420, Exit or
Disposal Cost Obligations, which is used by private-sector entities.

Tax Considerations
15.95 Health care entities owned and operated by a state or local government typically are exempt from federal income tax, pursuant to IRC Section
115, and also are exempt from the federal income tax filing requirements. Such
entities are exempt not only from regular federal income tax but also from the
tax on unrelated business income. If a health care entity is owned and operated by a separately-constituted authority or other legal entity, the entity's
management should consider whether such authority or other legal entity is
properly organized to preserve qualification of the tax exemption, pursuant to
IRC Section 115.
15.96 In some cases, state or local governmental entities will secure taxexempt status as an IRC Section 501(c)(3) organization.38 If such an exemption
is secured, the entity may become subject to federal unrelated business income
tax and filing requirements on the same basis as other tax-exempt entities, as
discussed in chapter 8 of this guide.

Disclosures
15.97 Paragraph 3 of GASB Statement 10 and NCGA Statement No.
4, as amended, require various disclosures related to claims and judgments.
Paragraphs 116 and 119–120 of GASB Statement No. 34 require disclosure of
certain information related to liabilities associated with claims and judgments.
These include beginning and ending liability balances, increases, decreases,
and the portion that is expected to be due within one year.

38
This is sometimes done to facilitate fundraising because Internal Revenue Code Section
501(c)(3) status assures potential donors that their contributions will be tax deductible.
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15.98 GASB standards require certain disclosures related to other liabilities, including the following:

r
r
r
r
r
r

Detailed disclosures about accounts payable balances when significant components of those balances have been obscured by aggregation. See paragraph 13 of GASB Statement No. 38.
Information about long-term operating liabilities, such as compensated absences and claims and judgments, including beginning and ending balances, increases, decreases, and the portions
of each item that are due within one year. See paragraphs 116
and 119–120 of GASB Statement No. 34.
Disclosures about pension benefits provided to employees of governmental health care entities. See paragraphs 20–22 of GASB
Statement No. 27, as amended, and paragraphs 7–9 of GASB
Statement No. 50.
Disclosures about other postemployment benefits. See paragraphs
24–27 and 34 of GASB Statement No. 45.
Disclosures about termination benefits. See paragraphs 18–21 of
GASB Statement No. 47.
Disclosure of actions taken to remedy significant violations of
finance-related legal or contractual provisions. See paragraph 9
of GASB Statement No. 38.

Net Assets (Equity)
15.99 GASB Statement No. 34 establishes requirements for reporting
net assets that differ in several respects from the requirements for not-forprofit health care entities. Under GASB Statement No. 34, net assets or equity
are reported in three components: restricted (distinguishing between major
categories of restrictions); invested in capital assets, net of related debt; and
unrestricted. When a portion of restricted net assets is required to be retained
in perpetuity, restricted net assets should be displayed in two additional components: expendable and nonexpendable.39 Either the term net assets or equity
may be used in referring to the difference between assets and liabilities.
15.100 The unrestricted component is the residual category of net assets. It includes all assets and liabilities that are not reported as restricted
or invested in capital assets, net of related debt. Unrestricted net assets are
available to finance day-to-day operations free of constraints imposed by debt
covenants, donor restrictions, irrevocable trusts, and so on. Net assets that are
board- or management-designated for specific purposes are reported in this
component.40
15.101 The invested in capital assets, net of related debt component is
not used by not-for-profit health care entities. As discussed in paragraph 33 of
GASB Statement No. 34, this component represents the sum of capital assets
shown in the balance sheet (net of accumulated depreciation) less any related
debt used to finance those assets (for example, the outstanding balances of any

39

See paragraph 35 of GASB Statement No. 34.
However, these designations should not be displayed on the face of the balance sheet. See
paragraph 15.108.
40
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bonds, mortgages, notes, or other borrowings that are attributable to the acquisition, construction, or improvement of those assets). If capital debt exceeds the
carrying value of capital assets, a negative amount should be reported, as discussed in item 7.23.9 of the GASB Q&A. Paragraph 15.103 provides additional
guidance about calculating the amount of the net asset component invested in
capital assets, net of related debt.
15.102 Governmental-restricted net assets differ in several respects from
the restricted net assets reported by not-for-profit health care entities. First,
GASB's definition of restricted is broader. In the not-for-profit sector, restrictions relate solely to limitations imposed by donors or grantors. In the governmental sector, restrictions arise from constraints on the use of assets
that are imposed (a) by external parties (for example, creditors, grantors,
and contributors) or laws or regulations of other governments41 or (b) by
law through constitutional provisions or enabling legislation.42 Thus, in addition to resources restricted for purposes identified by donors and grantors,
governmental-restricted net assets include net assets related to restricted assets, as discussed in paragraph 15.34, such as unexpended debt proceeds held
by trustees, bond sinking and debt service reserve funds, assets set aside to
meet statutory reserve requirements, and assets held in irrevocable malpractice self-insurance trusts. The underlying concept is that the government itself
cannot unilaterally establish a restriction, except by enabling legislation, and
cannot remove a restriction, except by fulfilling it. Thus, board designations on
the use of assets are not restrictions. Under GASB Statement No. 34, assets
and net assets are reported as restricted until the resources have been used
for the specified purpose or, in the case of time requirements, as long as the
resource provider requires (for example, in perpetuity).
15.103 Another difference is that GASB focuses on identifying specific
assets that are restricted, along with any related liabilities; thus, restricted
net assets represent restricted assets reduced by the liabilities related to those
assets. In not-for-profit reporting, the concept of restriction focuses on a donor's
restriction of the use of net assets versus restricting specific assets, as discussed
in paragraph 9.08 of this guide. Item 7.24.7 of the GASB Q&A states that generally, a liability relates to restricted assets if the asset results from incurring
the liability, or the liability will be liquidated with the restricted assets.|||| For
example, unexpended debt proceeds that must be used to acquire or construct
capital assets are restricted assets, and the portion of the debt attributable
to the unexpended proceeds is a related liability that should be offset, if significant, in calculating restricted net assets.43 If a bond indenture requires a
portion of the proceeds to be used to establish a reserve for the payment of
principal and interest, the assets of the reserve account are restricted assets,
and the portion of debt related to the establishment of the reserve is included in
the calculation of restricted net assets.44 However, some exceptions exist. If, for
example, a bond sinking fund contains assets held in trust that are restricted
for principal and interest payments on capital-related debt, the capital-related
41

See paragraphs 34–35 of GASB Statement No. 34.
See GASB Statement No. 46, Net Assets Restricted by Enabling Legislation—an amendment
of GASB Statement No. 34.
||||
This general rule is included in GASB Statement No. 63 Financial Reporting of Deferred
Outflows of Resources, Deferred Inflows of Resources, and Net Position, issued in June 2011.
43
See item 7.23.2 of the GASB Q&A.
44
See item 7.24.25 of the GASB Q&A.
42
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debt would not be offset against the restricted sinking fund assets in calculating restricted net assets. Instead, it is required to be netted against the capital
assets that were financed with the debt in calculating the net asset component
invested in capital assets, net of related debt.45
15.104 To determine the overall restricted net asset balance, the financial
statement preparer first must compare individual restricted asset line items
with their related liabilities and then aggregate the results. In comparing
individual restricted asset line items with related liabilities, negative amounts
should never be reported.46 If liabilities that relate to specific restricted assets
exceed those assets, the net asset balance for that line item would be zero, and
the deficit would reduce the unrestricted net assets component.
15.105 Financial reporting of permanently-restricted net assets is another
area where GASB and FASB standards differ. When a portion of restricted net
assets is required to be retained in perpetuity, restricted net assets must be
subdivided into expendable and nonexpendable components. In the governmental sector, restricted nonexpendable net assets should represent the reported
amount of restricted assets (typically endowments) subject to a donor-imposed
time requirement that they be invested and reinvested in perpetuity less any
related liabilities. If no related liabilities exist, then the amount of restricted
nonexpendable net assets equals the value of the restricted investments, even if
that value has fallen below the amount of the original gift.47 This differs from
the not-for-profit reporting model that focuses on maintaining permanentlyrestricted net assets at the amount determined at the time of the original gift
(see paragraphs 9.25–.31 of this guide). In calculating net asset balances associated with permanent endowments, care must be exercised to appropriately
reflect the expendable and nonexpendable components if endowment assets
include both corpus and spendable accumulated net appreciation (for example,
nonexpendable restricted assets are commingled with spendable restricted assets).
15.106 GASB's guidance related to the net asset component calculations
is prescriptive, and care must be employed when linking liabilities to specific
restricted or capital assets for purposes of calculating the net asset components.
Chapter 7 of the GASB Q&A contains guidance regarding the GASB staff's
views on how the standards should be applied in various scenarios.

Financial Reporting
15.107 Restricted assets are not required to be labeled as restricted on
the balance sheet, as long as the descriptions used on the face of the balance
sheet make it clear that such assets cannot be used to satisfy liabilities or
purposes other than those that are specifically intended to be satisfied with the
restricted assets (see paragraph 15.107). The supporting details of restricted
net assets (for example, major categories of restrictions) must be displayed on
the face of the statement of net assets or balance sheet; note disclosure is not
an acceptable alternative.48 Not-for-profit health care entities are permitted to
provide that information in either the notes to the financial statements or on
the face of the balance sheet.
45
46
47
48

See item 7.24.2 of the GASB Q&A.
See item 7.24.13 of the GASB Q&A.
See item 7.24.14 of the GASB Q&A.
See item 7.22.8 of the GASB Q&A.
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15.108 Paragraphs 37 and 98 of GASB Statement No. 34, as amended,
prohibit reporting internal designations of net assets separately within unrestricted net assets on the face of the balance sheet but allow disclosure in the
notes to the financial statements. Designations are management's plans for the
use of resources, which should not be afforded the same status as restrictions.
No prohibition exists against displaying the associated designated assets (for
example, investments set aside for future expansion or quasiendowment) on
the face of the balance sheet. Not-for-profit health care entities are permitted
to display designations within unrestricted net assets on the face of the balance
sheet or in the notes.

Health Care Service Revenue and Receivables
15.109 As discussed in chapter 10, "Health Care Service Revenue and Related Receivables," of this guide, under most third-party payor arrangements,
governmental health care entities receive payment amounts that are less than
their full established rates. The amount paid may be based on government
regulations, such as Medicare, Medicaid, and other government programs, or
contractual arrangements, such as PPOs, Blue Cross and Blue Shield plans,
HMOs, and commercial insurers. Under this guide, provisions recognizing contractual and other adjustments are recorded on an accrual basis and deducted
from gross service revenue to determine net service revenue. Charity care represents health care services that are provided but never expected to result in
cash flows; therefore, charity care does not qualify for recognition as revenue.
For financial reporting purposes, gross service revenue does not include charity
care, and net service revenue is reported net of contractual and other adjustments in the statement of revenues, expenses, and changes in net assets or
equity.49
15.110 Footnote 41 to paragraph 100 of GASB Statement No. 34 states,
"Revenues should be reported net of discounts and allowances with the discount
or allowance amount parenthetically disclosed on the face of the statement or
in a note to the financial statements. Alternatively, revenues may be reported
gross, with the related discounts and allowances reported directly beneath the
revenue amount." For purposes of that display and disclosure, discounts and
allowances include the difference between a health care provider's full established rates and its negotiated or contractual payment amounts previously
described. However, allowances, as used in footnote 41, also include increases
or decreases in the estimate of uncollectible accounts. As a result, the financial
statements of governmental health care entities display changes in the estimate of uncollectible accounts differently from the display of similar amounts
in financial statements of private-sector entities. Governmental health care
entities report those amounts as a deduction from revenue. Private-sector entities report them as bad debt expense, as discussed in paragraph 10.29 of this
guide. Paragraph 100 of GASB Statement No. 34 also requires governmental
health care entities to separately identify revenues that provide security for
revenue bonds.
15.111 Governmental health care entities that enter into arrangements in
which they finance or sell their patient accounts receivable as a cash flow management strategy apply criteria in GASB Statement No. 48, Sales and Pledges

49

See footnote 33.
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of Receivables and Future Revenues and Intra-Entity Transfers of Assets and
Future Revenues, in determining when transactions should be reported as a
collateralized borrowing or sale. Determining whether a transaction should be
reported as a sale, rather than a collateralized borrowing, requires an assessment of a government's continuing involvement with the receivables or future
transferred revenues. A significant aspect of that assessment is the degree
to which the selling or pledging government (the transferor) retains or relinquishes to the transferee control over the receivables or future transferred
revenues. FASB ASC 860 should not be applied as other accounting literature
by governmental health care entities because it conflicts with GASB Statement
No. 48.
15.112 Governmental health care entities are required to disclose certain
information about revenue and receivables, as follows:

r
r
r
r
r
r
r

The accounting policies used for recognizing revenues, as discussed in paragraph 69 of NCGA Statement No. 1 and paragraphs
90–94 of GASB Statement No. 62.
The policy for defining operating and nonoperating revenues, as
discussed in paragraphs 102 and 115 of GASB Statement No. 34.
Information about specific revenues pledged to collateralize or
secure debt, as discussed in paragraph 21 of GASB Statement No.
48.
Detailed disclosures about receivable balances when significant
components of those receivables have been obscured by aggregation, as discussed in paragraph 13 of GASB Statement No. 38.
Separate disclosure of significant receivable balances not expected
to be collected within one year of the balance sheet date, as discussed in paragraph 13 of GASB Statement No. 38.
The allowance for estimated uncollectible receivables should be
disclosed on the face of the financial statement either parenthetically or as a separate line item or in the notes to the financial
statements, as discussed in paragraph 33 of GASB Statement No.
62.
Management's policy for providing charity care, as well as the
level of charity care provided, measured based on the governmental health care entity's costs, units of service, or other statistical
measure.50 Private-sector health care entities disclose the information in paragraph 10.28 of this guide.

Chapter 6, "Revenues and Receivables," of the Audit and Accounting Guide
State and Local Governments contains additional guidance on accounting, financial reporting, and auditing considerations related to revenue and receivables.

Contributions and Other Nonexchange Transactions
15.113 Governmental health care entities may receive contributions,
grants, or tax support in transactions with no direct and equivalent exchange of value with the resource provider. Governmental health care entities
50

See footnote 33.
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follow GASB Statement No. 33, Accounting and Financial Reporting for Nonexchange Transactions, as amended, which establishes accounting and financial
reporting standards for the recognition of nonexchange transactions involving
financial or capital resources.51
15.114 Nonexchange transactions are classified into one of four classes
based on their principal characteristics, as discussed in paragraph 7 of GASB
Statement No. 33. Most contributions and grants received by governmental
health care entities are classified as voluntary nonexchange transactions. Revenue from voluntary nonexchange transactions should be recognized when
all applicable eligibility requirements have been met. Eligibility requirements
comprise one or more of the following:

r
r
r
r

Required characteristics of recipients
Time requirements
Reimbursements
Contingencies

Detailed guidance on the application of eligibility requirements is provided in
paragraphs 20–26 of GASB Statement No. 33.
15.115 Voluntary nonexchange transactions may be received with associated time or purpose restrictions. As discussed in paragraph 14 of GASB Statement No. 33, purpose restrictions imposed on nonexchange revenues, such as
grants, contributions, and endowments, do not affect when revenues are recognized. Rather, resulting net assets should be reported as restricted until the
resources have been used for the specified purpose or for as long as the resource
provider requires (for example, for endowments).
15.116 If the transaction is a permanent or term endowment, the resource provider's stipulation that the resources should be maintained intact
in perpetuity for a specified number of years or until a specific event has occurred (for example, the donor's death) is a time requirement, as described
in paragraph 20(b) of GASB Statement No. 33. In such situations, the time
requirement is considered met as soon as the recipient begins to honor the
provider's stipulation not to sell, disburse, or consume the resources, which
occurs upon receipt of the resources. Therefore, revenues from term or permanent endowments should be recognized at the time the resources are received, provided that all other eligibility requirements have been met. The
associated net assets should be reported as restricted for as long as the
donor's time requirements and purpose restrictions, if applicable, remain in
effect.
15.117 Promises of cash or other assets that nongovernmental entities,
including individuals, voluntarily make to governments may be referred to as
pledges, promises to give, promised donations, or some other term. Promised
assets may include permanently nonexpendable additions to endowments and

51
To date, GASB has not issued any guidance related to noncapital gifts-in-kind or contributed
services.
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other trusts; term endowments; contributions of works of art and similar assets to capitalized collections; or other kinds of capital or financial assets, with
or without purpose restrictions or time requirements. Governmental health
care entities that receive promises to give should recognize receivables and
revenues net of estimated uncollectible amounts only after all eligibility requirements are met, provided that the promise is verifiable, and the resources
are measurable and probable of collection.52 As noted in item Z.33.19 of the
GASB Q&A, governmental standards neither require nor prohibit the discounting of promises to give that are to be received over an extended period of
time. Private-sector standards require discounting of such promises. Transactions that are not recognizable because they are not measurable should
be disclosed.53 For term or permanent endowments, the health care entity
cannot begin to honor a provider's stipulation that the resources not be sold,
disbursed, or consumed until the resources are actually received. Therefore,
promises to give term or permanent endowments are not recognized in financial
statements.54
15.118 In some cases, it may become apparent after revenue has been
recognized in the financial statements that the GASB Statement No. 33 eligibility criteria are no longer met (for example, because an audit of a particular grant program determined that certain expenses did not meet purpose
restrictions). Paragraph 26 of GASB Statement No. 33 provides that if it is
probable that the recipient will return all or part of the transferred resources,
a liability or reduction of a receivable and an expense should be recognized
for the amount that the resource provider (grantor) is expected to cancel or
reclaim.
15.119 Governmental health care entities may be beneficiaries of charitable gifts structured as split-interest agreements. Common forms of splitinterest agreements include charitable gift annuity contracts, pooled life income trusts, charitable remainder unitrusts, charitable remainder annuity
trusts, and charitable lead annuity trusts. Item 7.72.11 of the GASB Q&A
provides guidance to governmental health care entities in situations in which
the health care entity is the trustee, as well as the beneficiary; thus, the
trust assets are under their control. The governmental health care entity
should recognize an asset for the fair value of the trust assets and a liability for the obligation to the beneficiary. The difference between the assets in the trust and the liability owed to the other beneficiary(ies) would
be reported as restricted net assets that are expendable or nonexpendable based on the nature of the donor's restrictions. Changes should be reflected in the statement of revenues, expenses, and changes in net assets or
equity.
15.120 Foundations, businesses, and other types of entities may provide
resources to health care entities under programs referred to as grants, awards,
or sponsorships. The asset transfers are likely exchange or exchangelike transactions if the potential public benefit is secondary to the resource providers'
potential direct benefits. The transfers are likely contributions (voluntary

52
See paragraph 25 and examples 21 and 21(a) in appendix D of GASB Statement No. 33,
Accounting and Financial Reporting for Nonexchange Transactions.
53
See paragraph 11 of GASB Statement No. 33.
54
See examples 24–25 in appendix D of GASB Statement No. 33.

AAG-HCO 15.118

State and Local Government Health Care Entities

303

nonexchange transactions) if the resource providers receive no value in exchange for the transferred assets or if the value received by the resource
provider is incidental to the potential public benefit from using the transferred
assets. For example, a research grant made by a foundation to a governmental
hospital would likely be a contribution if the research program is to be planned
and carried out by the hospital, and the hospital has the right to publish the
results. However, if the grant is made by a pharmaceutical manufacturer that
provides potential new medications to be tested in the hospital's research facilities and retains the right to any patents or other results, the grant would
likely be an exchange transaction.55 Item Z.33.1 in the GASB Q&A also discusses considerations related to determining whether a grant is an exchange
or a nonexchange transaction.
15.121 Statement of Position (SOP) 98-2, Accounting for Costs of Activities of Not-for-Profit Organizations and State and Local Governmental Entities
That Include Fund Raising (AICPA, Technical Practice Aids, ACC sec. 10,730),
provides guidance for state and local governmental entities, including health
care entities, that conduct fund-raising activities with activities related to other
functions, such as program activities or supporting services (joint activities).
FASB ASC 958-720 superseded SOP 98-1, Accounting for the Costs of Computer
Software Developed or Obtained for Internal Use, as it relates to nongovernmental entities; however, SOP 98-2 is still applicable to governmental entities.
SOP 98-2 establishes financial accounting standards for accounting for costs of
joint activities and requires financial statement disclosures about the nature
of the activities for which joint costs have been allocated and the amounts of
those joint costs.
15.122 GASB Statement No. 34 provides guidance related to the presentation of nonexchange transactions in financial statements. Contributions of
capital assets or financial resources required to be used to acquire capital assets are reported separately after nonoperating revenues and expenses in the
statement of revenues, expenses, and changes in net assets, as illustrated in
paragraph 15.17. Contributions of term and permanent endowments should be
reported in the same manner. All other contributions (both restricted and unrestricted) are reported as nonoperating revenues and expenses. As discussed
in paragraph 15.18, net assets released from restriction are not reported in the
statement of revenues, expenses, and changes in net assets, as is done in the
not-for-profit reporting model.
15.123 In the statement of net assets, an amount equal to unexpended
restricted contributions at the reporting date should be included in the restricted net assets component of net assets. GASB Statement No. 34 does
not require that restricted resources be used first when an expenditure is
made for a purpose for which both unrestricted and temporarily-restricted
net assets are available. Instead, each entity is required to establish a policy
for whether restricted or unrestricted resources will be used first when both
sources are available and to disclose that policy in the notes to the financial
statements.56

55
56

See example 22 in appendix D of GASB Statement No. 33.
See paragraph 115 of GASB Statement No. 34.
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The Reporting Entity and Related Entities ##
15.124 Governmental health care entities and private-sector health
care entities use different definitions of the financial reporting entity. GASB
Statement No. 14, The Financial Reporting Entity, as amended, establishes
standards for defining and reporting the governmental financial reporting entity and addresses issues related to the display of entities included within
the reporting entity, the application of the equity method of accounting, and
accounting and reporting considerations for various types of joint ventures
entered into by governmental entities. Unlike the private sector, which employs variable interest and voting interest models for defining the reporting
entity, GASB's reporting entity model is based on the concept of financial
accountability.57
15.125 Under GASB Statement No. 14, the governmental financial reporting entity consists of the primary government and any legally-separate
entities that meet the definition of a component unit. Component units are
(a) legally-separate entities for which the primary government is financially
accountable, as discussed in paragraph 15.126; (b) certain entities that are included in the reporting entity because of the nature and significance of their
relationship with the primary government, as described in GASB Statement
No. 39 and paragraph 15.128; and (c) other legally-separate organizations for
which the primary government is not financially accountable, but the nature
and significance of their relationship with the primary government are such
that exclusion would cause the reporting entity's financial statements to be
misleading or incomplete. A nonauthoritative flowchart in appendix D of GASB
Statement No. 39 aids in the evaluation of whether an entity is a component
unit.
15.126 A governmental health care entity is financially accountable for
another entity if it appoints a voting majority of the entity's governing body,
and it is able to impose its will on that entity, or a potential exists for the entity
to provide specific financial benefits to, or impose specific financial burdens
##
In November 2010, GASB issued GASB Statement No. 61. The objective of the statement
is to improve the financial reporting of a governmental financial reporting entity by modifying the
criteria for inclusion of component units and amending the criteria for blending. The statement
modifies certain requirements for inclusion of component units in the financial reporting entity.
For organizations that previously were required to be included as component units by meeting the
fiscal dependency criterion, a financial benefit or burden relationship also would need to be present
between the primary government and that organization for it to be included in the reporting entity
as a component unit. Further, for organizations that do not meet the financial accountability criteria
for inclusion as component units but that, nevertheless, should be included because the primary
government's management determines that it would be misleading to exclude them, GASB Statement
No. 61 clarifies the manner in which that determination should be made and the types of relationships
that generally should be considered in making the determination. It also amends the criteria for
reporting component units as if they were part of the primary government (that is, blending) in certain
circumstances. For component units that currently are blended based on the "substantively the same
governing body" criteria, it additionally requires that (a) the primary government and component unit
have a financial benefit or burden relationship, or (b) management of the primary government below
the level of the elected officials have operational responsibility, as defined in paragraph 8(a), for the
activities of the component unit. New criteria also are added to require blending of component units
whose total outstanding debt is expected to be repaid entirely or almost entirely with resources of the
primary government. Additional reporting guidance is provided for blending a component unit if the
primary government is a business-type activity that uses a single column presentation for financial
reporting. The statement also clarifies the reporting of equity interests in legally-separate entities.
It requires a primary government to report its equity interest in a component unit as an asset. The
provisions of GASB Statement No. 61 are effective for financial statements for periods beginning after
June 15, 2012.
57
See paragraphs 10–11 and 21 of GASB Statement No. 14.
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on, the governmental health care entity, as described in paragraphs 21–33 of
GASB Statement No. 14. A governmental health care organization also may
be financially accountable for an entity that is fiscally dependent on it, as
described in paragraphs 34–37 of GASB Statement No. 14.
15.127 Generally, significant investments made by a governmental entity primarily for the purpose of obtaining income or profit are evaluated as
investments, rather than potential component units.58
15.128 GASB Statement No. 39 amended GASB Statement No. 14 to provide additional guidance for determining whether certain entities (for example,
institutionally-related fund-raising foundations) for which the primary government is not financially accountable should be reported as discretely-presented
component units based on the nature and significance of their relationship with
the primary government. Paragraph 5 of GASB Statement No. 39 requires reporting as a discretely-presented component unit an organization that meets
all three of the following criteria:

r
r
r

The economic resources received or held by the separate organization are entirely or almost entirely for the direct benefit of
the governmental health care entity, its component units, or its
constituents.
The governmental health care entity or its component units is
entitled to, or has the ability to otherwise access, a majority of the
economic resources received or held by the separate organization.
The economic resources held by the separate organization are
significant to the governmental health care entity.

Additional considerations related to applying GASB Statement No. 39 are discussed in paragraphs 15.133–.138.
15.129 GASB Statement No. 14 also contains standards for displaying
component units in a financial reporting entity's basic financial statements.
Some component units are required by paragraph 53 of GASB Statement No.
14 to be blended with the financial information of the primary government
(similar to the presentation of consolidated subsidiaries in the private sector).
Those that are not required to be blended are discretely presented. In discrete
presentation, the financial information of the component unit is displayed separately from the financial information of the primary government (that is, in a
separate column or on a separate page).59 Component units included as a result
of meeting the criteria in GASB Statement No. 39 must always be discretely
presented.
15.130 If a primary government and its component units have different
fiscal year-ends, the financial reporting entity reports using the primary government's fiscal year and incorporates financial statements for the component
units' fiscal years ending during the reporting entity's fiscal year. If a component unit's fiscal year ends within the first quarter of the reporting entity's

58

See paragraph 55 of GASB Statement No. 14.
Some governmental health care entities may be organized and operated on a fund basis (for
example, they use several separate enterprise funds for the purpose of carrying on specific activities
or attaining certain objectives in accordance with regulatory restrictions or limitations). Item 4.28.10
of the GASB Q&A discusses various financial statement display options for governments that have
discretely-presented component units.
59
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subsequent fiscal year, the component unit's financial statements for that subsequent year may be used if doing so does not adversely affect the timely and
accurate presentation of the reporting entity's financial statements. The fiscal year of the component units included in the reporting entity should be
consistent from year to year.60 If transactions between component units that
have different fiscal years result in inconsistencies in amounts reported as intraentity receivables or payables, the governmental health care entity should
disclose the nature and amount of those transactions in the notes to the financial statements.61
15.131 Because of the separate nature of discretely-presented component
units, GASB Statement No. 34 generally requires that transactions between a
primary government and its discretely-presented component units (intraentity
transactions) be reported as if they were transactions with external parties.62
However, GASB Statement No. 48 requires that intraentity transfers of capital and financial assets should be reported based on the carrying value of the
transferor.63 In separately-issued financial statements of discretely-presented
component units, amounts receivable from, or payable to, the primary government should be reported on a separate line from other receivables (payables).
Chapter 9, "Interfund, Internal, and Intra-Entity Activity and Balances," of
the Audit and Accounting Guide State and Local Governments contains a detailed discussion of accounting and financial reporting considerations related
to intraentity activity and balances. Section Z.48 of the GASB Q&A provides
implementation guidance for GASB Statement No. 48.
15.132 Additional guidance is provided in chapter 3, "The Financial Reporting Entity," of the Audit and Accounting Guide State and Local Governments and chapters 4 and 7 of the GASB Q&A, which provide nonauthoritative
illustrations, examples, disclosures, and financial statement presentations. Appendix 4-2 of the GASB Q&A provides examples that evaluate potential component units for inclusion in the financial statements, and appendix 4-5 of the
GASB Q&A provides a useful flowchart for evaluating potential component
units.

Institutionally-Related Foundations
15.133 Legally-separate not-for-profit foundations may be established to
raise, hold, and invest funds on behalf of a governmental health care entity.
Because of its close relationship to the governmental health care entity, a
foundation should be evaluated to determine whether it is included in the
reporting entity because it is a component unit, as described in paragraph
15.125.
15.134 If the fundraising foundation is a component unit because it meets
the three criteria in paragraph 5 of GASB Statement No. 39, as discussed in
paragraph 15.128, the governmental health care entity is required to report the
fundraising foundation as a discretely-presented component unit. Distributions
made or promised by the foundation to the health care entity are reported as
expenses by the foundation and contribution revenue by the health care entity.
60

See paragraphs 59–60 of GASB Statement No. 14.
See paragraph 60 of GASB Statement No. 14.
62
See paragraph 61 of GASB Statement No. 34.
63
See paragraph 15 of GASB Statement No. 48, Sales and Pledges of Receivables and Future
Revenues and Intra-Entity Transfers of Assets and Future Revenues.
61
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The nonauthoritative exhibits E-1 and E-2 of GASB Statement No. 39 illustrate
discretely presenting the foundation by displaying the foundation's financial
statements in their original formats on separate pages. The nonauthoritative
exhibits E-3 and E-4 of GASB Statement No. 39 illustrate one way in which a
discretely-presented component unit could be displayed side-by-side on the face
of the health care entity's statement of net assets and statement of revenues,
expenses, and changes in net assets.
15.135 If the foundation is included in the reporting entity for one of
the other two reasons in paragraph 15.125 (that is, because the governmental health care entity is financially accountable or because, without it, the
financial statements of the governmental health care entity are misleading or
incomplete), the fundraising foundation will be either blended or discretely presented. The method to use is determined by applying the criteria in paragraph
53 of GASB Statement No. 14. If the foundation provides benefits entirely or
almost entirely to the governmental health care entity, the foundation is a
blended component unit of the health care entity.64 The foundation also is a
blended component unit if the governing bodies of the health care entity and
foundation are substantively the same. If neither of the criteria for blending is
met, the fundraising foundation is discretely presented.
15.136 In most cases, the foundation prepares its financial statements in
accordance with FASB standards. If a nongovernmental foundation's standalone financial statements state that the foundation and governmental health
care entity are financially interrelated, as described in FASB ASC 958-20,
then as explained in footnote a to paragraph 40(a) of GASB Statement No.
14, the governmental health care entity is able to otherwise access the majority of the economic resources received or held by the financially-interrelated
entity (the foundation). If the foundation meets the other two criteria in paragraph 5 of GASB Statement No. 39, it is a component unit. Paragraph 29
of the nonauthoritative basis for conclusions of GASB Statement No. 39 also
states that in these circumstances, the health care entity's financial statements
would be rendered misleading or incomplete if the financial statements of the
financially-interrelated entity (foundation) were excluded, particularly if the
financially-interrelated entity holds the majority of the primary government's
endowments, gifts, and contributions whereby the gift or earnings thereon are
restricted by donors for the activities of the primary government or its component units. A nongovernmental foundation that is financially interrelated with
a health care entity reports contributions according to the guidance discussed
in paragraph 11.35 of this guide. The governmental health care entity that is
the specified beneficiary does not report an interest in the net assets of the
foundation, as is done by private-sector health care entities; instead, a governmental health care entity recognizes contributions received from, or pledged
by, the foundation, in accordance with the standards in paragraphs 19–25 of
GASB Statement No. 33.
15.137 If a foundation's stand-alone FASB financial statements do not indicate whether the foundation and governmental health care entity are financially interrelated, the governmental health care entity's ability to otherwise
access a majority of the economic resources received or held by the separate
organization might be demonstrated in other ways. For example, historically,
the health care entity may have directly or indirectly received a majority of
64

See case 17 in appendix 4-2 of the GASB Q&A.
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the economic resources provided by the foundation, or previously, the foundation may have received and honored requests to provide resources to the
health care entity. If the ability to otherwise access the economic resources is
demonstrated, and the foundation meets the other two criteria in paragraph
5 of GASB Statement No. 39, it is a component unit. If the foundation does
not meet the three criteria in GASB Statement No. 39, the foundation should
be evaluated for inclusion as a component unit using the remaining two tests
described in paragraph 15.125. If the foundation does not meet any of those
three tests, then the foundation is not a component unit of the health care entity. The health care entity recognizes contributions received from, or pledged
by, the foundation, in accordance with the standards in paragraphs 19–25 of
GASB Statement No. 33.65
15.138 Section 4.33 of the GASB Q&A describes various ways in which
the financial statements of nongovernmental component units can be displayed
in the financial statements of the governmental reporting entity.

Business Combinations
15.139 Governmental health care entities may participate in business
combination transactions with other governmental entities or private-sector
entities. GASB has a project underway that will develop accounting and reporting standards for government combinations. Paragraph 534 of the nonauthoritative basis for conclusions of GASB Statement No. 62 states that governments should continue their current practice of accounting and reporting
of government combinations until GASB can develop specific accounting and
financial reporting standards.
15.140 In practice, some governmental health care entities, primarily
those that elected to follow post-November 30, 1989, FASB Statements and
Interpretations that do not conflict with or contradict GASB pronouncements,
applied FASB ASC 805, Business Combinations, to purchase transactions. Others accounted for purchase transactions in accordance with APB Opinion No.
16, Business Combinations, as amended and interpreted through November
30, 1989. For change of control transactions that did not involve an exchange
of consideration, many governmental health care entities applied accounting
similar to the pooling-of-interest method described in APB Opinion No. 16.
Governmental health care organizations were precluded from applying the
provisions of FASB ASC 958-805, which are applicable to not-for-profit health
care organizations.

General Auditing Considerations for Governmental
Health Care Entities
15.141 Chapter 2, "General Auditing Considerations," of this guide provides guidance on the unique application of the standards of fieldwork to
health care entities, including guidance for audits conducted in accordance
with financial audit standards contained in Government Auditing Standards,
65
If the foundation prepares its financial statements in accordance with FASB standards, it uses
the standards in the "Transfers of Assets to a Not-for-Profit Entity or Charitable Trust that Raises
or Holds Contributions for Others" sections of FASB ASC 958-605 to determine whether to recognize
contribution revenue or a liability when it receives contributions for the governmental health care
entity's use or benefit. Those standards are discussed in paragraphs 11.31–.38 of this guide.
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as amended, which is issued by the Comptroller General of the United States.
The AICPA Audit and Accounting Guide State and Local Governments discusses in detail the requirements for a generally accepted auditing standards
audit of financial statements prepared in accordance with the governmental
GAAP hierarchy described in paragraph 15.05. It contains information about
auditing considerations that are unique to the governmental financial reporting model that are not contemplated in this guide. Therefore, in performing
audits of separately-issued financial statements of governmental health care
entities, the auditing guidance contained in both the Audit and Accounting
Guide State and Local Governments and this guide will be useful.
15.142 Paragraph 4.32 of the Audit and Accounting Guide State and Local
Governments states that an auditor's consideration of whether a government's
basic financial statements are presented fairly, in all material respects and
in conformity with GAAP, should be based on opinion units. Auditors apply
the concept of opinion units in planning, performing, evaluating the results
of, and reporting on audits of governmental entities, including governmental
health care entities. The concept of opinion units is unique to audits of state and
local governmental entities. Chapters 4, "General Auditing Considerations"; 13,
"Concluding the Audit"; and 14, "Audit Reporting," of the Audit and Accounting
Guide State and Local Governments define opinion units and discuss the nature
and effect of opinion units in planning, performing, evaluating the results of,
and reporting on the audit of such entities' basic financial statements.
15.143 The number of opinion units will depend on whether the governmental health care entity (a) accounts for and reports its activities in a
single enterprise fund or multiple enterprise funds66 and (b) has any discretelypresented component units (see paragraphs 15.124–.138). A governmental
health care entity that reports its activities in a single enterprise fund and
has no discretely-presented component units will have a single opinion unit.
A governmental health care entity that operates in a single enterprise fund
and has one or more discretely-presented component units will have more
than one opinion unit: one for the primary government (the health care entity) and another for the discretely-presented component unit. If more than
one discretely-presented component unit exists, the opinion unit is referred
to as aggregate discretely-presented component units. A governmental health
care entity that reports its activities in multiple enterprise funds will have an
opinion unit for each major enterprise fund67 and an additional opinion unit
for all nonmajor funds in the aggregate (aggregate remaining fund information). If that entity also has one or more discretely-presented component units,
there will be an additional opinion unit for the aggregate discretely-presented
component unit(s).68
15.144 Paragraphs 2.15–.19 of this guide provide general guidance on
the concept of materiality. In accordance with paragraph .27 of AU section
66
Some governmental health care entities may be organized and operated on a fund basis (for
example, they use several separate enterprise funds for the purpose of carrying on specific activities
or attaining certain objectives in accordance with regulatory restrictions or limitations).
67
An exercise for determining major and nonmajor funds is included as exercise 5 in chapter 7
of appendix 7-3 of the GASB Q&A.
68
As discussed in chapter 4, "General Auditing Considerations," of the Audit and Accounting Guide State and Local Governments, if either the aggregate discretely-presented component units
opinion unit or the aggregate remaining fund information opinion unit is not quantitatively or qualitatively material to the primary government, those two units may be combined and titled the "Aggregate
Discretely-Presented Component Unit and Remaining Fund Information Opinion Unit."
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312, Audit Risk and Materiality in Conducting an Audit (AICPA, Professional
Standards), the auditor should determine a materiality level for the financial
statements as a whole, which in the context of a governmental audit means
establishing materiality levels by each opinion unit. Chapter 4 of the Audit
and Accounting Guide State and Local Governments provides detailed guidance on audit materiality determinations for governmental entities, including
guidance on assessing materiality based on the concept of opinion units. The
materiality evaluation for one opinion unit should not be affected by other information in the government's financial statements or, if applicable, quantitative
or qualitative factors relating to other opinion units.
15.145 Paragraphs 2.56–.58 of this guide discuss management's representations for financial statements. Paragraphs 13.09–.10 of the Audit and Accounting Guide State and Local Governments list the types of representations
that are particularly important in a governmental engagement. Paragraph .07
of AU section 558A, Required Supplementary Information (AICPA, Professional
Standards), states that the auditor should consider whether representations
for RSI should be included.***
15.146 Governmental health care entities are subject to various legal and
contractual provisions (compliance requirements) that may affect their financial statements. As discussed in paragraph 12.10 of the Audit and Accounting
Guide State and Local Governments, the auditor should consider whether it is
necessary to evaluate the entity's compliance with those requirements as part
of the financial statement audit.

Independent Auditor’s Reports
15.147 The AICPA's fourth standard of reporting requires that the auditor's report contain either an expression of opinion regarding the financial
statements as a whole or an assertion to the effect that an opinion cannot
be expressed. As discussed in chapter 14 of the Audit and Accounting Guide
State and Local Governments, auditors of governmental health care entities
express or disclaim opinions on a government's financial statements as a whole
by providing in the aggregate separate opinions or disclaimers of opinion on
the financial statements of each opinion unit. Examples 15-1 and 15-2 are illustrative reports for a governmental health care entity that accounts for and
reports its activities in a single enterprise fund. Note that in these illustrative reports, auditors do not express opinions on results of operations, as is
done for private-sector health care entities. Instead, auditors of governmental
health care entities opine on the change in financial position. Chapter 14 of
the Audit and Accounting Guide State and Local Governments contains numerous additional report examples, including examples for entities that use
multifund reporting and a number of situations unique to government reporting (for example, reporting on a single fund or department and reporting when
a component unit is omitted).

***
In February 2010, the Auditing Standards Board (ASB) issued Statement on Auditing Standards (SAS) No. 120, Required Supplementary Information (AICPA, Professional Standards, AU sec.
558). This SAS will supersede AU section 558A, Required Supplementary Information (AICPA, Professional Standards). SAS No. 120 is effective for audits of financial statements for periods beginning
on or after December 15, 2010. Early application is permitted. Appendix E, "Other Information, Supplementary Information, and Required Supplementary Information," of this guide provides additional
information on SAS No. 120. Management's representations are discussed in paragraph .09 of AU
section 558.
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15.148 The auditor's primary responsibility is to report on the results of
his or her audit of the basic financial statements. The auditor has additional
responsibilities related to RSI and, if applicable, supplementary information
(SI) other than RSI. Those responsibilities, which are discussed in detail in
chapter 14 of Audit and Accounting Guide State and Local Governments, are
briefly described subsequently.

RSI
15.149 As discussed in paragraph 15.28, GASB requires that certain information accompany the basic financial statements and be presented as RSI.
Unless the auditor has been engaged to examine and express an opinion on
RSI, the auditor's responsibility with respect to RSI is limited to applying certain limited procedures to RSI and reporting deficiencies in, or the omission of,
such information, as described in paragraphs .07–.08 of AU section 558A.††† If
the deficiencies described in paragraph .08 of AU section 558A do not exist, and
the auditor's report appears in an auditor-submitted document, the auditor's
report should be expanded in accordance with paragraph .15 of AU section
551A, Reporting on Information Accompanying the Basic Financial Statements
in Auditor-Submitted Documents (AICPA, Professional Standards). The following paragraph is an example that an auditor might use in the circumstances
to disclaim an opinion on unaudited RSI:69
The [identify the required supplementary information, such as management's discussion and analysis] on pages XX–XX are not a required
part of the basic financial statements but is (are) supplementary information required by accounting principles generally accepted in the
United States of America. We have applied certain limited procedures,
which consisted principally of inquiries of management regarding the
methods of measurement and presentation of the required supplementary information. However, we did not audit the information and
express no opinion on it.
If instead the auditor's report appears in a client-prepared document, the auditor is not required to add an explanatory paragraph to his or her report to refer
to the unaudited RSI or limited procedures, although a disclaimer paragraph
may be voluntarily included, if desired.
15.150 If any of the deficiencies described in paragraph .08 of AU section
558A exist (for example, the client omits MD&A or a portion of MD&A, or the
information is presented in a manner that does not meet the standards established by GAAP), this does not affect the auditor's conclusion regarding the fair
presentation of the basic financial statements because RSI is not considered
essential to the fair presentation of the basic financial statements. In such situations, the auditor's report should include an explanatory paragraph, such as
the following, after the auditor's opinion, which is required for such situations
by paragraph .08 of AU section 558A:‡‡‡
†††

See footnote ***.
Unaudited RSI is information that accompanies the basic financial statements on which the
auditor is not engaged to express an opinion whether it is fairly presented in conformity with GAAP.
Unless the auditor is engaged to audit the RSI, this section of this guide and the Audit and Accounting
Guide State and Local Governments refer to the information as unaudited, even though generally
accepted auditing standards require the auditor to perform specific procedures and, perhaps, report
on the information. See footnote 21 to paragraph 14.54 in the Audit and Accounting Guide State and
Local Governments.
‡‡‡
See footnote ***.
69
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The management's discussion and analysis for the year ended December 31, 20X7, on pages XX–XX is not a required part of the basic
financial statements as of and for the year then ended but is supplementary information required by the accounting principles generally
accepted in the United States of America. We have applied certain
limited procedures, which consisted principally of inquiries of management regarding the methods of measurement and presentation of
the required supplementary information. However, we did not audit the information and express no opinion on it. Health Care Entity
has not presented the management's discussion and analysis for the
year ended December 31, 20X6, that accounting principles generally
accepted in the United States of America require to supplement, although not to be part of, the basic financial statements for each year
presented.
This paragraph should be included regardless of whether the auditor's report
appears in a client-prepared document or an auditor-submitted document.
15.151 If an auditor is engaged to report on whether RSI is fairly stated,
in all material respects, in relation to the financial statements as a whole, AU
section 551A applies. For further discussion of AU section 551A, see paragraph
15.152.

SI
15.152 If SI is included in an auditor-submitted document, AU section
551A|||||| requires that the auditor either report on whether the SI is fairly
stated, in all material respects, in relation to the basic financial statements as
a whole or disclaim such an opinion. The auditor also may express an opinion
on a portion of SI and disclaim an opinion on the remainder. A paragraph,
such as the following, should be added to the standard report70 if the auditor
expresses an unqualified opinion on the basic financial statements and SI:
Our audit was conducted for the purpose of forming an opinion71 on the
Health Care Entity's basic financial statements. The [identify accompanying supplementary information] is (are) presented for purposes of
additional analysis and is (are) not a required part of the basic financial statements. Such information has been subjected to the auditing
procedures applied in the audit of the basic financial statements and,
in our opinion, is fairly stated, in all material respects and in relation
to the financial statements as a whole.
Paragraphs .13–.14 of AU section 551A provide examples for other circumstances, including those in which the opinion on the basic financial statements
is other than an unqualified opinion, or the auditor disclaims an opinion on all
or part of the accompanying information.

||||||
In February 2010, the ASB issued SAS No. 119, Supplementary Information in Relation to
the Financial Statements as a Whole (AICPA, Professional Standards, AU sec. 551). This SAS will
supersede AU section 551A, Reporting on Information Accompanying the Basic Financial Statements
in Auditor-Submitted Documents (AICPA, Professional Standards). SAS No. 119 is effective for audits
of financial statements for periods beginning on or after December 15, 2010. Early application is
permitted. Appendix E of this guide provides additional information on SAS No. 119.
70
Alternatively, the auditor may issue a separate report that precedes the additional information.
71
If multiple opinion units exist, this would instead refer to opinions.
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15.153 If the auditor has not been engaged to report on whether SI is fairly
stated, in all material respects and in relation to the financial statements as a
whole, the auditor has no obligation to perform any procedures to corroborate
other information contained in a document. However, AU section 550A, Other
Information in Documents Containing Audited Financial Statements (AICPA,
Professional Standards), states that the auditor should read the other information and consider whether such information or the manner of its presentation is
materially inconsistent with information or the manner of its presentation appearing in the financial statements.### The auditor is not required to reference
the SI in the auditor's report on the basic financial statements. However, the
auditor may include an explanatory paragraph disclaiming an opinion on the
SI. For example, an auditor may choose to include a disclaimer on the SI when
the auditor believes that he or she could be associated with the information,
and the user may infer a level of assurance that is not intended. If the auditor
chooses to include an explanatory paragraph that disclaims an opinion on SI,
that paragraph could read as follows:
Our audit was conducted for the purpose of forming an opinion on the
Health Care Entity's basic financial statements as a whole. The [identify the
other information] is (are) presented for purposes of additional analysis and is
(are) not a required part of the basic financial statements. Such information
has not been subjected to the auditing procedures applied by us in the audit of
the basic financial statements, and accordingly, we express no opinion on it.
15.154 Auditors often are engaged to report on some or all of the SI
that accompanies financial statements in client-prepared documents using AU
section 551A,**** although the scope of AU section 551A does not include clientprepared documents. Chapter 14 of the Audit and Accounting Guide State and
Local Governments provides guidelines for doing so. If the auditor has not been
engaged to audit SI included in a client-prepared document, the preceding paragraph is not required. However, the auditor may choose to issue a disclaimer
of opinion on the SI or ask the government to label the SI as unaudited.

###
In February 2010, the ASB issued SAS No. 118, Other Information in Documents Containing
Audited Financial Statements (AICPA, Professional Standards, AU sec. 550). This SAS will supersede AU section 550A, Other Information in Documents Containing Audited Financial Statements
(AICPA, Professional Standards). SAS No. 118 is effective for audits of financial statements for periods beginning on or after December 15, 2010. Early application is permitted. Appendix E of this guide
provides additional information on SAS No. 118.
****
See footnote ||||||.
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Example 15-1
Unqualified Opinion on Comparative Basic Financial Statements of a
Governmental Hospital (Special-Purpose Government) That Has a
Single Opinion Unit and for Which the Auditor Has Not Been
Engaged to Examine and Express an Opinion on RSI
Independent Auditor's Report
To the Board of Trustees
Sample Governmental Hospital Authority
We have audited the accompanying statements of net assets of the Sample
Governmental Hospital Authority (the Authority)[, a component unit of Feeling
County, State of Union,]72 as of December 31, 20X1 and 20X0, and the related
statements of revenues, expenses, and changes in net assets and statements
of cash flows for the years then ended. These financial statements are the
responsibility of the Authority's management. Our responsibility is to express
an opinion on these financial statements based on our audits.73
We conducted our audits74 in accordance with auditing standards generally
accepted in the United States of America. Those standards require that we
plan and perform the audit to obtain reasonable assurance about whether
the financial statements are free of material misstatement. An audit includes
examining, on a test basis, evidence supporting the amounts and disclosures
in the financial statements. An audit also includes assessing the accounting
principles used and significant estimates made by management, as well as
evaluating the overall financial statement presentation. We believe that our
audits75 provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all
material respects, the financial position of the Authority as of December 31,
20X1 and 20X0, and the changes in its financial position and its cash flows
for the years then ended in conformity with accounting principles generally
accepted in the United States of America.
The management's discussion and analysis on pages XX through XX is not a
required part of the basic financial statements but is supplementary information required by accounting principles generally accepted in the United States
of America.
We have applied certain limited procedures, which consisted principally of
inquiries of management regarding the methods of measurement and presentation of the required supplementary information. However, we did not audit
the information and express no opinion on it.
[Signature]
[Date]

72
If the entity being reported on is a component unit of a larger financial reporting entity, the
auditor's report should disclose that fact, as discussed in paragraph 14.45 of the Audit and Accounting
Guide State and Local Governments.
73
Because the report is covering audits for two years, the reference is to audits, rather than
audit.
74
See footnote 73.
75
See footnote 73.
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Example 15-2
Unqualified Opinions on Single-Year Basic Financial Statements of a
Governmental Hospital That Has One Opinion Unit for the Primary
Government and Another Opinion Unit for Its Discretely-Presented
Component Unit and for Which the Auditor Has Not Been Engaged to
Examine and Express an Opinion on RSI
Independent Auditor's Report
To the Board of Trustees
University Hospital
We have audited the accompanying statements of net assets and the related
statements of revenues, expenses and changes in net assets and statements
of cash flows76 of the University Hospital [, a component unit of University,
Any City and Any State]77 and of its discretely presented component unit as
of and for the year ended December 31, 20XY, which collectively comprise
the Hospital's basic financial statements. These financial statements are the
responsibility of the Hospital's management. Our responsibility is to express
opinions78 on these financial statements based on our audit.79
[Same second paragraph as in Example A-1]
In our opinion, the financial statements referred to above present fairly, in all
material respects, the respective financial position of the University Hospital
and of its discretely presented component unit as of December 31, 20XY, and
the respective changes in financial position and cash flows thereof for the year
then ended in conformity with accounting principles generally accepted in the
United States of America.
[Same disclaimer on MD&A as in Example A-1]
[Signature]
[Date]

76
Presentation of a statement of cash flows for the discretely-presented component unit is not
required.
77
See footnote 72.
78
Because two opinion units exist, the auditor is rendering two opinions (one on the Hospital
and one on the discretely-presented component unit), and the report should refer to opinions, rather
than opinion.
79
The opinion on a set of single-year statements refers to one audit. Even though the auditor
may be expressing multiple opinions, he or she is conducting only one audit of the opinion units.
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Appendix A—Cross-Reference Table for Predecessor
Guidance
Governmental Accounting Standards Board (GASB) Statement No. 62, Codification of Accounting and Financial Reporting Guidance Contained in PreNovember 30, 1989 FASB and AICPA Pronouncements1 directly incorporates
into GASB's authoritative literature certain pronouncements issued by the Financial Accounting Standards Board (FASB) and its predecessors. Chapter 15
references those standards using the paragraph numbers in GASB Statement
No. 62. As an interim measure, to facilitate the understanding of our readers,
the following table includes the paragraphs from GASB Statement No. 62 that
are cited in chapter 15 and the related predecessor guidance:

Paragraph
in Chapter
15

Paragraph
of GASB
Statement
No. 62

Statement of Net
Assets or Balance
Sheet

15.14

29–44

Chapter 3 of Accounting
Research Bulletin (ARB)
No. 43, Restatement and
Revision of Accounting
Research Bulletins

Statement of
Revenues,
Expenses, and
Changes in Net
Assets

15.23

45–50

Paragraphs 19–25 of
Accounting Principles
Board (APB) Opinion No.
30, Reporting the Results
of Operations—Reporting
the Effects of Disposal of a
Segment of a Business,
and Extraordinary,
Unusual and Infrequently
Occurring Events and
Transactions

15.22

63–89

APB Opinion No. 20,
Accounting Changes

15.35

113

Topical Section of
Chapter 15

Cash and Cash
Equivalents

Predecessor Guidance

Paragraph 18 of FASB
Statement No. 5,
Accounting for
Contingencies

1
The requirements of Governmental Accounting Standards Board (GASB) Statement No. 62,
Codification of Accounting and Financial Reporting Guidance Contained in Pre-November 30, 1989
FASB and AICPA Pronouncements, are effective for financial statements for periods beginning after
December 15, 2011. Earlier application is encouraged. The provisions of GASB Statement No. 62
generally are required to be applied retroactively for all periods presented.
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Paragraph
in Chapter
15

Paragraph
of GASB
Statement
No. 62

15.38

202–210

APB Opinion No. 18, The
Equity Method of
Accounting for
Investments in Common
Stock

15.39

202–210

APB Opinion No. 18

Financial
Reporting and
Disclosure

15.51

29–44

Chapter 3 of ARB No. 43

Capital
Assets—General

15.61

45–50

Paragraphs 19–25 of APB
Opinion No. 30

Leases

15.66

211–271

FASB Statement No. 13,
Accounting for Leases, as
amended and interpreted
as of November 30, 1989

Disclosures

15.69

95

Paragraph 5 of APB
Opinion No. 12, Omnibus
Opinion

15.69

223, 231,
239,
255–256,
and 270

Paragraphs 16, 23, 29,
and 47, as amended and
interpreted as of
November 30, 1989, of
FASB Statement No. 13,
Accounting for Leases;
paragraphs 17–18 of
FASB Statement 98,
Accounting for Leases:
Sale-Leaseback
Transactions Involving
Real Estate, Sales-Type
Leases of Real Estate,
Definition of the Lease
Term, and Initial Direct
Costs of Direct Financing
Leases—an amendment of
FASB Statements No. 13,
66, and 91 and a
rescission of FASB
Statement No. 26 and
Technical Bulletin No.
79-11; and paragraph 11

Topical Section of
Chapter 15
Investments

Predecessor Guidance

(continued)
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Topical Section of
Chapter 15

Paragraph
in Chapter
15

Paragraph
of GASB
Statement
No. 62

Predecessor Guidance
of GASB Statement No.
38, Certain Financial
Statement Note
Disclosures

Debt Defeasance
and
Extinguishment

15.76

124–127

Paragraphs 2–3 and 20 of
APB Opinion No. 26,
Early Extinguishment of
Debt, as amended by
paragraph 3 of FASB
Statement No. 76,
Extinguishment of
Debt—an amendment of
APB Opinion No. 26

Footnote 35
to 15.76

128–148

FASB Statement No. 15,
Accounting by Debtors
and Creditors for
Troubled Debt
Restructurings

Capitalization of
Interest Cost

15.77

19–20

Paragraphs 3–4 of FASB
Statement No. 62,
Capitalization of Interest
Cost in Situations
Involving Certain
Tax-Exempt Borrowings
and Certain Gifts and
Grants—an amendment of
FASB Statement No. 34

RetrospectivelyRated Policies and
Contracts

15.82

96–113

FASB Statement No. 5
and FASB Interpretation
No. 14, Reasonable
Estimation of the Amount
of a Loss—an
interpretation of FASB
Statement No. 5

Participation in
Public-Entity Risk
Pools

15.83

96–113

FASB Statement No. 5
and FASB Interpretation
No. 14

Health Care
Service Revenue
and Receivables

15.110

90–94

APB Opinion No. 22,
Disclosure of Accounting
Policies

15.110

33
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Appendix B1—Interim Guidance for Entities That Elect
Paragraph 7 of Governmental Accounting Standards
Board Statement No. 20
Governmental Accounting Standards Board (GASB) Statement No. 62, Codification of Accounting and Financial Reporting Guidance Contained in PreNovember 30, 1989 FASB and AICPA Pronouncements,2 supersedes the requirement of paragraph 17 of GASB Statement No. 34, Basic Financial
Statements—and Management's Discussion and Analysis—for State and Local
Governments. That paragraph required governmental health care entities that
report as special-purpose governments engaged only in business-type activities
to apply all GASB pronouncements and Financial Accounting Standards Board
(FASB) Statements and Interpretations, Accounting Principles Board Opinions, Accounting Research Bulletins of the AICPA Committee on Accounting
Procedure, and AICPA accounting interpretations issued on or before November 30, 1989, that do not conflict with or contradict GASB pronouncements.
Until the implementation of GASB Statement No. 62, pronouncements issued
on or before November 30, 1989, remain effective for governmental entities
as amended to that date, even if they are superseded, amended, or interpreted by subsequent FASB pronouncements. GASB Statement No. 62 and its
nonauthoritative basis for conclusions is useful in determining whether FASB
pronouncements issued before November 30, 1989, conflict with or contradict
GASB pronouncements.
GASB Statement No. 62 also eliminates the election provided in paragraph 7,
as amended, of GASB Statement No. 20, Accounting and Financial Reporting
for Proprietary Funds and Other Governmental Entities That Use Proprietary
Fund Accounting. That election permitted governmental entities engaged in
business-type activities to elect to apply all FASB Statements and Interpretations issued after November 30, 1989, that are applicable to private-sector
business enterprises and that do not conflict with or contradict GASB pronouncements. Governmental entities that elect to apply post-1989 FASB pronouncements must apply them on an all or none basis (that is, they may not
selectively choose certain pronouncements to apply). They also should apply superseding, amending, or interpreting FASB pronouncements, except for those
that conflict with or contradict GASB pronouncements. Paragraph 115 of GASB
Statement No. 34 requires disclosure in the summary of significant policies of
the entity's policy for applying FASB pronouncements issued after November
30, 1989.
Although GASB Statement No. 62 is effective for financial statements for periods beginning after December 15, 2011, this guide has been updated to reflect
the elimination of the election in paragraph 7 of GASB Statement No. 20. The
purpose of this appendix is to assist entities that make the paragraph 7 election
and have not yet implemented GASB Statement No. 62.
1
The Governmental Accounting Standards Board (GASB) did not clear the guidance set forth
in this appendix.
2
The requirements of GASB Statement No. 62, Codification of Accounting and Financial Reporting Guidance Contained in Pre-November 30, 1989 FASB and AICPA Pronouncements, are effective
for financial statements for periods beginning after December 15, 2011. Earlier application is encouraged. The provisions of GASB Statement No. 62 generally are required to be applied retroactively for
all periods presented.
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In addition, governmental entities can apply as other accounting literature
post-November 30, 1989, FASB pronouncements that do not conflict with or
contradict GASB pronouncements (see paragraph 15.09). This appendix may
be useful to those entities is determining when FASB pronouncements conflict.
This appendix lists FASB pronouncements issued since November 30, 1989,
and provides nonauthoritative guidance regarding the applicability of their
accounting and reporting requirements to governmental health care entities
that apply paragraph 7 of GASB Statement No. 20. This appendix will be
removed from the guide when GASB Statement No. 62 is fully effective.
This appendix discusses the applicability of all FASB Statements and Interpretations issued after November 30, 1989. If a FASB Statement or Interpretation is not listed in this appendix, GASB has previously indicated that it
contradicted or conflicted with GASB pronouncements. In addition, the FASB
pronouncements on income tax, stock compensation, and earnings per share
are not included in the appendix because their subject matter is typically not
applicable to governmental entities.
Paragraph 33 in the nonauthoritative basis for conclusions of GASB Statement
No. 20 also provided that AICPA pronouncements issued after November 30,
1989, and not specifically made applicable to governmental entities should be
applied using the same logic used in the application of FASB pronouncements.
Many of the AICPA pronouncements issued after November 30, 1989, provide guidance on specialized industries. Like the FASB pronouncements, they
should be applied on an all or none basis. Readers should note these AICPA
pronouncements in particular:

r
r
r
r
r
r

Audit and Accounting Guide Depository and Lending Institutions:
Banks and Savings Institutions, Credit Unions, Finance Companies and Mortgage Companies
Statement of Position (SOP) 93-7, Reporting on Advertising Costs
SOP 94-6, Disclosure of Certain Significant Risks and Uncertainties
SOP 97-1, Accounting by Participating Mortgage Loan Borrowers
SOP 97-3, Accounting by Insurance and Other Enterprises for
Insurance-Related Assessments
SOP 98-5, Reporting on the Costs of Start-Up Activities

FASB Pronouncements—Applicability Under Paragraph 7 of
GASB Statement No. 20
FASB Statements Issued After
November 30, 1989
104

Statement of Cash
Flows—Net Reporting of
Certain Cash Receipts and
Cash Payments and
Classification of Cash Flows
from Hedging
Transactions—an
amendment of FASB
Statement No. 95
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Apply?
Yes—See paragraph 74 of GASB
Statement No 9, Reporting Cash
Flows of Proprietary and
Nonexpendable Trust Funds and
Governmental Entities That Use
Proprietary Fund Accounting.
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FASB Statements Issued After
November 30, 1989

Apply?

107

Disclosures about Fair Value In Part—GASB Statement No. 31,
of Financial Instruments
Accounting and Financial
Reporting for Certain Investments
and for External Investment Pools,
requires many investments to be
reported at fair value and provides
related disclosures for investments
within its scope. GASB Statement
No. 51, Accounting and Financial
Reporting for Intangible Assets,
requires many derivatives to be
reported at fair value.

111

Rescission of FASB
Statement No. 32 and
Technical Corrections

Yes—Except for corrections of
standards that conflict with GASB
standards (FASB Statement No. 14,
Financial Reporting for Segments of
a Business Enterprise, and No. 76,
Extinguishment of Debt—an
amendment of APB Opinion No. 26).

114

Accounting by Creditors for
Impairment of a Loan—an
amendment of FASB
Statements No. 5 and 15

Yes

118

Accounting for Creditors for
Impairment of a
Loan—Income Recognition
and Disclosures—an
amendment of FASB
Statement No, 114

Yes

126

Exemption from Certain
Required Disclosures about
Financial Instruments for
Certain Nonpublic
Entities—an amendment of
FASB Statement No. 107

In Part—See preceding FASB
Statement No. 107. The decision on
whether to discontinue application
of FASB Statement No. 107 should
be based on the prevalent practice
in the reporting entity's industry
(for example, health care and so
forth).

129

Disclosure of Information
about Capital Structure

Yes—Paragraph 4 applies to debt
issued.
(continued)

AAG-HCO 15.156

322

Health Care Entities

FASB Statements Issued After
November 30, 1989

Apply?

135

Rescission of FASB
Statement No. 75 and
Technical Corrections

Yes—To the extent that it corrects
currently applicable FASB
pronouncements issued after
November 30, 1989, that do not
conflict with GASB standards and
that it amends FASB Statement
No. 35, Accounting and Reporting
by Defined Benefit Pension Plans,
and rescinds FASB Statement No.
75, Deferral of the Effective Date of
Certain Accounting Requirements
for Pension Plans of State and Local
Governmental Units—an
amendment of FASB Statement No.
35. For example, corrections to
FASB Statement No. 87,
Employers' Accounting for Pensions,
and the standards noted in this
table as conflicting would not apply.

139

Rescission of FASB
Statement No. 53 and
amendments to FASB
Statements No. 63, 89, and
121

Yes

141
(revised
2007)

Business Combinations

In Part—Applies only to business
combinations. (see paragraphs
3(d)–(e) of FASB Statement No.
141(R)). It does not apply to
combinations of or acquisitions by
not-for-profit organizations. Many
governmental enterprises have
similar characteristics. Applicable
GASB Statements should be used
in assigning amounts to assets
acquired and liabilities assumed
(for example, GASB Statement No.
13, Accounting for Operating Leases
with Scheduled Rent Increases; No.
16, Accounting for Compensated
Absences; No. 27, Accounting for
Pensions by State and Local
Governmental Employers; No. 31;
and No. 45, Accounting and
Financial Reporting by Employers
for Postemployment Benefits Other
Than Pensions).
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FASB Statements Issued After
November 30, 1989

Apply?

142

Goodwill and Other
Intangible Assets

In Part—Apply GASB Statement
No. 42, Accounting and Financial
Reporting for Impairment of
Capital Assets and for Insurance
Recoveries, as amended by GASB
Statement No. 51, Accounting and
Financial Reporting for Intangible
Assets, to impairment of tangible
and intangible capital assets. Does
not apply to intangibles acquired in
combinations between not-for-profit
organizations or arising from
acquisition of a for-profit by a
not-for-profit. Many governmental
enterprises have similar
characteristics.

143

Accounting for Asset
Retirement Obligations

In Part—Does not apply to asset
retirement obligations involving
pollution remediation obligations
within the scope of GASB
Statement No. 49, Accounting and
Financial Reporting for Pollution
Remediation Obligations, such as
asbestos removal obligations. Does
not apply to other conditional
obligations, unless probable of
occurrence. (Paragraphs 9 and 14 of
National Council on Governmental
Accounting (NCGA) Statement No.
4, Accounting and Financial
Reporting Principles for Claims and
Judgments and Compensated
Absence, as amended by GASB
Statement No. 10, Accounting and
Financial Reporting for Risk
Financing and Related Insurance
Issues, and No. 34, Basic Financial
Statements—and Management's
Discussion and Analysis—for State
and Local Governments. Paragraph
69 of NCGA Statement No. 4
requires the application of FASB
Statement No. 5, Accounting for
Contingencies.)
(continued)
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FASB Statements Issued After
November 30, 1989

Apply?

144

Accounting for the
Impairment or Disposal of
Long-Lived Assets

In Part—Apply GASB Statement
No. 42, as amended by GASB
Statement No. 51, to the
impairment of tangible and
intangible capital assets. A separate
display of net gain or loss from
discontinued operations conflicts
with GASB Statement No. 34.

145

Rescission of FASB
Statements No. 4, 44, and
64, Amendment of FASB
Statement No. 13, and
Technical Corrections

Yes—To the extent that it amends
currently applicable FASB
pronouncements, except that
paragraph 9(b) conflicts with
paragraph 56 of GASB Statement
No. 34, and paragraph 9(f)–(g)
conflicts with GASB Statement
Nos. 9 and 31. FASB Statement No.
4, Reporting Gains and Losses from
Extinguishment of Debt—an
amendment of APB Opinion No. 30,
conflicted with paragraph 55 of
GASB Statement No. 34.

146

Accounting for Costs
Associated with Exit or
Disposal Activities

In Part—Accounting for
termination benefits should follow
GASB Statement No. 47,
Accounting for Termination
Benefits. Apply nonconflicting
sections, such as contract
termination costs and employee
relocation costs. The requirement in
paragraph 18 for separate reporting
of discontinued operations conflicts
with the format required by GASB
Statement No. 34.

147

Acquisitions of Certain
Financial Institutions—an
amendment of FASB
Statements No. 72 and 144
and FASB Interpretation
No. 9

Yes—Does not apply to
transactions between mutual
enterprises. Many governmental
enterprises have similar
characteristics. Apply GASB
Statement No. 42, as amended by
GASB Statement No. 51, to the
impairment of tangible and
intangible capital assets.

150

Accounting for Certain
Financial Instruments with
Characteristics of both
Liabilities and Equity

Yes
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FASB Statements Issued After
November 30, 1989

Apply?

151

Inventory Costs—an
amendment of ARB No. 43,
Chapter 4

Yes

153

Exchanges of Nonmonetary
Assets—an amendment of
APB Opinion No. 29

In Part—FASB Statement No. 153
includes amendments to or related
to other FASB pronouncements
listed in this applicability table.
Those amendments are applicable
only to the extent that the related
FASB pronouncement is applicable,
as provided in this table.

157

Fair Value Measurements

In Part—Applies only when
another applicable pronouncement
requires measurement at fair value.
Paragraphs 7 and 10–11 of GASB
Statement No. 31 provide the
primary guidance for measuring
fair value for investments within its
scope. Apply GASB Statement No.
53, Accounting and Financial
Reporting for Derivative
Instruments, to derivatives.

163

Accounting for Financial
Yes
Guarantee Insurance
Contracts—an interpretation
of FASB Statement No. 60

FASB Interpretations Issued After
November 30, 1989

Apply?

39

Offsetting of Amounts
Related to Certain
Contracts—an interpretation
of APB Opinion No. 10 and
FASB Statement No. 105

In Part—This interpretation does
not apply to reinsurance
transactions of public-entity risk
pools, which are addressed in GASB
Statement No. 10.

40

Applicability of Generally
Accepted Accounting
Principles to Mutual Life
Insurance and Other
Enterprises—an
interpretation of FASB
Statements No. 12, 60, 97,
and 113

Yes

43

Real Estate Sales—an
interpretation of FASB
Statement No. 66

Yes
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NOTE
This Statement of Position (SOP) is an interpretive publication and represents the recommendations of the AICPA Health Care Pilot Task Force
of the AICPA Auditing Standards Board (ASB) regarding the application
of Statements on Standards for Attestation Engagements to agreed-upon
procedures attestation engagements performed to assist a health care
provider in evaluating the effectiveness of its corporate compliance program consistent with the requirements of a Corporate Integrity Agreement entered into with the Office of Inspector General of the U.S. Department of Health and Human Services. The ASB has found the recommendations in this SOP to be consistent with existing standards covered by
Rule 202, Compliance With Standards (AICPA, Professional Standards,
vol. 2, ET sec. 202.01), of the AICPA Code of Professional Conduct.
Interpretive publications are not as authoritative as pronouncements of
the ASB; however, if a practitioner does not apply the attestation
guidance included in this SOP, the practitioner should be prepared to
explain how he or she complied with the provisions of this SOP.
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Summary
This Statement of Position (SOP) provides guidance to practitioners in conducting and reporting on an agreed-upon procedures engagement performed
pursuant to the AICPA Statements on Standards for Attestation Engagements
to assist a health care provider in evaluating the effectiveness of its corporate
compliance program consistent with the requirements of a Corporate Integrity
Agreement (CIA) entered into with the Office of Inspector General (OIG) of the
U.S. Department of Health and Human Services. CIAs are specific to the entity
involved; consequently, users of this SOP should be familiar with the specific
requirements of the entity's CIA.
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Introduction and Background
.01 Within the past several years, the health care industry has experienced a significant increase in the number and magnitude of allegations of
fraud and abuse involving federal health care programs (for example, Medicare and Medicaid) and private health care insurance. These allegations have
triggered regulatory scrutiny, litigation, significant monetary settlements, and
negative publicity related to—among other things—coding and billing practices, patient referrals, cost reporting, quality of care, and clinical practices.
Typically, as part of the global resolution of these allegations, the entity enters into a Corporate Integrity Agreement (CIA) with the Office of Inspector
General (OIG) of the U.S. Department of Health and Human Services. Such
agreements require that management annually report on its compliance with
the terms of the CIA and that there be an assessment of the entity's compliance with the CIA. This assessment includes a billing analysis, which may
be performed by an independent review organization (such as a practitioner
or consultant) or the provider (if permitted by the OIG), and an agreed-upon
procedures engagement.
.02 This SOP provides guidance to practitioners in conducting and reporting on an agreed-upon procedures engagement performed pursuant to the
American Institute of Certified Public Accountants (AICPA) Statements on
Standards for Attestation Engagements (SSAEs) to assist an entity in evaluating the effectiveness of its corporate compliance program consistent with
the requirements of a CIA.1 The terms of a CIA are unique to the entity; consequently, users of this SOP need to be familiar with the actual CIA and its
requirements.
.03 This SOP applies to agreed-upon procedures engagements to assist in
evaluating an entity's compliance for a specified period. Such engagements
should follow the AICPA attestation standards, including AT section 201,
Agreed-Upon Procedures Engagements (AICPA, Professional Standards), and
the applicable sections of AT section 101, Attest Engagements, and AT section
601, Compliance Attestation (AICPA, Professional Standards). The engagement should be conducted in accordance with standards established by the
AICPA, including the criteria set forth in this SOP. However, this SOP is not
intended to provide all the required criteria set forth in individual CIAs, nor
all the applicable standards established by the AICPA. Additionally, the SOP
contains some guidance that may be applied in evaluating an organization's
corporate compliance program, even though the program was not imposed by
a CIA.

Overview of a Typical Corporate Integrity Agreement
.04 A CIA is an agreement between a health care provider and the OIG in
conjunction with a global settlement of a fraud investigation. Such an agreement typically seeks to establish a compliance program within the health care
1
The practitioner also might be engaged to assist in other areas beyond an agreed-upon procedures engagement such as providing consulting services in connection with evaluating the company's
billing practices, policies, and procedures as required by the CIA or in implementing, assessing,
and reporting on voluntarily adopted compliance programs. In addition, the practitioner may assist
in preparing an entity's self-disclosure reports to federal health agencies related to billing errors
and other compliance matters. Similarly, practitioners may be involved in an entity's preparation
of government-required (but not CIA-imposed) compliance reporting (for example, contract requirements for Medicare part C) beyond an agreed-upon procedures engagement.
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provider (for example, hospital, clinical lab, physician group) that will promote
compliance with the requirements of Medicare, Medicaid, and all other federal
health care programs.
.05 CIAs are case-specific. Their terms are tailored to address the organizational and operating deficiencies related to providing and billing for
health care services that have been identified by the OIG, the entity, or others. Detailed compliance requirements are imposed as a condition for continued participation in federal health care programs. A sample CIA, provided by
the OIG and intended to identify potential requirements, is included in appendix A [paragraph .32], "Sample Corporate Integrity Agreement." Typical
agreements cover five years and require the entity to address the following
areas:

r
r
r
r
r
r
r
r
r
r
r
r
r
r
r
r
r
r

Appointment of a compliance officer and establishment of a compliance committee
Establishment of a code of conduct
Establishment of policies and procedures regarding the compliance program
Development of an information and education program as to the
CIA requirements, compliance program and code of conduct
Annual assessment of billing policies, procedures, and practices
Establishment of a confidential disclosure program
Prohibition of employment of excluded or convicted persons
Notification to OIG of investigation or legal proceedings
Reporting of credible evidence of misconduct
Notifications to OIG of new provider locations
Provision of implementation and annual reports
Proper notification and submission of required reports
Granting of OIG access to documents and individuals to conduct
assessments
Documentation of record retention requirements
Awareness of disclosure criteria
Agreement to comply with certain default provisions, penalties,
and remedies
Review of rights as to dispute resolution
Review of effective and binding agreement clauses

Conditions for Engagement Performance
.06 A practitioner may perform an agreed-upon procedures engagement
related to management's compliance with a CIA if all of the conditions specified
in AT sections 201 and 601 are met.
.07 As discussed more fully in the AT sections identified in paragraph .06,
management's assertions as to its compliance must be capable of evaluation
against reasonable criteria that either have been established by a recognized
body or are stated in or attached to the practitioner's report in a sufficiently
clear and comprehensive manner. Generally, to avoid confusion, management's

AAG-HCO APP A

Statement of Position 99-1

333

assertions, which are based on the specific terms of its CIA, should be attached
to the practitioner's report. If the entity is not required to have a CIA, management may develop its assertions using the model CIA. A sample based on
the model CIA, which is not meant to be all-inclusive, is included as appendix
B (paragraph .33), "Sample Statement of Management's Assertions." [Revised,
June 2009, to reflect conforming changes necessary due to the issuance of recent
authoritative literature.]

Establishing an Understanding With the Client
.08 The practitioner should document the understanding in the working
papers, preferably through a written communication with the client, such as
an engagement letter. Appendix C [paragraph .34], "Sample Engagement Letter," contains a sample engagement letter that may be used for this kind of
engagement.

Responsibilities of Specified Parties
.09 AT section 201 identifies the users of an agreed-upon procedures report as specified parties. The specified parties to the agreed upon procedures
report described in this SOP typically would be the management of the health
care provider and the OIG. Management is responsible for ensuring that the
entity complies with the requirements of the CIA. That responsibility encompasses (a) identifying applicable compliance requirements, (b) establishing and
maintaining internal control policies and procedures to provide reasonable assurance that the entity complies with those requirements, (c) evaluating and
monitoring the entity's compliance, and (d) preparing reports that satisfy legal, regulatory, or contractual requirements. Management's evaluation may
include documentation such as accounting or statistical data, policy manuals,
accounting manuals, narrative memoranda, procedural write-ups, flowcharts,
completed questionnaires, internal auditors' reports, and other special studies or analyses. The form and extent of documentation will vary depending
on the nature of the compliance requirements and the size and complexity of
the entity. Management may engage the practitioner to gather information to
assist it in evaluating the entity's compliance. Regardless of the procedures
performed by the practitioner, management must accept responsibility for its
assertions and must not base such assertions solely on the practitioner's procedures. [Revised, June 2009, to reflect conforming changes necessary due to
the issuance of recent authoritative literature.]
.10 The specified parties are responsible for the sufficiency (nature, timing, and extent) of the agreed-upon procedures because they best understand
their own needs. The specified parties assume the risk that such procedures
might be insufficient for their purposes. In addition, the specified parties assume the risk that they might misunderstand or otherwise inappropriately
use findings properly reported by the practitioner. Use of an agreed-upon procedures report is restricted to the specified parties. [Revised, June 2009, to
reflect conforming changes necessary due to the issuance of recent authoritative literature.]

Practitioner’s Responsibilities
.11 The objective of the practitioner's agreed-upon procedures is to present
specific findings to assist the specified parties in evaluating an entity's compli-
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ance with the requirements specified in the CIA. (See appendix D [paragraph
.35], "Sample Procedures.") [Revised, June 2009, to reflect conforming changes
necessary due to the issuance of recent authoritative literature.]
.12 The practitioner's procedures generally may be as limited or extensive
as the specified parties desire, as long as the specified parties s agree upon
the procedures performed or to be performed and take responsibility for the
sufficiency of the agreed-upon procedures for their purposes. [Revised, June
2009, to reflect conforming changes necessary due to the issuance of recent
authoritative literature.]
.13 To satisfy the requirements that the practitioner and the specified
parties agree upon the procedures performed or to be performed and that
the specified parties take responsibility for the sufficiency of the agreedupon procedures for their purposes, ordinarily the practitioner should communicate directly with and obtain affirmative acknowledgment from each
of the specified parties. For the purposes of these engagements, an effective way to obtain this agreement ordinarily is to distribute a draft of the
report, detailing the procedures, that is expected to be issued to the OIG
with a request for any comments it may have. [Revised, June 2009, to reflect conforming changes necessary due to the issuance of recent authoritative
literature.]
.14 To avoid possible misunderstandings, the practitioner should circulate
the draft with a legend stating that these are the procedures expected to be
performed, and unless informed otherwise, the practitioner assumes that there
are no additional procedures that he or she is expected to perform. A legend
such as the following might be used.
This draft is furnished solely for the purpose of indicating the form
of report that we would expect to be able to furnish pursuant to the
request by Management of [Provider] for our performance of limited
procedures relating to [Provider's] compliance with the Corporate Integrity Agreement with the Office of Inspector General (OIG) of the
U.S. Department of Health and Human Services. Based on our discussions with [Provider], it is our understanding that the procedures
outlined in this draft report are those we are expected to follow. Unless informed otherwise within ninety (90) days of this transmittal,
we shall assume that there are no additional procedures that we are
expected to follow. The text of the definitive report will depend, of
course, on the results of the procedures.

Involvement of a Specialist 2
.15 The practitioner's education and experience enable him or her to be
knowledgeable about business matters in general, but he or she is not expected
to have the expertise of a person trained for or qualified to engage in the
practice of another profession or occupation. In certain circumstances, it may be
appropriate to involve a specialist to assist the practitioner in the performance
of one or more procedures. The following are examples:

2
A specialist is a person (or firm) possessing special skill or knowledge in a particular field
other than the attest function. As used herein, a specialist does not include a person employed by the
practitioner's firm who participates in the attestation engagement.
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An attorney might provide assistance concerning the application
of laws, regulations, or rules to a client's situation.
A medical specialist might provide assistance in understanding
the characteristics of diagnosis codes documented in patient medical records.

.16 The practitioner and the specified parties should agree to the involvement of a specialist in assisting a practitioner in the performance of an agreedupon procedures engagement. This agreement may be reached when obtaining
agreement on the procedures performed or to be performed and acknowledgment of responsibility for the sufficiency of the procedures, as discussed previously. The practitioner's report should describe the nature of the assistance
provided by the specialist. [Revised, June 2009, to reflect conforming changes
necessary due to the issuance of recent authoritative literature.]
.17 A practitioner may agree to apply procedures to the report or work
product of a specialist that does not constitute assistance by the specialist
to the practitioner in an agreed-upon procedures engagement. For example,
the practitioner may make reference to information contained in a report of a
specialist in describing an agreed-upon procedure. However, it is inappropriate
for the practitioner to agree to merely read the specialist's report solely to
describe or repeat the findings, or to take responsibility for all or a portion of
any procedures performed by a specialist or the specialist's work product.

Internal Auditors and Other Personnel 3
.18 The agreed-upon procedures to be enumerated or referred to in the
practitioner's report are to be performed entirely by the practitioner except as
discussed in paragraphs .16–.18 of this SOP. However, internal auditors or
other personnel may prepare schedules, accumulate data, perform an internal
assessment of management's compliance, or provide other information for the
practitioner's use in performing the agreed-upon procedures.
.19 A practitioner may agree to perform procedures on information documented in the working papers of internal auditors. For example, the practitioner may agree to—

r
r

Repeat all or some of the procedures.
Determine whether the internal auditors' working papers contain
documentation of procedures performed and whether the findings
documented in the working papers are presented in a report by
the internal auditors.

.20 However, it is inappropriate for the practitioner to—

r
r
r

Agree to merely read the internal auditor's report solely to describe or repeat its findings.
Take responsibility for all or a portion of any procedures performed by internal auditors by reporting those findings as the
practitioner's own.
Report in any manner that implies shared responsibility for the
procedures with the internal auditors.

3
AU sec. 322, The Auditor's Consideration of the Internal Audit Function in an Audit of Financial
Statements (AICPA, Professional Standards), does not apply to agreed-upon procedures engagements.
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Planning the Engagement
.21 Planning an agreed-upon procedures engagement involves working
with the specified parties to develop an overall strategy for the expected conduct and scope of the engagement. To develop such a strategy, practitioners
should have adequate technical training and proficiency in the attestation standards and have adequate knowledge in health care regulatory matters to enable
them to sufficiently understand the events, transactions, and practices that,
in their judgment, have a significant effect on the presentation of the assertions. [Revised, June 2009, to reflect conforming changes necessary due to the
issuance of recent authoritative literature.]

Documentation
.22 The practitioner should prepare and maintain attest documentation,
the form and content of which should be designed to meet the circumstances
of the particular attest engagement. Attest documentation is the principal
record of attest procedures applied, information obtained, and conclusions or
findings reached by the practitioner in the engagement. The quantity, type,
and content of attest documentation are matters of the practitioner's professional judgment and are discussed in paragraphs .100–.103 of AT section
101. Paragraphs .104–.107 of AT section 101 present further requirements
and guidance regarding attest documentation. [Revised, June 2009, to reflect conforming changes necessary due to the issuance of recent authoritative
literature.]
.23 Concern over access to the practitioner's documentation might cause
some clients to inquire about documentation requirements. In situations where
the practitioner is requested to not maintain copies of certain client documentation, or to not prepare and maintain documentation similar to client
documents, the practitioner may refer to the Auditing Interpretation No. 3,
"The Auditor's Consideration of the Completeness Assertion," of AU section
326, Audit Evidence (AICPA, Professional Standards, AU sec. 9326.24–.27),
for guidance. See Attestation Interpretation No. 4, "Providing Access to or
Copies of Attest Documentation to a Regulator," of AT section 101 (AICPA,
Professional Standards, AT sec. 9101.43–.46) for guidance related to providing
access to or copies of attest documentation to a regulator in connection with
work performed on an attestation engagement. [Revised, June 2009, to reflect conforming changes necessary due to the issuance of recent authoritative
literature.]

Management’s Representations
.24 The practitioner should obtain written representation from management on various matters including the following:
a. Acknowledging management's responsibility for complying with
the CIA
b. Acknowledging management's responsibility for establishing and
maintaining effective internal control over compliance
c. Stating that management has performed an evaluation of the entity's compliance with CIA-specified requirements
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d. Stating management's assertions about the entity's compliance
with all aspects of the CIA, including the specific issues that gave
rise to the CIA4,5
e. Stating that management has disclosed to the practitioner all
known noncompliance with the CIA
f. Stating that management has made available all documentation
relating to compliance with the CIA
g. Stating management's interpretation of any compliance requirements that have varying interpretations
h. Stating that management has disclosed any communication from
regulatory agencies, internal auditors, legal counsel, and other parties concerning matters regarding the design, implementation, and
monitoring of the policies and procedures in place, including communication received between the end of the reporting period and
the date of the practitioner's report (the date of signature)
i. Stating that management has disclosed any known noncompliance
occurring subsequent to the end of the reporting period
j. Describing any related material fraud or abuse, other fraud, abuse
or illegal acts that, whether or not material, involve management or
other employees who have a significant role in the entity's design,
implementation, and monitoring of the policies and procedures in
place upon which compliance is based
k. Stating that management has disclosed to the practitioners, orally
or in writing, information about past noncompliance issues covered
in the settlement agreement that gave rise to the CIA and the
related corrective measures taken to support compliance in those
areas
Management's refusal to furnish all appropriate written representations constitutes a limitation on the scope of the engagement sufficient to require withdrawal from the engagement.6

Reporting Considerations
.25 A practitioner should present the results of applying agreed-upon procedures to the specific subject matter in the form of findings. The practitioner
4
Footnote 21 in paragraph .100 of AT section 101, Attest Engagements (AICPA, Professional
Standards), indicates that attest documentation may also be referred to as working papers. [Footnote
added, June 2009, to reflect conforming changes necessary due to the issuance of recent authoritative
literature.]
5
Depending on the circumstances, representations in the following areas might be appropriate.

•
•

Violations or possible violations of laws or regulations, such as those related to the Medicare
and Medicaid antifraud and abuse statutes
Compliance of third-party billings with applicable coding guidelines (for example, ICD-9CM, CPT) and laws and regulations (including medical necessity, proper approvals, and
proper rendering of care)
Proper filing of all required Medicare, Medicaid, and similar reports under the applicable reimbursement rules and regulations (including nature of costs—allowable, patient-related,
properly allocated, in accordance with applicable rules and regulations, properly adjusted
to reflect prior audit adjustments) and adequacy of disclosures (including disputed costs)
[Footnote renumbered, June 2009, to reflect conforming changes necessary due to the issuance of recent authoritative literature.]
6
See paragraph .62 of AT section 101. [Footnote added, June 2009, to reflect conforming changes
necessary due to the issuance of recent authoritative literature.]

•
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should not provide negative assurance about whether the assertion is fairly
stated in accordance with established or stated criteria. For example, the practitioner should not include a statement that "nothing came to my attention
that caused me to believe that the assertion is not fairly stated in accordance
with (established or stated) criteria."
.26 The practitioner should report all findings from the application of the
agreed-upon procedures. The concept of materiality does not apply to findings
to be reported in an agreed-upon procedures engagement unless the definition
of materiality is agreed to by the specified parties. Any agreed-upon materiality
limits should be described in the practitioner's report. [Revised, June 2009, to
reflect conforming changes necessary due to the issuance of recent authoritative
literature.]
.27 The practitioner has no obligation to perform procedures beyond the
agreed-upon procedures. However, if noncompliance related to management's
assertion comes to the practitioner's attention by other means, such information ordinarily should be included in his or her report.
.28 The practitioner may become aware of noncompliance related to management's assertion that occurs subsequent to the reporting period but before
the date of the practitioner's report. The practitioner should consider including information regarding such noncompliance in his or her report. However,
the practitioner has no responsibility to perform procedures to detect such
noncompliance other than obtaining management's representation about noncompliance in the subsequent period.
.29 practitioner should follow the reporting guidance in AT section 201. A
sample report is included in appendix E (paragraph .36), "Sample Report."
.30 Evaluating compliance with certain requirements may require interpretation of the laws, regulations, rules, contracts, or other agreements that
establish those requirements. In such situations, the practitioner should consider whether he or she is provided with the reasonable criteria required to
evaluate an assertion under the third general attestation standard. If these interpretations are significant, the practitioner may include a paragraph stating
the description and the source of interpretations made by the entity's management. An example of such a paragraph, which should precede the procedures
and findings paragraph(s), follows:
We have been informed that, under [name of entity's] interpretation of
[identify the compliance requirement], [explain the nature and source
of the relevant interpretation].
.31 The date of completion of the agreed-upon procedures should be used
as the date of the practitioner's report.
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Appendix A
Sample Corporate Integrity Agreement Between the Office
of Inspector General of the Department of Health and Human
Services and [Provider]
I. Preamble
[Provider] ("[Provider]") hereby enters into this Corporate Integrity Agreement
("CIA") with the Office of Inspector General ("OIG") of the United States Department of Health and Human Services ("HHS") to ensure compliance by its
employees with the requirements of Medicare, Medicaid and all other Federal health care programs (as defined in 42 U.S.C. 1320a-7b(f)) (hereinafter
collectively referred to as the "Federal health care programs"). [Provider's]
compliance with the terms and conditions in this CIA shall constitute an element of [Provider's] present responsibility with regard to participation in the
Federal health care programs. Contemporaneously with this CIA, [Provider] is
entering into a Settlement Agreement with the United States, and this CIA is
incorporated by reference into the Settlement Agreement.
II. Term of the CIA
The period of the compliance obligations assumed by [Provider] under this CIA
shall be 5 years from the effective date of this CIA (unless otherwise specified).
The effective date of this CIA will be the date on which the final signatory of
this CIA executes this CIA (the "effective date").*
III. Corporate Integrity Obligations
[Provider] shall establish a compliance program that includes the following
elements:
A. Compliance Officer
Within ninety (90) days after the effective date of this CIA, [Provider]
shall appoint an individual to serve as Compliance Officer, who shall
be responsible for developing and implementing policies, procedures,
and practices designed to ensure compliance with the requirements
set forth in this CIA and with the requirements of the Federal health
care programs. The Compliance Officer shall be a member of senior
management of [Provider], shall make regular (at least quarterly)
reports regarding compliance matters directly to the CEO and/or to
the Board of Directors of [Provider] and shall be authorized to report
to the Board of Directors at any time. The Compliance Officer shall
be responsible for monitoring the day-to-day activities engaged in by
[Provider] to further its compliance objectives as well as any reporting
obligations created under this CIA. In the event a new Compliance
Officer is appointed during the term of this CIA, [Provider] shall notify
the OIG, in writing, within fifteen (15) days of such a change.
[Provider] shall also appoint a Compliance Committee within ninety
(90) days after the effective date of this CIA. The Compliance Committee shall, at a minimum, include the Compliance Officer and any other
*
Source: Office of the Inspector General of the United States Department of Health and Human
Services.
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appropriate officers as necessary to meet the requirements of this CIA
within the provider's corporate structure (e.g., senior executives of
each major department, such as billing, clinical, human resources,
audit, and operations). The Compliance Officer shall chair the Compliance Committee and the Committee shall support the Compliance
Officer in fulfilling his/her responsibilities.
B. Written Standards
1. Code of Conduct. Within ninety (90) days of the effective date of
this CIA, [Provider] shall establish a Code of Conduct. The Code
of Conduct shall be distributed to all employees within ninety (90)
days of the effective date of this CIA. [Provider] shall make the
promotion of, and adherence to, the Code of Conduct an element in
evaluating the performance of managers, supervisors, and all other
employees. The Code of Conduct shall, at a minimum, set forth:
a. [Provider's] commitment to full compliance with all
statutes, regulations, and guidelines applicable to Federal health care programs, including its commitment to
prepare and submit accurate billings consistent with Federal health care program regulations and procedures or
instructions otherwise communicated by the Health Care
Financing Administration ("HCFA") (or other appropriate
regulatory agencies) and/or its agents;
b. [Provider's] requirement that all of its employees shall
be expected to comply with all statutes, regulations, and
guidelines applicable to Federal health care programs and
with [Provider's] own policies and procedures (including
the requirements of this CIA);
c. the requirement that all of [Provider's] employees shall
be expected to report suspected violations of any statute,
regulation, or guideline applicable to Federal health care
programs or with [Provider's] own policies and procedures;
d. the possible consequences to both [Provider] and to any
employee of failure to comply with all statutes, regulations, and guidelines applicable to Federal health care programs and with [Provider's] own policies and procedures
or of failure to report such non-compliance; and
e. the right of all employees to use the confidential disclosure
program, as well as [Provider's] commitment to confidentiality and non-retaliation with respect to disclosures.
Within ninety (90) days of the effective date of the CIA, each employee shall certify, in writing, that he or she has received, read,
understands, and will abide by [Provider's] Code of Conduct. New
employees shall receive the Code of Conduct and shall complete the
required certification within two (2) weeks after the commencement
of their employment or within ninety (90) days of the effective date
of the CIA, whichever is later.
[Provider] will annually review the Code of Conduct and will make
any necessary revisions. These revisions shall be distributed within
thirty (30) days of initiating such a change. Employees shall certify
on an annual basis that they have received, read, understand and
will abide by the Code of Conduct.
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2. Policies and Procedures. Within ninety (90) days of the effective
date of this CIA, [Provider] shall develop and initiate implementation of written Policies and Procedures regarding the operation of
[Provider's] compliance program and its compliance with all federal and state health care statutes, regulations, and guidelines, including the requirements of the Federal health care programs. At
a minimum, the Policies and Procedures shall specifically address
[insert language relevant to allegations in the case]. In addition, the
Policies and Procedures shall include disciplinary guidelines and
methods for employees to make disclosures or otherwise report on
compliance issues to [Provider] management through the Confidential Disclosure Program required by section III.E. [Provider] shall
assess and update as necessary the Policies and Procedures at least
annually and more frequently, as appropriate. A summary of the
Policies and Procedures will be provided to OIG in the Implementation Report. The Policies and Procedures will be available to OIG
upon request.
Within ninety (90) days of the effective date of the CIA, the relevant
portions of the Policies and Procedures shall be distributed to all
appropriate employees. Compliance staff or supervisors should be
available to explain any and all policies and procedures.
C. Training and Education
1. General Training. Within ninety (90) days of the effective date of
this CIA, [Provider] shall provide at least two (2) hours of training
to each employee. This general training shall explain [Provider's]:
a. Corporate Integrity Agreement requirements;
b. Compliance Program (including the Policies and Procedures as they pertain to general compliance issues); and
c. Code of Conduct.
These training materials shall be made available to the OIG, upon
request.
New employees shall receive the general training described above
within thirty (30) days of the beginning of their employment
or within ninety (90) days after the effective date of this CIA,
whichever is later. Each year, every employee shall receive such
general training on an annual basis.
2. Specific Training. Within ninety (90) days of the effective date of
this CIA, each employee who is involved directly or indirectly in the
delivery of patient care and/or in the preparation or submission of
claims for reimbursement for such care (including, but not limited
to, coding and billing) for any Federal health care programs shall
receive at least [insert number of training hours] hours of training
in addition to the general training required above. This training
shall include a discussion of:
a. the submission of accurate bills for services rendered to
Medicare and/or Medicaid patients;
b. policies, procedures and other requirements applicable to
the documentation of medical records;
c. the personal obligation of each individual involved in the
billing process to ensure that such billings are accurate;
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d. applicable reimbursement rules and statutes;
e. the legal sanctions for improper billings; and
f. examples of proper and improper billing practices.
These training materials shall be made available to OIG, upon
request. Persons providing the training must be knowledgeable
about the subject area.
Affected new employees shall receive this training within thirty
(30) days of the beginning of their employment or within ninety
(90) days of the effective date of this CIA, whichever is later. If
a new employee has any responsibility for the delivery of patient
care, the preparation or submission of claims and/or the assignment of procedure codes prior to completing this specific training,
a [Provider] employee who has completed the substantive training shall review all of the untrained person's work regarding the
assignment of billing codes.
Each year, every employee shall receive such specific training on
an annual basis.
3. Certification. Each employee shall certify, in writing, that he or she
has attended the required training. The certification shall specify
the type of training received and the date received. The Compliance
Officer shall retain the certifications, along with specific course
materials. These shall be made available to OIG upon request.
D. Review Procedures
[Provider] shall retain an entity, such as an accounting, auditing or
consulting firm (hereinafter "Independent Review Organization"), to
perform review procedures to assist [Provider] in assessing the adequacy of its billing and compliance practices pursuant to this CIA.
This shall be an annual requirement and shall cover a twelve (12)
month period. The Independent Review Organization must have expertise in the billing, coding, reporting and other requirements of the
Federal health care programs from which [Provider] seeks reimbursement. The Independent Review Organization must be retained to conduct the assessment of the first year within ninety (90) days of the
effective date of this CIA. For purposes of complying with this review procedures requirement, the OIG at its discretion, may permit
the [Provider] to utilize internal auditors to perform the review(s). In
such case, the [Provider] will engage the Independent Review Organization to verify the propriety of the internal auditors' methods and
accuracy of their results. The [Provider] will request the Independent
Review Organization to produce a report on its findings which report
shall be included in the Annual Report to the OIG.
The Independent Review Organization (or the [Provider], if permitted
by the OIG, as set forth above) will conduct two separate engagements. One will be an analysis of [Provider's] billing to the Federal
health care programs to assist the [Provider] and OIG in determining compliance with all applicable statutes, regulations, and directives/guidance ("billing engagement"). The second engagement will
assist the [Provider] and OIG in determining whether [Provider] is in
compliance with this CIA ("compliance engagement").
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1. Billing Engagement. The billing engagement shall consist of a review of a statistically valid sample of claims for the relevant period.
The sample size shall be determined through the use of a probe
sample.1 At a minimum, the full sample must be within a ninety
(90) percent confidence level and a precision of twenty-five (25)
percent. The probe sample must contain at least thirty (30) sample
units and cannot be used as part of the full sample. Both the probe
sample and the sample must be selected through random numbers.
[Provider] shall use OIG's Office of Audit Services Statistical Sampling Software, also known as "RAT-STATS", which is available
through the Internet at www.hhs.gov/progorg/ratstat.html.
Each annual billing engagement analysis shall include the following components in its methodology:
a. Billing Engagement Objective: Provide a statement stating clearly the objective intended to be achieved by the
billing engagement and the procedure or combination of
procedures that will be applied to achieve the objective.
b. Billing Engagement Population: Identify the population,
which is the group about which information is needed.
Explain the methodology used to develop the population
and provide the basis for this determination.
c. Sources of Data: Provide a full description of the source
of the information upon which the billing engagement
conclusions will be based, including the legal or other
standards applied, documents relied upon, payment data,
and/or any contractual obligations.
d. Sampling Unit: Define the sampling unit, which is any of
the designated elements that comprise the population of
interest.
e. Sampling Frame: Identify the sampling frame, which is
the totality of the sampling units from which the sample
will be selected.
As part of the billing engagement:
a. Inquire of management as to the procedures and controls
affecting the billing process subject to the annual assessment as specified in the CIA. Document that aspect of the
billing process (e.g., flow of documents, processing activities), and those controls that will be tested in the sample.
The documentation may consist of flow charts, excerpts
from policies and procedures manuals, control questionnaires, etc.
b. Report the sample results, including the overall error rate
and the nature of the errors found (e.g., no documentation,
inadequate documentation, assignment of incorrect code).
c. Document findings related to [Provider's] procedures to
correct inaccurate billings and codings to the Federal
health care programs and findings regarding the steps

1

Probe sample is defined as a small, random preliminary sample.
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[Provider] is taking to bring its operations into compliance
or to correct problems identified by the audit.
2. Agreed-upon Procedures or Compliance Engagement. An Independent Review Organization (or the [Provider], if permitted by the
OIG) shall also conduct an agreed-upon procedures or compliance
engagement, which shall assist the users in determining whether
[Provider's] program, policies, procedures, and operations comply
with the terms of this CIA. This engagement shall include a section
by section analysis of the requirements of this CIA.
A complete copy of the Independent Review Organization's billing
and agreed-upon procedures or compliance engagement shall be
included in each of [Provider's] Annual Reports to OIG.
3. Disclosure of Overpayments and Material Deficiencies. If, as a result of these engagements, [Provider] or the Independent Review
Organization identifies any billing, coding or other policies, procedures and/or practices that result in an overpayment, [Provider]
shall notify the payor (e.g., Medicare fiscal intermediary or carrier)
within 30 days of discovering the deficiency or overpayment and
take remedial steps within 60 days of discovery (or such additional
time as may be agreed to by the payor) to correct the problem, including preventing the deficiency from recurring. The notice to the
payor shall include:
a. a statement that the refund is being made pursuant to
this CIA;
b. a description of the complete circumstances surrounding
the overpayment;
c. the methodology by which the overpayment was determined;
d. the amount of the overpayment;
e. any claim-specific information used to determine the overpayment (e.g., beneficiary health insurance number, claim
number, service date, and payment date);
f. the cost reporting period; and
g. the provider identification number under which the repayment is being made.
If [Provider] determines an overpayment represents a material
deficiency, contemporaneous with [Provider's] notification to the
payor as provided above, [Provider] shall also notify OIG of:
a. a complete description of the material deficiency;
b. amount of overpayment due to the material deficiency;
c. [Provider's] action(s) to correct and prevent such material
deficiency from recurring;
d. the payor's name, address, and contact person where the
overpayment was sent;
e. the date of the check and identification number (or electronic transaction number) on which the overpayment was
repaid.
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For purposes of this CIA, an "overpayment" shall mean the amount
of money the provider has received in excess of the amount due and
payable under the Federal health care programs' statutes, regulations or program directives, including carrier and intermediary
instructions.
For purposes of this CIA, a "material deficiency" shall mean anything that involves: (i) a substantial overpayment or improper payment relating to the Medicare and/or Medicaid programs; (ii) conduct or policies that clearly violate the Medicare and/or Medicaid
statute, regulations or directives issued by HCFA and/or its agents;
or (iii) serious quality of care implications for federal health care
beneficiaries or recipients. A material deficiency may be the result
of an isolated event or a series of occurrences.
4. Verification/Validation. In the event that the OIG determines that
it is necessary to conduct an independent review to determine
whether or the extent to which [Provider] is complying with its
obligations under this CIA, [Provider] agrees to pay for the reasonable cost of any such review or engagement by the OIG or any of
its designated agents.
E. Confidential Disclosure Program
Within ninety (90) days after the effective date of this CIA, [Provider]
shall establish a Confidential Disclosure Program, which must include measures (e.g., a toll-free compliance telephone line) to enable
employees, contractors, agents or other individuals to disclose, to the
Compliance Officer or some other person who is not in the reporting
individual's chain of command, any identified issues or questions associated with [Provider's] policies, practices or procedures with respect
to the Federal health care program, believed by the individual to be
inappropriate. [Provider] shall publicize the existence of the hotline
(e.g., e-mail to employees or post hotline number in prominent common
areas).
The Confidential Disclosure Program shall emphasize a nonretribution, non-retaliation policy, and shall include a reporting mechanism for anonymous, confidential communication. Upon receipt of a
complaint, the Compliance Officer (or designee) shall gather the information in such a way as to elicit all relevant information from the
individual reporting the alleged misconduct. The Compliance Officer
(or designee) shall make a preliminary good faith inquiry into the allegations set forth in every disclosure to ensure that he or she has
obtained all of the information necessary to determine whether a further review should be conducted. For any disclosure that is sufficiently
specific so that it reasonably: (1) permits a determination of the appropriateness of the alleged improper practice, and (2) provides an
opportunity for taking corrective action, [Provider] shall conduct an
internal review of the allegations set forth in such a disclosure and
ensure that proper follow-up is conducted.
The Compliance Officer shall maintain a confidential disclosure log,
which shall include a record and summary of each allegation received,
the status of the respective investigations, and any corrective action
taken in response to the investigation.
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F. Ineligible Persons
[Provider] shall not hire or engage as contractors any "Ineligible Person." For purposes of this CIA, an "Ineligible Person" shall be any individual or entity who: (i) is currently excluded, suspended, debarred or
otherwise ineligible to participate in the Federal health care programs;
or (ii) has been convicted of a criminal offense related to the provision
of health care items or services and has not been reinstated in the
Federal health care programs after a period of exclusion, suspension,
debarment, or ineligibility.
Within ninety (90) days of the effective date of this CIA, [Provider]
will review its list of current employees and contractors against
the General Services Administration's List of Parties Excluded from
Federal Programs (available through the Internet at http://www
.arnet.gov/epls) and the HHS/OIG Cumulative Sanction Report (available through the Internet at http://www.dhhs.gov/progorg/oig) to ensure that it is not currently employing or contracting with any Ineligible Person. Thereafter, [Provider] will review the list once semiannually to ensure that no current employees or contractors are or
have become Ineligible Persons.
To prevent hiring or contracting with any Ineligible Person, [Provider]
shall screen all prospective employees and prospective contractors
prior to engaging their services by (i) requiring applicants to disclose
whether they are Ineligible Persons, and (ii) reviewing the General
Services Administration's List of Parties Excluded from Federal Programs (available through the Internet at http://www.arnet.gov/epls)
and the HHS/OIG Cumulative Sanction Report (available through the
Internet at http://www.dhhs.gov/progorg/oig).
If [Provider] has notice that an employee or agent is charged with
a criminal offense related to any Federal health care program, or is
suspended or proposed for exclusion during his or her employment
or contract with [Provider], within 10 days of receiving such notice
[Provider] will remove such employee from responsibility for, or involvement with, [Provider's] business operations related to the Federal health care programs until the resolution of such criminal action,
suspension, or proposed exclusion. If [Provider] has notice that an employee or agent has become an Ineligible Person, [Provider] will remove
such person from responsibility for, or involvement with, [Provider's]
business operations related to the Federal health care programs and
shall remove such person from any position for which the person's
salary or the items or services rendered, ordered, or prescribed by the
person are paid in whole or in part, directly or indirectly, by Federal
health care programs or otherwise with Federal funds at least until
such time as the person is reinstated into participation in the Federal
health care programs.
G. Notification of Proceedings
Within thirty (30) days of discovery, [Provider] shall notify OIG, in
writing, of any ongoing investigation or legal proceeding conducted or
brought by a governmental entity or its agents involving an allegation
that [Provider] has committed a crime or has engaged in fraudulent
activities or any other knowing misconduct. This notification shall
include a description of the allegation, the identity of the investigating
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or prosecuting agency, and the status of such investigation or legal
proceeding. [Provider] shall also provide written notice to OIG within
thirty (30) days of the resolution of the matter, and shall provide OIG
with a description of the findings and/or results of the proceedings, if
any.
H. Reporting
1. Credible evidence of misconduct. If [Provider] discovers credible evidence of misconduct from any source and, after reasonable inquiry,
has reason to believe that the misconduct may violate criminal,
civil, or administrative law concerning [Provider's] practices relating to the Federal health care programs, then [Provider] shall
promptly report the probable violation of law to OIG. Defendants
shall make this disclosure as soon as practicable, but, not later
than thirty (30) days after becoming aware of the existence of the
probable violation. The [Provider's] report to OIG shall include:
a. the findings concerning the probable violation, including
the nature and extent of the probable violation;
b. [Provider's] actions to correct such probable violation; and
c. any further steps it plans to take to address such probable
violation and prevent it from recurring.
To the extent the misconduct involves an overpayment, the report
shall include the information listed in section III.D.3 regarding
material deficiencies.
2. Inappropriate Billing. If [Provider] discovers inappropriate or incorrect billing through means other than the Independent Review
Organization's engagement, the provider shall follow procedures in
section III.D.3 regarding overpayments and material deficiencies.
IV. New Locations
In the event that [Provider] purchases or establishes new business units after the effective date of this CIA, [Provider] shall notify OIG of this fact within
thirty (30) days of the date of purchase or establishment. This notification shall
include the location of the new operation(s), phone number, fax number, Federal health care program provider number(s) (if any), and the corresponding
payor(s) (contractor specific) that has issued each provider number. All employees at such locations shall be subject to the requirements in this CIA that apply
to new employees (e.g., completing certifications and undergoing training).
V. Implementation and Annual Reports
A. Implementation Report
Within one hundred and twenty (120) days after the effective date of
this CIA, [Provider] shall submit a written report to OIG summarizing
the status of its implementation of the requirements of this CIA. This
Implementation Report shall include:
1. the name, address, phone number and position description
of the Compliance Officer required by section III.A;
2. the names and positions of the members of the Compliance
Committee required by section III.A;
3. a copy of [Provider's] Code of Conduct required by section
III.B.1;
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4. the summary of the Policies and Procedures required by
section III.B.2;
5. a description of the training programs required by section
III.C including a description of the targeted audiences and
a schedule of when the training sessions were held;
6. a certification by the Compliance Officer that:
a. the Policies and Procedures required by section III.B have been developed, are being implemented, and have been distributed to all pertinent employees;
b. all employees have completed the Code of Conduct certification required by section III.B.1; and
c. all employees have completed the training and executed the certification required by section III.C;
7. a description of the confidential disclosure program required by section III.E;
8. the identity of the Independent Review Organization(s)
and the proposed start and completion date of the first
audit; and
9. a summary of personnel actions taken pursuant to section
III.F.
B. Annual Reports
[Provider] shall submit to OIG an Annual Report with respect to the
status and findings of [Provider's] compliance activities. The Annual
Reports shall include:
1. any change in the identity or position description of the
Compliance Officer and/or members of the Compliance
Committee described in section III.A;
2. a certification by the Compliance Officer that:
a. all employees have completed the annual Code of
Conduct certification required by section III.B.1;
and
b. all employees have completed the training and executed the certification required by section III.C;
3. notification of any changes or amendments to the Policies
and Procedures required by section III.B and the reasons
for such changes (e.g., change in contractor policy);
4. a complete copy of the report prepared pursuant to the Independent Review Organization's billing and compliance
engagement, including a copy of the methodology used;
5. [Provider's] response/corrective action plan to any issues
raised by the Independent Review Organization;
6. a summary of material deficiencies reported throughout
the course of the previous twelve (12) months pursuant to
III.D.3 and III.H;
7. a report of the aggregate overpayments that have been
returned to the Federal health care programs that were
discovered as a direct or indirect result of implementing
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this CIA. Overpayment amounts should be broken down
into the following categories: Medicare, Medicaid (report
each applicable state separately) and other Federal health
care programs;
a copy of the confidential disclosure log required by section
III.E;
a description of any personnel action (other than hiring)
taken by [Provider] as a result of the obligations in section
III.F;
a summary describing any ongoing investigation or legal
proceeding conducted or brought by a government entity
involving an allegation that [Provider] has committed a
crime or has engaged in fraudulent activities, which have
been reported pursuant to section III.G. The statement
shall include a description of the allegation, the identity
of the investigating or prosecuting agency, and the status of such investigation, legal proceeding or requests for
information;
a corrective action plan to address the probable violations
of law identified in section III.H; and
a listing of all of the [Provider's] locations (including locations and mailing addresses), the corresponding name
under which each location is doing business, the corresponding phone numbers and fax numbers, each location's
Federal health care program provider identification number(s) and the payor (specific contractor) that issued each
provider identification number.
The first Annual Report shall be received by the OIG no
later than one year and thirty (30) days after the effective
date of this CIA. Subsequent Annual Reports shall be submitted no later than the anniversary date of the due date
of the first Annual Report.

C. Certifications
The Implementation Report and Annual Reports shall include a certification by the Compliance Officer under penalty of perjury, that: (1)
[Provider] is in compliance with all of the requirements of this CIA,
to the best of his or her knowledge; and (2) the Compliance Officer
has reviewed the Report and has made reasonable inquiry regarding
its content and believes that, upon such inquiry, the information is
accurate and truthful.
VI. Notifications and Submission of Reports
Unless otherwise stated in writing subsequent to the effective date of this CIA,
all notifications and reports required under this CIA shall be submitted to the
entities listed below:
OIG:
Civil Recoveries Branch—Compliance Unit
Office of Counsel to the Inspector General
Office of Inspector General
U.S. Department of Health and Human Services
Cohen Building, Room 5527
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330 Independence Avenue, SW
Washington, DC 20201
Phone 202-619-2078; Fax 202-205-0604
[Provider]:
[Address and Telephone number of Provider's Compliance Contact]
VII. OIG Inspection, Audit and Review Rights
In addition to any other rights OIG may have by statute, regulation, or contract,
OIG or its duly authorized representative(s), may examine [Provider's] books,
records, and other documents and supporting materials for the purpose of verifying and evaluating: (a) [Provider's] compliance with the terms of this CIA; and
(b) [Provider's] compliance with the requirements of the Federal health care
programs in which it participates. The documentation described above shall be
made available by [Provider] to OIG or its duly authorized representative(s)
at all reasonable times for inspection, audit or reproduction. Furthermore, for
purposes of this provision, OIG or its duly authorized representative(s) may
interview any of [Provider's] employees who consent to be interviewed at the
employee's place of business during normal business hours or at such other
place and time as may be mutually agreed upon between the employee and
OIG. [Provider] agrees to assist OIG in contacting and arranging interviews
with such employees upon OIG's request. [Provider's] employees may elect to
be interviewed with or without a representative of [Provider] present.
VIII. Document and Record Retention
[Provider] shall maintain for inspection all documents and records relating to
reimbursement from the Federal health care programs or to compliance with
this CIA one year longer than the term of this CIA (or longer if otherwise
required by law).
IX. Disclosures
Subject to HHS's Freedom of Information Act ("FOIA") procedures, set forth in
45 C.F.R. Part 5, the OIG shall make a reasonable effort to notify [Provider]
prior to any release by OIG of information submitted by [Provider] pursuant
to its obligations under this CIA and identified upon submission by [Provider]
as trade secrets, commercial or financial information and privileged and confidential under the FOIA rules. [Provider] shall refrain from identifying any information as trade secrets, commercial or financial information and privileged
and confidential that does not meet the criteria for exemption from disclosure
under FOIA.
X. Breach and Default Provisions
[Provider] is expected to fully and timely comply with all of the obligations
herein throughout the term of this CIA or other time frames herein agreed to.
A. Stipulated Penalties for Failure to Comply with Certain Obligations
As a contractual remedy, [Provider] and OIG hereby agree that failure
to comply with certain obligations set forth in this CIA may lead to the
imposition of the following monetary penalties (hereinafter referred to
as "Stipulated Penalties") in accordance with the following provisions.
1. A Stipulated Penalty of $2,500 (which shall begin to accrue
on the day after the date the obligation became due) for
each day, beginning 120 days after the effective date of
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this CIA and concluding at the end of the term of this CIA,
[Provider] fails to have in place any of the following:
a. a Compliance Officer;
b. a Compliance Committee;
c. a written Code of Conduct;
d. written Policies and Procedures;
e. a training program; and
f. a Confidential Disclosure Program;
2. A Stipulated Penalty of $2,500 (which shall begin to accrue
on the day after the date the obligation became due) for
each day [Provider] fails to meet any of the deadlines to
submit the Implementation Report or the Annual Reports
to the OIG.
3. A Stipulated Penalty of $2,000 (which shall begin to accrue on the date the failure to comply began) for each day
[Provider]:
a. hires or contracts with an Ineligible Person after
that person has been listed by a federal agency as
excluded, debarred, suspended or otherwise ineligible for participation in the Medicare, Medicaid or any other Federal health care program
(as defined in 42 U.S.C. 1320a7b(f)). This Stipulated Penalty shall not be demanded for any time
period if [Provider] can demonstrate that it did
not discover the person's exclusion or other ineligibility after making a reasonable inquiry (as
described in section III.F) as to the status of the
person;
b. employs or contracts with an Ineligible Person
and that person: (i) has responsibility for, or involvement with, [Provider's] business operations
related to the Federal health care programs or
(ii) is in a position for which the person's salary
or the items or services rendered, ordered, or prescribed by the person are paid in whole or in part,
directly or indirectly, by the Federal health care
programs or otherwise with Federal funds (this
Stipulated Penalty shall not be demanded for any
time period during which [Provider] can demonstrate that it did not discover the person's exclusion or other ineligibility after making a reasonable inquiry (as described in III.F) as to the status
of the person);
c. employs or contracts with a person who: (i) has
been charged with a criminal offense related to
any Federal health care program, or (ii) is suspended or proposed for exclusion, and that person has responsibility for, or involvement with,
[Provider's] business operations related to the
Federal health care programs (this Stipulated
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Penalty shall not be demanded for any time period before 10 days after [Provider] received notice of the relevant matter or after the resolution
of the matter).
4. A Stipulated Penalty of $1,500 (which shall begin to accrue on the date the [Provider] fails to grant access) for
each day [Provider] fails to grant access to the information or documentation as required in section V of this
CIA.
5. A Stipulated Penalty of $1,000 (which shall begin to accrue
ten (10) days after the date that OIG provides notice to
[Provider] of the failure to comply) for each day [Provider]
fails to comply fully and adequately with any obligation of
this CIA. In its notice to [Provider], the OIG shall state the
specific grounds for its determination that the [Provider]
has failed to comply fully and adequately with the CIA
obligation(s) at issue.
B. Payment of Stipulated Penalties
1. Demand Letter. Upon a finding that [Provider] has failed to comply
with any of the obligations described in section X.A and determining that Stipulated Penalties are appropriate, OIG shall notify
[Provider] by personal service or certified mail of (a) [Provider's]
failure to comply; and (b) the OIG's exercise of its contractual right
to demand payment of the Stipulated Penalties (this notification is
hereinafter referred to as the "Demand Letter").
Within fifteen (15) days of the date of the Demand Letter,
[Provider] shall either (a) cure the breach to the OIG's satisfaction and pay the applicable stipulated penalties, or (b) request
a hearing before an HHS administrative law judge ("ALJ") to
dispute the OIG's determination of noncompliance, pursuant to
the agreed-upon provisions set forth below in section X.D. In
the event [Provider] elects to request an ALJ hearing, the Stipulated Penalties shall continue to accrue until [Provider] cures,
to the OIG's satisfaction, the alleged breach in dispute. Failure to respond to the Demand Letter in one of these two manners within the allowed time period shall be considered a material breach of this CIA and shall be grounds for exclusion under
section X.C.
2. Timely Written Requests for Extensions. [Provider] may submit a
timely written request for an extension of time to perform any act
or file any notification or report required by this CIA. Notwithstanding any other provision in this section, if OIG grants the
timely written request with respect to an act, notification, or report, Stipulated Penalties for failure to perform the act or file the
notification or report shall not begin to accrue until one day after
[Provider] fails to meet the revised deadline as agreed to by the
OIG-approved extension. Notwithstanding any other provision in
this section, if OIG denies such a timely written request, Stipulated Penalties for failure to perform the act or file the notification
or report shall not begin to accrue until two (2) business days after
[Provider] receives OIG's written denial of such request. A "timely
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written request" is defined as a request in writing received by OIG
at least five (5) business days prior to the date by which any act is
due to be performed or any notification or report is due to be filed.
3. Form of Payment. Payment of the Stipulated Penalties shall be
made by certified or cashier's check, payable to "Secretary of the
Department of Health and Human Services," and submitted to OIG
at the address set forth in section VI.
4. Independence from Material Breach Determination. Except as otherwise noted, these provisions for payment of Stipulated Penalties
shall not affect or otherwise set a standard for the OIG's determination that [Provider] has materially breached this CIA, which
decision shall be made at the OIG's discretion and governed by the
provisions in section X.C, below.
C. Exclusion for Material Breach of this CIA
1. Notice of Material Breach and Intent to Exclude. The parties
agree that a material breach of this CIA by [Provider] constitutes an independent basis for [Provider's] exclusion from participation in the Federal health care programs (as defined in 42
U.S.C. 1320a7b(f)). Upon a determination by OIG that [Provider]
has materially breached this CIA and that exclusion should be
imposed, the OIG shall notify [Provider] by certified mail of (a)
[Provider's] material breach; and (b) OIG's intent to exercise its
contractual right to impose exclusion (this notification is hereinafter referred to as the "Notice of Material Breach and Intent to
Exclude").
2. Opportunity to Cure. [Provider] shall have thirty-five (35) days from
the date of the Notice of Material Breach and Intent to Exclude
Letter to demonstrate to the OIG's satisfaction that:
a. [Provider] is in full compliance with this CIA;
b. the alleged material breach has been cured; or
c. the alleged material breach cannot be cured within the
35-day period, but that: (i) [Provider] has begun to take
action to cure the material breach, (ii) [Provider] is pursuing such action with due diligence, and (iii) [Provider]
has provided to OIG a reasonable timetable for curing the
material breach.
3. Exclusion Letter. If at the conclusion of the thirty-five (35) day period, [Provider] fails to satisfy the requirements of section X.C.2,
OIG may exclude [Provider] from participation in the Federal
health care programs. OIG will notify [Provider] in writing of its
determination to exclude [Provider] (this letter shall be referred
to hereinafter as the "Exclusion Letter"). Subject to the Dispute
Resolution provisions in section X.D, below, the exclusion shall
go into effect thirty (30) days after the date of the Exclusion Letter. The exclusion shall have national effect and will also apply to
all other federal procurement and non-procurement programs. If
[Provider] is excluded under the provisions of this CIA, [Provider]
may seek reinstatement pursuant to the provisions at 42 C.F.R.
§§1001.3001–.3004.
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4. Material Breach. A material breach of this CIA means:
a. a failure by [Provider] to report a material deficiency, take
corrective action and pay the appropriate refunds, as provided in section III.D;
b. repeated or flagrant violations of the obligations under
this CIA, including, but not limited to, the obligations addressed in section X.A of this CIA;
c. a failure to respond to a Demand Letter concerning the
payment of Stipulated Penalties in accordance with section X.B above; or
d. a failure to retain and use an Independent Review Organization for review purposes in accordance with section
III.D.
D. Dispute Resolution
1. Review Rights. Upon the OIG's delivery to [Provider] of its Demand
Letter or of its Exclusion Letter, and as an agreed-upon contractual
remedy for the resolution of disputes arising under the obligation
of this CIA, [Provider] shall be afforded certain review rights comparable to the ones that are provided in 42 U.S.C. §§1320a7(f) and
42 C.F.R. §1005 as if they applied to the Stipulated Penalties or
exclusion sought pursuant to this CIA. Specifically, the OIG's determination to demand payment of Stipulated Penalties or to seek
exclusion shall be subject to review by an ALJ and, in the event of
an appeal, the Departmental Appeals Board ("DAB"), in a manner
consistent with the provisions in 42 C.F.R. §§1005.2–.21. Notwithstanding the language in 42 C.F.R. §1005.2(c), the request for a
hearing involving stipulated penalties shall be made within fifteen
(15) days of the date of the Demand Letter and the request for a
hearing involving exclusion shall be made within thirty (30) days
of the date of the Exclusion Letter.
2. Stipulated Penalties Review. Notwithstanding any provision of Title 42 of the United States Code or Chapter 42 of the Code of
Federal Regulations, the only issues in a proceeding for stipulated
penalties under this CIA shall be (a) whether [Provider] was in full
and timely compliance with the obligations of this CIA for which
the OIG demands payment; and (b) the period of noncompliance.
[Provider] shall have the burden of proving its full and timely compliance and the steps taken to cure the noncompliance, if any. If the
ALJ finds for the OIG with regard to a finding of a breach of this CIA
and orders [Provider] to pay Stipulated Penalties, such Stipulated
Penalties shall become due and payable twenty (20) days after the
ALJ issues such a decision notwithstanding that [Provider] may
request review of the ALJ decision by the DAB.
3. Exclusion Review. Notwithstanding any provision of Title 42 of the
United States Code or Chapter 42 of the Code of Federal Regulations, the only issues in a proceeding for exclusion based on a
material breach of this CIA shall be (a) whether [Provider] was
in material breach of this CIA; (b) whether such breach was continuing on the date of the Exclusion Letter; and (c) the alleged
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material breach cannot be cured within the 35-day period, but that
(i) [Provider] has begun to take action to cure the material breach,
(ii) [Provider] is pursuing such action with due diligence, and (iii)
[Provider] has provided to OIG a reasonable timetable for curing
the material breach.
For purposes of the exclusion herein, exclusion shall take effect only after an ALJ decision that is favorable to the OIG.
[Provider's] election of its contractual right to appeal to the
DAB shall not abrogate the OIG's authority to exclude [Provider]
upon the issuance of the ALJ's decision. If the ALJ sustains the determination of the OIG and determines that exclusion is authorized, such exclusion shall take effect twenty
(20) days after the ALJ issues such a decision, notwithstanding
that [Provider] may request review of the ALJ decision by the
DAB.
4. Finality of Decision. The review by an ALJ or DAB provided for
above shall not be considered to be an appeal right arising under any statutes or regulations. Consequently, the parties to this
CIA agree that the DAB's decision (or the ALJ's decision if not appealed) shall be considered final for all purposes under this CIA
and [Provider] agrees to waive any right it may have to appeal the
decision administratively, judicially or otherwise seek review by
any court or other adjudicative forum.
XI. Effective and Binding Agreement
Consistent with the provisions in the Settlement Agreement pursuant to which
this CIA is entered, and into which this CIA is incorporated, [Provider] and OIG
agree as follows:
a. This CIA shall be binding on the successors, assigns and transferees of [Provider];
b. This CIA shall become final and binding on the date the final signature is obtained on the CIA;
c. Any modifications to this CIA shall be made with the prior written
consent of the parties to this CIA; and
d. The undersigned [Provider] signatories represent and warrant that
they are authorized to execute this CIA. The undersigned OIG signatory represents that he is signing this CIA in his official capacity
and that he is authorized to execute this CIA.
On Behalf of [Provider]

Date

Date

Date
[Please identify all signatories]
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ON BEHALF OF THE OFFICE OF INSPECTOR GENERAL OF THE
DEPARTMENT OF HEALTH AND HUMAN SERVICES

Lewis Morris

[Date]

Assistant Inspector General for Legal Affairs
Office of Inspector General
U.S. Department of Health and Human Services
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Appendix B
Sample Statement of Management’s Assertions
[Date]
In connection with the Corporate Integrity Agreement (CIA) entered into with
the Office of the Inspector General of the United States Department of Health
and Human Services dated [date], we make the following assertions, which are
true to the best of our knowledge and belief.
Governance
Within 90 days of the date of the CIA, we—
1. Established a Compliance Committee, which meets at least
monthly and requires a quorum to meet.
2. Appointed to our Compliance Committee members who include at
a minimum those individuals specified in the CIA.
3. Delegated to the Compliance Committee the authority to implement and monitor the CIA, as evidenced by the organization chart
or the Compliance Committee's charter.
4. Appointed a compliance officer, who reports directly to the individual specified in the CIA.
We appointed a compliance officer who—
1. Has sufficient staff and resources to carry out his or her responsibilities.
2. Actively participates in compliance training.
3. Has authority to conduct full and complete internal investigations
without restriction.
4. Periodically revises the compliance program to meet changing circumstances and risks.
Billing Practices, Policies, and Procedures
Although no system of internal controls can provide absolute assurance that
all bills comply in all respects with Medicare, Medicaid, and other federal
health care program guidelines, we are not aware of any material weaknesses
in our billing practices, policies, and procedures. Billings to third-party payors
comply in all material respects with applicable coding principles and laws and
regulations (including those dealing with Medicare and Medicaid antifraud
and abuse) and only reflect charges for goods and services that were medically
necessary, properly approved by regulatory bodies (e.g., the Food and Drug
Administration), if required and properly rendered. [Insert other assertions as
necessary to address matters covered in the CIA.] Any Medicare, Medicaid, and
other federal health program billing deficiencies that we identified have been
properly reported to the applicable payor within 60 days of discovery of the
deficiency.
Corporate Integrity Policy
1. Our policy was developed and implemented within [number] days
of execution of the CIA.
2. The policy addresses the Company's commitment to preparation
and submission of accurate billings consistent with the standards
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set forth in federal health care program statutes, regulations, procedures and guidelines or as otherwise communicated by Health
Care Financing Administration (HCFA), its agents or any other
agency engaged in the administration of the applicable federal
health care program.
3. The policy addressed the specific issues that gave rise to the settlement, as well as other risk areas identified by the OIG in published
Fraud Alerts issued through [date].
4. Further details on the development and implementation of our
policy were provided to the OIG in our letter dated [date].
5. Our policy was distributed to all employees, physicians and independent contractors involved in submitting or preparing requests
for reimbursement.
6. We have prominently displayed a copy of our policy on the Company's premises.
Information and Education Program
As discussed more fully in our letter to the OIG dated [date], we conducted an
Information and Education Program within [number] days of the CIA. The Information and Education Program requires that each officer, employee, agent
and contractor charged with administering federal health care programs (including, but not limited to billers, coders, nurses, physicians, medical records,
hospital administration and other individuals directly involved in billing federal health care programs) receive at least [number] hours of training.
The training provided to employees involved in billing, coding, and/or charge
capture consisted of instructions on submitting accurate bills, the personal
obligations of each individual to ensure billings are accurate, the nature of
company-imposed disciplinary actions on individuals who violate company policies and/or laws and regulations, applicable federal health care program rules,
legal sanctions against the company for submission of false or fraudulent information, and how to report potential abuses or fraud. The training material
addresses those issues underlying our settlement with the OIG.
The experience of the trainers is consistent with the topics presented.
Confidential Disclosure Program
Our Confidential Disclosure Program—
1. Was established within [number] days of the CIA.
2. Enables any employee to disclose any practices or billing procedures relating to federal health care programs.
3. Provides a toll-free telephone line maintained by the Company,
which Company representatives have indicated is maintained
twenty-four hours a day, seven days a week, for the purpose of
making any disclosures regarding compliance with the Company's
Compliance Program, the obligations in the CIA, and Company's
overall compliance with federal and state standards.
4. Includes policies requiring the review of any disclosures to permit a
determination of the appropriateness of the billing practice alleged
to be involved and any corrective action to be taken to ensure that
proper follow-up is conducted.
5. A detailed summary of the communications (including the number of disclosures by employees and the dates of such disclosures)
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concerning billing practices reported as, and found to be, inappropriate under the Confidential Disclosure Program, and the results
of any internal review and the follow-up on such disclosures are
summarized in Attachment [title] to our Annual Report.
Excluded Individuals or Entities
Company policy—
1. Prohibits the employment of or contracting with an individual or
entity that is listed by a federal agency as convicted of abuse or
excluded, suspended or otherwise ineligible for participation in federal health care programs.
2. Includes a process to make an inquiry into the status of any potential employee or independent contractor.
3. Provides for an annual review of the status of all existing employees and contractors to verify whether any individual had been
suspended or excluded or charged with a criminal offense relating
to the provision of federal health care services.
We are not aware of any individuals employed in contravention of the prohibitions in the CIA.
Record Retention
Our record retention policy is consistent with the requirements of the CIA.
Signed by:
[Chief Executive Officer]
[Chief Financial Officer]
[Corporate Compliance Officer]
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Appendix C
Sample Engagement Letter
The following is an illustration of a sample engagement letter that may be used
for this kind of engagement.
[CPA Firm Letterhead]
[Client's Name and Address]
Dear

:

This will confirm our understanding of the arrangements for our performance of
certain agreed-upon procedures in connection with management's compliance
with the terms of the Corporate Integrity Agreement (CIA) with the Office of
Inspector General (OIG) of the U.S. Department of Health and Human Services
(HHS) dated [date of CIA] for the period ending [date].
We will perform those procedures enumerated in the attachment to this letter.
Our responsibility is to carry out these procedures and report our findings. We
will conduct our engagement in accordance with standards established by the
American Institute of Certified Public Accountants. Our planned procedures
were agreed to by management and will be communicated to the OIG for its
review and are based on the terms specified in the CIA. The sufficiency of these
procedures is solely the responsibility of the specified parties to the report.
Consequently, it is understood that we make no representation regarding the
sufficiency of the procedures described in the attachment for the purpose for
which this report has been requested or for any other purpose.
Management is responsible for the Company's compliance with all applicable
laws, regulations, and contracts and agreements, including the CIA. Management also is responsible for the design, implementation, and monitoring of the
policies and procedures upon which compliance is based.
Our engagement to perform agreed-upon procedures is substantially less in
scope than an examination, the objective of which is the expression of an opinion
on management's compliance with the CIA. Accordingly, we will not express
such an opinion or any other form of assurance thereon.1
Working papers that are prepared in connection with this engagement are the
property of the independent accountant. The working papers are prepared for
the purpose of providing the principal support for the independent accountant's report. At the completion of our work, we expect to issue an agreed-upon
procedures report in the attached form.
1
The independent accountant may wish to include an understanding with the client about any
limitation or other arrangements regarding liability of the practitioner or the client in the engagement
letter. For example, the following might be included in the letter:
Our maximum liability relating to services rendered under this letter (regardless of form of
action, whether in contract, negligence or otherwise) shall be limited to the charges paid to us
for the portion of the services or work products giving rise to liability. We will not be liable
for consequential or punitive damages (including lost profits or savings) even if aware of their
possible existence.

You will indemnify us against any damage or expense that may result from any third-party claim
relating to our services or any use by you of any work product, and you will reimburse us for all
expenses (including counsel fees) as incurred by us in connection with any such claim, except
to the extent such claim (i) is finally determined to have resulted from our gross negligence or
willful misconduct or (ii) is covered by any of the preceding indemnities.
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If, however, we are not able to complete all of the specified procedures, we will
so advise you. At that time, we will discuss with you the form of communication,
if any, that you desire for our findings. We will ask you to confirm your request
in writing at that time. If you request that we delay issuance of our report until
corrective action is taken that will result in compliance with all aspects of the
CIA, we will do so only at your written request. Our working papers will be
retained in accordance with our firm's working paper retention policy.
The distribution of the independent accountant's report will be restricted to
the governing board and management of the Company and the OIG.
Our fees will be billed as work progresses and are based on the amount of time
required at various levels of responsibility plus actual out-of-pocket expenses.
Invoices are payable upon presentation. We will notify you immediately of any
circumstances we encounter that could significantly affect our initial estimate
of total fees.
We agree that to the extent required by law, we will allow the Comptroller
General of the United States, HHS, and their duly authorized representatives
to have access to this engagement letter and our documents and records to
the extent necessary to verify the nature and amount of costs of the services
provided to the Company, until the expiration of four years after we have
concluded providing services to the Company that are performed pursuant to
this Engagement Letter. In the event the Comptroller General, HHS, or their
duly authorized representatives request such records, we agree to notify the
Company of such request as soon as practicable.
In the event we are requested or authorized by the Company or are required
by government regulation, subpoena, or other legal process to produce our
documents or our personnel as witnesses with respect to our engagements for
the Company, the Company will, so long as we are not a party to the proceeding
in which the information is sought, reimburse us for our professional time and
expenses, as well as the fees and expenses of our counsel, incurred in responding
to such requests.
If this letter correctly expresses your understanding of this engagement, please
sign the enclosed copy where indicated and return it to us. We appreciate the
opportunity to serve you.
Sincerely,
[Partner's Signature]
[Firm Name or Firm Representative]
Accepted and agreed to:
[Client Representative's Signature]
[Title]
[Date]
[Revised, June 2009, to reflect conforming changes necessary due to the issuance of recent authoritative literature.]
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Appendix D
Sample Procedures
Procedure
Governance
1. We read the Company's corporate minutes and organization
chart and ascertained that, within [number] days of the date of
the Corporate Integrity Agreement (CIA), the Company—
a. Established a Compliance Committee, which is to meet
meets at least monthly and requires a quorum to meet.
b. Appointed to its Compliance Committee members who
include, at a minimum, those individuals specified in the
CIA.
c. Delegated to the Compliance Committee the authority
to implement and monitor the CIA, as evidenced by the
organization chart or the Compliance Committee's charter.
d. Appointed a compliance officer who reports directly to
the individual specified in the CIA.
2. We interviewed the compliance officer and were informed that,
in his or her opinion, the Compliance Officer—
a. Has sufficient staff and resources to carry out his or her
responsibilities.
b. Actively participates in compliance training.
c. Has the authority to conduct full and complete internal
investigations without restriction.
d. Periodically revises the compliance program to meet
changing circumstances and risks.
3. We read the OIG notification letter as specified in the CIA
and noted that the appropriate official signed the letter, that it
was addressed to the OIG, that it covered items (a) through (d)
in Step 1, and that it was dated within [number of] days of the
execution of the CIA.
Billing Practices, Policies, and Procedures
The practitioner might be engaged to provide consulting services
in connection with the evaluation of the company's billing practices, policies, and procedures. If so, generally no agreed-upon
procedures would be performed relating to this area.
Alternatively, if the procedures relating to the Company's billing
practices, policies, and procedures are performed by others such
as the Company's internal audit staff, the practitioner performs
Steps 4 through 9.
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4. We read the compliance work plan and noted the following:
a. The work plan's stated objectives include the determination that billings are accurate and complete, for services
rendered that have been deemed by medical specialists
as being necessary, and are submitted in accordance with
federal program guidelines.
b. The work plan sampling methodology sets confidence levels consistent with those defined in the CIA.
c. The work plan identifies risk areas, as defined in the
CIA (if applicable), and specifies testing procedures by
risk area.
d. The work plan specifies that samples are taken in risk
areas (if applicable) identified by the CIA.
e. The work plan includes testing procedures, which the
practitioner should modify as required by the CIA, for
the following risks areas (if applicable) identified in the
CIA:
(1) Clinical documentation, as follows:
(i) No documentation of service
(ii) Insufficient documentation of service
(iii) Improper diagnosis or treatment plan giving
rise to the provision of a medically unnecessary
service or treatment
(iv) Service or treatment does not conform medically with the documented diagnosis or treatment plan
(v) Services incorrectly coded
(2) Billing and coding, as follows:
(i) Noncovered or unallowable service
(ii) Duplicate payment
(iii) DRG window error
(iv) Unbundling
(v) Utilization
(vi) Medicare credit balances
[Note to Practitioner: Modify the preceding list as required by
the CIA.]
5. We selected [quantity] probe samples performed by the independent review organization for the following risk areas [list
risk areas tested]. For the probe samples selected, we noted that
the—
a. Sample patient billing files were randomly selected.
(continued)
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b. Sample size reflected confidence levels specified in the
CIA.
c. Sample plan describes how missing items (if any) would
be treated.
d. Patient billing files tested were pulled per the listing of
random numbers and all patient billing files were accounted for in the working papers.
e. Work plans for the specific sample described the risk
areas (if applicable) being tested and the testing approach/procedures.
f. Working papers noted the completion of each work plan
step.
g. Working papers contained a summary of findings for the
sample.
6. We reperformed the work plan steps [list of specific steps performed] for the sample patient billing files. The reperformance
of work plan steps related to the medical review of the sample
patient billing files was performed by the following individuals [note the professional qualifications of individuals without
listing names]. Any exceptions between our findings and the
Company's are summarized in the Attachment to this report.
7. We read the summary findings of all internal compliance reviews that the Company's Internal Audit department indicated
it had performed for the Company and noted that all material
billing deficiencies [specify material threshold as defined by the
Company] noted therein were discussed in written communications addressed to the appropriate payor (for example, Medicare
Part B carrier) and were dated within 60 days from the time the
deficiency occurred.1
8. We inquired of [individual] as to whether the Company took
remedial steps within [number of] days (or such additional time
as agreed to by the payor) to correct all material billing deficiencies noted in Step 7. We were informed that such remedial steps
had been taken.
9. By reading applicable correspondence, we noted that any material billing deficiencies noted in Step 7 were communicated to
the OIG, including specific findings relative to the deficiency,
the Company's actions taken to correct the deficiency, and any
further steps the Company plans to take to prevent any similar
deficiencies from recurring.

1
The CIA provides its own legal definition of a "material deficiency." Determination of whether a
billing or other act meets this definition is normally beyond the auditor's professional competence and
may have to await final determination by a court of law. Accordingly, to avoid confusion, a working
definition different from that provided in the CIA (e.g., a specified dollar threshold) may be necessary.
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Corporate Integrity Policy
10. We read the Company's Corporate Integrity Policy and noted
the following.
a. The policy was developed and implemented within [number of] days of execution of the CIA.
b. The policy addressed the Company's commitment to
preparation and submission of accurate billings consistent with the standards set forth in federal health care
program statutes, regulations, procedures, and guidelines or as otherwise communicated by HCFA, its agents,
or any other agency engaged in the administration of the
applicable federal health care program.
c. The policy addressed the specific issues that gave rise
to the settlement, as well as other risk areas identified
by the OIG in published Fraud Alerts issued through
[agency].
d. Correspondence addressed to the OIG covered the development and implementation of the policy.
e. Documentation indicating that the policy was distributed to all employees, physicians, and independent
contractors involved in submitting or preparing requests
for reimbursement.
f. The prominent display of a copy of the policy on the Company's premises.
11. We selected a sample of ten employees (involved in submitting and preparing requests for reimbursement) and examined
written confirmation in the employee's personnel file indicating
receipt of a copy of the Corporate Integrity Policy.
Information and Education Program
12. We read the Company's Information and Education Program
and noted the following.
a. The Information and Education Program agenda was
dated within [number of] days of execution of the CIA.
b. Correspondence covering the development and implementation of the Information and Education Program
was addressed to the OIG.
c. The Information and Education Program requires that
each officer, employee, agent, and contractor charged
with administering federal health care programs (including, but not limited to billers, coders, nurses, physicians,
medical records, hospital administration and other individuals directly involved in billing federal health care
programs) receive at least [number of] hours of training.
(continued)
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13. We selected a sample of ten employees involved in billing,
coding and/or charge capture and examined sign-in logs of the
training classes and noted that each had signed indicating that
they had received at least [number of] hours of training as specified in the Information and Education Program. We also reviewed
tests and surveys completed by each of the ten trained employees
noting evidence that they were completed.
14. We inquired as to the training of individuals not present
during the regularly scheduled training programs and were informed that each such individual is trained either individually or
in a separate make-up session. We inquired as to the names of
individuals not initially present and selected one such individual
and examined that individual's post-training test and survey for
completion.
15. We read the course agenda and noted that the training provided to employees involved in billing, coding, and/or charge capture consisted of instructions on submitting accurate bills, the
personal obligations of each individual to ensure billings are accurate, the nature of company-imposed disciplinary actions on
individuals who violate company policies and/or laws and regulations applicable to federal health care program rules, legal
sanctions against the company for submission of false or fraudulent information, and how to report potential abuses or fraud.
We also noted that the training material addressed the following
issues which gave rise to the settlement [practitioner list].
16. We inquired of the Corporate Compliance Officer as to the
qualifications and experience of the trainers and were informed
that, in the Corporate Compliance Officer's opinion, they were
consistent with the topics presented.
17. We noted that the Company's draft Annual Report to the OIG
dated [date] addresses certification of training.
Confidential Disclosure Program
18. We read documentation of the Company's Confidential Disclosure Program and noted that it—
a. Includes the printed effective date that was within [number of] days of execution of the CIA.
b. Consists of a confidential disclosure program enabling any
employee to disclose any practices or billing procedures
relating to federal health care programs.
c. Provides a toll-free telephone line maintained by the Company, which Company representatives have indicated is
maintained twenty-four hours a day, seven days a week,
for the purpose of making any disclosures regarding compliance with the Company's Compliance Program, the
obligations in the CIA, and Company's overall compliance
with federal and state standards.
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d. Includes policies requiring the review of any disclosures
to permit a determination of the appropriateness of the
billing practice alleged to be involved and any corrective action to be taken to ensure that proper follow-up is
conducted.
19. We made five test calls to the toll free telephone line (hotline)
and noted the following.
a. Each call was captured in the hotline logs and reported
with all other incoming calls.
b. Anonymity is not discouraged.
20. We noted that the Company included in its draft Annual
Report addressed to OIG dated [date] a detailed summary of the
communications (including the number of disclosures by employees and the dates of such disclosures) concerning billing practices
reported as, and found to be, inappropriate under the Confidential Disclosure Program, and the results of any internal review
and the follow-up on such disclosures.
21. We observed the display of the Company's Confidential Disclosure Program, including notice of the availability of its hotline, on the Company's premises.
Excluded Individuals or Entities
22. We read the Company's written policy relating to dealing
with excluded or convicted persons or entities and noted that
the policy—
a. Prohibits the hiring of or contracting with an individual
or entity that is listed by a federal agency as convicted of
abuse or excluded, suspended, or otherwise ineligible for
participation in federal health care programs.
b. Includes a process to make an inquiry into the status of
any potential employee or independent contractor.
c. Provides for a semi-annual review of the status of all
existing employees and contractors to verify whether any
individual had been suspended or excluded or charged
with a criminal offense relating to the provision of federal
health care services.
23. We selected a sample of ten employees hired over the course
of the test period as defined in the CIA and examined support in
the employee's personnel file documenting inquiries made into
the status of the employee, including documentation of comparison to the [source specified in the CIA].
24. We performed the following procedures related to the Company's semi-annual review of employee status.
(continued)
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a. Read documentation of the semi-annual review as evidence that a review was performed.
b. Selected and reviewed the lesser of ten or all exceptions
and determined that such employees were removed from
responsibility for or involvement with Provider business
operations related to the Federal health care programs.
c. Examined a notification letter addressed to the OIG and
dated within 30 days of the employee's removal from
employment.
d. Inquired of [officer] as to whether he or she was aware
of any individuals employed in contravention of the prohibitions in the CIA. If so, we further noted that [indicate specific procedures] to confirm that such situation
was cured within 30 days by [indicate how situation was
cured].
Annual Report
25. We read the Company's draft Annual Report dated [date] and
determined that it included the following items, to be modified
as appropriate, by the practitioner:
a. Compliance Program Charter and organization chart
b. Amendments to policies
c. Detailed descriptions of reviews and audits
d. Summary of hotline communications
e. Summary of annual review of employees
f. Cross-referencing to items noted in the CIA
Record Retention
26. We read the Company's record retention policy and noted
that it was consistent with the requirements as outlined in the
CIA.
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Appendix E
Sample Report
Independent Accountant's Report
[Date]
[Sample Health Care Provider]
Office of Inspector General of the U.S. Department of Health and Human
Services
We have performed the procedures enumerated in the Attachment, which were
agreed to by Sample Health Care Provider (Company) and the Office of Inspector General (OIG) of the U.S. Department of Health and Human Services,
solely to assist the users in evaluating management's assertion about [name
of entity's] compliance with the Corporate Integrity Agreement (CIA) with the
OIG dated [date of CIA] for the [period] ending [date], which is included as
Attachment A to this report. This agreed-upon procedures engagement was
performed in accordance with standards established by the American Institute
of Certified Public Accountants. The sufficiency of these procedures is solely
the responsibility of the specified users of the report. Consequently, we make
no representation regarding the sufficiency of the procedures described in Attachment B either for the purpose for which this report has been requested or
for any other purpose.
We were not engaged to and did not perform an examination, the objective of
which would be the expression of an opinion on management's compliance with
the CIA. Accordingly, we do not express such an opinion. Had we performed
additional procedures, other matters might have come to our attention that
would have been reported to you.
This report is intended solely for the information and use of the Compliance
Committee and management of the Company and the OIG, and is not intended
to be and should not be used by anyone other than those specified parties.
[Include as Attachments the CIA and the summary that enumerates procedures
and findings.]
[Signature]
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NOTE
This Statement of Position (SOP) is an interpretive publication and represents the recommendations of the AICPA Health Care Third-Party
Revenue Recognition Task Force of the Auditing Standards Board (ASB)
with regard to auditing financial statement assertions about third-party
revenues and related receivables of health care entities. The ASB has
found the recommendations in this SOP to be consistent with existing
standards covered by Rule 202, Compliance With Standards, (AICPA,
Professional Standards, vol. 2, ET sec. 202 par. .01) of the AICPA Code
of Professional Conduct.
Interpretive publications are not as authoritative as pronouncements of
the ASB; however, if an auditor does not apply the guidance included in
this SOP, the auditor should be prepared to explain how he or she complied with the provisions of Statements on Auditing Standards addressed
by this SOP.
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Summary
This Statement of Position (SOP) provides guidance to auditors regarding uncertainties inherent in health care third-party revenue recognition. It discusses
auditing matters related to testing third-party revenues and related receivables, and provides guidance regarding the sufficiency and appropriateness of
audit evidence and reporting on financial statements of health care entities
exposed to material uncertainties. [Revised, June 2009, to reflect conforming
changes necessary due to the issuance of recent authoritative literature.]
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Introduction and Background
.01 Most health care providers participate in payment programs that pay
less than full charges for services rendered. For example, some cost-based programs retrospectively determine the final amounts reimbursable for services
rendered to their beneficiaries based on allowable costs. With increasing frequency, even non-cost-based programs (such as the Medicare Prospective Payment System) have become subject to retrospective adjustments (for example,
billing denials and coding changes). Often, such adjustments are not known for
a considerable period of time after the related services were rendered.
.02 The lengthy period of time between rendering services and reaching
final settlement, compounded further by the complexities and ambiguities of reimbursement regulations, makes it difficult to estimate the net patient service
revenue associated with these programs. This situation has been compounded
due to the frequency of changes in federal program guidelines.
.03 Financial Accounting Standards Board (FASB) Accounting Standards
Codification™ (ASC) 954-605-45-2 states, in part, that "service revenue shall
be reported net of contractual and other adjustments in the statement of operations, including patient service revenue." As a result, patient receivables, including amounts due from third-party payors, are also reported net of expected
contractual and other adjustments. However, amounts ultimately realizable
will not be known until some future date, which may be several years after
the period in which the services were rendered. [Revised, June 2009, to reflect conforming changes necessary due to the issuance of recent authoritative
literature.]
.04 This SOP provides guidance to auditors regarding uncertainties inherent in health care third-party revenue recognition. It discusses auditing
matters related to testing third-party revenue and related receivables, including the effects of settlements (both cost-based and non-cost-based third-party
payment programs), and provides guidance regarding the sufficiency and appropriateness of audit evidence and reporting on financial statements of health
care entities exposed to material uncertainties. [Revised, June 2009, to reflect
conforming changes necessary due to the issuance of recent authoritative literature.]

Scope and Applicability
.05 This SOP applies to audits of health care entities falling within the
scope of the AICPA Audit and Accounting Guide Health Care Entities (the
guide). Its provisions are effective for audits of periods ending on or after June
30, 2000. Early application of the provisions of this SOP is permitted.

Third-Party Revenues and Related Receivables—Inherent
Uncertainties
.06 Health care entities need to estimate amounts that ultimately will be
realizable in order for revenues to be fairly stated in accordance with generally
accepted accounting principles (GAAP). The basis for such estimates may range
from relatively straightforward calculations using information that is readily
available to highly complex judgments based on assumptions about future
decisions.
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.07 Entities doing business with governmental payors (for example, Medicare and Medicaid) are subject to risks unique to the government-contracting
environment that are hard to anticipate and quantify and that may vary from
entity to entity. For example—

r

r
r
r
r
r

A health care entity's revenues may be subject to adjustment as
a result of examination by government agencies or contractors.
The audit process and the resolution of significant related matters (including disputes based on differing interpretations of the
regulations) often are not finalized until several years after the
services were rendered.
Different fiscal intermediaries (entities that contract with the federal government to assist in the administration of the Medicare
program) may interpret governmental regulations differently.
Differing opinions on a patient's principal medical diagnosis,
including the appropriate sequencing of codes used to submit
claims for payment, can have a significant effect on the payment
amount.1
Otherwise valid claims may be determined to be nonallowable
after the fact due to differing opinions on medical necessity.
Claims for services rendered may be nonallowable if they are later
determined to have been based on inappropriate referrals.2
Governmental agencies may make changes in program interpretations, requirements, or "conditions of participation," some of
which may have implications for amounts previously estimated.

.08 Such factors often result in retrospective adjustments to interim payments. Reasonable estimates of such adjustments are central to the third-party
revenue recognition process in health care, in order to avoid recognizing revenue that the provider will not ultimately realize. The delay between rendering
services and reaching final settlement, as well as the complexities and ambiguities of billing and reimbursement regulations, makes it difficult to estimate
net realizable third-party revenues.

Management’s Responsibilities
.09 Management is responsible for the fair presentation of its financial
statements in conformity with GAAP. Management also is responsible for
adopting sound accounting policies and for establishing and maintaining internal control that will, among other things, enable the entity to initiate, authorize, record, process, and report transactions (as well as events and conditions)
consistent with management's assertions embodied in the financial statements.
Despite the inherent uncertainties, management is responsible for estimating
1
Historically, the Health Care Financing Administration (HCFA) contracted with Peer Review
Organizations (PROs) to validate the appropriateness of admissions and the clinical coding from
which reimbursement was determined. Such reviews were typically performed within ninety days
of the claim submission date. However, the government has modified its policies with respect to
such reviews and now analyzes coding errors through other means, including in conjunction with
investigations conducted by the Office of the Inspector General (OIG) of the U. S. Department of
Health and Human Services.
2
Effective January 1, 1995, the Limitation on Certain Physician Referrals law prohibited physicians from referring Medicare and Medicaid patients to health care entities with which they had
a financial relationship for the furnishing of designated health services. Implementing regulations
have not yet been adopted as of the date of this publication.
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the amounts recorded in the financial statements and making the required disclosures in accordance with GAAP, based on management's analysis of existing
conditions. [Revised, June 2009, to reflect conforming changes necessary due
to the issuance of recent authoritative literature.]
.10 Management's assertions regarding proper valuation of its revenues
and receivables are embodied in the financial statements. Management is responsible for recognizing revenues when their realization is reasonably assured. As a result, management makes a reasonable estimate of amounts that
ultimately will be realized, considering—among other things—adjustments associated with regulatory reviews, audits, billing reviews, investigations, or
other proceedings. Estimates that are significant to management's assertions
about revenue include the provision for third-party payor contractual adjustments and allowances. [Revised, June 2009, to reflect conforming changes necessary due to the issuance of recent authoritative literature.]
.11 Management also is responsible for preparing and certifying cost reports submitted to federal and state government agencies in support of claims
for payment for services rendered to government program beneficiaries.

The Auditor’s Responsibilities
.12 The auditor's responsibility is to express an opinion on the financial
statements taken as a whole. In reaching this opinion, the auditor should
conclude whether sufficient appropriate evidence has been obtained to reduce
to an appropriately low level the risks of material misstatement in the financial
statements. In developing an opinion, the auditor should consider all relevant
audit evidence, including

r
r
r

the evidence in support of recorded amounts.
the reasonableness of management's estimates in the present circumstances,
the fairness of the presentation and adequacy of the disclosures
made by management,

[Revised, June 2009, to reflect conforming changes necessary due to the issuance of recent authoritative literature.]
.13 Current industry conditions, as well as specific matters affecting the
entity.3 provide relevant information when planning the audit. Among a number of procedures, the auditor's procedures may include an analysis of historical
results (for example, prior fiscal intermediary audit adjustments and comparisons with industry benchmarks and norms) that enable the auditor to better
assess the risk of material misstatements in the current period. When there
are heightened risks, the auditor should perform audit procedures that respond
to those risks, for example, more extensive tests covering the current period.
Exhibit 5-1 of the guide includes examples of procedures auditors may perform. [Revised, June 2009, to reflect conforming changes necessary due to the
issuance of recent authoritative literature.]
.14 With respect to auditing third-party revenues, a relevant consideration in addition to the usual revenue recognition considerations, is whether ultimately realizable amounts are known or will be presently known, or whether
3
Risk factors, including ones related to legislative and regulatory matters, are discussed annually in the AICPA Audit Risk Alert Health Care Industry Developments.
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those amounts are uncertain because they are dependent on some other future, prospective actions or confirming events. For example, under a typical
fee-for-service contract with a commercial payor, if the provider has performed
a service for a covered individual, the revenue to which the provider is entitled
should be determinable at the time the service is rendered. On the other hand,
if the service was provided under a cost-based government contract, the revenue ultimately collectible may not be known until certain future events occur
(for example, a cost report has been submitted and finalized after desk review
or audit). In this case, management estimates the effect of such potential future
adjustments. [Revised, June 2009, to reflect conforming changes necessary due
to the issuance of recent authoritative literature.]
.15 As stated previously, management is responsible for preparing the
estimates contained in the financial statements. The auditor should evaluate
the sufficiency and appropriateness of the evidence supporting those estimates,
including the facts supporting management's judgments, and the judgments
made based on conditions existing at the time of the audit. The fact that net
revenues recorded at the time services are rendered differ materially from
amounts that ultimately are realized does not necessarily mean the audit was
not properly planned or carried out. Similarly, the fact that future events may
differ materially from management's assumptions or estimates does not necessarily mean that management's estimates were not valid or the auditor did not
follow generally accepted auditing standards (GAAS) as described in this SOP
with respect to auditing estimates. [Revised, June 2009, to reflect conforming
changes necessary due to the issuance of recent authoritative literature.]

Audit Evidence
.16 The measurement of estimates is inherently uncertain and depends
on the outcome of future events. AU section 342, Auditing Accounting Estimates, and AU section 508, Reports on Audited Financial Statements (AICPA,
Professional Standards), provide guidance to the auditor when the valuation
of revenues is uncertain, pending the outcome of future events. In the current
health care environment, conclusive evidence concerning amounts ultimately
realizable cannot be expected to exist at the time of the financial statement
audit because the uncertainty associated with future program audits, administrative re-views, billing reviews, regulatory investigations, or other actions
will not be resolved until sometime in the future. [Revised, June 2009, to reflect conforming changes necessary due to the issuance of recent authoritative
literature.]
.17 The fact that information related to the effects of future program audits, administrative reviews, regulatory investigations, or other actions does
not exist does not lead to a conclusion that the evidence supporting management's assertions is not sufficient to support management's estimates. Rather,
the auditor's judgment regarding the sufficiency and appropriateness of the
evidence is based on the evidence that is available or can reasonably be expected to be available in the circumstances. If, after considering the existing
conditions and available evidence, the auditor concludes that the evidence is
sufficient and appropriate and supports management's assertions about the
valuation of revenues and receivables, and their presentation and disclosure in
the financial statements, an unqualified opinion ordinarily is appropriate. [Revised, June 2009, to reflect conforming changes necessary due to the issuance
of recent authoritative literature.]
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.18 The inability to obtain relevant evidence that the auditor needs may
require the auditor to express a qualified opinion or to disclaim an opinion because of a scope limitation. For example, if an entity has conducted an internal
evaluation (for example, of coding or other billing matters) under attorney–
client privilege and management and its legal counsel refuse to respond to the
auditor's inquiries and the auditor determines the information is necessary,
ordinarily the auditor would qualify his or her opinion for a scope limitation.
[Revised, June 2009, to reflect conforming changes necessary due to the issuance of recent authoritative literature.]
.19 The accuracy of management's assumptions will not be known until
future events occur. In evaluating the accuracy of those assumptions, the auditor normally should consider the entity's historical experience in making past
estimates and the auditor's experience in the industry. For certain matters, the
best evidence available to the auditor (particularly as it relates to clinical and
legal interpretations) may be the representations of management and its legal counsel, as well as information obtained through reviewing correspondence
from regulatory agencies. [Revised, June 2009, to reflect conforming changes
necessary due to the issuance of recent authoritative literature.]
.20 Pursuant to AU sec. 333, Management Representations (AICPA, Professional Standards), the auditor should obtain written representations from
management concerning the absence of violations or possible violations of laws
or regulations whose effects should be considered for disclosure in the financial
statements or as a basis for recording a loss contingency. Examples of specific
representations include the following:

r

Receivables
— Adequate consideration has been given to, and appropriate provision made for, estimated adjustments to revenue, such as for denied claims and changes to diagnosisrelated group (DRG) assignments.
— Recorded valuation allowances are necessary, appropriate, and properly supported.

r

— All peer review organizations, fiscal intermediary, and
third-party payor reports and information have been
made available.
Cost reports filed with third parties
— All required Medicare, Medicaid, and similar reports
have been properly filed.
— Management is responsible for the accuracy and propriety of all cost reports filed.
— All costs reflected on such reports are appropriate and allowable under applicable reimbursement rules and regulations and are patient-related and properly allocated to
applicable payors.
— The reimbursement methodologies and principles employed are in accordance with applicable rules and regulations.
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r

—

Adequate consideration has been given to, and appropriate provision made for, audit adjustments by intermediaries, third-party payors, or other regulatory agencies.

—

All items required to be disclosed, including disputed
costs that are being claimed to establish a basis for a
subsequent appeal, have been fully disclosed in the cost
report.

—

Recorded third-party settlements include differences between filed (and to be filed) cost reports and calculated
settlements, which are necessary based on historical experience or new or ambiguous regulations that may be
subject to differing interpretations. While management
believes the entity is entitled to all amounts claimed on
the cost reports, management also believes the amounts
of these differences are appropriate.

Contingencies
—

There are no violations or possible violations of laws or
regulations, such as those related to the Medicare and
Medicaid antifraud and abuse statutes, including but
not limited to the Medicare and Medicaid Anti-Kickback
Statute, Limitations on Certain Physician Referrals (the
Stark law), and the False Claims Act, in any jurisdiction,
whose effects should be considered for disclosure in the
financial statements or as a basis for recording a loss
contingency other than those disclosed or accrued in the
financial statements.

—

Billings to third-party payors comply in all material respects with applicable coding guidelines (for example,
ICD-9-CM and CPT-4) and laws and regulations (including those dealing with Medicare and Medicaid antifraud and abuse), and billings reflect only charges for
goods and services that were medically necessary; properly approved by regulatory bodies (for example, the Food
and Drug Administration), if required; and properly rendered.

—

There have been no communications (oral or written)
from regulatory agencies, governmental representatives,
employees, or others concerning investigations or allegations of noncompliance with laws and regulations in any
jurisdiction (including those related to the Medicare and
Medicaid antifraud and abuse statutes), deficiencies in
financial reporting practices, or other matters that could
have a material adverse effect on the financial statements.

.21 Management's refusal to furnish written representations constitutes
a limitation on the scope of the audit sufficient to preclude an unqualified opinion and is ordinarily sufficient to cause an auditor to disclaim an opinion or
withdraw from the engagement. However, based on the nature of the representations not obtained or the circumstances of the refusal, the auditor may
conclude that a qualified opinion is appropriate.
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Potential Departures From GAAP Related to Estimates and
Uncertainties
.22 The auditor also is responsible for determining whether financial
statement assertions and disclosures related to accounting estimates have
been presented in conformity with GAAP. Departures from GAAP related to
accounting estimates generally fall into one of the following categories:

r
r
r

Unreasonable accounting estimates
Inappropriate accounting principles
Inadequate disclosure

Therefore, in order to render an opinion, the auditor's responsibility is to evaluate the reasonableness of management's estimates based on present circumstances and to determine that estimates are reported in accordance with GAAP
and adequately disclosed. [Revised, June 2009, to reflect conforming changes
necessary due to the issuance of recent authoritative literature.]
.23 As discussed in AU section 326, Audit Evidence (AICPA, Professional
Standards), the auditor's objective is to obtain sufficient appropriate audit evidence to provide him or her with a reasonable basis for forming an opinion. As
discussed previously, Exhibit 5-1 of the guide provides a number of sample procedures that the auditor may perform in auditing an entity's patient revenues
and accounts receivable, including those derived from third-party payors. For
example, the guide notes that the auditor might "test the reasonableness of
settlement amounts, including specific and unallocated reserves, in light of the
payors involved, the nature of the payment mechanism, the risks associated
with future audits, and other relevant factors."4 [Revised, September 2008, to
reflect conforming changes necessary due to the issuance of Statement on Auditing Standards No. 105. Revised, June 2009, to reflect conforming changes
necessary due to the issuance of recent authoritative literature.]

Unreasonable Accounting Estimates
.24 The basis for management's assumptions regarding the nature of future adjustments and calculations as to the effects of such adjustments are relevant factors when evaluating the reasonableness of management's estimates.5
The auditor cannot determine with certainty whether such estimates are right
or wrong, because the accuracy of management's assumptions cannot be confirmed until future events occur. [Revised, June 2009, to reflect conforming
changes necessary due to the issuance of recent authoritative literature.]
.25 Though difficult to predict, it is reasonable for the auditor to expect
that management has made certain assumptions (either in detail or in the
aggregate) in developing its estimates regarding conditions likely to result
in adjustments (for example, consistency with historical experience and basis of management's underlying assumptions). In evaluating reasonableness,
the auditor should obtain an understanding of how management developed
the estimate. Based on that understanding, the auditor should use one or a
combination of the following approaches:

4
5

See paragraphs .25–.28.
The lack of such analyses may call into question the reasonableness of recorded amounts.
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a. Review and test the process used by management to develop the
estimate.
b. Develop an independent expectation of the estimate to corroborate
the reasonableness of management's estimates.
c. Review subsequent events or transactions occurring prior to completion of fieldwork (AU sec. 342.10).
[Revised, June 2009, to reflect conforming changes necessary due to the issuance of recent authoritative literature.]
.26 Because no one accounting estimate can be considered accurate with
certainty, the auditor may determine that a difference between an estimated
amount best supported by the audit evidence and the estimated amount included in the financial statements may be significant and such difference
would not be considered to be a likely misstatement. However, if the auditor
believes the estimated amount included in the financial statements is unreasonable, he or she should treat the difference between that estimate and the
closest reasonable estimate as a likely misstatement. (Paragraph .56 of AU
section 312, Audit Risk and Materiality in Conducting an Audit [AICPA, Professional Standards]). The auditor also should consider whether the difference
between estimates best supported by the audit evidence and the estimates included in the financial statements, which are individually reasonable, indicate
a possible bias on the part of the entity's management. For example, if each
accounting estimate included in the financial statements was individually reasonable, but the effect of the difference between each estimate and the estimate
best supported by the audit evidence was to increase income, the auditor should
reconsider the reasonableness of the estimates taken as a whole (Paragraph .58
of AU section 312 [AICPA, Professional Standards]). [Revised, June 2009, to reflect conforming changes necessary due to the issuance of recent authoritative
literature.]
.27 Approaches and estimates will vary from entity to entity. Some entities with significant prior experience may attempt to quantify the effects
of individual potential intermediary or other governmental (for example, the
Office of Inspector General and the Department of Justice) or private payor
adjustments, basing their estimates on very detailed calculations and assumptions regarding potential future adjustments. Some may prepare cost report6
analyses to estimate the effect of potential adjustments. Others may base their
estimates on an analysis of potential adjustments in the aggregate, in light
of the payors involved; the nature of the payment mechanism; the risks associated with future audits; and other relevant factors. [Revised, June 2009, to
reflect conforming changes necessary due to the issuance of recent authoritative literature.]
.28 One of the key factors in evaluating the estimate is the historical experience of the entity (for example, the aggregate amount of prior cost-report
6
Medicare cost reimbursement is based on the application of highly complex technical rules,
some of which are ambiguous and subject to different interpretations even among Medicare's fiscal
intermediaries. It is not uncommon for fiscal intermediaries to reduce claims for reimbursement that
were based on management's good faith interpretations of pertinent laws and regulations. Additionally, the Provider Reimbursement Review Board (PRRB) or the courts may be required to resolve
controversies regarding the application of certain rules. To avoid recognizing revenues before their
realization is reasonably assured, providers estimate the effects of such potential adjustments. This
is occasionally done by preparing a cost report based on alternative assumptions to help estimate contractual allowances required by generally accepted accounting principles. The existence of reserves
or a reserve cost report does not by itself mean that a cost report was incorrectly or fraudulently filed.
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adjustments and previous regulatory settlements) as well as the risk of potential future adjustments. The fact that an entity currently is not subject to a
governmental investigation does not mean that a recorded valuation allowance
for potential billing adjustments is not warranted. Nor do these emerging industry trends necessarily indicate that an accrual for a specific entity is warranted. [Revised, June 2009, to reflect conforming changes necessary due to
the issuance of recent authoritative literature.]
.29 In evaluating valuation allowances, the auditor may consider the entity's historical experience and potential future adjustments in the aggregate.
For example, assume that over the past few years after final cost report audits
were completed, a hospital's adjustments averaged 3 percent to 5 percent of
total filed reimbursable costs. Additionally, the hospital is subject to potential
billing adjustments, including errors (for example, violations of the three-day
window, discharge and transfer issues, and coding errors). Even though specific incidents are not known, it may be reasonable for the hospital to estimate
and accrue a valuation allowance for such potential future retrospective adjustments, both cost-based and non-cost-based. Based on this and other information obtained, the auditor may conclude that a valuation allowance for the
year under audit of 3 percent to 5 percent of reimbursable costs plus additional
amounts for potential non-cost-based program billing errors is reasonable.
.30 Amounts that ultimately will be realized by an entity are dependent
on a number of factors, many of which may be unknown at the time the estimate is first made. Further, even if two entities had exactly the same clinical
and coding experience, amounts that each might realize could vary materially due to factors outside of their control (for example, differing application
of payment rules by fiscal intermediaries, legal interpretations of courts, local
enforcement initiatives, timeliness of reviews, and quality of documentation).
As a result, because estimates are a matter of judgment and their ultimate accuracy depends on the outcome of future events, different entities in seemingly
similar circumstances may develop materially different estimates. The auditor may conclude that both estimates are reasonable in light of the differing
assumptions.

Inappropriate Accounting Principles
.31 As previously stated, the auditor also is responsible for determining
whether financial statement assertions and disclosures related to accounting
estimates are presented in accordance with GAAP. When the financial statements are materially affected by a departure from GAAP, the auditor should
expresses a qualified or adverse opinion. [Revised, June 2009, to reflect conforming changes necessary due to the issuance of recent authoritative literature.]
.32 Valuation allowances should be recorded so that revenues are not
recognized until the revenues are realizable. Valuation allowances are not
established based on the provisions of FASB ASC 450, Contingencies. [Revised,
June 2009, to reflect conforming changes necessary due to the issuance of recent
authoritative literature.]
.33 Indicators of possible measurement bias related to valuation allowances include
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valuation allowances that are not associated with any particular
program, issue, or time period (for example, cost-report year or
year the service was rendered).
distorted earnings trends over time (for example, building up specific or unallocated valuation allowances in profitable years and
drawing them down in unprofitable years).

[Revised, June 2009, to reflect conforming changes necessary due to the issuance of recent authoritative literature.]

Inadequate Disclosure
.34 If the auditor concludes that a matter involving a risk or an uncertainty is not adequately disclosed in the financial statements in conformity
with GAAP, the auditor should express a qualified or adverse opinion. FASB
ASC 275-10-50 provides guidance on the information that reporting entities
should disclose regarding risks and uncertainties existing as of the date of
the financial statements. [Revised, June 2009, to reflect conforming changes
necessary due to the issuance of recent authoritative literature.]
.35 In the health care environment, it is almost always at least reasonably possible that estimates regarding third-party payments could change in
the near term as a result of one or more future confirming events (for example,
regulatory actions reflecting local or national audit or enforcement initiatives).
For most entities with significant third-party revenues, the effect of the change
could be material to the financial statements. Where material exposure exists,
the uncertainty regarding revenue realization should be disclosed in the notes
to the financial statements. Because representations from legal counsel are
often key audit evidence in evaluating the reasonableness of management's
estimates of potential future adjustments, the inability of an attorney to form
an opinion on matters about which he or she has been consulted may be indicative of an uncertainty that should be specifically disclosed in the financial
statements. [Revised, June 2009, to reflect conforming changes necessary due
to the issuance of recent authoritative literature.]
.36 Differences between original estimates and subsequent revisions
might arise due to final settlements, ongoing audits and investigations, or
passage of time in relation to the statute of limitations. FASB ASC 954-605
requires that these differences be included in the statement of operations in
the period in which the revisions are made and disclosed. Such differences
are not treated as prior period adjustments unless they meet the criteria for
prior period adjustments as set forth in FASB ASC 250-10-45. [Revised, June
2009, to reflect conforming changes necessary due to the issuance of recent
authoritative literature.]
.37 Disclosures such as the following may be appropriate:
General Hospital (the Hospital) is a (not-for-profit, for-profit, or governmental hospital or health care system) located in (City, State). The
Hospital provides health care services primarily to residents of the
region.
Net patient service revenue is reported at estimated net realizable
amounts from patients, third-party payors, and others for services
rendered and includes estimated retroactive revenue adjustments due
to future audits, reviews, and investigations. Retroactive adjustments
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are considered in the recognition of revenue on an estimated basis in
the period the related services are rendered, and such amounts are
adjusted in future periods as adjustments become known or as years
are no longer subject to such audits, reviews, and investigations.
Revenue from the Medicare and Medicaid programs accounted for approximately 40 percent and 10 percent, respectively, of the Hospital's
net patient revenue for the year ended 1999. Laws and regulations
governing the Medicare and Medicaid programs are extremely complex and subject to interpretation. As a result, there is at least a
reasonable possibility that recorded estimates will change by a material amount in the near term. The 1999 net patient service revenue
increased approximately $10,000,000 due to removal of allowances
previously estimated that are no longer necessary as a result of final
settlements and years that are no longer subject to audits, reviews,
and investigations. The 1998 net patient service revenue decreased
approximately $8,000,000 due to prior-year retroactive adjustments
in excess of amounts previously estimated.
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Appendix
Other Considerations Related to Government Investigations
In recent years, the federal government and many states have aggressively increased enforcement efforts under Medicare and Medicaid anti-fraud and abuse
legislation. Broadening regulatory and legal interpretations have significantly
increased the risk of penalties for providers; for example, broad interpretations
of "false claims" laws are exposing ordinary billing mistakes to scrutiny and
penalty consideration. In such circumstances, evaluating the adequacy of accruals for or disclosure of the potential effects of illegal acts in the financial
statements of health care entities is a matter that is likely to require a high
level of professional judgment.
As previously discussed in this SOP, the far-reaching nature of alleged fraud
and abuse violations creates an uncertainty with respect to the valuation of
revenues, because future allegations of illegal acts could, if proven, result in a
subsequent reduction of revenues. In addition, management makes provisions
in the financial statements and disclosures for any contingent liabilities associated with fines and penalties due to violations of such laws. FASB ASC 450,
Contingencies, provides guidance in evaluating contingent liabilities, such as
fines and penalties under applicable laws and regulations. Estimates of potential fines and penalties are not accrued unless their payment is probable and
reasonably estimable.
The auditor's expertise is in accounting and auditing matters rather than operational, clinical, or legal matters. Accordingly, the auditor's procedures focus
on areas that normally are subject to internal controls relevant to financial reporting. However, the further that potential illegal acts are removed from the
events and transactions ordinarily reflected in the financial statements, the
less likely the auditor is to become aware of the act, to recognize its possible
illegality, and to evaluate the effect on the financial statements. For example,
determining whether a service was medically necessary, obtained through a
legally appropriate referral, properly performed (including using only approved
devices, rendered in a quality manner), adequately supervised, accurately documented and classified, or rendered and billed by nonsanctioned individuals
typically is not within the auditor's professional expertise. As a result, an audit in accordance with generally accepted auditing standards (GAAS) is not
designed to detect such matters.
Further, an audit conducted in accordance with GAAS does not include rendering an opinion or any form of assurance on an entity's compliance with laws
and regulations.1
Nor does an audit under GAAS include providing any assurance on an entity's
billings or cost report. In fact, cost reports typically are not prepared and
submitted until after the financial statement audit has been completed.
Certain audit procedures, although not specifically designed to detect illegal
acts, may bring possible illegal acts to an auditor's attention. When a potentially illegal act is detected, the auditor's responsibilities are addressed in AU
1
Even when auditors undertake a special engagement designed to attest to compliance with
certain provisions of laws, regulations, contracts, and grants (for example, an audit in accordance
with OMB Circular A-133), the auditor's procedures do not extend to testing compliance with laws
and regulations related to Medicare and Medicaid fraud and abuse.
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sec. 317, Illegal Acts by Clients (AICPA, Professional Standards). Disclosure of
an illegal act to parties other than the client's senior management and its audit
committee or board of directors is not ordinarily part of the auditor's responsibility, and such disclosure would be precluded by the auditor's ethical or legal
obligation of confidentiality, unless the matter affects the auditor's opinion on
the financial statements.2 [Revised, June 2009, to reflect conforming changes
necessary due to the issuance of recent authoritative literature.]

2
Statement on Auditing Standards No. 54, Illegal Acts by Clients (AICPA, Professional Standards, AU sec. 317.23) discusses circumstances in which a duty to notify parties outside the client of
detected illegal acts may exist.
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Information Sources
Further information on matters addressed in this guide is available through
various publications and services listed in the table that follows. Many nongovernment and some government publications and services involve a charge
or membership requirement.
Fax services allow users to follow voice cues and request that selected documents be sent by fax machine. Some fax services require the user to call
from the handset of the fax machine; others allow the user to call from any
phone. Most fax services offer an index document, which lists titles and other
information describing available documents.
Recorded announcements allow users to listen to announcements about a variety of recent or scheduled actions or meetings.
All listed telephone numbers are voice lines, unless otherwise designated as
fax (f) or data (d) lines.
Information Sources

Organization

General
Information

Fax Services

Available
Publications

American
Association
of Homes
and Services
for the
Aging
(AAHSA)

AAHSA
Publications
Dept. 5119
Washington, DC
20061-5119
202.783.2242
www.AAHSA.org

Continuing Care
Retirement
Communities: An
Industry in Action

American
Hospital
Association

Order Department
P.O. Box 92683
Chicago, IL
60675-2683
800.AHA.2626

Fax-on-Demand
312.422.2020

Hospital Statistics
National Hospital
Panel Survey
Report

American
Medical
Association

Order Department
515 N. State Street
Chicago, IL
60610-4325
800.621.8335

Information-onRequest Fax
Line
800.621.8335

"Socioeconomic
Resources in
Medicine: Review
of the Literature"

Center for
Health Care
Industry
Performance
Studies

Order Department
1550 Old
Henderson Road
Suite S277
Columbus, OH
43220-3626
800.859.2447

Almanac of
Hospital Financial
and Operating
Indicators

(continued)
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Organization
Healthcare
Financial
Management
Association

General
Information

Available
Publications

Fax Services

Order
Department
2 Westbrook
Corporate Center
Suite 700
Westchester, IL
60154
800.252.4362

hfm magazine
Issue Analysis
98-1, Compliance
with Laws and
Regulations for
Healthcare
Organizations

Order
HealthLeaders- Department
InterStudy
One Vantage
Way
B-300
Nashville, TN
37228
800.643.7600

Fax-on-Demand
615.385.4979

Competitive Edge:
The HMO
Industry Report

Medical Group Order
Management
Department
Association
P.O. Box 17603
Denver, CO
80217-0603
877.275.6462

Fax-on-Demand
303.784.6110

Cost Survey
Practice
Management:
Academic Practice

Organization

General
Information

American
Institute of
Certified
Public
Accountants

Order
Department
220 Leigh
Farm Road
Durham, NC
27707-8110
888.777.7077
If outside of
the United
States, call
919.402.2317

Financial
Accounting
Standards
Board

Order
Department
401 Merritt 7
P.O. Box 5116
Norwalk, CT
06856-5116
203.847.0700,
ext. 10
800.748.0659
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Website
Address

Recorded
Announcements

24 Hour Fax
www.aicpa.org
Hotline
800.362.5066

www.fasb.org

Action Alert
Telephone
Line
203.847.0700,
ext. 444
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Organization
Governmental
Accounting
Standards
Board

General
Information
Order
Department
401 Merritt 7
P.O. Box 5116
Norwalk, CT
06856-5116
203.847.0700
ext. 10
800.748.0659

Fax
Services

Recorded
Announcements

Website
Address
www.gasb.org

Government
441 G Street,
Accountability NW
Office
Washington, DC
20548

www.gao.gov

Government
Printing
Office

732 N. Capitol
Street, NW
Washington, DC
20401-0001

www.gpo.gov
www.gpoaccess
.gov

Office of
Management
and Budget

725 17th Street,
NW
Washington, DC
20503
202.395.3080

www.omb.gov

Securities and
Exchange
Commission
(SEC)

100 F Street,
NE
Washington, DC
20549
Publications
Unit
202.551.4040
SEC Public
Reference
202.551.8090
Information
Line
202.942.8088,
ext. 4 TTY
202.551.6020

www.sec.gov
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References to AICPA Technical Practice Aids
The following nonauthoritative questions and answers, commonly referred to
as Technical Questions and Answers (TISs), have been prepared by the AICPA
staff and are included in Technical Practice Aids. The questions and answers
have not been approved, disapproved, or otherwise acted upon by the Financial
Reporting Executive Committee or any other senior technical committee of the
AICPA. They are not sources of established accounting principles1 nor are they
sources of authoritative generally accepted auditing standards. The AICPA
staff believes that the questions and answers listed subsequently may be useful
and relevant for users of this guide. In addition to the following questions and
answers, not-for-profit health care entities may find the questions and answers
listed in TIS section 6140, "Not-for-Profit Entities" (AICPA, Technical Practice
Aids), useful. Other questions and answers may also be useful and relevant to
users of this guide, depending on the facts and circumstances.
TIS Section

Title

5250.15

"Application of Certain FASB Interpretation No. 48 (codified
in FASB ASC 740-10) Disclosure Requirements to Nonpublic
Entities That Do Not Have Uncertain Tax Positions"

6140.23

"Changing Net Asset Classifications Reported in a Prior Year"

6400.04

"Hospital as Collecting Agent for Physicians [Amended]"

6400.12

"General Obligation Bonds Issued for Current Use by City
Owned Hospital [Amended]"

6400.17

"Elimination of Profit on Intercompany Sales"

6400.19

"Offsetting of Limited Use Assets"

6400.20

"Format of Combined or Consolidated Financial Statements"

6400.25

"Accounting for Transfer of Assets From Not-for-Profit to
For-Profit Entities"

6400.26

"Transfer of Assets From Subsidiary For-Profit Entity to
Not-for-Profit Stockholder Parent"

6400.29

"Timing of Recording Transfers Between Related Entities"

6400.30

"Accounting for Transactions Involving Medicaid Voluntary
Contribution or Taxation Programs [Amended]"

6400.33

"Accounting for a Joint Operating Agreement"

6400.34

"Accounting for Computer Systems Costs Incurred in
Connection With the Health Insurance Portability and
Accountability Act of 1996 (HIPAA)"
(continued)

1
See chapter 1, "Overview and Unique Considerations of Health Care Entities," of this guide
for additional information regarding the hierarchy of generally accounting principles for nongovernmental health care entities.
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TIS Section

Title

6400.35

"Note to Sections 6400.36–.42—Implementation of FASB
ASC 958—Classification of a Beneficiary's Interest in the Net
Assets of a Financially Interrelated Fund-Raising Foundation
(in the Beneficiary's Financial Statements)"

6400.36

"Application of FASB ASC 958—Classification of a
Beneficiary's Interest in the Net Assets of a Financially
Interrelated Fund-Raising Foundation (The beneficiary can
influence the operating and financial decisions of the
foundation to such an extent that the beneficiary can
determine the timing and amount of distributions from the
foundation.)"

6400.37

"Application of FASB ASC 958—Classification of a
Beneficiary's Interest in the Net Assets of a Financially
Interrelated Fund-Raising Foundation (The beneficiary
cannot influence the operating and financial decisions of the
foundation to such an extent that the beneficiary can
determine the timing and amount of distributions from the
foundation.)"

6400.38

"Application of FASB ASC 958—Classification of a
Beneficiary's Interest in the Net Assets of a Financially
Interrelated Fund-Raising Foundation—Does Common
Control Lead to the Conclusion That the Beneficiary Can
Determine the Timing and Amount of Distributions from the
Recipient?"

6400.39

"Application of FASB ASC 958—Classification of a
Beneficiary's Interest in the Net Assets of a Financially
Interrelated Fund-Raising Foundation (More Than One
Beneficiary—Some Contributions Are Designated)"

6400.40

"Application of FASB ASC 958—Classification of a
Beneficiary's Interest in the Net Assets of a Financially
Interrelated Fund-Raising Foundation (The beneficiary
makes an expenditure that meets a purpose restriction on net
assets held for its benefit by the recipient entity—The
beneficiary can influence the operating and financial
decisions of the recipient to such an extent that the
beneficiary can determine the timing and amount of
distributions from the recipient.)"

6400.41

"Application of FASB ASC 958—Classification of a
Beneficiary's Interest in the Net Assets of a Financially
Interrelated Fund-Raising Foundation (The beneficiary
makes an expenditure that is consistent with a purpose
restriction on net assets held for its benefit by the recipient
entity—The beneficiary cannot influence the operating and
financial decisions of the recipient to such an extent that the
beneficiary can determine the timing and amount of
distributions from the recipient.)"
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TIS Section

Title

6400.42

"Application of FASB ASC 958—Classification of a
Beneficiary's Interest in the Net Assets of a Financially
Interrelated Fund-Raising Foundation (Recipient
Entity)—Accounting for Unrealized Gains and Losses on
Investments Held by the Foundation"

6400.43

"Application of FASB ASC 958—Classification of
Distributions From a Financially Interrelated Fund-Raising
Foundation (Recipient Entity) to a Health Care Beneficiary"

6400.45

"Applicability of FASB ASC 460—Accounting and Disclosure
Requirements for Guarantees, Including Indirect Guarantees
of Indebtedness of Others"

6400.46

"Applicability of FASB ASC 460—Guarantor's Accounting
and Disclosure Requirements for Guarantees, Including
Indirect Guarantees of Indebtedness of Others—Mortgage
Guarantees"

8700.03

"Auditor's Responsibilities for Subsequent Events Relative to
a Conduit Debt Obligor"

9110.15

"Reporting on Medicaid/Medicare Cost Reports"
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Other Information, Supplementary
Information, and Required Supplementary
Information
In February 2010, the Auditing Standards Board issued Statement on Auditing
Standards (SAS) No. 118, Other Information in Documents Containing Audited
Financial Statements; No. 119, Supplementary Information in Relation to the
Financial Statements as a Whole; and No. 120, Required Supplementary Information (AICPA, Professional Standards, AU sec. 550, 551, 558). These standards collectively supersede AU section 550A, Other Information in Documents
Containing Audited Financial Statements; 551A, Reporting on Information Accompanying the Basic Financial Statements in Auditor-Submitted Documents;
and 558A, Required Supplementary Information (AICPA, Professional Standards), respectively, and are effective for audits of financial statements for
periods beginning on or after December 15, 2010, with early application permitted.
Collectively, these statements address the auditor's responsibilities with respect to information that is required by a designated standard setter (the Financial Accounting Standards Board, the Governmental Accounting Standards
Board [GASB], the Federal Accounting Standards Advisory Board, or the International Accounting Standards Board) to accompany an entity's basic financial
statements and supplementary and other information that is presented outside
the basic financial statements. Because the effective date for these standards
is for periods ending after the date of this guide, the information in the various
chapters in this guide is not updated for the requirements of these standards.
The purpose of this appendix is to provide information on the requirements of
SAS Nos. 118–120, as well as implementation guidance and examples.

SAS No. 118, Other Information in Documents Containing
Audited Financial Statements
SAS No. 118, which is effective for audits of financial statements for periods
beginning on or after December 15, 2010, addresses the auditor's responsibility
in relation to other information (OI) in documents containing audited financial
statements and the auditor's report thereon. In the absence of any separate
requirement in the particular circumstances of the engagement, the auditor's
opinion on the financial statements does not cover OI, and the auditor has
no responsibility for determining whether such information is properly stated.
The objective of the auditor with respect to OI is to respond appropriately
when the auditor becomes aware that documents containing audited financial
statements and the auditor's report thereon include OI that could undermine
the credibility of those financial statements and the auditor's report.
SAS No. 118 defines OI as financial and nonfinancial information, other than
the financial statements and auditor's report thereon, that is included in a
document containing audited financial statements and the auditor's report
thereon, excluding required supplementary information (RSI). In the context
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of this guide, OI includes information included with municipal securities filings
(see chapter 7, "Municipal Bond Financing," of this guide).
Although OI is not a part of the basic financial statements nor required as
supplementary information (SI) by a designated standard setter, auditors are
required to perform certain procedures on unaudited OI.1 The auditor should
apply the following limited procedures to the OI, as required by paragraphs
.06–.17 of SAS No. 118:

r
r
r
r

Read the OI of which the auditor is aware in order to identify
material inconsistencies, if any, with the audited financial statements.
Make appropriate arrangements with management or those
charged with governance to obtain the OI prior to the report release date. If it is not possible to obtain all of the OI prior to the
report release date, the auditor should read such OI as soon as
practicable.
Communicate with those charged with governance the auditor's
responsibility with respect to the OI, any procedures performed
relating to the OI, and the results.
If, on reading the OI, the auditor identifies a material inconsistency, the auditor should determine whether the audited financial statements or OI needs to be revised and should consider the
following:
—

If a material inconsistency that requires revision of the
audited financial statements is identified by the auditor
prior to the report release date, and management refuses
to make the revision, the auditor should modify the auditor's opinion, in accordance with AU section 508, Reports
on Audited Financial Statements (AICPA, Professional
Standards).

—

When a material inconsistency that requires revision of
the OI is identified by the auditor prior to the report
release date, and management refuses to make the revision, the auditor should communicate with those charged
with governance and (a) include an explanatory paragraph in the auditor's report describing the material inconsistency, in accordance with paragraph .11 of AU section 508; (b) withhold the auditor's report; or (c) withdraw
from the engagement if withdrawal is possible under applicable law or regulation.2

1
Unaudited other information (OI) is financial and nonfinancial information (other than the
financial statements and auditor's report thereon) that is included in a document containing audited
financial statements and the auditor's report thereon, excluding required supplementary information
(RSI) on which the auditor is not engaged to express an opinion whether it is fairly presented in
conformity with generally accepted accounting principles (GAAP). Unless the auditor is engaged
to audit the OI, this guide refers to the information as unaudited, even though generally accepted
auditing standards (GAAS) require the auditor to perform specific procedures.
2
In audits of governmental entities, withdrawal from the engagement or withholding the auditor's report may not be options (see paragraph .A8 of AU section 550, Other Information in Documents
Containing Audited Financial Statements [AICPA, Professional Standards]). In such cases, the auditor may issue a report to those charged with governance and the appropriate statutory body, if
applicable, giving details of the inconsistency.
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— If a material inconsistency that requires revision of the
audited financial statements is identified by the auditor
subsequent to the report release date, the auditor should
apply the relevant requirements in AU section 561, Subsequent Discovery of Facts Existing at the Date of the
Auditor's Report (AICPA, Professional Standards).
— When a material inconsistency that requires revision of
the OI is identified by the auditor subsequent to the report release date, and management agrees to make the
revision to the OI, the auditor should carry out the procedures necessary under the circumstances.

r

— When a material inconsistency that requires revision of
the OI is identified by the auditor subsequent to the report release date, and management refuses to make the
revision to the OI, the auditor should notify those charged
with governance of the auditor's concerns regarding the
OI and take any further appropriate action.
If, on reading the OI for the purpose of identifying material inconsistencies, the auditor becomes aware of an apparent material
misstatement of fact, the auditor should discuss the matter with
management. After such discussions, if the auditor still believes
that an apparent material misstatement of fact exists, the auditor
should request management consult with a qualified third party,
such as legal counsel; consider the advice received by the entity
in determining whether such matter is a material misstatement
of fact; and consider the following:
— When the auditor concludes that the OI contains a material misstatement of fact that management refuses to
correct, the auditor should notify those charged with governance of the auditor's concerns regarding the OI and
take any further appropriate action (for example, obtaining advice from the auditor's legal counsel, withholding
the auditor's report if not yet released, or withdrawing
from the engagement).

SAS No. 119, Supplementary Information in Relation to
the Financial Statements as a Whole
SAS No. 119, which is effective for audits of financial statements for periods
beginning on or after December 15, 2010, addresses the auditor's responsibility when engaged to report on whether supplementary information (SI) is
fairly stated, in all material respects, in relation to the financial statements
as a whole. Paragraph .04 of SAS No. 119 defines SI as information presented
outside the basic financial statements, excluding RSI, that is not considered
necessary for the financial statements to be fairly presented in accordance with
the applicable financial reporting framework. SI may be presented in a document containing the audited financial statements or separate from the financial
statements. For purposes of this appendix, the auditor's responsibilities related
to SI that is presented in a document containing the audited financial statements will be discussed. Information related to the auditor's responsibilities
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for SI that is presented separate from the financial statements is discussed in
paragraphs .10 and .A16 of SAS No. 119.
In order to opine on whether SI is fairly stated, in all material respects, in
relation to the financial statements as a whole, the auditor should determine
that all of the following conditions are met, as required by paragraph .05 of
SAS No. 119:

r
r
r
r
r

The SI was derived from, and relates directly to, the underlying
accounting and other records used to prepare the financial statements.
The SI relates to the same period as the financial statements.
The financial statements were audited, and the auditor served as
the principal auditor in that engagement.
Neither an adverse opinion nor a disclaimer of opinion was issued
on the financial statements.
The SI will accompany the entity's audited financial statements, or such audited financial statements will be made readily
available3 by the entity.

The auditor's responsibilities with regard to unaudited SI4 are provided in SAS
No. 119. The auditor should apply the following limited procedures to the SI,
as required by paragraphs .06–.07 of SAS No. 119:

r

Obtain the agreement of management that it acknowledges and
understands its responsibility
—

for the preparation of the SI in accordance with the applicable criteria;

—

to provide the auditor with written representations

r
r
r
r

that it acknowledges its responsibility for the
presentation of the SI in accordance with the applicable criteria;
that it believes the SI, including its form and
content, is fairly presented in accordance with
the applicable criteria;
that the methods of measurement or presentation have not changed from those used in the
prior period or, if the methods of measurement or
presentation have changed, the reasons for such
changes;
about any significant assumptions or interpretations underlying the measurement or presentation of the SI; and

3
Audited financial statements are deemed to be readily available if a third-party user can
obtain the audited financial statements without any further action by the entity, such as posted on
the entity's website but not being available upon request.
4
Unaudited supplementary information (SI) is information that accompanies the basic financial
statements on which the auditor is not engaged to express an opinion whether it is fairly presented,
in all material respects, in conformity with GAAP. Unless the auditor is engaged to audit the SI, this
appendix refers to the information as unaudited, even though GAAS requires the auditor to perform
specific procedures.
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that when the SI is not presented with the
audited financial statements, management will
make the audited financial statements readily
available to the intended users of the SI no later
than the date of issuance by the entity of the SI
and the auditor's report thereon;

— to include in any document containing the SI the auditor's
report on the SI that indicates the auditor reported on
such SI; and

r

— to present the SI with the audited financial statements
or, if the SI will not be presented with the audited financial statements, to make the audited financial statements
readily available to the intended users of the SI no later
than the date of issuance by the entity of the SI and the
auditor's report thereon.
In addition to the procedures performed during the audit of the
financial statements, in order to opine on whether the SI is fairly
stated, in all material respects, in relation to the financial statements as a whole, the auditor should perform the following procedures, using the same materiality level used in the audit of the
financial statements:5
— Inquire of management about the purpose of the SI and
the criteria used by management to prepare the SI, such
as an applicable financial reporting framework, criteria
established by a regulator, a contractual agreement, or
other requirements.
— Determine whether the form and content of the SI complies with the applicable criteria.
— Compare and reconcile the SI to the underlying accounting and other records used in preparing the financial
statements or to the financial statements themselves.
— Obtain an understanding about the methods of preparing
the SI, and determine whether the methods of preparing
the SI have changed from those used in the prior period
and, if the methods have changed, the reasons for such
changes.
— Inquire of management about any significant assumptions or interpretations underlying the measurement or
presentation of the SI.
— Evaluate the appropriateness and completeness of the
SI, considering the results of the performed procedures
and other knowledge obtained during the audit of the
financial statements.

5
If the auditor's report on the financial statements of a governmental entity includes multiple
opinions, and materiality is considered by the auditor for each opinion unit, the auditor's opinion on
the SI is in relation to the financial statements as a whole and considered at a level that represents
the entire entity, as discussed in paragraph .A15 of AU section 551, Other Information in Relation to
the Financial Statements as a Whole (AICPA, Professional Standards).
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Obtain the previously-noted representations from management.

The date of the auditor's report on SI in relation to the financial statements
as a whole should not be dated earlier than the date on which the auditor
completed the procedures required in paragraph .07 of SAS No. 119. When
reporting on SI that is presented with the entity's financial statements, the
auditor should report on SI in either (a) an explanatory paragraph following
the opinion paragraph in the auditor's report on the financial statements or
(b) a separate report on SI. The contents of the explanatory paragraph are
discussed in paragraph .09 of SAS No. 120 and are as follows.

r

r

r

A statement that the
—

audit was conducted for the purpose of forming opinions
on the financial statements that collectively comprise the
government's basic financial statements

—

SI is presented for purposes of additional analysis and is
not a required part of the basic financial statements

—

SI is the responsibility of management and was derived
from, and relates directly to, the underlying accounting
and other records used to prepare the basic financial
statements

—

SI has been subjected to the auditing procedures applied
in the audit of the basic financial statements and certain additional procedures, including comparing and reconciling such information directly to the underlying accounting and other records used to prepare the financial
statements or to the financial statements themselves, in
accordance with GAAS

If the auditor issues an unqualified opinion on the basic financial
statements, and the auditor has concluded that the SI is fairly
stated, in all material respects, in relation to the basic financial
statements as a whole, a statement that in the auditor's opinion,
the SI is fairly stated, in all material respects, in relation to the
basic financial statements as a whole
If the auditor issues a qualified opinion on the basic financial
statements, and the qualification has an effect on the SI, a statement that in the auditor's opinion, except for the effects on the
SI of [refer to the paragraph in the auditor's report explaining the
qualification], such information is fairly stated, in all material
respects, in relation to the basic financial statements as a whole

When the auditor's report on the audited basic financial statements contains
an adverse opinion or a disclaimer of opinion, and the auditor has been engaged
to report on whether SI is fairly stated, in all material respects, in relation to
such financial statements as a whole, the auditor is precluded from expressing an opinion on the SI. When permitted by law or regulation, the auditor
may withdraw from the engagement to report on the SI. If the auditor does
not withdraw, the auditor's report on the SI should state that because of the
significance of the matter disclosed in the auditor's report, it is inappropriate
to, and the auditor does not, express an opinion on the SI.
If the auditor concludes, on the basis of the performed procedures, that the
SI is materially misstated in relation to the basic financial statements as a
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whole, the auditor should discuss the matter with management and propose
appropriate revisions of the SI. If management does not revise the SI, the
auditor should either

r
r

modify the auditor's opinion on the SI and describe the misstatement in the auditor's report or
withhold the auditor's report on the SI in the case of issuing a
separate report on the SI.

The auditor has no responsibility for the consideration of subsequent events
with respect to the SI. However, if information comes to the auditor's attention prior to the release of the auditor's report on the financial statements
regarding subsequent events that affect the financial statements, the auditor
should apply the relevant requirements of AU section 560, Subsequent Events
(AICPA, Professional Standards). In the event that information comes to the
auditor's attention subsequent to the release of the auditor's report on the financial statements regarding facts that may have existed at that date, which
might have affected the report had the auditor been aware of such facts, the
relevant requirements of AU section 561 should be applied.

SAS No. 120, Required Supplementary Information
SAS No. 120, which is effective for audits of financial statements for periods
beginning on or after December 15, 2010, addresses the auditor's responsibility with respect to information that a designated accounting standard setter
requires to accompany an entity's basic financial statements (RSI). In the context of this guide, the designated accounting standard setter is GASB, and
the most commonly required RSI applicable to governmental health care entities consists of management's discussion and analysis (MD&A) and certain
information related to employer-sponsored benefit plans. In the absence of any
separate requirement in the particular circumstances of the engagement, the
auditor's opinion on the basic financial statements does not cover RSI.
When GAAP designates information as RSI, the designated accounting standard setter considers the information to be an essential part of financial reporting for placing the basic financial statements in an appropriate operational,
economic, or historical context. Therefore, the omission of RSI or presentation
of RSI in a manner that does not meet the prescribed guidelines does not affect
the auditor's conclusion regarding the fair presentation of the basic financial
statements. In the prescribed guidelines for RSI, GAAP often requires notes
to RSI and specifies the placement of RSI in relation to the basic financial
statements. Those note and placement requirements are part of the prescribed
guidelines. RSI is normally presented separately from SI and OI, which are
discussed earlier in this appendix. The auditor should consider whether RSI
is sufficiently segregated from SI and OI. Except in specific situations, professional standards do not address whether RSI should be labeled as unaudited;
thus, it may or may not be so labeled.
Only the information that a designated standard setter (for example, GASB
in the context of governmental health care entities) requires to accompany an
entity's basic financial statements can be considered RSI. All other information
is considered SI or OI, even though law, regulation, or resource contributors
may require that such information accompany the basic financial statements.
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Although RSI is not a part of the basic financial statements, auditors are
required to perform certain procedures on unaudited RSI.6 If the auditor is not
engaged to audit RSI, the auditor should apply the following limited procedures
to RSI, as required by paragraph .05 of SAS No. 120:

r

r
r

Inquire of management about the methods of preparing the information, including whether (a) it is measured and presented in
accordance with prescribed guidelines, (b) methods of measurement or presentation have been changed from those used in the
prior period and the reasons for any such changes, and (c) there
were any significant assumptions or interpretations underlying
the measurement or presentation of the information.
Compare the information for consistency with (a) management's
responses to the foregoing inquiries, (b) the basic financial statements, and (c) other knowledge obtained during the audit of the
basic financial statements.
Obtain written representations from management (a) that it acknowledges its responsibility for RSI; (b) about whether RSI is
measured and presented in accordance with prescribed guidelines; (c) about whether the methods of measurement or presentation have changed from those used in the prior period and, if
so, the reasons for such changes; and (d) about any significant
assumptions or interpretations underlying the measurement or
presentation of RSI. See AU section 333, Management Representations (AICPA, Professional Standards), for additional requirements and guidance.

If the auditor is unable to complete these procedures, the auditor should consider whether management contributed to the auditor's inability to complete
the procedures. If the auditor concludes that the inability to complete the procedures is due to significant difficulties encountered in dealing with management,
the auditor should inform those charged with governance.
Paragraph .07 of SAS No. 120 states that the auditor should include an explanatory paragraph after the opinion paragraph in the auditor's report on the
financial statements to refer to RSI. The explanatory paragraph should include
language to explain the following circumstances, as applicable:

r
r
r
r
r

RSI is included, and the auditor has applied certain limited procedures (that is, the procedures are specifically delineated in the
explanatory paragraph and are those required by paragraph .05
of SAS No. 120).
RSI is omitted.
Some RSI is missing, and some is presented in accordance with
the prescribed guidelines.
The auditor has identified material departures from the prescribed guidelines.
The auditor is unable to complete the prescribed procedures.

6
Unaudited RSI is information that accompanies the basic financial statements on which the
auditor is not engaged to express an opinion whether it is fairly presented in conformity with GAAP.
Unless the auditor is engaged to audit RSI, this appendix refers to the information as unaudited,
even though GAAS requires the auditor to perform specific procedures.
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The auditor has unresolved doubts about whether RSI is presented in accordance with prescribed guidelines.

Paragraph .08 of SAS No. 120 discusses the auditor's reporting responsibilities when all or some RSI is presented. In such circumstances, the auditor
should include the following additional elements in the auditor's explanatory
paragraph, as applicable:

r
r
r

A statement that GAAP requires RSI to be presented to supplement the basic financial statements.
A statement that such information, although not a part of the
basic financial statements, is required by [designated standard
setter], who considers it to be an essential part of financial reporting for placing the basic financial statements in an appropriate
operational, economic, or historical context.
If the auditor is able to complete the procedures required in paragraph .05 of SAS No. 120, a statement that the auditor
— has applied certain limited procedures to RSI, in accordance with GAAS, which consisted of inquiries of management about the methods of preparing the information and comparing the information for consistency with
management's responses to the auditor's inquiries, the
basic financial statements, and other knowledge that the
auditor obtained during the audit of the basic financial
statements.

r

— does not express an opinion or provide any assurance on
the information because the limited procedures do not
provide him or her with sufficient evidence to express an
opinion or provide any assurance.
If the auditor is unable to complete the procedures required by
paragraph .05 of SAS No. 120 a statement that the auditor
— was unable to apply certain limited procedures to RSI, in
accordance with GAAS, and the reasons.

r

— does not express an opinion or provide any assurance on
the information.
If some RSI is omitted, a statement that
— management has omitted the [describe the missing RSI],
which is required by GAAP to be presented to supplement
the basic financial statements.
— such missing information, although not a part of the basic
financial statements, is required by [designated standard
setter], who considers it to be an essential part of financial
reporting for placing the basic financial statements in an
appropriate operational, economic, or historical context.

r

— the auditor's opinion on the basic financial statements is
not affected by the missing information.
If the measurement or presentation of RSI materially departs
from the prescribed guidelines, a statement that although the
auditor's opinion on the basic financial statements is not affected,
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r

material departures from prescribed guidelines exist. Describe
the material departures from GAAP.
If the auditor has unresolved doubts about whether RSI is measured or presented in accordance with prescribed guidelines, a
statement that although the auditor's opinion on the basic financial statements is not affected, the results of the limited procedures have raised doubts about whether material modifications
should be made to RSI for it to be presented in accordance with
guidelines established by GASB.

Paragraph .09 of SAS No. 120 discusses the auditor's reporting responsibilities
when RSI is omitted. In such circumstances, the auditor should include the
following additional statements in the auditor's explanatory paragraph:

r
r
r

Management has omitted the [describe the missing RSI], which
GAAP requires to be presented to supplement the basic financial
statements.
Such missing information, although not a part of the basic financial statements, is required by [designated standard setter], who
considers it to be an essential part of financial reporting for placing the basic financial statements in an appropriate operational,
economic, or historical context.
The auditor's opinion on the basic financial statements is not affected by the missing information.

The exhibit of SAS No. 120 provides the following examples for explanatory
paragraphs for various scenarios related to RSI:
The Required Supplementary Information Is Included, the Auditor Has Applied the Specified Procedures, and No Material
Departures From Prescribed Guidelines Have Been Identified
[Identify the applicable financial reporting framework (for example,
accounting principles generally accepted in the United States of America)] require that the [identify the required supplementary information] on page XX be presented to supplement the basic financial statements. Such information, although not a part of the basic financial
statements, is required by [identify designated accounting standard
setter] who considers it to be an essential part of financial reporting
for placing the basic financial statements in an appropriate operational, economic, or historical context. We have applied certain limited
procedures to the required supplementary information in accordance
with auditing standards generally accepted in the United States of
America, which consisted of inquiries of management about the methods of preparing the information and comparing the information for
consistency with management's responses to our inquiries, the basic
financial statements, and other knowledge we obtained during our audit of the basic financial statements. We do not express an opinion or
provide any assurance on the information because the limited procedures do not provide us with sufficient evidence to express an opinion
or provide any assurance.
All Required Supplementary Information Omitted
Management has omitted [describe the missing required supplementary information] that [identify the applicable financial reporting
framework (for example, accounting principles generally accepted in
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the United States of America)] require to be presented to supplement
the basic financial statements. Such missing information, although not
a part of the basic financial statements, is required by [identify designated accounting standard setter] who considers it to be an essential
part of financial reporting for placing the basic financial statements in
an appropriate operational, economic, or historical context. Our opinion on the basic financial statements is not affected by this missing
information.
Some Required Supplementary Information Is Omitted and
Some Is Presented in Accordance With the Prescribed Guidelines
[Identify the applicable financial reporting framework (for example, accounting principles generally accepted in the United States of America)]
require that [identify the included required supplementary information] be presented to supplement the basic financial statements. Such
information, although not a part of the basic financial statements, is
required by [identify designated accounting standard setter] who considers it to be an essential part of financial reporting for placing the
basic financial statements in an appropriate operational, economic,
or historical context. We have applied certain limited procedures to
the required supplementary information in accordance with auditing
standards generally accepted in the United States of America, which
consisted of inquiries of management about the methods of preparing
the information and comparing the information for consistency with
management's responses to our inquiries, the basic financial statements, and other knowledge we obtained during our audit of the basic
financial statements. We do not express an opinion or provide any
assurance on the information because the limited procedures do not
provide us with evidence sufficient to express an opinion or provide
any assurance.
Management has omitted [describe the missing required supplementary information] that [identify the applicable financial reporting
framework] require to be presented to supplement the basic financial
statements. Such missing information, although not a part of the basic financial statements, is required by [identify designated accounting
standard setter] who considers it to be an essential part of financial
reporting for placing the basic financial statements in an appropriate
operational, economic, or historical context. Our opinion on the basic
financial statements is not affected by this missing information.
Material Departures From Prescribed Guidelines Identified
[Identify the applicable financial reporting framework (for example,
accounting principles generally accepted in the United States of America)] require that the [identify the required supplementary information] on page XX be presented to supplement the basic financial statements. Such information, although not a part of the basic financial
statements, is required by [identify designated accounting standard
setter] who considers it to be an essential part of financial reporting
for placing the basic financial statements in an appropriate operational, economic, or historical context. We have applied certain limited
procedures to the required supplementary information in accordance
with auditing standards generally accepted in the United States of
America, which consisted of inquiries of management about the meth-
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ods of preparing the information and comparing the information for
consistency with management's responses to our inquiries, the basic
financial statements, and other knowledge we obtained during our
audit of the basic financial statements. Although our opinion on the
basic financial statements is not affected, the following material departures from the prescribed guidelines exist [identify the required
supplementary information and describe the material departures from
the prescribed guidelines]. We do not express an opinion or provide
any assurance on the information.
Specified Procedures Not Completed
[Identify the applicable financial reporting framework (for example, accounting principles generally accepted in the United States of America)]
require that the [identify the required supplementary information] on
page XX be presented to supplement the basic financial statements.
Such information, although not a part of the basic financial statements, is required by [identify designated accounting standard setter]
who considers it to be an essential part of financial reporting for placing the basic financial statements in an appropriate operational, economic, or historical context. We were unable to apply certain limited
procedures to the required supplementary information in accordance
with auditing standards generally accepted in the United States of
America because [state the reasons]. We do not express an opinion or
provide any assurance on the information.
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Illustrative Auditor’s Reports
Example E-1
Unqualified Opinion on Comparative Basic Financial Statements of a
Governmental Hospital (Special-Purpose Government) That Has a
Single Opinion Unit and for Which the Auditor Has Not Been
Engaged to Examine and Express an Opinion on RSI
Independent Auditor's Report
To the Board of Trustees
Sample Governmental Hospital Authority
We have audited the accompanying statements of net assets of the Sample
Governmental Hospital Authority (the Authority)[, a component unit of Feeling
County, State of Union,]7 as of December 31, 20X1 and 20X0, and the related
statements of revenues, expenses, and changes in net assets and statements
of cash flows for the years then ended. These financial statements are the
responsibility of the Authority's management. Our responsibility is to express
an opinion on these financial statements based on our audits.8
We conducted our audits9 in accordance with auditing standards generally
accepted in the United States of America. Those standards require that we
plan and perform the audit to obtain reasonable assurance about whether
the financial statements are free of material misstatement. An audit includes
examining, on a test basis, evidence supporting the amounts and disclosures
in the financial statements. An audit also includes assessing the accounting
principles used and significant estimates made by management, as well as
evaluating the overall financial statement presentation. We believe that our
audits10 provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all
material respects, the financial position of the Authority as of December 31,
20X1 and 20X0, and the changes in its financial position and its cash flows
for the years then ended in conformity with accounting principles generally
accepted in the United States of America.
Those accounting principles require that the management's discussion and
analysis on pages XX through XX be presented to supplement the basic financial statements. Such information, although not a part of the basic financial
statements, is required by the Governmental Accounting Standards Board, who
considers it to be an essential part of financial reporting for placing the basic
financial statements in an appropriate operational, economic, or historical context. We have applied certain limited procedures to the required supplementary
information in accordance with auditing standards generally accepted in the
United States of America, which consisted of inquiries of management about
the methods of preparing the information and comparing the information for
consistency with management's responses to our inquiries, the basic financial
7
If the entity being reported on is a component unit of a larger financial reporting entity, the
auditor's report should disclose that fact, as discussed in the paragraph 14.45 of the Audit and
Accounting Guide State and Local Governments.
8
Because the report is covering audits for two years, the reference is to audits, rather than
audit.
9
See footnote 8.
10
See footnote 8.
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statements, and other knowledge we obtained during our audit of the basic financial statements. We do not express an opinion or provide any assurance on
the information because the limited procedures do not provide us with sufficient
evidence to express an opinion or provide any assurance.
[Signature]
[Date]
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Example E-2
Unqualified Opinions on Single-Year Basic Financial Statements of a
Governmental Hospital That Has One Opinion Unit for the Primary
Government and Another Opinion Unit for Its Discretely-Presented
Component Unit and for Which the Auditor Has Not Been Engaged to
Examine and Express an Opinion on RSI
Independent Auditor's Report
To the Board of Trustees
University Hospital
We have audited the accompanying statements of net assets and the related
statements of revenues, expenses and changes in net assets and statements
of cash flows11 of the University Hospital [, a component unit of University,
Any City and Any State,]12 and of its discretely presented component unit as
of and for the year ended December 31, 20XY, which collectively comprise
the Hospital's basic financial statements. These financial statements are the
responsibility of the Hospital's management. Our responsibility is to express
opinions13 on these financial statements based on our audit.14
[Same second paragraph as in Example E-1]
In our opinion, the financial statements referred to above present fairly, in all
material respects, the respective financial position of the University Hospital
and of its discretely presented component unit as of December 31, 20XY, and
the respective changes in financial position and cash flows thereof for the year
then ended in conformity with accounting principles generally accepted in the
United States of America.
[Same disclaimer on MD&A as in Example E-1]
[Signature]
[Date]

11
Presentation of a statement of cash flows for the discretely-presented component unit is not
required.
12
See footnote 7.
13
Because two opinion units exist, the auditor is rendering two opinions (one on the Hospital
and one on the discretely-presented component unit), and the report should refer to opinions, rather
than opinion.
14
The opinion on a set of single-year statements refers to one audit. Even though the auditor
may be expressing multiple opinions, the auditor is conducting only one audit of the opinion units.
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The following terms can be found in the Financial Accounting Standards Board
(FASB) Accounting Standards Codification (ASC) glossary:
acquiree. The business or businesses that the acquirer obtains control of in
a business combination. This term also includes a nonprofit activity or
business that a not-for-profit acquirer obtains control of in an acquisition
by a not-for-profit entity.
acquirer. The entity that obtains control of the acquiree. However, in a business combination in which a variable interest entity is acquired, the primary beneficiary of that entity always is the acquirer.
acquisition by a not-for-profit entity. A transaction or other event in which
a not-for-profit acquirer obtains control of one or more nonprofit activities
or businesses and initially recognizes their assets and liabilities in the
acquirer's financial statements. When applicable guidance in FASB ASC
805, Business Combinations, is applied by a not-for-profit entity (NFP), the
term business combination has the same meaning as this term has for an
NFP. Likewise, a reference to business combinations in guidance that links
to FASB ASC 805 has the same meaning as a reference to acquisitions by
NFPs.
acquisition date. The date on which the acquirer obtains control of the acquiree.
advance refunding. A transaction involving the issuance of new debt to replace existing debt with the proceeds from the new debt placed in trust
or otherwise restricted to retire the existing debt at a determinable future
date or dates.
affiliate. A party that, directly or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with an entity.
agent. An entity that acts for and on behalf of another. Although the term
agency has a legal definition, the term is used broadly to encompass not
only legal agency, but also the relationships described in FASB ASC 958,
Not-for-Profit Entities. A recipient entity acts as an agent for and on behalf
of a donor if it receives assets from the donor and agrees to use those
assets on behalf of or transfer those assets, the return on investment of
those assets, or both to a specified beneficiary. A recipient entity acts
as an agent for and on behalf of a beneficiary if it agrees to solicit assets
from potential donors specifically for the beneficiary's use and to distribute
those assets to the beneficiary. A recipient entity also acts as an agent if
a beneficiary can compel the recipient entity to make distributions to it or
on its behalf.
business. An integrated set of activities and assets that is capable of being
conducted and managed for the purpose of providing a return in the form
of dividends, lower costs, or other economic benefits directly to investors
or other owners, members, or participants. Additional guidance on what a
business consists of is presented in paragraphs 4–9 of FASB ASC 805-1055.
business combination. A transaction or other event in which an acquirer
obtains control of one or more businesses. Transactions sometimes referred
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to as true mergers or mergers of equals also are business combinations.
See also [business and] acquisition by a not-for-profit entity.
capitation fee. A fixed amount per individual that is paid periodically (usually monthly) to a provider as compensation for providing comprehensive
health care services for the period. The fee is set by contract between
a prepaid health care plan and the provider. These contracts are generally with medical groups, independent practice associations, hospitals, and
other similar providers. Capitation fees may be determined actuarially or
negotiated based on expected costs to be incurred.
cash flow hedge. A hedge of the exposure to variability in the cash flows
of a recognized asset or liability, or of a forecasted transaction, that is
attributable to a particular risk.
charity care. Charity care represents health care services that are provided
but are never expected to result in cash flows. Charity care is provided
to a patient with demonstrated inability to pay. Each entity establishes
its own criteria for charity care consistent with its mission statement and
financial ability.
claim adjustment expenses. Expenses incurred in the course of investigating
and settling claims [(further industry-specific information is provided in
the following list of terms)].
collaborative arrangement. A contractual arrangement that involves a joint
operating activity (see FASB ASC 808-10-15-7). These arrangements involve two (or more) parties that meet both of the following requirements:
a. They are active participants in the activity (see paragraphs 8–9 of
FASB ASC 808-10-15).
b. They are exposed to significant risks and rewards dependent on the
commercial success of the activity (see paragraphs 10–13 of FASB
ASC 808-10-15).
compensation. Reciprocal transfers of cash or other assets in exchange for
services performed.
conditional promise to give. A promise to give that depends on the occurrence of a specified future and uncertain event to bind the promisor.
conduit debt securities. Certain limited-obligation revenue bonds, certificates of participation, or similar debt instruments issued by a state or
local governmental entity for the express purpose of providing financing
for a specific third party (the conduit bond obligor) that is not a part of the
state or local government's financial reporting entity. Although conduit
debt securities bear the name of the governmental entity that issues them,
the governmental entity often has no obligation for such debt beyond the
resources provided by a lease or loan agreement with the third party on
whose behalf the securities are issued. Further, the conduit bond obligor
is responsible for any future financial reporting requirements.
contribution. An unconditional transfer of cash or other assets to an entity or
a settlement or cancellation of its liabilities in a voluntary nonreciprocal
transfer by another entity acting other than as an owner. Those characteristics distinguish contributions from exchange transactions, which
are reciprocal transfers in which each party receives and sacrifices approximately equal value; from investments by owners and distributions to
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owners, which are nonreciprocal transfers between an entity and its owners; and from other nonreciprocal transfers, such as impositions of taxes
or legal judgments, fines, and thefts, which are not voluntary transfers.
In a contribution transaction, the value, if any, returned to the resource
provider is incidental to potential public benefits. In an exchange transaction, the potential public benefits are secondary to the potential proprietary
benefits to the resource provider. The term contribution revenue is used to
apply to transactions that are part of the entity's ongoing major or central
activities (revenues), or are peripheral or incidental to the entity (gains).
See also inherent contribution.
control. The direct or indirect ability to determine the direction of management and policies through ownership, contract, or otherwise.
diagnosis-related group. A patient classification scheme that categorizes
patients who are related medically with respect to primary and secondary
diagnosis, age, or complications [(further industry-specific information is
provided in the following list of terms)].
donor-imposed condition. A donor stipulation that specifies a future and
uncertain event whose occurrence or failure to occur gives the promisor
a right of return of the assets it has transferred or releases the promisor
from its obligation to transfer its assets.
donor-imposed restriction. A donor stipulation that specifies a use for a
contributed asset that is more specific than broad limits resulting from the
following:
a. The nature of the not-for-profit entity (NFP)
b. The environment in which it operates
c. The purposes specified in its articles of incorporation or bylaws or
comparable documents for an unincorporated association.
A donor-imposed restriction on an NFP's use of the asset contributed may
be temporary or permanent. Some donor-imposed restrictions impose limits that are permanent, for example, stipulating that resources be invested
in perpetuity (not used up). Others are temporary, for example, stipulating that resources may be used only after a specified date, for particular
programs or services, or to acquire buildings and equipment.
economic interest. A not-for-profit entity's (NFP's) interest in another entity
that exists if any of the following criteria are met:
a. The other entity holds or utilizes significant resources that must be
used for the unrestricted or restricted purposes of the NFP, either
directly or indirectly by producing income or providing services.
b. The NFP is responsible for the liabilities of the other entity.
See FASB ASC 958-810-55-6 for examples of economic interests.
endowment fund. An established fund of cash, securities, or other assets used
to provide income for the maintenance of a not-for-profit entity (NFP). The
use of the assets of the fund may be permanently restricted, temporarily
restricted, or unrestricted. Endowment funds generally are established by
donor-restricted gifts and bequests to provide either of the following:
a. A permanent endowment, which is to provide a permanent source
of income
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b. A term endowment, which is to provide income for a specific period.
Alternatively, an NFP's governing board may earmark a portion of its
unrestricted net assets as a board-designated endowment fund.
equity transfer. An equity transfer is nonreciprocal. An equity transfer is a
transaction directly between a transferor and a transferee. Equity transfers are similar to ownership transactions between a for-profit parent and
its owned subsidiary (for example, additional paid-in capital or dividends).
However, equity transfers can occur only between related not-for-profit entities if one controls the other or both are under common control. An equity
transfer embodies no expectation of repayment, nor does the transferor
receive anything of immediate economic value (such as a financial interest
or ownership).
financially interrelated entities. A recipient entity and a specified beneficiary are financially interrelated entities if the relationship between them
has both of the following characteristics:
a. One of the entities has the ability to influence the operating and
financial decisions of the other.
b. One of the entities has an ongoing economic interest in the net
assets of the other.
functional classification. A method of grouping expenses according to the
purpose for which costs are incurred. The primary functional classifications
are program services and supporting activities.
fundraising activities. Activities undertaken to induce potential donors to
contribute money, securities, services, materials, facilities, other assets, or
time.
health maintenance organization (HMO). A generic group of medical care
entities organized to provide defined health care services to members in
return for fixed, periodic premiums (usually paid monthly) that are paid
in advance.
incurred but not reported claims. Claims relating to insured events that
have incurred but have not yet been reported to the insurer or reinsurer
as of the date of the financial statements [(further industry-specific information is provided in the following list of terms)].
inherent contribution. A contribution that results if an entity voluntarily
transfers assets (or net assets) or performs services for another entity in
exchange for either no assets or for assets of substantially lower value and
unstated rights or privileges of a commensurate value are not involved.
in-substance defeasance. Placement by the debtor of amounts equal to the
principal, interest, and prepayment penalties related to a debt instrument
in an irrevocable trust established for the benefit of the creditor [(further
industry-specific information is provided in the following list of terms)].
intermediary. Although in general usage the term intermediary encompasses
a broad range of situations in which an entity acts between two or more
other parties, in this usage, it refers to situations in which a recipient
entity acts as a facilitator for the transfer of assets between a potential
donor and a potential beneficiary (donee) but is neither an agent or trustee
nor a donee and donor.
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legal entity. Any legal structure used to conduct activities or to hold assets.
Some examples of such structures are corporations, partnerships, limited
liability companies, grantor trusts, and other trusts.
maintenance costs. Costs associated with maintaining records relating to
insurance contracts and with the processing of premium collections and
commissions [(further industry-specific information is provided in the following list of terms)].
management and general activities. Activities that are not identifiable
with a single program, fundraising activity, or membership-development
activity but that are indispensable to the conduct of those activities and to
an entity's existence.
membership development activities. Membership development activities
include soliciting for prospective members and membership dues, membership relations, and similar activities. However, if there are no significant
benefits or duties connected with membership, the substance of membership development activities may, in fact, be fundraising.
merger date. The date on which the merger becomes effective.
merger of not-for-profit entities. A transaction or other event in which the
governing bodies of two or more not-for-profit entities (NFPS) cede control
of those entities to create a new NFP.
natural expense classification. A method of grouping expenses according
to the kinds of economic benefits received in incurring those expenses.
Examples of natural expense classifications include salaries and wages,
employee benefits, supplies, rent, and utilities.
net assets. The excess or deficiency of assets over liabilities of a not-for-profit
entity, which is classified into three mutually exclusive classes according
to the existence of absence of donor-imposed restrictions. See also unrestricted net assets, temporarily restricted net assets, and permanently restricted net assets.
nonfinancial assets. An asset that is not a financial asset. Nonfinancial assets
include land, buildings, use of facilities or utilities, materials and supplies,
intangible assets, or services.
nonprofit activity. An integrated set of activities and assets that is capable of
being conducted and managed for the purpose of providing benefits, other
than goods or services at a profit or profit equivalent, as a fulfillment of an
entity's purpose or mission (for example, goods or services to beneficiaries,
customers, or members). As with a not-for-profit entity, a nonprofit activity
possesses characteristics that distinguish it from a business or a for-profit
business entity.
not-for-profit entity. An entity that possesses the following characteristics,
in varying degrees, that distinguish it from a business entity:
a. Contributions of significant amounts of resources from resource
providers who do not expect commensurate or proportionate pecuniary return
b. Operating purposes other than to provide goods or services at a
profit
c. Absence of ownership interests like those of business entities
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Entities that clearly fall outside this definition include the following:
a. All investor-owned enterprises
b. Entities that provide dividends, lower costs, or other economic benefits directly and proportionately to their owners, members, or participants, such as mutual insurance entities, credit unions, farm
and rural electric cooperatives, and employee benefit plans
performance indicator. A performance indicator reports results of operations. A performance indicator and the income from continuing operations
reported by for-profit health care entities generally are consistent, except
for transactions that clearly are not applicable to one kind of entity (for
example, for-profit health care entities typically would not receive contributions, and not-for-profit health care entities would not award stock
compensation). That is, a performance indicator is analogous to income
from continuing operations of a for-profit entity.
permanently restricted net assets. The part of the net assets of a not-forprofit entity (NFP) resulting from the following:
a. Contributions and other inflows of assets whose use by the NFP
is limited by donor-imposed stipulations that neither expire by the
passage of time nor can be fulfilled or otherwise removed by the
actions of the NFP.
b. Other asset enhancements and diminishments subject to the same
kinds of stipulations.
c. Reclassification from or to other classes of net assets as a consequence of donor-imposed stipulations.
permanent restriction. A donor-imposed restriction that stipulates that resources be maintained permanently but permits the not-for-profit entity
to use up or expend part or all of the income or other economic benefits
derived from the donated assets.
prepaid health care plan. A plan in which the provider is compensated in
advance by the sponsoring entity. The sponsoring entity pays or compensates the provider based on either a fixed sum or a per-enrollee amount.
Prepaid health care plans include health maintenance organizations, preferred provider organizations, eye care plans, dental care plans, and similar plans. Under such plans, the financial risk of delivering the health care
is transferred to the provider of services.
prepaid health care services. Any form of health care service provided to a
member in exchange for a scheduled payment (or payments) established
before care is provided, regardless of the level of service subsequently
provided.
prepaid health care services providers. Entities that provide or arrange
for the delivery of health care services in accordance with the terms and
provisions of a prepaid health care plan. Providers assume the financial
risk of the cost of delivering health care services in excess of preestablished
fixed premiums. However, some or all of the financial risk may be contractually transferred to other providers (affiliated entities) or by purchasing
stop-loss insurance. Other providers of prepaid health care services may
include comprehensive medical plans, physicians groups (for example, independent practice associations), and hospitals.
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program services. The activities that result in goods and services being distributed to beneficiaries, customers, or members that fulfill the purposes
or mission for which the not-for-profit entity (NFP) exists. Those services
are the major purpose for and the major output of the NFP and often relate
to several major programs.
prospective rate setting. Prospective rate setting is a method used to set
payment rates in advance of the delivery of health care services. Such
payment rates determine what third parties will pay for health care services during the rate period (generally one year). Prospective rate setting
may result from a contractual agreement with a third party, such as a
Blue Cross plan, or it may be mandated through legislation. The intent of
prospective rate setting is to establish payment rates before the period to
which they will apply and that are not subject to change.
reinsurance. A transaction in which a reinsurer (assuming entity), for a consideration (premium), assumes all or part of a risk undertaken originally
by another insurer (ceding entity). For indemnity reinsurance, the legal
rights of the insured are not affected by the reinsurance transaction and
the insurance entity issuing the insurance contract remains liable to the
insured for payment of policy benefits. Assumption or novation reinsurance
contracts that are legal replacements of one insurer by another extinguish
the ceding entity's liability to the policyholder [(further industry-specific
information is provided in the following list of terms)].
retrospective rate setting. Under retrospective rate setting, third parties
usually determine an interim payment rate and, during the rate period
(generally one year), pay the health care entity for services rendered using
that rate. After the rate period has ended, a final settlement is made in
accordance with federal or state regulations or contractual agreements.
Under a retrospective system, an entity may be entitled to receive additional payments or may be required to refund amounts received in excess
of amounts earned under the system. Although final settlements are not
made until a subsequent period, they are usually subject to reasonable
estimations and are reported in the financial statements in the period in
which services are rendered.
stop-loss insurance. A contract in which an entity agrees to indemnify
providers for certain health care costs incurred by members.
tail coverage. Insurance designed to cover malpractice claims incurred before,
but reported after, cancellation or expiration of a claims-made insurance
policy.
temporarily restricted net assets. The part of the net assets of a not-forprofit entity (NFP) resulting from the following:
a. Contributions and other inflows of assets whose use by the NFP
is limited by donor-imposed stipulations that either expire by passage of time or can be fulfilled and removed by actions of the NFP
pursuant to those stipulations
b. Other asset enhancements and diminishments subject to the same
kinds of stipulations
c. Reclassification from or to other classes of net assets as a consequence of donor-imposed stipulations, their expiration by passage
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of time, or their fulfillment and removal by actions of the NFP
pursuant to those stipulations
trading securities. Securities that are bought and held principally for the
purpose of selling them in the near term and therefore held for only a
short period of time. Trading generally reflects active and frequent buying
and selling, and trading securities are generally used with the objective of
generating profits on short-term differences in price.
trustee. An entity that has a duty to hold and manage assets for the benefit of
a specified beneficiary in accordance with a charitable trust agreement. In
some states, not-for-profit entities (NFPs) are organized under trust law
rather than as corporations. Those NFPs are not trustees as defined because, under those statutes, they hold assets in trust for the community or
some other broadly described group, rather than for a specific beneficiary.
unrestricted net assets. The part of net assets of a not-for-profit entity (NFP)
that is neither permanently restricted nor temporarily restricted by donorimposed stipulations. The only limits on the use of unrestricted net assets
are the broad limits resulting from the following:
a. The nature of the NFP
b. The environment in which the NFP operates
c. The purposes specified in the NFP's articles of incorporation or
bylaws
d. Limits resulting from contractual agreements with suppliers, creditors, and others entered into by the NFP in the course of its business
Unrestricted net assets generally result from revenues from providing services, producing and delivering goods, receiving unrestricted contributions,
and receiving dividends or interest from investing in income-producing assets, less expenses incurred in providing services, producing and delivering
goods, raising contributions, and performing administrative functions.
variable interest entity. A legal entity subject to consolidation according to
the provisions of the "Variable Interest Entities" subsections of FASB ASC
810-10.
voluntary health and welfare entity. A not-for-profit entity (NFP) that is
formed for the purpose of performing voluntary services for various segments of society and that is tax exempt (organized for the benefit of the
public), supported by the public, and operated on a not-for-profit basis.
Most voluntary health and welfare entities concentrate their efforts and
expend their resources in an attempt to solve health and welfare problems
of society and, in many cases, those of specific individuals. As a group,
voluntary health and welfare entities include those NFPs that derive their
revenue primarily from voluntary contributions from the general public
to be used for general or specific purposes connected with health, welfare,
or community services. For purposes of this definition, the general public excludes government entities when determining whether an NFP is a
voluntary health and welfare entity.
The following is a list of additional terms that have been used in this guide and
further information on select terms defined in the FASB ASC glossary:
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acquisition costs. Marketing costs that are (a) directly related to the acquisition of specific subscriber contracts and member enrollment and (b)
incremental to general marketing activities.
acute care. Inpatient general routine care provided to patients who are in
a phase of illness that does not require the concentrated and continuous
observation and treatment provided in intensive-care units.
administrative services only (ASO). A contract between a third-party company and self-funded plan in which the third-party company performs
administrative services only and does not assume any risks. The employer
is at risk for the cost of provided health care services. Services normally
include claims processing but may include other services, such as actuarial
analysis, utilization review, data reporting, and stop-loss coverage. This is
a common arrangement when an employer sponsors a self-funded health
care program.
advance fee. A payment required to be made by a continuing care retirement
community (CCRC) resident prior to, or at the time of, admission to the
CCRC for future services and the use of facilities specified in a contract
that remains in effect for as long as the resident resides in the CCRC.
allocated loss adjustment expense. Claim expense that can be assigned
to individual claims (for example, attorney's fees, claim adjusting service
fees, or court costs).
allowable costs. Costs that are allowable under the principles of reimbursement of Medicare and Medicaid or contractual agreements with their payors, such as Blue Cross and Blue Shield.
allowance. The difference between gross patient service revenues charged
at established rates for services rendered and amounts received or to be
received from patients or third-party payors. Allowances are to be distinguished from uncollectible losses. The types of allowances are as follows:

r
r
r

Charity allowances. The difference between charges at established rates and amounts received from indigent patients, voluntary agencies, or governmental units on behalf of specific indigent
patients. Charity allowances are subtracted from gross charges to
compute gross patient service revenue.
Contractual allowances. The difference between charges at established rates and amounts received from third-party payors
under contractual agreement. Contractual allowances are subtracted from gross patient service revenue to compute net patient
service revenue.
Courtesy allowances. The difference between charges at established rates and amounts received from doctors, clergymen, employees, and employees' dependents. Also called policy discounts.
Courtesy allowances are subtracted from gross patient service
revenue to compute net patient service revenue.

ambulatory care. Provision of health care services to outpatients and other
patients who do not require admission to the hospital as inpatients. Any
type of medical care provided to a patient who is not hospitalized.
ambulatory care organization. A partnership, association, corporation, or
other legal entity organized to deliver health care services to patients that
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come or are brought to a health care facility for a purpose other than
admission as an inpatient (for example, emergency room services, clinic
services, or outpatient surgery).
ambulatory payment classifications (APC). The Medicare reimbursement
mechanism that sets the prospectively established rate for outpatient reimbursement, which is similar to the diagnosis-related group (DRG) system
that is used for inpatient reimbursement. APCs are based upon procedure
versus diagnosis (as is used for DRGs) or encounter.
ancillary services. Services performed for diagnostic or therapeutic purposes.
Ancillary services generally are those special services for which charges in
addition to routine charges customarily are made (for example, laboratory,
radiology, surgical, or other services).
anticipated revenues. Amounts including third-party payments (for example, those from Blue Cross and Blue Shield); contractually- or statutorilycommitted investment income from sources related to the activities of a
continuing care retirement community (CCRC); contributions pledged by
donors to support CCRC activities; periodic fees expected to be collected;
or the balance of deferred nonrefundable advance fees.
asserted claim. A claim made against a health care entity by or on behalf of
a patient alleging improper professional service.
assets limited as to use. Assets that are segregated and limited regarding
how the assets may be used either by the board or management (for example, designated for expenditure in the acquisition of property and equipment or for the liquidation of long-term debt) or by outside third parties
other than a donor or grantor (for example, funds under bond agreements
or malpractice arrangements).
associated entity. An individual practice association, hospital, medical group,
or similar health care entity that contracts with a prepaid health care
provider to provide health care services.
bad-debt expense. The current period charge for actual or expected doubtful
accounts resulting from the extension of credit.
benchmark. The process of comparing an entity's operations and financial
data with that of other entities, particularly comparing one entity with the
entity considered the best in the industry. Quantitative benchmarks are
used to establish performance objectives. Among physicians, it is often the
standard for quality medical care and can be applied to any condition or
procedure.
best-efforts remarketing agreement. A financing agreement in which the
agent agrees to buy only those securities that it is able to sell to others; if
the agent is unable to remarket the debt, the issuer is obligated to pay off
the debt.
board-designated funds. Unrestricted resources set aside by the governing
board for specific purposes or projects or for investment to produce income
as if they were endowment funds.
capitation arrangement. An arrangement in which certain medical and
other defined health care services are provided by third-party health care
providers to a specified population under contractual arrangement with
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payors. In a capitation arrangement, the primary entity retains responsibility for the quality and performance of the provided services.
case mix. Grouping of patients possessing similar clinical attributes and output utilization patterns, primarily for purposes of cost accounting and
reimbursement. The classifications or categories of patients treated by a
hospital. Case mix directly influences the length of stays and intensity,
cost, and scope of services provided by a hospital. Also defined as a weighting of a patient's acuity in which the average acuity is one.
census, average daily. The average number of inpatients, excluding newborns, in the hospital or facility each day for a given period of time. Average daily census for any classification is computed by taking the total
number of patient days of care for that classification throughout the period
and dividing those days by the total number of days in that period.
Centers for Medicare & Medicaid Services (CMS). The federal agency
responsible for Medicare and Medicaid programs.
claim adjustment expenses. Claim adjustment expenses include any legal
fees and the costs of paying claims and all related expenses (defined in the
FASB ASC glossary, as presented in the first section of this glossary).
claims-made insurance policy. A policy that covers only malpractice claims
reported to the insurance carrier during the policy term, regardless of the
date of the incident giving rise to the claim.
clinic. A freestanding facility or part of another health care entity used for
diagnosis and treatment of outpatients.
coinsurance. A percentage that the insured member pays after the plan's
deductible is exceeded and until the policy's stop-loss provision is reached.
Sometimes used synonymously with copayment, but a copayment is a flat
fee. See also copayment.
commercial paper. Short-term, unsecured promissory notes that represent
a flexible and low-cost form of short-term financing. Taxable commercial
paper is sold on a discount basis, rather than an interest-bearing basis,
with the discount determined by the maturity of the notes, the creditworthiness of the issuer or its credit support, and general market demand. The
primary risk is the variable interest rate exposure. Issuance often requires
some form of credit enhancement or liquidity support.
community rating. The rating methodology required of federally-qualified
health maintenance organizations (HMOs); HMOs under the laws of many
states; and, occasionally, indemnity plans under certain circumstances.
The HMO must obtain the same amount of money per member for all
members in the plan. Community rating does allow for variability by allowing the HMO to factor in differences for age, sex, mix (average contract
size), and industry factors; however, not all factors are necessarily allowed
under state laws.
component unit. Component units are legally separate organizations for
which the elected officials of the primary government are financially accountable. In addition, component units can be other organizations for
which the nature and significance of their relationship with a primary
government are such that exclusion would cause the reporting entity's financial statements to be misleading or incomplete. A component unit may
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be a governmental organization, except those that meet the definition of a
primary government, nonprofit corporation, or for-profit corporation.
conduit financing. A financing arrangement involving a government or other
qualified agency using its name in an issuance of fixed income securities,
generally for financing a not-for-profit entity's capital project. See also
conduit debt securities in the FASB ASC glossary, as presented in the
first section of this glossary.
continuing-care contract. An agreement between a resident and continuing
care retirement community (CCRC) specifying the services and facilities to
be provided by the CCRC to a resident over an established period of time,
usually the remaining life of the resident.
continuing care retirement community (CCRC). A legal entity sponsoring
or guaranteeing residential facilities, meals, and health care services for a
community of retired persons who may reside in apartments; other living
units; or, in some cases, a nursing center. Also called a residential care
facility or life-care retirement community.
contract period. The period (typically one year) for which premium rates are
fixed by contract.
contractual adjustments. The differences between revenue at established
rates and the amounts realizable from third-party payors under contractual agreements.
copayment. That portion of a claim or medical expense that a member must
pay out of pocket. Typical copayments are fixed or variable flat amounts for
physician office visits, prescriptions, or hospital services. Sometimes used
synonymously with coinsurance, but coinsurance is a percentage payment.
See also coinsurance.
cost-plus. A third-party administrator contract in which the employer pays
the administrator a fee based on paid claims, such as a percentage of paid
claims. The administrator funds the payment of claims and, therefore, is
liable for unpaid claims if the employer is unable to pay the claims.
costs of acquiring initial continuing-care contracts. Costs incurred to
originate a contract that result from, and are essential to, the acquisition
of the initial contracts and are incurred through the date of substantial
occupancy but no later than one year from the date of completion of construction. These costs include the following:

r
r

r
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The costs of processing the contract, such as evaluating the
prospective resident's financial condition; evaluating and recording guarantees, collateral, and other security arrangements; negotiating contract terms; preparing and processing contract documents; and closing the transaction
The costs from activities in connection with soliciting potential
initial residents, such as model units and their furnishings, sales
brochures, semipermanent signs, tours, grand openings, and sales
salaries. These costs do not include advertising, interest, administrative costs, rent, depreciation, or any other occupancy or equipment costs
The portion of an employee's compensation and benefits that relates to the initial contract acquisitions
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courtesy and policy discounts. The differences between revenue recorded
at established rates and amounts realizable for services provided to specific individuals, such as employees, medical staff, and clergy. See also
allowance.
covered charges. The charges incurred by a patient that are covered under
the contractual agreements with third-party payors.
common procedural terminology (CPT) coding. A coding structure used
to code surgical procedures for statistical analysis and billing purposes.
CPT coding was copyrighted by the American Medical Association, and
the Centers for Medicare & Medicaid Services mandates the use of these
codes for Medicare billing.
credibility. A measure of the statistical significance of a provider's own data,
dependent on its stability and volume in relation to the stability and volume of the industry data. Actuaries use credibility to blend an estimate
from a provider's own experience with a broader estimate based on the
experience of similar institutions. A provider's own experience may be
assigned a credibility weight less than 100 percent due to year-to-year
volatility. Such volatility is often a function of the size of the provider.
Large providers generally have less volatility than small providers. In
such an instance, a broader and more stable body of experience of similar
providers would be used to supplement the specific provider's experience.
credit enhancement. Typically, a bank letter of credit that guarantees investors will receive principal and interest in the event of an issuer default.
A line of credit provides liquidity support to an issuer but does not provide
a guarantee of the repayment of principal and interest in the event of issuer default. The liquidity support provides a loan to issuers in the event
that the issuer is unable to place large amounts of maturing commercial
paper with investors.
crossover refunding. A type of advance refunding in which the old debt
is not immediately replaced. The proceeds from the new debt; additional
cash deposits, if any; and the income earned on the related investments
are sufficient to pay the principal and any call premium of the old debt and
interest on the new debt until the date of crossover. Until the crossover,
the proceeds from the new debt serve as collateral for that debt. The old
debt is serviced by the entity until the date of crossover, at which time
the proceeds from the new debt are used to retire the old debt, and the
entity becomes obligated to service the new debt. The old debt remains as
a liability on the issuer's books until the crossover, when it is called in
accordance with the call provisions of its indenture. Also called a delayed
defeasance.
debt reserve funds. The amount of funds or cash that needs to be set aside
to fund debt repayment.
deductible. The portion of a member's health care expenses that must be paid
out of pocket before any insurance coverage applies. Deductibles are common in indemnity insurance plans and preferred provider organizations,
or PPOs, but uncommon in health maintenance organizations, or (HMOs).
defeasance. Legal satisfaction of refunded debt without the debt necessarily
being retired.
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diagnosis-related group (DRG). A statistical system of classifying any inpatient stay into groups for purposes of payment. DRGs may be primary
or secondary, and an outlier classification also exists. This is the form of
reimbursement that the Centers for Medicare & Medicaid Services uses to
pay hospitals for Medicare recipients. Also used by a few states for all payors and by some private health plans for contracting purposes (defined in
the FASB ASC glossary, as presented in the first section of this glossary).
donated services. Services of personnel who receive no monetary compensation or partial compensation. The term is usually applied to services
rendered by members of religious orders, societies, or similar groups to
institutions operated by, or affiliated with, such institutions.
durable medical equipment (DME). Medical equipment that is not disposable (that is, used repeatedly) and is only related to care for a medical
condition. Examples would include wheelchairs and home hospital beds.
An area of increasing expense, particularly in conjunction with case management.
Emergency Medical Treatment and Labor Act (EMTALA). A federal law
governing assessment and transfer of patients seeking emergency care.
Sometimes called Emergency Medical Treatment and Active Labor Act.
enrollee. An individual who is a subscriber or an eligible dependent of a
subscriber in a prepaid health care plan.
enterprise fund. In governmental accounting, an enterprise fund may be used
to report any activity for which a fee is charged to external users for goods
or services. An enterprise fund is a proprietary fund that is generally used
to account for governmental activities that are similar to activities that
may be performed by a commercial enterprise.
estimated costs of future services. Amounts that are expected to be incurred
to provide services and the use of facilities to individuals over their remaining lives under continuing-care contracts. Examples include resident care,
dietary, health care, facility, general and administrative, interest, depreciation, and amortization costs.
excess levels. The level of insurance coverage that applies to that portion of a
loss or damage that exceeds a specified amount.
exposure. The amount of potential claim risk. The basis for reflecting differences in the claim potential among providers' bases for charging insurance
premiums or allocating member contributions to a captive. Exposure bases
for hospital professional liability include the number of occupied beds,
outpatient visits, emergency room visits, and the number of residents by
specialty.
Federal Employee Health Benefits Program. The program that provides
health benefits to federal employees.
fee-for-service system. The traditional health care payment system under
which providers receive a fee for each delivered service. Under the fee-forservice system, the total bill will increase not only if the fees increase but
also if more units of service are rendered.
fee schedule. A comprehensive listing of fee maximums used to reimburse a
provider on a fee-for-service basis. May also be referred to as fee maximums
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or a fee allowance schedule. A listing of the maximum fee that a health
plan will pay for a certain service based on common procedural terminology
billing codes.
final settlement. The ultimate liability of the health care entity to the thirdparty payor or the amount due to the health care entity from the payor as a
result of determining the final total allowable cost for the reporting period
and comparing that number with the amount that has been received from
the payor for the reporting period.
floating rate note (FRN). A debt instrument that allows issuers to borrow at
a floating short-term rate with a long-term stated maturity without some
of the risks traditionally associated with commercial paper. The investor is
subject to principal risk to the degree that the issuer's credit deteriorates
or investor demand for FRNs decreases. Most health care issuers of FRNs
require credit enhancement and a bank liquidity facility in conjunction
with an FRN program.
full medical risk. The risk from uncertainties about the frequency, severity,
and health care costs of rendered medical services.
fund. A self-contained accounting entity set up to account for a specific activity
or project.
gross charges. The total charges at established rates for services rendered to
a patient.
gross service revenues. Gross charges less charity allowances (charity care
at established rates).
health care costs. For managed care services, health care costs include costs
incurred to provide benefits to members under risk arrangements, such
as costs of capitation, wellness, network management, utilization management, quality assurance, and other health care services. Health care
costs generally exclude general and administrative, selling, maintenance,
marketing, and interest costs.
health care services. Services provided to individuals related to the diagnosis
or treatment of physical or mental illness.
Health Insurance Portability and Accountability Act (HIPAA) of 1996.
Enacted by the federal government to improve patient security and confidentiality and also to standardize the formatting of electronic transactions.
home care. This level of care involves visits by health care workers to the
home of the patient.
home health agency. An agency organized to provide health and supportive
services in a person's home. These services may include nursing; nutritional; and therapeutic aid, such as physical therapy and dialysis, and the
rental, as well as sale, of medical equipment.
hospital. A health care institution with an organized medical and professional
staff and permanent facilities that include inpatient beds and provide medical, nursing, and other health-related services to patients (each state has
its own definition of hospital for accreditation purposes).
incremental costs. Costs that vary with, and are directly attributable to,
changes in business, such as an additional employer or health maintenance
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organization, or HMO, contract. Fixed costs, such as building depreciation
or general overhead, that do not change with the addition or loss of a
contract are not incremental costs.
incurred but not reported (IBNR). Costs associated with health care services incurred during a financial reporting period but not reported to the
health care entity until after the financial reporting date. IBNR is also defined as potential claims for incidents associated with professional service
that have occurred but have not yet been reported to the health care entity
(defined in the FASB ASC glossary, as presented in the first section of this
glossary).
indenture. An agreement between two or more persons specifying the reciprocal rights and duties of the parties under a contract, such as a lease,
mortgage, or contract between bondholders and the issuer of the bond.
individual practice association (IPA). A partnership, association, corporation, or other legal entity organized to provide or arrange for the delivery
of health care services to members of a prepaid health care plan and nonmember patients. In return, the IPA receives either a capitation fee or
specified fee for rendered services.
inpatient. Under most circumstances, a patient who is provided with room,
board, and general nursing service and is expected to remain in the health
care facility at least overnight and occupy a bed.
in-substance defeasance. A form of advance refunding in which the debtor
places into an irrevocable trust an amount of assets estimated to be sufficient to satisfy all future principal and interest payments of a specific
obligation. In such cases, the debtor is not legally released from being the
primary obligor (defined in the FASB ASC glossary, as presented in the
first section of this glossary).
integrated delivery system. A provider or group of providers that is organized to deliver and finance acute and preventive health care services. An
integrated delivery system generally will provide or arrange to provide a
complete continuum of health care services (for example, inpatient acute
care; ambulatory care; outpatient surgery; and home health care, including long-term care) to an enrolled population, generally for fixed, prepaid
fees called premiums.
interest rate swaps. An agreement to exchange interest payments without
actually exchanging the underlying principal. The two parties each agree
to make interest payments based on the calculation formula for the other's
debt. Swaps can be used for a variety of purposes, such as to reduce the
overall cost of borrowing, lock in forward rates, reduce interest rate risk,
or adjust the ratio of variable- and fixed-rate debt liabilities. Interest rate
swaps do not change the amount or type of outstanding debt, but they do
affect the issuer's debt portfolio and risk profile.
intermediate care facility (ICF). A facility that provides care to individuals
whose mental or physical conditions require services that are above the
level of room and board and that can be made available only through institutional facilities. The care provided at an ICF does not require hospitals
or skilled nursing facilities. See also nursing center.
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lag analysis. A report that tells managers the age of the claims that are being
processed and the amount paid out each month (both for that month and
any earlier months) and that compares those numbers with the amount of
money that was accrued for expenses each month. A powerful tool used to
determine whether the plan's reserves are adequate to meet all expenses.
Plans that fail to properly perform lag studies may find themselves staring
into the abyss.
length of stay (LOS). Number of calendar days that elapse between an inpatient's admission and discharge.
length of stay (average). A statistical measure of patient turnover determined by dividing the total number of patient days of care in a given period
of time by the total number of inpatients who were discharged during that
period.
London Interbank Offered Rate (LIBOR). A daily reference rate based on
the interest rates at which banks offer to lend unsecured funds to other
banks in the London wholesale money market.
long-term care. Provision of health, social, or personal care services on a
recurring or continuous basis to persons with chronic physical or mental
conditions who live in environments ranging from institutions to their own
homes. This level of care is also called custodial care.
maintenance costs. Costs associated with maintaining enrollment records
and processing premium collections and payments (defined in the FASB
ASC glossary, as presented in the first section of this glossary).
managed care. A system of providing health care services to enrolled members in a plan through a defined network of health care providers who
are given the responsibility to provide quality medical care while controlling the utilization of resources, use of expensive technologies, and access
to specialists. Managed care can include a spectrum of systems, ranging
from managed indemnity to preferred provider organizations, or, point of
service, and open- and closed-panel health maintenance organizations, or
HMOs.
managed care entities. A generic term applied to a managed care plan. These
plans usually integrate the financing and delivery of health care services
to an enrolled population. Managed care organizations contract with an
organized provider network that either shares financial risks or has some
incentive to deliver quality, cost-effective services. Also called managed
care organizations.
mandatory tender. The requirement that a holder of a security surrender
the security to the issuer or its agent (for example, a tender agent) for
purchase. The tender date may be established under the bond contract or
specified by the issuer upon the occurrence of an event specified in the bond
contract. The purchase price typically is at par. Also called a mandatory
put.
margin for risk of adverse deviation. Actuarially-determined estimate of
the additional funding requirement to obtain a specific confidence level
that losses will not exceed the amount paid into the self-insurance fund.
Margins are determined using statistical simulation techniques.
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Medicaid. Federal program created by Title XIX, "Medical Assistance," of the
1965 amendment to the Social Security Act of 1935 that provides health
care benefits to indigent and medically-indigent persons (called Medi-Cal
in California). Funded by the federal and state governments and administered by the states.
medical group. An association of physicians and other licensed health care
professionals organized on a group basis to practice medicine.
Medicare. Federal program created by Title XVIII, "Health Insurance for the
Aged," of the 1965 amendment to the Social Security Act of 1935 that
provides health insurance benefits primarily to persons over the age of 65
and others eligible for Social Security benefits.
Medicare Administrative Contractors (MAC). A term used to describe
those entities that are agents of the government in the application and
provision of Medicare services. Previously referred to as a Medicare fiscal
intermediary.
Medicare Part A. The portion of the Medicare program applicable to the
reimbursement of inpatient hospital stays, critical access hospital services,
certain care in a skilled nursing facility, hospice care, and some home
health care.
Medicare Part B. The portion of the Medicare program applicable to the reimbursement of physician services, outpatient hospital care, durable medical
equipment, and some medical services that are not covered by Medicare
Part A.
Medicare Part C. The portion of the Medicare program created under the
Balanced Budget Act of 1997 that includes the Medicare Advantage plans
(formerly called Medicare+Choice) through which beneficiaries can enroll
in additional types of health plans, including managed care plans.
Medicare Part D. The portion of the Medicare program created under the
Medicare Modernization Act of 2003 featuring a voluntary outpatient prescription drug benefit, along with an interim prescription drug discount
card and transitional assistance programs.
medium-term notes. An intermediate-term security offered on a continuous
basis providing flexibility for an issuer to vary the amount of outstanding
notes as its funding requirements change. The broad range of possible
maturities enables an issuer to borrow at the most attractive yield at the
time of each issuance. They can be issued domestically or abroad.
member. An individual who is enrolled as a subscriber or an eligible dependent
of a subscriber in a prepaid health care plan.
minimum premium contract. A third-party administrator contract in which
the administrator provides stop-loss insurance. A minimum fee is paid by
an obligated entity, such as an employer, to a third-party administrator,
such as an insurance company, in exchange for the third party administering the payment of claims up to a specified amount. Typically, the obligated
entity is responsible for claims up to a certain limit, such as a percentage of
total claims or specified amount, and uses the third party to pay the claims
on its behalf, usually out of an employer-owned bank account. However,
the third-party administrator is responsible for all payments above the
predetermined limit.
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multiprovider captive. An insurance entity owned by two or more health
care entities that underwrites malpractice insurance for its owners.
Municipal Swap Index. The Securities Industry and Financial Markets Association Municipal Swap Index, which is a commonly used underlying for
interest rate swaps that are used as hedges of interest rate risk associated
with variable-rate tax-exempt debt. Also called the SIFMA Index.
net advance refunding. A type of advance refunding in which the proceeds
from the new debt; additional cash deposits, if any; and the income earned
on the related investments are sufficient to pay the interest, principal, and
call premium on the old debt. After the advance refunding, the old debt is
serviced by the investments in trust, and the new debt is serviced by the
entity.
net service revenue. Gross service revenue less provisions for contractual
adjustments with third-party payors, courtesy and policy discounts, or
other adjustments and deductions, excluding charity care.
nonexchange transaction. As used in governmental financial accounting
standards, an external transaction in which a government gives or receives
value without directly receiving or giving equal value in exchange.
nursing center. A facility that provides nursing care to residents with a variety of needs or medical conditions. A nursing center may be a component
of a continuing care retirement community. Also called a health center,
skilled-nursing facility, intermediate-care facility, continuing-care facility,
or basic-care home.
nursing home. Institution with an organized professional staff and permanent facilities, including inpatient beds, that provides continuous nursing
and other health-related, psycho-social, and personal services to patients
who are not in an acute phase of illness but who primarily require continued care on an inpatient basis.
occurrence-basis policy. A policy that covers claims resulting from incidents
that occur during the policy term, regardless of when the claims are reported to the insurance carrier.
official statement (OS). The common term used for the offering document
or offering circular prepared in connection with a new issue of municipal securities. Although functionally equivalent to the prospectus used in
connection with registered securities, an official statement for municipal
securities is exempt from the prospectus requirements of the Securities
Act of 1933.
outliers. In referring to the Medicare Prospective Payment System, additional
payments that are made for cases that have either unusually long lengths
of stay or charges in excess of the cost outlier threshold.
outpatient. A patient who is not confined overnight in a health care institution. An ambulatory patient who visits the hospital for services but is not
admitted to a hospital bed.
patient day. A common statistical measurement of hospital and inpatient
activity. It represents one patient in the hospital or other facility overnight
when the official patient census is taken. Many hospitals and providers
follow the procedure of charging patients for fractional parts of a day or
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the day of discharge if the patient leaves after a particular hour referred
to as the check-out time.
per diem reimbursement. Reimbursement of a health care entity based on
a set rate per day, rather than charges. Per diem reimbursement can
be varied by service (for example, medical or surgical, obstetrics, mental
health, and intensive care) or uniform regardless of intensity of services.
periodic fees. Amounts paid to a continuing care retirement community by a
resident at periodic intervals for continuing-care services. Such fees may
be fixed or adjustable. Also called maintenance fees or monthly fees.
preferred provider organization (PPO). A plan that contracts with independent providers at a discount for services. The panel is limited in size
and usually has some type of utilization review system associated with it. A
PPO may be risk bearing, such as an insurance company, or nonrisk bearing, such as a physician-sponsored PPO that markets itself to insurance
companies or self-insured companies via an access fee.
premium. The consideration paid for providing contract coverage. Also called
a subscriber fee.
premium period. The period to which a premium payment applies (generally
one month) that entitles a member to health care services according to the
contract provisions.
prevailing charge. A charge that falls within the range of charges most
frequently used in a locality for a particular service or procedure.
primary care. Care that is rendered in an ambulatory fashion, such as in an
emergency room, outpatient clinic, or other outpatient department.
primary government. The foundation of a primary government is a separately elected governing body that is elected by the citizens in a general,
popular election. As the nucleus of the financial reporting entity, the primary government generally is the focal point for the users of the financial
statements. A primary government is any state government or generalpurpose local government, municipality, or county. A primary government
is also a special-purpose government (for example, a hospital district) that
meets all of the following criteria:
a. It has a separately elected governing body.
b. It is legally separate.
c. It is fiscally independent of other state and local governments.
prospective payment system (PPS). Medicare payment made at a predetermined, specific rate for each Medicare discharge, based on the patient's
diagnosis. Each discharge is classified according to a series of diagnosisrelated groups. Prospective rate setting is used to set provider rates under
a PPS. See also diagnosis-related group.
protected health information (PHI). As defined by the Health Insurance
Portability and Accountability Act of 1996 regulations, health information
that is created or received by a health care provider and relates to the past,
present, or future physical or mental health or condition of an individual.
provider. A person or entity that undertakes to provide health care services.
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rate setting. Process of establishing rates for providers of health care services by taking into account the financial needs of the provider. See also
prospective rate setting and retrospective rate setting (defined in
the FASB ASC glossary, as presented in the first section of this glossary).
refundable advance fees. The portion of an advance fee that is payable to
a resident of a continuing care retirement community or the resident's
estate.
refunded debt. Debt for which payment at a specified future date has been
provided by the issuance of refunding debt.
refunding debt. Debt issued to provide funds to pay for refunded debt at a
specified future date.
rehabilitation facility. Facility that provides medical, health-related, social,
or vocational services to disabled persons to help them attain their maximum functional capacity.
reimbursement, cost-based. Payment by a third-party payor to a hospital of
all allowable costs covered by the contract that are incurred by the hospital
in the provision of services to patients.
reimbursement, prospective. Method of third-party payment by which costs
to be incurred by an institution in providing services to patients are based
not on actual costs but estimates made at the beginning of a fiscal period.
reimbursement, retroactive. Additional payment by a third-party payor to
an institution for services not identified at the time of initial reimbursement.
reimbursement, retrospective. Method of third-party payment by which
costs incurred by a hospital in providing services to covered patients are
based on actual costs determined at the end of a fiscal period.
reinsurance. Reinsurance includes insurance purchased by a health plan
to protect it against extremely high cost cases. It is a type of protection
purchased by health maintenance organizations (HMOs) from insurance
companies specializing in underwriting specific risks for a stipulated premium. Typical reinsurance risk coverages are individual stop-loss, aggregate stop-loss, out-of-area, and insolvency protection. As HMOs grow in
membership, they usually reduce their reinsurance coverage and related
direct costs as they reach a financial position to assume such risks themselves (defined in the FASB ASC glossary, as presented in the first section
of this glossary).
resource-based relative value scales (RBRVS). A system to determine
how much money medical providers should be paid. It is currently used by
Medicare and many health maintenance organizations, or HMOs.
Resource Utilization Group (RUG). A system that categorizes skilled nursing facilities' patients into similar medical diagnoses for purposes of Medicare reimbursement.
retrospectively-rated insurance policy. An insurance policy with a premium that is adjustable based on the experience of the insured health care
entity or group of health care entities during the policy term.
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risk contract. A contract between a provider of health care services and a
prepaid health care plan that exposes the provider to the uncertainty of
financial gain or loss by obligating the provider to provide specified health
care services to enrollees of the plan for a negotiated price, which may
be an amount per case, service, or day. The price may vary based on the
volume of services furnished during the contract period.
risk pool. A risk pool accumulates all the monies received from the capitation
agreement and all the costs associated with providing patient services.
At the end of the period, the excess of capitation payments over claims
payments is distributed to the risk pool participants based upon the risksharing arrangement. See also capitation arrangement.
secondary care. Care that is rendered to inpatients in hospitals that offer
short-term, acute-care services of either a general or specialized nature.
self-insurance. That portion of risk or loss assumed by a health care entity
when no external insurance coverage exists.
self-insured obligation. The obligation for that portion of risk or loss assumed
by a health care entity when no external insurance coverage exists.
self-insured plan or self-funded plan. A health plan in which the risk for
medical cost is assumed by the company, rather than an insurance company or a managed care plan. Under the Employee Income Retirement
Security Act of 1974, self-funded plans are exempt from state laws and
regulations, such as premium taxes and mandatory benefits. Self-funded
plans often contract with insurance companies or third-party administrators to administer the benefits.
sinking fund. A sinking fund is a means of repaying debt whereby the issuer
makes periodic payments to a trustee who retires part of the issue, often
by purchasing bonds on the open market.
skilled nursing facilities (SNF). These facilities provide services on a daily,
inpatient basis. The services provided by an SNF are ordered by a physician
and require the skilled services of technical or professional personnel.
subscriber. The person who is responsible for the payment of premiums or
whose employment is the basis for eligibility for membership in a prepaid
health care plan.
tender option. A provision in a bond contract under which the investor has
the right to surrender the securities to the issuer or someone acting on the
issuer's behalf, such as a tender agent, at the predetermined price (usually
par) and on specified dates after the required notification. Also called an
optional tender or put option.
tertiary care. Care that is rendered in hospitals that possess the personnel,
equipment, and expertise to handle complex cases.
third-party administrator (TPA). A party unrelated to a plan who contracts
to be responsible for plan administration.
third-party payor. Any entity, such as Blue Cross and Blue Shield, Medicare,
or a commercial insurance entity, that contracts with health care entities
and patients to pay for the care of covered patients.
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trust fund. A fund established with an outside entity to be used for a specific
purpose, such as to pay malpractice claims and related expenses as they
arise.
ultimate cost. Total claims payments, including costs associated with litigating or setting claims.
unasserted claim. A medical malpractice claim that has not been formally
asserted against a health care provider by, or on behalf of, a patient alleging improper professional service. It may relate to either reported or
unreported incidents.
unrelated business. An activity that is a trade or business, regularly carried
on, and not substantially related to furthering the exempt purpose of the
not-for-profit entity. An unrelated business is subject to unrelated business
income tax.
unreported incident. An occurrence in which improper professional service
may have been administered by a health care provider, which may result
in a malpractice claim of which the provider is not yet aware.
utilization (third party). The ratio of hospital services provided to thirdparty beneficiaries in relation to services provided to all patients of the
hospital. This is usually based upon days, charges, or costs.
variable-rate demand notes (VRDN). Issuers may call the notes on any
monthly interest payment date, which provides issuers the opportunity to
refinance short-term obligations with long-term bonds if market conditions
make this alternative attractive.
wholly-owned captive. An insurance entity subsidiary of a health care entity
that provides malpractice insurance primarily to its parent entity.

AAG-HCO GLO

437

Index

Index
A
ACCOUNTING CHANGES, NOT-FOR-PROFIT
HEALTH CARE ENTITIES . . . . . . . . . . . . 3.22
ACCOUNTING ESTIMATES . . . . . . . . . . 2.44–.46

ACCOUNTING PRACTICES AND
PROCEDURES (NAIC) . . . . . . . . . . 2.67–.68
ACCOUNTING PRINCIPLES
. Accounting Principles Board. See APB
Opinion
. Financial Accounting Standards. See FAS
. Generally accepted accounting principles. See
GAAP
. National Council on Governmental Accounting.
See NCGA

ACCOUNTING TRENDS AND
TECHNIQUES—NOT-FOR-PROFIT
ENTITIES (AICPA) . . . . . . . . . . . . . . . . . . . 3.42
ACCOUNTS RECEIVABLE, DEFINED . . . .11.52
ACQUISITION COSTS, MANAGED CARE
SERVICES . . . . . . . . . . . . . . . . . . . . . 13.21–.22
ADVANCE FEES, THIRD-PARTY REVENUES
AND RELATED RECEIVABLES . . . . . 10.16
AFFILIATES, DEFINED . . . . . . . . . . . . . . . . . .12.75
AGENCY FUNDS, COMPENSATION AND
RELATED BENEFITS . . . . . . . . . . . . 8.74–.75
AICPA
. Accounting Trends and
Techniques—Not-for-Profit Entities . . . . . 3.42
AICPA PROFESSIONAL STANDARDS
. Accounting Standards Codification. See ASC
. Attestation Standards. See AT section
. Interim updates. See AU section
. Statement of Position. See SOP
. Technical Questions and Answers. Appendix D.
See also TIS section
AMERICAN BAR ASSOCIATION
. Statement of Policy Regarding Lawyers’
Responses to Auditors’ Requests for
Information . . . . . . . . . . . . . . . . . . . . . . . . . . 8.111
AMERICAN HOSPITAL ASSOCIATION
. Estimated Useful Lives of Depreciable Hospital
Assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6.47
AMERICAN INSTITUTE OF CERTIFIED PUBLIC
ACCOUNTANTS. See AICPA
ANTICIPATED INVESTMENT INCOME
CONSIDERATION, MANAGED CARE
SERVICES . . . . . . . . . . . . . . . . . . . . . . . . . 13.17
APB OPINION NO. 16, BUSINESS
COMBINATIONS . . . . . . . . . . . . . . . . . . 15.140

APB OPINION NO. 30, REPORTING THE
RESULTS OF OPERATIONS—REPORTING
THE EFFECTS OF DISPOSAL OF A
SEGMENT OF A BUSINESS, AND
EXTRAORDINARY, UNUSUAL AND
INFREQUENTLY OCCURRING EVENTS
AND TRANSACTIONS . . . . . . . . . . . . . . 15.23
APPLICABILITY OF GUIDE . . . . . . . . . . 1.02–.06
ARBITRAGE, MUNICIPAL BOND FINANCING
7.41
ASC 205, PRESENTATION OF FINANCIAL
STATEMENTS . . . . . . . . . . 6.23, 6.28, 6.30
ASC 210, BALANCE SHEET
. Contingencies and other liabilities . . . . . . . .8.06
. Managed care services . . . . . . . . . . . . . . . . 13.23
. Medical malpractice . . . . . . . . . . . . . . . . . . . . 8.33
. Municipal bond financing . . . . . . . . . . . . . . . . 7.47
. Not-for-profit health care entities . . . . . . . . . 3.06
. Third-party revenues and related receivables,
estimated final settlements . . . . . . . . . . . 10.51
ASC 220, COMPREHENSIVE INCOME
15.24–.25
ASC 225, INCOME STATEMENT . . . . . . . . 7.65
ASC 230, STATEMENT OF CASH FLOWS
. Cash and cash equivalents . . . . . . . . . . . . . . 4.06
. Disclosures . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.66
. Financial statement presentation . . . . . . . . .4.66
. Government health care entities . . . . . . . . 15.25
. Investment pools . . . . . . . . . . . . . . . . . 4.42, 4.44
. Investments . . . . . . . . . . . . . . . . . . . . . . 4.19, 4.66
. Not-for-profit health care entities . . . 3.33, 3.36
ASC 250, ACCOUNTING CHANGES AND
ERROR CORRECTIONS . . . . . 6.25, 10.46,
12.72
ASC 270, INTERIM REPORTING . . . . 7.75–.76
ASC 275, RISKS AND UNCERTAINTIES
. Accounting estimates . . . . . . . . . . . . . . . . . . . 2.44
. Contingencies and other liabilities . . . . . . . 8.03,
. . . . . . . . . . . . . . . . . . . . . . 8.90–.91, 8.94, 8.96
. Managed care services, disclosures . . . . 13.30
. Medical malpractice . . . . . . . . . . . . . . . . . . . . 8.50
. Third-party revenues and related receivables,
estimated final settlements . . . . . . .10.48–.49
ASC 280, SEGMENT REPORTING . . . . . . 15.26
ASC 310, RECEIVABLES . . . . . . . 10.40, 10.42
ASC 320, INVESTMENTS—DEBT AND EQUITY
SECURITIES
. Auditing considerations . . . . . . . . . . . . . . . . . 4.74
. Disclosures . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.68
. Financial statement presentation . . . . . . . . .4.68
. Government health care entities . . . . . . . . 15.47

AAG-HCO ASC

438

Health Care Entities

ASC 320, INVESTMENTS—DEBT AND EQUITY
SECURITIES—continued
. Impairment of investments . . . . . . . . . . 4.49–.58
. Investor-owned health care
entities . . . . . . . . . . . . . . . . . . . . . . . . . . .4.24–.27
. Reporting entity and related entities, financial
statement presentation . . . . . . . . . . . . . . .12.61
ASC 323, INVESTMENTS—EQUITY METHOD
AND JOINT VENTURES
. Accounting for related entity transfers . . 12.78
. Auditing considerations . . . . . . . . . . . . . . . . . 4.74
. Disclosures . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.70
. Fair value option . . . . . . . . . . . . . . . . . . . . . . . . 4.22
. Financial statement presentation . . . . . . . . .4.70
. Investment pools . . . . . . . . . . . . . . . . . 4.43, 4.45
. Not-for-profit health care entities, relationships
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Exhibit 12-1
. Reporting entity and related entities,
not-for-profit health care entities . . . . . .12.18,
. . . . . . . . . . . . . . . . . . . . . . . . . 12.33–.36, 12.42,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12.44, 12.52
. TIS 6400 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11.55
ASC 325, INVESTMENTS—OTHER
. Disclosures . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.68
. Financial statement presentation . . . . . . . . .4.68
. Impairment of investments . . . . . . . . 4.49, 4.53
. Investor-owned health care entities . . . . . . 4.24
ASC 340, OTHER ASSETS AND DEFERRED
COSTS . . . . . . . . . . . . . . . . . . . . . . . . 6.05, 8.23
ASC 350, INTANGIBLES—GOODWILL AND
OTHER
. Impairment or disposal . . . . . . . . . . . . . . . . . .6.25
. Long-lived assets . . . . . . . . . . . . . 6.34, 6.36–.39
ASC 360, PROPERTY, PLANT, AND
EQUIPMENT
. Auditing considerations . . . . . . . . . . . . . . . . . 6.48
. Generally . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .6.05
. Government health care entities . . . . . . . 15.47,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.59
. Impairment or disposal . . . . . . . . . . . 6.21, 6.23,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6.26–.28
. Investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.15
. Long-lived assets . . . . . . . . . . . . . . . . . . .6.38–.39
. Not-for-profit health care entities, intermediate
subtotals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.18
ASC 405, LIABILITIES
. Debt extinguishment . . . . . . . . . . . . . . . . . . . . 7.28
. Defeasance . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7.23
. Extinguishment and modification
transactions . . . . . . . . . . . . . . . . . . . . . . 7.14–.15
ASC 410, ASSET RETIREMENT AND
ENVIRONMENTAL OBLIGATIONS
. Contingencies and other liabilities . . . 8.59–.60
. Government health care entities . . . . . . . . 15.67
. Property, plant and equipment . . . . . . 6.18–.20
ASC 420, EXIT OR DISPOSAL COST
OBLIGATIONS . . . . . . . . . . . . . . . 3.18, 15.94
ASC 440, COMMITMENTS . . . . . . . . 6.13, 8.03

AAG-HCO ASC

ASC 450, CONTINGENCIES
. Generally . . . . . . . . . . . . . . . . . . . . . . . . . . 8.03–.04
. Medical malpractice . . . . . . . . 8.17, 8.20, 8.23,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8.45–.46
. Understanding entity, environment and internal
control . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.40
ASC 460, GUARANTEES
. Contingencies and other liabilities . . . . . . . .8.03
. Management representations . . . . . . . . . . . .2.57
. Physician guarantees and
agreements . . . . . . . . . . . . . . . . . . . . . . 8.53–.55
ASC 470, DEBT
. Balance sheet presentation . . . . . . . . . . . . . .7.47
. CCRC classification of refundable advance
fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14.26
. Debt extinguishment . . . . . . . . . . . . . . . . . . . . 7.28
. Debt issuance costs . . . . . . . . . . . . . . 7.34, 7.36
. Disclosures . . . . . . . . . . . . . . . . . . . . . . . . 7.66–.67
. Due-on-demand or put provisions . . . . 7.48–.54
. Extinguishment and modification
transactions . . . . . . . . . . . . . . . . . . . . 7.14, 7.17
. Gain or loss on debt extinguishment . . . . . 7.32
. Government health care entities . . . . . . . . 15.76
. Long-term debt with covenant
violation . . . . . . . . . . . . . . . . . . . . 7.58–.59, 7.61
. Modifications . . . . . . . . . . . . . . . . . . . . . . . . . . . 7.31
. Statement of operations . . . . . . . . . . . . . . . . 7.65
. Subjective acceleration clause . . . . . . 7.55–.56
ASC 605, REVENUE RECOGNITION
. Gross revenue reporting indicators . . . . . 13.28
. Income and cash flow statement . . . 13.26–.27
. Net revenue reporting indicators . . . . . . . 13.29
. Property, plant and equipment, rebates and
discounts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6.12
. Reporting entity and related entities,
not-for-profit health care entities . . . . . . 12.53
. Third-party revenues and related
receivables . . . . . . . . . . . . . . . . . . . . . . . . . . 10.01
ASC 710, COMPENSATION—GENERAL
. Contingencies and other liabilities . . . . . . . 8.63,
. . . . . . . . . . . . . . . . . . . . . . . . . . . 8.67, 8.69, 8.71
. Government health care entities . . . . . . . . 15.93
ASC 712,
COMPENSATION—NONRETIREMENT
POSTEMPLOYMENT BENEFITS . . . . 8.63,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8.73
ASC 715, COMPENSATION—RETIREMENT
BENEFITS
. Contingencies and other liabilities . . . . . . . 8.63,
. . . . . . . . . . . . . . . . . . . . . . . . . . . 8.67, 8.70, 8.73
. Not-for-profit health care entities, performance
indicators . . . . . . . . . . . . . . . . . . . . . . . . . . . . .3.16
ASC 718, COMPENSATION—STOCK
COMPENSATION . . . . . . . . . . . . . . . . . . . . 8.63
ASC 720, OTHER EXPENSES
. Contributions received and made . . . . . . . 11.39
. Insurance recovery recognition . . . . . . . . . . 8.08
. Long-lived assets . . . . . . . . . . . . . . . . . 6.34, 6.36

Index
ASC 720, OTHER EXPENSES—continued
. Medical malpractice . . . . 8.12, 8.32–.33, 8.36
. Nonreciprocal transfers . . . . . . . . . . . . . . . . . 6.32
ASC 740, INCOME TAXES . . . . . . . . . . . . . . .8.87
ASC 805, BUSINESS COMBINATIONS
. Accounting for related entity
transfers . . . . . . . . . . . . . . . . 12.71–.72, 12.79
. Government health care entities . . . . . . .15.140
. Mergers and acquisitions . . . . . . . . . 12.85–.86,
. . . . . . . . . . 12.92–.97, 12.102, 12.105–.108
ASC 808, COLLABORATIVE
ARRANGEMENTS . . . . . . . . . . 12.05, 12.53
ASC 810, CONSOLIDATION
. Accounting for related entity transfers . . 12.78
. Financial statement
presentation . . . . . . 12.59–.60, 12.65, 12.67
. Investment pools . . . . . . . . . . . . . . . . . . . . . . . 4.46
. Investor-owned health care entities . . . . 12.55,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12.57
. Not-for-profit health care entities.
Exhibit 12-1, . . . . . 12.09, 12.26, 12.28–.32,
. . . . . . . . . . . . . . . . . . 12.34, 12.37–.39, 12.41
ASC 815, DERIVATIVES AND HEDGING
. Calls and puts in debt . . . . . . . . . . . . . . . . . . . 5.34
. Cash flow hedges . . . . . . . . . . . . . . . . . . 5.11–.12
. Embedded derivatives . . . . . . . . . . . . . . 5.30–.33
. Fair value hedges . . . . . . . . . . . . . . . . . . . . . . . 5.09
. Financial statement presentation . . . . . . . . .5.39
. Generally . . . . . . . . . . . . . . . . 5.01–.02, 5.05–.08
. Hedge accounting . . . . . . . . . . . . . . . . . . 5.16–.20
. Investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.14
. Investor-owned health care entities .4.24, 4.26
. Nonhedging derivatives . . . . . . . . . . . . . . . . . 5.43
. Not recorded under fair value option,
investments . . . . . . . . . . . . . . . . . . . . . . . . . . 4.28
. Not-for-profit health care entities . . . . . . . . . 5.44
. Qualifying hedges . . . . . . . . . . . . . . . . . . 5.40–.42
. Shortcut method . . . . . . . 5.22–.25, 5.27, 5.29
. Split-interest agreements . . . . . . . . . . . . . . . .5.37
ASC 820, FAIR VALUE MEASUREMENTS AND
DISCLOSURES
. Contributions received and made . . . . . . . 11.02
. Financial statement presentation . . . . . . . . .4.72
. Investments . . . . . . . . . . . . . . . . 4.19, 4.37, 4.48
. Investments, disclosures . . . . . . . . . . . . . . . . 4.72
. Municipal bond financing, disclosures . . . . 7.69
ASC 825, FINANCIAL INSTRUMENTS
. Disclosures . . . . . . . . . . . . . . . . . . . . . . . . 4.68–.69
. Financial statement presentation . . . . 4.68–.69
. Impairment of investments . . . . . . . . . . . . . . 4.51
. Investment pools . . . . . . . . . . . . . . . . . 4.39, 4.43
. Investments . . . . . . . . . . . . . . . . . . . . . . . .4.17–.22
. Investor-owned health care entities . . . . . . 4.24
. Municipal bond financing, disclosures . . . . 7.69
. Not-for-profit health care entities, relationships.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Exhibit 12-1
. Reporting entity and related entities,
not-for-profit health care entities . . . . . .12.33,
. . . . . . . . . . . . . . . . . . . . . . . 12.36, 12.40, 12.52

439

ASC 825, FINANCIAL
INSTRUMENTS—continued
. Third-party revenues and related receivables,
patient receivables . . . . . . . . . . . . . . . . . . . 10.41
ASC 835, INTEREST
. Auditing considerations . . . . . . . . . . . . . . . . . 6.46
. Capitalized interest . . . . . . . . . . . . . . . . . 6.06–.11
. Contingencies and other liabilities . . . . . . 8.101
. Contributions received and made, fund-raising
and special event cost reporting . . . . . . 11.28
. Municipal bond financing, statement of
operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7.64
ASC 840, LEASES . . . . . . . . .6.15, 6.17, 14.07
ASC 850, RELATED PARTY DISCLOSURES
. Financial statement presentation . . . . . . . 12.66
. Generally . . . . . . . . . . . . . . . . . . . . . . . . . 12.83–.84
. Not-for-profit health care entities . . . . . . . 12.12,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12.14–.15
ASC 855, SUBSEQUENT EVENTS
. Contingencies and other liabilities, risks and
uncertainties . . . . . . . . . . . . . . . . . . . . 8.91, 8.94
. Medical malpractice . . . . . . . . . . . . . . . . . . . . 8.50
. Municipal bond financing, disclosures . . . . 7.71
. Not-for-profit health care entities . . . . 3.38–.39
ASC 860, TRANSFERS AND SERVICING
. Debt restructuring . . . . . . . . . . . . . . . . . . . . . . 7.84
. Defeasance . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7.25
. Disclosures . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.71
. Financial statement presentation . . . . . . . . .4.71
. Government health care entities . . . . . . . 15.50,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.111
. Investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.71
. Securities lending activities . . . . . . . . . . . . . .4.60
. Third-party revenues and related receivables,
patient receivables . . . . . . . . . . . . . . . . . . . 10.42
ASC 944, FINANCIAL SERVICES—
INSURANCE . . . . . . . . . . . . . . 8.12–.13, 8.23
ASC 946, FINANCIAL SERVICES—
INVESTMENT COMPANIES . . . . . . . . . . 4.37
ASC 954, HEALTH CARE ENTITIES
. Accounting and financial reporting . . . . . 10.30,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10.32–.33
. Accounting for related entity
transfers . . . . . . 12.70, 12.76, 12.80, 12.82
. Acquisition costs . . . . . . . . . . . . . . . . . .13.21–.22
. Balance sheet presentation . . . . . . . . . . . . 13.23
. Cash and cash equivalents . . . . . . . . . . 4.07–.08
. Charity care . . . . . . . . . . . . . . . . . . . 10.26, 10.28
. Compensation and related benefits . . . . . . 8.74
. Complete set of financial statements . . . . .3.04
. Contingencies and other liabilities . . . . . . . .8.05
. Continuing care retirement
communities . . . . . . . . . . . . 14.01, 14.13–.15,
. . . . . . . . . . . . . . . . . . . . .14.16–.23, 14.30–.32,
. . . . . . . . . . . . . . . . . . 14.35–.37, 14.39, 14.41
. Contributions received and made . . . . . . . 11.47
. Estimated final settlements . . . . . 10.44, 10.46
. Expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.28

AAG-HCO ASC

440

Health Care Entities

ASC 954, HEALTH CARE
ENTITIES—continued
. Fees and payment methods . . . . . . . 14.13–.15
. Financial statement presentation . . . . . . . . 5.44,
. . . . . . . . . . . 12.63, 14.36–.37, 14.39, 14.41
. Future services and use of facilities
accounting . . . . . . . . . . . . . . . . . . . . . . 14.30–.32
. Health care cost accounting . . . . . . . 13.08–.10
. Initial contract acquisition cost
accounting . . . . . . . . . . . . . . . . . . . . . . . . . . 14.35
. Insurance recovery recognition . . . . . . . . . . 8.07
. Intermediate subtotals . . . . . . . . . . . . . . . . . . 3.18
. Investments . . . . . . . . . . . . . . . . . . . . . . 4.15, 4.21
. Investor-owned health care entities . . . . . . 1.08,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12.55
. Long-lived assets . . . . . . . . . . . . . . . . . . . . . . 11.07
. Loss contract accounting . . . . . . . . . 13.14–.15
. Managed care services . . . . . . . . . . . 13.08–.10,
. . . . . . . . . . . . . . . . . . . . . 13.14–.15, 13.21–.23
. Medical malpractice . . . 8.12–.17, 8.19, 8.25,
. . . . . . . . . . . . 8.29, 8.36–.40, 8.42–.44, 8.46
. Mergers and acquisitions . . . . . . . 12.102–.104
. Municipal bond financing . . . . . . . . . . 7.42, 7.45
. Nonrefundable advance fee
accounting . . . . . . . . . . . . . . . . . . . . . . . . . . 14.23
. Not recorded under fair value option,
investments . . . . . . . . . . 4.28, 4.30, 4.34–.35
. Not-for-profit health care
entities . . . . . . . . . . . . . . . . . . .1.08, 3.01, 3.04,
. . . . . . . . . . . . . . . . 3.10, 3.12–.16, 3.18, 3.28,
. . . . . . . . . . . . . . . . 5.44, 12.04, 12.06, 12.10,
. . . . . . . . . . . 12.20, 12.35, 12.40–.41, 12.46
. Patient receivables . . . . . . . . . . . . . . . . . . . . 10.39
. Performance indicators . . . . . . . . . . . . . 3.12–.16
. Premium and capitation
revenues . . . . . . . . . . . . . . . . 10.34–.35, 10.37
. Property, plant and equipment . . . . 6.05, 6.30,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6.41–.42
. Rate-setting . . . . . . . . . . . . . . . . . . . . 10.06, 10.10
. Reclassifications of net assets . . . . . . . . . . .9.24
. Refundable advance fee
accounting . . . . . . . . . . . . . . . . . . . . . . 14.16–.20
. Relationships . . . . . . . . . . . . . . . . . . . . . . . . . .12.06
. Reoccupancy proceeds fee
accounting . . . . . . . . . . . . . . . . . . . . . . 14.21–.22
. Reporting entity and related entities . . . .12.04,
. . . . . . . . . . .12.10, 12.20, 12.35, 12.40–.41,
. . . . . . . . 12.46, 12.55, 12.63, 12.70, 12.76,
. . . . . . . . . . . . . . . . 12.80, 12.82, 12.102–.104
. Statement of operations . . . . . . . . . . . . . . . . 3.10
. Stop-loss insurance accounting . . . . . . . . 13.19
. Tax considerations . . . . . . . . . . . . . . . . . . . . . 8.81
. Third-party revenues and related
receivables . . . . . . . . . . . 10.26, 10.28, 10.30,
. . . . . . . . . . . . . . . . . 10.32–.35, 10.37, 10.39,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10.44, 10.46
. TIS 6400 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11.55
ASC 958, NOT-FOR-PROFIT ENTITIES
. Accounting for related entity
transfers . . . . . . . . . . . . . . . . . . . . . . . .12.74–.77
. Auditing considerations . . . . . . . . . . . . . . . . 11.53

AAG-HCO ASC

ASC 958, NOT-FOR-PROFIT
ENTITIES—continued
. Balance sheet presentation . . . . . . . . . 3.06–.08
. Cash and cash equivalents . . . . . . . . . . . . . . 4.10
. Classes of net assets . . . . . . . . . . . . . 9.05, 9.08
. Complete set of financial statements . . . . 3.02,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.05
. Consolidation precluded where control or
economic interest exist . . . . . . . . . . . . . . 12.14
. Consolidation required where controlling
financial interest exists . . . . . . . . . . . . . . . 12.09
. Contributions received and made . . . . . . 11.02,
. . . . . . . . . . . . . . . . . . . . . 11.39–.41, 11.43–.46
. Control through other means coupled with
economic interest . . . . . . . . . . . . 12.12, 12.14
. Disclosures . . . . . . . . . . . . 4.68, 4.73, 9.35–.36
. Discontinued operations . . . . . . . . . . . . . . . . 3.21
. Donor-restricted endowment
funds . . . . . . . . . . . . . . . . . . . . . . 9.25–.27, 9.29
. Embedded derivatives in split-interest
agreements . . . . . . . . . . . . . . . . . . . . . . . . . . 5.37
. Exchange transactions
distinguished . . . . . . . . . . . . 11.14–.15, 11.17
. Expenses . . . . . . . . . . . . . . . . . . . . . . . . . . 3.26–.28
. Expiration of donor-imposed
restrictions . . . . . . . . . . . . . . . . . . . . . 11.11–.12
. Extraordinary items . . . . . . . . . . . . . . . . . . . . . 3.21
. Financial statement presentation . . . . . . . . 4.65,
. . . . . . . . . . . . . . . . . . . 4.68, 4.73, 5.45, 12.58,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12.62–.64
. Fund-raising and special event cost
reporting . . . . . . . . . . . 11.19–.20, 11.22–.23,
. . . . . . . . . . . . . . 11.25–.28, 11.31, 11.33–.37
. Fund-raising organizations . . . . . . . . 12.16–.19,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12.22–.23
. Generally . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .3.01
. Government health care entities . . . . . . 15.121,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.140
. Impairment of investments . . . . . . . . . . . . . . 4.49
. Intermediate subtotals . . . . . . . . . . . . . . 3.18–.20
. Investment pools . . . . . . . . . . . 4.39, 4.41, 4.43,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.45–.47
. Investments . . . . . . . . . . . 4.21, 4.28–.35, 4.39,
. . . . . . . . . . . . . . . . . . . . . . 4.41, 4.43, 4.45–.47,
. . . . . . . . . . . . . . . . 4.49, 4.62–.63, 4.65, 4.68,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.73
. Long-lived assets . . . . . . . . . . . . . . . . . 11.05–.07
. Majority voting interest coupled with economic
interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12.11
. Management representations . . . . . . . . . . . .2.58
. Mergers and acquisitions . . . . . . 12.86, 12.88,
. . . . . . . . . . . . . . . . . . . 12.90–.95, 12.97–.103,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12.107–.108
. Net assets . . . . . . . . . . . 3.30, 3.32, 9.05, 9.08,
. . . . . . . . . . . 9.11, 9.16, 9.18–.19, 9.21–.22,
. . . . . . . . . . . . . . . . . . . . . . . . 9.25–.27, 9.35–.36
. Not recorded under fair value option,
investments . . . . . . . . . . . . . . . . . . . . . . 4.28–.35
. Other special-purpose entities . . . . . . . . . . 12.54
. Performance indicators . . . . . . . . . . . . . . . . . 3.16
. Permanently restricted net assets . . . . . . . 9.11

Index
ASC 958, NOT-FOR-PROFIT
ENTITIES—continued
. Property, plant and equipment . . . . 6.17, 6.41,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6.43
. Reclassifications of net assets . . . . . . . . . . 9.19,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9.21–.22
. Relationships . . . . . . . . Exhibit 12-1, 12.05–.06,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12.08
. Services . . . . . . . . . . . . . . . . . . . . . . . . . 11.09–.10
. Special-purpose leasing entities . . . . 12.46–.49
. Statement of cash flows . . . . . . . . . . . . 3.33–.36
. Statement of changes . . . . . . . . . . . . 3.30, 3.32
. Statement of operations . . . . . . . . . . 3.09, 3.11
. TIS 6400 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11.55
. Transfers of assets to not-for-profit entities or
charitable trusts . . . . . . . . . . . . . . . . . . 4.62–.63
. Unrestricted net assets . . . . . . . . . . . 9.16, 9.18
. Voluntary health and welfare entities . . . . . 1.08
ASC 970, REAL ESTATE
. CCRC, initial contract acquisition cost
accounting . . . . . . . . . . . . . . . . . . . . . . . . . . 14.35
. Investor-owned health care entities . . . . . 12.56
. Not-for-profit health care entities,
relationships . . . . . . . . . . . . . . . . . . . Exhibit 12-1
. Reporting entity and related entities, not-forprofit health care entities . . . . . . . . 12.35–.36,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12.39–.43
ASSERTIONS, AUDITING
CONSIDERATIONS . . . . . . . . . . . . . 2.20–.21
ASSET RETIREMENT AND ENVIRONMENTAL
REMEDIATION OBLIGATIONS
. Conditional asset retirement obligations,
defined . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8.59
. Contingencies and other
liabilities . . . . . . . . . . . . . . . . . . . . . . . . . 8.59–.61
. Government health care
entities . . . . . . . . . . . . . . . . . . . . . . . . . 15.67–.68
. Property, plant and equipment . . . . . . 6.18–.20
ASSETS. See specific types of assets
AT SECTION 201, AGREED-UPON
PROCEDURES ENGAGEMENTS . . . 7.100,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7.103
ATTESTATION STANDARDS, PCAOB. See AT
section
ATTORNEYS GENERAL . . . . . . . . . . . . . . . . . . 1.10
AU SECTION 150, GENERALLY ACCEPTED
AUDITING STANDARDS . . . . . . . . . . . . .2.01,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.73, 4.75

441

AU SECTION 314, UNDERSTANDING THE
ENTITY AND ITS ENVIRONMENT AND
ASSESSING THE RISKS OF MATERIAL
MISSTATEMENT
. Analytical procedures . . . . . . . . . . . . . . . . . . . 2.27
. Contributions received and made . . . . . . . 11.49
. Discussion among audit team . . . . . . . . . . . 2.30
. Generally . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2.22
. Risk assessment procedures . . . . . . . . . . . . 2.26
. Service organizations . . . . . . . . . . . . . . . . . . . 2.49
. Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.31
AU SECTION 317, ILLEGAL ACTS BY
CLIENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.52
AU SECTION 324, SERVICE
ORGANIZATIONS . . . . . . . . . . . . . 2.50, 4.76
AU SECTION 325, COMMUNICATIONS ABOUT
CONTROL DEFICIENCIES IN AN AUDIT OF
FINANCIAL STATEMENTS . . . . . . . . . . 2.65,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.72
AU SECTION 326, AUDIT EVIDENCE
. Assertions, use of . . . . . . . . . . . . . . . . . . . . . . 2.20
. Contingencies and other
liabilities . . . . . . . . . . . . . . . . . Exhibit 8-1, 8.116
. Contributions received and
made . . . . . . . . . . . . . . . . . . . . . . . . . . Exhibit 11-1
. Investments . . . . . . . . . . . . . . . . . . . . . . .Exhibit 4-1
. Municipal bond financing . . . . . . . . . . . Exhibit 7-1
. Net assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9.37
. Property, plant and equipment . . . . . . . . . . . 6.49
. Reporting entity and related
entities . . . . . . . . . . . . . . . . . . . . . . . . Exhibit 12-2
. Third-party revenues and related
receivables . . . . . . . . . . . . . . . . . . . . Exhibit 10-1
. Understanding entity, environment and internal
control . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.25
AU SECTION 328, AUDITING FAIR VALUE
MEASUREMENTS AND
DISCLOSURES . . . . . . . . . . . . . . . . . . . . . 11.51
AU SECTION 329, ANALYTICAL
PROCEDURES . . . . . . . . . . . . . . . . . . . . . . .2.27
AU SECTION 330, THE CONFIRMATION
PROCESS . . . . . . . . . . . . . 10.56, 11.52–.53
AU SECTION 332, AUDITING DERIVATIVE
INSTRUMENTS, HEDGING ACTIVITIES,
AND INVESTMENTS IN
SECURITIES . . . . . . . . . . . . . . 4.74–.75, 5.46
AU SECTION 333, MANAGEMENT
REPRESENTATIONS . . . . . . . . . 2.56, 8.104

AU SECTION 310, APPOINTMENT OF THE
INDEPENDENT AUDITOR . . . . . . . . . . . . 2.06

AU SECTION 334, RELATED
PARTIES . . . . . . . . . . . . . . . . . . . . . . . . . . . 12.83

AU SECTION 311, PLANNING AND
SUPERVISION . . . . . . . . . . . . . . . . .2.03, 2.06

AU SECTION 336, USING THE WORK OF A
SPECIALIST
. Contingencies and other
liabilities . . . . . . . . . . . . . . . . . . . . . . . 8.108–.109
. Investments . . . . . . . . . . . . . . . . . . . . . . .Exhibit 4-1
. Municipal bond financing . . . . . . . . . . . . . . . . 7.83

AU SECTION 312, AUDIT RISK AND
MATERIALITY IN CONDUCTING AN AUDIT
. Audit risk . . . . . . . . . . . . . . . . . . . . . . . . . . 2.11–.12
. Government health care entities . . . . . . .15.144
. Materiality . . . . . . . . . . . . . . . . . . . . . . . . 2.17, 2.19

AAG-HCO AUS

442

Health Care Entities

AU SECTION 337, INQUIRY OF A CLIENT’S
LAWYER CONCERNING LITIGATION,
CLAIMS, AND ASSESSMENTS
. Contingencies and other liabilities . . . . . .8.105,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8.112–.113
. Generally . . . . . . . . . . . . . . . . . . . . . . . . . Exhibit 8-1
AU SECTION 342, AUDITING ACCOUNTING
ESTIMATES . . . . . . . . . . . . . . . . . .2.44, 8.102
AU SECTION 380, THE AUDITOR’S
COMMUNICATION WITH THOSE
CHARGED WITH GOVERNANCE . . . . . 7.90
AU SECTION 508, REPORTS ON AUDITED
FINANCIAL STATEMENTS . . . . . . . . . 8.114
AU SECTION 532, RESTRICTING THE USE OF
AN AUDITOR’S REPORT . . . . . . . . . . . . . 7.96
AU SECTION 550A, OTHER INFORMATION IN
DOCUMENTS CONTAINING AUDITED
FINANCIAL STATEMENTS . . . . 7.86, 7.91,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.153
AU SECTION 551A, REPORTING ON
INFORMATION ACCOMPANYING THE
BASIC FINANCIAL STATEMENTS IN
AUDITOR-SUBMITTED
DOCUMENTS . . . . . 15.149, 15.151–.152,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.154
AU SECTION 558A, REQUIRED
SUPPLEMENTARY
INFORMATION . . . . 15.145, 15.149–.150
AU SECTION 600, OTHER TYPES OF
REPORTS . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.08
AU SECTION 623, SPECIAL
REPORTS . . . . . . . . . . . . . 2.68, 7.73, 12.68
AU SECTION 634, LETTERS FOR
UNDERWRITERS AND CERTAIN OTHER
REQUESTING
PARTIES . . . . . . . . . . . . . . . . 7.86, 7.98–.102
AU SECTION 711, FILINGS UNDER FEDERAL
SECURITIES STATUTES . . . . . . . . 7.92–.94
AU SECTION 801, COMPLIANCE
AUDITS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2.63
AUDIT PLANNING
. Business associates agreements . . . . . . . . 2.10
. GAAP and . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.02
. Generally . . . . . . . . . . . . . . . . . . . . . . . . . . 2.02–.05
. Other comprehensive basis of accounting
(OCBOA) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.02
. Scope of engagement . . . . . . . . . . . . . . 2.06–.09
AUDIT RISK . . . . . . . . . . . . . . . . . . . . . . . . . 2.11–.14
AUDITING CONSIDERATIONS . . . . . . . 2.01–.73
. Accounting estimates . . . . . . . . . . . . . . 2.44–.46
. Assertions, use of . . . . . . . . . . . . . . . . . . 2.20–.21
. Audit planning. See audit planning
. Audit risk . . . . . . . . . . . . . . . . . . . . . . . . . . 2.11–.14
. Communications . . . . . . . . . . . . . . . . . . . 2.72–.73
. Contingencies and other liabilities. See
contingencies and other liabilities

AAG-HCO AUS

AUDITING CONSIDERATIONS—continued
. Continuing care retirement
communities . . . . . . . . . . . . . . . . . . Exhibit 14-3,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14.43–.48
. Contributions received and made . . 11.48–.54
. Derivatives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5.46
. Generally . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2.01
. Government health care
entities . . . . . . . . . . . . . . . . . . . . . . . 15.141–.146
. Illegal acts . . . . . . . . . . . . . . . . . . . . . . . . . 2.51–.55
. Independent auditor reports . . . . .15.147–.148
. Independent auditor reports . . . . Example 15-1,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example 15-2
. Investments . . . . . . . . . . . . Exhibit 4-1, 4.74–.76
. Management representations . . . . . . . 2.56–.58
. Medical malpractice . . . . . . . . . . . . . . . 8.98–.101
. Municipal bond financing. See municipal bond
financing
. Net assets . . . . . . . . . . . . . . . . . . . . . . . . Exhibit 9-1
. Planning materiality . . . . . . . . . . . . . . . . .2.15–.17
. Property, plant and equipment . . . . .Exhibit 6-1,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6.44–.49
. Qualitative aspects of materiality . . . . 2.18–.19
. RBC formula . . . . . . . . . . . . . . . . . . . . . . . 2.70–.71
. Reporting entity and related
entities . . . . . . . . . . . . . . . . . . . . . . . . Exhibit 12-2
. Required supplementary information
(RSI) . . . . . . . . . . . . . . . . . . . . . . . . . 15.149–.151
. Service organizations . . . . . . . . . . . . . . 2.47–.50
. Single Audit Act . . . . . . . . . . . . . . . . . . . . 2.59–.65
. Statutory reporting considerations . . 2.66–.69
. Supplementary information (SI) . . 15.152–.154
. Third-party revenues and related
receivables . . . . . . . . . . . . . . . . . . . . Exhibit 10-1,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10.52–.56
. Understanding entity, environment and internal
control. See understanding entity,
environment and internal control
AUDITING STANDARDS
. GASB. See Government Accounting Standards
Board
. Generally accepted accounting principles. See
GAAP
. PCAOB. See Public Company Accounting
Oversight Board

B
BALANCE SHEET PRESENTATION. See also
ASC 210
. Government health care entities . . . 15.13–.16
. Managed care services . . . . . . . . . . . 13.23–.24
. Municipal bond financing . . . . . . . . . . . . 7.45–.47
. Not-for-profit health care entities . . . . 3.06–.08
BOND INSURANCE, MUNICIPAL BOND
FINANCING . . . . . . . . . . . . . . . . . . . . . . . . . 7.10
BUSINESS COMBINATIONS. See also ASC
805
. Defined . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .12.105
. Government health care entities, reporting
entity and related entities . . . . . 15.139–.140

Index

C
CALLS AND MODE CONVERSIONS,
MUNICIPAL BOND
FINANCING . . . . . . . . . . . . . . . . . . . . . 7.18–.19
CAPITAL ASSETS, GOVERNMENT HEALTH
CARE ENTITIES . . . . . . . 15.58–.61, 15.69
CAPITALIZED INTEREST, PROPERTY, PLANT
AND EQUIPMENT . . . . . . . . . . . . . . .6.06–.11
CAPITATION ARRANGEMENTS, MANAGED
CARE SERVICES . . . . . . . . . . . . . . . . . . . 13.07
CAPITATION PAYMENTS, THIRD-PARTY
REVENUES AND RELATED
RECEIVABLES . . . . . . . . . . . . . . . . . . . . . 10.17
CAPTIVE INSURANCE COMPANIES, MEDICAL
MALPRACTICE . . . . . . 8.27–.30, 8.38–.40
CASH AND CASH EQUIVALENTS . . . .4.01–.11
. Centralized cash management
arrangements . . . . . . . . . . . . . . . . . . . . 4.03–.06
. Defined . . . . . . . . . . . . . . . . . . . . . 4.01–.02, 4.05,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.33
. Generally . . . . . . . . . . . . . . . . . . . . . . . . . . 4.01–.02
. Government health care entities . . . 15.33–.36
. Restricted donations . . . . . . . . . . . . . . . . . . . . 4.07
. Restricted or designated cash
amounts . . . . . . . . . . . . . . . . . . . . . . . . . 4.08–.11
CASH FLOW HEDGES . . . . . . . . . . . . . . . 5.11–.13
CASH FLOW STATEMENTS. See statement of
cash flows
CCRC. See continuing care retirement
communities (CCRC)
CHARITY CARE, THIRD-PARTY REVENUES
AND RELATED RECEIVABLES . . . . . 10.15
CIRCULAR. See OMB Circular
CLAIMS-MADE INSURANCE, MEDICAL
MALPRACTICE . . . . . . . . . . . . . . . . . 8.31–.33
CLASSIFICATION OF HEALTH CARE
ENTITIES . . . . . . . . . . . . . . . . . . . . . . . 1.07–.08

CODIFICATION OF STAFF ACCOUNTING
BULLETINS (SEC) . . . . . . . . . . . . . . . . . . . 4.53
COMMUNICATIONS, AUDITING
CONSIDERATIONS . . . . . . . . . . . . . 2.72–.73
COMPENSATION AND RELATED BENEFITS
. Agency funds . . . . . . . . . . . . . . . . . . . . . . 8.74–.75
. Complex pay practices . . . . . . . . . . . . . . . . . .8.64
. Disclosures . . . . . . . . . . . . . . . . . . . . . . .15.97–.98
. Generally . . . . . . . . . . . . . . . . . . . . . . . . . . 8.62–.63
. Government health care
entities . . . . . . . . . . . . . . . . . . . . . . . . . 15.87–.97
. Incentive and deferred compensation
plans . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8.65–.70
. Postretirement and postemployment benefit
plans . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8.72–.73
. Sabbaticals and other compensated
absences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8.71

443

COMPLETE SET OF FINANCIAL
STATEMENTS, NOT-FOR-PROFIT HEALTH
CARE ENTITIES . . . . . . . . . . . . . . . . .3.02–.05
COMPLEX PAY PRACTICES, COMPENSATION
AND RELATED BENEFITS . . . . . . . . . . . 8.64
COMPONENT UNITS, DEFINED . . . . . . . 15.125
CONDUIT BONDS TRADED IN PUBLIC
MARKETS, MUNICIPAL BOND
FINANCING . . . . . . . . . . . . . . . . . . . . . 7.06–.08
CONTINGENCIES AND OTHER
LIABILITIES . . . . . . . . . . . . . . . . . . . 8.01–.116
. Accounting estimates . . . . . . . . . . . . 8.102–.106
. Actuaries and actuarial methods, use
of . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8.107–.110
. Agency funds . . . . . . . . . . . . . . . . . . . . . . 8.74–.75
. Asset retirement and environmental
remediation obligations . . . . . . . . . . . 8.59–.61
. Auditing considerations . . . . . . . . . . . .8.97–.116
. Auditing considerations . . . . . . . . . . . . Exhibit 8-1
. Compensation and related benefits. See
compensation and related benefits
. Complex pay practices . . . . . . . . . . . . . . . . . .8.64
. Disclosures . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.80
. Evaluating lawyers’ responses . . . . 8.111–.114
. Generally . . . . . . . . . . . . . . . . . . . . . . . . . . 8.01–.02
. Government health care entities . . . 15.79–.86
. Incentive and deferred compensation
plans . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8.65–.70
. Income taxes . . . . . . . . . . . . . . . . . . . . . . . . . 8.115
. Insurance recovery recognition . . . . . .8.07–.08
. Managing risk of loss . . . . . . . . . . . . . . . 8.09–.11
. Medicaid voluntary contribution or taxation
programs . . . . . . . . . . . . . . . . . . . . . . . . 8.88–.89
. Medical malpractice . . . . . . . . . . . . . . . 8.98–.101
. Physician guarantees and
agreements . . . . . . . . . . . . . . . . . . . . . . 8.51–.58
. Postretirement and postemployment benefit
plans . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8.72–.73
. Private inurement and intermediate
sanctions . . . . . . . . . . . . . . . . . . . . . . . . 8.82–.83
. Recognition, measurement and
disclosure . . . . . . . . . . . . . . . . . . . . . . . . 8.03–.06
. Risks and uncertainties . . . . . . . . . . . . . 8.90–.96
. Sabbaticals and other compensated
absences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8.71
. State and local taxes . . . . . . . . . . . . . . . . . . . 8.85
. Tax considerations . . . . . . . . . . . . . . . . . 8.76–.89
. Tax positions . . . . . . . . . . . . . . . . . . . . . . 8.86–.87
. Unrelated business income . . . . . . . . . . . . . . 8.84
CONTINUING CARE RETIREMENT
COMMUNITIES (CCRC) . . . . . . . 14.01–.48
. Advance fees . . . . . . . . . . . . . . . . . . . . . . . . . 14.08
. Auditing considerations . . . . . . . . . . Exhibit 14-3,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14.43–.48
. Classification of refundable advance
fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14.25–.29
. Fees and payment methods . . . . . . . 14.13–.15
. Financial statement presentation . . . 14.36–.42

AAG-HCO CON

444

Health Care Entities

CONTINUING CARE RETIREMENT
COMMUNITIES (CCRC)—continued
. Future services and use of facilities
accounting . . . . . . . . . . . . . . . . . . . . Exhibit 14-2,
. . . . . . . . . . . . . . . . . . . . . . . . . .14.30–.34, 14.48
. Generally . . . . . . . . . . . . . . . . . . . . . . . . . 14.01–.05
. Initial contract acquisition cost
accounting . . . . . . . . . . . . . . . . . . . . . . . . . . 14.35
. Nonrefundable advance fee
accounting . . . . . . . . Exhibit 14-1, 14.23–.24,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14.48
. Periodic fees . . . . . . . . . . . . . . . . . . . . . . . . . . 14.09
. Refundable advance fee
accounting . . . . . . . . Exhibit 14-1, 14.16–.20,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14.48
. Reoccupancy proceeds fee
accounting . . . . . . . . . . . . . . . . . . . . . . 14.21–.22
. Types of contracts . . . . . . . . . . . . . . . . 14.06–.10
. Types of living accommodations . . . 14.11–.12
. Use fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14.10
CONTRIBUTIONS RECEIVED AND MADE
11.01–.55
. Auditing considerations . . . . . . . . . . Exhibit 11-1,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11.48–.54
. Contributions made . . . . . . . . . . . . . . . . . . . .11.39
. Contributions received . . . . . . . . . . . . 11.02–.38
. Defined . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6.32
. Exchange transactions
distinguished . . . . . . . . . . . . . . . . . . . . 11.14–.17
. Expiration of donor-imposed
restrictions . . . . . . . . . . . . . . . . . . . . . 11.11–.13
. Generally . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11.01
. Government health care
entities . . . . . . . . . . . . . . . . . . . . . . . 15.113–.123
. Long-lived assets . . . . . . . . . . . . . . . . . 11.05–.07
. Other considerations . . . . . . . . . . . . . . 11.40–.47
. Services . . . . . . . . . . . . . . . . . . . . . . . . . 11.08–.10
. Split-interest agreements . . . . . . . . . . . . . . 11.40
. TIS 6400 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11.55
CONTROL, DEFINED . . . . . . . . . . . . . . . . . . . 12.08
CREDIT ENHANCEMENT, MUNICIPAL BOND
FINANCING . . . . . . . . . . . . . . . . . . . . . 7.09–.11

D
DEBT EXTINGUISHMENT
. Gain or loss on . . . . . . . . . . . . . . . . . . . . . 7.32–.33
. Municipal bond financing . . . . . . . . . . . . . . . . 7.28

DERIVATIVES—continued
. Defined . . . . . . . . . . . . . 5.02, 5.05, 5.30, 15.53
. Elements of . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.52
. Embedded derivatives. See embedded
derivatives
. Fair value hedges . . . . . . . . . . . . . . . . . . 5.09–.10
. Financial statement presentation . . . . . . . . .5.39
. Generally . . . . . . . . . . . . . . . . 5.01–.05, 5.06–.08
. Government health care entities . . . 15.52–.56
. Hedge accounting . . . . . . . . . . . . . . . . . . 5.15–.20
. Hedging derivatives . . . . . . . . . . . . . . . . . . . 15.54
. Investment derivatives . . . . . . . . . . . . . . . . . 15.54
. Leverage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.52
. Net settlement . . . . . . . . . . . . . . . . . . . . . . . . 15.52
. Nonhedging derivatives . . . . . . . . . . . 5.14, 5.43
. Not-for-profit health care entities . . . . 5.44–.45
. Qualifying hedges . . . . . . . . . . . . . . . . . . 5.40–.42
. Settlement factors . . . . . . . . . . . . . . . . . . . . 15.52
. Shortcut method . . . . . . . . . . . . . . . . . . . 5.21–.29
DISCLOSURES
. Capital assets . . . . . . . . . . . . . . . . . . . . . . . . . 15.69
. Compensation and related
benefits . . . . . . . . . . . . . . . . . . . . . . . . . 15.97–.98
. Contingencies and other liabilities . . . . . . 15.80
. Government health care entities . . . . . . . 15.51,
. . . . . . . . . . . . . . . . . . . . . . 15.69, 15.78, 15.80,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.97–.98
. Investments . . . . . . . . . . . . . . . . 4.68–.73, 15.51
. Managed care services . . . . . . . . . . . . . . . . 13.30
. Medical malpractice . . . . . . . . . . . . . . . . 8.45–.50
. Municipal bond financing . . . . .7.66–.72, 15.78
. Net assets . . . . . . . . . . . . . . . . . . . . . . . . . 9.32–.36
. Reporting entity and related
entities . . . . . . . . . . . . . . . . . 12.83–.84, 12.108
DISCONTINUED OPERATIONS,
NOT-FOR-PROFIT HEALTH CARE
ENTITIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.21
DISCOUNTING OF LIABILITIES, MEDICAL
MALPRACTICE . . . . . . . . . . . . . . . . . 8.22–.26
DONOR-RESTRICTED ENDOWMENT
FUNDS . . . . . . . . . . . . . . . . . . . . . . . . . 9.25–.31

E
ECONOMIC INTERESTS, DEFINED . . . . . 12.08
EDGAR (ELECTRONIC DATA GATHERING,
ANALYSIS, AND RETRIEVAL) . . . . . . . .3.42

DEBT ISSUANCE COSTS, MUNICIPAL BOND
FINANCING . . . . . . . . . . . . . . . . . . . . . 7.34–.36

ELECTRONIC MUNICIPAL MARKET ACCESS
(EMMA) . . . . . . . . . 3.42, 7.74, 7.97, 7.104

DEBT SECURITIES, DEFINED . . . . . . . . . . . . 4.74

EMBEDDED DERIVATIVES
. Calls and puts in debt . . . . . . . . . . . . . . 5.34–.35
. Defined . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5.30
. Generally . . . . . . . . . . . . . . . . . . . . . . . . . . 5.30–.33
. Split-interest agreements . . . . . . . . . . . 5.36–.38

DEFEASANCE, MUNICIPAL BOND
FINANCING . . . . . . . . . . . . . . . . . . . . . 7.20–.26
DERECOGNITION, MUNICIPAL BOND
FINANCING . . . . . . . . . . . . . . . . . . . . . . . . . 7.26
DERIVATIVES . . . 5.01–.46. See also ASC 815
. Auditing considerations . . . . . . . . . . . . . . . . . 5.46
. Cash flow hedges . . . . . . . . . . . . . . . . . . 5.11–.13

AAG-HCO CON

EMERGENCY MEDICAL TREATMENT AND
ACTIVE LABOR ACT . . . . . . . . . . . . . . . . . 1.11
EMMA (ELECTRONIC MUNICIPAL MARKET
ACCESS) . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.42

445

Index
EPISODIC PAYMENTS, THIRD-PARTY
REVENUES AND RELATED
RECEIVABLES . . . . . . . . . . . . . . . . . . . . . 10.17
EQUITY SECURITIES, DEFINED . . . . . . . . . 4.74,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.42–.43
EQUITY TRANSFERS . . . . . . . . . . . 12.70, 12.76
ESTIMATED FINAL SETTLEMENTS,
THIRD-PARTY REVENUES AND RELATED
RECEIVABLES . . . . . . . . . . . . . . . . .10.43–.51

ESTIMATED USEFUL LIVES OF DEPRECIABLE
HOSPITAL ASSETS (AMERICAN
HOSPITAL ASSOCIATION) . . . . . . . . . . .6.47
EXCHANGE TRANSACTIONS,
CONTRIBUTIONS
DISTINGUISHED . . . . . . . . . . . . . . . 11.14–.17
EXPENSES
. Managed care services . . . . . . . . . . . . . . . . 13.20
. Not-for-profit health care entities . . . . 3.26–.28
EXTERNAL INVESTMENT POOLS,
DEFINED . . . . . . . . . . . . . . . . . . . . . . 15.42–.43
EXTINGUISHMENT AND MODIFICATION
TRANSACTIONS, MUNICIPAL BOND
FINANCING . . . . . . . . . . . . . . . . . . . . . 7.14–.17
EXTRAORDINARY ITEMS, NOT-FOR-PROFIT
HEALTH CARE ENTITIES . . . . . . . . . . . . 3.21

F
FAIR VALUE, DEFINED . . . . . . . . . . . . . . . . . . .4.48
FAIR VALUE HEDGES . . . . . . . . . . . . . . . 5.09–.10
FAIR VALUE MEASUREMENTS,
INVESTMENTS . . . . . . . . . . . . . . . . . . . . . . 4.48
FAIR VALUE OPTION,
INVESTMENTS . . . 4.17–.22. See also not
recorded under fair value option,
investments
FALSE CLAIMS ACT . . . . . . . . . . . . . . . . . . . . . 1.11
FAS 13, ACCOUNTING FOR LEASES . . . 15.66
FAS 76, EXTINGUISHMENT OF DEBT . . . 7.66
FAS 116, ACCOUNTING FOR
CONTRIBUTIONS RECEIVED AND
CONTRIBUTIONS
MADE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.11
FAS 117, FINANCIAL STATEMENTS OF
NOT-FOR-PROFIT
ORGANIZATIONS . . . . . . . . . . . . . . . . . . 15.11
FAS 124, ACCOUNTING FOR CERTAIN
INVESTMENTS HELD BY
NOT-FOR-PROFIT
ORGANIZATIONS . . . . . . . . . . . . . . . . . . 15.11
FAS 125, ACCOUNTING FOR TRANSFERS
AND SERVICING OF FINANCIAL ASSETS
AND EXTINGUISHMENTS OF
LIABILITIES . . . . . . . . . . . . . . . . . . . . . . . . . .7.66

FAS 136, TRANSFERS OF ASSETS TO A
NOT-FOR-PROFIT ORGANIZATION OR
CHARITABLE TRUST THAT RAISES OR
HOLDS CONTRIBUTIONS FOR
OTHERS . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.11
FAS 142, GOODWILL AND OTHER
INTANGIBLE ASSETS . . . . . . . . . . . . . . 15.65
FAS 164, NOT-FOR-PROFIT ENTITIES:
MERGERS AND
ACQUISITIONS . . . . . . . . . . . . . . . . . . . . . 15.11
FASB CONCEPTS STATEMENT NO. 4,
OBJECTIVES OF FINANCIAL REPORTING
BY NONBUSINESS
ORGANIZATIONS . . . . . . . . . . . . . . . . . . . . 1.07
FASB CONCEPTS STATEMENT NO. 5,
RECOGNITION AND MEASUREMENT IN
FINANCIAL STATEMENTS OF BUSINESS
ENTERPRISES . . . . . . . . . . . . . . . . . . . . . 10.18
FASB CONCEPTS STATEMENT NO. 7, USING
CASH FLOW INFORMATION AND
PRESENT VALUE IN ACCOUNTING
MEASUREMENTS . . . . . . . . . . . 8.22, 8.101,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14.33
FEDERAL EMPLOYEES HEALTH
BENEFITS . . . . . . . . . . . . . . . . . . . . . . . . . .10.11
FEDERAL NATIONAL MORTGAGE
ASSOCIATION (FANNIE MAE) . . . . . . . 5.25
FEE-FOR-SERVICE ARRANGEMENTS,
THIRD-PARTY REVENUES AND RELATED
RECEIVABLES . . . . . . . . . . . . . . . . . . . . . 10.17
FINANCIAL ACCOUNTING STANDARDS (FAS).
See FAS
FINANCIAL ACCOUNTING STANDARDS
BOARD (FASB). See FASB
FINANCIAL ASSETS, DEFINED . . . . . . . . . . .4.17
FINANCIAL INSTRUMENTS, DEFINED . . . 4.68
FINANCIAL REPORTING EXECUTIVE
COMMITTEE (FINREC)
. Anticipated investment income
consideration . . . . . . . . . . . . . . . . . . . . . . . . 13.17
. Capitation arrangements . . . . . . . . . . . . . . . 13.07
. CCRC classification of refundable advance
fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14.29
. On impairment of investments . . . . . . . . . . . 4.59
. Medical malpractice . . . . . . . . .8.22, 8.26, 8.49
FINANCIAL STATEMENT PRESENTATION
. Balance sheet presentation. See balance sheet
presentation
. Classification of investments . . . . . . . . 4.65–.67
. Continuing care retirement
communities . . . . . . . . . . . . . . . . . . . . 14.36–.42
. Derivatives . . . . . . . . . . . . . . . . . . . . . . . . .5.39–.45
. Financial statement defined . . . . . . . . . . . . . 3.40
. Government health care entities . . . 15.12–.32
. Investments . . . . . . . . . . . . . . . . . . . . . . . .4.65–.73
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FINANCIAL STATEMENT
PRESENTATION—continued
. Management’s discussion and analysis
(MD&A) . . . . . . . . . . . . . . . . . . . . . . . . . 15.28–.32
. Municipal bond financing. See municipal bond
financing
. Nonhedging derivatives . . . . . . . . . . . . . . . . . 5.43
. Not-for-profit health care entities . . . . 5.44–.45
. Property, plant and equipment . . . . . . 6.40–.43
. Qualifying hedges . . . . . . . . . . . . . . . . . . 5.40–.42
. Reporting entity and related entities 12.58–.68
. Required supplementary information
(RSI) . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.28–.32
. Segment reporting . . . . . . . . . . . . . . . . 15.26–.27
. Statement of cash flows . . . . . . . . . . . 3.33–.36,
. . . . . . . . . . . . . . . . . . . . . . . . . .13.25–.27, 15.25
. Statement of revenues, expenses and changes
in net assets . . . . . . . . . . . . . . . . . . . . 15.17–.24
FINANCIALLY-INTERRELATED ENTITIES,
DEFINED . . . . . . . . . . . . . . . . . . . 12.18, 12.22
FIXED ASSET CONSTRUCTION, PROPERTY,
PLANT AND EQUIPMENT . . . . . . . 6.14–.17
FORM 8-K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .7.104
FORM 10-K . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7.104
FUND-RAISING AND SPECIAL EVENT COST
REPORTING
. Generally . . . . . . . . . . . . . . . . . . . . . . . . . 11.18–.20
. Investment gain or loss related to
donor-restricted contributions . . . . . . . . 11.30
. Pledges . . . . . . . . . . . . . . . . . . . . . . . . . . 11.21–.29
. Transfer of assets to not-for-profit entity or
charitable trust . . . . . . . . . . . . . . . . . . 11.31–.38
FUTURE SERVICES AND USE OF FACILITIES
ACCOUNTING, CCRC . . . . . . . Exhibit 14-2,
. . . . . . . . . . . . . . . . . . . . . . . . 14.30–.34, 14.48

G
GAAP
. Assertions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.20
. Audit planning . . . . . . . . . . . . . . . . . . . . . . . . . . 2.02
. Hierarchy for government health care
entities . . . . . . . . . . . . . . . . . . . . . . . . . 15.05–.08
GASB. See Government Accounting
Standards Board (GASB)
GASB INTERPRETATION NO. 2, DISCLOSURE
OF CONDUIT DEBT
OBLIGATIONS . . . . . . . . . . . . . . . . . . . . . 15.78
GASB INTERPRETATION NO. 3, FINANCIAL
REPORTING FOR REVERSE REPURCHASE
AGREEMENTS . . . . . . . . . . . . . 15.37, 15.50
GASB STATEMENT NO. 3, DEPOSITS WITH
FINANCIAL INSTITUTIONS,
INVESTMENTS (INCLUDING
REPURCHASE AGREEMENTS), AND
REVERSE REPURCHASE
AGREEMENTS . . . . . . . . .15.37, 15.50–.51
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REFUNDINGS RESULTING IN
DEFEASANCE OF DEBT . . . . . . 15.73–.74,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.78
GASB STATEMENT NO. 9, REPORTING CASH
FLOWS OF PROPRIETARY AND
NONEXPENDABLE TRUST FUNDS AND
GOVERNMENTAL ENTITIES THAT USE
PROPRIETARY FUND
ACCOUNTING . . . . . . . . . . . . . . 15.25, 15.33
GASB STATEMENT NO. 10, ACCOUNTING
AND FINANCIAL REPORTING FOR RISK
FINANCING AND RELATED INSURANCE
ISSUES
. Compensation and related benefits . . . . . 15.97
. Contingencies and other liabilities . . . . . . . 8.13,
. . . . . . . . . . . . . . . . . . . . . . . . . .15.79–.84, 15.86
. Derivatives . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.53
. Investments . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.37
GASB STATEMENT NO. 13, ACCOUNTING
FOR OPERATING LEASES . . . . . . . . . 15.66
GASB STATEMENT NO. 14, THE FINANCIAL
REPORTING ENTITY . . . . . . . 15.124–.126,
. . . . . . . . . . . . . . 15.128–.129, 15.135–.136
GASB STATEMENT NO. 16, ACCOUNTING
FOR COMPENSATED
ABSENCES . . . . . . . . . . . . . . . . . . . . . . . . 15.93
GASB STATEMENT NO. 20, ACCOUNTING
AND FINANCIAL REPORTING FOR
PROPRIETARY FUNDS AND OTHER
GOVERNMENTAL ENTITIES THAT USE
PROPRIETARY FUND
ACCOUNTING . . . . .15.10, 15.65, 15.156
GASB STATEMENT NO. 23, ACCOUNTING
AND FINANCIAL REPORTING FOR
REFUNDINGS OF DEBT REPORTED BY
PROPRIETARY
ACTIVITIES . . . . . . . . . . . . . . . . . 15.73, 15.75
GASB STATEMENT NO. 27, ACCOUNTING
FOR PENSIONS BY STATE AND LOCAL
GOVERNMENTAL EMPLOYERS
. Compensation and related benefits . . . . . 15.98
. Generally . . . . . . . . . . . . . . . . . . 15.31, 15.88–.89
. Postretirement and postemployment benefit
plans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .15.90
GASB STATEMENT NO. 28, ACCOUNTING
AND FINANCIAL REPORTING FOR
SECURITIES LENDING
TRANSACTIONS . . . . . . . . . . . . . . 15.50–.51
GASB STATEMENT NO. 28, ACCOUNTING
AND FINANCIAL REPORTING FOR
SECURITIES LENDING
TRANSACTIONS . . . . . . . . . . . . . . . . . . . 15.37
GASB STATEMENT NO. 29, THE USE OF
NOT-FOR-PROFIT ACCOUNTING AND
FINANCIAL REPORTING PRINCIPLES BY
GOVERNMENTAL ENTITIES . . . . . . . .15.11
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GASB STATEMENT NO. 31, ACCOUNTING
AND FINANCIAL REPORTING FOR
CERTAIN INVESTMENTS AND FOR
EXTERNAL INVESTMENT POOLS
. Generally . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.11
. Investments . . . . . . . 15.37, 15.39–.43, 15.46,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.51
GASB STATEMENT NO. 33, ACCOUNTING
AND FINANCIAL REPORTING FOR
NONEXCHANGE TRANSACTIONS
. Contributions received and
made . . . . . . . . . . . . . . . . 15.113–.116, 15.118
. Generally . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.11
. Reporting entity and related
entities . . . . . . . . . . . . . . . . . . . . . . . 15.136–.137
GASB STATEMENT NO. 34, BASIC FINANCIAL
STATEMENTS—AND MANAGEMENT’S
DISCUSSION AND ANALYSIS—FOR
STATE AND LOCAL GOVERNMENTS
. Applicability . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.09
. Balance sheet presentation . . . . . . . . . . . . 15.14
. Capital assets . . . . . . . . . . 15.58, 15.61, 15.69
. Compensation and related benefits . . . . . 15.98
. Contributions received and
made . . . . . . . . . . . . . . . . . . . . . . . . 15.122–.123
. Generally . . . . . . . . . . . . . . . . . . . . . . . . . 15.11–.12
. Investments . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.48
. Municipal bond financing . . . . . . . . . . . . . . . 15.78
. Net assets . . . . . . . . . . . . . 15.99, 15.101–.102,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.108
. Reporting entity and related entities . . . 15.131
. Required supplementary information
(RSI) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.29
. Segment reporting . . . . . . . . . . . . . . . . 15.26–.27
. Statement of cash flows . . . . . . . . . . . . . . . 15.24
. Statement of net assets . . . . . . . . . . . . . . . 15.14
. Statement of revenues, expenses and changes
in net assets . . . . . . . . . . 15.17, 15.20, 15.23
. Third-party revenues and related
receivables . . . . . . . . . . . . . . . . 15.110, 15.112
GASB STATEMENT NO. 38, CERTAIN
FINANCIAL STATEMENT NOTE
DISCLOSURES
. Compensation and related benefits . . . . . 15.98
. Generally . . . . . . . . . . . . . . . . . . . . . . 15.16, 15.21
. Investments . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.51
. Municipal bond financing . . . . . . . . . . . . . . . 15.78
. Third-party revenues and related
receivables . . . . . . . . . . . . . . . . . . . . . . . . 15.112
GASB STATEMENT NO. 39, DETERMINING
WHETHER CERTAIN ORGANIZATIONS
ARE COMPONENT UNITS
. Generally . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.11
. Reporting entity and related
entities . . . . . . . . . . . . . .15.125, 15.128–.129,
. . . . . . . . . . . . . . . . . . . . . . 15.134, 15.136–.137
GASB STATEMENT NO. 40, DEPOSIT AND
INVESTMENT RISK
DISCLOSURES . . . . . 15.35, 15.37, 15.51
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GASB STATEMENT NO. 42, ACCOUNTING
AND FINANCIAL REPORTING FOR
IMPAIRMENT OF CAPITAL ASSETS AND
FOR INSURANCE
RECOVERIES . . . . . . . . . . 15.59–.60, 15.69
GASB STATEMENT NO. 45, ACCOUNTING
AND FINANCIAL REPORTING BY
EMPLOYERS FOR POSTEMPLOYMENT
BENEFITS OTHER THAN
PENSIONS . . . . .15.31, 15.90–.91, 15.98
GASB STATEMENT NO. 47, ACCOUNTING
FOR TERMINATION BENEFITS . . . . 15.94,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.98
GASB STATEMENT NO. 48, SALES AND
PLEDGES OF RECEIVABLES AND FUTURE
REVENUES AND INTRA-ENTITY
TRANSFERS OF ASSETS AND FUTURE
REVENUES . . . . . . . . 15.111–.112, 15.131
GASB STATEMENT NO. 49, ACCOUNTING
AND FINANCIAL REPORTING FOR
POLLUTION REMEDIATION
OBLIGATIONS . . . . . . . . . . . . . . . . . 15.67–.68
GASB STATEMENT NO. 50, PENSION
DISCLOSURES . . . . . . . . . . . . . 15.88, 15.98
GASB STATEMENT NO. 51, ACCOUNTING
AND FINANCIAL REPORTING FOR
INTANGIBLE ASSETS . . . . . . . . . 15.62–.65
GASB STATEMENT NO. 52, LAND AND
OTHER REAL ESTATE HELD AS
INVESTMENTS BY
ENDOWMENTS . . . . . . . . . . . . 15.37, 15.44
GASB STATEMENT NO. 53, ACCOUNTING
AND FINANCIAL REPORTING FOR
DERIVATIVE INSTRUMENTS . . . . . . .15.37,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.53–.56
GASB STATEMENT NO. 55, THE HIERARCHY
OF GENERALLY ACCEPTED
ACCOUNTING PRINCIPLES FOR STATE
AND LOCAL GOVERNMENTS . . . . . . 15.05
GASB STATEMENT NO. 59, FINANCIAL
INSTRUMENTS OMNIBUS . . . . . . . . . .15.37
GASB STATEMENT NO. 62, CODIFICATION
OF ACCOUNTING AND FINANCIAL
REPORTING GUIDANCE CONTAINED IN
PRE-NOVEMBER 30, 1989 FASB AND
AICPA PRONOUNCEMENTS . . 15.09–.11,
. . . . . . . 15.14, 15.20, 15.22–.23, 15.155
. Capital assets . . . . . . . . . . . . . . . . . 15.61, 15.69
. Contingencies and other
liabilities . . . . . . . . . . . . . . . . . . . . . . . . 15.85–.86
. Disclosures . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.69
. Goodwill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.65
. Investments . . . . . . . . . . . . . . . 15.38–.39, 15.51
. Leases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.66
. Municipal bond financing . . . . . . . . . . 15.76–.77
. Reporting entity and related entities . . . 15.139
. Third-party revenues and related
receivables . . . . . . . . . . . . . . . . . . . . . . . . 15.112
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GASB TB NO. 2006-1, ACCOUNTING AND
FINANCIAL REPORTING BY EMPLOYERS
FOR PAYMENTS FROM THE FEDERAL
GOVERNMENT PURSUANT TO THE
RETIREE DRUG SUBSIDY PROVISIONS OF
MEDICARE PART D. . . . . . . . . . . . . . . . 15.92
GENERALLY ACCEPTED ACCOUNTING
PRINCIPLES. See GAAP
GOODWILL, GOVERNMENT HEALTH CARE
ENTITIES . . . . . . . . . . . . . . . . . . . . . . . . . . 15.65
GOVERNMENT ACCOUNTABILITY
OFFICE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.65
GOVERNMENT ACCOUNTING STANDARDS
BOARD (GASB)
. Comprehensive Implementation Guide . . 15.08
. Interpretations. See specific GASB
Interpretation
. Statements. See specific GASB Statement

GOVERNMENT AUDITING STANDARDS
(GAS) . . . . . . . . . . . . . . . . . .2.63–.65, 15.141
GOVERNMENT HEALTH CARE
ENTITIES . . . . . . . . . . . . . . . . . . . . . . 15.01–.56
. Applicability . . . . . . . . . . . . . . . . . . . . . . 15.03–.04
. Asset retirement and environmental
remediation obligations . . . . . . . . . . 15.67–.68
. Auditing considerations . . . . . . . . . 15.141–.146
. Balance sheet presentation . . . . . . . . 15.13–.16
. Business combinations . . . . . . . . . 15.139–.140
. Capital assets . . . . . . . . . . . . . 15.58–.61, 15.69
. Capitalization of interest . . . . . . . . . . . . . . . 15.77
. Cash and cash equivalents . . . . . . . . 15.33–.36
. Claims-made policies . . . . . . . . . . . . . . . . . . 15.81
. Classification of . . . . . . . . . . . . . . . . . . . . . . . . 1.08
. Compensation and related benefits .15.87–.97
. Contingencies and other liabilities . . 15.79–.86
. Contributions received and made 15.113–.123
. Debt defeasance and
extinguishment . . . . . . . . . . . . . . . . . . 15.73–.76
. Defined . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.03
. Derivatives . . . . . . . . . . . . . . . . . . . . . . . 15.52–.56
. Disclosures . . . . . 15.51, 15.69, 15.78, 15.80,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.97–.98
. Financial reporting requirements . . . . . . . 15.51,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.107–.108
. Financial statement presentation . . . 15.12–.32
. GAAP hierarchy . . . . . . . . . . . . . . . . . . . 15.05–.08
. Goodwill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.65
. Impairment of investments . . . . . . . . 15.46–.47
. Independent auditor reports . . . . Example 15-1,
. . . . . . . . Example 15-2, 15.147–148, 15.154
. Institutionally-related foundations 15.133–.138
. Insurance-related contingencies . . . . . . . . 15.79
. Intangible assets . . . . . . . . . . . . . . . . . . 15.62–.64
. Investments . . . . . . . . . . . . . . . . . . . . . . 15.37–.51
. Irrevocable self-insurance trusts . . . . . . . . 15.84
. Leases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.66
. Management’s discussion and analysis
(MD&A) . . . . . . . . . . . . . . . . . . . . . . . . . 15.28–.32
. Municipal bond financing . . . . . . . . . . 15.70–.78
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ENTITIES—continued
. Net assets . . . . . . . . . . . . . . . . . . . . . . 15.99–.108
. Other contingencies . . . . . . . . . . . . . . . . . . . 15.86
. Pensions . . . . . . . . . . . . . . . . . . . . . . . . . 15.88–.89
. Physician guarantees and agreements . . 15.85
. Postretirement and postemployment benefit
plans . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.90–.92
. Property, plant and equipment . . . . . . . . . 15.57
. Public-entity risk pools . . . . . . . . . . . . . . . . . 15.83
. Recognition, measurement and
disclosure . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.80
. Reporting entity and related
entities . . . . . . . . . . . . . . . . . . . . . . . 15.124–.140
. Required supplementary information
(RSI) . . . . . . . . . . . . . .15.28–.32, 15.149–.151
. Retrospectively-rated policies and
contracts . . . . . . . . . . . . . . . . . . . . . . . . . . . .15.82
. Return on investments . . . . . . . . . . . . 15.48–.49
. Reverse repurchase agreements . . . . . . . 15.50
. Sabbaticals and other compensated
absences . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.93
. Securities lending activities . . . . . . . . . . . . 15.50
. Segment reporting . . . . . . . . . . . . . . . . 15.26–.27
. Statement of cash flows . . . . . . . . . . . . . . . 15.25
. Statement of revenues, expenses and changes
in net assets . . . . . . . . . . . . . . . . . . . . 15.17–.24
. Supplementary information (SI) . . 15.152–.154
. Tax considerations . . . . . . . . . . . . . . . . 15.95–.96
. Termination benefits . . . . . . . . . . . . . . . . . . . 15.94
. Third-party revenues and related
receivables . . . . . . . . . . . . . . . . . . . 15.109–.112
GROSS REVENUE REPORTING INDICATORS,
MANAGED CARE SERVICES . . . . . . . 13.28

H
HEALTH AND HUMAN SERVICES
DEPARTMENT . . . . . . . . . . . . . . . . . . . . . . .1.09
HEALTH CARE AND EDUCATION
RECONCILIATION ACT OF
2010 . . . . . . . . . . . . . . . . . . . . . 1.11–.12, 2.31
HEALTH CARE COST ACCOUNTING,
MANAGED CARE SERVICES . . .13.08–.12
HEALTH CARE ENTITIES . . . . . . . . . . . . 1.01–.15
. Applicability of guide . . . . . . . . . . . . . . . 1.02–.06
. Classification of . . . . . . . . . . . . . . . . . . . . 1.07–.08
. Guide purpose . . . . . . . . . . . . . . . . . . . . . . . . . .1.01
. Reform of health care . . . . . . . . . . . . . . 1.12–.15
. Regulatory environment . . . . . . . . . . . . .1.09–.11
HEALTH INFORMATION TECHNOLOGY FOR
ECONOMIC AND CLINICAL HEALTH
(HITECH) ACT . . . . . . . . . . . . . . . . . . . . . . . 2.10
HEALTH INSURANCE PORTABILITY AND
ACCOUNTABILITY ACT OF 1996 (HIPAA)
. Privacy Rule . . . . . . . . . . . . . . . . . . . . . . 1.11, 2.10
. Security Rule . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.10
HEDGING ACTIVITIES. See derivatives
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IRS FORM 990-T . . . . . . . . . . . . . . . . . . . . . . . . 8.86
IRS NOTICE 2008-31, VOLUNTARY CLOSING
AGREEMENT PROGRAM FOR
TAX-EXEMPT BONDS AND TAX CREDIT
BONDS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7.44
IRS PUBLICATION 4078, TAX-EXEMPT
PRIVATE ACTIVITY BONDS . . . . . . . . . .7.40

J
JUSTICE DEPARTMENT . . . . . . . . . . . . . . . . . 1.10

INITIAL CONTRACT ACQUISITION COST
ACCOUNTING, CCRC . . . . . . . . . . . . . . 14.35

L

INSURANCE RECOVERY RECOGNITION,
CONTINGENCIES AND OTHER
LIABILITIES . . . . . . . . . . . . . . . . . . . . . 8.07–.08

LEASES, GOVERNMENT HEALTH CARE
ENTITIES . . . . . . . . . . . . . . . . . . . . . . . . . . 15.66

INTANGIBLE ASSETS, GOVERNMENT HEALTH
CARE ENTITIES . . . . . . . . . . . . . . . 15.62–.64
INTERMEDIATE SUBTOTALS,
NOT-FOR-PROFIT HEALTH CARE
ENTITIES . . . . . . . . . . . . . . . . . . . . . . . 3.18–.20
INTERNAL REVENUE SERVICE, GUIDANCE RE
TAX-EXEMPT HOSPITALS 1.14. See also
IRS
INVESTMENTS . . . . . . . . . . . . . . . . . . . . . . 4.12–.76
. Auditing considerations . . . . . . . . . . . Exhibit 4-1,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.74–.76
. Classification . . . . . . . . . . . . . . . . . . . . . . 4.65–.67
. Disclosures . . . . . . . . . . . . . . . . . 4.68–.73, 15.51
. Equity transactions . . . . . . . . . . . . . . . . . . . . . 4.62
. Fair value measurement . . . . . . . . . . . . . . . . . 4.48
. Fair value option . . . . . . . . . . . . . . . . . . . 4.17–.22
. Financial reporting requirements . . . . . . . 15.51
. Financial statement presentation . . . . 4.65–.73
. Generally . . . . . . . . . . . . . . . . . . . . . . . . . . 4.12–.16
. Government health care entities . . . 15.37–.51
. Impairment of investments . . . . . . . . . 4.49–.59,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.46–.47
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recorded under fair value option, investments
. Regulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.64
. Return on investments . . . . . . . . . . . . 15.48–.49
. Reverse repurchase agreements . . . . . . . 15.50
. Securities lending activities . . . . . . 4.60, 15.50
. Transfer of assets to not-for-profit entity or
charitable trust . . . . . . . . . . . . . . . . . . . 4.61–.63

LIABILITIES. See contingencies and other
liabilities
LOCAL GOVERNMENT HEALTH CARE
ENTITIES. See government health care
entities
LONDON INTERBANK OFFERED RATE
(LIBOR) . . . . . . . . . . . . . . . . . . . . . . . . . 5.25–.26
LONG-LIVED ASSETS
. Contributions received and made . . 11.05–.07
. Property, plant and equipment . . . . . . 6.34–.39
LOSS CONTRACT ACCOUNTING, MANAGED
CARE SERVICES . . . . . . . . . . . . . . 13.13–.16

M
MANAGED CARE SERVICES . . . . . . . 13.01–.30
. Acquisition costs . . . . . . . . . . . . . . . . . .13.21–.22
. Anticipated investment income
consideration . . . . . . . . . . . . . . . . . . . . . . . . 13.17
. Balance sheet presentation . . . . . . . . 13.23–.24
. Capitation arrangements . . . . . . . . . . . . . . . 13.07
. Disclosures . . . . . . . . . . . . . . . . . . . . . . . . . . . 13.30
. Expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13.20
. Generally . . . . . . . . . . . . . . . . . . . . . . . . . 13.01–.02
. Gross revenue reporting indicators . . . . . 13.28
. Health care cost accounting . . . . . . . 13.08–.12
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. Loss contract accounting . . . . . . . . . 13.13–.16
. Net revenue reporting indicators . . . . . . . 13.29
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revenue . . . . . . . . . . . . . . . . . . . . . . . . .13.03–.06
. Stop-loss insurance accounting . . . . 13.18–.19

AAG-HCO MAN

450

Health Care Entities

MANAGEMENT REPRESENTATIONS,
AUDITING CONSIDERATIONS . . .2.56–.58
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ANALYSIS (MD&A), GOVERNMENT
HEALTH CARE ENTITIES . . . . . . 15.28–.32
MATERIAL WEAKNESSES, DEFINED . . . . .2.65
MATERIALITY
. Defined . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.15
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. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8.38–.40
. Claims-made insurance . . . . . . . . . . . . . 8.31–.33
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. Disclosures . . . . . . . . . . . . . . . . . . . . . . . . 8.45–.50
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1987 . . . . . . . . . . . . . . . . . . . 1.11, 2.51, 2.57
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. Defined . . . . . . . . . . . . . . . . . . . . . . . . 12.90, 12.92
. Disclosures . . . . . . . . . . . . . . . . . . . . . . . . . . 12.108
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entities . . . . . . . . . . . . . . . . . . . . . . . 12.105–.107
. Not-for-profit health care entities . . 12.90–.101
. Performance indicators . . . . . . . . . 12.102–.104
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entities . . . . . . . . . . . . . . . . . . . . . . . . 12.85–.107
MODEL AUDIT RULE . . . . . . . . . . . . . . . . . . . . . 2.73
MSRB. See Municipal Securities Rulemaking
Board (MSRB)
MUNICIPAL BOND FINANCING . . . . 7.01–.104
. Arbitrage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7.41
. Assets limited as to use . . . . . . . . . . . . . . . . . 7.63
. Attestation engagements . . . . . . . . . . . . . . 7.103
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. SSAPs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.69
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. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.71
NCGA STATEMENT NO. 4, ACCOUNTING AND
FINANCIAL REPORTING PRINCIPLES FOR
CLAIMS AND JUDGMENTS AND
COMPENSATED ABSENCES . . . . . . 15.85,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15.97
NCGA STATEMENT NO. 6, NOTES TO THE
FINANCIAL STATEMENTS
DISCLOSURE . . . . . . . . . . . . . . . . . . . . . . 15.69
NET ASSETS (EQUITY) . . . . . . . . . . . . . . 9.01–.37
. Auditing considerations . . . . . . . . . . . . Exhibit 9-1
. Defined . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9.02
. Disclosures . . . . . . . . . . . . . . . . . . . . . . . . 9.32–.36
. Donor-restricted endowment funds . . 9.25–.31
. Government health care
entities . . . . . . . . . . . . . . . . . . . . . . . . 15.99–.108
. Investor-owned health care entities . . . . . . 9.01
. Not-for-profit health care entities . . . . 9.02–.18
. Permanently restricted net assets . . . 9.09–.11
. Reclassifications . . . . . . . . . . . . . . . . . . . 9.19–.24
. Temporarily restricted net assets . . . 9.12–.14
. Unrestricted net assets . . . . . . . . . . . . . 9.15–.18
NET REVENUE REPORTING INDICATORS,
MANAGED CARE SERVICES . . . . . . . 13.29
NONFINANCIAL ASSETS, DEFINED . . . . 11.09
NONRECIPROCAL TRANSFERS, PROPERTY,
PLANT AND EQUIPMENT . . . . . . . 6.31–.33
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Introducing eXacct: Financial Reporting Tools & Techniques.
We appreciate your business and would like to take this opportunity
to tell you about eXacct, an online tool from the AICPA that builds
on our flagship publication Accounting Trends & Techniques. For
more than 60 years, Accounting Trends & Techniques has provided
guidance on satisfying U.S. GAAP presentation and disclosure
requirements, as well as statistical reporting trends and actual
reporting examples from the AICPA’s survey of annual reports
from 500 of the country’s top public companies. eXacct adds
to this content for a fuller picture of current financial reporting
practices and makes it interactive — ready to be searched, filtered,
downloaded and used exactly as you need it.
This tool not only provides all available annual report XBRL data
files submitted to the SEC by our 500 survey companies, it
allows you to search them for specific attributes and disclosures,
providing full tag information and highlighting company
extensions with the click of a button. eXacct allows you to search
and view all 500 annual reports in our survey for many of the
common disclosures you need. It can sort content by industry,
giving you crucial insight into presentation and disclosure
methods across a wide variety of industries. With companies
from virtually every non-regulated sector represented, you’ll get
a rich diversity of financial statement disclosure examples that
will save you hours of financial reporting time.
Please visit CPA2Biz.com/tryeXacct for more information on
eXacct and what it can do for you.
Thank you for your continued support.
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